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Introduction  There is considerable uncertainty about the repro-
ducibility of the various instruments used to measure dyspnea, their
ability to reflect changes in symptoms, whether they accurately
reflect the patient’s experience and if its evolution is similar
between acute heart failure syndrome patients and nonacute heart
failure syndrome patients. URGENT was a prospective multicenter
trial designed to address these issues.
Methods Patients were interviewed within 1 hour of first physician
evaluation, in the emergency department or acute care setting, with
dyspnea assessed by the patient using both a five-point Likert
scale and a 10-point visual analog scale (VAS) in the sitting (60º)
and then supine (20º) position if dyspnea had not been considered
severe or very severe by the sitting versus decubitus dyspnea
measurement.
Results Very good agreements were found between the five-point
Likert and VAS at baseline (0.891, P <0.0001) and between
changes (from baseline to hour 6) in the five-point Likert and in
VAS (0.800, P <0.0001) in acute heart failure (AHF) patients.
Lower agreements were found when changes from baseline to H6
measured by Likert or VAS were compared with the seven-point
comparative Likert (0.512 and 0.500 respectively) in AHF patients.
The worse the dyspnea at admission, the greater the amplitude of
improvement in the first 6 hours; this relationship is stronger when
dyspnea is measured with VAS (Spearman’s rho coefficient =
0.672) than with the five-point Likert (0.272) (both P <0.0001) in
AHF patients. By the five-point Likert, only nine patients (3% (1%
to 5%)) reported an improvement in their dyspnea, 177 (51%
(46% to 57%)) had no change, and 159 (46% (41% to 52%))
reported worse dyspnea supine compared with sitting up in AHF
patients. The PDA test with VAS was markedly different between
AHF and non-AHF patients.
Conclusions Both clinical tools five-point Likert and VAS showed
very good agreement at baseline and between changes from
baseline to tests performed 6 hours later in AHF patients. The PDA
test with VAS was markedly different between AHF and non-AHF
patients. Dyspnea is improved within 6 hours in more than three-
quarters of the patients regardless of the tool used to measure the
change in dyspnea. The greater the dyspnea at admission, the
greater the amplitude of improvement in the first 6 hours.
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Endotracheal intubation in the emergency room: 
a multicenter questionnaire
SB Bélorgey1, L Montésino2
1CHSF Gilles de Corbeil, Corbeil Essonnes, France; 2CHG,
Longjumeau, France
Critical Care 2009, 13(Suppl 1):P2 (doi: 10.1186/cc7166)
Introduction Endotracheal intubation (ETI) engages the patient’s
life and demands a good experience. A preliminary prospective
study has shown in one hospital that emergency physicians (EPs)
rarely performed ETI. Do the EPs in Ile de France (Paris region)
have sufficient experience and regular training to realise this
procedure safely in the emergency room (ER)?
Methods We conducted a descriptive telephone-based question-
naire study to assess EPs’ endotracheal intubation skills through all
ERs in Ile de France public hospitals. A questionnaire was
completed by the investigator during a 10-minute telephone call
with at least one EP in each ER. The structure of hospitals, number
of ETIs performed, devices and personnel available and the
existence of protocols were collected. Their usual practice of
sedation and intubation, training and proposals for changes were
noted.
Results The study was made through all of the 64 public hospitals
of Ile de France. Fifty-six hospitals have an ICU, 37 a mobile ICU.
We questioned 96 EPs; that is, 10% of EPs from our region. All of
the 96 EPs called responded. These physicians were certified
emergency physicians (CAMU) for 90% of them. The median of
ETI declared was 24.5/year per ER. Thirty-eight percent of EPs
performed less than five ETIs during the past 2 years. The success
rate reported was 85%. In 94% of ERs, metallic blades and
Eischmann mandrin were available and about two nurses can help
during the procedure. Predictive criteria for difficult ETI cited the
most were: short neck, obesity, small mouth opening and
otorhinolaryngology disease or previous history of cervical
radiotherapy. Seventy-six percent of EPs followed the
recommendations for preoxygenation and 91% performed rapid
sequence induction. The vast majority (76%) of ERs did not have
standardized procedures for airway management. Theoretical
training was acquired for 46% of EPs by the CAMU, practical
training occurring in the operating room for 71%. Among the EPs
interviewed, 87% believe that they should remain the principal
actor for ETI – although as high as 89% of them consider that they
were insufficiently trained in ETI management and only 41%
pursued continuing medical education on that theme. Seventy-
seven percent proposed to spend time in the operating room to
improve their practice of ETI.
Conclusions ETI is rarely performed in the ER. It should be part of
the EP curricula and written procedures should be made.S2
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Introduction Incorrect positioning of the endotracheal tube (ETT)
within the airway after emergent intubation can result in serious
complications. Accidental mainstem bronchus intubation is
associated with contralateral atelectasis, tension pneumothorax,
hypotension, and decreased survival. Conversely, failure to place
the tube several centimeters beyond the vocal cords may result in
inadvertent extubation, aspiration, pneumonia, or laryngeal spasm
[1]. The aim of this study was to investigate the occurrence of ETT
malpositioning after emergency intubation in the out-of-hospital
setting.
Methods  A retrospective study of a 5-year time period, using
records of 1,081 patients admitted to the trauma emergency room
(ER) at a university hospital. Within 30 minutes after admission, a
chest X-ray or whole-body CT scan was routinely performed in
intubated patients to determine the tube–tip–carina relationship.
Results  Sixteen out of 1,081 patients died immediately after
admission to the trauma ER and were not further radiologically
diagnosed. Of the surviving 1,065 patients, 346 (32.5%) were
female and 719 (67.5%) male. In the group of 488 intubated
patients, 346 (70.9%) were correctly intubated, 89 (18.2%) were
not correctly intubated – herein were 64 patients (14.7%)
intubated with tip–carina distance <2 cm, and 25 patients (5.7%)
were endobronchially intubated. Chest X-ray scans were not
available for 53 patients (10.9%). Detailed data on ETT placement
were available in 435 patients; 346 (79.5%) with correct ETT
placement, 89 (20.5%) with incorrect ETT placement. None of the
patients displayed an esophageal or pharyngeal intubation (0%).
Of 435 patients, 324 had been intubated preclinically on scene –
254 (78.4%) were correctly intubated, 70 (21.6%) were not
correctly intubated.
Conclusions This study clearly shows that ETT misplacement in
emergency patients is still a serious problem with an incidence of
21.6% in our study, of which 5.7% were endobronchially
intubated. We conclude that the skill level of the operator may be
key in determining efficacy of endotracheal intubation. Based on
our findings, all efforts should be made to verify the tube position
with immediate radiographic confirmation after admission to the
ER.
Reference
1. Owen RL, Cheney FW: Endobronchial intubation: a pre-
ventable complication. Anesthesiology 1987, 67:255-257.
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Introduction  A bedside chest ultrasound (bCUS) programme
performed by intensivists after 18 months of training was
introduced on a regular basis in a 10-bed emergency ICU from
April to November 2008, in order to check its effectiveness in the
early diagnosis and treatment of pleural effusion (PE). The results
have been compared with those of a control group, when bCUS
was not part of the ICU procedures.
Methods The procedure was performed within the first 24 hours
after admittance. All of the 92 patients were examined supine, with
the probe perpendicular to the chest wall, using all of the
intercostal spaces as the acoustic window. With this technique,
once we identified the lung’s base, we looked for signs of PE
according to the following criteria: (a) space between the two
pleural layers; (b) variation in the interpleural distance of this space
during breathing. For each patient the following data were
collected: age, sex, weight, height, SAPS II, number of chest
drains, number of ultrasound scans performed, number of
significant PE (at least 2 cm of width between the two pleurae),
amount of ultrasound-guided drainage actually performed within
the first 24 hours, timing of resolution of PE. Data were compared
with those of a group of patients admitted to the ICU from January
to March 2008, when bCUS was not part of the daily procedures
and only chest CT and X-ray scans were used as evidence of PE.
We considered P <0.05 statistically significant.
Results A total of 103 bCUS were performed on the first day in
the control group, against the 12 bCUS performed in the study
group. A total of 59 PEs for which drainage proved to be useful
were found. An amount of 27 pleural drainages were performed
within the first 24 hours. We have no evidence of complications.
All of the positive cases for PE have been successfully treated. All
drainage was performed within the first 24 hours or at least within
the first 48 hours.
Conclusions  Compared with the control group (25.9%), in the
study group 45% of drainage performed was done within the first
24 hours thanks to the skill of intensivists. As far as PE is
concerned, the introduction of bCUS performed by intensivists in
the ICU daily routine determines an increase of early diagnosis and
treatment. However, the increase in the number of the first-day
treatments was not significant since this procedure is now turning
from a purely diagnostic approach into an operative one. This will
necessarily need time.
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Portable chest radiography in mechanically ventilated ICU
patients: does synchronizing with end-inspiration improve
the quality of films?
A Cheng1, K Tang1, H Yip1, W Kwan1, Y Lee2, A Lee2, K Lee2, 
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Introduction  The quality of portable chest radiographs (CXRs)
taken in the ICU is inferior to films taken in the radiology
department. The inability of sedated, ventilated patients to hold
their breath during CXR will also affect the degree of lung inflation
and contribute to lack of correlation between serial CXR changes
and clinical status [1]. We studied the effect on CXR quality by
manually synchronizing the ventilator to end-inspiration in
mechanically ventilated ICU patients.
Methods  A pair of CXRs was taken after recruiting intubated,
ventilated patients within 24 hours of emergency ICU admission.
Intubated post-elective surgical patients were excluded due to the
high likelihood of normal lungs. The control film was taken in theS3
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usual way, at a random phase of the ventilator cycle. For the
synchronized film, the investigator wore a lead apron and
dosimeter, stood 1 to 1.5 meters away from the patient, and
pressed the inspiratory hold button. The sequence of the paired
films was computer-randomized. The ventilator model, settings,
patient position and portable X-ray machine settings were kept
constant between films. Patients served as their own controls.
Films were independently scored (1 = not clear/poorly inflated, 5 =
very clear/well inflated) by two specialist radiologists based on five
criteria: (i) clarity of lines and tubes, (ii) definition of pulmonary
vasculature, (iii) visibility of mediastinum, (iv) definition of the
diaphragm and (v) degree of lung inflation. Linear regression,
taking two radiologists’ scores of each patient into account, was
used to examine whether there were any differences in the criteria
ratings between random and synchronized films. Radiologists and
statistician were blinded.
Results We recruited 110 patients; there were no complications
from the breath-hold maneuver. Dosimeter readings were
negligible. Synchronized films had higher total scores and mean
scores for criteria (ii) to (v), 95% confidence interval. P values were
statistically significant: for total score, P <0.001; and for criteria (ii),
P = 0.001; (iii), P <0.001; (iv), P <0.01; and (v), P <0.001.
Conclusions Synchronizing the CXR to end-inspiration improves
the quality of the film and is safe.
Reference
1. Langevin PB, Hellein V, Harms SM, Tharp WK, Cheung-Seekit
C, Lampotang S: Synchronization of radiograph film expo-
sure with the inspiratory pause. Effect on the appearance
of bedside chest radiographs in mechanically ventilated
patients. Am J Respir Crit Care Med 1999, 160:2067-2071.
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Introduction  The use of continuous positive airway pressure
(CPAP) is beneficial in the hospital and home care environment. It
is used to support ventilation during neurological disease,
ventilatory defects, congestive heart failure and obstructive sleep
apnea. Field emergency medicine has inherent complications for
the delivery and monitoring of patients receiving CPAP. We
completed an internal quality audit to determine whether CPAP
had benefit and whether capnography could be comfortably used
in parallel with a CPAP device to monitor ventilation.
Methods  The data collection was completed on patients with
respiratory distress. Data were collected pre-CPAP and post-
CPAP. Patients were monitored with capnography and pulse
oximetry. Emergency Medical Services and Emergency Depart-
ment staff evaluated acceptance and ease of use of the equipment.
A one-tailed paired test and descriptive statistics were completed.
Results  Eighteen respiratory distress patients received CPAP:
eight female, nine male and one patient had missing data (sex entry
was blank). Mean age was 79 years. Statistical significance was
determined at P <0.05. There was no significant difference in heart
rate: mean pre-CPAP = 116, mean post-CPAP = 114, P = 0.19.
There was a significant improvement in arterial oxygen saturation per-
centage: pre-CPAP = 81.5, mean post-CPAP = 90.2, P = 0.0003.
There was a significant improvement in end-tidal carbon dioxide
(etCO2) (ventilation parameter): mean pre-CPAP = 40.1, mean
post-CPAP = 35.1, P = 0.038. There was a significant decrease in
respiratory rate: pre-CPAP = 36, post-CPAP = 33, P = 0.031.
Using a Borg scale for severity of respiratory distress, there was a
significant improvement after CPAP: pre-CPAP = 8.06, post-
CPAP = 5.7, P  = 0.0001. The emergency medical technicians
found the devices, CPAP, mask, and etCO2, easy to use, and 16
patients ranked it comfortable. Two patients were uncomfortable
with CPAP. The most comfortable score was 10; the population
scored the overall comfort of CPAP with etCO2 at 7.8.
Conclusions  CPAP in field emergency medicine can be easily
applied, is well tolerated, and results can be monitored by
capnography. Capnographic measurements indicated improved
ventilation by a decrease in carbon dioxide. CPAP and etCO2 can
be used in field emergencies to support and monitor ventilation
during respiratory distress.
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Introduction  During mechanical ventilation, signal pulses within
pressure and flow curves can be observed that are related to the
activity of the beating heart. From a signal-processing view, these
cardiogenic oscillations (COS) can be understood as repeated
pulses that are transferred via the lungs and airways to the airway
opening. It was demonstrated earlier that COS, achieved during
breath-holding maneuvers, were influenced by changes in
mechanical properties of the thorax [1]. We hypothesized that
these COS can be extracted from the airway pressure and flow
signal during spontaneous breathing. Furthermore, we hypo-
thesized that these isolated signals contain information about the
mechanical properties of the respiratory system.
Methods  Fifteen healthy volunteers breathed spontaneously
against continuous positive airway pressure (CPAP) of 0 to
9 cmH2O at normal thorax or at thorax bending, limiting motility to
90% of the normal circumference. Airway pressure and flow as
well as an electrocardiogram were recorded at a sample frequency
of 200 Hz. To isolate the signals that are related to the activity of
the heart, pressure and flow data were aligned in time to the R-
wave of the QRS complex and averaged.
Results Highly characteristic pressure and flow oscillations could
be extracted from the spontaneous breathing signals. Both signals
were closely related (r2 = 0.97 ± 0.02, each P  <0.0001). The
pressure amplitude of the COS was influenced by CPAP
(P = 0.049) and thorax motility (P <0.001); in contrast, the flow
amplitude was influenced only by thorax motility (P <0.001).
Conclusions COS can be extracted from the airway pressure and
flow signal during spontaneous breathing. They contain information
about the mechanical properties of the respiratory system. After
further investigations, our new method potentially allows an
estimation of compliance of the respiratory system during
spontaneous breathing.
Reference
1. Bijaoui E, Baconnier PF, Bates JH: Mechanical output
impedance of the lung determined from cardiogenic oscil-
lations. J Appl Physiol 2001, 91:859-865.S4
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Introduction  Respiratory failure is a common indication for
admission to a pediatric intensive care unit (PICU). Tracheal
intubation and invasive ventilation carries some risk and can
contribute to morbidity and possible mortality. Noninvasive positive
pressure ventilation (NIPPV) is a mode in which ventilation is
applied without tracheal intubation but via nasal prongs or a face
mask. We hypothesized that using NIPPV in infants with pending
respiratory failure may improve their outcome.
Methods In this prospective study, we enrolled infants admitted
with pending respiratory failure to the PICU. NIPPV was delivered
using silicone INCA nasal prongs (Ackrad Labs, Trumbull, CT,
USA) connected to an INFANT STAR 950 standard ventilator. The
NIPPV mode of support (continuous positive airway pressure vs.
synchronized nasal intermittent positive pressure ventilation) was
set to meet patient needs. Vital signs, ventilator settings and
laboratory results were recorded electronically. The primary
outcome was prevention of invasive ventilation. Secondary
outcomes were seeking a physiological marker for NIPPV failure
and complications from NIPPV.
Results  Between December 2007 and November 2008, 18
patients (15 infants, three enrolled twice) were eligible to receive
NIPPV based on the attending physician’s decision. Median age
was 3 months (15 days to 17 months). Eleven patients had apnea
and seven patients had respiratory distress. Among them, five
patients had bronchiolitis, two had central hypotonia, two had
Pertussis and six patients had other miscellaneous respiratory
conditions needing support. Fourteen infants (78%) were
improved and weaned off NIPPV while four (22%) infants had to
be intubated. The mean length of NIPPV was 47 hours. No
complication secondary to the NIPPV was recorded. No single vital
sign or laboratory test predicted whether a patient would improve
or fail NIPPV, although the improvement (when happened) was
noticed within hours of NIPPV. All four failures were due to
continuum of apnea.
Conclusions Our study shows that NIPPV is a safe and successful
method to support infants suffering from pending respiratory
failure. Lacking a physiological or biological marker that could
distinguish between so-called responders and nonresponders to
NIPPV, and the high rate of success in preventing the need for
invasive ventilation, supports our recommendation to trial any infant
in pending respiratory failure with NIPPV.
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Introduction Noninvasive ventilation (NIV) is useful for improving
oxygenation, decreasing hypercapnia, and avoiding invasive
mechanical ventilation in patients with chronic obstructive
pulmonary disease (COPD) exacerbations and acute respiratory
failure [1,2]. During the hospitalization, the treatment intensity is
quite variable on the basis of the patient’s clinical condition. Often,
after the acute phase, patients need only periods of NIV followed
by oxygenotherapy. NIV reduces the work of breathing and
probably improves the respiratory muscular strength even when
the ventilation is ended [3]. The aim of this study is to evaluate this
effect in COPD submitted to NIV.
Methods We studied 10 patients (seven male; three female; age
74.2 ± 5.3 years) admitted to our hospital with a COPD
exacerbation and acute respiratory failure. After a period of clinical
stabilization, patients underwent spirometry and arterial blood gas
as basal examinations. For each patient, NIV was applied for
2 hours and than spirometry and arterial blood gas were repeated.
Results are presented as mean ± SD. Data were evaluated by
paired  t test and a value of P <0.05 was taken as statistically
significant.
Results At the end of NIV, the forced ventilatory capacity (FVC)
and the forced expiratory volume at the first second (FEV1)/FVC
ratio were significantly increased compared with the basal value:
FVC 47.9 ± 11.0% basal, 55.3 ± 15.6% after NIV, P = 0.02;
FEV1/FVC 68.5 ± 17.1 basal, 59.3 ± 15.2 after NIV, P = 0.007.
Compared with the basal value, arterial carbon dioxide pCO2 was
significantly decreased: 68.0 ± 2.5 mmHg (basal), 55.3 ± 4.5 mmHg
(after NIV), P <0.02; and arterial oxygen was increased:
50.0 ± 14.2 mmHg (basal), 56.3 ± 15.3 mmHg (after NIV).
Conclusions The results of this study demonstrate that, in COPD
exacerbation, NIV determines a decrease of the pulmonary
hyperinflaction. This effect could improve the clinical status and the
work of breathing.
References
1. West JB: COPD. In Pulmonary Physiology and Pathophysiol-
ogy. Baltimore, MD: Lippincott Williams & Wilkins; 2001:33-
53.
2. Brochard L: Mechanical ventilation: invasive versus non
invasive. Eur Respir J 2003, 22(Suppl 47):31s-37s.
3. Lightowler JV, et al.: Non-invasive positive pressure ventila-
tion to treat respiratory failure resulting from exacerbation
of COPD disease: Cochrane systematic review and meta-
analysis. BMJ 2003, 326:185-187.
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Introduction Noninvasive ventilation (NIV) is an option in patients
with acute respiratory failure [1-3]. However, NIV complications
and failure are not yet completely understood [1,2]. Our objective
was to evaluate the indications, complications and failure of NIV in
an adult general ICU.
Methods From 1 August to 27 October we analyzed prospectively
all patients admitted to a 40-bed clinical–surgical ICU of a tertiary
care hospital. From those patients, we included the ones who
received NIV (total face mask coupled to a BIPAP Vision® or
Synchrony®) and evaluated the indications, causes of failure and
the complications of this ventilatory support.
Results During the study period, 465 patients were admitted to
the ICU; 111 patients (23.9%) received NIV. The main indications
for NIV were: hypoxemic respiratory failure in 22 patients (19.8%),
respiratory infection in 19 (17.1%), acute COPD in 14 (12.6%), as
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part of a weaning strategy in 16 (14.4%), cardiogenic pulmonary
edema in 15 (13.5%), ALI/ARDS in nine (8.1%), palliative care in
six (5.4%), neuromuscular disease in one (0.9%) and others in nine
patients (8.1%). NIV did not avoid intubation in 31 patients
(27.9%). The main reasons for failure were: progressive acute
respiratory failure in 23 patients (71.9%) and neurological
deterioration in five patients (15.6%). NIV was used after extu-
bation in 16 patients, and in five of them (31%) it was necessary
reintubation. The only complication observed was gastric
insufflation in six patients (5.4%).
Conclusions NIV is frequently used in a general ICU and the main
indication is acute hypoxemic respiratory failure. The NIV failure
incidence was significant but similar to the medical literature.
References
1. Demoule A, et al.: Benefits and risk of success or failure of
noninvasive ventilation. Intensive Care Med 2006, 32:1756-
1765.
2. Celikel T, et al.: Comparison of noninvasive positive pres-
sure ventilation with standard medical therapy in hyper-
capnic acute respiratory failure. Chest 1998,  114:
1636-1642.
3. Wysocki M, et al.: Noninvasive pressure support ventilation
in patients with acute respiratory failure. A randomized
comparison with conventional therapy. Chest 1995, 107:
761-768.
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Introduction Nasal continuous positive airway pressure (nCPAP)
is accepted as an effective and relatively complication-free method
of respiratory support of premature infants [1,2]. We intended to
compare the effectiveness of two nCPAP devices/approaches
(Hudson prongs/bubble (H), and Infant Flow (IF)), in different
groups of very low birth weight infants in a large trial.
Methods  Infants weighing 750 to 1,500 g, gestational age
<32 weeks, were enrolled from April 2006 to July 2008 at 12
centers. The newborns, categorized into three study groups, were
randomly assigned to one of the nCPAP devices in the first 6 hours
of life. Study group A (n = 119) were neonates placed immediately
on nCPAP. Group B (n = 157) were placed on nCPAP after
receiving surfactant. Group C (n = 56) were treated with conven-
tional ventilation and nCPAP was used as the method of weaning
from mechanical ventilation.
Results There were no statistically significant differences between
the two devices with regard to treatment success, pneumothorax
or bronchopulmonary dysplasia. The incidence of severe nasal
complications was lower in the infants treated with Infant Flow:
0.8% (IF), 6.6.% (H) (P = 0.01) in group A; 0.6% (IF), 5.1% (H)
(P = 0.01) in group B; and 0% (IF), 5.3% (H) (P = 0.1) in group C.
The incidence of necrotizing enterocolitis was also lower in the
group A infants treated with Infant Flow: 2.5% (IF), 8.3% (H)
(P = 0.03).
Conclusions (1) The two nCPAP methods are comparable with
regard to the incidence of pulmonary complications and primary
effectiveness. (2) The Infant Flow method resulted in fewer severe
nasal complications.
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Introduction During the past decade, noninvasive ventilation (NIV)
has imposed itself as an alternative to endotracheal intubation.
Several recent studies let us believe that this technique could be
also beneficial at the precocious extubation. The purpose of our
survey is to value the place of NIV at the precocious extubation in
ventilated patients.
Methods  A prospective, randomized and controlled survey has
been driven in a medical resuscitation unit during 6 months (June
to December 2007). After 48 hours of mechanical ventilation (MV),
if the patients have no fever, no neurological anomalies nor
hemodynamic instability and SaO2 >90% with 40% FiO2, a
spontaneous breathing trial (T-piece) is performed. If after the
T-piece test the clinical status, blood gas and hemodynamic data
were good, the patient was extubated. If these criteria were not
filled, the MV was continued and a daily assessment performed.
On the other hand, if the patient was anxious, agitated, with
polypnea >35/minute, PaO2 <50 mmHg under 40% FiO2, heart
rate >145/minute, systolic arterial pressure >170 mmHg or
<70 mmHg or arrhythmia, the patient is randomized for one of the
two protocols: in the first, the patient was extubated and NIV
(pressure support – positive end-expiratory pressure) via a facial
mask was performed; in the second, a classic weaning was
performed with pressure support ventilation. The quantitative
variables are expressed as the average or median ± standard
derivation, and the qualitative variables by as the percentage. The
univariate analysis was based on the chi-squared test or Fisher test
for the qualitative variables and the Student test for the quantitative
ones. P <0.05 is considered significant. The statistic analysis was
based on SPSS 11.0 for Windows.
Results  Twenty-four patients (13 men and 11 women) were
enrolled (12 in each group: NIV group and control group). The
mean age was 42 ± 2 years. The length of hospitalization for the
NIV group is less than that for the control group (P = 0.001). The
weaning of MV was more precocious in the NIV group than in the
control group (P = 0.001). Also, nosocomial pneumonia occurred
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less in the NIV group than in the control group (P = 0.04). No case
of mortality was noticed.
Conclusions It seems that NIV permits one to shorten the duration
of MV and length of stay in the ICU at the precocious extubation.
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Introduction  Guidelines pertaining to the details of intubation
practices in neonates and children are not well established. We
sought to describe the current practices with regard to the
intubation of newborns and children.
Methods The study was performed in 2007. Anonymous question-
naires were sent out to all Polish neonatal (n = 418) and pediatric
(n = 45) ICUs. The overall response rate was 65%. The response
rate in level III of neonatal care was 86.7% and in the pediatric ICU
(PICU) was 65.1%. The responders were asked to provide
information regarding the frequency of specific practices. Data
analysis (the difference between neonatal units and PICUs) was
performed by means of procedures available in SAS software.
Results  Seventy-four percent of neonatal units and 89.3% of
PICUs have a policy for elective intubation. Only a part of the units
has a written policy (from 48% in level III neonatal ICUs to 19.4%
in level I neonatal units). Unplanned extubation was found an
important problem in 3.0% of neonatal units and 7.1% of PICUs
(P = 0.05). A written protocol for difficult airways intubation was
available in 48.1% of PICUs and 3.0% of neonatal units
(P = 0.0001). In total, 92.2% of PICUs have regular sedative
practices for elective intubation. Only 44.6% of neonatal units have
such a policy (P = 0.0001). Numerous combinations of either
sedatives or muscle relaxants were found to be used by units.
However the most common policy in neonatal units (69.0%) was a
single dose of midazolam. Combination of thiopental or midazolam,
muscle relaxant and/or atropine was used frequently (79.4%) in
PICUs. Only 74% of PICUs and 37.5% of neonatal ICUs have a
policy for elective extubation (P = 0.0001).
Conclusions When compared with similar studies, a lower number
of Polish neonatal and pediatric ICUs have a written policy for
elective intubation. Only a minority of PICUs fail to provide any
sedation prior to elective intubation. More than one-half of neonatal
units have no such policy despite strong evidence of physiologic
and practical benefits. This phenomenon was found also by others.
A lack of written guidelines for the extubation procedure is another
finding for a future educational programme.
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Introduction  The development of hemodynamic instability
following emergent endotracheal intubation and the initiation of
positive pressure ventilation is a potentially life-threatening adverse
event. Unfortunately, the incidence of post-intubation hemo-
dynamic instability (PIHI) is relatively unknown. The objective of this
study is to estimate the risk of PIHI in adult patients who require
emergent intubation and to identify factors contributing to the
likelihood of this adverse event.
Methods This is a systematic review of published adult, inhospital
studies of emergent endotracheal intubation. A systematic search
of Medline (1950 to November 2008) and relevant bibliographies
was completed. No restrictions were placed on the language of
publication, patient diagnosis, indication for intubation, or
intubation method employed. One author independently reviewed
all citations, and two authors reviewed all candidate articles during
the process of final selection. Data were independently retrieved
on a standardized data abstraction form by two authors. Random-
effects meta-analysis was used to estimate the pooled prevalence
of PIHI across studies.
Results A total of 22 relevant studies were identified and included
in our analysis. One randomized controlled trial and 21 obser-
vational studies met the eligibility criteria. Sample sizes ranged
from 33 to 2,833 patients (median, 214). The prevalence of post-
intubation hypotension ranged from 0% to 39%, with a random-
effects, pooled estimate of 8.5% (95% CI, 4.8% to 14.5%).
Studies that defined PIHI with a temporal relationship between
blood pressure reduction and intubation had a PIHI prevalence of
13.9% (95% CI, 8.8% to 21.2%) compared with a prevalence of
5.0% (95% CI, 1.6% to 15.0%) in studies that did not.
Heterogeneity between studies limits conclusions on the effect of
indication for intubation, intubator experience, medications utilized
to facilitate intubation, and management strategies used for PIHI.
Conclusions  Post-intubation hemodynamic instability occurs
commonly after emergent intubations. Efforts are required to
identify risk factors, and potential preventative and therapeutic
interventions for PIHI.
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Introduction Commercially available endotracheal tube (ETT) cuffs
are made of PVC polymer that shows little stretch upon inflation,
resulting in a need for a cuff diameter larger than the trachea. Such
cuffs form folds, which became a ready passageway for bacteria-
colonized subglottic secretions. We developed an elastic and
smooth balloon with no folds upon inflation.
Methods In vitro study. Six different ETTs with the newly designed
cuff were tested for leakage in a 20 mm internal diameter acrylic
tube at 20 cmH2O (1.96 kPa) inflation pressure, pouring 20 ml
methylene-blue colored water into the acrylic tracheal tube above
the cuff to visualize any leak. We observed the ETT cuff for
24 hours for possible leakage.
In vivo study. Four Yukatan minipigs were intubated with the new
ETT cuff and mechanically ventilated for ~40 hours. Methylene-
blue colored water was poured into the subglottic space through a
line attached to the ETT. We looked for blue discoloration of
mucus retrieved during the tracheal suction at 5, 10 and
30 minutes following instillation. At autopsy, tracheal mucosa was
examined for possible cuff-related damage.
Results  The Lycra cuff was devoid of folds upon inflation, and
touched the wall of the mock trachea. There was no leakage of
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methylene-blue colored water. Instead, the average leakage across
the Mallinkrodt Hi-Lo cuff was 1,182.2 ± 1,321.0 ml/hour (P<0.0001
vs. the Lycra prototype); the average leakage across the Microcuff
was 12.2 ± 3.6 ml/hour (P <0.0001 vs. the Lycra prototype, and
P <0.01 vs. the Microcuff).
We observed no methylene-blue in tracheal secretions. The pig
trachea appeared normal at autopsy, with no signs of erosion.
Conclusions We showed that a new concept, a smooth ultrathin
elastic tracheal tube cuff, can perform better than present
commercially available tracheal tubes.
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Introduction  There are several advantages of tracheostomy if
compared with orotracheal intubation, such as a more comfortable
state for the patient, more effective aspiration of the sputum of
respiratory ways, reduction of respiratory way resistance and
availability of peroral nutrition. These advantages also include more
safe maintenance of the passableness of respiratory ways,
reducing the terms of carrying out respiratory support and the
patient staying in the ICU, decreasing the pneumonia development
risk. This study is designed to compare the duration of weaning in
patients with tracheostomy versus patients suffering orotracheal
intubation.
Methods For this observational prospective cohort study, multiple
trauma patients requiring more than 72 hours of mechanical
ventilation were prospectively selected. A group of patients that
underwent early tracheostomy before weaning attempts (ET) were
compared with a group of patients that underwent weaning
attempts while being orotracheally intubated. Tracheostomy was
performed for these patients only in case there were several
unsuccessful attempts of weaning (forced tracheostomy) lasting
more than 7 days (FT). The general patient state was estimated by
the APACHE II score, traumatic damages have been estimated by
the injury severity score, and the degree of infringement of
consciousness has been estimated by the GCS.
Results Seventy-one patients meeting the inclusion criteria were
subject to our trial. The ET group included 41 patients that
underwent tracheostomy lasting 2 to 5 days from the moment of
mechanical ventilation being started. The FT group consisted of 30
patients and tracheostomy was performed for 60% of them. Both
groups of patients were statistically comparable. The median
duration of mechanical ventilation was shorter in the ET group of
patients (256 vs. 314 hours, P = 0.047). The median duration of
weaning was also shorter in the ET group of patients (61 vs.
103 hours,  P = 0.008) if compared with the FT group. In total,
34.1% of patients of the ET group suffered pneumonia, while in the
FT group the percentage was 50% (P = 0.032). The mortality rate
was almost the same in both groups (P = 0.944).
Conclusions Results of this study show that early tracheostomy, if
performed for patient’s suffering severe combined trauma, reduces
the duration of weaning. Early tracheostomy results in a decrease
of the frequency of complications such as ventilator-associated
pneumonia. The duration of tracheostomy did not affect the
mortality rate of the investigated groups of patients.
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Introduction Percutaneous tracheotomy (PT) is one of the most
frequent procedures carried out in critically ill patients. However, it
carries contraindications in the patient group younger than
16 years of age, in cases with known or anticipated difficult
endotracheal intubations, in infection of surgical areas and in cases
with cricoid cartilage not identified. In this retrospective study, we
evaluated the safety of performing the PT-associated blunt
dilatational exploration with a right-angle clamp in patients having
cricoid cartilage not identified.
Methods  We reviewed retrospectively the data of 122 PTs in
patients having cricoid cartilage not identified due to obesity or
postural deformity, between January 2006 and October 2008. The
data obtained from charts included age, sex, timing of PT, duration
of the procedure, minor or major complications and mortality. All of
the procedures were performed at the bedside in the ICU. After as
maximal a positioning of the patient as could be performed, local
anesthetic infiltration was applied to 1 to 2 cm superior of the
jugular notch of manibrium sterni (according to the structure of
patient’s neck). After incision (~2 cm) of skin and subcutaneous
tissue, all layers of subcutaneous tissue were passed through until
feeling the trachea by finger using a right-angle clamp (blunt
dilatational exploration). So, cricoid cartilage was directly palpated
by the tip of the finger, and the attempt (Griggs technique) was
performed between the first and second tracheal cartilages below
the cricoid cartilage.
Results The patients were mechanically ventilated for an average
of 12.9 ± 2.6 days. They were 57 ± 14 (26 to 86) years old, and
64 of them were female, 58 of them were male. The duration of the
technique was 2.5 to 5 minutes. There was no death or cardiac
arrest related to tracheotomy. There were 113 PTs (92.6%)
documented as uncomplicated. There was no technically difficult
procedure, and none of the patients changed into a surgical
approach during the procedure. However, major hemorrhage
developed during first 24 hours in eight patients. In one patient,
pneumomediastinum was determined in the 48th hour after the
procedure. The overall complication ratio was established as 7.4%.
Conclusions PT associated with using a right-angle clamp seems
to be safe; it could be performed in the patients having cricoid
cartilage not identified.
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Introduction  Percutaneous dilational tracheostomy (PDT) is a
common procedure in ICU patients. In this study we evaluated
perioperative complications. Moreover we looked for late compli-
cations by telephone interview together with a clinical evaluation in
the suspected cases.
Methods We included 170 consecutive patients admitted to GB
Morgagni Hospital ICU, between June 2005 and June 2007 who
underwent PDT. Demographic data, clinical data and severity
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scores (SAPS II), data about the tracheostomy technique and
tracheostomy major complications were collected. We used the
Ciaglia technique with endoscopic guidance throughout the
procedure. Twelve months after discharge, we traced and
interviewed our patients about possible late complications
connected with the tracheostomy. Symptomatic patients were
referred to the ENT specialist for fiberoptic laryngoscopy control.
Results  PDT was performed in 170 patients as a routine
procedure by intensivists. The main primary indications for PDT
were weaning failure (29%) and neurological dysfunction (71%).
One hundred and five patients were male and 65 female, with an
age average of 68 ± 15 years. The mean SAPS II was 53 ± 10
points. The intubated time before PDT was 5 ± 2 days and the
time in the ICU after PDT was 14 ± 8 days. The ICU mortality was
16%. Placement was successful in all cases. The total incidence of
major complications was 1.18%: a simple pneumothorax success-
fully treated with chest tube insertion and one early (after 72 hours)
cannula displacement evolved to cardiorespiratory arrest and
death. We traced 38 patients alive 12 months after discharge; 22
patients answered the telephone interview. None complained of
respiratory symptoms, Four patients described symptoms that
were considered worth further examination and were invited to an
ENT control. In two patients, swallowing uncoordination was
found. In another two patients, a 20% tracheal stenosis was found.
The stenosis was, however, asymptomatic.
Conclusions  In our experience PDT had an overall low rate of
major complications (1.8%). Only one patient had severe early
complication. We did not find severe late complication. In selected
patients, PDT with endoscopic guidance guarantees a high safety
standard [1,2].
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Introduction The aim of this study is to analyse our experience
with tracheostomies performed in the critical care unit of a tertiary
university hospital.
Methods A retrospective clinical records review of patients who
underwent this procedure in a 7-year period.
Results From January 2001 to December 2007, 6,333 patients
were admitted to our unit; 1,528 needed mechanical ventilation
(MV) for more than 48 hours and 443 underwent tracheostomy.
The median age was 56 years (14 to 88 years); 66% were male.
The median APACHE II score was 20 (4 to 44). The main
diagnoses were polytrauma including head injury in 24.2%, other
structural neurological diseases in 21%, and prolonged weaning of
various aetiologies in 35%. The percutaneous dilational technique
was used in the majority of cases (90%). The mean duration of MV
prior to tracheostomy was 13.8 days (SD = 6.4). The overall
complication rate was 6%. Intraprocedural complications were
atelectasis (0.4%) and bleeding (2%). Two of the patients needed
surgical control or transfusion (0.4%). Two stoma infections
developed in the open tracheostomy group. The most frequent
complication was tracheal stenosis, encountered in 15 patients
(3%). The ICU mortality was 20.7%. Of the 351 patients
discharged from the ICU, 45.8% were decannulated prior to
discharge from the ICU and 31% in the ward; 23% of them could
not be decannulated at any moment. Ward mortality in the group of
patients decannulated in the ICU was 5%, 10% in the patients
decannulated in the ward and 37% in those who failed
decannulation, for a total of 50 deaths before hospital discharge
(11%). The main diagnoses of the patients who died on the ward
were: residual encephalopathy in 62% (postanoxic, posttraumatic
or other causes), severe chronic respiratory failure in 10%, spinal
cord injury in 6%, and neuromuscular disease in 4%.
Conclusions We had a low rate of early complications, similar to
other series, with no procedure-related deaths [1]. Our main
complication was airway stenosis. As in other studies, patients
who needed a tracheostomy belonged to a group of patients with a
high severity and mortality. Some of them do not recover a
satisfactory neurological and functional status to be decannulated
and present a high ward mortality.
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Introduction  Neurointensive care patients often require elective
tracheostomy for prolonged ventilatory support, control of intra-
cranial pressure as sedation is weaned and for impaired pharyn-
geal and laryngeal reflexes. The possibility of raised intracranial
pressure, worsened by patient positioning and intraprocedural
occult hypercarbia, makes it a higher risk procedure [1]. There is
little information on the timing of percutaneous dilational tracheo-
stomy (PDT) or periprocedural complications in neurointensive
care patients.
Methods Out of 80 patients who underwent PDT over a period of
1 year, information was obtained and analysed on 52 patients.
Baseline demographical information collected included the date of
admission, date of PDT, level of the operator, supervision, and
periprocedural complications. We also looked at the use of post-
procedure chest radiography (CXR). Analysis was then carried out
to determine the timing of PDT, the incidence of complications and
the use of CXR.
Results  Fifty-two patients were included, median age 56 years
(range 20 to 79 years). The procedure was carried out either by
two trainees with a consultant supervising (40%) or by a consul-
tant and a trainee (57%). Two patients who had a difficult
anatomical approach had the procedure done by two consultants.
The timing of PDT ranged from 1 day to 22 days with a mean of
7.69 days and SD of 4.29 days. There were only three reported
complications (5%), none of them major or involving raised
intracranial pressure. CXR was requested in 68% of cases; of the
35 patients who did have CXR, only 51% had recorded reports in
the notes.
Conclusions In spite of recommendations that CXR is not required
following uncomplicated PDT, most operators still request one, a
habit that leads to unnecessary patient and staff exposure to
radiation. The majority of the PDTs was performed by trainees in
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our unit, and the low complication rate proves that the technique is
safe and easy. PDT in neurointensive care patients carries a higher
risk, but with proper patient selection and senior input the
procedure is as safe as in general intensive care patients.
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Introduction We prospectively studied the tracheostomy compli-
cation rate in ICU patients (four ICUs, 36 beds) over a 6-month
period. Quoted complication rates following tracheostomy vary
widely [1,2].
Methods We evaluated all tracheostomies sited in ICU patients in
our trust between June and November 2008. Complications on
insertion, whilst cannulated and post (tracheal) decannulation were
recorded. Patients were followed up until 4 weeks post de-
cannulation, hospital discharge or death.
Results  Sixty-four patients underwent tracheostomy (58 per-
cutaneous, six surgical). The mean time with tracheostomy was
24.8 days. Twenty-six insertion complications occurred in 20
(31%) of 64 patients. Fifty-five patients received follow-up (four
transferred to another hospital, one died, four lost to follow up
before first visit). Eighteen complications occurred whilst
cannulated in 12 (22%) of 55 patients. The number (%) of
insertion complications were: all, 26 (41%); major, five (8%) –
major bleed, four (6%); posterior tracheal wall injury, one (2%);
minor – minor bleed, 12 (19%); abandonment/conversion to
surgical procedure, four (6%); tracheal cartilage fracture, three
(5%); other, two (3%). The numbers (%) of complications whilst
cannulated were: all, 18 (33%); major, seven (13%) – tracheo-
stomy tube blockage/displacement, four (7%); loss of airway with
severe hypoxia, three (5%); minor – prolonged bleeding, two (4%);
local infection, one (2%); surgical revision, two (4%); other, six
(11%). Post decannulation, 38 patients were followed up. There
were no major complications. The number (%) of post-decannu-
lation complications were: all, 28 (74%); difficulty swallowing, eight
(21%); regurgitation of liquid, eight (21%); voice change, six
(16%); hoarseness, two (5%); regurgitation of solids, two (5%);
altered cough, one (3%); abnormal breathing, one (3%). One
patient had complications lasting >30 days post decannulation.
Overall patient outcomes 30 days post decannulation (excluding
15 patients transferred to other hospitals) were: 59% discharged
from hospital, 29% dead, 12% inpatient decannulated.
Conclusions Although the tracheostomy complication rate in our
trust was 41% at insertion (8% major), 33% whilst cannulated
(13% major) and 74% post decannulation, only one post-decan-
nulation complication persisted beyond 30 days and none was
major. Seventy-one per cent of patients undergoing tracheostomy
survived to 30 days post decannulation.
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Introduction Unplanned extubation (UE) is a frequent complication
in ICU patients associated with increased morbidity, mortality,
duration of mechanical ventilation, ICU stay and hospital stay.
Although UE has been studied, still not much is known on the
incidence, determinants and outcome. The aim of the study was to
assess the incidence and determinants of UE in a tertiary-care ICU.
Methods From 1 December 2005 to 1 June 2008 a prospective
case–control study was undertaken. Cases were consecutive adult
patients in a 29-bed medical, surgical, neurosurgical, and thoracic-
surgical ICU who experienced an UE. The UE was defined as
premature removal of the tube by the patient. For each case, four
controls were randomly selected. Controls were mechanical
ventilated patients who did not experience an UE at the time a
case occurred. Demographics and clinical characteristics were
obtained from the electronic medical records. Wilcoxon rank-sum
and chi-squared tests were used as appropriate. To determine
independent risk factors for UE, univariate logistic regression was
used. Determinants significant in the univariate analysis were
included in the multivariate logistic regression. This model was
tested for the clinically relevant interaction between determinants.
Results In the study period, 74 UEs occurred and 296 controls
were collected. The incidence of UE is 2.1% for mechanically
ventilated patients and 0.4% per ventilation day. Cases and
controls did not differ significantly with respect to age, type of
admittance or diagnosis category. Forty-seven percent of the
cases had to be reintubated, 77% did not experience another
complication. Cases had significantly lower median length of
intubation (5 vs. 7 days, P = 0.069), ICU mortality (18 vs. 27%,
P = 0.096) and hospital mortality (19 vs. 34%, P = 0.028).
Significant predictors of UE in the multivariate analysis were
admittance to the thoracic surgery unit (OR = 2.63, 95% CI =
1.06 to 6.53, P = 0.037) and a Ramsay sedation score of 1 (OR =
30.57, 95% CI = 3.18 to 294.2, P = 0.003), 2 (OR = 25.47, 95%
CI = 3.00 to 217.0, P = 0.003), and 3 (OR = 7.02, 95% CI = 0.78
to 63.01, P = 0.082) compared with the most sedated score.
Protective factors are female gender (OR = 0.55, 95% CI = 0.26
to 1.19, P = 0.131), and use of midazolam at the time of UE (OR =
0.44, 95% CI = 0.19 to 0.99, P = 0.048).
Conclusions Although UE can be defined as a complication we
could not find a correlation with morbidity and mortality.
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Introduction  Numerous studies have shown that ventilator
weaning protocols are likely to reduce the duration of mechanical
ventilation and ICU stay. In 2001 a taskforce of pulmonary and
critical care experts developed guidelines for weaning and
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discontinuation of mechanical ventilation that recommended the
development and implementation of respiratory weaning protocols
for nonphysician healthcare professionals in the ICU [1]. Our
weaning protocol was established in 2005 based on clinical
evidence and best-practice recommendation at the time. The
primary aim of this audit is to ascertain the extent of protocol
adherence in our unit. The secondary aims include correlation of
protocol-driven weaning to outcome as defined by successful
extubation and reduction in the length of mechanical ventilation.
Methods  A prospective study of all patients who received
mechanical ventilation over a 1-month period, excluding patients
who had tracheostomy insertion and patients who had their
treatment withdrawn. We looked at the rate of compliance with our
weaning protocol, the reason for noncompliance and outcome.
Results Fifty-two patients were included, 18 protocol-driven and
34 nonprotocol-driven weaning. The most common reason for
nonprotocol weaning was clinical decision (40.4%). In total, 19.2%
of patients had an alternative spontaneous breathing trial from the
protocol and were counted as nonprotocol. There were no
differences in the rate of successful extubation between patients
who were weaned from protocol versus nonprotocol, 94.4% vs.
79.4% respectively (Fisher’s exact test P  = 0.236). Duration of
ventilation was also similar in the protocol and nonprotocol groups,
mean ± SEM = 84.7 ± 16.6 vs. 76.4 ± 12.8 hours (unpaired t test
P = 0.699). The overall success rate of extubation was 86.5%.
Conclusions  Our compliance rate is 34.6%, and the protocol-
driven weaning trial does not improve outcome in our unit.
However this could be due to the small sample size, the timing of
the study and a nondiscriminatory protocol.
Reference
1. MacIntyre NR, et al.:  Evidence-based guidelines for
weaning and discontinuing ventilatory support: a collec-
tive task force facilitated by the American College of
Chest Physicians; the American Association for Respira-
tory Care; and the American College of Critical Care Medi-
cine. Chest 2001, 120(6 Suppl):375S-395S.
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Introduction We compared a computer-driven weaning protocol
(SmartCare on Evita XL; Dräger, Lübeck, Germany) with our paper-
based nurse-driven weaning protocol.
Methods The ICU is a 10-bed intensivist-led unit in a 500-bed
teaching hospital. We compared our paper-based nurse-driven
weaning protocol [1] with SmartCare in a prospective cohort
study. All consecutive patients receiving mechanical ventilation
between May and October 2008 and fulfilling the inclusion criteria
were included. Patients were included if the intensivist on his twice
daily rounds considered the patient ready for withdrawal of the
ventilator and if patients were on pressure support with no more
than 50% oxygen and no more than 8 mbar positive end-expiratory
pressure, had no fever, had a normal pH, were arousable and had
no more than 5 μg/kg/min dopamine. Patients were excluded if
they were ready for immediate extubation or if they had a
tracheostomy. For the first 3 months of the study, patients were
allocated to the paper-based nurse-driven weaning protocol, and
for the last 3 months to SmartCare.
Results  The results are presented in Tables 1 and 2. Normally
distributed data are presented as the mean and SD, nonparametric
data as the median and interquartile range. Thirty-two patients
were enrolled in the study. Baseline characteristics were similar in
the two groups. The main result was that the median weaning time
was significantly shorter in the SmartCare group: 4.5 hours vs.
2.6 hours.
Conclusions  SmartCare reduces the weaning duration when
compared with a paper-based nurse-driven weaning protocol.
Reference
1. Wulff A, Kalkman B, Orsini M, Van der Hoeven M, Van der
Velden J, Tangkau P, et al.: The effect of a protocol on the
duration of weaning. Intensive Care Med 2004, 30(Suppl
1):S21.
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Introduction Unnecessary prolongation of mechanical ventilation
is related to increased morbidity. On the contrary, early discon-
tinuation of mechanical ventilation with reintubation is also related
to bad prognosis. High respiratory rate, cardiac load and neuro-
muscular dysfunction are known factors related to weaning failure.
Oxygen tissue saturation (StO2) obtained by near-infrared spectro-
scopy (NIRS) reflects the balance between oxygen delivery and
consumption at the muscle level. StO2 evolution during weaning
may have a role in assessing respiratory muscle performance and
help us to predict patient readiness to be weaned. The study
objective is to describe respiratory muscle StO2 during a T-tube
test.
Methods A patient with mild head injury and pulmonary contusion
was submitted to a T-tube trial after obtaining stability on day 5.
The NIRS signal from serratus anterior muscle was acquired by
placing an Inspectra device probe on the skin surface of the
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Baseline characteristics
Paper SmartCare 
(n = 17) (n = 17) P value
Age 70.5 (9.4) 62.4 (13.8) 0.07 
t test
APACHE II score 13.7 (5.2) 13.5 (4.4) 0.90 
t test
Days ventilated 3 (2 to 4) 3 (2 to 4) 0.97 
Mann–Whitney 
U test
Table 2 (abstract P25)
Results
Paper SmartCare 
(n = 15) (n = 17) P value
Wean time (hours) 4.5  2.6  0.007 
(2.8 to 21.3) (1.8 to 3.6) Mann–Whitney 
U test
Reintubation 0/15 (0%) 2/17 (12%) 0.49 
Fisher exact test
28-day mortality 1/15 (7%) 0/17 (0%) 0.47 
Fisher exact testS11
muscle [1]. Simultaneously, the respiratory rate, heart rate, mean
arterial pressure and arterial oxygen saturation were recorded.
Results After 5 minutes the patient failed on his first T-tube trial,
showing profuse sweating, accessory muscle recruitment and
increasing respiratory rate and mean arterial pressure (Figure 1).
The StO2 signal decreased during ventilatory failure until the
patient was on assistance again.
Conclusions NIRS was sensitive to respiratory muscle fatigue but
further research is in process to assess its predictive capability.
Reference
1. Moalla W, et al.:  Respiratory muscle deoxygenation and
ventilatory threshold assessments using near infrared
spectroscopy in children. Int J Sports Med 2005, 26:576-
582.
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Introduction There is evidence that formal weaning protocols can
reduce the duration of mechanical ventilation (MV) and compli-
cations of prolonged unnecessary ventilation [1]. In our ICU we do
not employ a formal protocol, but have a standard practice where
patients with spontaneous respiratory efforts on pressure-
controlled ventilation (PCV) have a trial of assisted spontaneous
breathing (ASB). Patients on ASB with pressure support
≤10 cmH2O will then have a trial of unassisted continuous positive
airway pressure (CPAP) with high-flow oxygen.
Methods A retrospective audit was conducted on 47 patients in a
13-bed general medical and surgical ICU of a university hospital.
The length of time between first spontaneous breaths while on
PCV and a trial of ASB was recorded. The length of time from
achieving pressure support ≤10 cmH2O on ASB to a trial of
unassisted CPAP was recorded. A retrograde step was defined as
going back on to PCV from ASB, or to ASB from unassisted
CPAP. If the trial of weaning was repeated within 12 hours of a
retrograde step, this was noted as a continuous attempt at
weaning. Similar data were collected for subsequent retrograde
steps.
Results  The median duration of MV from initiation to
discontinuation was 85 hours (range 1 to 345 hours), with a
median time of 37 hours (range 1 to 245 hours) on PCV and
32 hours (range 0 to 264 hours) on ASB. The median time from
recorded spontaneous breaths on PCV to ASB was 1 hour (range
0 to 34 hours). Twenty-nine (62%) patients on PCV progressed on
ASB without any retrograde steps. The median time from having
pressure support ≤10 cmH2O on ASB to unassisted CPAP was
2 hours (range 0 to 41 hours). Thirty-one (66%) patients on ASB
progressed on CPAP without any retrograde steps. Forty-one
patients (87.2%) had a first attempt to wean from PCV to ASB and
40 patients (85%) from ASB to CPAP within 10 hours of eligibility.
Maximum delay in initiating first attempts to ASB was 34 hours,
and 41 hours to CPAP. Reasons for retrograde steps included
respiratory instability (n = 19), signs of poor tolerance or haemo-
dynamic instability on ASB/unassisted CPAP (n = 18) and inter-
ventions, for example bronchoscopy, imaging, theatre, and so forth
(n = 13).
Conclusions  The median duration on MV in our unit compares
favourably with a large randomised controlled trial with a similar
patient population [1]. Most patients had their first attempt to wean
within 10 hours from eligibility. A significant number of patients
may have weaned more quickly if a formal protocol was in place.
Reference
1. Marelich GP, Murin S, Battistella F, Inciardi J, Vierra T, Roby
M: Protocol weaning of mechanical ventilation in medical
and surgical patients by respiratory care practitioners and
nurses: effect on weaning time and incidence of ventila-
tor-associated pneumonia. Chest 2000, 118:459-467.
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Introduction  The purpose of this study was to evaluate the
dependency for mechanical ventilation among morbidly obese
patients (MOP) defined by BMI ≥40 kg/m2, admitted to our ICU.
Because of reduced functional residual capacity, increased risk of
atelectasis, increased work of breathing and decreased
compliance of the lungs and chest wall [1], MOP are expected to
have a high dependency of mechanical ventilation. Early tracheo-
tomy has a beneficial outcome in a medical population of patients
admitted to the ICU [2], and one should assume benefits of early
tracheotomy in MOP because they are at high risk of pulmonary
complication. A subject of debate as a study has shown morbid
obesity associated with increased risk of complications [3].
Methods All MOP admitted for more than 24 hours in a 12-bed
mixed ICU at a Danish university hospital in the period of 2007 and
2008 were retrospectively included. The ICU stay was registered
as well as airway management, length of mechanical ventilation
and time for tracheotomy after intubation.
Results  Twenty-one morbidly obese patients were admitted.
Fifteen patients (71.4%) needed mechanical ventilation. Three of
these patients had a period of noninvasive ventilation. The median
duration of ventilation was 13 days (range 4 to 71 days) and
median length of stay was 16 days (range 4 to 71 days). Eleven
patients were tracheotomised after a median 7 days (range 1 to
11 days). Six patients had no need for mechanical ventilation. Their
median length of stay was 3 days (range 1 to 12 days). There was
Available online http://ccforum.com/supplements/13/S1
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StO2 evolution during the T-tube trial. HR, heart rate; RR, respiratory
rate; MAP, mean arterial pressure.S12
no difference in age and BMI between the two groups.
Female/male ratio was 8/7 in the ventilated group versus 5/1 in the
nonventilated group. Surgical/medical ratio was 11/4 in the
ventilated group versus 6/0 in the nonventilated group. Only one
patient died in the ICU.
Conclusions  A high proportion of MOP admitted to our ICU
needed mechanical ventilation (71.4%) and a very high proportion
was tracheotomised. Further studies are needed to evaluate the
beneficial effects of early tracheotomy in this patient group.
References
1. Marik P, et al.: The obese patient in the ICU. Chest 1998,
113:492-498.
2. Rumbak MJ, et al.: A prospective, randomised, study com-
paring early percutaneous dilational trachetomy to pro-
longed translaryngeal intubation (delayed tracheotomy) in
critically ill medical patients. Crit Care Med 2004, 32:1689-
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3 Solh A, Jaafar W: A comparative study of the complications
of surgical tracheostomy in morbidly obese critically ill
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Introduction During high-frequency oscillatory ventilation (HFOV),
drying of the airways and mucous plug formation can be compli-
cations associated with inadequate humidification. This study
compares water vapor delivery of a standard passover humidifier
and a conchatherm humidifier typically used during HFOV with a
novel humidifier that employs the principle of capillary force
vaporization.
Methods The Sensormedics 3100B oscillatory ventilator (Cardinal
Health, Yorba Linda, CA, USA) was connected to a test lung at the
following settings: mean airway pressure, 30 cmH2O; power, 6.0;
inspiratory time percentage, 33%; frequency of 6 Hz and bias flow
30 l/min on room air. The 3100B was run at the above settings first
using five different MR850 passover humidifiers (Fisher & Paykel,
Auckland, New Zealand), followed by five different Hydrate OMNIs
(Hydrate Inc., Midlothian, VA, USA) and then five different
ConchaTherm Neptunes (Teleflex Medical, Research Triangle Park,
NC, USA). The gas temperature and relative humidity were
recorded continuously using an electronic hygrometer/thermo-
meter (SHT75; Sensirion, Staefa, Switzerland) in two circuit
configurations: (1) between the test lung/patient wye (triangular
plastic connector that connects the inspiratory and expiratory limbs
of the circuit with the patient endotracheal tube) and (2) distal to a
condensation tube placed between the test lung/patient wye. The
condensation tube served to approximate the upper airways in our
lung model and collect the condensate. Water condensate was
collected over a 30-minute test period for each run. All humidifiers
were set to 37°C.
Results See Table 1.
Conclusions  In this model, the Hydrate OMNI provided the
highest absolute humidity during HFOV. The difference was
amplified at the end of the condensation tube. Further study on
humidification during HFOV is warranted.
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Introduction Several diseases of different origin as well as pro-
longed mechanical ventilation result in diaphragmatic dysfunction
and atrophy. To date most in vitro experiments on the mechanics of
diaphragm muscles are performed at isolated muscle strips. Since
the improvement of the knowledge about the diaphragm
functionality is lacking in view of the position and curvature, a
model of the whole diaphragm appears necessary. Here we
present a new in vitro model of an isolated whole rat diaphragm
inside a bioreactor [1].
Methods The bioreactor consists of a pressure chamber on which
a highly flexible membrane is attached. A rat diaphragm is fixed on
this membrane. By application of a gas volume into the pressure
chamber, a defined deflection of the diaphragm is achieved. The
highly flexible membrane adapts a given shape thus allowing the
diaphragm to take up its in vivo profile. Electrical stimulation results
in a contraction of the diaphragm. These diaphragm-twitches
generate pressure pulses inside the pressure chamber. Rat
diaphragms were excised rapidly and kept at room temperature in
Krebs–Henseleit solution bubbled with oxygen. By application of
one of two different initial pressures (P1: 7 mbar; P2: 12 mbar) the
diaphragms were set to a defined degree of deflection. Using a
platinum wire electrode, the diaphragms were electrically
stimulated at impulses of 6V. The stimulation train duration was set
to 500 ms or 1 second. The pulse duration was set to 50 ms at a
frequency of 50 Hz. The pressure pulses resulting as the response
on muscle contraction were measured inside the pressure
chamber.
Results  An increase of the initial pressure led to an increased
pressure caused by the muscle contraction. An enlarged muscle
regeneration time led to an increase of the diaphragmatic twitch-
induced pressure.
Conclusions  Our new in vitro model of an isolated whole rat
diaphragm allows the performance of mechanical and physiological
investigations on the entire diaphragm. A dependency of pressure
development of the diaphragm on its deflection state could be
demonstrated. Furthermore, we found effects of diaphragm muscle
fatigue. Our new model could be used in numerous types of
investigations, such as releasing factors of diaphragmatic dysfunc-
tion or respiratory muscle fatigue.
Reference
1. Schumann S, Stahl CA, Möller K, Schneider M, Metzke R,
Wall WA, Priebe HJ, Guttmann J: Contact-free determina-
tion of material characteristics using a newly developed
pressure-operated strain-applying bioreactor. J Biomed
Mater Res B Appl Biomater 2008, 86B:483-492.
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Wye  Wye absolute  Distal absolute 
temperature humidity (mg/l) humidity (mg/l)
MR850 34.4 ± 0.9 33.7 ± 1.3 17.2 ± 6.1
OMNI 34.4 ± 1.3 37.2 ± 2.6 26.8 ± 5.0
Neptune 32.0 ± 0.9 30.8 ± 1.7 17.7 ± 1.0
Data presented as mean ± SD.S13
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Introduction  Mechanical ventilation is a lifesaving supportive
therapy for patients with acute respiratory failure. However,
prolonged mechanical ventilation results in the complete absence
of neural activation and mechanical activity of the diaphragm and
has been shown to induce ventilator-induced diaphragmatic
dysfunction (VIDD) [1]. Few studies have shown that maintaining
spontaneous ventilation could prevent VIDD in in vitro animal
studies [2]. Adaptive support ventilation (ASV) is an automatic
ventilation mode that allowed pressure-controlled breaths in active
patients able to trigger. The aim of our study was to compare ASV
with controlled ventilation (CV) without paralysing agents on
diaphragmatic contractile properties in an in vivo piglet study.
Methods Two groups of six anesthetized piglets were ventilated
during a 72-hour period. Piglets in the CV group (n = 6) were
ventilated without any spontaneous ventilation and piglets in the
ASV group (n = 6) were ventilated with the possibility of triggering
spontaneous ventilation. The main endpoint was the transdiaphrag-
matic pressure (Pdi) (after bilateral, supramaximal, transjugular
stimulation of the two phrenic nerves), which represents the in vivo
contractile function of the diaphragm. A force–frequency curve
was drawn after stimulation from 20 to 120 Hz of the phrenic
nerves.
Results  The piglets in the ASV group were maintained with
spontaneous ventilation during 80% of the study period instead of
less than 1% in the CV group. At 72 hours, Pdi was decreased by
35% in the CV group although it was not modified in the ASV
group (Figure 1).
Conclusions Spontaneous breathing with ASV prevents VIDD in
comparison with totally CV in an in vivo healthy piglet model.
References
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Introduction The aim of the present study was to gain insight into
the mechanical ventilator adjustment process, particularly events
that prompt clinicians to adjust the ventilator, the indications,
considerations, and methods used to assess the successfulness of
the adjustment episode.
Methods  A prospective, observational, noninterventional study
was conducted in a 24-bed adult, medical and surgical intensive
care unit at a regional hospital. Patient demographics, ventilator
adjustment episodes, and clinical decisions related to these adjust-
ments were collected. Clinicians were asked to complete a
ventilator flowsheet before and after any ventilator adjustment
episode. Simultaneously, they were asked to complete an open-
ended questionnaire related to the process of ventilator adjustment
episode.
Results A total of 168 ventilator adjustment episodes derived from
26 mechanically ventilated patients were evaluated. Among these
episodes, the ventilator mode was adjusted 33 times (20%), the
minute volume 37 times (22%), the positive end-expiratory
pressure 19 times (11%), the pressure support 21 times (12%),
and the fraction of inspired oxygen 61 times (36%). Triggers which
stimulate the process of mechanical ventilator adjustment were
categorized into: routine ventilator checks (35%), routine arterial
blood gases (ABG) (20%), weaning trials (13%), and calls from
nurses (9%). The most common indications to adjust the ventilator
were hyperoxygenation (28%) and weaning trials (26%). Peripheral
oxygen saturation, ABG, and level of consciousness were the most
common considered variables during the process of ventilator
adjustment. In 42% of the total adjustment episodes, clinicians did
not consider any technical, physiological or psychological variable
while they adjusted ventilator parameters. Clinicians based their
decisions to adjust ventilator settings on clinical experience (72%),
trial and error (15%), protocols (11%), and scientific equations
(2%). Clinicians assessed their decisions via ABG results (47%),
peripheral oxygen saturation (23%), and general patient
assessment (9%).
Conclusions  The process of ventilator adjustment is mainly
stimulated by routine ventilator checks and ABG. ABG and
weaning trials are the most common indications. Most ventilator
adjustment decisions are based on clinical experience, evaluated
via ABG and peripheral oxygen saturation.
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Pdi evolution during the study. P <0.05 CV vs. ASV group at 48 hours.S14
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mechanical ventilation is employed in a tertiary-care
hospital
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Introduction Advances in our knowledge of the pathophysiology of
respiratory failure have forced major revisions of our approach to
ventilatory support. We describe how mechanical ventilation is
employed in four different ICUs (surgical, clinical, cardiac and
neurological) of a tertiary-care Brazilian hospital where a ventilatory
support team composed of intensivists is responsible for a daily-
basis follow up.
Methods A prospective observational study enrolled all invasive
mechanically ventilated patients admitted to four ICUs from May
2004 through June 2008. Daily recorded data included:
demographics, diagnosis, modes of ventilation, tidal volume/kg
(Vt), positive end-expiratory pressure (PEEP) level, peak inspiratory
pressure, plateau pressure (Pplat), recruitment maneuvers, use of
sedation and neuromuscular blocking agents (NBA), tracheotomy,
barotrauma, ventilation days, and length of stay (LOS) in the ICU.
Results are expressed as the mean ± SD and percentage.
Differences were assessed by one-way ANOVA followed by the
Tukey test. P <0.05 was considered significant.
Results A total of 1,715 patients was studied. Diagnosis prevailed
depending on the ICU’s characteristics. Ventilatory data are
depicted in Table 1. Recruitment maneuvers were used in less than
2% of patients. The most frequent type of ventilatory mode was
spontaneous (P <0.05). Barotrauma was similar and occurred in
less than 0.63% (P >0.05). Intravenous sedation was administered
for no more than 40% of the time on mechanical ventilation. NBA
was used for no more than 0.25% of patients. LOS and ventilation
days were different among ICUs (P <0.05).
Table 1 (abstract P33)
Ventilatory data
Vt (ml/kg) PEEP (cmH2O) Pplat (cmH2O)
Surgical 6.6 ± 2 8.9 ± 3.2 22 ± 6.3
Clinical 6.6 ± 1.7 8.6 ± 2.7 22 ± 5.9
Neuro 6.7 ± 2.1 8.3 ± 2.3 22.7 ± 4.4
Cardiac 6.8 ± 1.5 8.7 ± 2.1 21.3 ± 4
Conclusions Daily interaction of the ventilatory support team and
the ICU practitioners guaranteed a homogeneous and up-to-date
form of ventilatory support care to the patients in the different
ICUs.
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Introduction  Supplemental oxygen is part of the supportive
treatment of hypoxaemic respiratory failure. Prolonged exposure to
high fractions of inspired oxygen (FiO2) has been shown to be
injurious to the lung in vitro [1]. The optimal paO2 in critical illness
has not been established but the clinical impression is that patients
are frequently exposed to a higher FiO2 than is necessary. The aim
of this study was to investigate current oxygen treatment in
patients undergoing prolonged mechanical ventilation and
determine whether this resulted in exposure to a higher FiO2 than
that required to adequately oxygenate haemoglobin (SaO2 >95%).
Methods  Indices of oxygenation were collected for 30 patients
requiring mechanical ventilation >2 days. Data were collected
4-hourly for 48 hours. The PaO2:FiO2 ratio was determined for
each data point and used to model the theoretical FiO2 required to
maintain an SaO2 of 95% (paO2 = 10.7 kPa).
Results The results are shown in Figure 1. Data are expressed as
medians (IQR). The median observed FiO2 was 0.4 throughout the
study whereas the median FiO2, calculated to maintain an SaO2 of
95%, was 0.3.
Conclusions Our data demonstrate that critically ill patients may
be exposed to a higher FiO2 than that required to maintain
adequate oxygenation. Further, these results highlight an area of
ICU care that has received little study, with no published clinical
trials examining the effect of FiO2 on outcome.
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Introduction Johannesburg Hospital is a level I trauma center in
Gauteng. We routinely do chest X-rays (CXRs) in indicated cases,
if feasible, and prefer to perform a CXR after intercostal drain (ICD)
insertion to maintain quality and direct further care [1].
Methods  A prospective data collection of patients who had
injuries that required the insertion of an ICD over a period of
8 months from 1 August 2006 to 30 March 2007. A questionnaire
was developed and it included the patients’ demographics, mecha-
nism of injury, reason for ICD insertion, findings of both the initial
and post-ICD insertion CXR, change in management and any
acute complications noted.
Results  One hundred and forty patients were identified for the
study, 129 (92.1%) were males and 11 (7.9%) were females. The
average age was 32 (range 11 to 64) years. Eighty-four (60%)
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patients sustained stab wounds and 20 (14.3%) had gunshot
wounds. The remaining 36 (25.7%) sustained blunt injury. One
hundred and four (74.3%) patients had an ICD inserted for both
radiological and clinical findings, while 19 (13.6%) patients had
drains inserted due to radiological findings and 14 (10%) patients
on clinical grounds only. Three (2.1%) patients had drain insertion
after CT scan findings.
In patients who had an initial CXR, clinical and/or radiological find-
ings confirmed 47 (36.7%) patients with haemopneumothoraces,
49 (38.3%) patients with pneumothoraces, 26 patients (20.3%)
with haemothoraces and four (3.1%) patients had significant
surgical emphysema with fractures and two (1.6%) patients had no
abnormalities on CXR. No acute complications to chest tube
insertion were noted.
In 89 (63.6%) patients, the post-ICD CXR showed good position
of the drain with improvement in pathology, in 31 (22.1%) patients
an inadequate ICD position was noted, in 17 (12.1%) patients
significant retained haemothoraces were shown and in three
(2.1%) patients poor lung expansion was detected. The post-ICD
CXR contributed to change in management in 29 (20.7%) of the
cases. Twenty-two (15.7%) patients required a change in position
of the tube, six (4.3%) had surgery performed, and one (0.7%)
patient had their conservative treatment escalated. Four (2.9%)
patients should have had their tubes adjusted.
Conclusions  Routine usage of post-ICD CXR contributes to a
change in management in one out of five trauma patients.
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Introduction  A bedside chest ultrasound (bCUS) programme
performed by intensivists after 18 months of ultrasound training
was introduced in the ICU routine between April and November
2008 in order to evaluate its effects on the number of chest X-ray
(CXR) and CT scans. The setting was a 10-bed emergency ICU.
Methods  From April to November 2008 every patient has
undergone a bCUS within the first 48 hours since admittance, then
between the fourth and the sixth days of their stay. All of the 92
patients were examined supine, with a convex probe perpendicular
to the chest wall, using all the intercostal spaces as the acoustic
window. From the lung base, every intercostal space has been
examined, looking for a pleural effusion, attaining to the following
criteria: a space between the visceral and parietal pleura,
movement of that space in agreement with the respiratory pattern.
As for the volume esteem of the effusion, the distance (mm)
between the posterior part of the lung and the posterior chest wall
was measured. For each patient the following data were collected:
age, sex, weight, height, SAPS II, number of CXR and CT scans
done. Data were compared with those of a group of patients
admitted to the ICU from January to March 2008, when bCUS was
not part of the daily procedures. P <0.05 was considered
statistically significant.
Results  The two groups of patients were statistically
homogeneous. Comparing the control group with the study group,
CXRs were reduced by 22.63% (from 433 to 335; P = not signi-
ficant) and CT scans were reduced by 42.36% (from 144 to 83; P
<0.05).
Conclusions The use of daily routine bCUS is useful to reduce the
traditional radiology requests. The decrease of CT scans is
statistically relevant. As far as CXR requests are concerned, the
decrease does not appear significant since the CXR is relatively
easy to perform and it is mandatory after radiopaque device
positioning. These amount to 34% of the total CXRs performed.
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Introduction Protective ventilation with low tidal volumes became
the standard of care in acute lung injury (ALI). Although spon-
taneous breathing activity may be beneficial even in early ALI,
protective ventilation is usually performed as controlled ventilation.
Theoretically, pressure support ventilation (PSV) may be advan-
tageous over pressure-controlled ventilation (PCV), particularly if
combined with variability in the form of noisy PSV [1,2].
Methods Two protocols (A and B) were performed in pigs (20 to
30 kg). Animals were anesthetized, intubated, mechanically venti-
lated and ALI was induced by surfactant depletion. In protocol A,
animals (n = 12) were randomly assigned to a sequence of PCV,
PSV and noisy PSV, being ventilated for 1 hour in each mode
(crossover design). The distribution of lung aeration and perfusion
were determined. In protocol B, animals (n = 24) were randomly
assigned to 6 hours of mechanical ventilation with PCV or PSV or
noisy PSV, and lungs were extracted for quantification of
inflammation and lung damage. In both protocols, gas exchange
and respiratory parameters were determined. Statistical analysis
was performed with univariate and multivariate tests, as appro-
priate. Significance was accepted at P <0.05.
Results Compared with PCV, arterial oxygenation, intrapulmonary
shunt, mean airway pressure and elastance of the respiratory
system were improved by PSV and further improved by noisy PSV.
Also, noisy PSV reduced the work of breathing and respiratory
drive compared with PSV. Lung damage and inflammation were
reduced by assisted mechanical ventilation, but comparable
between noisy PSV and PSV. The distribution of lung aeration did
not differ among the three modes, but PSV and noisy PSV were
associated with more redistribution of pulmonary blood flow
towards better aerated ventral areas compared with PCV.
Conclusions  The combination of variability with PSV enhances
lung protection and function in experimental ALI. The main
mechanism of improvement of lung function by assisted
mechanical ventilation using pressure support is not recruitment of
dorsal areas, but rather redistribution of pulmonary blood flow to
ventral zones.
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Introduction Acute respiratory distress syndrome (ARDS) is a life-
threatening situation in patients on the ICU. Most patients have to be
ventilated mechanically to provide adequate oxygenation. Reduction
of tidal volumes as low as 6 ml/kg adjusted bodyweight has been
convincingly shown to reduce ARDS and mortality in the ARDSnet
trial [1] and is now recommended in treating such patients. In the
ARDSnet trial, body weight has been calculated by a formula
implementing the body height [1]. We suggest that in most patients
on ICUs the correct height is not known or is at best estimated, but
very seldom correctly measured. We searched for both an easily ob-
tainable and reproducible body mark to correctly predict body height.
Anthropological and forensic data have shown a close correlation
between the ulna length and body size. We prospectively measured
body height and right and left ulna length in ventilated ICU patients.
Methods In a 2-month period, 39 men and 42 women from four
ICUs in a teaching hospital were included consecutively (mean age
62 years, range 23 to 87 years). Body height was measured
following a standardized protocol, ulna length was measured from
the edge of the olecranon to the caput ulnae.
Results Eighty-one patients were included. Thirty-nine men: height
145 to 199 cm (mean 178.5 cm), right ulna 25 to 32 cm (mean
28.3 cm), left ulna 24.5 to 32 cm (mean 28.3 cm). Forty-two
women: height 142 to 185 cm (mean 165.7 cm), right ulna 21 to
29 cm (mean 25.0 cm), left ulna 21 to 28 cm (mean 24.9 cm).
Regression analyses were made in SAS 9.1 and showed a
significant correlation between the body height (men and women)
and the length of the ulna. Regression analyses for men: body
height in cm = 3.9314 x (right ulna; in cm) + 67.059 cm
(r2 = 53.25%; SD = 6.79) and body height in cm = 3.9786 x (left
ulna; in cm) + 65.824 cm (r2 = 52.50%; SD = 6.84). Regression
analyses for women: body height in cm = 4.88 x (right ulna; in cm)
+ 43.76 cm (r2 = 55.53%; SD = 6.61) and body height in cm =
5.41 x (left ulna; in cm) + 30.95 cm (r2 = 60.67%; SD = 6.21).
Conclusions Ulna length is an easily obtainable estimate of total
body height. It may aid in implementing low-tidal-volume ventilation.
Anthropological data correlate reasonably with a contemporary
ventilated ICU population. Whether ulna-derived estimates of body
height may improve adherence to established guidelines has to be
studied.
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Introduction Pleural effusion is a common finding in acute lung
injury/acute respiratory distress syndrome (ALI/ARDS) patients.
However, the effect of pleural effusion on gas exchange, respira-
tory mechanics and response to positive end-expiratory pressure
(PEEP) in ALI/ARDS patients, during mechanical ventilation, has
never been prospectively studied.
Methods Patients with a diagnosis of ALI/ARDS, who underwent a
CT scan at 5 cmH2O PEEP for clinical reasons, were included in
the study. Lung and pleural effusion were outlined separately; lung
total weight and pleural effusion volume were computed with
dedicated software. A PEEP test at 5 and 15 cmH2O with
constant minute ventilation was performed. Exclusion criteria were:
age <18 years, hemodynamic instability, chronic obstructive pul-
monary disease and evidence of barotrauma.
Results We enrolled 11 ALI/ARDS patients (10 male). The mean
clinical characteristics on admission to the ICU were: age 67.5 ± 9.9
years, BMI 24.4 ± 2.1 kg/m2, PaO2/FiO2 203.1 ± 56.1 mmHg,
PEEP 9.1 ± 2.8 cmH2O and pH 7.394 ± 0.048. The volume of
pleural effusion was not significantly related with the change in
PaCO2 (r2 = 0.068; P = 0.437), PaO2 (r2 = 0.015; P = 0.722) and
dead space (VD/VT) (r2 = 0.019; P = 0.682) going from PEEP 15
to PEEP 5 cmH2O.
Conclusions Pleural effusion does not seem to influence the gas-
exchange response to PEEP.
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Introduction CT-scan lung morphology (lobar or nonlobar) is the
main determinant of positive end-expiratory pressure (PEEP)
response. Repartition of gas and tissue probably influences the
response to a recruitment maneuver (RM), but to date there is no
proof. The aim of this study was to assess RM-induced changes in
lung morphology and gas exchange during and after RM in acute
respiratory distress syndrome (ARDS) patients.
Methods Nineteen patients with ARDS were included in the study.
Patients were ventilated with volume control ventilation (Gallileo;
Hamilton Medical, Bonaduz, Switzerland) with Vt = 6 ml/kg (ideal
body weight) and respiratory rate to keep PaCO2 >55 mmHg
without intrinsic PEEP. After a first CT scan in zero end-expiratory
pressure conditions, a pressure–volume curve was performed and
the PEEP was set above the lower inflection point. After a
stabilisation period, a second CT scan (in PEEP) was performed.
Then a RM was performed, using continuous positive airway
pressure 40 cmH2O for 40 seconds. At the end of the RM
(between 35 and 39 s) a third CT scan was performed. Five
minutes after the RM, a fourth CT scan was performed in PEEP
conditions (same level of PEEP). Blood gas analysis was sampled
at each step of the study. CT-scan analysis was performed using
specific volumetric software (IRMA).
Results  Ten men and nine women, 63 ± 11 years old, were
included in the study. SAPS II was 44 ± 8. Nine presented a
nonlobar CT-scan attenuation and eight a focal loss of aeration. All
patients presented early ARDS (onset between ARDS diagnostic
and study inclusion was 18 ± 11 hours). Setting PEEP 2 cmH2O
above the lower inflection point increased PaO2/FiO2 from
167 ± 110 to 205 ± 72 mmHg (P <0.001), and 265 ± 80 mmHg
after the RM (P <0.005 vs. PEEP) and 273 ± 96, 5 minutes after
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the RM. The RM-induced recruited volume at the same level of
PEEP was 8 ± 45 ml in the case of lobar CT-scan attenuation
versus 96 ± 63 ml in nonlobar CT-scan attenuation (P <0.005).
The overinflated lung volume after RM was 121 ± 170 ml in the
case of lobar attenuation versus 18 ± 22 ml in diffuse (P <0.005).
During the RM, the overinflated lung volume was over 50% in the
case of lobar CT-scan attenuation.
Conclusions As for PEEP, lung morphology predicts the response
to a RM. In the case of lobar loss of aeration, RM induced
overinflation more than the recruited volume and should be
avoided.
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Introduction  Different levels of positive end-expiratory pressure
(PEEP) associated or not with alveolar recruitment maneuver
(ARM) may have a significant impact on ventilator-induced lung
injury [1], but this issue has not been well addressed in a model of
lung injury using inhaled hydrochloric acid. We aimed to evaluate
the effects of PEEP and ARM on respiratory mechanics and lung
tissue in an inhaled hydrochloric acid acute lung injury (ALI) model.
Methods Thirty-two pigs (22.9 ± 2.8 kg), were randomly allocated
into one of four groups (I – Control-PEEP, II – Control-ARM, III –
ALI-PEEP, IV – ALI-ARM). ALI was induced by intratracheal
instillation of hydrochloric acid. PEEP values were progressively
increased and decreased from 5, 10, 15 and 20 cmH2O in all
groups. Three alveolar recruitment maneuvers of 40 cmH2O for
20 seconds were applied to the assigned groups at each interval
of PEEP level increase or decrease. Histological analysis was
made to evaluate the presence of inflammatory infiltrates, alveolar
wall thickening, atelectasis, hemorrhage, alveolar edema and
alveolar disruption. Histomorphometrical analyses of the lungs
were also performed to determine alveolar dimensions.
Results  Inflammation and alveolar disruption were statistically
greater in group II when compared with group I. There were no
statistical differences between groups III and IV with respect to
hemorrhage, alveolar edema, inflammation and alveolar disruption.
Mean alveolar area and mean alveolar intercept were higher in
group IV when compared with groups I and II (P <0.05). The mean
alveolar area was significantly smaller in the diaphragmatic lobes
when compared with other middle and upper pulmonary lobes, but
no statistical difference was found among groups.
Conclusions  The association of PEEP with ARM promoted a
greater degree of alveolar disruption.
Acknowledgement  Grants from LIM08-Anesthesia; FAPESP
02/08621-1.
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Introduction Postoperative pulmonary dysfunction in patients under-
going cardiac surgery with cardiopulmonary bypass is a significant
clinical problem and has long been recognized. Postoperative hypox-
emia carries high morbidity leading to prolonged postoperative
recovery and hospital stays. We hypothesized that adding high posi-
tive end-expiratory pressure (PEEP) would be effective for treatment
of postoperative hypoxemia after cardiac surgery with cardiopul-
monary bypass, independently of the mode of ventilation or the use
of nitric oxide.
Methods During 2 years, 210 patients undergoing coronary artery
bypass with pump surgery after diagnosis of hypoxemia (PO2/FiO2
<200) were randomized into six groups after operation (35 in each
group): pressure-controlled ventilation (PCV) with inhaled nitric
oxide and ideal PEEP (group 1), PCV without inhaled nitric oxide
and ideal PEEP (group 2), PCV without inhaled nitric oxide and
PEEP 5 cmH2O (group 3), volume-controlled ventilation (VCV)
with inhaled nitric oxide and ideal PEEP (group 4), VCV without
inhaled nitric oxide and ideal PEEP (group 5) and VCV without
inhaled nitric oxide and PEEP 5 cmH2O (group 6). Arterial and
mixed venous blood were drawn and analyzed before the interven-
tions, 1, 2, 4 and 6 hours after the interventions in the ICU to deter-
mine the PaO2/FiO2 ratio. Hemodynamic measurements were
analyzed. The time to extubation was compared among groups,
accordingly to the ICU weaning protocol.
Results  There was no significant difference among the groups
regarding hemodynamic measurements (mean arterial blood pres-
sure, heart rate, central venous pressure and SVO2). Oxygenation
was higher in both high-PEEP groups (groups 1, 2, 4 and 5) than
in the PEEP 5 groups (groups 3 and 6) during the mechanical ven-
tilation period (P <0.01). Also, the time to extubation was signifi-
cantly lower in high PEEP groups than in the PEEP 5 groups (220
min vs. 428 min, P <0.03).
Conclusions Ventilation with high PEEP after cardiac surgery is
associated with improvement of oxygenation and less time of
mechanical ventilation independently of the mode of ventilation and
of the use of nitric oxide.
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Introduction  An automated respiratory mechanics control was
developed to individually adapt the energy transfer from the
Available online http://ccforum.com/supplements/13/S1S18
ventilator to the respiratory system. The controller titrates the
positive end-expiratory pressure (PEEP) and tidal volume (VT) to
ventilate the lung at its maximal compliance in order to avoid
excessive lung overinflation as well as underinflation.
Methods The mechanics controller consists of a software program
to set PEEP and VT and a user interface to observe the compli-
ance and the controller state. The program has following structure:
(1) Dynamic compliance is calculated breath by breath using the
implemented slice function [1]. This function divides VT into six
consecutive volume slices of equal size. (2) For each volume slice,
one value of dynamic compliance (CSLICE) is determined by least-
squares fit using the linear resistance and compliance model within
each slice [2]. The six CSLICE values are plotted over the
corresponding volume, giving the compliance–volume curve. (3)
The shape-compliance function of the controller identifies one out
of six shape categories [3]. (4) The PEEP and VT-change function
calculates the PEEP and VT titration depending on the shape
category and sends a command to the ventilator for setting the
new PEEP and VT automatically.
Results The system was tested with previously recorded patient
data (McRem) [4]. The compliance controller retrospectively
analysed the respiratory data and determined the shape category
depending on the course of CSLICE. For shapes representing an
intratidal increase of CSLICE, the controller increased the PEEP. A
reduction of PEEP occurred when CSLICE decreased intratidally.
PEEP was maintained when CSLICE was maximal and constant.
Furthermore, for hybrid shape categories (one part in the linear
region and one part in the increasing and/or decreasing region) the
VT was reduced.
Conclusions The automated respiratory mechanics control system
titrates PEEP and VT automatically until intratidal compliance
reaches its maximal value within an appropriate VT.
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Introduction The optimal positive end-expiratory pressure (PEEP)
is a balance between the prevention of overdistention in the
nondependent part and alveolar collapse in the dependent part.
Electrical impedance tomography (EIT) has been introduced to
monitor regional change of ventilation at the bedside. We
evaluated the effect of changes in PEEP on regional ventilation in
mechanically ventilated patients with or without lung disorders.
Methods  Functional EIT (fEIT) images were obtained in 14
patients on pressure-controlled ventilation with constant driving
pressure at four PEEP levels (15, 10, 5 and 0 cmH2O). fEIT
images made before each reduction in PEEP were subtracted from
those recorded after each PEEP step to evaluate the regional
increase/decrease in tidal impedance in each EIT pixel.
Results  The response of regional tidal impedance to PEEP
showed a significant difference from 15 to 10 cmH2O (P = 0.002)
and from 10 to 5 cmH2O (P = 0.001) between patients with and
without lung disorders (Figure 1). During the decrease in PEEP
from 15 to 10 cmH2O, tidal impedance increased in the ventral
parts in both groups, but decreased markedly in the dorsal parts in
the patients with lung disorders. From PEEP 10 to 5 cmH2O, tidal
impedance increased in the ventral parts and decreased in the
dorsal parts in patients without lung disorders, whereas in patients
with lung disorders tidal impedance decreased in both regions.
Lowering the PEEP from 5 to 0 cmH2O decreased tidal
impedance in both regions in both groups.
Conclusions During a decremental PEEP trial, EIT can visualize
improvement or loss of ventilation in dependent and nondependent
parts, indicating lung collapse or decreased overdistention.
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Introduction Monitoring the end-expiratory lung volume (EELV) is a
valuable tool to optimize respiratory settings that could be of
particular importance in mechanically ventilated pediatric patients.
We evaluated the feasibility and precision of an ICU ventilator with
an inbuilt nitrogen washout/washin technique in mechanically
ventilated pediatric patients.
Methods  Duplicate EELV measurements were performed in 26
patients between 5 and 30 kg after cardiac surgery. All
measurements were taken during pressure-controlled ventilation at
0 cmH2O positive end-expiratory pressure (PEEP).
Results Linear regression between duplicate measurements was
excellent (R2 = 0.99). Also, there was good agreement between
duplicate measurements, bias –1.0% (–1.7 ml) ± 5.7% (15.5 ml)
(Figure 1). The mean EELV was 18.9 ± 4.4 ml/kg at 0 cmH2O
PEEP. The EELV correlated significantly with age (P <0.001,
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r = 0.92, R2 = 0.79), body weight (P <0.001, r = 0.90, R2 = 0.77)
and height (P <0.001, r = 0.90, R2 = 0.79).
Conclusions This ICU ventilator with an inbuilt nitrogen washout/
washin EELV technique can measure EELV with precision, and can
easily be used for mechanically ventilated pediatric patients.
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Introduction Intraabdominal hypertension is a condition affecting
respiratory mechanics in many situations such as laparoscopy or
morbid obesity. We investigated the effects of different intra-
abdominal pressures (IAP) at different positive end-expiratory pressure
(PEEP) levels on nonlinear respiratory mechanics and the effects on
hemodynamics and oxygenation in a rat model. The application of a
pneumoperitoneum served as a model for elevated IAP.
Methods  A helium pneumoperitoneum was established in 20
anesthetized female Wistar rats that were randomly allocated to
one of four PEEP levels (0, 3, 6 and 9 mbar). IAP of 9, 12, 15 and
18 mbar was instilled in a random sequence in each rat, followed
by respiratory mechanics measurement and blood gas analysis.
From the low flow maneuvers’ pressure–volume loops, the lower
inflection point and the mathematical turning point within the
expiratory limb were detected and compared with the IAP applied
during the measurement. For investigation of the lung’s intratidal
compliance, 10 consecutive breaths before and after low flow
maneuvers were analyzed. Intratidal nonlinear compliance was
calculated using a modified SLICE method [1].
Results A higher IAP led to a decreased steepness of quasi-static
pressure–volume loops resulting in a right shift of the expiratory
lower inflection point. The pressure at the mathematical turning
point of the expiratory limb correlated well with the IAP (r = 0.97,
P <0.001). Intratidal compliance decreased with increasing IAP
before and after the low flow maneuvers. After execution of the low
flow maneuvers the compliance increased. Relative compliance
gain caused by the low flow maneuvers was dependent on PEEP,
IAP and slice (all P <0.001). The peak inspiratory pressure
increased with increasing IAP and was significantly smaller after
recruitment maneuvers (P <0.001). The peak inspiratory pressure
was dependent on PEEP and IAP (P <0.001). PaO2 was dependent
on PEEP (P = 0.008) but not on IAP (P = 0.153). Arterial pressure
was not dependent on PEEP (P = 0.068) or IAP (P = 0.292).
Conclusions  Intraabdominal hypertension alters respiratory
mechanics. IAP has no effect on oxygenation as long as PEEP is
applied. The examination of nonlinearity holds important information
for the evaluation of respiratory mechanics. The success of recruit-
ment maneuvers on healthy lungs depends strongly on the IAP.
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Introduction Vibration response imaging (VRI) is a bedside lung
sound monitoring system. The VRI measurement has been proven
sensitive to changes in ventilator settings, including changes in the
mode of mechanical ventilation or in positive end-expiratory
pressure (PEEP). In the present study, we correlate lung sound
distribution with functional residual capacity (FRC).
Methods Thirty-nine lung sound measurements were performed on
seven mechanically ventilated critically ill patients at different levels
of PEEP before and after recruitment maneuver. The FRC was
obtained for each measurement. Lung sound distribution was
monitored using the sound distribution index (SDI), an index
revealing the lung sound distribution at peak inspiration and
computed from the percentages of lung sound distribution in four
lung segments (right lower (RL), left lower (LL), right upper (RU),
left upper (LU)) as SDI = 100 – abs(RL + LL – RU – LU) / 2 –
abs(RU + LU – RL – LL) / 2 (range 0% to 100%). P values were
obtained using the Wilcoxon two-sample test.
Results Significantly increased mean (± SD) SDI was registered in
cases with higher FRC. In two out of five measurements with FRC
above 2.9 l, a low SDI was obtained (~70%).
Conclusions Lung SDI significantly increased with FRC. At very
high volumes, a decreased SDI may indicate possible hyperinflation.
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Introduction Improvement of oxygenation during acute lung injury
(ALI) and acute respiratory distress syndrome (ARDS) requires a
high level of positive end-expiratory pressure (PEEP) to recruit
nonaerated lung zones and decrease pulmonary shunt. However,
monitoring of alveolar recruitment at the bedside is difficult, as
neither the PaO2/FiO2 ratio, thoracopulmonary compliance or
generation of pressure curve are indices of alveolar recruitment
and avoidance of lung hyperinflation. Monitoring of the functional
residual capacity (FRC) at the bedside may be useful to monitor
directly lung recruitment and to optimize the PEEP level [1]. The
aims of this study are to evaluate the FRC by a modified nitrogen
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multiple washout technique (NMBW) in ALI/ARDS patients, and to
set PEEP levels on data of FRC values.
Methods Twenty patients with ALI/ARDS were enrolled in the study.
All patients were ventilated in pressure-controlled ventilation with an
Engstrom carestation ventilator (GE Healthcare, Helsinki, Finland) in
accordance with the ARDSnet guidelines. FRC measurement was
carried out with the COVX module integrated within the ventilator (GE
Healthcare) by a NMBW technique. Every patient had a basal FRC
measurement and then three measurements at PEEP 15/10/5
cmH2O during a derecruiting maneuver. After all measurements, PEEP
was set as the PEEP at which value FRC started to decrease. At
basal time (T0) and after setting the best PEEP (T1) the PaO2/FIO2
ratio and static compliance were measured too. All data are reported
as the mean ± SD. A t test was used to compare changes during time.
Results Table 1 presents the main results of the study.
Table 1 (abstract P48) 
Parameter T0 T1
FRC (ml) 2,330 ± 400 2,933 ± 300*
PaO2/FiO2 164 ± 74 251 ± 107*
Compliance (ml/cmH2O) 38 ± 12 49 ± 15*
*P <0.05 T1 vs. T0.
Conclusions  FRC measurement by the NMBW technique
integrated in the ventilator is useful to assess functional lung
impairment at the bedside. Setting PEEP on FRC measurements
may improve lung recruitment and oxygenation, but anatomical
studies (CT scan) are also warranted.
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Introduction Early identification of progression to acute lung injury
(ALI) in patients at risk may change therapy and potentially improve
outcome. Central to the pathogenesis of ALI is pulmonary micro-
vascular injury and increased permeability resulting in pulmonary
edema. We proposed that the pulmonary vascular permeability
index (PVPI) (extravascular lung water (EVLW) (ml) / pulmonary
blood volume (PBV) (ml)) reflects the severity of this injury and
predicts progression to ALI in patients at risk.
Methods The PVPI was measured prospectively in 27 patients
who either were at increased risk to develop ALI (n = 17) or who
had ALI on presentation (n = 10) for the first 5 days after
admission to the ICU.
Results Ten out of 17 patients at risk for ALI progressed to it. The
mean (± SEM) PVPI on day 1 was lower in patients who did not
develop ALI vs. those that did (1.4 ± 0.1 vs. 2.6 ± 0.4, P = 0.01) in
the 17 patients who did not have ALI on presentation (Figure 1).
There was no difference in PVPI for those that developed ALI vs.
those that had it on presentation (2.6 ± 0.4 vs. 2.7 ± 0.3, P = 0.5).
A cutoff PVPI value of 1.9 or less discriminated those that would
not develop ALI from those who did or who had it on presentation
with a sensitivity and specificity of 100% and 85%, respectively
(Figure 2).
Conclusions Increased PVPI is a feature of early ALI and predicts
progression to ALI in patients at increased risk. Early identification
of patients with elevated PVPI and who are at risk to develop ALI
may lead to consideration of early initiation of lung protective
ventilator strategies.
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Introduction Electrical impedance tomography (EIT) is a promising
bedside device with the potential to assess changes in regional
ventilation and lung blood flow [1]. The purpose of our study was
to monitor lung images and changes in impedance by EIT in a
model of hemorrhagic shock with endotoxemia followed by fluid
resuscitation.
Methods  Twelve anesthetized, mechanically ventilated, supine
pigs were submitted to hemorrhagic shock (50% blood volume)
and endotoxin infusion. Animals were randomly allocated to control
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(n = 6) or a treatment group with lactated Ringer’s (n = 6). The
mean arterial pressure (MAP), central venous pressure (CVP),
blood gas, extravascular lung water index (EVLWI), intrathoracic
blood volume index (ITBVI), lung compliance and pulmonary EIT
(Dräger, Germany) were measured before shock (Tbasal), 60 minutes
after hemorrhagic shock (Tshock) and hourly in the treatment period
(T1, T2 and T3). Statistical analysis was based on one-way ANOVA
(P <0.05).
Results In Tshock there was a significant decrease in MAP, CVP,
SvO2, lung compliance, cardiac index, EVLWI and ITBVI and an
increase in lactate (P <0.05). Fifty percent of control animals died
between T2 and T3. In treated animals, at T3 the EVLWI reached
values near those of Tbasal whereas ITBVI remained below baseline
(P <0.05) and above Tshock (P <0.05). There was sensible change
in functional EIT images (Figure 1) and significant differences in
impedance along time. Significant global impedance change
occurred in T2 relative to Tshock (P <0.05). Most of the EIT changes
were attributable to the ventral lobes (local1), which showed
significant differences in T2 and T3 relative to Tbasal (P <0.05) and
of T1, T2 and T3 relative to Tshock (P <0.05).
Conclusions  Pulmonary impedance changes induced by the
proposed model of shock and resuscitation were monitored
successfully with the EIT device. Changes were suggestive of
alterations in regional ventilation and ventilation–perfusion
mismatch.
Acknowledgement  Grants from FAPESP 08/50063-0,
08/50062-4 and LIM08/FMUSP.
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Introduction  Electrical impedance tomography (EIT) has the
potential for bedside monitoring of regional lung function.
Evaluation of EIT imaging requires the identification of the lung
area in the images. A functional EIT-based method (fEIT) has been
proposed to identify the lung area in EIT images for patients with
healthy lungs [1,2]. However, in patients with certain lung
diseases, the fEIT method will fail to include those lung regions
where a low ventilation change is present. Besides, identified lung
regions may include the cardiac-related area. A method to estimate
the lung area accurately is missing. The aim of this study was to
develop an improved method for lung area estimation in EIT images
(LAE), which is suitable for both healthy subjects and patients with
serious pulmonary diseases.
Methods In our LAE method, the lung area as determined by fEIT
is mirrored and the cardiac-related area, which is distinguished in
the frequency domain, is subtracted. Forty-nine mechanically
ventilated patients were investigated (test group: 39 patients,
thoracic surgery; control group: 10 patients, orthopedic surgery
without pulmonary disease). An EIT video sequence of 5 minutes
duration comprising about 60 breathing cycles from every
participant was recorded and subsequently analyzed. Statistical
analysis was performed by one-way ANOVA. P <0.01 was
considered statistically significant. Data are presented as means
and standard deviations.
Results It is assumed that the fraction of the lung in the thorax for
different people should be more or less in the same range, in spite
of the state of the lung. The sizes of the lung area determined with
fEIT are in control group S_C, fEIT = 361 ± 35.1 and in test group
S_T, fEIT = 299 ± 60.8 (P  <0.01). On the contrary, the sizes
estimated with the LAE method are in control group S_C, LAE =
353 ± 27.2 and in test group S_T, LAE = 353 ± 61.1 (P = 0.41).
Conclusions The result demonstrates that the novel LAE method
can better access the lung region in EIT images, from which the
analysis of regional lung ventilation will benefit. Further validation
will be pursued by comparing the results with anatomic computed
tomography image of the chest morphology.
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Introduction  Micromechanical properties of alveolar walls are
needed for finite element modeling of the lung that in turn may be
used to guide mechanical ventilation therapy. The aim of this
project is to develop an endomicroscopic device [1] to measure
the local mechanics of alveolar walls in vitro and in vivo under
varying conditions. Here we report on the development and the
evaluation of the endoscopic system, which is – on the first run –
performed in an artificial environment (bioreactor) with known
mechanical properties.
Methods A system of two concentric trocars was built to adjust
and monitor the local pressure by means of a flushing fluid in the
endoscopic field of view. The fluid is pumped through the double
trocar system that is surrounding the endoscope. By adjusting the
flow rate of the fluid, the mean pressure P2 in the endoscopic field
of view, can be kept constant. The alveolar pressure is changed by
adjusting the airway pressure P1. The transpulmonary pressure
(Pt) for the observed subpleural alveoli is thus Pt = P1 – P2
(Figure 1b). Pt is varied by applying different continuous positive
airway pressure values to animal-model airways. The mechanical
reaction of the observed alveoli is, thereby, recorded by video
endoscopy. Assuming that the recorded outlines reflect changes in
the diameter of an observed alveolus allows calculation of
mechanical properties such as the stress–strain relationship of the
alveolar wall. For evaluation, the endoscopic system is applied to
an artificial membrane with known mechanical properties in a
bioreactor. A pattern of particles on the membrane allows
quantifying the three-dimensional deformation under pressure
changes. Mechanical membrane properties can be determined by
the relation between membrane-deformation and transmembrane
pressure Pm = Pa – Pb (Figure 1a).
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Results Preliminary results were obtained in the bioreactor with a
polymer membrane (polydimethylsiloxan) of 100 μm thickness.
Graphite particles were used to produce a particle pattern.
Deformation due to different Pt′ was observed and recorded
successfully.
Conclusions The in vivo estimation of micromechanical properties
such as the stress–strain relationship of elastic walls is feasible.
For that, the developed system has to be technically optimized.
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Introduction  In several studies it has been shown that inhaled
pulmonary vasodilators (NO and iloprost) can decrease the
pulmonary hypertension and also improve the oxygenation during
acute respiratory distress syndrome (ARDS) [1]. We investigated
the effects of prone and supine positioning on the effects of
inhaled iloprost in an animal-ARDS model.
Methods After approval of the animal ethics committee, 10 pigs
were anesthetized and intubated. Invasive systemic and pulmonary
arterial catheterizations were performed (T1). ARDS was induced
in all animals with the infusion of oleic acid (0.15 to 0.30 ml/kg).
The study design is shown in Figure 1. Hemodynamic and
respiratory parameters and ventilation parameters were measured;
arterial and mixed venous blood samples were drawn; and were
recorded in T1 to T6. Pigs were ventilated in volume-controlled
ventilation mode with FiO2 100%, with 4 cmH2O positive end-
expiratory pressure (PEEP) in the beginning and with 8 cmH2O
PEEP after induction of ARDS. Statistical analysis was made with
Student’s t test, repeated measures of ANOVA (with Tukey as the
post-hoc test) and paired t tests. P <0.05 was significant.
Results There was no significant difference between the sequences.
Iloprost decreased the mean pulmonary arterial pressure in both
supine (37 vs. 31 mmHg) and prone (38 vs. 29 mmHg) positions
significantly, but there was no significant difference between both
positions. Prone position was associated with an improvement in
oxygenation compared with supine position both with or without
iloprost application. There was no spillover effect of iloprost.
Conclusions  Iloprost decreased pulmonary arterial pressures in
both positions. On the other hand, the prone position improved
oxygenation. The decrease in pulmonary arterial pressures and
improvement in oxygenation was better in prone position +
iloprost; however, these findings were not statistically significant.
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Introduction Endothelial injury is an important prognostic factor in
acute respiratory distress syndrome (ARDS) [1,2]. Vascular endo-
thelial growth factor (VEGF) plays a critical role in endothelial
destruction and angiogenesis [3]. The expression of VEGF in
ARDS varies, depending on epithelial and endothelial damage
[4,5]. The objective of this study was to investigate the expression
of VEGF in lung tissue from ARDS patients.
Methods  Lung specimens were obtained by autopsy from 10
patients with severe ARDS and were compared with a control
group of 10 non-ARDS patients autopsied. All lung samples were
stained for standard histopathological analysis and for immuno-
histochemical methods using a specific mouse monoclonal
antibody.
Results  Compared with expression in non-ARDS control
individuals, pulmonary expression of VEGF was significantly
decreased (P <0.001) in ARDS patients. Alveolar macrophages
were similarly immunopositive in both groups. No differences were
noted with regard to the individual patient’s characteristics (age,
gender, period of ARDS condition, number of ICU days).
Conclusions  A decrease in alveolar type II cellularity, due to
apoptosis, has been observed during ARDS that may reduce the
production of VEGF in the alveolar space and may participate in
the decrease in lung perfusion.
Acknowledgement  Research Grant No. 136/IDEI from the
National Authority of Scientific Research, Romania.
References
1. Medford ARL, Millar AB: Vascular endothelial growth factor
(VEGF) in acute lung injury (ALI) and acute respiratory dis-
tress syndrome (ARDS): paradox or paradigm? Thorax
2006, 61:621.
2. Dvorak HF: Angiogenesis: update 2005. J Thromb Haemost
Critical Care    March 2009 Vol 13 Suppl 1 29th International Symposium on Intensive Care and Emergency Medicine
Figure 1 (abstract P52) Figure 1 (abstract P53)
Ilop, iloporost; Pron, prone; Sup, supine.S23
2005, 3:1835-1842.
3. Gerber HP, Wu X, Yu L, Wiesmann C, et al.: Mice express-
ing a humanized form of VEGF-A may provide insights
into the safety and efficacy of anti-VEGF antibodies. Proc
Natl Acad Sci U S A 2007, 104:3478-3483.
4. Fehrenbach H: Development of the pulmonary surfactant
system. Pneumologie 2007, 61:488.
5. Shibuya M: Differential roles of vascular endothelial
growth factor receptor-1 and receptor-2 in angiogenesis. J
Biochem Mol Biol 2006, 39:469-478.
P55
The selective α α7 nicotinic acetylcholine receptor agonist
GTS-21 attenuates ventilator-induced inflammation and
lung injury
M Kox, JC Pompe, M Vaneker, LM Heunks, JG Van der Hoeven,
CW Hoedemaekers, P Pickkers
Radboud University Nijmegen Medical Centre, Nijmegen, the
Netherlands
Critical Care 2009, 13(Suppl 1):P55 (doi: 10.1186/cc7219)
Introduction Mechanical ventilation (MV) induces an inflammatory
response that contributes to lung injury such as in acute lung injury
or acute respiratory distress syndrome. The efferent vagus nerve
can limit the inflammatory response via the α7 nicotinic acetyl-
choline receptor (α7nAChR), the so-called cholinergic anti-inflam-
matory pathway. The aim of this study was to evaluate the effect of
the selective α7nAChR agonist GTS-21 on pulmonary and
systemic inflammation and lung injury induced by MV using
clinically relevant ventilator settings.
Methods C57BL6 mice (n = 40) were intraperitoneally injected
with 8 mg/kg GTS-21 or placebo, after which they were
mechanically ventilated for 4 hours (tidal volume 8 ml/kg; positive
end-expiratory pressure 1.5 cm H2O; FiO2 0.45). Untreated, not
mechanically ventilated mice were used as controls. Arterial blood
gases were obtained at the end of the experiment and TNFα, IL-6,
IL-1α, IL-1β, keratinocyte-derived cytokine (IL-8 homologue) and
IL-10 were determined in plasma and lung homogenates. Lung
TNFα and IL-10 mRNA expression was measured using
quantitative PCR.
Results In GTS-21-treated mice, the alveolar–arterial gradient after
MV was significantly reduced compared with placebo (14.0 ± 0.76
vs. 16.2 ± 0.59 kPa; P = 0.03). MV resulted in an increase of all
cytokines in plasma and lung compared with control mice. TNFα
was significantly lower in plasma of GTS-21-treated animals
compared with placebo (196.2 ± 50.8 vs. 331.9 ± 31.9 pg/ml;
P = 0.04). Similarly, in lung homogenates a distinct trend was
observed towards lower TNFα levels in GTS-21-treated mice
(53.9 ± 12.5 vs. 79.1 ± 5.6 pg/mg protein; P = 0.06). IL-10 levels
were unaffected by GTS-21. MV strongly increased TNFα mRNA
expression in lungs of placebo animals (21-fold compared with
controls); this was significantly lower in GTS-21-treated mice (11-
fold compared with controls; P = 0.02). IL-10 mRNA expression
was similar in GTS-21-treated and placebo animals.
Conclusions MV with clinically relevant ventilator settings results
in activation of the immune system. GTS-21 inhibits proinflam-
matory cytokine production while not affecting the anti-inflam-
matory cytokine IL-10. The reduced alveolar–arterial gradient in
GTS-21-treated animals indicates attenuation of lung injury. In
conclusion, limiting the inflammatory response appears to reduce
lung injury, and therefore the cholinergic anti-inflammatory pathway
may represent new treatment options for MV-induced lung injury.
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Introduction A retrospective observational study was conducted
to evaluate whether the plasma level of soluble E-selectin [1] might
be a specific pathologic marker of acute lung injury/acute
respiratory distress syndrome (ALI/ARDS).
Methods The data of 52 critically ill patients admitted to the ICU
with systemic inflammatory response syndrome and initiated on
mechanical ventilation were retrospectively evaluated.
Results The plasma levels of soluble E-selectin determined within
24 hours of admission were significantly correlated with the
Sequential Organ Failure Assessment scores determined within
24 hours of admission. Furthermore, the scores for both respiratory
failure (evaluated by the PaO2/FiO2 ratio) and liver dysfunction
(evaluated by the serum bilirubin value) in the Sequential Organ
Failure Assessment scoring system were significantly correlated
with plasma levels of soluble E-selectin. In relation to respiratory
failure, the plasma level of soluble E-selectin was higher in patients
with ALI/ARDS than in those without (Figure 1), and receiver
operating characteristic analysis revealed that this parameter might
be a specific marker of ALI/ARDS (Figure 2).
Conclusions Soluble E-selectin might be specific and useful marker
for the clinicopathologic assessment of ALI/ARDS in critically ill
patients with systemic inflammatory response syndrome. However,
further investigation is clearly needed to determine whether soluble
E-selectin can indeed predict the development of ALI/ARDS.
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Introduction  Diffuse alveolar damage (DAD) is the histopatho-
logical hallmark of acute respiratory distress syndrome (ARDS).
DAD is due, in part, to dysregulated angiogenesis, with over-
expression of angiogenic and downregulation of angiostatic chemo-
kines. The objective of this study was to measure the levels of
epithelial neutrophil activating peptide 78 (ENA78) as an angio-
genic chemokine and monokine induced by IFNγ (MIG) as an
angiostatic chemokine in bronchoalveolar lavage fluid of critically ill
children with ARDS to determine the prognostic value of the
ENA78/MIG ratio in assessing illness severity and patient outcome.
Methods The study included 35 mechanically ventilated pediatric
patients with ARDS and 28 mechanically ventilated patients due to
nonpulmonary causes as a control group with mean age
16.5 ± 10.2 and 29.1 ± 8.1 months, respectively. They were
subjected to fibroaptic bronchoscopic examination and broncho-
alveolar lavage was done to estimate the ENA-78 and MIG levels
using the ELISA technique.
Results  Both ENA-78 and MIG levels were found to be
significantly higher among patients versus controls (P <0.01)
(390.3 ± 159.7 vs. 80.3 ± 17.6 pg/ml and 235.6 ± 92 vs. 91.0 ±
18.9 pg/ml, respectively). ENA-78 was found to be significantly
higher among nonsurvivors, while MIG was significantly lower
among nonsurvivors in comparison with the survivors (P <0.01)
(455.3 ± 142 vs. 277.8 ± 29.1 pg/ml and 186.3 ± 43 vs. 359.0 ±
56.4 pg/ml, respectively). Applying a receiver operating charac-
teristic curve indicated that ENA78/MIG ratio was the best
discriminator between survivors and nonsurvivors at cutoff value
1.02 with 100% sensitivity and specificity.
Conclusions  Imbalance between angiogenic and angiostatic
chemokines is the determining factor of ARDS patients’ outcome.
Future studies to investigate therapeutic modalities to enhance
angiostatic factors or inhibit angiogenesis to delay diffuse alveolar
damage and improve the outcome are recommended.
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Introduction  In vitro studies have shown that cortisol-binding
globulin (CBG) can be cleaved by neutrophil elastase with a
resulting reduction in affinity for cortisol [1]. Local elastase
production by activated neutrophils may trigger cortisol release by
CBG cleavage, providing a potential mechanism for targeted delivery
of corticosteroids to inflamed tissues. We looked for evidence of this
process at sites of inflammation in critically ill patients.
Methods  Sera and bronchoalveolar lavage (BAL) fluid were
collected from six mechanically ventilated patients with a clinical
diagnosis of ventilator-associated pneumonia or acute respiratory
distress syndrome (ARDS). These samples, along with sera from
six healthy controls, were subjected to gel electrophoresis
(SDS-PAGE) and immunoblotting for CBG. Densitometry was
used to quantify the proportion of cleaved CBG.
Results CBG cleavage product was seen within the BAL but not
the sera of patients with acute inflammatory lung disease. Figure 1
shows a typical western blot comparing control sera (C1 and C2),
septic sera (S1 and S2) and BAL from the same septic patients (B1
and B2, respectively). The mean percentage of CBG in the cleaved
form was 63.3% ± 21.8 in BAL compared with 0.94% ± 1.73 in
sera from the same patients and 12.5% ± 11.4 from healthy
controls (see Figure 2; all comparisons statistically significant).
Conclusions  This study provides the first in vivo support for a
mechanism of enhanced cortisol delivery to sites of inflammation
that involves local CBG cleavage.
Acknowledgement  Study supported by the Intensive Care
Society (UK).
Reference
1. Pemberton PA, et al.: Nature 1988, 336:257-258.
Critical Care    March 2009 Vol 13 Suppl 1 29th International Symposium on Intensive Care and Emergency Medicine
Figure 1 (abstract P58)
SDS-PAGE and immunoblotting of CBG. MW, molecular weights
(arrows mark the place of the relevant molecular weight markers).
Figure 2 (abstract P56)
Receiver operating characteristic curves of soluble E-selectin. CRP,
C-reactive protein; WBC, white blood cell count; E-XDP, elastase
digests of cross-linked fibrin.S25
P59
Vascular connexins have differing responses to tumor
necrosis factor
Y Ouellette
Mayo Clinic, Rochester, MN, USA
Critical Care 2009, 13(Suppl 1):P59 (doi: 10.1186/cc7223)
Introduction  Cell-to-cell communication via gap junctions has
been implicated in the control of vascular tone and may be altered
in sepsis. Endothelial cells express connexin (Cx) 37, Cx40 and
Cx43 and cytokines may modulate their function in sepsis resulting
in altered gap junctional intercellular communication. Our hypothe-
sis is that tumor necrosis factor (TNF) will decrease gap-junction-
dependent cell-to-cell communication of vascular connexin.
Methods Transformed HeLa cells expressing vascular Cx37, Cx40
or Cx43 were used in these experiments. HeLa cells were treated
with TNF (20 ng/ml) for up to 2 hours. In dye-transfer experiments,
carboxyfluroscein (HeLaCx40 and HeLaCx43) or Alexa Fluor-480
(HeLaCx37) was injected into one cell for 10 seconds and cell
transfer was allowed to proceed for 10 minutes and the number of
labeled cells counted. Cell lysates were prepared in Triton X-100
lysate buffer and detergent-soluble fractions collected. Cx37, Cx40
and Cx43 were detected by western blot.
Results After 1 hour, TNF treatment resulted in near total loss of
dye-coupling in HeLaCx37 and HeLaCx43 (P <0.02, n = 14 to 16)
and remained constant up to 2 hours. Dye coupling in HeLaCx40
cells remained unchanged after 1 hour and decreased after 2 hours
(P <0.05, n = 10). Western blots indicated that TNF treatment did
not affect detergent solubility of Cx40 and Cx43. However, TNF
caused a significant increase in detergent solubility of Cx37.
Conclusions These results suggest that inflammatory mediators
affect connexins differently. The loss of Cx37 function may be due
to the loss of detergent resistance, suggesting internalization of
Cx37 in response to TNF.
Acknowledgement Transformed HeLa cells were a gift from Dr K.
Willecke.
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Introduction The most appropriate advanced airway intervention in
out-of-hospital cardiac arrest (OHCA) remains unproven. Trained
ambulance personnel may attempt endotracheal intubation in the
field for OHCA patients. This study aims to review prehospital
airway management in OHCA.
Methods Observational, retrospective case review over a 4-year
period. All cases of OHCA brought to the Emergency Department
of the Royal Infirmary of Edinburgh, Scotland were identified.
Patient demographics, the airway management technique and
documented complications were recorded. The primary endpoint
measure was survival to hospital admission.
Results In total, 794 OHCA cases were identified. The aetiology
of cardiac arrest was medical in 95.2%, traumatic in 3.9% and
unrecorded in 0.9% of cases. Prehospital endotracheal intubation
was attempted in 628 (79%) cases and was successful in 573
(91.2%) cases. A significant complication (multiple attempts,
displaced endotracheal tube or oesophageal intubation) occurred
in 55 (8.8%) cases. In total, 165 (20.8%) patients survived to
hospital admission, of whom 110 (17.5%) had undergone pre-
hospital intubation. Fifty-five (33.1%) patients who did not undergo
prehospital intubation survived to hospital admission.
Conclusions Prehospital endotracheal intubation for out-of-hospital
cardiac arrest is associated with significant complications. For ambu-
lance crews not routinely undertaking endotracheal intubation, a supra-
glottic airway device may be more appropriate. Reliable methods of
confirming endotracheal intubation in the field should be utilised.
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Introduction  The study evaluated the ability of focused echo-
cardiography (F-ECHO) and capnography to differentiate between
pulseless electrical activity (PEA) and pseudo-PEA during resus-
citation from out-of-hospital cardiac arrest (OHCA).
Methods Patients in PEA, with stable values of end-tidal PCO2
(PETCO2) during compression pauses, underwent subxiphoid
F-ECHO examinations during pauses for carotid pulse evaluation,
assessing for the presence or absence of cardiac kinetic activity
(synchronous myocardial wall and valvular movement). Patients
with stable PETCO2 during the time of F-ECHO examinations who
had cardiac kinetic activity underwent a compression pause of
15 seconds during which an additional 20 IU bolus of vasopressin
and a 0.9% NaCl bolus were given. If pulselessness persisted after
the 15-second pause, compressions were resumed. This group
was denominated the F-ECHO group (November 2007 to October
2008,  n = 16) and was compared with a NON-ECHO group
(November 2005 to October 2007, n = 48) who also had PEA
with stable PETCO2 and were managed according to 2005
European Resuscitation Council guidelines without F-ECHO.
Results There were no statistically significant differences between
groups with regards to sex, suspected cause of arrest, initial cardiac
rhythm, witnessed arrest, time elapsed before initiation of
cardiopulmonary resuscitation (CPR), and bystander CPR. Primary
outcome (ICU admission: 88% vs. 50%; adjusted values: OR =
22.4, 95% CI = 4.2 to 86.9, P <0.001) and secondary outcome
(return of spontaneous circulation (carotid pulses palpable): 94% vs.
54%, adjusted: OR = 28.4, 95% CI = 3.9 to 96.1, P <0.001; 24-
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hour survival: 81% vs. 41%; adjusted: OR = 19.8, 95% CI = 3.1 to
72.6, P <0.001; hospital survival: 56% vs. 15%; adjusted values:
OR = 31.4, 95% CI = 2.9 to 85.7, P <0.001; neurological outcome
– CPC 1 (good cerebral performance) to CPC 2 (moderate cerebral
disability): 50% vs. 8%; adjusted values: OR = 36.4, 95% CI = 4.8
to 115.4, P <0.001) were significantly better in the F-ECHO group.
In the NON-ECHO group, significantly higher doses of epinephrine
were needed (P = 0.009) and CPR lasted longer (P = 0.003).
Conclusions  F-ECHO and capnography during PEA in OHCA
facilitates return of spontaneous circulation, ICU admission, 24-
hour survival, and hospital survival. This effect was attributed to the
ability to distinguish between PEA and pseudo-PEA and to
institute appropriate treatment during CPR. The confirmation of
these results in a large study is warranted.
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Introduction  The overall incidence of ventricular tachycardia/
ventricular fibrillation (VT/VF) as the first recorded electrical rhythm
in out-of-hospital cardiac arrest has declined from ~70% to ~25%
over the past 30 years. This change has been attributed to primary
and secondary prevention of cardiovascular disease and VT/VF.
We evaluated whether the incidence of VT/VF as first recorded
rhythm differed by location among bystander-applied automatic
external defibrillator (AED) patients and emergency medical
services (EMS)-witnessed cardiac arrests.
Methods  A prospective cohort study of nontraumatic cardiac
arrest from December 2005 to April 2007 in the Resuscitation
Outcomes Consortium database from 10 US and Canadian sites.
The incidence of an initial shockable rhythm on AED or documen-
ted VT/VF was compared among bystander-applied AED patients
and EMS-witnessed arrests in public versus private settings.
Results  The first rhythm was known in 13,235 out of 14,059
(94%) adult EMS-treated cardiac arrests. Of the 13,235 with
known rhythms, 3,436 (26%) had VT/VF. Among 1,115 EMS-
witnessed arrests, 61/161 (38%) had VT/VF in public settings and
224/954 (23%) in private settings. Similarly, for bystander AED
applied in the private setting, 39/114 (34%) were shocked. But, in
contrast, 125/159 (79%) (P <0.001 vs. all other) were shocked by
the AED in the public setting. Witnessed arrests in both the private
setting (vs. public) and in EMS-witnessed cases (vs. bystander
AED applied) were more likely to occur in older subjects and
females. After adjusting for age and gender via logistic regression
models, a significant difference in the odds of having a shockable
rhythm in a public versus private location of arrest remained in
EMS-witnessed arrests (P <0.005). The difference also remained
in bystander AED-applied arrests (P <0.001) after adjusting for
age, gender, and bystander-witnessed status.
Conclusions The incidence of VT/VF is far greater in the public
setting particularly for bystander-witnessed AED-applied arrests.
Patients in the private home setting, even for EMS-observed
arrests, are far less likely to benefit from AED application than
bystander-witnessed patients in the public setting. Cardiopulmo-
nary resuscitation strategies may need to be tailored by arrest location.
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Introduction  To improve survival from out-of-hospital cardiac
arrest, the American Heart Association released guidelines in
2005. We examined the effect of these guidelines on survival in
the Resuscitation Outcomes Consortium (ROC) Epistry – Cardiac
Arrest. We hypothesized that survival would increase after
guideline implementation.
Methods  One hundred and seventy-four emergency medical
service (EMS) agencies from eight out of 10 ROC sites were
surveyed to determine 2005 American Heart Association guideline
implementation, or crossover, date. Two sites with 2005 com-
patible treatment algorithms prior to guideline release were not
included. Patients with out-of-hospital cardiac arrest secondary to
a noncardiac cause, EMS-witnessed events, patients <18 years
old, and patients with do-not-resuscitate orders were excluded. A
linear mixed-effects model was applied for survival controlling for
time and agency. The crossover date was added to the model to
determine the effect of the 2005 guidelines.
Results Of 174 agencies, 83 contributed cases to both cohorts
during the 18-month period between 1 December 2005 and 31
May 2007. Of 7,403 cases, 4,897 occurred during the 13-month
(median) interval before crossover and 2,506 occurred in the
5-month (median) interval after crossover. The overall survival rate
was 5.9%. Our model estimated an overall increase in survival over
time (monthly OR = 1.02, 95% CI = 0.99 to 1.04, P = 0.23), a
decrease in survival at crossover (OR = 0.92, 95% CI = 0.66 to
1.26, P = 0.59), and a further increase in survival over time after
crossover (monthly = OR 1.005, 95% CI = 0.96 to 1.05,
P = 0.84).
Conclusions The present study found a trend towards increased
survival over time and no statistically significant effect of the 2005
guidelines early after implementation. This observed increase in
survival over time may be attributed to the Hawthorne effect or
participation in the ROC or improved quality assurance. A delay in
knowledge and skill acquisition amongst EMS providers and the
need to rechoreograph their cardiac arrest treatment may explain
why no significant increase in survival was observed after imple-
mentation. EMS providers may require more time to gain pro-
ficiency in the guideline changes before the full potential of the
guidelines can be realized. Further longitudinal study is needed to
determine the full impact of the guidelines on survival.
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Introduction ICU admission post cardiac arrest accounts for 6%
of admissions to the ICU [1]. ICU survival post cardiac arrest
ranges from 25% to 35% [2]. We reviewed the records of both
out-of-hospital and inhospital cardiac arrest admissions to our ICU
to audit their outcomes, the primary outcome variable being
survival to ICU and hospital discharge. Secondary objectives were
to determine the length of stay in the ICU and hospital of both
survivors and nonsurvivors.
Methods We performed a retrospective review of all admissions to
our ICU post cardiac arrest between January 2003 and December
2006. Our data were sourced from the ICU access database, ICU
discharge summary and individual chart review. We recorded
demographics and data regarding each arrest.
Results One hundred and forty-seven patients were admitted to
our ICU during the 4-year period. The mean age was 59 years,
ranging from 16 to 88 years. Out-of-hospital cardiac arrest
accounted for 51% (n = 75) of cases, inhospital cardiac arrest for
49% (n = 72). Asystole was the first identifiable rhythm in 39%, of
which 21% survived to hospital discharge, 42% of whom had a
poor neurological outcome. Ventricular fibrillation/ventricular
tachycardia accounted for 32% of cases, of which 39% survived,
all of whom had a good neurological outcome. Pulseless electrical
activity accounted for 29% of cases, of which 25% survived to
hospital discharge, 10% of whom had a poor neurological
outcome. Overall survival was 27%, of which 15% had a poor
neurological outcome. The mean ICU length of stay was 9.2 days
for survivors and 6.8 days for nonsurvivors.
Conclusions The high prevalence of asystole in both groups is not
in keeping with previous audit series [3] in which ventricular
fibrillation/ventricular tachycardia is the predominant arrest rhythm
and may reflect a delayed response time. Our survival figures are
comparable with international data [3], which are limited. The
higher male to female ratio is consistent with previous audit series
[4], possibly reflecting the higher incidence of ischaemic heart
disease in males.
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Introduction Some clinical diagnoses such as sepsis, renal failure,
metastatic cancer, house-bound lifestyle, and stroke are asso-
ciated with worse prognosis after inhospital cardiac arrest (IHCA)
[1-3]. But there are a few reports about chronic liver disease, Asian
people, and the incidence of IHCA is rarely reported in the
literature. The aim of this study was to evaluate the hospital
mortality of adult patients who had experienced IHCA by
underlying disease and the incidence of IHCA.
Methods Between March and October 2008, 69 patients who
experienced IHCA were prospectively enrolled in the study.
There were 64,345 total admissions to the hospital in this
period. Patients who had cardiac arrests in the ICU, emergency
room, and operating room were excluded from this study. The
hospital mortality compared group A (chronic liver disease, 10
patients and cancer, 24 patients) with group B (chronic lung
disease and heart failure, chronic renal disease and diabetes
mellitus).
Results  The incidence of IHCA was 1.07 events per 1,000
hospital admissions. Of the 69 enrolled patients, 34 were assigned
to group A and 35 to group B. The mean patient age of group B
was higher than group A (66.7 vs. 56.5 years, P = 0.003). There
was no difference of return of spontaneous circulation (ROSC)
more than 20 minutes between the two groups (group A, 53% vs.
group B, 63%, P = 0.40). The hospital mortalities of underlying
disease were presented: chronic liver disease (90%), cancer
(88%), chronic lung disease (20%), and heart failure (54%). The
hospital mortality was higher in group A than in group B (88.2% vs.
45.7%, P <0.001). The hospital mortality was higher during the
night compared with during the day (80% vs. 50%, P = 0.01) and
ROSC was higher during the day than during the night (80% vs.
41%, P = 0.001).
Conclusions In this study, the chronic liver disease and cancer
group had poor prognosis compared with the other underlying
diseases such as chronic lung disease or heart failure.
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Introduction  Mild induced hypothermia (MIH) in comatose
survivors of out-of-hospital cardiac arrest (OHCA) is highly
recommended [1,2]. Still, there is great uncertainty when it comes
to age limits for the therapy as the initial randomised studies
excluded the majority of patients over 75 years of age.
Methods  We retrospectively studied 115 OHCA survivors that
were treated with MIH in our ICU from 2002 to 2008 with regard
to cerebral performance category (CPC) at hospital discharge.
Inclusion criteria were the same as in the Hypothermia after
Cardiac Arrest Study Group except for the age limits. Bad
outcome was defined as severe disability (CPC3), vegetative state
(CPC4) and death (CPC5).
Results Bad outcome was significantly more frequent in patients
older than 60 years (chi-square P = 0.003), but even in patients
older than 80 years we had good outcome in more than 50% of
cases. The neurological outcome according to the different age
groups is displayed in Figure 1.
Conclusions Although age seems to influence outcome, we found
a surprisingly high incidence of good outcome even in the oldest
comatose survivors after ventricular fibrillation OHCA treated with
Available online http://ccforum.com/supplements/13/S1S28
MIH. Hence, our data do not support a limitation of neurointensive
care based on age alone.
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Introduction  Cerebral performance of survivors from cardiopul-
monary arrest is usually based on the Glasgow–Pittsburgh
Cerebral performance categories (GP-CPC), and favorable
neurological outcome are GP-CPC 1 (good cerebral performance)
and GP-CPC 2 (moderate cerebral disability). Especially, CPC 1 is
called full recovery. However, do the patients categorized as GP-
CPC 1 work as they did before? We evaluated higher brain
function among patients who were classed GP-CPC 1 and
analyzed the factors influencing it.
Methods  A retrospective, observational, cohort study was
conducted on consecutive patients (age ≥18 years) who were
survivors from cardiopulmonary arrest hospitalized through the
Emergency Department between 1 October 2006 and 31 March
2008 in an urban teaching hospital of Japan. There were 428
patients with cardiopulmonary arrest (CPA), and 136 patients
(32%) were admitted to our hospital. Fifteen patients were
categorized GP-CPC 1 and their higher brain functions were
evaluated by physical therapists 1 month after CPA. Data were
based on the Utstein style and collected on age, gender, location
of cardiac arrest, witnessed, bystander cardiopulmonary resus-
citation (CPR), defibrillator and cardioversion (DC) or automated
external defibrillator (AED) use, return of spontaneous circulation
prior to Emergency Department arrival, estimated time of cardiac
arrest, cardiac cause, and therapeutic mild hypothermia.
Results Among 15 eligible patients, eight cases with nonhigher
brain dysfunction and seven cases with higher brain dysfunction
were analyzed. In patients with nonhigher dysfunction: bystander
CPR, eight cases (100%); witnessed, eight cases (100%); and
DC (AED) use, eight cases (100%). In patients with higher brain
dysfunction: bystander CPR, three cases (43%); witnessed, five
cases (71%); and AED (DC) use, six cases (86%). Patients with
nonhigher brain dysfunction were more likely to receive bystander
CPR than those with higher brain dysfunction (Fisher’s exact test
P = 0.026).
Conclusions One-half of patients who were generally called full
recovery could not work as they did before because they had
higher brain dysfunction after resuscitation. It is important to
analyze factors that influence the recovery to higher brain function
in patients with GP-CPC 1 to improve the outcome of
cardiopulmonary cerebral resuscitation.
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Introduction Two randomized clinical trials explored that induced
hypothermia improved outcomes in adults with coma after
resuscitation from ventricular fibrillation [1,2]. In this study, we
present the usefulness of intracranial pressure (ICP) monitoring to
predict the patient’s outcome after induced hypothermia.
Methods Hypothermia (34°C, 48 hours) was induced in patients
after the recovery of spontaneous circulation. The indication was
as follows: motor response of Glasgow coma scale ≤5, at least
one of the brain stem reflexes intact and age 15 to 80 years. ICP
and oxygen saturation of the jugular vein (SjO2) monitoring were
performed during hypothermia.
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Results  Hypothermia was induced in 23 patients (55%) after
resuscitation. The outcome of nine patients (39%) was modified
Rankin Scale 0 to 2, 11 patients (48%) were 3 to 5 and three
patients (13%) were dead. ICP during hypothermia did not
increase beyond 10 mmHg in neurologically good outcome
patients (Figure 1). SjO2 tended to be <80% in neurologically
good outcome patients (Figure 2).
Conclusions  ICP monitoring during hypothermia was extremely
useful to predict the patient’s outcome. SjO2 monitoring during
hypothermia was also predictable about the patient’s outcome.
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Introduction Cardiac arrest is a medical emergency that, in certain
groups of patients, is potentially reversible if treated early enough.
Outcome after cardiac arrest is mostly determined by the degree of
hypoxic brain damage. Patients recovering from cardiopulmonary
resuscitation are at great risk of subsequent death or severe neuro-
logical damage, including a persistent vegetative state. The early
definition of prognosis for these patients has ethical and economic
implications; it is estimated that the cost for the care of severely
brain-damaged survivors runs into billions of dollars each year.
Methods The main purpose of this study was to investigate the
value of serum neuron-specific enolase (NSE) in predicting
outcomes in patients early after inhospital cardiac arrest. This study
was carried on 30 patients who had inhospital cardiac arrest
during their admission to the critical care unit and for whom cardio-
pulmonary resuscitation was performed according to the protocol
of the European Resuscitation Guidelines, who survived for at least
12 hours after the event and for whom informed consent was
obtained. We excluded patients with neoplastic diseases known to
increase NSE levels (small cell lung cancer, melanoma and
malignancy of the kidney and testicles, stroke (ischemic and/or
hemorrhagic) or traumatic brain injury).
Results  As regards NSE, it was found that the NSE level at
24 hours in patients with good recovery ranged between
0.80 ng/ml and 10.20 ng/ml with a mean of 5.60 ± 3.26 ng/ml,
and for those with severe disability the NSE level ranged between
18.30 ng/ml and 20.50 ng/ml with a mean of 19.40 ± 1.56 ng/ml.
Vegetative patients had a higher NSE level than others with a mean
of 64.38 ± 26.16 ng/ml, and patients who died had a mean NSE
level of 22.61 ± 9.93 ng/ml. The difference was statistically
significant, showing a higher NSE level in patients with more
hypoxic brain insult after arrest who died or remained in a
persistent vegetative state. (P significant, P <0.001.)
Conclusions The present study demonstrated that the NSE value
at 24 hours after return of spontaneous circulation was one of the
best predictors for neurological outcome as NSE levels, and it
tended to increase in patients with a bad neurological outcome.
The NSE level tended to decrease in those with a good
neurological outcome. If NSE concentrations increase by
>15 ng/ml, prognosis tends to be bad.
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Introduction Recent investigations have revealed that the state of
post-ischemic brain recirculation is of major importance in recovery
from sudden death, and we developed an isolated global ischemic
brain model that excludes the confounding variables of bypass,
donor blood, and whole body damage to investigate the strategy of
controlled reperfusion. This study examines primary damage of
cerebral function and tissue with uncontrolled brain reperfusion
following 30 minutes of brain ischemia, and tests whether
controlled brain reperfusion can attenuate the damage.
Methods  Sixteen pigs underwent 30 minutes of global brain
ischemia by clamping major neck vessels via a small suprasternal
incision. Seven pigs then received uncontrolled reperfusion with
normal blood, while the other nine pigs received controlled
reperfusion by infusing a modified (leukodepleted, hypocalcemic,
hyperosmolar, alkalotic, normoglycemic, antioxidant enriched)
warm blood solution into both carotid arteries for 20 minutes. Six
pigs underwent Sham operation. Brain oxygen uptake and venous
conjugated dienes (CD) were measured during reperfusion. The
neurologic deficit score (NDS) (0 = normal, 500 = brain death)
was determined at 24 hours after ischemia, and brain water
contents and cerebral infarction by 2,3,5-triphenyl tetrazolium
chloride staining were assessed post mortem.
Results  Sham pigs were neurologically normal at 24 hours.
Uncontrolled reperfusion resulted in two early deaths with brain
herniation, multiple seizures, low brain oxygen uptake*, high CD
levels (1.64 ± 0.03 A233 nm)*, and high NDS (244 ± 19 in
survivors)* indicating marked functional neurologic impairment.
Postmortem analysis showed marked brain edema (84.3 ± 0.6%)*
and extensive brain infarcts*. In contrast, pigs receiving controlled
reperfusion had high brain oxygen uptake, low CD levels
(1.3 ± 0.07 A233 nm), no post seizures, and low NDS (41 ± 11),
with all pigs being able to sit and eat, and three showing complete
recovery. Brain edema was reduced (81.8 ± 0.5%), and 2,3,5-
Available online http://ccforum.com/supplements/13/S1
Figure 2 (abstract P68)
SjO2 during hypothermia monitoring.S30
triphenyl tetrazolium chloride staining showed no infarction.
*P <0.05 uncontrolled vs. controlled, mean ± SEM.
Conclusions Our novel ischemic brain model provides an effective
tool to study brain ischemia. More importantly, these data indicate
that controlled reperfusion attenuates reperfusion injury in the brain
as it has been applied in other organs, and introduces the potential
of using controlled reperfusion as a new treatment for sudden
death and stoke.
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Introduction Perioperative hypothermia in coronary artery bypass
graft (CABG) is associated with adverse outcomes [1,2]. An
underbody forced-air warming blanket was developed for use in
cardiac surgery. The primary aim of this investigation was to study
whether this blanket could prevent postoperative hypothermia in
routine CABG.
Methods  Sixty low-risk patients who underwent elective CABG
were assigned into an intervention group that received the full
underbody forced warm-air system (n = 30) and a control group
that received standard thermal care (n = 30). Routine heat-
conservation methods were applied in both groups including
draping of the patient, fluid warming and normothermic cardio-
pulmonary bypass (CPB) at core temperature ~36.5ºC. The forced
warm-air system was set at 43ºC at the end of perfusion until
departure from the operating room (OR). Bladder temperature was
measured at: T1 – end of perfusion, T2 – departure from the OR,
T3 – arrival in the ICU, T4 – 1 hour after arrival in the ICU, and T5 –
3 hours after arrival in the ICU.
Results The number of patients arriving in the ICU with a bladder
temperature  ≥36ºC was significantly higher in the intervention
group than in the control group, respectively 27 patients (90%) vs.
14 patients (46.7%) (P <0.001). Initial temperatures (mean ± SD)
at T1 were similar in both groups: 36.7ºC ± 0.3ºC vs. 36.5ºC ±
0.2ºC, respectively (P = 0.091). At time points T2, T3 and T4, the
core temperature was significantly lower in the control group as
compared with the intervention group, T2: 36.0ºC ± 0.3ºC vs.
36.5ºC ± 0.3ºC, respectively (P <0.001); T3: 35.9ºC ± 0.4ºC vs.
36.2ºC ± 0.3ºC (P <0.001); and T4: 36.0ºC ± 0.6ºC vs. 36.4ºC ±
0.5ºC (P = 0.026). At T5, 3 hours after arrival in the ICU, both
groups had similar bladder temperatures (37.3ºC ± 0.6ºC vs.
37.2ºC ± 0.7ºC; P = 0.568). The temperature drop from the end of
CPB to arrival in the ICU was significantly less in the intervention
group compared with the control group (0.4ºC ± 0.3ºC vs. 0.6ºC
± 0.4ºC; P = 0.027).
Conclusions  The present study shows that additional warmth
management with a full underbody forced warm-air system, applied
in the OR to patients undergoing normothermic CABG, prevents
hypothermia with its deleterious effects in the early postoperative
phase.
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Introduction  Mild induced hypothermia (MIH) has become a
standard of care in comatose survivors of out-of-hospital cardiac
arrest (OHCA) [1,2]. Even though the initial randomised trails
excluded victims with noncoronary causes of OHCA, MIH may still
be useful to attenuate ischemic brain damage in this group of patients.
Methods  We retrospectively studied 172 coronary and 32
noncoronary OHCA survivors that were treated with MIH in our
ICU from 2002 to 2008 with regard to cerebral performance
category (CPC) at hospital discharge. Bad outcome was defined
as severe disability (CPC3), vegetative state (CPC4) and death
(CPC5).
Results Bad outcome was significantly more frequent in patients
with noncoronary cause of OHCA (chi-square P  <0.0001). The
subgroups of noncoronary cardiac arrest differed substantially with
regard to outcome. The outcome after coronary and noncoronary
OHCA treated with MIH is displayed in Figure 1.
Conclusions No randomised controlled clinical trial supports the
use of MIH in noncoronary OHCA. Although noncoronary OHCA
seems to influence outcome negatively, further studies are
warranted to examine the potential benefit of MIH in this category
of patients.
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Introduction  Nasopharyngeal cooling during cardiopulmonary
resuscitation has been shown to ease the resuscitation effort and
to improve the resuscitation rate, survival and neurologic outcome
in porcine models of both prolonged ventricular fibrillation and
pulseless electrical activity arrest. The aim of this study was to
determine whether nasopharyngeal cooling initiated during resus-
citation improves the resuscitation rate (return of spontaneous
circulation (ROSC)), survival and neurologic outcome.
Methods The study is ongoing. Cooling was performed using a
novel device (RhinoChill; BeneChill, Inc., San Diego, CA, USA)
that sprays a volatile coolant into the nasal cavity. Patients were
randomized to nasopharyngeal cooling during resuscitation or no
cooling in the field, followed by cooling for all patients in hospital.
All patients with witnessed arrest and a downtime less than
20 minutes deemed eligible for resuscitation were included. Naso-
pharyngeal cooling was initiated either before or after defibrillation
and was continued until systemic cooling could be initiated.
Patients who had achieved ROSC were excluded. Resuscitation
was continued until ROSC was achieved or for 30 minutes.
Results Five patients were randomized to treatment and six were
controls. ROSC was achieved in five out of five (100%) treated
patients but in only three out of six (50%) controls. All five (100%)
treated patients survived to hospital admission as compared with
one out of six (16.7%) controls. At 24 hours, three out of five
(60%) treated patients were alive as compared with none of the
controls. The first treated patient who completed the 1-week
evaluation was neurologically intact.
Conclusions Nasopharyngeal cooling initiated during resuscitation
may improve the ROSC rate and survival to 24 hours. The impact
of this treatment on long-term survival and neurologic outcome
remains to be determined.
P74
Introduction of an external noninvasive cooling device for
effective implementation of Intensive Care Society
standards post cardiac arrest
J McGrath, K Williams, D Howell, J Down
University College Hospital London, UK
Critical Care 2009, 13(Suppl 1):P74 (doi: 10.1186/cc7238)
Introduction  Despite cardiac arrests accounting for 5.8% of
admissions to intensive care, there is significant variation in the
management and outcome of these patients in different units [1].
Randomised controlled trials have demonstrated that active
cooling to 32 to 34°C for 12 to 24 hours after return of
spontaneous circulation (ROSC) significantly improves the
outcome of patients who have an out-of-hospital ventricular fibril-
lation arrest [2]. However there are a range of cooling techniques
employed, and no trials have demonstrated that any particular
system is superior [3].
Methods All adult patients admitted to critical care following out-
of-hospital cardiac arrest with Glasgow coma scale <9 after
ROSC were included. The initial audit included nine patients
admitted between August 2006 and March 2007 who were
cooled primarily with standard methods such as ice packs/cooling
pads. Performance was re-audited between August 2007 and
December 2007 following the introduction of CritiCool, and
included nine patients. Data were collected using an audit form, a
computerised ICU patient database (CIMS) and clinical notes. We
assessed neurological outcome at ICU discharge by calculating
the cerebral performance category (CPC). The CPC is scored on a
scale (0 to 5) where higher scores indicate worse functional
impairment.
Results  Following introduction of the CritiCool there was
improvement in the speed of cooling to the target temperature
range (patients effectively cooled within 4 hours: 33% vs. 57%).
There was also improved ability to maintain patients within the
target temperature range over the 24-hour period (57% vs. 70%).
There was also a trend towards improvement in the mean CPC
score at ICU discharge from 3.4 to 2.3.
Conclusions  We have shown an improvement in the speed of
cooling and target temperature maintenance. Our study also
shows that the introduction of CritiCool correlated with an
improvement in CPC. We suggest that more widespread use of
noninvasive cooling devices may improve implementation of
standards, avoid risks associated with invasive cooling devices and
potentially improve neurological outcome.
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Introduction Therapeutic hypothermia (TH) improves survival and
neurologic recovery in resuscitated cardiac arrest patients.
However, three published surveys with low response rates (<20%)
reported most physicians have never used TH. We sought to
evaluate current physician use, and barriers to use, of TH in
Canada.
Methods  We developed a web-based questionnaire asking
physicians to self-report their experience with TH using the
Pathman framework of changing physician behavior. We surveyed
all members of the Canadian Association of Emergency Physicians
and the Canadian Critical Care Forum using the Dillman survey
method between 19 March and 21 May 2008. Adjusted odds
ratios were generated from a multiple logistic regression model
that included all reported predictor variables.
Available online http://ccforum.com/supplements/13/S1S32
Results  We surveyed 1,266 physicians, and 37% responded.
Most (78%) respondents were emergency physicians, 54%
worked at academic/tertiary-care hospitals, and 62% treated more
than 10 arrests annually. Almost all respondents were aware of TH
(99%) and agreed that TH was beneficial (91%), but only two-
thirds (68%) had used TH in clinical practice. Only one-half (50%)
reported using standardized cooling protocols. Critical care
physicians were more likely to use TH than emergency physicians
(93% vs. 61%, OR = 6.3, 95% CI = 2.5 to 16.0) and physicians
who worked at a facility with a cooling protocol were more likely to
use TH than their colleagues at other facilities (86% vs. 43%,
OR = 5.6, 95% CI = 3.1 to 10.0). Physicians ≤10 years post
residency were more likely to have used TH (73% vs. 63%, OR =
2.0, 95% CI = 1.2 to 3.3) as were physicians who treated >10
cardiac arrests annually (78% vs. 53%, OR = 2.6, 95% CI = 1.6 to
4.1). The use of TH was similar comparing academic/tertiary-care
hospitals with community hospitals (OR = 1.6, 95% CI = 0.92 to
2.88). Common barriers reported by physicians included: lack of
awareness (31%), perceptions of futility or poor prognosis (25%),
too much work required to cool (20%) and staffing shortages
(20%).
Conclusions  Self-reported adoption of TH is higher than
previously reported at 68% among Canadian emergency and
critical care physicians. Adoption is more likely by critical care
physicians, those with protocols, and those treating >10 arrests
annually. Several barriers were reported; overcoming these may
improve the adoption of TH.
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Introduction  Diagnosis of brain death is very important.
Confirmatory tests have been used to corroborate brain death, but
they are expensive, nonattainable in all ICUs and in some instances
have no correlation with clinical tests [1]. The Cerebral State Index
(CSI) (Danmeter, Odense, Denmark) is a portable apparatus that
has been made for determination of the depth of anesthesia based
on brain waves determination and analysis [2].
Methods This is a study on 65 head-injured patients and 72 alert
head-injured patients. Eighteen to 24 hours after confirmation of
brain death by clinical tests applied by a neurologist, the CSI was
recorded according to the company’s instruction. The CSI was
recorded if the electromyography was zero on the screen and the
quality index was above 70%.
Results If the CSI score was ≤3 for detection of brain death and
the CSI score was ≥3 for detection of nonbrain-dead patients, the
CSI can detect 100% of cases with brain death from nonbrain-
dead patients. Furthermore, if burst suppression (BS%) >75% is
for detection of brain death and BS% between 0% and 75% is for
detection of nonbrain-dead patients, the CSI could detect 100%
brain-dead patients from nonbrain-dead patients.
Conclusions  MRI, CT and electroencephalography are time
consuming and expensive, and require specialized people. In a
previous study the Bispectral index scale (BIS) had been used for
confirmation of brain death [3], but was not successful because
the range of EEG filtration of BIS is wider than that of CSI and the
calculation methods are different; moreover they did not consider
BS% in addition to BIS. In the present study all of the clinically
diagnosed brain-dead patients had CSI = 3 and BS% = 75%, and
all of the clinically no-brain-death patients had CSI ≥3 and BS%
≤75. So the sensitivity and specificity of CSI for detection of brain
death is 100%.
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Introduction  Cushing’s triad of bradycardia, hypertension and
abnormal breathing due to critically raised intracranial pressure
was described in 1903 [1] and is generally accepted clinically. We
recognised that our patients undergoing uncal herniation and brain
stem compression (whilst intubated and ventilated) did not appear
to exhibit this classic response.
Methods  We identified suitable patients from the Scottish
Intensive Care Society Wardwatcher audit database for our ICU
admissions from August 1999 to February 2007. We used the
search terms subarachnoid haemorrhage and traumatic brain injury
both linked to brain stem death testing. From the resultant 175
patients, a consecutive sample of 50 patients was chosen for chart
review. There were 30 males, mean age 40.5 years, and 20
females, mean age 50 years. Diagnoses were subarachnoid
haemorrhage n = 27, stroke n = 6, traumatic brain injury n =5 ,
subdural haematoma n = 3, intracerebral haemorrhage n = 6, other
n = 3. The time of coning was identified by the development of
fixed dilated pupils and loss of cough reflex. Haemodynamics were
recorded 1 hour before coning occurred, at the time of coning and
1 hour later. In 43 ventilated patients a hypertensive surge was
documented. One other patient underwent the blood pressure
surge breathing spontaneously and was not intubated. In six
patients the haemodynamic surge had not been documented by
the bedside nurse. It was evident from chart review that coning had
occurred in the hour between haemodynamic recordings.
Results  In 44 patients there was a significant rise in blood
pressure at the time of confirmation of uncal herniation with a
subsequent fall. This was accompanied by a major tachycardia in
38 patients and a normal heart rate in five patients. Only one
patient exhibited a bradycardia and had been extubated as part of
withdrawal of therapy.
Conclusions  We have demonstrated that the haemodynamic
response to critically raised intracranial pressure in a ventilated
patient is not a bradycardia. We have used an approach akin to
that of Cushing but all of the six patients in Cushing’s original
paper were breathing spontaneously. All but one of our patients
was ventilated. We suggest that by avoiding hypoxaemia and
hypercapnic acidosis the cardiac response is altered. It is
important for clinicians to be aware of this to aid recognition of
coning for diagnostic and prognostic reasons.
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Introduction The aim was to analyze heart-beating organ donation
patterns in four countries using the Donor Action (DA) Program [1]
nationally, to identify bottlenecks in their donation process and
suggest areas for improvement.
Methods  A retrospective medical record review (MRR) of all
critical care deaths between January 2006 and December 2007
(n = 18,118) from 166 hospitals in 381 critical care units from
Belgium, Finland, France and Switzerland was made using the
DA’s Diagnostic Review process. The upper age limit for medical
suitability was 75 years. Data were entered into the DA System
Database for analysis.
Results  From 6,561 patients (36.2% of all records) with no
absolute contraindications to donation, 2,973 (45.3%) met
preconditions for brain death (BD) diagnosis, 2,063 had signs of
severe brain damage and 1,891 met criteria for formal BD
diagnosis (= potential donors). Belgium had the utmost number of
patients with formal BD diagnosis (75.7%), and Switzerland
(57.4%, P <0.0001) the lowest. Although donor identification rates
were higher in France (93.6%) with the lowest in Finland (47.7%,
P <0.0001), Finland excelled in donor referral (93.9% of identified
cases) vs. only 63.8% in Switzerland (P <0.0001), and excelled in
family approach rates (92.7%) vs. only 70.2% in France
(P <0.0001). Consent rates as a percentage of families
approached were superior in Belgium and Finland (89.5%), with
the most inferior in France (65.7%, P <0.0001). Conversion rates
as a percentage of potential donors vs. actual donors were higher
in France (43.1%) and Belgium (42.9%) and were significantly
lower in Finland (34.9%) and Switzerland (33.5%) (P = 0.0187).
Only Belgium had a nonheart-beating donation policy during the
study period, resulting in 11.2% more donors added to the
country’s donor pool.
Conclusions  The DA MRR proved to be an excellent tool to
identify areas of improvement within certain steps of the donation
pathway, such as donor identification, BD diagnosis, donor referral,
family approach and obtaining consent. Moreover, the DA MRR
has shown to be applicable in different countries and environments
and should be considered a unique tool for comparing countries’
donation performance.
Reference
1. Donor Action Program [www.donoraction.org]
P79
Critical care staff attitudes to organ donation impact on
national donation rates: data from the Donor Action
Database
L Roels1, C Spaight1, J Smits2, B Cohen1
1Donor Action Foundation, Linden, Belgium; 2Eurotransplant,
Leiden, the Netherlands
Critical Care 2009, 13(Suppl 1):P79 (doi: 10.1186/cc7243)
Introduction The aim was to investigate whether critical care (CC)
staff attitudes to organ donation, the concept of brain death (BD)
and self-reported skills in donation-related tasks impact on national
donation rates.
Methods  Donor Action [1] Hospital Attitude Survey data were
collected from 19,537 CC staff (MDs: 3,422, nurses: 13,977,
others: 2,138) in 11 countries (Australia, Belgium, Croatia, Finland,
France, Israel, Italy, Japan, Norway, Poland, Switzerland) between
November 2006 and October 2008. Medical and nursing staff
attitudes from each country were correlated with each country’s
donors per million population rates in 2007 (Council of Europe
data). Data examined included average support to donation,
respondents’ willingness to donate their own, their children’s and
relatives’ organs, the acceptance of the BD concept and reported
confidence levels with donation-related tasks.
Results  National donation rates significantly correlated with
respondents’ attitudes to donation (R = 0.783,  P = 0.0029),
acceptance of the BD concept (R = 0.651, P = 0.0279), explain-
ing organ donation to family (R = 0.544, P = 0.0845), introducing
organ donation to family (R = 0.0182, P = 0.0182) and obtaining
consent for donation (R = 0.628, P = 0.0368).
Conclusions  Average CC staff attitudes and donation-related
skills clearly influence their assessment and are a strong predictor
of a country’s donation rate, as demonstrated in this study.
Measures to improve donation rates should focus on guidance and
education of CC staff so as to ensure that these practitioners have
sufficient knowledge and confidence with donation-related issues.
Reference
1. Wight C, Cohen B, Roels l, Miranda B: Donor Action: a quality
assurance program for intensive care units that increases
organ donation. J Intensive Care Med 2000, 15:104-114.
P80
Effect of endotracheal suctioning on intracranial pressure
in severe head-injured patients
S Gholamzadeh, M Javadi
Shiraz Medical University, Shiraz, Iran
Critical Care 2009, 13(Suppl 1):P80 (doi: 10.1186/cc7244)
Introduction Endotracheal suctioning (ETS) is a routine nursing
procedure used to decrease pulmonary complications; however, in
severe head-injured patients it can result in a sudden increase in
intracranial pressure (ICP) and may put the patient at risk for
further cerebral damage [1-3]. The purpose of this study was to
examine the effect of ETS on ICP in severe head-injured patients.
Methods  Twenty-one patients with acute severe head injury
(Glasgow coma score ≤8, range 4 to 8) were studied. Each
subject received four passes of insertion of a standardized suction
catheter and application of negative pressure limited to 10 to
15 seconds in each procedure of suctioning. The ETS procedure
consisted of administration of 16 breaths at 135% of the patients’
tidal volume, 100% FIO2 before and after suctioning with a
standardized catheter (16 French) and duration between 10 and
15 seconds. A repeated-measures model for ANOVA was used to
examine the changes in mean ICP 1 min before and during the first,
second, third and fourth passes of catheter insertion.
Results ICP significantly increased during suctioning (P <0.001).
The change in ICP was significantly greater in the fourth pass of
catheter insertion than in other passes.
Conclusions  Changes in ICP induced by ETS in severe head-
injured patients are significant. Suction passes should be limited to
two to three per procedure. Repeated suctioning may increase
ICP.
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Introduction The blood ammonia concentration has been reported
to be elevated by hemorrhagic shock in animal studies, but this
finding has been reported in only one clinical study in a small
number of selected surgical patients. We therefore conducted a
study to determine whether plasma ammonia is elevated in trauma
patients at hospital admission and can be used as a predictive
factor for serious hemorrhage.
Methods The subjects were consequent trauma patients admitted
to our level 1 trauma center between November 2006 and
November 2007. Blood was sampled on admission from patients
who met the inclusion criteria to determine plasma ammonia and
arterial lactate concentrations. Patients requiring blood transfusion
or intervention for bleeding within 24 hours were classified into a
blood transfusion and intervention group (BTI group). Patients not
requiring the transfusion or the interventions were classified into a
non-BTI group. Logistic regression analysis was performed using
patients requiring BTI as the dependent variable and ammonia
concentration, lactate concentration, shock index on admission,
systolic blood pressure on admission, and ISS as independent
variables.
Results The subjects were 148 trauma patients. The mean age
was 44.8 ± 20.8 years, and the mean injury severity scale was
17.7 ± 13.2. Patients showed a significant correlation between
ammonia and lactate concentrations (r = 0.46,  P < 0.001). Inter-
vention for arterial bleeding was required in 16 patients. Blood
transfusion was required in 17 patients. The BTI group consisted
of 21 patients. The BTI group had more hemodynamic instability
and significantly higher ammonia and lactate concentrations than
the non-BTI group. Logistic regression analysis shows that only
plasma ammonia was a significant independent variable for BTI
(P = 0.001). The odds ratio of requiring blood transfusion and/or
intervention for arterial bleeding was 18.2 when ammonia was
≥80 μg/dl.
Conclusions Elevated ammonia concentration on admission will
be a predictive factor for traumatic hemorrhage requiring treatment.
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Introduction  We have previously shown that a significant
proportion of patients have increased numbers of lymphocytes
proliferating in response to myelin basic protein 10 days post
traumatic brain injury (TBI); associated with a trend for more
favourable outcome [1]. This suggests that the adaptive immune
response may have a protective role following TBI, as demon-
strated in animal models [2]. In this study, we further explored this
process by examining the effect of TBI on regulatory T cell (Treg)
numbers, and determining whether a change in Treg frequency
was long lived.
Methods We recruited 12 patients with severe or moderate TBI
who required protocol-driven therapy to maintain cerebral
perfusion and intracranial pressure. Blood samples were taken
within 72 hours and 10 days post TBI. A separate group of
patients was studied 6 months post TBI. Age-matched and sex-
matched healthy volunteers were used as controls. Peripheral
blood mononuclear cells (PBMCs) were isolated. Flow cytometry
was used to identify Tregs according to the surface expression of
markers (CD4/CD25high/CD45ROhigh/CD127low).
Results When compared with controls, patients at 10 days and at
6 months post TBI showed a greater proportion of PBMCs with a
Treg phenotype (Mann–Whitney U test; P <0.01 and P <0.05,
respectively). The proportion of Treg cells at 72 hours was higher
than controls, but this difference did not reach significance. See
Figure 1.
Conclusions We have shown that TBI upregulates CD4+ T cells
with a regulatory phenotype. This effect is sustained for at least
6 months, and may modulate protective autoimmunity. Better
understanding of the functional capacity and specificity of
lymphocytes identified as Tregs may provide therapeutic targets.
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Introduction It is very hard to achieve optimal water balance in
severe head injury (SHI) patients (Glasgow coma score ≤8).
Cardiopulmonary complications are common after SHI: neurogenic
pulmonary edema, cardiac failure, and so on [1-4]. In this study we
present the alteration of cardiopulmonary function on pulse contour
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analysis calibrated by transpulmonary thermodilution (PiCCO-plus)
monitoring after SHI.
Methods Plasma catecholamines, natriuretic polypeptides, throm-
bomodulin and D-dimer of nine patients were measured
immediately after SHI. The cardiopulmonary functions of nine
consecutive patients were monitored by PiCCO-plus daily during a
week after SHI.
Results  Noradrenalin, dopamine and brain natriuretic peptide
concentrations were significantly high during the entire study
period. Significantly higher elevations of plasma thrombomodulin
and D-dimer concentrations were also observed after SHI. The
intrathoracic blood volume was maintained in spite of systemic
hypovolemia, and this fluid redistribution caused hydrostatic fluid
retention in lung tissues on PiCCO-plus monitoring after SHI. See
Figures 1 and 2.
Conclusions  Persistent catecholamine release and the different
sensitivity of blood vessels to catecholamine cause the blood
volume redistribution: systemic hypovolemia and hydrostatic
pulmonary edema. The excess cardiac preload due to catechol-
amine release leads to brain natriuretic peptide release resulting in
natriuresis.
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Introduction  The RESCUEicp study (Randomised Evaluation of
Surgery with Craniectomy for Uncontrollable Elevation of
Intracranial Pressure) aims to provide Class 1 randomised
evidence as to whether decompressive craniectomy is effective for
the management of patients with raised and refractory intracranial
pressure (ICP) following traumatic brain injury.
Methods An international multicentre randomised trial comparing
decompressive craniectomy with medical management. Patients
(n = 50 for the pilot phase, n = 600 for the main study) with
traumatic brain injury and raised ICP (>25 mmHg) refractory to
initial treatment measures are eligible for the study. Patients are
randomised to one of two arms: continuation of optimal medical
management (including barbiturates) versus surgery (decompressive
craniectomy). The inclusion criteria are: traumatic brain injury, age
10 to 65 years, abnormal CT scan and the exclusion criteria:
bilateral fixed and dilated pupils, bleeding diathesis, devastating
injury not expected to survive 24 hours. Outcome is assessed
using the extended Glasgow Outcome Score and the SF-36
quality of life questionnaire at 6 months, 1 year and 2 years. See
Figure 1.
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Figure 1 (abstract P83)
Volume management of SHI patients on PiCCO-plus monitoring. CVP,
central venous pressure; SVV, stroke volume variation; PPV, pulse
pressure variation.
Figure 2 (abstract P83)
Lung water content of SHI patients on PiCCO-plus. ELWI,
extravascular lung water index; PVPI, pulmonary vascular permeability
index; EVLW, extravascular lung water; PBV, pulmonary vascular
permeability index.
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Results Over 170 patients have been recruited to date. At present
we have achieved 97% data collection and 94% follow up. The
study is ongoing.
Conclusions Randomising patients with traumatic brain injury to
decompressive craniectomy versus optimal medical management
is feasible. Whether the operation is effective and safe remains to
be seen. We would welcome more centers’ participation.
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Introduction  Bedside measurement of regional cerebral blood
flow (rCBF) is a promising technology to detect vasospasm after
aneurysmal subarachnoid hemorrhage [1]. The Bowman® rCBF
monitor facilitates continuous and quantitative assessment of brain
tissue perfusion in ml/100 g tissue/minute with a thermodiffusion
microprobe. The probe is self-calibrating at user-definable time
intervals from 1 to 120 minutes. To estimate the necessary recali-
bration frequency, we looked at the measurement drift between
two calibration points.
Methods  In 32 patients with aneurysmal subarachnoid hemor-
rhage, a Bowman® rCBF probe was implanted in the vascular
territory of the aneurysm-harboring vessel. According to previous
experience, we performed automatic recalibration of the rCBF
device every 30 minutes, thus yielding measurement periods of
25 minutes. CBF was recorded once per second. Data were
averaged over 1 minute and all measurement cycles were pooled.
Results  The mean analyzed monitoring time per patient was
6.9 days. The mean rCBF was 24.4 ml/100 g/min at the beginning
and 25.6 ml/100 g/min at the end of the measurement cycles
between two recalibration periods, thus representing a mean drift
of 1.15 ml/100 g/min per 25-minute measurement period
(P <0.001). This drift was heterogeneous in different patients
(range –3.67 to 12.0 ml/100 g/min). Patients number 24 to 32
who were monitored more recently showed a significant upward
drift of 7.57 ml/100 g/min, whereas data from patients number 1 to
23 had a downward drift of –0.67 ml/100 g/min. Explanation for
this phenomenon is a revision of the monitor software by the
manufacturer that was performed after patient 23. This finding was
verified with external data.
Conclusions The current implementation of the Bowman® rCBF
monitor shows a severe upward measurement drift that is clinically
relevant. At present, the only solution is to perform recalibrations as
frequently as possible.
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Introduction  The objective is to study the relationship between
end-tidal carbon dioxide (EtCO2) and cerebrovascular pressure
reactivity in traumatic brain injury (TBI). Cerebrovascular pressure
reactivity is the ability of cerebral vessels to respond to changes in
transmural pressure. A cerebrovascular pressure reactivity index
(PRx) can be determined as the moving correlation coefficient
between the mean intracranial pressure (ICP) and mean arterial
blood pressure. A negative or zero value reflects a normally
reactive vascular bed whereas positive values reflect passive, non-
reactive vessels. This index correlates significantly with outcome
after TBI [1]. Carbon dioxide affects the cerebral vascular
response. Our aim is to identify the optimal EtCO2, at which PRx
reaches its lowest value.
Methods  A prospective observational study of 20 patients with
TBI at the Royal London Hospital. All patients were managed
according to the local guidelines for the management of TBI. PRx
was determined by ICM+ (Cambridge University) software by
calculating the correlation coefficient between ICP and arterial
blood pressure. A total of 965 hours of data were recorded
including the mean arterial pressure, ICP, cerebral parfusion
pressure, PRx and EtCO2.
Results  We plotted EtCO2 against PRx to identify the optimal
EtCO2 and the range of carbon dioxide reactivity. The graph of PRx
compared with EtCO2 indicated a U-shaped curve, suggesting that
too low or too high ETCO2 was associated with a disturbance in
pressure reactivity (Figure 1). We found this pattern in 66% of the
patients. In the other patients (34%) there was no such correlation,
so it was not possible to identify optimal EtCO2, probably
indicating loss of carbon dioxide reactivity.
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Conclusions PRx allows the determination of the carbon dioxide
level at which cerebrovascular pressure reactivity reaches its
optimal value in individual patients. That would allow a dynamic
approach to the carbon dioxide target in TBI.
Reference
1. Zweifel C, et al.: Continuous monitoring of cerebrovascular
pressure reactivity in patients with head injury. Neurosurg
Focus 2008, 25:E2.
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Introduction  Current prognostic information following severe
traumatic brain injury (TBI) is of limited clinical utility. We
hypothesized that wide practice variation exists in determining
prognosis in this population. We conducted a survey of Canadian
intensivists to better understand prognosis determination and
decisions regarding level of care following severe TBI.
Methods Survey items were generated to assess the perceived
utilization and utility of different tests for prognosis determination,
and the perception of prognosis and decision on the level of care.
We used direct questions and scenario-based questions (five-
point Likert scales). We pretested the questionnaire to assess its
clinical sensibility, and conducted test–retest reliability. Canadian
intensivists were identified at all level I and level II trauma centers.
The survey was administered electronically. Nonrespondents were
sent a paper questionnaire.
Results  The response rate was 73% (180/215). Most respon-
dents worked in teaching hospitals (95%), mixed medical/surgical
ICUs (87%) with more than 40 severe TBI cases/year (65%). Poor
neurological prognosis at 1 year was defined as Glasgow outcome
scale 1, 2 or 3 for 69% of respondents. More than 60%
considered that accurate prognosis determination would be most
helpful within 7 days following severe TBI. Most respondents cited
monitoring (>70%), clinical examination (>85%) and CT scan
(>90%) as being the most frequently used source of information
for evaluating prognosis, as opposed to MRI (30%) or
somatosensory evoked potentials (15%). When asked if a 25-year-
old male with severe TBI had a poor neurological prognosis at 1
year, 40% of respondents disagreed/strongly disagreed, 30% had
no opinion and 30% agreed/strongly agreed. When asked how
comfortable they would be to recommend withdrawal of life-
support measures, 82% reported being uncomfortable/very
uncomfortable, 9% had no opinion and 9% were comfortable/very
comfortable.
Conclusions We observed significant variation in perceptions of
neurological prognosis and in decisions regarding level of care
among Canadian intensivists. Considering the importance of such
prognostic information in clinical practice, a better understanding
of prognosis determination in TBI is warranted.
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Introduction Review of practice is a way to enhance quality of
care. We developed a high-rate recording tool able to store the
data of critical care patients [1]. We recorded 15 severely brain-
injured patients and analyzed our team’s practice according to
commonly admitted recommendations.
Methods Fifteen patients were recorded at a rate of one value
each 2 seconds during a total of 750 hours. We analyzed the data
to identify 5-minute or longer episodes of cerebral hypoperfusion
(CHP) and intracranial hypertension (ICHT). The episodes were
electronically detected among the signal files and manually
validated using software allowing signal graph visualization and
scrolling.
Results Two hundred and forty-one episodes were detected: 135
episodes of ICHT and 106 episodes of CHP. ICHT and CHP
episodes were grouped in 84 cases (34%). CHP episodes were
shorter than ICHT episodes (P <0.02). Medical reactions were
observed in 128 cases (53%) and more often concerned episodes
lasting more than 30 minutes (n = 88, 59%) than shorter episodes
(n = 61, 41%). Electronic analysis of CHP showed that overall
reactions are made to increase the mean arterial pressure (47%)
rather than to lower intracranial pressure (35%). Adequacy of
medical decisions for mean arterial pressure and intracranial
pressure management was, respectively, 45% and 55%
considering recommendations made for severe head trauma
management.
Conclusions Actual monitoring of severely injured patients misses
short episodes. Computers could help to better detect such
episodes by adequate algorithms. This method will lower the
human performance usually observed in complex management
protocols and could help to improve decision-making if
implemented at the bedside.
Reference
1. Allart L, Vilhelm C, Mehdaoui H, et al.: An architecture for
online comparison and validation of processing methods
and computerized guidelines in intensive care units.
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Introduction Besides intracranial pressure (ICP) monitoring, brain
tissue oxygenation (pbtO2) monitoring with the Licox system
(Integra Neuroscience, Germany) is on the verge of clinical routine
in acute brain injury. Recently, a new pbtO2 probe by a different
manufacturer (Raumedic AG, Germany) was introduced into the
market. As this new probe facilitates measurement of ICP as well,
its use would reduce invasiveness of multimodal neuromonitoring.
Therefore, we investigated the agreement of pbtO2 values of both
Available online http://ccforum.com/supplements/13/S1S38
probes in patients with aneurysmal subarachnoid hemorrhage
necessitating ICP and pbtO2 monitoring.
Methods  Eight patients with pbtO2 monitoring probes of both
types implanted side by side in the same vascular territory were
investigated. Multimodal monitoring data were stored online with
dedicated software. Data were analyzed using the method
proposed by Bland and Altman [1].
Results The mean measurement time per patient was 8.6 days. All
data pooled, the mean bias was –0.66 mmHg. The precision range
(two standard deviations of the bias) was –32.9 to 32.6 mmHg.
The Licox probe showed a tendency for higher values at high
pbtO2, while the Raumedic probe showed higher values at low
pbtO2. Analysis of single patients revealed no discernible pattern in
the relationship of measurement values of both probes. Three of
the new probes ceased to function prematurely.
Conclusions Our data suggest that measurements of both pbtO2
probes cannot be interchanged. No easy algorithm for conversion
of measurement data from one system to the other is available.
More rigorous bench testing is necessary before implementation of
the new system in the clinical routine.
Reference
1. Bland JM, Altman DG: Statistical methods for assessing
agreement between two methods of clinical measure-
ment. Lancet 1986, 1:307-310.
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Introduction  Cerebral dysfunction frequently complicates septic
shock. A marker of cerebral dysfunction could be of significant
value in managing sedated septic patients. Plasma S100 (S100B)
proteins increase in sepsis. S100B is present in the brain, but also
in other tissues. To date, the source of this protein has not been
investigated in sepsis. The aim of this study is to determine
whether the brain is the source of S100B in an experimental sepsis
model.
Methods Twenty-seven pigs were anesthetized and randomized to
either infusion of endotoxin at the rate of 1 μg/kg/hour (n = 19) or
saline (n = 8). Catheters were inserted into a cervical artery and
the superior sagittal sinus. Blood samples were collected from
both sites and physiological data were registered before the start
of the endotoxin infusion and hourly. After 6 hours, the animals
were terminated and brain tissue samples were taken from the left
hemisphere. S100B in plasma was measured by ELISA. Brain
tissue samples were stained with biotinylated S100B antibodies.
Results  S100B levels increased in plasma and expression of
S100B in cerebral tissue was higher in endotoxemic animals
compared with controls. Statistically higher sinus versus arterial
S100B concentration was only found at 2 hours in the
endotoxemic animals (Figure 1).
Conclusions  Although other sources exist, the brain is a major
source of S100B in endotoxemia, making it a potential marker of
cerebral dysfunction in septic shock.
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Introduction After severe brain injury, anemia can adversely affect
cerebral oxygen delivery and brain tissue oxygen (PbtO2). How-
ever, it is unclear whether low hemoglobin (Hb) contributes to
brain tissue hypoxia or compromises oxidative metabolism.
Methods We studied 28 consecutive patients with severe brain
injury (15 with subarachnoid hemorrhage, 8 with intracerebral
hemorrhage, and 5 with traumatic brain injury) who underwent
multimodality intracranial pressure, PbtO2 and microdialysis
monitoring. The relationship between Hb levels and the risk of
brain tissue hypoxia (BTH), defined as PbtO2 ≤15 mmHg, and
metabolic crisis (MC), defined as lactate/pyruvate ratio ≥40 and
glucose <0.7 mmol/l, was analyzed with general linear models of
logistic function for dichotomized outcomes utilizing generalized
estimating equations for model estimation.
Results The mean age was 53 (20 to 83) years, 18 (64%) patients
were female, median Glasgow coma scale was 6 (IQR 4 to 8) and
32% were dead at discharge. A total of 3,209 hours of monitoring
and 297 Hb measurements were collected and analyzed. The
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Brain sinoarterial S100B concentration differences over time.
Mean/SE. *P <0.05.
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Relative frequency of metabolic crisis across hemoglobin ranges.S39
mean Hb was 10.1 ± 1.5 mg/dl. Hb values were categorized into
four ranges: ≤8 mg/dl, 8.1 to 9 mg/dl, 9.1 to 10 mg/dl and
>10 mg/dl. The range with lowest frequency of MC and BTH (9.1
to 10 mg/dl) was defined as the reference. For every reduction in
Hb range below the reference, there was an increased risk of MC
(adjOR = 1.7 (95% CI = 1 to 2.9), P = 0.048 for 1 to 9 mg/dl; and
adjOR = 4.2 (1.6 to 11.4), P <0.01 for ≤8 mg/dl) (Figure 1). A
reduction in Hb below 8 mg/dl was also associated with increased
risk of BTH (adjOR = 2.5 (1 to 6.5), P = 0.04) (Figure 2). The
number of hours per day monitored spent in MC, but not with BTH,
was associated with mortality at discharge (adjOR = 1.6 (1.1 to
2.4), P = 0.02).
Conclusions  Mild reductions in blood Hb below 9 mg/dl are
associated with an increased risk of MC and BTH after severe
brain injury. MC had a more pronounced relationship with anemia
and was associated with a greater risk of death.
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Introduction  Nonconvulsive seizures (NCSZ) and periodic epi-
leptiform discharges (PEDs) are common and associated with
poor outcome after intracerebral hemorrhage (ICH). Our objective
is to describe the frequency of renal, liver, metabolic and
thrombotic dysfunction after ICH and its association with non-
convulsive status epilepticus (NCSE), NCSZ and PEDs.
Methods  We retrospectively identified all patients with spon-
taneous ICH who underwent cEEG monitoring between 1998 and
2006. Data assessed included admission creatinine and maximum
values during the first 14 days for creatinine and bilirubin, and
minimum values for bicarbonate, base excess and platelets. Acute
renal failure (ARF) was defined as an increase in creatinine >50%
from baseline, and severity was assessed by the RIFLE criteria.
Other continuous variables were dichotomized using the mean
value as the cutoff point to define the presence of liver dysfunction,
acidosis and thrombocytopenia. ICH characteristics were based
on CT scans. Univariate logistic regression was conducted to
identify associations between predictors and NCSE, NCSZ and
PEDs. Significant (P <0.25) and clinically relevant variables were
then included in a multivariable logistic regression model to identify
independent associations.
Results A total of 102 patients were studied. The mean age was
62 ± 17 years and 55 (56%) were male. Twenty-six (26%) patients
were comatose on admission and 15 (17%) had an increase in
ICH volume >30%. Seven (6%) patients developed NCSE, 18
(18%) NCSZ and 17 presented PEDs. ARF developed in 30
(29%) patients, liver dysfunction in 30 (29%), metabolic dys-
function in 48 (47) and thrombocytopenia in 55 (54%). Patients
with NCSZ and PEDs more frequently developed ARF (56 vs.
24%, P = 0.01 and 47 vs. 26%, P = 0.08, respectively). After
adjusting for age, gender, coma at admission and increase in ICH
volume, patients with ARF were six times more likely to develop
NCSZ (OR = 5.9, 95% CI = 1.4 to 24.6, P = 0.01) as compared
with those without ARF. Similarly, after adjusting for age, gender
and coma/stupor at admission, each one-point increase in the
RIFLE criteria doubles the odds of developing PEDs (OR = 2.0,
95% CI = 1.1 to 3.6, P = 0.02). No significant associations were
found for NCSE.
Conclusions  ICH location within 1 mm from the cortex, an
increase in ICH volume, coma or stupor at admission and the
presence of ARF were independently associated with the
development of NCSZ and PEDs after ICH.
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Introduction  Central nervous system (CNS) failure along with
other systems is included in septic multiorgan failure; however, in
our opinion, it is the less studied. Earlier, a S100β level rise was
described for septic encephalopathy patients, but together with
this sites of a local ischemia or a bleed were discovered according
to computer tomography in a brain [1]. The purpose of the present
study is to determine whether it is the functional or the organic
CNS insult that defines septic encephalopathy and to study the
dependence of septic encephalopathy on the severity of sepsis.
Methods  The prospective study involves 28 septic patients
according to sepsis criteria and ACCP/SCCM classifications. The
primary site localization of infection in our study excluded the CNS
according to computer tomography. After the approval of the
hospital ethics committee we investigated the patients without
neurological disturbances. The patients were divided into two
groups. The first group (n = 12) included the patients with various
degrees of impairment of consciousness (<15 points of the
Glasgow coma scale). The second group (n = 16) included
patients without any disturbances of consciousness. There were
no differences between groups in age, gender, severity of sepsis,
the cortisone level, lactate, and arterial and jugular bulb blood
saturation.
Results The S100β level in group 1 was reliably higher than in
group 2, and on average it surpassed the normal rate by 2.6 times
(group 2 showed the S100β level as not exceeding the normal
level of 0.15 units/ml). Venous blood saturation in the two groups
reliably did not differ and was within the norm. However, the
saturation of the jugularis blood in group 1 was equal to 57.64 ±
13.3, which is below the norm. Venous blood lactate exceeded in
group 2, while group 1 showed a normal rate both in venous and
jugular blood (lactate jugular = 1.76). The 28-day mortality was
reliably higher in group 1. The S100β level correlated with
mortality.
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Relative frequency of brain tissue hypoxia across hemoglobin ranges.S40
Conclusions  CNS failure under septic encephalopathy is of
organic character and relates to CNS cell necrosis that is not of
focal character. The results obtained have suggested that the
S100β level may be considered a marker of unfavorable outcome
in patients with severe sepsis.
Reference
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Introduction One of the most controversial areas of traumatic brain
injury (TBI) critical care is the management of cerebral perfusion
pressure (CPP). Since optimal CPP levels depend on whether
cerebral autoregulation is preserved, these levels must be determined
for individual cases. The aim of this study was to investigate the role of
jugular venous saturation (SjO2) and brain tissue oxygen tension
(PbrO2) monitoring in addition to CPP and intracranial pressure (ICP)
monitoring in the acute management of patients with TBI.
Methods Thirty-six severe TBI patients (ages 16 to 69 years, GCS
score 4 to 7) admitted to our neurosurgical critical care unit were
evaluated. ICP (Camino), CPP, and SjO2 (Abbott) were
continuously monitored in the 36 patients, and PbrO2 (LICOX) was
continuously monitored in the last 10 patients. The treatment goal
was aimed at keeping ICP <20 mmHg and CPP >60 mmHg.
Patients with good recovery or moderate disability on the Glasgow
Outcome Scale at 6 months after injury were regarded as having
favorable outcomes, and those with severe disability, vegetative
state, or death were regarded as having unfavorable outcomes.
Results Thirteen patients had favorable outcomes. PbrO2 values
showed a positive correlation with CPP (r = 0.380, P <0.0001).
SjO2 tended to be abnormally high when the simultaneous PbrO2
values were <15 or >45 mmHg. High SjO2 combined with low
CPP or low PbrO2 was associated with unfavorable outcome. The
occurrence rate of CPP above 60 mmHg during the first 5 days of
monitoring was 89.8% of the measurements in favorable outcome
patients vs. 72.7% of those in unfavorable outcome patients
(likelihood ratio = 1.2). These proportions were altered to 70.3% vs.
46.8% (likelihood ratio = 1.5) when the simultaneous SjO2 values
were normal, and to 85.8% vs. 51.2% (likelihood ratio = 1.7) when
the simultaneous PbrO2 values were more than 20 mmHg.
Conclusions The present data emphasize the clinical significance
of brain oxygen monitoring in TBI and provide evidence for high
SjO2 caused by cerebral hypoperfusion. SjO2 and PbrO2 measure-
ments in combination with ICP and CPP should help in improving
the accuracy of monitoring intracranial pathophysiology and
response to treatment.
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Introduction  The purpose of the treatment of subarachnoid
hemorrhage (SAH) is to prevent or reverse ischemic disabilities
through hemodynamic therapy (4H therapy) [1]. We add some
criteria to the index to assess patients with SAH.
Methods  Informed consent for each patient/family, APACHE II
score, weekly Sequential Organ Failure Assessment, serum
glucose, lactate, calcium, sodium and magnesium, measurement of
axillary temperature and hourly diuresis as the additional prognostic
index Sequential Organ Failure Assessment were obtained. The
study enrolled 91 patients diagnosed with SAH, confirmed by CT
in the ICU. The conduct to approach these new criteria was the
same in all patients. These patients were divided into two groups
according to their development in the ICU: Group I – patients who
had satisfactory development (out of the ICU), and Group II –
patients who progressed to death.
Results Among 91 patients, Group I had 55 patients (60.4%) and
the 36 remaining patients (39.6%) were classified as a Group II.
See Table 1.
Conclusions Regarding the criteria used to assess patients with
SAH, we concluded the only criteria that showed statistical signifi-
cance in the prediction of death was the serum sodium (P = 0.002).
Reference
1. Naval NS, et al.:  Controversies in the management of
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Introduction Cerebral aneurysms affect between 1% and 5% of
the adult population and are responsible for significant rates of
morbidity and mortality. The treatment of intracranial aneurysms
has evolved substantially since the introduction of endovascular
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Results of the criteria examined in the study obtained in both groups
Group I (n = 55) Group II (n = 36)
Criterion Frequency (95% CI) OR Frequency (95% CI) OR P value
Arterial lactate 50.9 (37.1 to 64.6) 1.0  50.0 (32.9 to 67.1) 0.96 0.5
Serum calcium  49.1 (35.4 to 62.9) 1.0 55.6 (38.1 to 72.1) 1.3 0.3
Serum glucose 23.6 (13.2 to 37.0) 1.0 36.1 (20.8 to 53.8) 1.8 0.1
Serum magnesium 10.9 (4.1 to 22.2) 1.0 0 (0 to 9.7) 0 0.04
Serum sodium  23.6 (13.2 to 37.0) 1.0 55.6 (38.1 to 72.1) 4.0 0.002
Hourly diuresis 78.2 (65.0 to 88.2) 1.0 72.2 (54.8 to 85.8) 0.7 0.3
Axillary temperature 16.4 (7.8 to 28.8) 1.0 30.6 (16.3 to 48.1) 2.2 0.06S41
neurosurgery by Guglielmi detachable coils in the 1990s. The
ablation overtook clipping as the initial method in many centers,
including Brazil, because of the safety and feasibility of this method.
Methods This cohort retrospective study analyses the clinical and
epidemiological variables. It was conducted from a database of
patients submitted for an ablation in the neurosurgery department
of São José do Avaí Hospital (Itaperuna – RJ, Brazil) in the period
December 2006 to May 2007.
Results  We studied 510 patients submitted for ablation: 406
females (79.6%) and 104 males (20.4%). The average age of
patients was 50.9 years (OR = 14). The total of patients studied
that required hospitalization in the ICU was 176 (34.4%), staying
on average 6.1 days (OR = 5.0). Hunt–Hess scale prevalence: 1 –
57.0%, 2 – 27.2%, 3 – 11.8%, 4 – 3.5%, 5 – 0.5%, and Fisher
(tomography scale): 1 – 41.8%, 2 – 24.0%, 3 – 23.5%, 4 – 10.6%.
We found risk factors involved in cerebral vascular accident.
Conclusions We note the predominance of females for the occur-
rence of cerebral vascular aneurysmatic accident. The average age
of patients was 50.9 years. Systemic hypertension and smoking
showed a strong association with the presence of intracranial
aneurysms. The arteries of the previous segment were those that
had a higher incidence of aneurysms. The majority of patients did
not require hospitalization in the ICU. The mortality rate of cerebral
vascular accident in patients with endovascular coiling was 11.3%.
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Introduction  Nonconvulsive status epilepticus (NCSE), non-
convulsive seizures (NCSZ) and periodic epileptiform discharges
(PEDs) are common and associated with poor outcome after
subarachnoid hemorrhage (SAH). The objective of this study is to
describe the frequency of renal, liver, thrombotic and metabolic
dysfunction after SAH and their association with NCSE, NCSZ
and PEDs.
Methods We studied all patients with SAH who underwent cEEG
monitoring from 1997 to 2004. Data assessed included admission
creatinine, maximum values during the first 14 days for creatinine
and total bilirubin, and minimum bicarbonate, base excess and
platelets. Renal failure was defined either as a maximum creatinine
>1.1 mg/dl or as an increase in creatinine >50% from baseline.
Severity of renal dysfunction was assessed by the RIFLE criteria.
The other continuous variables were dichotomized using the mean
value as the cutoff point that defined liver dysfunction, metabolic
acidosis and thrombocytopenia. Univariate logistic regression was
conducted to identify associations between predictor variables
with NCSE, NCSZ and PEDs. Significant (P <0.25) and clinically
meaningful variables were then included in a multivariable logistic
regression model to identify independent associations.
Results A total of 116 patients were studied. The mean age was
58 ± 16 years and 80 (69%) were female. Eighty-eight percent of
the patients had a Hunt–Hess grade at admission of 3 or worse.
Twelve patients (10%) developed NCSE, 17 (15%) NCSZ and 26
(22%) PEDs. Acute renal failure (ARF) developed in 18 (15%)
patients, liver dysfunction in 24 (21%), low bicarbonate in 37
(32%), low base excess in 72 (62%) and thrombocytopenia in 55
(47%). After adjusting for age, gender and Hunt–Hess grade,
patients with severe metabolic acidosis were six times more likely
to develop NCSZ as compared with those without acidosis (OR =
5.9, 95% CI = 1.2 to 27.8, P = 0.03). Similarly, after adjusting for
age, gender and Hunt–Hess grade, patients with renal dysfunction
were six times more likely to develop NCSE as compared with
those without ARF (OR = 5.8, 95% CI = 1.5 to 21.8, P = 0.01).
No association was found with PEDs.
Conclusions Organ dysfunction is common after SAH. Metabolic
acidosis and renal dysfunction were independently associated with
the development of NCSZ and NCSE, respectively.
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Introduction  Volume management is crucial in intensive care;
however, in some patients it is very hard to achieve optimal water
balance. The subarachnoid hemorrhage (SAH) patient is a repre-
sentative example [1-3]. Cardiopulmonary complications are
common after SAH: neurogenic pulmonary edema, cardiac failure,
and so on. In this study we will present the time course of
catecholamines and natriuretic polypeptides and fluid redistribution
on pulse contour analysis calibrated by transpulmonary thermo-
dilution PiCCO-plus monitoring after SAH.
Methods Plasma catecholamines and natriuretic polypeptides of
54 consecutive patients were measured every other day during
2 weeks after SAH. The cardiopulmonary functions of 37 conse-
cutive patients were monitored by PiCCO-plus daily during
2 weeks after SAH.
Results Noradrenalin, dopamine and brain natriuretic polypeptide
concentrations were significantly high during the entire study
period. Intrathoracic blood volume was maintained in spite of
systemic hypovolemia, and this fluid redistribution caused
hydrostatic fluid retention in lung tissues on PiCCO-plus
monitoring after SAH. See Figures 1 and 2.
Conclusions  Persistent catecholamine release and the different
sensitivity of blood vessels to catecholamine cause the blood
volume redistribution: systemic hypovolemia and hydrostatic pul-
monary edema. The excess cardiac preload due to catecholamine
release leads to BNP release resulting in natriuresis.
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Introduction  Liberal use of packed red blood cell (PRBC)
transfusion to a predefined threshold has been shown to worsen
Available online http://ccforum.com/supplements/13/S1S42
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PiCCO-plus monitoring after SAH. ELWI, extravascular lung water index; PVPI, pulmonary vascular permeability index; EVLW, extravascular lung
water; PBV, pulmonary blood volume.
Figure 1 (abstract P99)
Plasma catecholamine and natriuretic peptide concentrations after SAH. NOR, noradrenalin; DOA, dopamine.S43
the outcome of ICU patients. However, in an effort to improve
neurologic outcomes of patients with nontraumatic subarachnoid
hemorrhage (SAH), transfusions are still used frequently to
maintain hemoglobin of 10 g/dl. We hypothesized that PRBC
transfusion in patients with SAH would worsen their outcomes.
Methods  We conducted a 19-month retrospective study of 84
patients with nontraumatic SAH in an intensivist-run, high-volume,
academic ICU. Patients who received at least 1 unit PRBC
transfusion during their hospital stay (n = 42, median 3 units) were
compared with those who did not (n = 42). Outcomes of interest
were vasospasm (defined both clinically and by transcranial
Doppler velocities), 28-day mortality, poor neurologic outcome
(defined as modified Rankin score of ≥4), and occurrence of
nosocomial infections (defined by National Healthcare Safety
Network criteria). Associations of PRBC transfusions with these
outcomes were measured using univariate and multivariate analysis
that adjusted for age, gender, ethnicity, comorbidities, neurologic
status upon presentation, and procedures.
Results Patients with and without PRBC transfusions were similar
in age, gender, ethnicity, comorbidities, and neurologic status upon
presentation. There was no difference in the incidence of
vasospasm with transfusions (52% vs. 37%, P = 0.12) or mortality
(12% vs. 17%, P  = 0.53). PRBC transfusions were associated
with nosocomial infections (69% vs. 33%, P = 0.001) and poor
neurologic outcome (69 vs. 48%, P = 0.046) in univariate analysis.
After adjustment for potential confounders, PRBC transfusion was
an independent predictor of nosocomial infections (OR = 3.7,
95% CI = 1.2 to 11.6, P = 0.03) but not poor neurologic outcome
(OR = 1.9, 95% CI = 0.4 to 10.6, P = 0.45).
Conclusions Use of PRBC transfusion in ICU patients with SAH
does not improve neurologic outcome but increases risk of
nosocomial infections. Hence, restricted use of PRBC may be
justified in this segment of the ICU population, as well.
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Introduction  Various pieces of research have been done on
prevention or treatment of symptomatic vasospasm and normal
pressure hydrocephalus after subarachnoid hemorrhage due to
ruptured cerebral aneurysm. However, this important issue is still
unresolved. In this preliminary report, we introduce our surgical
strategy and techniques of subarachnoid hemorrhage due to
ruptured cerebral aneurysm and discuss the prevention of
symptomatic vasospasm and normal pressure hydrocephalus in the
surgical aspect.
Methods The subjects consisted of 19 consecutive patients with
subarachnoid hemorrhage due to a ruptured cerebral aneurysm
who were surgically treated in acute stage between 2006 and
2007. All aneurysms were located at the anterior circulation. Hunt
& Kosnik classifications were 1 to 3, WFNS were 1 or 2, and the
Fisher group was 2 or 3. We performed neck clipping of the
aneurysm through the lateral supraorbital or pterional approach.
We opened surrounded cisterns of the Circle of Willis and
removed the hematoma as much as we could. The lamina
terminalis was routinely opened during the operation. We did not
insert any drainage tube postoperatively.
Results  Symptomatic vasospasms were noted in four patients.
However, the symptoms were not severe and were transient in all
patients. There were no patients with normal pressure hydro-
cephalus. The clinical outcomes were good or excellent. There
were almost no perioperative complications due to surgical
procedures.
Conclusions  The surgical techniques with certain contributions
might prevent symptomatic vasospasm and normal pressure
hydrocephalus after subarachnoid hemorrhage due to a ruptured
cerebral aneurysm. An accumulation of cases is necessary.
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Introduction  Vasospasm occurs in up to 70% of subarachnoid
hemorrhages (SAHs). Transcranial Doppler (TCD) and cerebral
angiography (AGF) are used to monitor and guide its treatment;
however, no systematic approach to interpret their values exists
yet. The aim of our study was to evaluate the correspondence
between sonographic and angiographic findings and the efficacy
of the endovascular treatment.
Methods  One hundred and one patients were admitted to our
neurological ICU with SAH from June 2006 to September 2008.
All of them were examined with daily TCD. Mean flow velocity in
the middle cerebral artery >200 cm/s or an increase >50 cm/s/day
or a mean flow velocity in the other arteries more than two times
the normal values were interpreted as indicative of severe
vasospasm. If a second TCD showed high blood velocities, an
AGF was performed. If the vasospasm was confirmed, the patient
was considered eligible for endovascular treatment. Ten patients
developed severe vasospasm and were analyzed in this study.
Results All patients presented poor clinical condition at admission
(Hunt Hess 4 ± 0.9, Fisher grade 3.7 ± 0.4). Sixty percent
developed intracranial hypertension and 30% needed barbiturate
coma and decompressive craniectomy. Severe vasospasm occur-
red 9 days after SAH (8.5 ± 4.4). In 100% there was
correspondence between sonographic and angiographic diagnosis
of vasospasm. Eighteen endovascular treatments were performed
(70% either intra-arterial nimodipine or transluminal balloon
angioplasty, 30% intra-arterial nimodipine). Angiographical and
clinical improvement was obtained in 80% of endovascular
procedures, the sonographical efficacy in 75% of them. Nine
patients developed recurrent vasospasm after the endovascular
therapy. Each patient received 1.8 ± 1.03 treatments. Two patients
with refractory vasospasm died in the neurological ICU for
intracranial hypertension; the other eight patients had good
recovery at discharge (Glasgow coma scale 12 ± 2.3). At the
6-month follow-up all patients had a favorable Glasgow outcome
score (3.9 ± 1.59).
Conclusions  Our study confirmed the excellent correlation
between TCD and angiography in patients with middle cerebral
artery flow velocity >200 cm/s. TCD can be considered a very
useful bedside tool for early detection of vasospasm. The
endovascular management of vasospasm appeared to be safe and
effective. The efficacy of the association of pharmacological and
mechanical approach in improving outcomes after SAH and in
reducing the frequency of secondary neurologic deficits was
demonstrated.
Available online http://ccforum.com/supplements/13/S1S44
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Introduction Vasospasm is the main cause of death and cognitive
deficits in patients with subarachnoid hemorrhage after rupture of
an aneurysm (aSAH). Some trials have shown that statins in the
acute phase of aSAH reduce the incidence, morbidity and mortality
of cerebral vasospasm [1]. The purpose of this study is to evaluate
the potential of simvastatin (SVT) as prevention against vasospasm.
Methods We realized a prospective, randomized, nonblind study
with the use of 80 mg SVT (night) in the first 72 hours of the
beginning of bleeding, and a control group that did not use SVT,
for 21 days between January and December 2008. Informed
consent was obtained for all patients. CT scans were performed as
a control and another CT scan was performed in patients with
altered neurological signals. In the presence of changes
suggestive of vasospasm or correlation in clinical conditions and
CT scans, the patients were taken for a cerebral arteriography
examination followed by an angioplasty procedure if necessary.
Liver and renal function and LDL cholesterol were evaluated
weekly, and total creatine kinase was evaluated every 3 days.
Exclusion criteria: liver and renal disease, pregnant elevation of
serum transaminases (three times normal value), creatinine ≥2.5,
rhabdomyolysis or total creatine kinase ≥1,000 U/l.
Results We excluded two patients with bleeding for more than
72 hours. There was no significant change in the levels of total
creatine kinase, and renal or liver function. We included 21
patients, 11 in the SVT group and 10 in the control group. Mortality
was eight patients (38%), six patients in the control group and two
of the SVT group. Vasospasm was confirmed by cerebral
arteriography examination in four patients in the control group and
one patient in the SVT group. All the patients who died showed
Fisher scale IV.
Conclusions SVT at a dose of 80 mg was effective in reducing the
mortality (18.1% against 60%) compared with the group that did
not use SVT, and also decreased the incidence of cerebral
vasospasm despite the APACHE II score being higher in the group
that used SVT (14.3 vs. 10.7). Less morbidity occurred in the SVT
group, with an average Glasgow outcome score of 3.25 vs. 2.1.
Reference
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Introduction We propose this study in order to reach two points: the
clinical incidence of vasospasm morbidity, confirmed by CT; and the
mortality of subarachnoid hemorrhage (SAH) patients in 28 days [1].
It shows the comparison of a group of patients that used magnesium
(Mg) (intervention, Group 1) with those that did not use Mg
(control, Group 2).
Methods  After institutional approval and informed consent, a
prospective, randomized, nonblind study was carried out between
February and November 2008. The main goal of the study was to
achieve a Mg serum concentration from 2.5 to 3.5 mg/dl, using a
solution of Mg 2% (saline solution 5% 400 ml + MgSO4 10%
100 ml/24 hours), during the first 14 days of aneurysm rupture.
Admission criteria: patients diagnosed with SAH and ΔT <96 hours.
Exclusion criteria: patients with SAH and ΔT >96 hours.
Results In a previous study evaluation we analysed a total of 56
patients with (n = 26 in Group 1 and n = 30 in Group 2) (Tables 1
and 2). Main results: Group 1 – vasospasm frequency 26.9% (n =7 )
and mortality 19.2% (n  = 5) in 28 days; Group 2 – vasospasm
frequency 46.7% (n = 14) and mortality 33.3% (n = 10) in 28 days.
Conclusions  According to the outcome, we can conclude that
Group 1 obtained greater protection on the vasospasm incidence
and decrease of mortality in comparison with Group 2. The P value
was not significant due to a still small number of patients.
Reference
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Introduction  Subarachnoid hemorrhage (SAH) from rupture of
cerebral aneurysms is associated with significant mortality and
morbidity. About 10% to 25% die before reaching hospital, and of
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Table 1 (abstract P104)
Average age APACHE II score Average Mg level
Group I (n = 26) 52.3 8.2 2.32
Group II (n = 30) 50.3 15.6 1.9
Table 2 (abstract P104)
Group I (n = 26) Group II (n = 30)
Frequency  95% confidence  Frequency  95% confidence 
(% (n)) interval Odds  ratio (%  (n)) interval Odds  ratio P value
Vasospasm 26.9 (7) 11.6 to 47.8 0.4 46.7 (14) 28.3 to 65.7 1 0.1
Mortality in 28 days 19.2 (5) 6.6 to 39.4 0.5 33.3 (10) 17.3 to 52.8 1 0.2S45
those who survive about 40% to 50% develop significant
neurological deficits [1]. Ventilator-associated pneumonia (VAP) is
defined as pneumonia occurring more than 48 hours after initiation
of mechanical ventilation. About 20% of post-aneurysmal SAH
patients are reported to experience VAP [2]. In this trial, we aimed
to report the short-term outcomes of VAP. We performed a
surveillance analysis on aneurysmal SAH patients who required
mechanical ventilation for more than 48 hours.
Methods  After obtaining approval from the Human Studies
Committee of the University of Louisville to retrospectively analyze
the prospectively collected patient data, we reviewed the elec-
tronic records of our aneurismal SAH patients admitted between
2004 and 2007. VAP was diagnosed and confirmed by the
Clinical Pulmonary Infection Score supported with culture results
on days 0 and 3. We analyzed host-specific and disease-specific
and care-related risk factors. Categorical variables were compared
with the chi-square test, and continuous data were analyzed with
the unpaired t and Kruskal–Wallis tests.
Results Within 86 aneurysmal SAH patients admitted to the ICU,
45 patients needed to be ventilated for more than 48 hours (52%),
and 16 of them developed VAP (19%). More than 80% of patients
with SAH required either surgical or vascular procedure. The
majority of VAP were late-onset pneumonias (88%). The duration
of mechanical ventilation was longer in the VAP patients. About
20% of VAP group patients were also diagnosed with sepsis.
However, the duration of ICU stay was neither influenced by VAP
nor by sepsis. Four patients who did not experience any VAP were
diagnosed with stroke during their ICU stay. All-cause mortality
was not longer in patients with VAP.
Conclusions In this preliminary report of a prospective cohort trial,
it appeared that VAP did not contribute to additional morbidity or
mortality. The majority of VAP occurred late in the course of
ventilation. This supports the theory that VAP occurs primarily due
to the disease itself and that detailed and prolonged care is
required for the management of aneurysmal SAH patients.
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Introduction  A retrospective assessment of the outcome of
patients with poor-grade (World Federation of Neurosurgeons
Grades 4 and 5) subarachnoid haemorrhage (SAH) at a regional
neurosurgical centre. Previous studies have shown aggressive
treatment of patients with a poor clinical grade of SAH is
warranted as grading can improve following resuscitation and
drainage of cerebrospinal fluid [1,2]. Many units still withdraw
treatment if these patients do not improve neurologically in the first
48 to 72 hours [3].
Methods A retrospective analysis of the notes of 116 patients who
were recorded as having a diagnosis of SAH was performed
between October 2002 and January 2006. Patients were excluded
if they were World Federation of Neurosurgeons Grade 1, 2 or 3,
had a traumatic SAH or been incorrectly classified as having SAH.
Results Of 116 patients identified with a diagnosis of SAH, 12
patients were excluded as they had a traumatic SAH, one patient
had a dissection, one patient a subdural haemorrhage and one
patient a basal ganglia haematoma. Thirteen patients had a
Glasgow coma score >12. Eighty-eight patients were correctly
deemed as poor grade. All poor-grade patients were admitted to
the intensive therapy unit. Of these 88 patients, 34 (38.6%)
survived. Twenty-four (70%) of the survivors were discharged
home, eight (24%) to a care home, and two (6%) remained in
hospital. Seventeen (50%) had a Glasgow Outcome Score of 4 or 5.
Conclusions  Outcomes from poor-grade SAH at James Cook
University Hospital compare favourably with published data.
Review of the literature gives a wide variation in outcome between
3.2% and 42%. It is our hypothesis that a combination of more
aggressive critical care management combined with early
intervention should result in a reevaluation of treatment plans in
those with a historically perceived poor outcome.
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Introduction  The most widely adopted scale to assess
consciousness in severely brain-damaged patients is the Glasgow
coma scale (GCS) [1]. Its major shortcomings are the failure to
assess the verbal component in intubated patients, the inability to
test brainstem reflexes and breathing patterns. In 2005, Wijdicks
and colleagues proposed a new coma scale, the Full Outline of
Unresponsiveness (FOUR) scale [2], which consists of four
components (eye, motor, brainstem, and respiration), each compo-
nent having a maximal score of 4. Our objective was to validate the
French version of the new FOUR coma scale in a general ICU and
to assess its predictive value as compared with the GCS.
Methods  We performed FOUR and GCS evaluations in
randomized order in 176 acutely brain-injured patients (days from
insult to randomization <1 month). We assessed the association
between GCS and FOUR scores using the Spearman correlation
coefficient. A logistic regression analysis adjusted for age and
etiology of coma was performed to assess the link between the
studied scores and the outcome based on the Glasgow outcome
scales 3 months after injury (n = 63).
Results  The GCS and FOUR showed a significant correlation
(r = 0.807). The GCS verbal component was scored 1 in 146
patients; among these, 131 were intubated. The FOUR total scores
(corrected for age) showed superior outcome prediction at 3 months
(OR = 0.83; 95% CI = 0.70 to 0.98, P = 0.03) as compared with
GCS total scores (OR = 0.85; 95% CI = 0.70 to 1.03, P = 0.09).
Conclusions The FOUR scale does not need a verbal response,
thus allowing complete testing in intubated patients (in our sample
90% of patients showing a GCS V1 score were intubated). Most
importantly, the FOUR scale demonstrated a better discrimination
between the good (recovery of independent living) and poor
neurological status at 3 months as compared with the GCS.
Available online http://ccforum.com/supplements/13/S1S46
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Introduction Annually, Guillain-Barré syndrome (GBS) affects one
to four cases/100,000. Intravenous immunoglobulins (IVIg) and
plasma exchange (PE) are the main treatment in this disease. The
purpose of this study is to compare the efficacy of IVIg versus PE
in the treatment of GBS in a medical ICU.
Methods  This is a prospective, monocentric, nonrandomized
study, realized in the medical ICU of the Ibn Rochd university
hospital of Casablanca, during 5 years (2002 to 2006). We
included all patients with GBS who required mechanical ventilation
(MV). An electromyogram was realized in all patients and found
axonal demyelinization. We defined two groups: group 1 (group
treated by IVIg: 0.4 g/kg/day during 5 days) and group 2 (group
treated by PE: 4 PEs during 10 to 14 days). We collected
demographic characteristics, clinical and therapeutic aspects and
outcome. We evaluated the beginning of motility recuperation and
MV weaning essentially. The quantitative variables are expressed
as the average or median ± standard deviation, and the qualitative
variables by percentage. The univariate analysis was based on the
Pearson chi-square test or the Fisher test for the qualitative
variables and the Student test for the quantitative ones. P <0.05 is
considered significant. The statistical analysis was based on SPSS
11.0 for Windows.
Results Forty-one patients (21 in group 1 and 20 in group 2) were
enrolled. The mean age was 37 ± 9 years, with a masculine
predominance (75.4%). The mean length of hospitalization was
32 days. The length of hospitalization of group 1 was less than that
of group 2 (P = 0.02). The weaning of MV was more precocious in
the patients of group 1 than those of group 2 (P = 0.01). Also, the
beginning of motility recuperation was more precocious in group 1
than in group 2 (P = 0.001).
Conclusions  Although the results of the literature are not
conclusive, our work – of which the most important slant is the
absence of randomization – reveals that there is a meaningful
difference for MV weaning between the group receiving IVIg in
relation to the PE group. These encouraging results would merit
confirmation by controlled and randomized works.
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Introduction  Neuromuscular weakness is a condition which is
often found during long-term ICU treatment. Critical illness poly-
neuropathy (CIP) is the main reason for neuromuscular weakness.
Diagnosis of CIP is difficult in the ICU setting. The reasons, even
predisposing factors, for CIP are not fully studied. The aim of this
study was to analyze whether sedation, duration of ventilation, and
duration of ICU stay are good determinants of CIP.
Methods A prospective investigation of patients treated in the ICU
for longer than 7 days during a 6-month period (1 May 2008 to 31
October 2008) was made. All ICU survivors were included in the
study. The APACHE II scores, first ICU day SOFA scores, duration
of sedation, amount of sedation, and duration of ventilation were
calculated. Electroneuromyography was performed for every
patient. Data of patients with (CIP group) and without (control
group) CIP were compared.
Results  Thirty-seven patients were included in the study. In 16
cases CIP was diagnosed (43.2% of patients). The was no age
difference in both groups of patients (55.37 ± 16.5 years in CIP
group; 51.86 ± 17.92 in control group; P = 0.55). The APACHE II
score in the CIP group was high in comparison with the control
group – 20.31 ± 7 vs. 15.8 ± 5.89 (P = 0.04). The CIP group
admission-day SOFA score was higher in comparison with the
control group – 7.87 ± 4.05 vs. 5.09 ± 2.52 (P = 0.01). Duration
of ICU stay was 20.37 ± 15.54 days in the CIP group and 15.19 ±
10.95 in the control group (P = 0.24). Duration of sedation in the
CIP group was 118.68 ± 219.59 hours and in the control group
was 78.9 ± 94.22 hours (P = 0.45). The sedation volume in the
CIP group was 5,386.8 ± 18,112.04 mg and in the control group
was 892.25 ± 1,440.97 mg (P = 0.26). There was no difference in
duration of ventilation in both groups (330.62 ± 376.28 hours in
CIP group and 159.92 ± 273.27 hours in control group; P = 0.11).
Conclusions  CIP is often a complication of long-term ICU
treatment (43.2% in our ICU). Correlation exists between the
APACHE II score, admission-day SOFA score and development of
CIP in cases of long (>7 days) ICU treatment according to our
results. No correlation between duration of sedation and venti-
lation, volume of sedation, duration of ICU treatment and develop-
ment of CIP was found. Larger studies are needed to establish the
determinants of CIP.
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Introduction  Neurally adjusted ventilatory assistance (NAVA)
delivers pressure (Paw) in proportion to the electrical activity of the
diaphragm (EAdi). It is not known whether EAdi adequately reflects
the respiratory drive in patients with critical illness polyneuro-
myopathy (CIPM) and would be sufficient to deliver assistance
using NAVA.
Methods Fifteen invasively ventilated patients (median (quartiles):
66 (59; 73) years old, APACHE II score 19 (17; 24)) with
electrophysiologically documented CIPM were studied. A level of
adequate unloading (NAVAAL) was identified daily based on the
characteristic response in Paw and tidal volume (Vt) to stepwise
increasing NAVA (titration) as previously described [1]. NAVAAL
was used for a maximum of 72 hours.
Results NAVAAL was implemented in 13 patients for 54 (40; 61)
hours. Three patients were liberated from mechanical ventilation
during the study. NAVA could not be used in two patients
(diaphragm myoclonic; excessive respiratory drive). At NAVAAL
peak inspiratory EAdi was reduced by 30 (25; 40)% compared
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with the lowest NAVA level used during the titration. The breathing
pattern, heart rate, and mean arterial pressure remained stable
during NAVA. See Table 1.
Conclusions  EAdi was sufficient to use NAVA in most of our
patients with moderate to severe CIPM. Implementation of a
titrated NAVA level for up to 72 hours resulted in low Vt, improved
oxygenation over time, and stable cardiorespiratory function.
Acknowledgement  Supported by the Swiss National Science
Foundation 3200B0-113478/1.
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Introduction Muscle weakness and atrophy due to critical illness
polyneuromyopathy (CIPM) is common in long-stay intensive care
patients. Recent nerve excitability studies suggest that the
recovery cycle after a single supramaximal stimulus provides useful
information about axonal membrane potential and ion channel
function in neuropathies. We previously found that critical illness
polyneuropathy is associated with nerve depolarization, and that
this depolarization is strongly correlated with serum potassium in
patients with renal failure [1]. We have adapted this method to
human muscle fibres, by measuring the changes in conduction
velocity of muscle fibres [2]. The muscle relative refractory period
(RRP) increases and supernormality (SN) decreases in ischaemia,
suggesting that these measures may be indicators of membrane
potential also in the muscle [2]. The aim of this study was to
evaluate muscle RRP and SN in patients with CIPM.
Methods Nine patients (age 44 to 73 years) with electrophysio-
logically proven CIPM were studied on two occasions within
1 week. Multifibre responses to direct muscle stimulation through
needle electrodes were recorded from the brachioradialis, and the
latency changes measured as conditioning stimuli were applied at
interstimulus intervals of 2 to 1,000 ms. RRP and SN were
compared with an age-matched control group.
Results  In patients with CIPM, muscle RRP was abnormally
prolonged (6.25 ± 2.74 ms (mean ± SD) vs. 3.27 ± 0.45 ms in
healthy subjects; P = 0.0015) and supernormality was reduced
(3.6 ± 3.1% vs. 9.3 ± 3.4%; P = 0.013). Moreover, during renal
failure (8/18 measurements), muscle supernormality correlated
strongly with serum potassium (R = 0.95, P = 0.0004).
Conclusions Muscle fibres are depolarized in CIPM. If, as we have
previously suggested, nerve membrane depolarization is an
important cause of neuropathy in critical illness, it seems likely that
muscle membrane depolarization may be an important cause of
myopathy. Serum potassium is an important factor for muscle
membrane depolarization in patients with renal failure.
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Introduction  The use of intensive insulin therapy (IIT) in neuro-
critical care patients is controversial: IIT failed to improve mortality
and morbidity in brain-injury patients in a number of trials.
Hypoglycemia increases the risk of death and may contribute to
the development of secondary brain injury in these patients. The
aim of this study was to identify risk factors for hypoglycemia in
critically ill neurological patients.
Methods  We performed a retrospective nested case–control
study in the ICU of a tertiary-care teaching hospital in neurological
ICU patients admitted between January 2007 and July 2007.
Neurological ICU patients were defined as patients admitted
primarily to the ICU, as a result of their neurological illness.
Patients were considered as cases if at least one episode of hypo-
glycemia (defined as a glucose level <3.0 mmol/l (<54 mg/dl))
occurred while admitted to the ICU. Only the first hypoglycemic
event (index moment) of a patient was used to match with a control
patient. Control patients were randomly selected from the same
population, admitted for at least the same duration until the index
moment, without previous hypoglycemic events. A number of
potential risk factors for the development of hypoglycemia were
predefined based on the literature in ICU patients. All variables
were analyzed with univariate and multivariate regression analysis,
correcting for age, gender and APACHE II score.
Results  Of the 127 neurological ICU patients, 35 developed
hypoglycemia (27.6%). Mean arterial pressure (OR = 0.93; 95%
CI = 0.87 to 0.99 per increase of 1 mmHg), having a Sepsis-
related Organ Failure Assessment score for hemodynamic
instability ≥1 (OR = 5.53; 95% CI = 1.23 to 24.81), dosage of
norepinephrine (OR = 8.39; 95% CI = 1.38 to 51.12 per increase
of 1 mg/hour), creatinine clearance (OR = 0.98; 95% CI = 0.96 to
1.00 per increase of 1 ml/min) and gastric residual volume without
adjusting the insulin dosage (OR = 11.66; 95% CI = 1.24 to
109.20) were independently associated with a risk for developing
hypoglycemia.
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Table 1 (abstract P110)
Mean inspiratory  Vt (ml/kg predicted  Respiratory rate 
PaO2/FiO2 PaCO2 (mmHg) EAdi (μV) body weight) (breaths/min)
NAVAAL day 1 227 (158; 286) 36 (30; 45) 5.6 (3.4; 7.8) 6.7 (5.8; 8.3) 30 (23; 34)
NAVAAL day 3 263 (212; 380)* 42 (39; 45)* 5.2 (2.9; 6.6) 6.5 (5.4; 7.6) 27 (22; 35)
Data presented as median (quartiles). *P <0.05 vs. day 1.S48
Conclusions Hypoglycemia occurs in a significant proportion of
neurological ICU patients. We suggest more frequent control of
blood glucose values, especially in patients suffering from
hemodynamic instability, renal failure and gastroparesis.
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Introduction  Cerebral oedema is a common, life-threatening
complication of paediatric diabetic ketoacidosis (DKA). Several risk
factors at presentation are known, including urea, and pCO2. It has
recently been suggested that changes in effective osmolality
during treatment may also convey risk, but this has not been
confirmed due to a lack of prospective data.
Methods A prospective observational study over 24 hours of 50
children admitted to a regional ICU with severe DKA (median pH at
presentation 6.90). Development of cerebral oedema was defined
clinically as a deterioration in Glaser score of >2 points during the
24 hours after presentation (equating to a Glasgow coma scale <8
to 10). Changes in effective osmolality, uncorrected and corrected
sodium were modelled using linear (random coefficients) mixed
models, with adjustment for baseline covariates of urea and pCO2.
Results  Consistent with previous studies, baseline urea was
higher and pCO2 lower in patients who subsequently showed
neurological deterioration. All three osmolality variables (effective
osmolality, uncorrected and corrected sodium) were similar at
baseline between the two groups. The best-fitting model utilized
corrected sodium (lowest Akaike information criterion). This
showed a significant interaction effect (P = 0.01), in that corrected
sodium increased over time at a rate of 0.35 mmol/l/hour in
patients who did not develop neurological symptoms, but did not
change in those who did.
Conclusions Lack of change in corrected sodium is associated with
neurological deterioration in the treatment of severe DKA in children.
This variable may be useful if incorporated into treatment guidelines.
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Introduction  Monitoring of blood parameters, such as glucose,
hemoglobin and oxygen saturation, is essential in critically ill
patients. The current invasive methods are not frequent enough for
efficient tight glycemic control, and result in a high rate of
hypoglycemia. In addition, there is a growing need for a continuous
hemoglobin measurement in postoperative care units and ICUs.
The purpose of this study is to evaluate the feasibility of the fully
noninvasive blood monitor (NBM device; OrSense Ltd, Nes Ziona,
Israel) for continuous monitoring of glucose, hemoglobin and
oxygen saturation in critically ill patients.
Methods The study was conducted on 14 patients (seven female,
seven male, ages 34 to 92 years) in the ICU of the Rabin Medical
Center, upon receipt of informed consent. The NBM probe was
placed on patients’ thumbs, where it performed measurements for
up to 24 hours, with readings every 10 minutes. Patient compli-
ance was good and no adverse effects were identified. The results
obtained from the NBM device were compared with blood samples
taken through an arterial line every 30 to 60 minutes and were
analyzed with a blood gas machine (ABL 700; Radiometer,
Copenhagen, Denmark).
Results A total of 208 paired data points were obtained in the trial.
At each point, an algorithm based on a uniform model (with
personal glucose calibration) was used to calculate the three blood
parameters. The reference glucose range was 62 to 369 mg/dl.
The median relative absolute difference was 7.3%, and a Clarke
error grid analysis showed that 95.2% of the measurements fell
within zones A (74.5%) and B (20.7%). The reference range of the
hemoglobin was 7 to 14.5 g/dl and the median absolute error
obtained was 1 g/dl. Oxygen saturation levels were tracked simul-
taneously with a mean error of 2.5%.
Conclusions The present study indicates the potential use of the
noninvasive NBM for continual, accurate, safe, and easy-to-use
multiparameter monitoring in critically ill patients. The device holds
the promise of improving patient care and survival, as well as
reducing staff workload.
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Introduction Treatment of hyperglycemia with an insulin infusion
protocol (IIP) has improved outcomes in ICU and cardiac surgery
patients [1]. Many studies have reported morning glucose values
as representative of whole-day glucose control. We recently
demonstrated that in a mixed ICU population this assumption does
not hold [2]. Since it has been proposed that glucose control may
be especially important in cardiac surgery ICU patients, we asked
whether morning glucose accurately represented whole-day
glucose and determined whether glucose varied over the course of
the day in this patient group.
Methods A prospective, observational single-center study in the
cardiac surgical ICU of a university tertiary-care hospital. All
glucose measurements in cardiac surgical ICU patients receiving
an IIP targeting blood glucose 80 to 110 mg/dl were recorded
from 1 June 2006 to 28 February 2007.
Results We recorded 12,109 glucose measurements from 125
patients on IIPs. The glucose measurements were widely
distributed with 1%, 7%, 47%, 33%, 9% and 2% in the ranges
<60, 61 to 79, 80 to 110, 111 to 150, 151 to 200 and
>200 mg/dl, respectively. After 8 hours of IIP, the proportion of
values in the target range increased to 49%. The 06:00-hour
glucose values were lower than other values (mean ± SD: 105 ±
24 mg/dl (n = 482) vs. 113 ± 33 mg/dl (n = 10,688); P <0.0001).
The 06:00 values were poorly correlated with the average glucose
recorded for the remainder of the day (r2 = 0.029), which was
confirmed by Bland–Altman analysis. The time-averaged glucose
data exhibited ultradian variation, peaking at 10:00 and 19:00
hours. The insulin dose varied with a similar pattern.
Conclusions  In cardiothoracic ICU patients receiving an IIP,
glucose exhibited an ultradian pattern with peaks at 10:00 and
19:00 hours, and was lower in the early morning than during the
remainder of the day. Consideration of this ultradian variation may
avoid hypoglycemic and hyperglycemic episodes and so facilitate
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better glucose control with an IIP. Studies targeting control of
hyperglycemia should report mean blood glucose values for the
entire day rather than early morning values.
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Introduction  Hypoglycaemia, a common complication of strict
glucose control in critically ill patients, has controversial effects on
mortality. The hyperglycaemic index (HGI) takes into account the
unequal time distribution of blood glucose sampling and is a better
predictor of death than other methods to quantify hyperglycaemia
[1]. By analogy with the HGI, we defined the hypoglycaemic index
(HGI-60) as the area above the glucose curve and lower than
60 mg/dl divided by the length of ICU stay. The objective of the
study was to evaluate the effects of hypoglycaemia on inhospital
mortality in critical care patients using a new method for quanti-
fication of hypoglycaemia, the hypoglycaemic index (HGI-60).
Methods  A retrospective study performed in four mixed ICUs.
From 2004 through 2006, patients treated with continuous insulin
therapy were included. Admission type, sex, age, the occurrence of
hypoglycaemia <60 mg/dl, APACHE II score and outcome
(hospital dead) were recorded. The HGI-60 is calculated after
simple interpolation of all glucose values measured during the ICU
stay. The relations between independent variables and hospital
mortality were determined by logistic regression analysis.
Results One hundred and ninety-six patients were included. The
mean age was 60.5 years and 56% were male. The mean
APACHE II score was 22.8 and the hospital mortality was 51.5%.
The HGI-60 median was 0.02 mg/dl/hour (interquartile range 0 to
0.13) in survivors versus 0.07 mg/dl/hour (interquartile range 0 to
0.23) in nonsurvivors (P = 0.01). Results of logistic regression
analysis show that HGI-60 was associated with higher hospital
mortality independently of the APACHE II score (OR = 7.2; 95%
CI = 1.6 to 32.1; P = 0.009). The HGI-60 had a higher area under
the receiver operating characteristic curve (0.70) than the
occurrence of hypoglycaemia (0.67).
Conclusions Hypoglycaemia during the ICU stay is a marker of
increased mortality. The hypoglycaemic index (HGI-60) is a better
predictor of mortality than the occurrence of hypoglycaemia.
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Introduction  A postoperative diabetic patient, stabilized on 96
units/day Actrapid by syringe pump, when changed to a burette
administration set required 1,200 units/day to achieve glycaemic
control. The problem resolved when reverting to a syringe. An ex
vivo experiment confirmed variable adsorption to syringes and
burettes.
Methods  Postulating insulin adsorption to the infusion inline
burette as the cause of this excessively high insulin requirement,
we confirmed by an in vitro experiment with (a) a Terumo® syringe
with B-Braun extension tubing and (b) a B-Braun Dosifix® inline
burette system. Neutral insulin (Actrapid) with a concentration of
1 unit in 1 ml isotonic sodium chloride was run at 10 units/hour.
The insulin concentration at the point of exit from the infusion
system was analysed periodically (Table 1).
Results Immediately after priming, there was approximately a 56%
loss of insulin from the solution being delivered from the burette
system, compared with 37% from the syringe system. This
syringe–burette variability persisted throughout our study. At
9 hours, there had been an 81% loss of insulin from the burette
system compared with 47% from the syringe. A second similar
experiment also confirmed this observation.
Conclusions  Data on stability of insulin solutions and infusion
systems are sparse. The insulin concentration is affected more
when administered via inline burette infusion sets compared with
syringe pump infusion lines [1]. When managing hyperglycaemia,
apart from endogenous causes and true insulin resistance as
reasons for escalating insulin requirements, insulin adsorption to
the infusion systems should also be considered. More studies are
required to elucidate this further.
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Introduction High blood glucose (BG) variability is considered to
affect the prognosis of acutely ill patients. However, the signifi-
cance of BG variability is not clearly elucidated. We investigated
the significance of BG variability with a bedside-type artificial
pancreas (AP).
Methods Strict BG control was performed by an AP, the STG22.
Patients were evaluated at early (E) phase and late (L) phase
(1 week after E phase). The number of patients was 83, among
which 67 patients with daily mean BG (BGm) below 200 mg/dl
were selected, because patients with BGm above 200 mg/dl had
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Table 1 (abstract P117) 
Syringe concentration  Burette concentration 
Time (min) (units/100 ml) (units/100 ml)
120 67.2 52.4 
240 68.1 44
360 63.3 41.2
540 52.9 18.8S50
extremely high mortality, or 56%. They were classified into two
groups, a group with high BG variability and a group without,
based on the daily standard deviation of BG (BGsd). The two
groups were compared regarding the following items: (1) mortality;
(2) BGm, daily maximal and minimal BG (BGmax, BGmin), and
daily BG difference (BGd); (3) demographic data; (4) administered
glucose and insulin; and (5) degree of organ dysfunction and
SOFA score.
Results (1) In the E phase, patients with BGsd above 14 mg/dl
(group H, n = 26, mean BGsd 25 ± 11) had significantly higher
mortality (46% vs. 17%) as compared with those with BGsd below
14 mg/dl (group N, n = 41, mean BGsd 9 ± 3). In the L phase,
mortality was not significantly different between the groups with
higher BGsd and those with lower BGsd at any point. (2) There
was no significant difference in BGm between group H and group
N (173 ± 24 vs. 173 ± 15). (3) BGmax and BGd in group H were
significantly higher than those in group N (228 ± 42 vs. 191 ± 18,
and 93 ± 39 vs. 37 ± 14, respectively). BGmin in group H was
significantly lower than that in group N (132 ± 28 vs. 154 ± 16).
(4) There was no significant difference in the abovementioned
another items between group H and group N.
Conclusions High BG variability in the acute phase proved to be
one of the highest risk factors. Therefore, strict BG control
focusing on stabilization of BG variability especially in the acute
phase was considered one of the important therapies. The AP was
most reliable and therefore useful for clarifying the significance of
strict BG control, and strict BG control using an AP should be
considered in order to obtain the better outcome.
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Introduction Endocrine disturbances during critical illness lead to
a feeding-resistant wasting syndrome, characterised by profound
protein breakdown, promoting delayed recovery and poor
outcome. Parenteral nutrition failed to counteract the hypercata-
bolic state, possibly due to aggravation of the detrimental hyper-
glycemic response to critical illness. In our rabbit model of
prolonged critical illness we investigated the impact of varying
intravenous glucose load, while maintaining normoglycemia, on
mortality, organ damage, and catabolism/anabolism.
Methods Critically ill rabbits were randomised into a fasting group,
a standard parenteral nutrition group, and two groups receiving
either an intermediate or high additional amount of intravenous
glucose within the physiological range, all maintained normo-
glycemic with insulin. These normoglycemic groups were com-
pared with a hyperglycemic group (similar high glucose load as the
last normoglycemic group) and with healthy rabbits. Protein and
lipid load was equal for all fed groups.
Results  Varying intravenous glucose load did not affect the
mortality or organ damage, provided normoglycemia was main-
tained. Fasted critically ill rabbits lost weight, which was attenuated
by increasing intravenous glucose load. As compared with healthy
rabbits, mRNA expression of several components of the
ubiquitin–proteasome pathway was elevated in skeletal muscle of
fasted critically ill rabbits, which was counteracted by intravenous
feeding. Except in the normoglycemic group with intermediate
glucose load, circulating insulin-like growth factor 1 and thyroid
hormone levels decreased in all groups, most pronounced in
hyperglycemic rabbits.
Conclusions  Provided normoglycemia is maintained, increasing
intravenous glucose within the physiological range is safe for organ
function and survival of critically ill rabbits and reduces catabolism
compared with fasting.
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Introduction  Incubation of whole blood has been used in
numerous in vitro investigations. The purpose of the present study
was to test the hypothesis that glucose and insulin concentrations
declined during incubation.
Methods  Six young, healthy and fasting males donated blood.
Aliquots containing heparin-anticoagulated whole blood were
added to with different quantities of insulin (Actrapid; Novo
Nordisk, Bagsvaerd, Denmark) and bacterial endotoxin
(Escherichia coli lipopolysaccharide serotype 026:B6; Difco
Laboratories, Detroit, MI, USA). Aliquots were incubated for 6
hours at 37°C in an atmosphere of humidified 5% CO2 and 95%
air. Concentrations of blood glucose were measured every hour,
whereas insulin was measured at baseline and 6 hours. The
Wilcoxon signed-rank test was used to compare medians.
Results  The glucose concentration in aliquots to which insulin
30 nmol/l and lipopolysaccharide 1,000 ng/ml were added
decreased linearly and approached zero after 6 hours (median 0.6
vs. 4.75 mmol/l, P = 0.027; presented as a line chart of medians
with range in Figure 1). The insulin content in blood samples
without any additions was reduced by more than 50% during
incubation (median 22.5 vs. 48.0 pmol/l, P = 0.028; depicted as
box plots with median lines, 25th to 75th percentile boxes and
10th to 90th percentile error bars in Figure 1). Similar glucose and
insulin measurements were performed during incubation of other
selected aliquots. The reductions of glucose and insulin content
were analogous to the results above; the magnitude of reduction
seemed to be independent of the addition of insulin and/or
lipopolysaccharide.
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Figure 1 (abstract P120)
Glucose and insulin concentrations during incubation.S51
Conclusions The concentration of glucose was reduced to almost
zero during 6 hours of incubation; the decline was probably due to
glycolysis in blood cells rather than the effects of insulin. The
resulting hypoglycaemia may affect cellular functions, and addition
of glucose should therefore be performed during in vitro
incubations. The decline in insulin content was unexpected, as
insulin is mostly degraded in the liver and kidney, but to some
extent also in blood cells and extracellularly.
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Introduction  Whether blood glucose management is a
cornerstone in reducing ICU mortality is still under debate.
Nevertheless, conscientious glucose regulation by intensive insulin
therapy has become an indicator in the evaluation of the medical
quality of ICUs in the Netherlands. In recent years, however, there
have been several reports of increased hypoglycemic events and
clinical harm due to stringent glucose regulation [1].
The general ICU in our hospital consists of two units with a
comparable patient population with separate nursing staff but the
same medical staff. Both units work with the same nurse-driven
guideline for the blood glucose management providing some liberty in
the decision-making process. The frequency of glucose measurement
with a point-of-care device is left to the nurses’ discretion. A glucose
level of 4.5 to 7 mmol/l was set as the target value on both wards.
Methods After 2 years the total number of tests done on each
ward, the achieved average glucose level, and the number of
hypoglycemic events (glucose <2.5 mmol/l) and hyperglycemic
events (glucose >8 mmol/l) according to our hospital laboratory
database were evaluated.
Results Unit 1 had a total of 700 patients with 5,717 ICU-days
and performed 27,218 tests according to an average of 4.8
tests/patient/day. Unit 1 achieved an average glucose level of
6.9 mmol/l with 0.6% hypoglycemia and 32% hyperglycemia. Unit
2 had a total of 504 patients with 5,384 ICU-days and performed
39,400 tests according to an average of 7.3 tests/patient/day. Unit
2 achieved an average glucose level of 6.4 mmol/l with 0.9%
hypoglycemia and 20% hyperglycemia.
Conclusions Using a nurse-driven protocol, both units achieved
comparable and satisfying average glucose levels with acceptable
numbers of hypoglycemic events. There was a striking difference in
the number of tests performed between the two wards depending
on interpretation of the same guideline.
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Introduction To implement a tight glycemic control protocol in the
ICU, it is essential to obtain active nurse involvement [1,2]. Our
objective was to evaluate nurses’ perceptions about three different
blood glucose control protocols for critically ill patients.
Methods  As part of a randomized control trial comparing three
blood glucose control protocols in ICU patients, we issued a
questionnaire to all nurses who participated in the study to
evaluate their perception on protocol efficacy, benefits, safety,
risks, feasibility and a question asking which protocol the nurses
would like to be adopted in their ICU. The randomized control trial
arms were: a computer-assisted insulin protocol (CAIP) with
continuous insulin infusion to maintain blood glucose between 100
and 130 mg/dl; a Leuven protocol with insulin infusion to maintain
blood glucose between 80 and 110 mg/dl; and conventional
treatment with subcutaneous insulin if glucose >150 mg/dl.
Results Sixty nurses answered the questionnaires. The CAIP was
considered the most efficient by 57% of the nurses. About 58% of
the nurses evaluated its performance as good or very good,
compared with 22% for the Leuven protocol (P <0.001) and 40%
for conventional treatment (P = 0.08). The CAIP was considered
easier to use than the Leuven protocol (P <0.001) and as easy as
conventional treatment (P = 0.78). Fifty-six percent of the nurses
chose the CAIP as the protocol they would like to be adopted in
their institution.
Conclusions The CAIP was more efficacious, safer and easier to
use than the Leuven protocol. Compared with conventional
treatment, the feasibility and safety of the CAIP were considered
similar. Most nurses chose the CAIP as the protocol they would
like to be adopted in their ICU.
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Introduction Tight glycemic control (TGC) in the ICU is difficult,
and is associated with an increased risk of hypoglycemia [1]. We
use a nurse-wise insulin titration protocol for TGC in our ICU. The
purpose of this study was to examine the impact of a simple
computer alert on the quality of TGC.
Methods  An alert was created with the EventManager® of
MetaVision®. The nurses received a pop-up message on the
bedside workstation, with a simple suggestion for the timing of the
next measurement and a nonspecific instruction to check caloric
intake and insulin dose, at the following blood glucose (BG)
thresholds: BG >180 mg/dl, >110 mg/dl, <80 mg/dl, <60 mg/dl.
When BG was <40 mg/dl, an alert was sent to all workstations,
and to both doctors and nurses. The alert was implemented on 1
August 2007. We performed an observational cohort study,
including all adults (>18 years) who were in our ICU between 31
January and 31 July 2007 (control group, n = 731), and between
31 August 2007 and 6 February 2008 (alert group, n = 654).
StatView® was used for statistical analysis.
Results  The mean BG per patient, the glycemic penalty index
(GPI) [2] and the hyperglycaemic index (HGI) [3] were significantly
lower after implementation of the alert. There were fewer patients
in the alert group who experienced at least one episode of BG
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<40 mg/dl. The amount of BG samples drawn per patient was
similar in both groups (Table 1).
Conclusions  Even in an environment where TGC is performed
well, a simple computer alert can further improve BG level control
and reduce the risk of hypoglycemia, without increasing the BG
sample rate.
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Introduction  This study was performed to determine the effect
variables supposed to affect optimal blood glucose concentrations
between 80 and 150 mg/dl in postoperative/post-traumatic patients.
Methods  From January 2007 to December 2007, 826 post-
operative/post-traumatic critically ill patients admitted to a
university adult ICU performing intensive insulin therapy were
surveyed daily using computer assistance with respect to minimal
and maximal daily blood glucose concentrations and insulin
therapy. The variables age, sex, sepsis, neurosurgical patient,
steroids, adrenaline and/or noradrenaline infusion rate, acute renal
failure, liver function assessed by the Model of Endstage Liver
Disease score [1], organ dysfunctions reflected by the Sequential
Organ Failure Assessment score [2], and severity of disease by the
Simplified Acute Physiology Score II [3] were monitored.
Results Seven hundred and sixty-four patients with an ICU stay
>48 hours were eligible for evaluation. In multiple logistic
regression with backward elimination to determine the most
relevant parameters, sepsis (OR = 1.2, with corresponding 95%
CI = 1.1 to 1.4), neurosurgical patients (OR = 1.6, CI = 1.3 to
1.9), steroids (OR = 1.5, CI = 1.2 to 1.9), noradrenaline infusion
(OR = 1.4, 95% CI = 1.2 to 1.6), and age (per year) (OR = 1.02,
CI = 1.01 to 1.02) were associated with an increased risk not to
lay within an optimal blood glucose range of 80 to 150 mg/dl
(P <0.01).
Conclusions  Sepsis, neurosurgery, steroids, catecholamine
infusions and age may be associated with increased risk for
difficult blood glucose control in postoperative/post-traumatic
patients.
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Introduction  In critical illness, hyperglycemia is a frequent
complication resulting from metabolic and hormonal changes.
Recent findings suggest increased glycemic variability may confer
a strong independent risk of mortality in the critically ill [1].
Conventional measurements of glucose control include morning
glucose, mean daily glucose, percentage of glucose readings in
the goal range, and the hyperglycemic index (HGI) [2]. The
objective of this study was to determine the most appropriate
method for assessing glycemic control in cardiovascular (CV)
surgery patients.
Methods Data were obtained from a continuous glucose monitor-
ing system (Medtronic CGMS® System Gold™; Medtronic
Diabetes, Northridge, CA, USA) database containing continuous
glucose monitoring system, fingerstick, and morning laboratory
blood glucose values from adult CV ICU patients. A total of 23
patients contributed to the dataset. The area under the curve every
24 hours was calculated to determine the HGI. The mean and
median daily glucose, percentage of glucose readings within and
above the goal range (80 to 115 mg/dl) and the mean morning
glucose were calculated. Statistical analysis was performed
utilizing Spearman’s rho correlation to determine which
measurement of glucose control correlates best with the HGI. The
HGI served as the comparator group, as it is a validated and
comprehensive method of assessing glucose control over time.
Results See Table 1.
Conclusions Mean glucose was the most reflective and practical
method for determining glycemic control in critically ill CV surgery
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Table 1 (abstract P125) 
Mean glucose Median glucose % glucose 80 to 115 mg/dl % glucose >115 mg/dl Morning glucose
Spearman 0.735 (<0.001) 0.519 (<0.01) –0.578 (<0.001) 0.494 (<0.01) 0.196 (0.26)
Table 1 (abstract P123) 
Control Alert P value
Mean BG 116 ± 17 114 ± 17 0.003
GPI 22 ± 11 21 ± 11 0.037
HGI (mg/dl) 14 ± 16 12 ± 13 0.005
Samples/patient 58 ± 93 57 ± 92 0.680
Patients, BG <40 mg/dl 6.6% (48) 4.0% (26) 0.032
Data presented as the mean ± SD or percentage (count).S53
patients. The morning glucose correlated the least with the HGI,
demonstrating morning glucose may not be the most appropriate
method to define glycemic control.
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Introduction  The purpose of this study was to determine the
effects of exogenous glucagon-like peptide 1 (GLP-1) on the
glycaemic response to enteral nutrition in nondiabetic, critically ill
patients. Exogenous GLP-1 lowers blood glucose concentrations
in both healthy humans and patients with type 2 diabetes, via
suppression of glucagon, stimulation of insulin secretion and
slowing gastric emptying. As the humoral effects are glucose
dependent, the use of GLP-1 is not associated with hypo-
glycaemia. The effects of GLP-1 on glycaemia in critical illness
have hitherto not been evaluated.
Methods Seven, nondiabetic, critically ill patients (four males, three
females; age 58 ± 6 years) received, on two separate days,
intravenous GLP-1 (1.2 pmol/kg/min) or placebo between t = 0
and 270 minutes, in randomised double-blind fashion. Between
t = 30 and 270 minutes a liquid nutrient was infused intra-
duodenally at a rate of 1.5 kcal/min. Blood glucose, plasma insulin
and glucagon concentrations were measured. Data are presented
as the mean ± SEM. Statistical analyses were performed using the
paired t test or repeated-measures ANOVA.
Results Compared with placebo, GLP-1 decreased peak glucose
concentrations (10.1 ± 0.7 mmol/l vs. 12.7 ± 1.1 mmol/l; P = 0.01)
and markedly attenuated the overall glycaemic response to enteral
nutrition (blood glucose area under the curve 30 to 270 min,
2,077 ± 145 mmol/l/240 min vs. 2,568 ± 208 mmol/l/240 min;
P <0.02) (Figure 1). GLP-1 caused a transient, but nonsustained,
suppression of plasma glucagon concentrations (t = 30 min, 90 ±
12 pmol/ml vs. 104 ± 10 pmol/ml; P  <0.01) and tended to
increase the plasma insulin/blood glucose ratio (between t = 0 and
270 min, mean Δinsulin/glucose ratio 5.0 ± 2.0 mU/mmol vs. 2.5 ±
0.9 mU/mmol; P = 0.12).
Conclusions  Acute, exogenous GLP-1 infusion markedly
attenuates the glycaemic response to enteral nutrition in the
critically ill. Exogenous GLP-1 represents a potentially novel
therapy for the management of hyperglycaemia in the critically ill.
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Introduction Recent recommendations on tight glucose control in
general critically ill patients questioned its effect on patient
outcome [1,2]. The aim of our work is to determine whether the
implementation of tight glucose control to our practice improved
our patients’ outcome.
Methods In this retrospective cohort study we used baseline data
from our intensive care register. An intravenous insulin protocol to
maintain tight glucose control was implemented in our practice on
6 June 2003. In the study we enrolled patients admitted to our six-
bed multidisciplinary ICU over a 2-year period before (years 2001
and 2002 – group with usual glucose control) and a 2-year period
after (years 2004 and 2005 – group with tight glucose control) the
introduction of tight glucose control. In total 231 adult mecha-
nically ventilated patients, admitted primarily or within the first
24 hours to our ICU, were included. We recorded the length of
ICU stay, length of artificial ventilation, cost, APACHE II and SOFA
scores, and examined the incidence of nosocomial infections and
mortality in both groups of critically ill patients.
Results One hundred and fifteen patients in the group with usual
glucose control and 116 patients in the group with tight glucose
control were analyzed; no significant difference on severity of
disease in both groups (APACHE II score 23.7 vs. 24.14,
P = 0.765 and SOFA score 7.9 vs. 7.8, P = 0.743) was detected.
Tight glucose control was associated with a significant reduction
of nosocomial pneumonia (20% vs. 11%, OR = 0.34, 95% CI =
0.19 to 0.86). There was no significant difference in hospital
mortality, length of stay, artificial ventilation and cost.
Conclusions  Tight glucose control was associated with a
significant reduction of nosocomial pneumonia, but not with a
reduction of hospital mortality, length of stay, artificial ventilation
and hospital cost.
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Introduction  Critically ill infants and children often develop
hyperglycaemia. In adults it is associated with worsened outcome.
Available online http://ccforum.com/supplements/13/S1
Figure 1 (abstract P126)
Glycaemic response to enteral nutrition is markedly attenuated
(***P <0.02).S54
No studies have so far investigated the feasibility and outcome of a
standardized insulin/glucose protocol in children with congenital
heart disease after cardiac surgery.
Methods We prospectively studied children with congenital heart
disease after cardiac surgery, for glucose intake, concomitant
blood glucose values and results of insulin treatment. Results are
expressed as the median and range, P  <0.05 considered
statistically significant.
Results  Eighty-nine children were evaluated (male 56.2%), age
0.9 years (1 day to 17.9 years), length of ICU stay 22 hours (2.5 to
28.0 hours). All children survived. Fifty children were treated with
and 39 without insulin. Overall, first blood glucose on admission to
the ICU was 5.7 mmol/l (3.1 to 21.6 mmol/l), after 6 hours was
8.2 mmol/l (4.7 to 23.0 mmol/l), highest blood glucose was
9.9 mmol/l (3.4 to 23.7 mmol/l), and 77.5% was hyperglycaemic
during admission (>8.0 mmol/l). Fifty out of the 70 children with
hyperglycaemia were treated with insulin. Time to reach normo-
glycaemia in insulin-treated children was 6.4 hours (0.3 to
17.2 hours), total length of insulin treatment was 11.9 hours (2.3 to
23.0 hours) and the length of hyperglycaemia was 6.7 hours (1.2
to 17.0 hours) (Table 1). The duration of hyperglycaemia of treated
and untreated children was not significantly different. Hypogly-
caemia (<4.0 mmol/l) occurred in 10 children (11.2%); none of
them had severe hypoglycaemia (<2.2 mmol/l).
Conclusions This study shows that a majority (77.5%) of children
admitted after cardiac surgery develops hyperglycaemia and
72.5% were treated with insulin. The duration of hyperglycaemia
was not different between children with or without insulin
treatment. It can be questioned whether beneficial effects of insulin
therapy can be expected with the short duration of insulin
treatment (11.9 hours), which was noticed in this study.
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Introduction Fifty years’ worth of published evidence has inferred
benefits of glucose–insulin–potassium (GIK) infusion to critically ill
patients. We sought to measure the treatment effect of GIK
infusion on mortality in critically ill patients.
Methods  We conducted a systematic review of the Cochrane
Library, MEDLINE, EMBASE, CINAHL, conference proceedings,
clinical practice guidelines, and other sources using a
comprehensive strategy. We identified randomized controlled trials
comparing GIK treatment with standard care or placebo in critically
ill adult patients. The primary outcome variable was mortality. Two
authors independently extracted data and assessed study quality
using standardized instruments; consensus was reached by
conference. Preplanned subgroup analysis included studies of
high-quality methodology, septic shock or other circulatory shock
populations. We used the chi-square test and the proportion of
total variation in study estimates that is due to heterogeneity (I2)t o
assess for statistical heterogeneity (P <0.10,  I2 >25%). The
primary analysis was based on the random effects model to
produce pooled ORs with 95% CIs.
Results  The search yielded 1,720 potential publications; 23
studies were included in the final analysis, providing a sample of
22,525 patients. Included studies only contained populations of
acute myocardial infarction and cardiovascular surgery patients.
The combined results demonstrate no statistically significant
heterogeneity (P = 0.57, I2 = 0%) and no effect on mortality (OR =
1.02; 95% CI = 0.93 to 1.11) with GIK treatment. Among the high-
quality studies (n = 4) there was no effect on mortality (OR = 1.04;
95% CI = 0.95 to 1.14). No experimental studies of shock or
sepsis populations were identified.
Conclusions  This meta-analysis found that there is no mortality
benefit to GIK infusion in critically ill patients; however, study
populations were limited to acute myocardial infarction and
cardiovascular surgery patients. No studies were identified utilizing
GIK in patients with septic shock or other forms of circulatory
shock, providing an absence of evidence regarding the effect of
GIK as a therapy in patients with shock.
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Introduction A linear correlation between serum triglyceride and
risk of intensive care mortality was identified. Various clinical and
metabolic situations such as sepsis, renal failure, hepatic failure
and administration of certain drugs have been associated with
hypertriglyceridemia (HTG). It is well known that HTG is
associated with acute pancreatitis. Development of systemic
inflammatory response syndrome or the onset of organ system
dysfunction are the complications of severe acute pancreatitis that
is an episode of acute pancreatitis. The aim of this study was to
determine the incidence of HTG in patients receiving artificial
nutrition in an ICU, to describe their characteristics and to
establish the relevance of risk factors associated with HTG.
Methods A prospective, observational, cohort study performed in a
general ICU of Toulouse University Hospital, Toulouse, France from
1 May 2007 to 31 July 2008. We included consecutive intensive
care patients with an initial serum triglyceride level less than
3 mmol/l who received at least 7 days of artificial nutrition and with
at least three biochemical serum triglyceride analyses with a
1-week interval. The chi-square test and a multivariate logistic
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Table 1 (abstract P128)
Low intake High intake Inadequate intake
Highest glucose  Duration of  Highest glucose  Duration of  Highest glucose  Duration of 
(mmol/l) hyperglycaemia (hours) (mmol/l) hyperglycaemia (hours) (mmol/l) hyperglycaemia (hours)
Insulin 10.7 7.3 13.4  6.6 10.3 8.0
No insulin 7.5  2.7 10.3  3.1 8.1  4.8S55
regression model were performed for statistical analysis. A total of
17 clinical factors were studied as independent variables.
Results  A total of 107 patients were included in the study.
Administration of lipid was 0.83 ± 0.36 g/kg/day. The incidence of
HTG was calculated as 17.9% per year. Multivariate analysis
identified three independent risk factors for HTG: age (P = 0.02;
adjusted β-coefficient = –0.83), insulin dosage (P = 0.01; adjusted
β-coefficient = 0.83), hepatic failure (P = 0.04; adjusted β-
coefficient = 1.27).
Conclusions  The present study showed that ICU-admitted
patients receiving artificial nutrition are prone to develop HTG.
Hepatic failure and the insulin infusion rate were the most
important risk factors for HTG. Age had a protective effect. Our
results raise three important matters: (1) serum triglyceride
measurement is necessary in seriously ill patients receiving artificial
nutrition; (2) elevated triglycerides reflect the degree of insulin
resistance and severity of critical illness; and (3) the hyper-
triglyceridemic profile of young patients admitted to the ICU is very
important to consider.
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Introduction  Major surgery carries a significant risk of post-
operative infections, such as surgical site infections. An estimated
500,000 surgical site infections occur annually at a cost of more
the $1 billion/year in the US alone. Surgical trauma leads to an
initial excessive inflammatory response, together with an almost
immediate and dramatic depression of cell-mediated immunity. This
immnosuppression may be due to a significant decrease in plasma
arginine levels observed following surgery. This arginine deficiency
can severely impair T-cell proliferation and key T-cell receptor
function. Perioperative arginine administration can prevent arginine
deficiency and restore cellular immunity. The purpose of this meta-
analysis was to examine the relationship between immune-
modulating enteral nutrition therapy (IMENT) containing arginine
and infectious complications, length of stay, and mortality rates in
surgical patients.
Methods All prospective randomized controlled trials of arginine-
containing IMENT versus standard enteral nutrition in surgical
patients conducted from 1990 to 2008 were identified from
multiple databases. Studies included in the analysis evaluated
infectious complication, length of stay, and/or mortality rates.
Methodological quality of individual studies was scored and
necessary data were abstracted in duplicate and independently.
Results  Thirty randomized trials with a total of 2,789 patients
compared the use of arginine-containing IMENT with standard
enteral nutrition in surgical patients. Arginine-containing IMENT
significantly decreased infectious complications (relative risk =
0.58, 95% CI = 0.48 to 0.69, P <0.00001) and overall length of
stay (weighted mean difference = –2.09, 95% CI = –3.20 to
–0.97, P = 0.0002) versus standard enteral nutrition. As expected
in a low-mortality surgical population, however, no effect was
observed on mortality (relative risk = 1.06, 95% CI = 0.60 to 1.80,
P = 0.84).
Conclusions The cumulative results show that arginine-containing
IMENT significantly reduces overall infections and length of stay in
surgical patients. Based on this evidence, arginine-containing
IMENT could soon become the standard of care in the surgical
patient. This large treatment effect demands definitive evaluation in
a large multicenter trial.
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Introduction Asymmetric dimethylarginine (ADMA) is an inhibitor
of the arginine–NO pathway. ADMA accumulates when degrada-
tion in the liver by dimethylarginine dimethylaminohydrolase  is
impaired. In theory, plasma citrulline, formed when arginine is
converted by NO synthase, and when ADMA is metabolized, would
be lowered and ornithine, formed by the degradation of arginine in
the urea cycle, would be potentially elevated when ADMA
accumulates as in sepsis and in liver failure [1].
Methods Fourteen male Wistar rats were randomly allocated to
lipopolysaccharide (LPS) or hemihepatectomy (HH). Plasma levels
of arginine, ADMA, citrulline and ornithine were measured before
and 120 minutes after 5 mg/kg LPS and HH, respectively.
Results See Table 1.
Conclusions Plasma levels of arginine and derivatives should not
be interpreted as a reflection of metabolism at the tissue level. In
HH, the elevated ADMA levels suggest dimethylarginine dimethyl-
aminohydrolase  activity depends on the liver tissue mass.
Reference
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Results
LPS HH
Parameter (μmol/l) t = 0 t = 120 t = 0 t = 120
Arginine 151.3 ± 28.7 99.1 ± 27.9* 138.0 ± 43.7 221.4 ± 57.1*
ADMA 1.14 ± 0.19 1.32 ± 0.24 0.59 ± 0.06 1.48 ± 0.27*
Citrulline 107.2 ± 19.3 129.1 ± 20.3* 83.5 ± 7.36 118.4 ± 18.5*
Ornithine 99.8 ± 29.2 129.6 ± 39.1* 66.4 ± 19.2 170.7 ± 50.6*
*Significant difference.S56
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Introduction Delayed gastric emptying is one of the major reasons
for enteral feeding intolerance in ICU patients [1-3]. We studied
the effect of ginger supplementation to the diet on development of
ventilator-associated pneumonia (VAP) and adult respiratory
distress syndrome (ARDS) in ICU patients [2].
Methods In a prospective, randomized, placebo-controlled fashion,
32 ARDS mechanically ventilated patients who were fed entrally
were studied. Patients were randomized into two groups; one
group had ginger added and the other had placebo added to their
enteral feeding. The amount of feeding tolerated in the first
48 hours, the amount of feeding tolerated during the entire study
period, development of VAP, the number of ICU-free days, the
number of ventilator-free days and morality were evaluated.
Results Enteral feeding tolerated in the first 48 hours of study was
significantly higher in patients with the ginger-supplemented diet
(51% vs. 57%, P <0.005). However this was not different during
the entire study period (92% vs. 93%, P = 0.42). VAP was seen in
6.3% of the patients in the ginger group and in 31.3% of the
control group, which was not statistically significant (P = 0.08).
The ICU mortality of 15.6% was similar in the two groups. The
median number of ventilator-free days of 10 versus 7 days and
ICU-free days of 7 versus 4 days were significantly higher in the
ginger extract group, with respective P values of 0.02 and 0.04.
Conclusions Supplementing the diet with ginger extract in ARDS
patients reduces the delayed gastric emptying risk and helps
reduce the duration of mechanical ventilation and increases ICU-
free days.
References
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Introduction  We hypothesized that constitutively expressed
arginase 1 (Arg-1) may be released from hepatocytes to the circu-
latory compartment to play the role of extinguisher at the front and
to serve a protective function by modulating inflammation. We
used a cell culture model of epithelial barrier dysfunction to deter-
mine whether liver cytosolic proteins could decrease NO￿
production and preserve enterocyte paracellular barrier function on
that basis.
Methods We exposed immunostimulated Caco 2BBe enterocyte-
like cells to human liver cytosol (LC). Cytomix (IFNγ, TNFα, and
IL-1β) was used to stimulate the cells. Arginase activity in cell
supernatants and murine serum was measured by following the
generation of citrulline and urea from arginase. Tissue lysates and
conditioned media were untreated or treated with the enzyme
inhibitors (S)-(2-boronoethyl)-L-cysteine-HCl (BEC) and L-N(6)-(1-
iminoethyl) lysine (L-NIL), which inhibit arginases and inducible
nitric oxide synthase (iNOS), respectively.
Results Cytomix increased paracellular permeability, and induced
the expression of iNOS and release of NO￿. LC protein
(400 μg/ml) applied to the basal but not apical compartment
preserved barrier function and completely blocked the release of
NO￿ but only slightly decreased the magnitude of iNOS protein
expression in a dose-dependent and time-dependent manner.
Ultrafiltration and ultracentrifugation demonstrated that microsomal
Arg-1 prepared from LC decreased iNOS-dependent NO￿
production. BEC and anti-Arg-1 antibody inhibited the NO￿
blocking ability of LC. Surprisingly, LC arginase activity required
activation by a cell-derived factor and its release could be blocked
by treating cells with L-NIL. Increased consumption of arginase by
activated LC Arg-1 led to decreased iNOS dimerization, which
decreased NO￿ production. In the serum from endotoxemic mice,
arginase activity was significantly increased. Furthermore, iNOS
existed in ileal mucosa predominantly in the inactive monomeric
form at 18 hours after lipopolysaccharide injection, consistent with
decreased iNOS activity in the absence of arginase.
Conclusions Arg-1 is one such liver-derived protein that increases
in serum during endotoxemia and other inflammatory states.
Modulation of mucosal iNOS activity following activation of
circulating Arg-1 may be protective because it would be expected
to decrease epithelial barrier dysfunction as a result of decreased
NO￿ production.
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Introduction  During the excessive organ/tissue demand of
glutamine (Gln) in episodes of stress following major surgery,
endogenous Gln production may not be sufficient to meet the
increased requirements. The aim of the study was to evaluate the
effect of parenteral Gln supplementation on the outcome of
surgical cancer patients after major surgery [1].
Methods The study was performed on 40 adult patients admitted
to the surgical ICU at the National Cancer Institute requiring total
parenteral nutrition (TPN) for at least 5 days. Patients were
assigned to two groups: control group, 20 patients received
nutritional support as the usual protocol; and Gln group, 20
patients received nutritional support as the usual protocol +
dipeptiven 300 mg/day for 7 days. Standard vitamins, trace
elements, electrolytes and insulin therapy were supplied. The rate
of infections, ICU and total hospital lengths of stay, severe
hyperglycemia and days of mechanical ventilation were recorded.
Results There were no differences between groups according to
the demographic data, metabolic and nutritional parameters and
the numbers of diabetic patients. There was also no difference in
the duration of TPN. The incidence of pneumonia, surgical wound
infection, sepsis, urinary or intravenous catheter infection were
significantly lower in the Gln group compared with the control
group. The days of mechanical ventilation among ventilated
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patients and the ICU length of stay were significantly lower in the
Gln group compared with the control group. The nitrogen balance
was more negative in control patients than in Gln-supplemented
patients (the difference was insignificant). Hyperglycemia episodes
were significantly lower and easy controlled in the Gln group. Total
plasma amino acid concentrations and the Gln plasma level
increased about 40% in patients receiving Gln supplementation.
The number of adverse events per patient was significantly lower in
the Gln group (2.1 vs. 2.9, P <0.01).
Conclusions  Parenteral Gln-supplemented TPN reduces the
clinical complications of surgical patients, mainly through a lower
incidence of pneumonia and better metabolic tolerance. This forms
a strong rationale for the use of Gln-supplemented regimens for
surgical ICU patients.
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Introduction Multiple organ failure (MOF) is a frequent cause of
death in the critically ill patient. The gut could be the cornerstone of
MOF, the first step being an early splanchnic ischemia, inducing
the loss of barrier function, systemic infections and MOF [1].
Plasma citrulline (normal 20 to 60 μmol/l) reflects a small bowel
mass and is decreased in various small bowel diseases [2]. The
objectives of the study were to study plasma citrulline kinetics and
their prognostic value in adults hospitalized in the ICU.
Methods  A prospective monocentric observational study,
including adults consecutively admitted to the ICU without small
bowel disease, and without chronic renal failure. We studied at
onset, hour 12, hour 24, day 2, and day 7 of plasma citrulline, and
clinical, biological, prognostic and therapeutic parameters. The
univariate analysis of plasma citrulline (0 to 10 μmol/l, 11 to
20 μmol/l, and >20 μmol/l) with other variables and multivariate
analysis.
Results Sixty-seven patients were included, mean age 60 years,
organ dysfunctions and/or infections model ODIN score of 2.4,
IGS2 score (Simplified Acute Physiology Score) of 50, and a 28-
day mortality of 34%. During the first day, mean plasma citrulline
decreased from 18.8 to 13.5 μmol/l, and it decreased more in
nonsurvivors than in survivors among patients without acute renal
failure (37% vs. 18%). A lower plasma citrulline at hour 24 was
associated with higher plasma C-reactive protein, nosocomial
infection rate, and 28-day mortality (P = 0.006, P = 0.03 and P =
0.03). A lower plasma citrulline at day 2 was associated with a
higher use of catecholamines, and a lower use of enteral feeding
(P = 0.02 and P = 0.01). In multivariate analysis, plasma citrulline
at hour 24 and ODIN score at admission ≥3 were associated with
28-day mortality (P = 0.04 and P = 0.04).
Conclusions A lower plasma citrulline at hour 24 was associated
with higher plasma C-reactive protein, nosocomial infection rate,
and 28-day mortality. A lower plasma citrulline at day 2 was
associated with a higher use of catecholamines, and a lower use of
enteral feeding. Such results could reflect the systemic conse-
quences of acute intestinal failure in patients hospitalized in the ICU.
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Introduction  Within the frame of postoperative total parenteral
nutrition, a frequent consequence due to postaggression meta-
bolism is an inhibition of lipoprotein lipase leading to
hypertriglyceridemia [1]. The aim of this study was to investigate
whether the administration of a fish-oil-containing lipid emulsion
(SMOF) compared with a lipid emulsion based on olive and
soybean oil led to a better utilisation of the lipids.
Methods A prospective randomised study. After approval of the
ethical committee, 44 postoperative surgical patients with an
indication for parenteral nutrition therapy were included in the
study. Nonprotein calories were given as 60% glucose and 40%
lipid emulsion. The total energy intake per day was 25 kcal/kg body
weight. The sedation regimen was standardised (midazolam and
fentanyl), propofol (a lipid emulsion) was avoided. Patients were
divided into two groups: group A (n = 22) received SMOF
(SMOFlipid® 20%), and group B (n = 22) received an emulsion
based on olive and soybean oil (ClinOleic20%). Lipid emulsions
were administered for 5 days continuously. Trigylceride (TG) levels
were measured before the start of infusion (d0), at day 1 (d1), day 2
(d2), and day 5 (d5) after the start of infusion. A pathological TG
level was defined at 300 mg/dl and the significance level at P <0.05.
Results  There were no significant differences in TG levels at
baseline (d0: group A: 119 ± 35 vs. group B: 120 ± 45 mg /dl;
P = 0.87), whereas at d2 (group A: 151 ± 52 vs. group B: 202 ±
108 mg/dl; P < 0.03) and at d5 (group A: 163 ± 72 vs. group B:
233 ± 94 mg/dl; P < 0.01) the TG levels in the SMOF group were
significant lower than in the control group. At d5 the incidence of
pathological TG levels was significant lower in patients receiving
SMOF (0%) compared with the control group (31.8%).
Conclusions  The administration of a fish-oil-containing lipid
emulsion within a parenteral nutrition regimen led at d2 and d5 of
the nutrition regimen to significantly reduced TG levels compared
with a lipid emulsion based on olive and soybean oil, indicating a
better utilisation of the administered TGs.
Reference
1. Piper SN, et al.: Eur J Anaesthesiol 2008, 25:557-565.
P139
Gastrointestinal function in critically ill trauma patients
using motility capsule technology
S Rauch1, K Krueger2, N Roewer1
1University of Wuerzburg, Germany; 2University of Louisville, KY, USA
Critical Care 2009, 13(Suppl 1):P139 (doi: 10.1186/cc7303)
Introduction The aim of this study was to investigate the gastric
emptying time and small bowel transit time, using a novel wireless
Available online http://ccforum.com/supplements/13/S1S58
motility capsule in trauma patients with intracranial hemorrhage.
We hypothesized that gastric emptying and small bowel transit are
delayed.
Methods  We recruited eight trauma patients with intracranial
hemorrhage (six male/two female, mean age 40 years, APACHE III
score 41 ± 7, Glasgow coma scale 8 ± 2) who were intubated,
mechanically ventilated, sedated, and older than 18 years in this
prospective, controlled, Institution Review Board-approved trial.
The historical control group consisted of 81 healthy volunteers
studied in a separate trial (Protocol #122205: Assessment of
whole gut transit time using the SmartPill capsule: a multicenter
study). A pH, pressure and temperature sensing capsule
(SmartPill™; SmartPill Inc., Buffalo, NY, USA) was positioned with
a capsule delivery device (AdvanCE™; US Endoscopy, Mentor,
OH, USA) into the patient’s stomach. The data were transmitted to
a recorder attached to the patient’s abdomen. The data were
analyzed by two independent observers.
Results  There was a significant difference (P  = 0.004) in the
gastric emptying time for ICU patients, 28.8 ± 31.3 hours (mean ±
SD), and healthy volunteers, 3.3 ± 1.1 hours. There was no
significant difference between the small bowel transit times in ICU
patients, 7.1 ± 3.6 hours, and 4.1 ± 1.6 hours in healthy volun-
teers. There was no difference in sedation and analgesia consump-
tion between the ICU patients. None of the patients received any
proton pump inhibitor or prokinetic medication.
Conclusions  Gastric emptying is significantly delayed in major
trauma patients; however, small bowel transit times are similar to
those in healthy volunteers.
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Introduction Enteral nutrition is the standard of nutritional support
in acute severe pancreatitis. Nutrients are routinely delivered below
the Treitz angle either by jejunostomy or by an endoscopically
placed nasojejunal tube. In recent years the safety of intragastric
delivery was under scrutiny [1]. Our study aimed to evaluate the
characteristics of intragastric nutrition and its safety in acute
severe pancreatitis.
Methods The retrospective study included all patients with acute
severe pancreatitis (admission APACHE II score >12) admitted to
an emergency university hospital during a 3-year period (2005 to
2007). Nutritional support was assessed as type, route and timing.
Collected data were age, admission and highest severity scores,
intraabdominal pressure, antibiotic use, surgery, ICU and hospital
lengths of stay, and outcome. The safety of intragastric nutrition
was assessed as the outcome.
Results  Forty-two patients were enrolled. Enteral nutrition was
used in 25 patients (59.5%). The majority (20 patients, 80%)
received at least for several days associated parenteral nutrition
until the caloric needs could be met by the enteral route. Route of
administration: intragastric, 16 patients (only oral intake, nine
patients; nasogastric tube, five patients; combined oral and
jejunostomy, two patients) and only jejunostomy, nine patients. No
patient had a nasojejunal tube. Intragastric nutrition started on the
4.4th hospital day (mean value) (range 2 to 10 days). There were
no statistically significant differences between patients with
intragastric versus jejunal nutrition concerning the demographics
and severity scores on admission. The patients with intragastric
nutrition compared with the jejunostomy group had a significantly
lower rate of surgery (31.2% vs. 100%, P <0.01), antibiotic use
(81.2% vs. 100%, P = 0.05) and lower mortality rate (25% vs.
55.5%, P = 0.01).
Conclusions  Despite the classical presumption that gastric
nutrition may worsen the evolution of acute severe pancreatitis, our
study shows that intragastric administration does not increase
mortality.  Even more, compared with jejunostomy, it is associated
with improved outcome, a lower rate of surgical interventions, and
less antibiotic use.
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Introduction  Erythromycin is the most potent prokinetic drug
available. It is commonly used intravenously. The aim of our study
was to determine the effective lowest dose of enteral erythromycin,
its tolerability and comparing the dose with the severity of the
disease and outcome.
Methods All patients admitted to the trauma ICU between January
2004 and January 2008 who developed feeding intolerance were
included (residual volume >500/24 hours). The starting dose was
125 mg erythromycin twice daily; if no response, the dose was
increased up to a maximum of 1 g twice daily. Data were entered in
SPSS software. The chi-square test + one-way ANOVA with post
hoc analysis were used. P <0.05 was significant.
Results One hundred and seven patients were included, with 85%
being male, average age 41 ± 18 years. The majority of patients
(54%) suffered from traumatic brain injury, 74% were ventilated,
51% on inotropes, 55% on three opioids, 84% on enteral feeding.
The Sequential Organ Failure Assessment score was significantly
higher and the Glasgow coma scale was significantly lower in
patients receiving 1g erythromycin (P <0.05). See Table 1.
Conclusions A low dose of enteral erythromycin 125 mg twice
daily is potentially effective in patients on intravenous
metoclopromide having enteral feeding intolerance. Combining
prokinetic therapy and keeping the administration of erythromycin
as short as possible can prevent the development of bacterial
resistance.
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Table 1 (abstract P141)
Response rate and outcome related to enteral erythromycin dose
Dosage Percentage  Response 
(mg, of  rate  Average  Outcome 
twice daily) patients (%) days  (%)
125 45 100 4 71
250 37 97.5 9 55
500 13 85.6 12 43
1,000 5 40 11 0S59
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Introduction Failure to establish early nasogastric (NG) feeding is
common in paediatric intensive care (PIC) and influences the
outcome. Decreased gastrointestinal motility is multifactorial in
origin. NG feeds may be administered continuously or by
intermittent bolus; we hypothesise that bolus enteral feeds are
more physiological when compared with continuous NG feeds.
We aimed to compare bolus versus continuous NG feeding in PIC.
The outcome measures were the time to achieve maximal
nutritional requirement by volume of feed and to identify the
frequency of adverse events.
Methods Following ethical approval and informed consent, eligible
admissions to a tertiary PIC from April 2006 to February 2008 were
prospectively randomised and enrolled into the study. Gastrostomy
feeding, use of motility drugs, gastroesophageal reflux and
gastrointestinal surgery were the exclusion criteria. Patients were
randomised to receive either 3-hourly bolus feeds or continuous
feeding over 21 hours per day, for a 48-hour study period. NG
tubes were aspirated 3-hourly and the gastric residual volume was
recorded. The protocol was designed to give equal feed volume in a
24-hour period. Intolerance was defined as gastric residual volume
more than 125% of feed administered. Data are expressed as the
median (interquartile range). Mann–Whitney’s test and Fisher’s
exact test were used to test for associations.
Results  Seventy-six patients were enrolled (1.2:1, male:female),
median age 11.6 (2.8 to 49.0) months and weight 10 (4.5 to 16.2)
kg. Bolus group subjects achieved maximal feed potential by
21 hours (95% CI = 18.6 to 25), the continuous group required
27 hours (95% CI = 19.5 to 30, P = 0.035). The demographic
characteristics, sedation, muscle relaxant or inotrope usage
between groups were comparable. There was no statistically
significant difference in the incidence of adverse events (bolus
n = 3 and continuous n = 4, P = 0.71).
Conclusions  This is the first study comparing enteral feeding
techniques in PIC patients. In PIC, bolus feeding methods may be
more beneficial, in achieving maximal nutritional requirements
earlier, when compared with continuous feeds. The risk of aspiration
of aspiration or vomiting is low with both feeding techniques.
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Introduction The purpose of this study was to describe current
nutrition practices in ICUs and to determine the best achievable
practice relative to the Critical Care Nutrition Clinical Practice
Guidelines (CPGs).
Methods  We conducted an international, prospective, obser-
vational, cohort study. In January 2007, each ICU recorded data on
nutrition practices on a consecutive cohort of 20 mechanically
ventilated adult patients that stayed in the ICU for at least
72 hours. Data were collected from the time of admission to the
ICU to ICU discharge, or for a maximum of 12 days. Relative to the
CPGs, we report average, best, and worst site performance on key
nutrition practices.
Results A total of 158 ICUs from 20 countries participated, and
each enrolled an average of 18.6 patients for a total of 2,946
patients. Adherence to CPG recommendations was high for some
recommendations; namely, use of enteral nutrition (EN) in
preference to parenteral nutrition (PN) (site average 61.7% (range
1 to 97.3%) of patients received EN alone), glycemic control (site
average 7.5 (range 3.5 to 10.4) mmol/l), lack of utilization of
arginine-enriched enteral formulas (site average 3.5% (range 0 to
92.3%) of patients on EN), delivery of hypocaloric PN (site average
16.8 (range 2.7 to 35.5) kcal/kg), and the presence of a feeding
protocol (79.7% of ICUs). However, significant practice gaps were
identified for other recommendations. The average time to start of
EN was 46.5 hours (range 8.2 to 149.1 hours). The average use of
motility agents and small bowel feeding in patients with high
gastric residual volumes was 58.7% (range 0 to 100%) and
14.7% (range 0 to 100%), respectively. There was poor compli-
ance with recommendations for the use of enteral formulas
enriched with fish oils, glutamine supplementation, timing of
supplemental PN, and avoidance of soy-bean-oil-based parenteral
lipids. Average nutritional adequacy was 59% (range 20.5 to
94.7%) for energy and 60.3% (range 18.6 to 153.5%) for protein.
Conclusions  Large gaps exist between the evidence-based
recommendations and actual practice in ICUs, and consequently
nutrition therapy is suboptimal. We have identified best achievable
practice that can serve as targets for future quality improvement
initiatives.
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Introduction  The delivery of adequate enteral nutrition (EN) in
critically ill patients with shock is problematic. The purpose of this
study is to describe how EN is delivered in patients with shock
from the REDOXS© study, a multicentre, randomized controlled
trial of pharmaconutrition.
Methods In 20 centres in Canada and Europe, we randomized
mechanically ventilated adults with two or more organ failures to
one of four groups: (1) glutamine, (2) antioxidants, (3) glutamine
plus antioxidants, (4) placebo. EN and parenteral nutrition were
initiated and maintained independently as per the Canadian
Clinical Practice Guidelines. Shock was defined as the presence
of hypoperfusion requiring vasopressors for at least 2 hours. Daily
data including the timing of EN, volumes received, incidence of
high gastric residual volumes (hGRVs), use and timing of motility
agents and small bowel feeding were collected.
Results From May 2007 to July 2008, 159 patients with shock
were randomized, 122 (77%) received EN only, and 13 (8%)
patients received EN in combination with parenteral nutrition. EN
was started 20.2 hours (median, range 0 to 204.8 hours) after ICU
admission. The mean duration of EN was 9.2 days (median 6.8,
range 0.1 to 30 days) and the mean volume of EN received was
67% (range 2.5 to 199%) of that prescribed. In total 73/135
(55%) had hGRVs >250 ml, and in these patients motility agents
and small bowel feeding were used in 78.1% and 41.1% of
patients, respectively. Motility agents were started before onset of
hGRVs in 21% patients, on the same day as hGRVs in 40%
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patients and on average 1.6 ± 0.9 days after hGRVs in 39%
patients. The percentage mean prescribed volume of EN received
24 hours before and after the start of motility agents was 35.1%
vs. 55.9% (P = 0.009). Small bowel feeding was started before
onset of hGRVs in 20% patients, on the same day as hGRVs in
14% patients and was started on average 4.7 ± 3.5 (mean, SD)
days after hGRVs in 67% patients. The percentage mean
prescribed volume of EN received 24 hours before and after the
start of small bowel feeding was 54.2% vs. 67.3% (P = 0.36).
Conclusions  In critically ill patients with shock, EN can be
provided in the early phases of acute illness to the majority of
patients. The delivery of EN in this population can be maximized by
better adoption of motility agents and small bowel feeding.
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Introduction  The molecular adsorbent recirculating system
(MARS; Teraklin Industry, Rostock, Germany) is an extracorporeal
acute liver failure support system method using albumin-enriched
dialysate to remove albumin-bound toxins.
Methods  Between 2004 and 2007, we performed 133 MARS
treatments in 46 patients: Sequential Organ Failure Assessment
score 11.8 ± 4.5. Indication for MARS included 16 cases of fulmi-
nant hepatic failure, 21 cases of acute failure on cirrhosis, one
intractable pruritus, eight moderate or severe acute liver failure
(Bernuau criteria). Among all these patients, 16 had acute renal
failure (hepatorenal syndrome). It was a retrospective study. All data
were recorded before (T0) and at the end of MARS treatment (T).
Results Among 16 fulminant hepatic failure patients, we observed
a significant decrease of encephalopathy (P = 0.04). On the other
hand we did not observe significant improvement of hemodynamic
parameters (norepinephrine dose, mean arterial pressure), meta-
bolic parameters (pH, lactate) or hepatic tests (aspartate
aminotransferase, alanine aminotransferase, γ-glutamyltransferase,
prothrombin time, factor V). In this subgroup, hospital mortality is
31% at day 28. In the group treated for acute on chronic liver
failure, the results did not show a difference between grade of
encephalopathy before and after the session. We only observed a
trend of improvement in hemodynamic and biologic parameters but
this was not statistically significant except for cholestase
parameters (γ-glutamyltransferase P = 0.022, bilirubin P = 0.002).
Hospital mortality is 71% at day 28. Among the patients with
hepatorenal syndrome, 62.5% were anuric. We observed a
significant increase of diuresis output (P  <0.01). We did not
observe any significant adverse event.
Conclusions  Our results confirmed that nonbiologic hepatic
support by MARS was safe. The results were disappointing above
all in cirrhosis patients. Nevertheless, results in hepatorenal syn-
drome were encouraging.
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Introduction  Fecal incontinence is prevalent in patients in the
acute/ICU setting [1,2]. The primary objective of this study was to
assess and compare the economic impact on fecal containment
with use of catheter A or catheter B at 12 sites (A, seven sites; B,
five sites) in the acute/ICU setting. Catheter A is Zassi Bowel
Management System (Hollister Inc.) and catheter B is Flexi-Seal
Fecal Management System (ConvaTec, Inc.).
Methods  An analysis of 146 patients (A, 76 patients; B, 70
patients) on the number of bedding and dressing change visits per
patient-day (frequency of nursing visits per day spent changing
bedding/dressings due to fecal contamination) can be used as an
indirect economic measure of catheter leakage and containment.
Routine daily bedding/dressing changes were not included, only
catheter-related bedding/dressing changes were recorded.
Results  A nearly 30% reduction (1.20 vs. 1.71) in the rate of
bedding/dressing changes per patient-day were observed for
catheter A compared with catheter B (P = 0.0035). For catheter A
sites, 735 bedding/dressing change visits occurred over 612
patient-days; and for catheter B sites, 705 bedding/dressing
change visits occurred over 413 patient-days. Although non-
significant, lower observed rates of leakage (A, 1.1; B, 1.4), reposi-
tions due to leakage (A, 0.25; B, 0.39), and devices expelled (A,
0.02; B, 0.07) may have contributed to the significant reduction in
bedding/dressing changes associated with the use of catheter A
compared with catheter B.
Conclusions The use of indwelling bowel management systems to
divert, collect, and contain liquid stools may provide an economic
advantage in an acute/ICU setting for patients with fecal
incontinence. These results suggest that catheter A may have a
greater economic value compared with catheter B by decreasing
the number of nursing visits per patient-day.
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Introduction  A considerable body of evidence indicates the
contribution of the immune system to the mechanisms leading to
acute pancreatitis [1]. Data focusing on the early course of events
at the clinical ground of the process are lacking. The aim of the
present study was to provide a complex evaluation of peripheral
blood monocyte and subpopulations of lymphocytes in patients with
acute pancreatitis and systemic inflammatory response syndrome.
Methods Forty-three patients were enrolled in the study; 33 with
acute pancreatitis and systemic inflammatory response syndrome,
and 10 healthy subjects. Peripheral blood immune cells were
studied on days 1 and 4 by flow cytometry.
Results Percentages of natural killer (NK) cells and of apoptosis of
CD4 lymphocytes upon diagnosis are presented in Table 1.
Changes of NK cells and of monocyte apoptosis are presented in
Table 2.
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Conclusions Results indicate an early and significant response of
NK cells and of CD4 apoptosis in the initial events of acute
pancreatitis.
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Introduction  Selenium is one of the most investigated trace
elements and an important link in the antioxidant system [1]. It is
known that selenium levels are lower than normal at the time of
admittance to the ICU in critically ill patients [2]. Several cohort
surveys highlight the role of selenium deficiency in the carcino-
genesis of oesophageal cancer [3]. Mortality and morbidity data
after oesophagectomy may vary, but remain considerably high [4].
Methods In three Hungarian university centres, 36 patients who
were operated on with oesophageal cancer (OG-group) and
admitted to the ICU, and 96 healthy volunteers (C-group) were
recruited. In the OG-group, full blood selenium levels were
measured preoperatively (t0) and on the first (t1) and second (t2)
postoperative days. Selenium levels were measured by atomic
absorption spectrometry in the laboratories of Byosin Arzneimittel
GmbH (Fellbach, Germany), blinded to patient’s condition or group
assignment. All data are presented as the mean ± SD. To test the
normal distribution the Kolgomorov–Smirnov test was used. For
statistical analysis the independent-samples t test and ANOVA
were used as appropriate. For statistical analysis the Statistical
Program for Social Sciences (SPSS® version 15.0) software for
Windows was used. Statistical significance was considered at P
<0.05.
Results There was a significant difference in the full blood
selenium levels between the controls and preoperative samples
(t0) of the OG-group (123.86 ± 19.14 μg/l vs. 98.36 ± 19.02 μg/l;
P  <0.001). In the OG-group selenium levels decreased signifi-
cantly during the study period; t0, 98.36 ± 19.02 μg/l; t1, 86.92 ±
17.04 μg/l; t2, 81.44 ± 18.31 μg/l; P = 0.001.
Conclusions  This study has shown significantly lower selenium
levels in OG-patients as compared with controls and a significant
decrease in the postoperative period. Whether this has any
influence on outcome requires further investigation.
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Introduction  Selenium (Se) and selenocysteine residues are
essential for the activity of glutathione peroxidase enzyme (GPX).
GPX plays an important role in antioxidant defense. Se deficiency
is reported in critically ill patients due to deficient dietetic intake,
unsupplemented parenteral nutrition, catabolic state and increased
losses. The objective of the study was to study the Se and GPX
status in critically ill children with cardiac dysfunction and the
effects of Se supplementation.
Methods Thirty-five critically ill cardiac children (mean age: 2.82 ±
3.41 years) with different cardiac disorders (15 with myocarditis,
15 with cardiomyopathy and five with rheumatic heart disease)
were investigated for blood Se and GPX levels and
echocardiographic parameters at admission and after 3 days of
parenteral Se supplementation (initial dose of 2 μg/kg/day on the
first day followed by 1 μg/kg/day). Fifteen healthy children were
included as controls.
Results  At admission, Se and GPX levels were significantly
decreased in patients (6.61 ± 1.16 μg/l and 10.8 ± 1.14 U/l)
compared with controls (16.06 ± 2.08 μg/l and 20.64 ± 2.13 U/l)
(P <0.001). Se levels did not differ between studied cardiac
diseases (P >0.05). Se levels correlated positively with
corresponding ejection fraction values (EF) (r = 0.57 and P <0.05)
and fractional shortening values (FS) (r = 0.45 and P <0.05), and
negatively with left ventricular end-diastolic diameter (r = –0.50
and P <0.05). After Se supplementation, Se and GPX were raised
(16.53 ± 2.25 μg/l and 19.71 ± 2.63 U/l). Clinical examination
revealed that orthopnea improved in 88.6% of cases and dys-
rhythmia disappeared in 65.7%. Echocardiography showed that EF
and FS were also significantly improved (admission values for EF
and FS were 34.6 ± 7.4 and 16.8 ± 4.1, compared with 52.6 ±
11.4 and 27.7 ± 6.8 after Se supplementation; P <0.05).
Conclusions Se deficiency is one of the mechanisms of worsening
cardiac dysfunction in critically ill patients regardless of the
underlying cardiac etiology. Se supplementation can reverse such
a mechanism and improve cardiac performance.
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Table 1 (abstract P147)
NK cells and CD4-lymphocyte apoptosis
Acute Healthy 
Median (%) pancreatitis controls P value
CD(16 + 56)+/CD3– 15.09 6.50 0.036
ANNEXIN+/CD4+ 7.16 4.63 NS
Table 2 (abstract P147)
Alterations over follow-up
Day 1 Day 4 P value
CD(16 + 56)+/CD3– 43.67 52.16 0.036
ANNEXIN+/CD14+ 66.37 40.39 0.021S62
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Introduction  High doses of selenium (Se) may improve the
condition of ICU patients with respect to its involvement in
antioxidative protection and other tasks. In the previous work we
concluded, that the decrease of 28-day mortality is not significant.
Now procalcitonin (PCT), C-reactive protein (CRP) and Sequential
Organ Failure Assessment (SOFA), as markers of the severity of
actual status, were monitored and evaluated in relation to the
plasma Se concentration.
Methods One hundred and forty patients were randomized into
groups A and B. Group A received standard Se substitution: 30 to
75  μg/day NaSelenite intravenously; group B received Se
substitution according to a protocol: 1,000 μg at day 1, followed
with 500 μg at days 2 to 14. These groups were divided into four
subgroups: systemic inflammatory response syndrome, sepsis,
severe sepsis and septic shock. Plasma levels of Se, CRP and
PCT were examined. SOFA and 28-day mortality were evaluated
as clinical markers. Relations between parameters were evaluated
statistically. In both groups, transitions among subgroups during
treatment were evaluated. All patients monitored less than three
times were excluded.
Results Negative correlations between Se x PCT, Se x SOFA and
Se x CRP were found (Table 1). Correlation coefficients (r) were
statistically significantly higher in group B. Evaluation of transitions
among subgroups during treatment showed there was a difference
in subgroup septic shock between groups A and B. Into the less
severe stage of sepsis moved 28% in group A (14 examinations)
and 44% (16 examinations) in group B.
Table 1 (abstract P150)
Negative correlations
Parameter Group A Group B Significance
Se x PCT r = –0.24 r = –0.29 P < 0.05
Se x CRP r = –0.41 r = –0.53 P < 0.05
Se x SOFA r = –0.29 r = –0.03 NS
Conclusions  There were more significant negative correlations
between plasmatic Se and parameters of inflammation in the group
of patients supplemented with high doses of Se. In accordance
was a finding of more frequent transition from septic shock to a
less severe stage of sepsis. Even if a decrease of mortality was
again not found, the presented results may perhaps indicate a
positive metabolic influence in critical illness.
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Introduction  Mathematical models are widely used to simulate
physiological processes in the human body and can be exploited
for diagnostic purpose or the automation of therapeutic measures
[1]. Usually these models focus on one single aspect of the human
physiology. Complex models with interaction between different
physiological processes usually do not consist of interchangeable
submodels. We therefore designed a versatile software based on
Matlab with dynamically exchangeable subsystems within the three
model families of respiratory mechanics, gas exchange and
cardiovascular dynamics.
Methods For each submodel the parameters have been extracted
from the corresponding literature. Common interfaces were defined
for each model family based on these parameters to ensure
interchangeability within the same model family. For simulation of
human body gas exchange we used a two-compartment model
with oxygen and carbon dioxide dissociation curves. The model
family of cardiovascular dynamics consisted of a single-
compartment model and a six-compartment model including the
response to pleural pressure. The respiratory mechanics were
based on a first-order resistance-compliance model and a second-
order resistance-compliance model. Model parameters were fit to
human test data or to data taken from the literature. Simulation is
executed using a dedicated caller program to combine the
selected submodels and to execute them subsequently at each
time step. Submodel selection and basic parameter specification
can be done via a graphical user interface. The software was
tested with different model combinations. Each combination was
supplied with alterations in ventilation frequency and positive end-
expiratory pressure.
Results Simulation based on parameters from the literature with
the variations described above showed plausible results. Altera-
tions in ventilation frequency indicated a response time consistent
with data acquired by Jensen and colleagues [2].
Conclusions The developed software is able to simulate different
combinations of submodels at variable complexity. Simulation
results are consistent with experimental data. Interaction between
submodels can be seen in the simulation output.
References
1. Lozano S, Moller K, Brendle A, et al.:  AUTOPILOT-BT: a
system for knowledge and model based mechanical venti-
lation. Technol Health Care 2008, 16:1-11.
2. Jensen MC, Lozano S, Gottlieb D, et al.: An evaluation of
end-tidal CO2 change following alteration in ventilation
frequency [abstract]. In  MBEC Antwerpen Conference;
2008.
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Introduction Application of the intraaortic balloon pump (IABP) for
patients with acute myocardial infarction complicated by cardio-
genic shock is undoubted. But the time of IABC initiation is
questionable. The goal of the study was to evaluate the influence of
the IABP initiation time and dose of dopamine for patient hemo-
dynamic data and inhospital mortality.
Methods  Sixty-two consecutive acute myocardial infarction
patients managed with IABP were included in the study. The
initiation time of IABP and administered dopamine doses were
compared. Two subgroups of patients were separated: those
receiving less than 10 μg/kg/minute dopamine, and others receiv-
ing 10 μg/kg/minute dopamine or more. Standard hemodynamic
indices of cardiac output (CO), cardiac index (CI), stroke volume
(SV), stroke index (SI), pulmonary capillary wedge pressure
(PCWP), mean pulmonary artery pressure (PAmean), cardiac
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power (CP = CO x MAP / 451, where MAP is mean arterial
pressure) and cardiac power index (CPI = CI x MAP / 451) were
measured.
Results  CO in the first group was 3.58 ± 1.12 l/minute, in
comparison with 2.54 ± 1.08 l/minute (P <0.0001) in the second
group. CI correspondingly was 1.9 ± 0.6 l/minute/m2 and 1.38 ±
0.61 l/minute/m2 (P  = 0.001), SV was 43.8 ± 26.14 ml and
30.01 ± 13.75 ml (P = 0.012), SI was 23.93 ± 15.58 ml/m2 and
16.28 ± 7.75 ml/m2 (P = 0.017), CP was 0.68 ± 0.25 W and
0.4 ± 0.23 W (P  <0.0001), CPI was 0.36 ± 0.14 W/m2 and
0.22 ± 0.13 W/m2 (P <0.0001), PCWP was 21.32 ± 6.04 mmHg
and 24.16 ± 7.42 mmHg (P  = 0,104), PAmean was 28.74 ±
8.53 mmHg and 30.23 ± 7.05 mmHg (P = 0.47). In the second
subgroup, hemodynamic indices (CO, CI, SV, SI, CP and CPI)
were statistically significantly lower (P <0.05) in comparison with
the data of patients receiving less than 10 μg/kg/minute, while
PCWP and CVP values differed insignificantly. Inhospital mortality
was higher among patients receiving 10 μg/kg/minute dopamine
or more. Among 31 patients receiving less than 10 μg/kg/minute
dopamine 16 (51.6%) died, while among those 31 receiving
10 μg/kg/minute or more 27 (87.1%) died. This was a significant
difference according to the Pearson χ2 criterion (χ2 = 9.182,
P = 0.002).
Conclusions  Initiation of aortic counterpulsation should be
considered as soon as possible, while the patient with acute
myocardial infarction is treated with low doses of vasopressors.
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Introduction Acute myocardial infarction (AMI) is one of the most
common cardiovascular emergencies. Female patients have
different features to male patients. The objective of our study was
to analyze risk factors for female patients with AMI.
Methods Five hundred and eighty female patients were compared
with 2,058 male patients for age, occupation, positive family
history, type 2 diabetes mellitus, hypertension, and hyperlipemia.
Then, according to age, patients with AMI were divided into four
groups: <55 years, 55 to 64 years, 65 to 74 years, ≥75 years. Risk
factors were compared between female patients and male patients
in each group.
Results Compared with male patients, female patients were older
(P <0.01); The morbidity of type 2 diabetes mellitus and hyper-
tension and the rate of physical labors were significantly higher in
female patients (P <0.01,  P <0.01,  P <0.01); the morbidity of
hyperlipemia and the rate of mental labors and positive family
history were significantly lower in female patients (P <0.01,
P <0.01, P <0.05). In the <55 years group, the morbidity of type 2
diabetes mellitus and hypertension and the rate of physical labors
were significantly higher in female patients (P <0.05,  P <0.01,
P <0.01); the rate of mental labors were significantly lower in
female patients (P <0.01). In the 55 to 64 years group, the
morbidity of type 2 diabetes mellitus and hypertension and the rate
of physical labors were significantly higher in female patients
(P <0.01, P <0.05, P <0.01); the rate of mental labors was signifi-
cantly lower in female patients (P <0.01). In the 65 to 74 years
group, the morbidity of type 2 diabetes mellitus and hypertension
and the rate of physical labors were significantly higher in female
patients (P <0.05, P <0.01, P <0.01); the rate of mental labors
was significantly lower in female patients (P <0.01). In the
≥75 years group, the rate of physical labors was significantly higher
in female patients (P <0.01); the rate of mental labors was
significantly lower in female patients (P <0.01).
Conclusions Compared with male patients, female patients with
AMI were older, and type 2 diabetes mellitus and hypertension
probably played more important roles in female patients. A higher
rate of physical labors and a lower rate of mental labors in female
patients probably contribute to prevent them from AMI.
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Introduction The aim of this study was to measure the effects of
increasing mean arterial pressure (MAP) on systemic oxygen
metabolism and regional tissue perfusion in septic shock.
Methods Twenty patients with the diagnosis of septic shock who
required pressor agents to maintain a MAP ≥65 mmHg after fluid
resuscitation to a pulmonary artery occlusion pressure (PAOP)
≥12 mmHg were included. Norepinephrine was titrated to MAPs of
65 mmHg, 75 mmHg and 85 mmHg in 20 patients with septic
shock.
Results  At each level of MAP, hemodynamic parameters (heart
rate, PAOP, cardiac index, left ventricular stroke work index, and
systemic vascular resistance index), metabolic parameters (oxygen
delivery, oxygen consumption, blood lactate), and regional
perfusion parameters (gastric mucosal PCO2, skin capillary blood
flow and red blood cell velocity, urine output) were measured.
Increasing the MAP from 65 to 85 mmHg with norepinephrine
resulted in increases in cardiac index from 3.5 ± 0.4 l/min/m2 to
5.0 ± 0.5 l/min/m2 (P < 0.03). Blood lactate was 3.5 ± 0.8 mEq/l
at a MAP of 65 mmHg and 3.0 ± 0.8 mEq/l at 85 mmHg (P = NS).
The gradient between arterial PCO2 and gastric intramucosal
PCO2 was 11 ± 3 mmHg (1.5 ± 0.3 kPa) at a MAP of 65 mmHg
and 15 ± 3 mmHg at 85 mmHg (2.0 ± 0.3 kPa, P = NS). Urine
output at 65 mmHg was 40 ± 10 ml/hour and was 45 ± 12 ml/hour
at 85 mmHg (P = NS). As the MAP was raised, there were no
significant changes in skin capillary blood flow or red blood cell
velocity.
Conclusions Increasing the MAP from 65 mmHg to 85 mmHg
with norepinephrine does not significantly affect systemic oxygen
metabolism, skin microcirculatory blood flow, urine output, or
splanchnic perfusion.
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Introduction  More than 20% of patients with congestive heart
failure (CHF) exhibit one form or another of mechanical
dyssynchrony, intraventricular conduction impairment, or bundle
branch block. The concept of dual-chamber pacing in refractory
heart failure was introduced to be followed later by the technique
of biventricular pacing to restore cardiac synchrony in the failing
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heart. The aim of the present study was to address the issue of
applying the technique of left ventricular (LV) pacing to that
substrate of heart failure patients with a narrow rather than wide
QRS complex, and with LV rather than biventricular pacing in order
to permit the use of an ordinary dual-chamber pacemaker.
Methods We conducted an acute study on 20 patients (15 male,
five female; mean age 43 years); all had CHF (12 ischemic and
eight idiopathic) with normal QRS duration on ECG. All patients
were under maximal tolerated doses of antifailure treatment. All
patients were subjected to M-mode and two-2D echocardiography
to measure: left ventricular end-diastolic dimension (LVEDD), left
ventricular end-systolic dimension (LVESD), fractional shortening
(FS), ejection fraction (EF), mitral regurge area and cardiac output
before and 15 minutes after LV pacing. All patients were subjected
to temporary dual-chamber right atrium, LV pacing; the LV lead
was passed retrogradely via the transaortic route. The pulmonary
capillary wedge pressure (PCWP) was measured using a trilumen,
balloon-tipped thermodilution Swan–Ganz catheter. Patients were
divided into group I (PCWP >15 mmHg, 10 patients) and group II
(PCWP <15 mmHg, 10 patients).
Results Echocardiographic measurements after pacing in group I
showed significantly lower LVEDD (5.12 vs. 6.53 cm, P <0.004),
lower LVESD (4.01 vs. 4.65 cm, P <0.034), smaller mitral regurge
area (9.7 vs. 13.4 cm2,  P <0.005), higher FS (18.9 vs. 17,
P <0.04) and higher EF (37.9 vs. 35.5%, P <0.02). In contrast,
following pacing in group II, the hemodynamics were not
significantly different from pre-pacing values.
Conclusions Single LV – rather than biventricular – pacing could
achieve remarkable hemodynamic beneficial effects in patients with
CHF even with normal QRS, but only in that substrate of patients
with a high PCWP. Although this is an acute study, our findings
open the scope for widespread application of the concept of
multisite pacing.
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Introduction Despite advances in drug treatment, congestive heart
failure (CHF) remains a major healthcare problem associated with
a poor quality of life and a high mortality rate. During the past
decade, cardiac resynchronisation therapy (CRT) using biventri-
cular (BIV) pacing emerged as a promising technique improving
the quality of life, exercise tolerance and mortality in patients with
severe CHF. Left univentricular (LV) pacing is able to achieve the
same mechanical synchronisation as BIV pacing in experimental
studies and in humans resulting in significant improvement in
functional class, quality of life and exercise tolerance at the same
extent as those observed with BIV stimulation. The aim was to
study the acute hemodynamic effects of LV pacing in the category
of patients with severe CHF and QRS duration <130 ms and to
determine whether pulmonary capillary wedge pressure (PCWP)
>15 mmHg could have an impact on these changes in hemo-
dynamics.
Methods We conducted an acute study on 20 patients (15 male,
five female; mean age 43 years); all had CHF (12 ischemic and
eight idiopathic) with a QRS duration <130 ms. All patients had an
ejection fraction <40%. Group I comprised 10 patients with
PCWP >15 mmHg, group II comprised 10 patients with PCWP
<15 mmHg. Haemodynamics were measured using a Swan–Ganz
catheter at baseline and during LV VDD pacing. All patients were
under maximal tolerated doses of antifailure treatment.
Results After LV pacing, group I showed a significant decrease in
right atrial pressure (P = 0.001), and PCWP also significantly
decreased (P = 0.0001), while the cardiac output ignificantly
increased (P = 0.04). In group II none of these hemodynamic
parameters showed any significant improvement. The improvement
of hemodynamics in group I occurred despite the greater increase
in QRS duration after LV pacing when compared with group II (24
vs. 21%, respectively).
Conclusions LV pacing acutely benefits CHF patients with PCWP
>15 mmHg irrespective of the QRS duration. Although this is an
acute study, our findings open the scope for revising the current
wide QRS duration as an indication for CRT and to consider the
less expensive LV rather than BIV pacing when a patient is
considered a candidate for resynchronization.
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Introduction  Postoperative atrial fibrillation is one of the most
frequent complications after cardiopulmonary bypass (CPB). The
aim of the present study was to investigate the correlation between
preoperative left atrial dysfunction assessed by tissue Doppler and
postoperative new-onset atrial fibrillation (NOAF) after coronary
artery bypass grafting (CABG).
Methods  Preoperative transthoracic echocardiography Doppler
was performed on elective cardiac surgery patients. Left atrial
function was evaluated with tissue Doppler imaging of the mitral
annulus.
Results We studied 92 patients, 73 (79%) males and 19 (21%)
females, mean age 67 ± 10 years, in preoperative sinus rhythm
who underwent elective CABG surgery under CPB. Nineteen
patients (20.6%) developed NOAF at 34 ± 12 postoperative
hours. Patients with NOAF were older (71 ± 7 vs. 66 ± 10 years,
P = 0.034), had a larger left atrial diameter (LAD), lower peak atrial
systolic mitral annular Doppler velocity (A′m) and higher E′/A′ ratio
in a bivariate analysis. Stepwise logistic regression analysis
showed that LAD (OR = 2.23, 95% CI = 1.05 to 4.76; P = 0.033)
and lower A′m (OR = 0.70, 95% CI = 0.55 to 0.99; P = 0.034)
were independently associated with postoperative NOAF.
Conclusions  A preoperative left atrial dysfunction assessed by
tissue Doppler imaging may identify the patients at risk of post-
operative NOAF.
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Introduction  Takotsubo syndrome (TS) is characterized by a
transient apical ballooning of the left ventricle, reversible ST-T-
segment abnormalities and mildly elevated troponin without
coronary artery stenosis, mimicking myocardial infarction (MI).
Originally described as a disturbance of the left ventricle, recently
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an involvement of the apex of the right ventricle (RV) has been
recognized affecting approximately one-quarter of cases.
Methods TS was diagnosed in 10 patients (nine female, one male;
mean age 67 years) who displayed typical signs of acute
myocardial ischemia, showed typical ECG changes and slightly
elevated troponin I (0.8 ng/ml; n ± 3.5 ng/ml; normal <0.3 ng/ml).
Echocardiography was obtained on admission in all patients. TS
was presumed by identification of the typical LV apical ballooning
configuration (echo positive). In 10 patients left heart catheteri-
zation was then performed immediately.
Results All patients displayed LV apical ballooning on LV angio-
graphy without coronary artery lesions. Nine patients were echo
positive (90%; sensitivity 91%, specificity 100%); in the one echo-
negative patient the LV angiogram showed only a very small apical
ballooning area. In all of the nine patients classified as echo
positive, involvement of the RV apex was identified as well.
Additional hypokinesia of the middle part of the RV was seen in
two patients; however, the basal RV wall segments were never
compromised. One patient showed dynamic LV outflow tract
obstruction.
Conclusions  RV involvement was a common feature in TS,
involving 90% of patients. In all cases, the apical portion of the RV
was compromised, the basal segments were never affected. In
most patients the typical wall motion disturbance was readily seen
on transthoracic echocardiogram. RV involvement was identified in
all echo-positive patients. Probably, identification of RV apical
ballooning may aid in differentiating TS from MI.
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Introduction  Bradycardia is described as a side effect of α2-
sympothomimetic infusion. It is supposed as a dose-dependent
phenomenon. Cholinergic antagonists or β-sympathomimetics are
recommended for the bradycardia correction. We propose that the
severity of bradycardia associated with α2-sympothomimetic
infusion depends on the level of hypothyroidism. The aim of this
report is to provide evidence for our point of view.
Methods Fifteen patients after sellar region tumor surgery were
included in the study. Resistant arterial hypotension developed in
the early postoperative period in all patients and they were
monitored with a Swan–Ganz catheter for this reason. The
hormonal profile (triiodothyronine, thyroxine, free triiodothyronine,
free thyroxine, and cortisol) was investigated daily during the whole
period of hemodynamic monitoring.
Results  The cause of resistant arterial hypotension in all cases
was decreased vascular tone (systemic vascular resistance index =
1,503 ± 624 dyn·s·cm5·m2), and so phenylephrine as the α2-
sympothomimetic was the drug of choice. Administration of
phenylephrine started with the mean dose of 2.9 μg/kg/minute,
and the maximal mean dose during the period of arterial
hypotension was 5 μg/kg/minute. Bradycardia developed in four
patients during infusion of phenylephrine. All these patients had
clinical signs of hypothyroidism (hypothermia, dynamic ileus, etc.)
and decreased levels of T3, T4, free T3 and free T4. In order to
correct bradycardia, the infusion of phenylephrine was combined
with cholinergic antagonists and β-sympathomimetics. Simul-
taneously, dose administration of thyroid hormones was increased.
Heart rates reached the normal range, when clinical signs of
hypothyroidism were corrected, and the level of thyroid hormones
tended to rise. In 11 patients without clinical signs of hypo-
thyroidism and normal levels of thyroid hormones in plasma,
bradycardia never developed even if they received high doses of
phenylephrine (5.5 μg/kg/min).
Conclusions  Bradycardia, associated with α2-sympothomimetic
infusion, is a consequence of hypothyroidism in patients after sellar
region tumor surgery. This phenomenon is not dose dependent.
Patients with bradycardia, developed after beginning α2-sympotho-
mimetic infusion, need to be screened for hypothyroidism. If
hypothyroidism is confirmed, therapy with L-thyroxin should be
administrated immediately. In patients having received thyroid
hormones, their doses need to be increased.
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Introduction  Epicardial accelerometers have proved to detect
myocardial ischemia with high sensitivity [1]. In this combined
experimental and clinical study using an epicardial accelerometer,
we aimed to test two methods for real-time automated detection of
myocardial ischemia.
Methods One accelerometer (5 x 5 x 2 mm3) was sutured in the
perfusion area of the left anterior descending artery (LAD).
Epicardial acceleration was simultaneously recorded with ECG,
and the ECG QRS complex was automatically detected for timing
of systole. From the epicardial acceleration, signal circumferential
peak velocity and displacement was automatically calculated within
a time interval of 150 ms after peak R on the ECG. Experimental
model: in 10 open-chest pigs, regional left ventricular function was
reduced by temporary LAD occlusion and global myocardial
function changed by esmolol infusion. The myocardial circum-
ferential strain measured by echocardiography was used to confirm
ischemia. Clinical model: the accelerometer methods were tested
in seven patients, receiving coronary artery bypass grafting. LAD
was occluded for 3 minutes before grafting and the accelerometer
measurements were compared for hemodynamics, ECG ST-
segment analysis and strain by transoesophageal echocardio-
graphy.
Results  Accelerometer systolic displacement was superior to
systolic velocity to detect ischemia by automated analysis.
Accelerometer systolic displacement demonstrated dyskinesia
during LAD occlusion in pigs (11.5 ± 2.3 to –1.2 ± 2.8 mm,
P <0.01), while hypokinesia was found in patients (12.8 ± 8.1 to
3.5 ± 4.4 mm, P <0.01). Ischemia was confirmed by strain echo-
cardiography in both models (P <0.01). No significant changes in
hemodynamics and in the ECG ST segment were seen during LAD
occlusion in patients. In the experimental model, esmolol infusion
induced fewer changes in the automated accelerometer
measurements than LAD occlusion (P < 0.01) and ischemia was
detected with a sensitivity of 100% and specificity of 95 to 100%.
Conclusions Sensitive real-time detection of myocardial ischemia
was feasible by the use of automated analysis of continuous
epicardial accelerometer signals. This technique may improve real-
time detection of ischemia during and after cardiac surgery.
Reference
1. Halvorsen PS, et al.: Br J Anaesth 2009, 102:29-37.
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Introduction Insufficient reliability and specificity of cardiac output
(CO) as a widely used parameter for prognosis of acute myocardial
infarction (AMI) outcomes led to investigations and a search for
new methods and parameters. Cardiac power (CP) (a parameter
proportional to the product of CO and mean arterial pressure) was
introduced after studies mainly performed using the invasive
intermittent thermodilution (ITD) technique. The aim of this study
was to investigate the reliability and specificity of the new
parameter mainly by means of noninvasive techniques such as
impedance cardiography (ICG).
Methods  CO and CP were evaluated by both ITD and ICG
methods in patients with AMI, admitted within 12 hours from the
onset of pain. CP was evaluated using the suggested formula:
CP = CO x MAP / 451, where MAP = mean arterial pressure.
During the period of 2004 to 2008, 289 (196 men and 93 women)
patients were investigated. The standard eight-electrode ICG
registration was used. The optimal binning method using the
minimal description length principle was used to predict outcomes
after AMI: inhospital mortality, survival after 6 months and survival
after 12 months.
Results  CP evaluated on the first day was found as the only
valuable prognostic parameter using the model entropy method in
the group of patients where noninvasive evaluation of CO was
used. Inhospital mortality was predicted with single cut point 0.65,
sensitivity 100% and specificity 92.2%, while survival of 12 months
was predicted with single cut point 0.90, sensitivity 88.9% and
specificity 73.0%. Only prediction of inhospital mortality was
possible in the group of patients where CO was evaluated using
the ITD technique. The most significant criteria using minimized
entropy model were CP evaluated on the third day (single cut point
0.79, sensitivity 84.6%, specificity 100.0%) and CO evaluated
also on the third day (single cut point 4.00, sensitivity 84.6%,
specificity 100.0%).
Conclusions Cardiac power is a reliable predictor for inhospital
mortality and survival within the first year after acute myocardial
infarction. It could be evaluated using ITD and with sufficient
accuracy by means of a noninvasive method – ICG – as well.
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Introduction Left ventricular (LV) torsion is a primary mechanism
used to eject blood during systole. We hypothesized that LV
torsion is impaired during dyssynchronous contractions and
restored with cardiac resynchronization therapy (CRT) in
proportion to the degree that global LV performance improves.
Methods  Seven anesthetized open-chest dogs had high fidelity
pressure and conductance volume catheters to assess LV
performance. Basal and apical Grayscale echo images were
recorded. Right atrial (RA) pacing served as the control. Right
ventricular (RV) outflow tract pacing created a left bundle branch
block (LBBB) to simulate dyssynchrony. Simultaneous RV–LV free
wall and RV–LV apex pacing were modeled CRT (CRTfw and
CRTa). Torsion was estimated as the difference between apical
and basal rotation in degrees.
Results  Torsion during RA pacing was 7.0 ± 3.6°. RV pacing
decreased torsion (5.1 ± 3.6°, P <0.05 vs. control), reduced the
stroke volume (SV), stroke work (SW), and dP/dtmax compared
with RA (21 ± 5 vs. 17 ± 5 ml, 252 ± 61 vs.151 ± 64 mJ, and
2,063 ± 456 vs. 1,603 ± 424 mmHg/s, P <0.05). CRTa improved
torsion, SV, SW and dP/dtmax compared with RV pacing (7.7 ±
4.7°, 23 ± 3 ml, 240 ± 50 mJ and 1,947 ± 647 mmHg/s, respec-
tively, P <0.05), whereas CRTfw did not (5.1 ± 3.6°, 18 ± 5 ml,
175 ± 48 mJ and 1,699 ± 432 mmHg/s, respectively, P <0.05)
(Figure 1). Changes in torsion compared with RA covaried with
changes in SW during RV, CRTa and CRTfw.
Conclusions  LV torsion, as quantified by speckle tracking
echocardiography in an acute canine model, was reduced by
dyssynchrony contraction and restored by CRT in proportion to the
degree to which global measures of LV performance also
improved. Thus, torsion and global LV performance are linked
during synchronous, dyssynchronous contractions and CRT.
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Introduction  Pregnancy, labour and the postpartum period
constitute major stresses on the cardiovascular system. Patients
with heart disease may decompensate due to the physiologic
changes that occur during pregnancy and may develop a cardiac
event with obstetric events.
Methods A retrospective collection of data for all obstetric patients
admitted to our ICU in a 13-year period (September 1995 to
September 2008). Data collected include the antepartum or
peripartum heart status (abnormal finding on physical examination,
ECG and echocardiography), reason for admission, stay on the
ICU prognostic scoring (APACHE II, Obstetrical SAPS) and the
outcome.
Results During 13 years there were 42 obstetric admissions to our
ICU. The reason for admission was due to pulmonary edema 16
(38.1%) cases, hemorrhagic shock 11 (26.2%) cases, cardiogenic
shock 8 (19%) cases, pulmonary emboli 4 (9.5%) cases, stroke 2
(4.8%) cases and recent myocardic infarction 1 (2.4%) case.
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Admission was unplanned for 36 (85.7%) parturients following
emergency caesarean section. Status of the heart was severe
aortic or mitral stenosis 21 (50%) cases, mitral or aortic
regurgitation with heart failure 5 (11.9%) cases, mechanical
prosthetic valve requiring anticoagulation 8 (19%) cases, myo-
cardial infarction 1 (2.4%) case and peripartum cardiomyopathy 7
(16.6%) cases. The median duration of stay was 4 days (range 1
to 11 days), median Obstetrical SAPS was 19.3 (range 10 to 32)
and APACHE II score was 13 (range 8 to 32). There were five
(11.9%) maternal deaths, due to two cases PPCM, one cerebral
death and two prothesis thrombus.
Conclusions  The majority of the cases of parturients was
unbooked for antenatal care; this leads us to acknowledge the
existence of risk factors related to pregnancy. Maternal functional
class is an important predictor of outcome; a high index of
suspicion for cardiac diseases is essential to identify risk [1], once
these patients are referred for a cardiologic opinion there is a
needed for cardiologist to develop a systematic approach to their
evaluation. Ideally these considerations should be commenced
during prepregnancy consultations, but continued throughout
pregnancy and the postpartum period [1].
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Introduction Nitric oxide (NO) plays a central role in the patho-
genesis of septic cardiomyopathy. However, the relative contri-
bution of inducible nitric oxide synthase (iNOS) and endothelial
nitric oxide synthase (eNOS) remains unclear. The aim of this study
is to elucidate the influence of eNOS and iNOS on cardiac
function, NO production rate and survival in the clinically relevant
polymicrobial cecum ligation and puncture (CLP) model of sepsis.
Methods B6/c57 wildtype (WT) and eNOS–/– mice were rendered
septic by CLP or were sham operated. Immediately, the selective
iNOS inhibitor 1400W (6.6 mg/kg body weight intraperitoneally
and subcutaneously) or carrier were applied. At 12 hours after
sepsis induction, heart function was assessed by pressure–volume
loops (1.4 Fr Millar catheter). NOx levels and endogenous NO
production (blood plasma/heart tissue) were measured via gas-
phase chemiluminescence detection, high-performance liquid
chromatography and electron paramagnetic resonance spectro-
scopy. To evaluate apoptosis and inflammation, quantitative
immunochemistry was applied. iNOS expression was analyzed via
RT-PCR.
Results Cardiac function was significantly impaired solely in septic
WT mice with diminished left ventricular developed pressure/dPdtmax
(dPdtmax: WT CLP = 10,981 ± 1,100 mmHg/s vs. WT sham =
13,408 ± 827 mmHg/s; P <0.01) and increased left-ventricular
volumes. Inhibition of iNOS in septic WT mice resulted in
ameliorated cardiovascular impairment, whereas no signs of septic
cardiomyopathy were observed in septic eNOS–/–. In contrast to
septic eNOS–/– mice, septic WT mice developed a significant
increase in NO3–, NO2
– and bioactive NO levels. eNOS deficiency
was associated with diminished apoptosis and modified
inflammation. In eNOS–/– mice, a decreased iNOS expression was
observed compared with septic WT mice. Both genetic eNOS
deficiency and pharmacologic iNOS inhibition was associated with
a significant survival benefit. While eNOS–/– mice survived longest,
additional iNOS inhibition in the latter diminished this benefit
significantly.
Conclusions  In this clinically relevant model of sepsis, eNOS
constitutes an important factor mediating septic cardiomyopathy.
To what extent the diminished inflammation, apoptosis, NO
production rate, iNOS expression and prolonged survival in
eNOS–/– mice contribute to the observed benefits remains to be
clarified in future studies.
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Introduction Myocardial dysfunction observed within the context
of sepsis is partially due to desensitization of the cardiac muscle to
vasoactive agents. Levosimendan, a calcium sensitizer and a K+-
ATP channel opener, plays a significant role in the treatment of
myocardial depression although its use in sepsis has not yet been
established.
Methods We studied 42 patients (66.1 ± 7.54 years, 24 male)
who met the criteria for sepsis (infection by Gram-negative bacteria
and at least two SIRS criteria) and displayed severe heart
dysfunction (cardiac index (CI) ≤2.2, ejection fraction (EF) ≤35%).
The APACHE II score was 21.2 ± 4.9. Patients were randomized
to receive additionally to their standard treatment levosimendan
(0.1 μg/kg/minute 24-hour infusion) (group A, n = 23) without
loading dose or dobutamine (5 to 10 μg/kg/minute 24-hour infusion)
(group B, n = 19). Noradrenaline was used to preserve the mean
arterial pressure above 65 mmHg. The primary goal was mortality
at 7 and 30 days.
Results Mortality at 7 and 30 days was 30% and 60% in group A
versus 36% and 68% in group B (P = 0.05, P = 0.03, respec-
tively). The CI and EF significantly increased in group A (ΔCI:
1.79 ± 0.16 vs. 1.4 ± 0.12, P = 0.027; ΔEF: 4.8 ± 0.2% vs. 3.5 ±
0.7%, P = 0.04), and also SvO2 (P = 0.012) and mean arterial
pressure (P = 0.035) were significantly increased.
Conclusions Levosimendan compared with dobutamine improves
the hemodynamic profile of septic patients with myocardial dys-
function; and while there is evidence that it reduces mortality,
further studies are needed to verify this.
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Introduction  Myocardial contractile function following cardiac
surgery often requires inotropic support. Traditionally, phospho-
diesterase inhibitors and catecholamines are used [1,2]. Levo-
simendan is a novel inotropic agent–calcium sensitizer that
Available online http://ccforum.com/supplements/13/S1S68
enhances myocardial contractility without increasing intracellular
calcium and myocardial oxygen demand [3]. The aim of our study
was to evaluate circulation following levosimendan infusion, to find
out the efficiency of tissue oxygen supply and to evaluate other
inotrope dosage rates during levosimendan infusion.
Methods  Thirteen patients with acute heart failure following
elective cardiac surgery under cardiopulmonary bypass treated
with levosimendan and other inotropes were enrolled.
Haemodynamic parameters (mean arterial pressure, central venous
pressure, mean pulmonary artery pressure, cardiac index), PaO2,
SvO2, plasma lactate, cardiac troponin I and other inotropes rates
were obtained at baseline, 30 minutes, 1 hour, 6 hours and
24 hours after the start of levosimendan infusion. Levosimendan
was administered at a rate of 0.1 μg/kg/minute (no bolus) with a
total 24-hour dose of 12.5 mg for each patient. Other inotropic
agents used were epinephrine (range 0.03 to 0.15 μg/kg/min),
norepinephrine (range 0.03 to 0.18 μg/kg/min), dobutamine (range
3.5 to 7 μg/kg/min) and corotrope (range 0.3 to 0.6 μg/kg/min).
Results  Thirteen patients (nine female, four male) were investi-
gated. Forty-six per cent of patients had III to IV (New York Heart
Association) stage of congestive heart failure (ejection fraction
<40%). Six patients died within 24 hours and were excluded.
Maximal changes occurred 24 hours after levosimendan infusion.
Mean arterial pressure increased, while the mean pulmonary artery
pressure and central venous pressure decreased. The cardiac
index did not change considerably. Oxidative stress markers
improved. Mean infusion rates of epinephrine, dobutamine and
corotrope decreased, while the norepinephrine mean rate did not
change.
Conclusions Levosimendan improves circulation by means of its
positive inotropic effect, increases mean arterial pressure, and
decreases pulmonary pressure. Levosimendan could be a drug of
choice in myocardial hypoxia, probably combined with right heart
failure.
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Introduction  Patients with poor left ventricular function require
inotropic drug support after cardiopulmonary bypass (CPB). The
use of levosimendan in these patients is associated with a better
postoperative function [1]. A recent study has attributed this
phenomenon to preconditioning effects of levosimendan [2].
However, a recent study showed no benefit in starting levo-
simendan before CPB [3]. We hypothesized that admitting the
patient to intensive care 24 hours before CPB and starting levo-
simendan preoperatively could reduce postoperative cardiac
damage.
Methods  Fifty patients with an ejection fraction less than 30%
scheduled for elective cardiac surgery with CPB received
anesthesia with propofol, cisatracurium and sufentanil. The patients
were randomly assigned to two protocols. Group A: levosimendan
0.1 μg/kg/minute started before CPB after induction + dobutamine
5  μg/kg/minute started after the release of the Aox. Group B:
levosimendan 0.1 μg/kg/minute started on the ICU 24 hours
before CPB + dobutamine 5 μg/kg/minute started after the release
of the Aox. Data analysis: SV, dobutamine, noradrenaline time and
dose, cardiac enzymes, global hemodynamic variables, ICU and
hospital length of stay. Statistical significance was accepted at
P 0.05.
Results There was no difference in postoperative stroke volume
and troponin I. The incidence of postoperative atrial fibrillation in
both groups was very low. There was a significant difference in
ICU length of stay but not in hospital length of stay.
Conclusions In cardiac surgery patients with a low preoperative
ejection fraction there is no difference in cardiac function and
postoperative troponin I levels between the two different
levosimendan treatment modalities. The incidence of postoperative
atrial fibrillation is low when levosimendan is used perioperatively.
There is a significant reduction in the ICU length of stay, but not in
the hospital length of stay.
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Introduction Levosimendan, a novel calcium sensitizer, has been
shown to improve hemodynamic function in patients with acute
heart failure [1]. The aim of the study was to assess the hemo-
dynamic effects of levosimendan as a rescue medication in
addition to conventional therapy in patients with low cardiac output
(LCO) after cardiac surgery or myocardial infarction.
Methods Forty-one patients with LCO admitted to the cardiac ICU
between June 2004 and November 2008 were included in this
observational hemodynamic study. Thirty-four patients were
admitted after open heart surgery and seven patients for ischemic
acute heart failure. Levosimendan (0.1 μg/kg/min x 24 hours,
without bolus) was added to conventional inotropes and/or intra-
aortic balloon pump (IABP) support. The measured parameters
were: cardiac output/index, pulmonary artery occlusion pressure
(PaoP), left ventricular ejection fraction (LVEF), and mixed venous
oxygen saturation (SvO2). Baseline data were collected before
levosimendan administration and the following datasets were
obtained at 6, 24 and 48 hours. Length of stay (LOS) in the
cardiac ICU and inhospital mortality were also registered. Data
were expressed as the mean ± SD. Fisher’s exact test and a
nonpaired  t  test were used when appropriate. P <0.05 was
considered significant.
Results All patients were on dobutamine and epinephrine. IABP
support was used in 28 (68%) of cases. The addition of levo-
simendan significantly improved cardiac index (from 2.27 ± 0.9
l/min/m2 to 3.05 ± 0.9 l/min/m2 at 6 hours (P <0.01); 2.93 ± 0.8
l/min/m2 at 24 hours (P  <0.02) and 2.93 ± 1.0 l/min/m2 at
48 hours (P <0.05)). LVEF increased with 19.8% (from 30 ± 8%
to 37 ± 9% at 48 hours (P <0.05)). SvO2 improved significantly
from 57 ± 13% to 69 ± 8% at 48 hours (P  <0.01). PaoP
decreased significantly only in the first 6 hours from 19 ± 5 mmHg
to 15 ± 4 mmHg (P <0.05). The mean LOS in the cardiac ICU was
14 ± 13 days. Inhospital mortality was 24.4%.
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Conclusions In our case series, addition of levosimendan following
ineffective conventional therapy resulted in substantial hemo-
dynamic improvement. These preliminary results support the use of
levosimendan in patients with LCO as a rescue medication with
favorable short-term effects.
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Introduction  Microvascular resuscitation is a crucial therapeutic
goal in sepsis. The current study was performed to test the
hypothesis that a combination of levosimendan and inhaled nitric
oxide (INO) may improve microvascular perfusion in septic shock.
Methods  After initial hemodynamic stabilization (mean arterial
pressure between 65 and 75 mmHg; mixed venous oxygen
saturation  ≥65%), seven patients with catecholamine-dependent
septic shock received intravenous levosimendan 0.2 μg/kg/minute
for 24 hours. At the end of the first 24 hours of the study period,
inhaled nitric oxide (35 ppm) was added for another 12 hours.
Sublingual microvascular perfusion was analyzed using the side-
stream dark field method. The total vessel density (mm/mm2),
perfused vessel density (mm/mm2), De Backer score (1/mm),
microcirculatory flow index of small vessels (MFIs) and micro-
circulatory flow index of medium vessels (MFIm) were obtained at
baseline and after 24 and 36 hours.
Results  Levosimendan significantly (P <0.05 vs. baseline)
increased perfused vessel density from 11.3 mm/mm2 (10.7; 12.6)
to 14.8 mm/mm2 (13.7; 16.1) and MFIs from 2 (1.9; 2.2) to 3 (2.8;
3). Addition of INO further increased MFIm from 2.6 (2.5; 2.8) to 3
(3; 3). Data are presented as median (25%; 75% range). No
statistically significant differences were found in any of the other
investigated parameters.
Conclusions  The combination of Levosimendan and INO may
improve microvascular perfusion in septic shock.
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Introduction  Nonhemodynamic mechanisms of cell injury might
play a role in the loss of glomerular filtration rate during sepsis [1].
We hypothesized that levosimendan may positively affect renal
function by a combination of systemic and regional hemodynamic,
anti-inflammatory and anti-apoptotic effects. We therefore
performed a case–control study to investigate the effects of levo-
simendan on creatinine clearance in patients with septic shock.
Methods Ninety-nine septic shock patients received levosimendan
(0.2 μg/kg/min for 24 hours) within the first 36 hours following
onset of septic shock. For each study patient, a control subject
from a group of patients with septic shock of an institutional
database was matched for Simplified Acute Physiology Score II,
baseline creatinine concentration, delay from shock onset, age,
and gender. Serum creatinine concentrations were analyzed just
before the start of the 24-hour period of levosimendan infusion
(baseline) and 96 hours after levosimendan had been initiated. The
glomerular filtration rate was estimated by applying the
Cockcroft–Gault formula.
Results  Compared with the control cohort, levosimendan
significantly increased the glomerular filtration rate after 96 hours
(62 ± 46 vs. 50 ± 33 ml/min, P < 0.05). In addition, the maximum
serum creatinine concentration was lower in the levosimendan
group (2.2 ± 1.3 vs. 2.6 ± 2 mg/dl, P <0.05 vs. control) during the
96-hour study period.
Conclusions  The present data suggest that levosimendan may
improve renal function in patients with septic shock.
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Introduction Levosimendan is a calcium sensitizer that increases
cardiac contractility without increasing intracellular calcium levels.
Its efficacy has been demonstrated in acute decompensated heart
failure but has not been evaluated in severe sepsis/septic shock.
We hypothesized that levosimendan increases the cardiac index
similar to dobutamine in patients with severe sepsis/septic shock.
Methods In a randomized, open-label trial, 42 patients admitted to
the ICU with severe sepsis/septic shock were randomized to
receive either levosimendan (group L) or dobutamine (group D) as
part of an early-goal directed therapy protocol [1]. Study drugs
were titrated incrementally to an ScvO2 ≥70% or to a maximum
dose, whichever was achieved first, and were continued for a total
of 24 hours only. Group L received levosimendan 0.05 μg/kg/
minute intravenously that was increased by 0.05 μg/kg/minute
every 30 minutes (maximum 0.2 μg/kg/min). Group D received
dobutamine 5 μg/kg/minute intravenously which was increased by
5 μg/kg/minute every 30 minutes (maximum 20 μg/kg/min). Rescue
therapy consisted of dobutamine 10 μg/kg/minute intravenously
titrated to ScvO2 ≥70% or a maximum of 20 μg/kg/minute, which-
ever was achieved first. Hypotension (mean arterial pressure
(MAP) <65 mmHg) was treated with norepinephrine infusion,
titrated to a MAP ≥65 mmHg. ScvO2 was recorded hourly. Cardiac
output was measured continuously using the FloTrac™ device
(Edwards Lifesciences, Irvine, CA, USA). Continuous data were
analyzed using repeated-measures ANOVA, and proportions were
compared using Fisher’s exact test. Results are presented as the
mean ± SD unless otherwise indicated. Significance was defined
as P <0.05.
Results APACHE II scores were 21 ± 7 versus 27 ± 7 (P = 0.02),
and the ICU mortality was 10 (48%) versus 13 (62%) (P = 0.35)
for groups L and D, respectively. The cardiac index was lower in
group L compared with group D (estimated marginal mean ± SEM:
2.8 ± 0.1 vs. 3.2 ± 0.1, respectively, P <0.01) but the ScvO2
changes over time did not differ between groups (P  >0.5).
Norepinephrine was administered to 17 (81%) patients in group L
and 21 (100%) in group D (P = 0.04).
Available online http://ccforum.com/supplements/13/S1S70
Conclusions Dobutamine increased the cardiac index more than
did levosimendan, although there was no difference between the
two drugs with regard to their effects on ScvO2.
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Introduction  The calcium sensitizer levosimendan enhances
myocardial contractility, which could be advantageous in patients
with myocardial ischemia requiring inotropic support.
Methods  During 3 years 3,852 patients with high-risk acute
coronary syndrome (ACS) underwent percutaneous coronary
intervention in our department. In 106 cases ACS was compli-
cated with cardiogenic shock (mean age: 68.6 ± 1.2 years); more-
over, in 26 cases patients had to be resuscitated (cardiopulmonary
resuscitation (CPR)). Short-term and long-term effects of
levosimendan on cardiac functions and on survival of cardiogenic
shock and post-CPR patients were analyzed. Levosimendan was
administrated in 39 of 106 cases as add-on therapy for patients
with impaired left ventricular function, by extensive wall motion
abnormality and by high blood cardiac enzyme concentration.
Levosimendan therapy was started in most cases on the second or
third day and applied for 6 hours as a continuous infusion (0.1
μg/kg/min). The mean time spent in the primary cardiac care center
(inhospital time) was 6.0 ± 0.4 days, and the whole follow-up was
204.6 ± 29.9 days long.
Results In the post-CPR patient group there was no significant
difference in survival according to levosimendan treatment during
short-term follow-up (36.5% vs. 40.0%, P = 0.790) and during
long-term follow-up (15.6% vs. 15.0%, P = 0.754). On the other
hand, for nonresuscitated patients the survival rates were signifi-
cantly higher in the levosimendan-treated patient group during
short-term follow-up (84.4% vs. 57.9%, P <0.001) and during
long-term follow-up (47.3% vs. 23.0%, P <0.001). The time inter-
val between the onset of myocardial infarction and percutaneous
coronary intervention did not influence the effect of levosimendan
on short-term and long-term mortality.
Conclusions  In summary, levosimendan may improve cardiac
function and decrease short-term and even long-term mortality in
cardiogenic shock patients independently of the time interval of
myocardial infarction. This positive effect of levosimendan may be
abolished by post-CPR patients.
P173
Study of hemodynamics in patients treated with landiolol
in the ICU
T Imabayashi, H Murayama, C Kuroki, N Kiyonaga, T Oryouji, 
S Tashiro, T Yasuda, Y Kakihana, A Matunaga, Y Kanmura
Kagoshima University Hospital, Kagoshima, Japan
Critical Care 2009, 13(Suppl 1):P173 (doi: 10.1186/cc7337)
Introduction  We experienced patients whose cardiac functions
were maintained or deteriorated during the treatment of a short-
acting β-blocker, landiolol. We therefore investigated the effects of
landiolol on the cardiac function in patients.
Methods From January through December 2007, 21 patients were
selected if they had tachycardia (heart rate (HR) >100 beats/min)
and they were treated with continuous infusion of landiolol.
Hemodynamics were recorded using pulmonary artery catheters at
four time points (before administration of landiolol, 1 hour after
beginning of administration, immediately before discontinuation of
administration, and 1 hour after discontinuation of administration).
Infusion of landiolol was discontinued if the HR fell below
90 beats/min or the cardiac index (CI) fell below 2.0 l/min/m2. The
paired Student t test was used to compare the differences.
P <0.05 was statistically significant.
Results Between the point before administration of landiolol (2.4 ±
1.8 (mean ± SD) μg/kg/min) and 1 hour after beginning of adminis-
tration, although the HR was decreased from 137 ± 20 beats/min
to 109 ± 20 beats/min (P <0.01), the stroke index (SI) was
increased from 20.4 ± 8.1 ml/beats/m2 to 22.5 ± 7.0 ml/beats/m2,
and thus the CI was maintained (2.76 ± 1.05 l/min/m2 and 2.43 ±
0.78 l/min/m2). Between the point before discontinuation of
administration (1.4 ± 1.1 μg/kg/min) and 1 hour after discontinua-
tion of administration, the HR was not increased significantly (93 ±
18 beats/min and 100 ± 16 beats/min), however the SI was
increased 21.5 ± 6.7 ml/beats/m2 to 25.7 ± 5.4 ml/beats/m2
(P <0.05), and therefore the CI was increased 1.93 ± 0.54
l/min/m2 to 2.50 ± 0.40 l/min/m2 (P <0.01). Infusion of landiolol
was discontinued because the HR fell below 90 beats/min in 12
patients and the CI fell below 2.0 l/min/m2 in nine cases. There
were no significant differences in the catecholamine index,
pulmonary artery pressure, and central venous pressure.
Conclusions We investigated hemodynamics in 21 patients who
used landiolol and recognized the effects of rate control and
depression of the SI and the CI; thus when we use landiolol, we
have to pay attention to the HR and cardiac function [1].
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Introduction  Pulmonary hypertension (PAH) is a life-threatening
disease commonly seen in ICU septic patients. PAH is characterized
by alterations in the pulmonary circulation leading to right ventricular
failure and is associated with poor outcome in such patients. Various
agents such as nitric oxide, prostaglandins and phosphodiesterase
inhibitors have been used for its treatment. Drugs that induce
pulmonary vasodilatation, increase contractility and maintain a stable
haemodynamic profile seem an attractive treatment option in acute
PAH patients. However, there is lack of evidence-based guidelines in
the current medical literature. Although oral diltiazem has been
shown to improve haemodynamics in chronic PAH patients, it has
not been used for the treatment of acute PAH. The aim of the
present study was to evaluate the effects of intravenous diltiazem on
a porcine model of acute PAH during sepsis.
Methods  PAH was induced in 16 anaesthetized, mechanically
ventilated pigs (25 kg) by intravenous infusion of 0.5 mg/kg LPS
(Escherichia coli, 111: B4) in a period of 30 minutes. After LPS
administration, animals were randomly divided into two groups.
Group A received intravenous diltiazem 280 to 400 μg/kg, and
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Group B an equal dose of placebo (normal saline) and served as
the control. Haemodynamic measurements, including parameters
of systemic and pulmonary circulation, were performed before and
after LPS administration and every 20 minutes for 2 hours.
Results  After LPS infusion, both systolic pulmonary pressure
(PAPs) and diastolic pulmonary pressure (PAPd) exhibited a
statistically significant increase (PAPs from 18 ± 1 to 48 ± 7 mmHg,
P <0.01 and PAPd, from 7.7 ± 0.7 to 27 ± 4 mmHg, P <0.01) and
remained elevated over time. Diltiazem administration reduced
significantly both PAPs and PAPd in relation to placebo
(P <0.001), but not to baseline levels. The heart rate, cardiac
output and systemic haemodynamics exhibited no difference
between groups throughout the time period.
Conclusions  Intravenous diltiazem was associated with a
reduction of pulmonary pressure without any systemic hypotension
in a porcine model of endotoxin-induced acute PAH. This may
represent a significant advance in the treatment of acute PAH.
Potential clinical implications merit further study.
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Introduction Amiodarone is the antiarrhythmic drug of choice in
treatment of patients suffering from acute tachyarrhythmias and
haemodynamic instability due to impaired cardiac function. The
intravenous form of amiodarone hydrochloride (IvAm) has individual
antiarrhythmic, rate-controlling efficacy, and the dosage is
empirical. The main adverse effects are hypotension, severe
bradycardia, asystole, acute heart failure, and impaired liver
function. Acute liver failure (ALF) is a known but rare complication
of IvAm that may be reversible by eliminating the infusion in most
cases. The few papers in the literature suppose ALF may be
caused by polysorbate 80, the vehicle of IvAm. Oral administration
does not to have such an adverse effect, therefore IvAm can be
changed to oral form in any cases.
Methods Our aim was to investigate retrospectively the incidence
of ALF and relation of IvAm and ALF in cardiac patients. The
history, treatment sheets and laboratory parameters of 11,722
patients treated in the Heart Center between 2005 and 2007 were
analyzed. Patients were considered severe ALF patients if
transaminase levels exceeded 80 x upper limit of normal (ULN)
during their stay in our clinic. The cutoff point was determined to
differentiate ALF patients from heart failure and myocardial infarct
patients with elevated transaminase levels.
Results According to the enzyme levels, 55 patients suffered from
severe ALF during the 3 years; 26 of them had IvAm treatment. On
the basis of treatment sheets, start and elimination of IvAm treatment,
status of acute myocardial infarct and heart failure and transaminase
kinetics, eight patients had ALF induced by IvAm. Indication for
amiodarone was atrial fibrillation (n = 6) and ventricular tachycardia.
Average multipliers of ULN were 379 ± 190 at aspartate
aminotransferase, 191 ± 87 at alanine aminotransferase, 57 ± 22 at
lactate dehydrogenase. The time from start of IvAm to detection of
ALF was 17 ± 4.6 hours. One-quarter of these patients died in ALF.
Liver enzymes decreased to 10 x ULN during 2.5 ± 0.6 days.
Conclusions ALF is a rare but potentially life-threatening adverse
effect of IvAm. Authors suggest monitoring liver enzymes from the
start of IvAm treatment. Rapid elevation in liver enzyme levels indi-
cates a hepatotoxic effect of IvAm. In these cases the immediate
cessation of IvAm administration and start of intensive care is life-
saving.
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Introduction Incidence of arrhythmia after lobectomies is between
10% and 20% and approaches 40% after pneumonectomy.
Postoperative arrhythmia is associated with higher morbidity and
mortality [1]. The objective of this study was to compare the effect
of oral β-blocker (celiprolol) and intravenous magnesium (Mg) on
the frequency of supraventricular arrhythmia (SVA) after pulmonary
resection.
Methods  Twenty-six patients undergoing pneumonectomy or
bilobectomy were randomised to receive either celiprolol (group 1,
n= 13) or intravenous Mg (group 2, n= 13). Patients were excluded
if they had a history of congestive heart failure, second-degree or
greater heart block, a history of SVA, or were receiving oral β-blocker,
diltiazem, or verapamil. Patients of group 1 received oral celiprolol
(100 mg every 8 hours) starting before operation and continued for
10 days postoperatively. Group 2 received intravenously 2 g Mg at
the time of the thoracotomy, at 6 hours then every day for 3 days. All
patients were followed clinically with at least four daily ECGs for up to
10 days. Statistical analyses were performed using the statistical
package SPSS version 11.0. P<0.05 was considered significant.
Results The mean age of the 26 patients was 53 ± 14 years. SVA
developed in 42.3% of the patients and atrial fibrillation (AF) in
19.2%. The mean cardiac frequency was 82 ± 10 pulses/minute in
group 1 versus 92 ± 10 pulses/minute in group 2. The incidence
of SVA was significantly higher in group 2 (30.4% vs. 11.4%,
P = 0.047). However, the incidence of AF was similar in the two
groups (group 1: 3.8% vs. group 2: 15.2%, P = 0.135). The peak
for the occurrence of SVA was on postoperative day 2. Right
pneumonectomy and intrapericardial resection were not associated
with increased development of postoperative SVA. No serious
adverse effects caused by celiprolol or magnesium were seen.
Conclusions Terzi and colleagues [2] demonstrated a significant
reduction in the incidence of AF using Mg. In our study Mg has no
role in the prophylaxis of SVA in lung surgery. Perioperative
celiprolol can reduce the frequency of SVA without serious side
effects. In fact, increased sympathetic activity is one of the
predominant factors in the cause of this complication.
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Introduction In kidney transplantation, low-dose dopamine (LDD)
(0.5 to 2.5 μg/kg/min) is used to increase urine output and to
Available online http://ccforum.com/supplements/13/S1S72
prevent arterial vasospasm and acute tubular necrosis, but there is
some controversy about its use [1-4]. The aim of the study was to
evaluate the effectiveness of LDD in the early post-transplant
period.
Methods Fifty kidney transplant recipients admitted to the ICU in
the early post-transplant period were allocated to two groups: A
(n = 20) treated and B (n = 30) not treated with LDD. All patients
underwent postoperative intensive monitoring, control of blood
sample and kidney functioning at 0, 6 and 12 hours in the ICU.
Postoperative therapy was the same for all patients, except for
LDD. The intravascular volume was kept effective by maintaining
central venous pressure >5 mmHg and ScVO2 >70%. We
collected donors’ and transplant kidney parameters (age, sex,
death cause, ischaemia time), recipients’ parameters (age, sex,
weight, height, BMI, duration of dialysis, end stage renal disease,
Simplified Acute Physiology Score II), intraoperative parameters
(metabolic, respiratory and hemodynamic), hemodynamic and
kidney functioning parameters in the ICU (heart rate, mean arterial
pressure, central venous pressure, ScVO2, lactate, diuresis, blood
urea nitrogen, creatinine, fluid balance), and outcome parameters
(ICU length of stay, postoperative complications, acute rejection at
28 days, mortality at 6 months).
Results There were no significant difference in donors’ and graft
data, recipients’ data, intraoperative data, hemodynamic and kidney
functioning data and outcomes in both groups. The significant
differences between the two groups of patients were: Simplified
Acute Physiology Score II was higher in group B (A: 24.4 ± 12.9;
B: 31.2 ± 9.4; P <0.05); heart rate was higher in group A at each
observation time (at 6 hours A: 94.2 ± 17.03; B: 85.6 ± 12.2; at
12 hours A: 92.7 ± 15.5; B: 82.6 ± 15.2; P <0.05); ICU length of
stay was shorter in group B (A: 28.9 ± 17.3; B: 20 ± 7.2; P <0.05).
Conclusions  LDD in kidney transplantation does not improve
kidney function during the postoperative period, nor short-term and
medium-term outcome, but it increases the heart rate and ICU
length of stay.
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Introduction  Impaired tissue perfusion is often observed in
patients with acute heart failure. We tested whether low-dose
nitroglycerin (NTG) improves microcirculatory blood flow in
patients admitted for acute heart failure.
Methods  In 20 acute heart failure patients, NTG was given as
intravenous infusion at a fixed dose of 33 μg/minute. Using
sidestream dark field imaging, sublingual microvascular perfusion
was evaluated before (T0, average of two baseline measurements)
and 15 minutes after initiation of NTG (T1). In a subgroup of seven
patients, NTG was stopped for 20 minutes, whereupon sidestream
dark field measurements were repeated. Capillaries were defined
as the microvessels with a diameter of <20 mm. The perfused
capillary density (PCD) was determined as the parameter of tissue
perfusion. Values are expressed as the median and interquartile
range (P25; P75).
Results The median age of the subjects was 60 (52; 73) years
and 65% were male. Patients were in a stable condition before
starting NTG. NTG decreased the central venous pressure (17
(13; 19) mmHg at T0 vs. 16 (13; 17) mmHg at T1, P = 0.03) and
pulmonary capillary wedge pressure (23 (18; 31) mmHg at T0 vs.
19 (16; 25) mmHg at T1, P = 0.03). NTG increased PCD (10.7
(9.9; 12.5) mm/mm2 at T0 vs. 12.4 (11.4; 13.6) mm/mm2 at T1,
P = 0.01). After cessation of NTG, PCD returned to baseline
values (P = 0.04).
Conclusions Low-dose NTG significantly reduces cardiac filling
pressures and improves microvascular perfusion in patients
admitted for acute heart failure.
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Introduction Esophagectomy with gastric tube reconstruction is
the surgical treatment for cancer of the esophagus. The perfusion
of the distal part of the gastric tube depends exclusively on the
microcirculation, making it susceptible to hypoperfusion and
ischemia. It is unknown whether an increased perfusion pressure
can exert a beneficial effect on gastric tissue perfusion.
Methods  For this purpose we performed a gastric tube recon-
struction in 12 pigs, mean bodyweight 32 ± 1 kg (mean ± SE).
Besides systemic hemodynamic parameters, the gastric micro-
vascular blood flow (MBF) was assessed on pylorus, corpus and
fundus with laser Doppler flowmetry and gastric microvascular HbO2
saturation (mHbSO2) and hemoglobin concentration (mHbcon) with
spectrophotometry. Animals were evenly randomized over two
groups: in both groups the mean arterial pressure was increased
from 50 to 110 mmHg with infusion of noradrenaline; however, in the
nitroglycerin (NTG) group the central venous pressure was
maintained below 10 mmHg throughout the entire experiment with
intravenous NTG. In this way, we aimed to increase the perfusion
pressure gradient over the gastric tube tissue.
Results Central venous and pulmonary capillary wedge pressures
were lower in the NTG group. Although the systemic circulation
tended to be more dynamic in the NTG group at baseline, all
systemic hemodynamic parameters were similar in both groups
throughout the experiment. Baseline MBF was all-over higher in the
NTG group. Following surgery, in both groups the MBF decreased
severely especially in the upper gastric tube. At higher mean
arterial pressure (MAP), MBFs tended to be higher than at the
lowest MAP levels. Overall, MBFs were higher in the NTG group.
mHbcon levels increased significantly with the initial decreases in
flow and remained lower in the NTG group. mHbSO2 values were
no different between groups and did not change accordingly at
different MAP levels.
Conclusions  In our experimental model, tissue perfusion is
severely compromised following formation of the gastric tube; this
effect is aggravated by systemic hypotension independent from
cardiac output. Venous congestion might contribute to this effect
and can be prevented with continuous intravenous administration
of NTG. Clinical studies will have to demonstrate an effect on
anastomotic healing and outcome.
Critical Care    March 2009 Vol 13 Suppl 1 29th International Symposium on Intensive Care and Emergency MedicineS73
P180
Norepinephrine: more than blood pressure cosmetics?
L Hiltebrand, S Brandt, O Kimberger, E Koepfli
University Hospital Bern, Switzerland
Critical Care 2009, 13(Suppl 1):P180 (doi: 10.1186/cc7344)
Introduction  Norepinephrine (NE) is used to increase blood
pressure (mean arterial pressure (MAP)) if hypotension arises.
Increasing the perfusion pressure may increase blood flow in
regions at risk. But vasoconstriction might worsen microcirculatory
flow. We investigated the effects of NE on systemic, splanchnic
and microcirculatory (microvascular blood flow (MBF)) blood flow
in hypotensive pigs after major surgery.
Methods  Twenty-seven pigs (30 ± 3 kg) were anesthetized,
ventilated and underwent laparotomy. They were randomized to
one of the following treatments: Group Low received 3 ml/kg/hour
Ringer’s lactate (RL) throughout the study. Group H received
hydroxyethyl starch (130/0.4) to maintain SvO2 ≥60%. Group NE
received 3 ml/kg/hour RL and NE to increase blood pressure to 65
and to 75 mmHg to match the MAP of Group H. Systemic,
splanchnic, MBF blood flow and intestinal tissue oxygen tension
were measured.
Results Baseline MAP was similar in all groups. To increase MAP
to 65 and 75 mmHg, 0.035 and 0.12 μg/kg/minute NE were
needed, respectively. The effects of NE on blood pressure, sys-
temic, regional and MBF blood flow are shown in Figures 1 and 2.
Conclusions NE increased MAP efficiently but had no beneficial
effects on regional or MBF in the splanchnic region. This suggests
that administration of vasopressors such as NE could be an unsafe
way to maintain MAP because it may leave intestinal hypoperfusion
undetected.
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Introduction Vasopressin has been suggested as a useful vaso-
active agent in the support of vasodilatory shock in adults;
however, its effect in children is unclear. We hypothesized that
low-dose vasopressin in this population, administered as an
adjunctive vasoactive agent, would lead to more rapid reversal of
vasodilatory shock when compared with placebo.
Methods In this multicenter, double-blind trial, children with clinical
evidence of vasodilatory shock were randomized to receive either
low-dose vasopressin (0.0005 to 0.002 U/kg/min) or placebo in
addition to open-label vasoactive agents. Vasoactive infusions
were titrated according to established guidelines to maintain target
mean arterial pressure and adequate perfusion. The primary
outcome was the time to vasoactive-free hemodynamic stability.
Secondary outcomes included mortality, organ-failure free days,
length of stay, and adverse and serious adverse events.
Results Sixty-five out of 69 children (94%) who were randomized
received the study drug (33 vasopressin, 32 placebo) and were
included in the analysis. There was no significant difference
between the vasopressin and placebo groups in the time to vaso-
active-free hemodynamic stability (49.7 vs. 47.1 hours, respec-
tively, P = 0.85). There were 10 deaths (30%) in the vasopressin
group and five deaths (15.6%) in the placebo group (relative risk =
1.94; 95% CI = 0.75 to 5.05, P = 0.24). There were no significant
differences between the two groups with respect to organ-failure
free days (22 vs. 25.5 days, P = 0.11), ventilator-free days (16.5
vs. 23 days, P = 0.15), length of pediatric critical care unit stay (8
vs. 8.5 days, P = 0.93), or the adverse and serious adverse event
rate ratios (12.0%, 95% CI = –2.6 to 26.7, P = 0.15; and 3.2%,
95% CI = –13.7 to 7.8, P = 0.55, respectively).
Conclusions  In this multicenter, randomized, placebo-controlled
trial in pediatric patients with vasodilatory shock, low-dose
vasopressin did not demonstrate any beneficial effects but a
concerning trend in mortality.
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Introduction  The V1a/V2 receptor dual-agonist arginine
vasopressin (AVP) is increasingly used in catecholamine-resistant
septic shock [1]. While V1a receptor stimulation results in
Available online http://ccforum.com/supplements/13/S1
Figure 1 (abstract P180)
Target MAP 65 mmHg (mean ± SD).
Figure 2 (abstract P180)
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vasoconstriction, V2 receptor stimulation promotes coagulation, at
least in part through an increase in plasma von Willebrand factor
antigen (vWF:Ag) activity. We hypothesized that, at an intravenous
infusion rate representative of the requirements for the treatment of
sepsis-induced vasodilatory hypotension in sheep [2], AVP
provides procoagulant activities. We tested this hypothesis by
measuring vWF:Ag activity in unanesthetized healthy sheep during
administration of AVP in comparison with the vWF:Ag activity
increase induced by the selective V2 receptor agonist desmo-
pressin (dDAVP).
Methods After two to four measurements of vWF:Ag activity and
hemoglobin (Hb) over a 1-hour baseline (BL) period, 13 female
sheep were randomly administered one of two treatments: an intra-
venous bolus of dDAVP (1 nmol/kg; n = 7) or a 2-hour intravenous
infusion of AVP (3 pmol/kg/min; n = 6). vWF:Ag activity and Hb
were measured every 30 minutes over 2 hours from the time of
dDAVP administration or the initiation of AVP administration. For
each sheep, vWF:Ag activity was corrected for plasma volume by
calculating the vWF:Ag activity/Hb ratio and was expressed as
percentage of the mean BL value. Data are expressed as the mean
± SEM.
Results Following dDAVP bolus injection and during AVP infusion,
the vWF:Ag activity/Hb ratio increased to a maximum of 135 ± 4%
(n = 7) and 135 ± 6% (n = 4) of mean BL value, respectively
(P < 0.001 and P = 0.002 vs. BL, respectively). The vWF:Ag
activity/Hb ratio did not increase beyond the maximal fluctuation
range of BL measurements in two out of the six sheep treated with
AVP (maximum increases of 96% and 101%).
Conclusions At an intravenous infusion rate representative of the
requirements for the treatment of sepsis-induced vasodilatory
hypotension in sheep [2], the V1a/V2 receptor dual-agonist AVP
increased vWF:Ag activity to the same extent as the selective V2
receptor agonist dDAVP. Because of its V2 receptor agonist
activity, the use of AVP may potentially amplify the microcirculation
impairment caused by sepsis-induced coagulopathy.
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Introduction The present study was designed as a prospective,
randomized, laboratory experiment to compare the effects of a
selective V1-agonist (Phe2-Orn8-vasotocin), a selective V2-
antagonist ((propionyl1-D-Tyr(Et)2-Val4-Abu6-Arg8,9)-vasopressin)
and arginine vasopressin (AVP), when given as first-line therapy, on
hemodynamics, metabolic changes, mesenteric blood flow (Qma)
and mortality using a clinically relevant model of septic shock [1].
Methods  Fecal peritonitis was induced in 21 anesthetized,
invasively monitored, mechanically ventilated sheep. A combination
of crystalloids and 6% hydroxyethyl starch was titrated to maintain
constant hematocrit. Following the shock time (ST), defined as
mean arterial pressure (MAP) <60 mmHg, sheep were randomly
assigned to receive either a continuous infusion of 1 μg/kg/hour
V2-antagonist, 0.05 μg/kg/minute V1-agonist or 0.5 mU/kg/minute
AVP (n = 7 each). Norepinephrine was titrated up to a maximum of
1 μg/kg/minute to maintain MAP at 70 ± 5 mmHg in all groups.
Data are expressed as the mean ± SEM.
Results No significant differences between groups were detected
at baseline and ST. The cardiac index and urine flow were similar
between groups. The V1-agonist led to a higher Qma than in both
other groups from 5 to 8 hours after ST (P  <0.05 each).
Compared with AVP, selective V1-agonism stabilized MAP more
effectively and allowed a reduction in cumulative norepinephrine
requirements from 4 to 8 hours. The V1-agonist and the V2-
antagonist did not differ in these variables. V2-antagonism
attenuated the decrease in base excess compared with both other
groups and was associated with increased fluid requirements
compared with V1-agonism (18 ± 1 vs. 14 ± 1 ml/kg/hour). Com-
pared with AVP, the V1-agonist and the V2-antagonist reduced
arterial lactate levels (3.5 ± 0.5 and 4.1 ± 0.3 mmol/l vs. 5.5 ± 0.2
mmol/l, P <0.02 each) and prolonged survival (13 ± 1 hour and
14 ± 1 hour vs. 10 ± 1 hour; P <0.01 each).
Conclusions  Whereas V2-antagonism reduced metabolic
acidosis, V1-agonism stabilized hemodynamics more effectively
compared with AVP. Because of the prolonged survival time,
selective V1-agonism and V2-antagonism might be superior to
AVP infusion in septic shock. Future studies are warranted to
investigate the combination of these two therapeutic strategies.
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Introduction Drug administration is an integral part of advanced
life support (ALS). The coronary perfusion pressure (CorPP) during
cardiopulmonary resuscitation (CPR) predicts the probability of
return of spontaneous circulation, while the cerebral perfusion
pressure (CPP) affects brain damage. Guidelines for cardiac arrest
treatment recommend giving adrenaline (ADR) although there is no
evidence showing long-term benefit from any medication. Vaso-
pressin was probably the most effective alternative studied in both
experimental and clinical trails. As vasopressin has never been
available in Europe, we evaluated the effect of its synthetic
analogue, terlipressin (TER), on vital organ perfusion in an animal
model of ventricular fibrillation (VF) (Terlipressin in Cardiac Arrest
(TERCA) study). The use of TER in VF has never been studied
before.
Methods A prospective, experimental study in 14 domestic pigs
(30 to 35 kg) randomly assigned into two groups: A (ADR + TER;
n = 7) and B (ADR + NaCl; n = 7). CorPP and CPP were
calculated from right atrial, aortic and intracerebral pressures. VF
was induced using an intracardiac pacing electrode. After
5 minutes of untreated arrest, chest compressions were started
using the AutoPulse system (Zoll Circulation, Sunnyvale, CA, USA)
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simulating hands-only CPR. At a time of 15 minutes after onset of
VF, ALS was started for the next 45 minutes. ADR 30 μg/kg and
TER 30 μg/kg were administered intravenously 19 minutes after
induction of VF in group A, while ADR and NaCl were given in
group B. Equal doses of ADR were then repeated every 3 minutes
in both groups. The design of the study reflected the real-life time
intervals achieved in clinical trials. The primary endpoint was to
compare CorPP and CPP between groups A and B. Data were
analysed using SigmaStat. P <0.05 was considered statistically
significant.
Results CorPP (mean ± SD) measured 35, 40 and 45 minutes
after the onset of VF was 12 ± 4, 13 ± 4 and 11 ± 6 mmHg in
group A (with adjunct TER), and 6 ± 4, 2 ± 7 and 1 ± 5 mmHg in
control group B (P <0.05, P <0.01 and P <0.01). CPP at the
same times was 23 ± 7, 24 ± 8 and 20 ± 7 mmHg in group A, and
13 ± 7, 8 ± 6 and 6 ± 5 mmHg in control group B (P <0.05,
P <0.01 and P <0.01).
Conclusions Our results suggest a significant increase of CorPP
and CPP after early adjunct treatment of VF with TER added to
standard doses of ADR during prolonged CPR in pigs.
Acknowledgement  Supported by research project MZO
00179906.
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Introduction  Vasopressin is commonly used as an adjunct to
catecholamines to support blood pressure in refractory septic
shock. Its effect on vasoplegic shock after cardiac surgery is
unknown. We hypothesized that low-dose vasopressin as
compared with norepinephrine would decrease the length of stay
in the ICU in patients submitted to cardiac surgery with a pump.
Methods We assigned patients who presented vasoplegic shock
after cardiac surgery in the first 24 hours after arrival in the ICU.
During 6 months, out of 458 patients undergoing cardiac surgery,
82 developed vasoplegia shock and participated in the study. We
randomly assigned patients to receive norepinephrine (initial doses
of 5 mg) or vasopressin (0.01 to 0.04 U/min). All vasopressor
infusions were titrated and tapered according to protocols to
maintain a target blood pressure. The primary endpoint was the
length of ICU stay. Secondary endpoints were mortality, timing of
needing vasopressors, incidence of organ dysfunction and adverse
effects.
Results A total of 82 patients were included in the analysis – 42
patients received norepinephrine and 40 patients received
vasopressin. There was a significant difference between the
norepinephrine and vasopressin groups in the length of ICU stay
(4.2 days vs. 7.3 days, P <0.005). Also, the vasopressin group of
patients presented a lower incidence of renal failure compared
with the norepinephrine group (4.5% vs. 8.9%, P <0.001). There
was no significant difference in the overall rates of adverse events,
rates of mortality and timing of vasopressor therapy.
Conclusions  Low-dose vasopressin reduced the length of ICU
stay and the incidence of renal failure in patients with vasoplegic
shock after cardiac surgery compared with norepinephrine. Also,
the vasopressin group did not present more adverse events.
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Introduction Although there are many studies on arterial catheter-
related infection (ACRI), there are scarce data on such infection
according to the catheter access site. Which particular arterial
catheter site is associated with a higher risk of infection remains
controversial. The guidelines of the Centers for Disease Control
and Prevention make no recommendation about which site or sites
minimize the risk of catheter-related infection. In previous studies,
we have found a higher incidence of ACRI in arterial femoral than
in radial access sites. In the present study, we increased the
number of arterial catheters in order to increase the probability of
finding significant differences in the incidence of ACRI between
other arterial accesses. The objective of this study was to analyze
the incidence of ACRI according to different access sites.
Methods We performed a prospective observational study of all
consecutive patients admitted to our 24-bed medical and surgical
ICU of a 650-bed university hospital during 6 years (1 May 2000 to
30 April 2006). ACRI included catheter-related local infection and
catheter-related bloodstream infection.
Results A total of 1,085 arterial femoral catheters were inserted
during 6,497 days, 2,088 radial during 12,007 days, 174 dorsalis
pedis catheters during 1,050 days and 141 brachial during
852 days. We detected 33 cases of ACRI (11 with bacteremia
and 22 with local infection) in femoral catheters, 12 cases of ACRI
(three with bacteremia and nine with local infection) in radial
catheters, zero in dorsalis pedis catheters, and zero in brachial
catheters. The ACRI incidence per 1,000 arterial catheter days
was significantly higher for femoral (5.08) than for radial (1.76)
access (OR = 5.1, 95% CI = 2.56 to 10.81; P ≤0.001), dorsalis
pedis (0) access (OR = 7.6; 95% CI = 1.37 to infinite; P = 0.01)
and brachial (0) access (OR = 6.2, 95% CI = 1.11 to infinite;
P = 0.03). We did not find significant differences in the ACRI
incidence per 1,000 arterial catheter days between radial and
dorsalis pedis (OR = 1.5; 95% CI = 0.24 to infinite; P = 0.73); and
between radial and brachial access (OR = 1.2; 95% CI = 0.20 to
infinite; P = 0.88).
Conclusions  Our results suggest that femoral arterial access
should be avoided in order to minimize the risk of arterial catheter-
related infection.
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Introduction Particulate contamination of infusion solution implies
a potential health risk for intensive care patients with a background
of debilitation and impaired host responses. Particles have been
shown to induce thrombogenesis, deterioration of microcirculation
and modulation of immunoresponse. We assessed the effect of
inline filtration on the reduction of major complications in critically ill
children (Clinical Trials.gov ID NCT 00209768).
Methods  In a randomised, prospective trial, paediatric patients
admitted to the interdisciplinary pediatric ICU of a tertiary university
Available online http://ccforum.com/supplements/13/S1S76
hospital were assigned to either a control or an interventional
group, the latter receiving inline filtration (infusion filter Pall
ELD96LLCE/ NOE96E, Braun Intrapur Lipid/Intrapur Neonat Lipid)
throughout infusion therapy. Prior to this study, the infusion
regimen was optimised to prevent precipitation and incompati-
bilities of solutions and drugs. Primary objectives were a reduction
in the incidence of sepsis, thrombosis, systemic inflammatory
response syndrome (SIRS) or organ failure (liver, lung, kidney,
circulation).
Results Interim analysis of 398 children (171 female, 227 male,
mean age 72 months) revealed a heterogeneous background of
underlying diagnoses and a Gaussian distribution to either the
control group (208 patients) or inline filtration group (190
patients). First analyses demonstrated a significant reduction in the
incidence of SIRS for the interventional group (95% CI = 68 to
112; P <0.035).
Conclusions The occurrence of sepsis, SIRS, thrombosis or organ
failure often complicates the course of disease in critically ill
patients. Inline filtration is most effective reducing the incidence of
SIRS. Additional analyses are expected to confirm the preliminary
results as well as to further identify the influence of inline filtration
on other complications.
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Introduction  We performed a retrospective analysis of central
venous catheter (CVC) infection over a 12-month period in a
tertiary referral teaching hospital general ICU to establish
incidence of infection and clinical factors associated with CVC
infection.
Methods We reviewed data from all patients admitted to the ICU
over a 12-month period. CVC tips from surviving patients were
cultured. Patient demographic data, diagnoses and therapeutic
interventions from our audit database were entered into a spread-
sheet. Blood pressure, pulse, temperature and ventilatory data
were collected from ICU charts. Haematological and biochemical
variables were accessed from the hospital results server. Other
potential risk factors entered included the use of steroids,
chemotherapy, diabetes, renal replacement therapy, tracheostomy
or arterial catheter. Data were anonymised, and nested logic arrays
were used for processing and error checking. Risk factor analysis
was performed by logistic regression against the presence of a
positive CVC culture.
Results Of 865 patients, 191 had no CVC. Data were inadequate
in a further 109 patients. In the remaining 565 patients, 836 CVCs
were inserted. The median patient age was 61 years (IQR 49 to
71 years) with 51.6% male. In total, 19.5% of CVCs were two-
lumen vascular access catheters for dialysis, and 80.5% were four-
lumen CVCs for monitoring and drug infusion. A total of 637
central lines were inserted via the internal jugular route, 106
femoral and 71 subclavian. The mean number of CVCs per person
was 1.47, median 1, range 1 to 15. One hundred and nineteen
catheters (14.2%) became infected. The median duration of CVC
was 4 days (IQR 2 to 8 days). Logistic regression correctly
predicted CVC infection on 85.9% of occasions, with a specificity
of 97.4%, but a relatively poor sensitivity of 18.6%. Independently
predictive factors included subclavian placement (OR = 0.35),
standard central line (v dialysis catheter, OR = 0.75); days of
catheterisation (1.31), peak temperature (1.42) and peak C-reactive
protein (1.002).
Conclusions In this study, subclavian placement was associated
with a threefold reduction in risk of infection. There was a 31% per
day increase in infection, and this was likely to be associated with
pyrexia and a raised C-reactive protein. Interestingly, disease
factors such as diabetes, chemotherapy and steroids were
unimportant. These data call into question the common practice of
preferentially placing CVCs in the internal jugular vein.
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Introduction  Previous studies have investigated the impact of
different types of bloodstream infection (BSI) (primary, secondary,
catheter-related) on the outcome of critically ill patients, including
only the first BSI episode in the analysis [1-3]. Our study aimed at
evaluating the impact of different BSI types on ICU mortality
including the total number of each type of BSI in the analysis.
Methods  All patients admitted in the ICU during a 46-month
period were prospectively followed. Data recorded included:
demographics, medical history, admission category (medical,
elective surgical, emergency surgical, trauma), APACHE II score at
admission to the ICU, BSI episodes, isolated pathogens,
continuous renal replacement therapy (CRRT) implementation,
blood product transfusions, ICU length of stay (LOS) and ICU
outcome. BSIs were defined as primary (PBSI), secondary,
catheter-related or mixed based on standard criteria. Data were
analyzed with logistic regression, and the statistical significance
level set at P <0.05.
Results Four hundred and twenty-six consecutive patients (295
males, 131 females) were included in the analysis. Age (mean ±
SD) was 52.5 ± 19.4 years, APACHE II score at admission to the
ICU 18.3 ± 6.6. The BSI incidence density was 26.3 episodes per
1,000 patient-days. ICU LOS was 21.6 ± 20.6 days. ICU mortality
rate was 17.8% (95% CI = 14.3 to 21.6). In univariable analysis,
the APACHE II score, age, admission category, CRRT implemen-
tation, PBSI episodes, and packed red blood cell (pRBC) units
transfused during the ICU LOS were significantly associated with
ICU mortality. In multivariable analysis, age (OR = 1.2, P = 0.003),
APACHE II score (OR = 1.1, P <0.001), infection at admission
(OR = 2.9, P  = 0.007), CRRT implementation (OR = 9.3, P
<0.001), PBSI episodes (OR per episode = 2.7, P = 0.002) and
pRBC transfusions (OR = 1.1, P  = 0.003) were independently
associated with ICU mortality. None of the other BSI types showed
association with ICU mortality.
Conclusions In our patient sample, PBSI episodes during the ICU
LOS were independently associated with ICU mortality, each PBSI
episode conferring a 2.7-fold probability of ICU death after
adjustment for potential confounders. The other BSI types (secon-
dary, catheter-related) showed no association with ICU mortality.
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Introduction The objective of our study was to determine the utility
of a multiple system intervention to reduce catheter-related blood-
stream infections (CR-BSI) in an ICU.
Methods We carried out a prospective cohort study in a medical
and surgical ICU. We determined the rate of CR-BSI per 1,000
catheter-days during the application of an evidence-based
intervention used to decrease the CR-BSI in 2007 (March to
December) compared with the rate during the same period in
2006 in which we just applied conventional measures of preven-
tion. During the intervention period we applied five measures:
giving educational sessions about how to insert and maintain
central catheters, cleaning the skin with chlorhexidine, filling in a
checklist during the insertion of the catheter, using the subclavian
vein as the preferred site and avoiding the femoral site if possible,
and removing unnecessary catheters. CR-BSI were defined as the
recovery of the same organism (same species, same antibiotic
susceptibility profile) from the catheter tip and blood cultures.
Results During the control and intervention periods we registered
4,289 versus 4,174 patient-days and 3,572 versus 3,296 catheter-
days, respectively. During the intervention period eight CR-BSI
were diagnosed compared with 24 CR-BSI in the control period.
The mean incidence rate of CR-BSI was 6.7/1,000 catheter-days
in the control period and 2.4/1,000 catheter-days in the inter-
vention period (RR = 0.3; 95% CI = 0.1 to 0.7; P  = 0.03). A
nursing intervention during the filling of the checklist was required
in 17.7% of the insertions. The ratio of use of the catheter was
81.5% during the control period and 80.6% in the intervention
period without significant differences between periods.
Conclusions The implementation of a multiple system intervention
with an evidence-based measure significantly reduces the CR-BSI
in our ICU.
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Introduction  Catheter-related bloodstream infection (CRBSI)
accounts for 10% to 20% of hospital-acquired infections in the UK
and is associated with both increased ICU stay and mortality.
Rates of CRBSI may be modified by clinical care during insertion
and utilisation of central venous catheters (CVCs) [1]. As such, the
incidence of CRBSI has been proposed as a quality indicator.
There is currently no consensus regarding the definition of CRBSI.
Methods  We applied two internationally recognised guidelines
[1,2] to evaluate the CRBSI prevalence in a prospective study of
CVC replacements over 3 months on an adult cardiothoracic ICU.
We utilised these criteria for confirmed CRBSI but considered
additionally CVC colonisation and possible CRBSI. CVC tips were
sent for semiquantitative culture, and contemporaneous blood was
drawn for qualitative culture from both the CVC and a peripheral
vein. Possible CRBSI was defined as positive CVC blood culture
and tip in the absence of a peripheral blood culture; colonised
CVC was defined as a positive tip and negative blood culture.
Results A total of 33 CVCs were replaced for: clinical suspicion of
a CRBSI (64%); duration of use (24%); incidental positive blood
culture (9%); and clinical evidence of catheter site infection (3%).
Ninety-one per cent of CVC tips were sent for culture. Fifty-eight
per cent of cases had paired blood cultures sent. The incidence of
antimicrobial therapy at the time of blood sampling was 85%. Only
a single CVC replacement (3%) was associated with a confirmed
CRBSI. By contrast, the incidence of possible CRBSI was greater
(45%).
Conclusions  Clinical suspicion of CRBSI was associated with
infrequent microbiological confirmation. The impact of antibiotic
therapy on diagnostic sensitivity is unknown. The incidence of
possible CRBSI was much greater; we believe this entity encom-
passes unknown proportions of both colonised CVCs and CRBSI.
The widely used definitions of CRBSI probably therefore under-
estimate the true incidence: this limits their utility to describe a
parameter that may benchmark different ICUs and drive quality
improvement processes within an ICU. We propose that both con-
firmed and possible CRBSI rates should be recorded as (different)
surrogates for the true rate. Finally, this illustrates the shortcomings
of assessing outcomes (CRBSI rate). Measuring adherence to
quality control processes (care bundles) may be a better
comparator.
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Introduction Central venous catheters (CVCs) are very useful in
the management of patients hospitalized in the ICU, but are not
devoid of complications. Among the complications related to the
permanence of CVCs, infection stands out. This may increase the
morbidity, mortality, costs and length of stay in the ICU. The
purpose of this study was to compare the duration of standard
CVCs with those impregnated with antiseptic: silver sulfadiazine
and chlorhexidine.
Methods  A prospective randomized, alternate, nonblind study.
Central venous access was taken, alternating the type of CVC
used in each patient. Were recorded for each patient the sex, age,
APACHE II score, Glasgow coma score, site of the puncture,
reason for withdrawal of the catheter and the type of catheter
used. The tip of the catheter was cultured (qualitative). The groups
were divided: group I (41 patients, 54 punctures) used the stan-
dard CVC, and group II (38 patients, 54 punctures) used an
impregnated CVC.
Results See Table 1. We included 62 patients (48.38% female).
We studied 108 periods of catheterization, of which 54 were
standard CVCs and 54 were impregnated CVCs. The average
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length of stay was higher in impregnated CVCs (14.11 days)
compared with standard CVCs (10.7 days). Excluding death in
both groups, the length of stay of the catheter in group I was 10.86
days, compared with 15.43 days in group II. Adding all periods of
catheterization for each group, group I had an amount of 578 days
and group II had 762 days. The total duration of group II was
31.84% higher than group I. Regarding the reason for withdrawal
of the CVC, the suspected infection predominated in 77.8% of the
time in standard CVCs and 49.1% of the time in impregnated
CVCs. The culture of the catheter’s tip was positive on 10
occasions (18.5%) in standard CVCs, against eight occasions
(15.1%) in the impregnated group. Most patients had Glasgow
coma score <9. The average APACHE II score was 17.97 in
patients of group I, compared with an average of 19.63 in group II
patients. The predominant site of puncture in this study was the
subclavian vein (56.48%), and the catheters remained a long time
on this site when compared with others (jugular and femoral vein).
But when we considered only group II (impregnated), the catheters
located in the jugular vein remained longer. The impregnated
catheter cost 40% more than the conventional.
Conclusions The length of stay with the use of impregnated CVCs
was higher (15.43 days) than the standard CVC (10.86 days). The
rate of colonization was higher in the standard CVC. Patients who
require a CVC for long periods have benefited with the use of
impregnated CVCs, because they present a long use term, a lower
rate of colonization, avoiding complications related to the
procedure of successive punctures and related to the permanence
of the catheters. In view of the clinical benefits already mentioned,
the benefit reached from the use of antiseptic-impregnated
catheters compensated the initial expensive cost of 40%.
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Introduction  Prompt central venous catheter (CVC) removal is
often recommended in candidemic patients [1,2]. To investigate
further, we evaluated relationships between CVC status and 28-
day and 42-day survival post-treatment initiation, overall treatment
success, and time to mycological eradication.
Methods Data from two randomized, double-blind, phase 3 mica-
fungin trials evaluating treatment of candidemia and invasive
candidiasis (n = 842) were analysed. Univariate analysis was
performed to evaluate: associations of baseline CVC removal
within 24 hours (CVC24) and 48 hours (CVC48) versus non-
removal with each treatment outcome; and associations of poten-
tial confounding factors with treatment outcomes. A final multi-
variate analysis was performed on those associations with P ≤0.10.
Results Univariate analysis revealed that CVC24 was associated
with 28-day survival (P = 0.05) and 42-day survival (P = 0.05), and
CVC48 with 28-day survival (P = 0.01), 42-day survival (P = 0.01),
and overall treatment success (P = 0.02). Neither CVC24 nor
CVC28 were associated with time to mycological eradication.
After controlling for confounding variables such as baseline
Candida species, APACHE II score, underlying disease, and so on,
multivariate analysis revealed that neither CVC24 nor CVC48 were
statistically significant prognostic indicators for 28-day and 42-day
survival (Figure 1). In addition, CVC48 was not associated with
overall treatment success.
Conclusions  Early CVC removal (within 48 hours of treatment
start) had no statistically significant effect on treatment success or
survival during treatment of invasive candidiasis.
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Multivariate analysis
Standard CVC Impregnated CVC
Variable Value 95% CI Value 95% CI P value (OR*)
Age (average) 52.42 47.43 0.17
Sex (female) 50% 36.1 to 63.9 54.7% 40.4 to 68.4 0.3
Subclavian vein 46.3% 32.6 to 60.4 66.0% 51.7 to 78.5 0.03 (2.3)*
Glasgow coma score <8 59.3% 45.0 to 72.4 56.6% 42.3 to 70.2 0.5 (0.9)
APACHE II score (mean) 17.97 19.63 0.21
Site infection 77.8% 64.4 to 88.0 49.1% 35.1 to 63.1 0.002(0.3)*
Infection length 10.86 15.43 0.005*
Positive cultures 18.5% 9.3 to 31.4 15.1%  6.7 to 27.6 0.41 (1.3)
Figure 1 (abstract P193)S79
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Introduction  Protection of the catheter site by antimicrobial
ointments is one of the most important factors in the prevention of
infection [1,2]. Povidone iodine, chlorhexidine gluconate and
octenidine hydrochloride are the most common used agents for
dressing. The purpose of this study is to compare the effects of
povidone iodine, chlorhexidine gluconate and octenidine
hydrochloride in preventing catheter-related infections.
Methods The study was performed in an adult ICU. Fifty-seven
patients who have arterial, central venous catheterization were
eligible to be included in the study. Patients were randomized to
receive 4% chlorhexidine gluconate (group I, n = 19), 10%
povidone iodine (group II, n = 19) or octenidine hydrochlorodine
(group II, n = 19) for cutaneous antisepsis.
Results  The clinical characteristics of the patients and the risk
factors for infection were similar in the groups. There was a
statistically significant difference between groups in catheter-
related sepsis and colonization (P <0.001). The documented
catheter-related sepsis rate was 10.5% in the povidone iodine and
octenidine hydrochlorodine groups. The catheter-related coloniza-
tion rate was 26.3% in the povidone iodine group and 21.5% in
the octenidine hydrochlorodine group. In the chlorhexidine group,
there was no catheter-related sepsis or colonization.
Conclusions Chlorhexidine is an effective disinfectant agent. The
use of 4% chlorhexidine rather than 10% povidone iodine or
octenidine hydrochlorodine for cutaneous disinfection before
insertion of an intravascular device and for postinsertion site care
can substantially reduce the incidence of catheter-related infection.
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Introduction Central venous catheterisation is a core component
of intensive care management. Despite advances in medicine,
central venous catheters are associated with infection rates
ranging between 2.5 and 70% [1,2]. There is, however, little
isolated information regarding rates of central line sepsis in
neurointensive patients. Microbiology results from the 3 months
preceding this study identified six line-related infections. Following
implementation of a new evidence-based medicine technique for
central lines, this study set out to review central line sepsis in
patients at Walton Neurological ITU.
Methods Eighty-seven patients were identified by the study criteria
as suitable for inclusion, of which information on 65 patients was
obtained. Baseline demographical information was collected on
patient sex, age, catheter insertion site and procedural compli-
cations. Analysis was then carried out to review the rates of line
sepsis in this neurologically compromised group of patients, along
with identifying any obvious trends in central venous insertion.
Results A total of 69.2% (n = 45) of the cohort of 65 patients had
a central line in situ. Of these, 47% (n = 29) were femoral, 24%
(n = 15) were internal jugular, 23% (n = 14) were subclavian whilst
6% (n = 4) were unknown (site not mentioned in records). In total,
4.8% (n = 3) had reported line infections, two of which were
coagulase-negative staphylococcus grown from femoral lines while
one patient was reported to have grown Candida albicans from
their internal jugular central line site.
Conclusions  Despite best practice evidence favouring cervical
lines, the study found that femoral line insertion was more
appropriate in this subset of patients with unstable head injuries. In
addition, this study highlighted a 50% reduction in central line
sepsis in the 3 months following our central line insertion and
maintenance policies. Furthermore, early resiting on day 3 in the
case of femoral lines resulted in a reduction in contaminated
central lines.
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Introduction Central venous catheterization is a routine procedure
in intensive care, and internal jugular access (IJA) is often used due
to its high success rates. However, complications can happen in
up to 4.2% of internal jugular punctures and it is contraindicated in
the presence of coagulopathy. The external jugular access (EJA) is
underused, has low complications rates and is successful in up to
90% of cases. So far, there has been no randomized, controlled
trial comparing both accesses. The objective of this study was to
determine the success and early complication rates of internal and
external jugular vein access [1].
Methods A prospective, randomized study, performed in two adult
general ICUs. Inclusion criteria were all patients who need central
venous catheterization with a visible external jugular vein and no
contraindication for IJA. All included venous catheterizations were
performed by the first-year and second-year critical care residents,
supervised by a staff physician. Admission type, APACHE II score
and outcomes were recorded.
Results Sixty-nine patients were included. The mean APACHE II
score was 22.8 (SD = 6.4). Thirty-three patients (47.8%) were
randomized to EJA and 36 (52.2%) to IJA. The percentage of
success was 72.7% with EJA and 88.9% with IJA (risk ratio =
0.82; 95% CI = 0.64 to 1.04; P = 0.09). Complications occurred
in 2/33 (6%) EJA patients and in 1/33 (3%) IJA patients (risk
ratio = 2.1; 95% CI = 0.2 to 22.6; P = 0.28). Besides central
venous catheterization failure, the only complications were carotid
puncture (one patient in IJA) and external hematoma (two patients
in EJA).
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Conclusions External jugular venous access is a good alternative
to internal venous catheterization and it is associated with minor
and low complications rates. Our results show a lower but not
significant probability of success with the EJA. Considering that
the procedure was done by physicians not familiar with the
technique, however, we did not find definite evidence to indicate
that IJA is superior to EJA.
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Introduction Totally implantable access ports (TIAPs) are exten-
sively used for long-lasting intravenous access. They can be
associated with early and late complications, which are related to
an optimal site of insertion and tip positioning [1]. Despite
fluoroscopic guidance being the gold standard, ultrasound can be
a suitable and easier tool to guide venipuncture and catheter
positioning, provided a postprocedural chest X-ray is taken to rule
out tip malpositioning [2]. Our aim was to assess safety of this
technique in terms of the best site of insertion, tip position and rate
of complications.
Methods A total of 360 TIAPs were implanted between December
2007 and September 2008 in a dedicated surgical room at the
ICU of the University of Florence, Italy. Insertion was performed by
trained intensivists, using an ultrasound-guided technique. A chest
X-ray scan was performed after the procedure to rule out a
catheter’s tip malposition and pneumothorax. Early and late
complications were noted and recorded. A Fisher test (P <0.05)
was done to test for association between the site of insertion and
either tip position or occurrence of complications.
Results  From a total of 360 TIAPs implanted, the rate of
malposition was seven catheters (1.9%). The site of insertion that
consented the best rate of correct placement was the right internal
jugular vein (P <0.05). The incidence of complications was 17 out
of 360 procedures (4.7%). Early complications included five
arterial punctures and one pneumothorax, while late complications
included four TIAP displacements, one pocket infection, three
catheter-related infections and three thromboses. A correlation
was found between occurrence of late complications and left
insertion sites (P <0.05).
Conclusions  Ultrasound-guided venipuncture for TIAP implan-
tation was safely conducted in the majority of patients. The right
internal jugular vein was the best insertion site in terms of the best
rate of correct catheter tip position and lower incidence of
complications.
References
1. Ignatov A, Hoffman O, Smith B, Fahlke J, Peters B, Bischoff J,
Costa SD: An 11-year retrospective study of totally
implanted central venous access ports: complications and
patient satisfaction. Eur J Surg Oncol 2008, in press. [Epub
ahead of print]
2. Brooks AJ, Alfredson M, Pettigrew B, Morris DL: Ultrasound-
guided insertion of subclavian venous access ports. Ann R
Coll Surg Engl 2005, 1:25-27.
P198
Ultrasound-guided catheterization of the subclavian vein: 
a prospective comparison with the landmark technique in
ICU patients
Y Alic, A Torgay, A Pirat
Baskent University School of Medicine, Ankara, Turkey
Critical Care 2009, 13(Suppl 1):P198 (doi: 10.1186/cc7362)
Introduction  Ultrasound (US)-guided internal jugular vein
catheterization has been recommended to increase the procedural
success rate and to enhance patient safety. However, there are
few data on the potential advantages of the use of US guidance for
subclavian vein (SV) catheterization. The aim of this study was to
evaluate whether US-guided catheterization of SV improves the
procedural success rate of the traditional landmark method in ICU
patients.
Methods Ethics Committee approval and written informed consent
from all patients or their next of kin were obtained. We prospec-
tively and randomly evaluated an US-guided method in 35 patients
undergoing SV catheterization (Group US) and compared the
results with 35 patients in whom a landmark-guided technique was
used (Group LM). All procedures were performed by the same
physician, who was experienced in both techniques. The catheteri-
zation success rate at the first attempt, the overall catheterization
success rate, the number of attempts, the time to catheterization,
and catheterization-related mechanical complications were
recorded. Bedside chest X-ray scans were used to evaluate the
position of the catheter tip, pneumothorax, and hemothorax.
Results  The groups were similar in terms of physical
characteristics, systemic disease, and risk factors for difficult SV
catheterization. Catheterization success rate at the first attempt
(Group LM 63% and Group US 63%, P  = 1.00) and overall
success rate (Group LM 94% and Group US 89%, P  = 0.67)
were similar in both groups. The number of attempts for SV
catheterization were no different in the groups (Group LM 1.6 ±
1.0 attempts and Group US 1.7 ± 1.1 attempts, P = 0.61). Three
patients in Group LM developed six mechanical complications
while four patients in Group US had four such complications
(P >0.05 for all). The time to catheterization was significantly
longer in Group US than Group LM (Group LM 178 ± 128 s vs.
Group US 230 ± 127 s, P = 0.008).
Conclusions Compared with the landmark technique, real-time
two-dimensional US did not increase the overall or first attempt
success rate in subclavian vein catheterization in ICU patients. The
time to catheterization was significantly longer with real-time two-
dimensional US guidance than with landmark guidance.
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Perioperative fluid administration in pancreatic surgery:
comparison of three regimens
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Introduction  Perioperative fluid administration represents an
important issue in perioperative medicine, because an incorrect
strategy is associated with increased morbidity and mortality. The
aim of this study was to compare three fluid administration
regimens in patients who have undergone pancreatic surgery.
Methods A randomized prospective trial. Fifty-nine patients,
American Society of Anesthesiologists class 1 to 3, were assigned
to one of three perioperative fluid regimens (PFRs). Interventions:
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general balanced anesthesia; PFR1, liberal (21 patients): colloids
and crystalloids (in a 1:3 rate) 12 ml/kg/hour; PFR2, restricted (18
patients): colloids 4 ml/kg/hour; and PFR3, goal targeted (20
patients): colloid infusion targeted to achieve stroke volume
variation (SVV) <13%. Hemodynamic monitoring was performed
using the Vigileo/FloTrac system (cardiac output (CO) and SVV).
Recorded outcome variables were hospital length of stay, starting
of enteral nutrition, bowel movement, blood transfusion, and
perioperative complications.
Results  Data regarding significant differences are presented in
Table 1. Hemodynamic monitoring showed a higher variability of
CO and SVV in PFR1. Postoperative major complications were
also higher in PFR1. Fistulas occurred in eight cases of PFR1 and
in three and four cases in PFR2 and PFR3, respectively (P <0.05).
Conclusions  Our study in still ongoing; however, ad interim
analysis suggests that a restricted or goal-targeted perioperative
fluid administration seems to provide more stable hemodynamics
and a reduction of major abdominal complications.
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Introduction The plasma B-type natriuretic peptide concentration
(BNP) appears not to predict fluid responsiveness in septic shock
but no account has been made for the potential influence of
cardiac rhythm [1]. Also, no comparison has been made between
BNP and other clinical guides to fluid therapy, such as the Doppler
aortic flow time corrected for heart rate (FTc) or central venous
pressure (CVP). The aim of this preliminary study was to compare
BNP, FTc and CVP as predictors of fluid responsiveness in septic
shock patients without cardiac dysrhythmia.
Methods  A prospective study of 10 consecutive adult septic
shock patients (in sinus rhythm; 60% mechanically ventilated)
treated with intravenous fluid challenge (4% albumin 250 ml over
15 min) in an Australian tertiary ICU. Results presented as the
mean ± SD.
Results The APACHE II score was 21.8 ± 12.7. Haemodynamic
assessment incorporating transcutaneous aortic Doppler (USCOM®)
occurred before and 5 minutes after fluid challenge. Concurrent
with the initial assessment, blood samples were collected for BNP
assay (ADIVA Centaur®). Four patients demonstrated an increase
in stroke volume ≥15% (responders). Three of the responders had
an elevated baseline BNP (>144 pg/ml). The percentage change
in stroke volume correlated with baseline FTc (r = –0.81;
P = 0.004) but not with BNP (r = –0.3; P = 0.4) or CVP (r = –0.4;
P = 0.2).
Conclusions Our data confirm that neither BNP nor CVP appear
to predict fluid responsiveness. Furthermore, elevated BNP should
not be viewed as a contraindication to fluid challenge in septic
shock, as it does not exclude favourable haemodynamic response.
Transcutaneous FTc offers promise as a predictor of fluid
responsiveness and should be evaluated further.
Reference
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Introduction Stroke volume variation (SVV) is a good and easily
obtained predictor of fluid responsiveness that can be used to
guide fluid therapy in mechanically ventilated patients. During major
abdominal surgery in patients with compromised cardiovascular
reserves, inappropriate fluid management may result in occult
organ hypoperfusion or in fluid overload and increased
postoperative morbidity. The aim of our study was to evaluate the
influence of SVV-guided fluid optimization on organ functions and
postoperative morbidity and mortality in high-risk patients
undergoing major abdominal surgery.
Methods Patients undergoing elective intraabdominal vascular and
nonvascular surgery were randomly assigned to a control group
with routine intraoperative care and a SVV group with fluid
management guided by SVV derived from the Vigileo/FloTrac
system. The intervention target was to maintain the SVV index
below 10% with colloid boluses of 3 ml/kg. Postoperative ICU
care was the same for both groups. Demographic parameters,
comorbidities, performed surgical procedures, mortality and ICU
and hospital lengths of stay were assessed. Laboratory parameters
of organ hypoperfusion in the perioperative period (pH, base
excess, serum lactate) and number of infectious and organ
complications on day 7 and day 30 after operation were evaluated.
The Mann–Whitney, unpaired t  test and chi-squared test were
used accordingly; P <0.05 was considered statistically significant.
The study was approved by the local hospital ethic committee.
Results A total of 80 patients were enrolled and randomized in the
SVV (n = 40) and control (n = 40) groups. No significant
differences between both groups in assessed parameters were
found except for a difference in arterial pH (7.37 ± 0.05 vs. 7.35 ±
0.05; P  = 0.04), lactate serum concentration at the end of the
operation (median (IQR): 1.5 (1.2 to 1.9) mmol/l vs. 2.2 (1.39 to
2.35) mmol/l; P = 0.03) and the trend to lower rate of
complications on day 30 in the SVV group (11 patients (39%) vs.
20 patients (57%); P = 0.06).
Conclusions  Fluid optimization guided by SVV during major
abdominal surgery decreases blood lactate at the end of operation
and may be associated with a trend for a lower rate of post-
operative organ complications.
Acknowledgement  Supported by the research grant
MSM0021620819.
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Main results
Liberal, Goal,  Restricted, 
PFR1 PFR3 PFR2
Age (years) 60 55 60
Surgery duration (hours) 6 6 5.5
Colloids (ml) 1,000 500 1,100
Crystalloids (ml) 4,600 2,200 1,450
Enteral nutrition (days from surgery) 4 4 3
Bowel movement (days from surgery) 3 4 3
Hospital length of stay (days) 11.5 11.5 9S82
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Introduction  Most ICU patients on continuous venovenous
hemodiafiltration (CVVHDF) are in multisystem failure and require
extensive monitoring [1]. Impedance cardiography (ICG) techno-
logy provides a measurement of fluid status using the thoracic fluid
content (TFC), along with cardiac output (CO), cardiac index (CI)
and systemic vascular resistance index (SVRI). NICCOMO®
(Medis, Germany), a noninvasive ICG device that provides trust-
worthy measures, could be a complementary monitor for CVVHDF,
supporting fluid balance and helping avoid hemodynamic instability
[2].
Methods The study was an analysis of coma patients with acute
renal failure while undergoing CVVHDF (Equasmart®; Hemodec,
Italy). By means of NICCOMO® the TFC, CI, CO, mean arterial
pressure and SVRI were constantly recorded. Employing the
Pearson method, the percentage variations in each of the para-
meters during the CVVHDF treatment were correlated to the
amount of fluid removed (FR), normalized to body weight.
Results Ten patients were studied (six men and four women); the
age range was 53.1 ± 15.2 years. A total of 16.6 l of fluid was
removed during CVVHDF (830 ml/day over 20 treatment days).
The median FR per day was 1,837 ml and the median hourly FR
rate was 252 ml. TFC diminished in all patients at the end of
CVVHDF treatment (average reduction 14.8 ± 9/kΩ), while all
other hemodynamic parameters showed both increases and
decreases. We found that the percentage TFC changes were
closely and inversely related with those of FR (r = –0.68,
P <0.001); other hemodynamic parameters showed a moderate
correlation with FR. The ICG device was helpful to promptly
identify one patient who experienced hemodynamic instability and
to prevent it.
Conclusions  TFC is a reliable and noninvasive method for
evaluating the quantity of FR during CVVHDF. This parameter
changed consistently with fluid subtraction and TFC
measurements can guide the extent of FR. This compact ICG
device provides safe and accurate readings and seems to be one
of the best options for evaluation of basic hemodynamic
parameters and TFC during hemodiafiltration.
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Introduction  The use of pulse pressure variation (PPV) and
systolic pressure variation (SPV) is possible during controlled
mechanical ventilation (MV) [1]. Even in acute respiratory failure,
controlled MV tends to be replaced by assisted ventilatory support,
which may generate a tidal volume (Tv) inadequate to change the
pulmonary venous flow and swing in pleural pressure [2]. This
makes the use of dynamic indices unreliable. Our hypothesis was
that during a pressure-support-assisted ventilatory (PSV) approach
few imposed breaths (flow-triggered synchronized intermittent
mechanical ventilation (SIMV)) could allow the monitoring of PPV
and SPV. We therefore tested whether PPV and SPV during PSV
+ SIMV could be as accurate as in controlled MV.
Methods A prospective case–control study. Thirty patients who
met the criteria of weaning from controlled MV were included. PPV
and SPV were measured, first, during 20 minutes in PSV with three
per minute flow-triggered SIMV breaths (10 ml/kg, duration 5 s,
inspiration to expiration ratio 1:3) (T1), and then during three
consecutive breaths in controlled MV (respiratory rate 12/min,
duration 5 s, inspiration to expiration ratio 1:3, Tv 10 ml/kg, positive
end-expiratory pressure and FiO2 as in PSV) (T2). Throughout
20 minutes of data collection, saline infusions were kept constant
(3 ml/hour) without performing any fluid loading. Correlation and
Bland–Altman analysis were used to compare respective values of
PPV and SPV in the two modes of ventilation.
Results  Significant correlations were found between dynamic
indices in SIMV during pressure support ventilation and those in
controlled MV mode. The mean differences between two
measurements were: PPV 0.6 ± 2.8% (limit of agreement: –5.0
and 6.2), SPV 0.5 ± 2.3 mmHg (limit of agreement: –4.0 and 5.1).
Conclusions PPV and SPV measured during SIMV fitted with the
findings in controlled MV. Dynamic indexes could be accurately
monitored in patients breathing with assisted respiratory
assistance adding an imposed large enough SIMV breath [3].
References
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Introduction  Dynamic parameters predict fluid responsiveness
and improve fluid management during surgery. We intend to
demonstrate that the noninvasive pleth variability index (PVI) guides
peroperative fluid management and optimizes the circulatory
status.
Methods  Patients scheduled for major abdominal surgery were
randomized into two groups comparing the peroperative PVI-
directed fluid management (group P) versus standard care
(control, group C). Protocol: induction of general anesthesia was
followed by, in group P, 500 ml followed by 2 ml/kg/hour
crystalloids; 250 ml colloids infused if PVI >13% for more than
5 minutes; if required, vasoactive support was introduced after
lowering PVI <10%. In group C, 500 ml crystalloids followed by
fluids at the discretion of the anesthesiologist.
Results Eighty-two patients completed the protocol. No difference
was detected in preoperative characteristics, type of surgery and
anesthesia. Peroperative and postoperative (24-hour) crystalloid
infusions were significantly different. Lactate levels were
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significantly lower in group P, whereas the peroperative and post-
operative volumes infused in group P were lower (Figure 1).
Conclusions The PVI improves peroperative fluid management in
abdominal surgery. The reduced mean volume infused associated
with reduced lactate levels suggests the capacity of the PVI to
infer tailored fluid administration.
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Introduction  New predictors of fluid responsiveness have been
obtained from plethysmographic waveforms displayed on pulse
oxymeters. However, they require recordings on a PC and offline
operator-dependent analysis. A new parameter called the
plethysmography variability index (PVI) has been proposed by a
pulse oxymetry manufacturer to be used for the purpose of fluid
responsiveness. Its advantage is that it can be automatically
calculated and displayed on the screen of the pulse oxymetry
monitor. The aim of the study is to test the accuracy of this
parameter to predict fluid responsiveness in critically ill patients.
Methods Inclusion criteria were septic shock patients fully adapted
to their respirator and on sinus rhythm. Methods involved
simultaneous recording of the following tracings: invasive blood
pressure, plethysmography pulse oxymeter (Philips™), ECG, airway
pressure and digit values inscribed on the device (Masimo™).
Echocardiography was used to calculate the velocity–time integral
(VTI). We infused fluid (500 ml saline) in patients with pulse
pressure variation (ΔPP) ≥15% and performed passive leg raising
(PLR) in patients with ΔPP <15%. We compared the PVI with ΔPP
and with the variability of pulse oxymeter wave amplitude (ΔPPleth)
and sought the best threshold PVI value that predicted ΔPP
>15%. Patients who increased their VTI by more than 15% in
response to fluid or to PLR were defined as responders. The
significance of the PVI threshold to distinguish between
responders and nonresponders was examined.
Results  In the first step 25 patients were enrolled. Fifty paired
values were analysed. The r2 coefficients between ΔPP–PVI,
ΔPPleth–PVI and ΔPP–ΔPPleth were 0.81, 0.79 and 0.74,
respectively. A threshold PVI value of 20 identified patients with
ΔPP >15% with a sensitivity of 84% and specificity of 90%. In a
second step 18 other patients were enrolled. All patients with PVI
>20 (n = 8) were fluid responders and 10 patients with PVI <20
were PLR nonresponders.
Conclusions The PVI automatically obtained from a pulse oxymetry
device seems an accurate index of fluid responsiveness. The
numerical value of 20 distinguished responders from non-
responders with good sensitivity and specificity.
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Introduction We evaluated the effect of the calibration interval on
the reliability of pulse contour cardiac output (COpc) measurement
[1].
Methods  Eleven patients were investigated for over 10 hours
using two COpc monitors simultaneously. One COpc (COpcCAL)
monitor was calibrated hourly, while the other (COpcNOCAL) was
calibrated once initially without any further calibration. COpcCAL
was compared with COpcNOCAL.
Results A total of 116 pairs of cardiac output measurement was
obtained. After 3 hours, the correlation between COpcCAL and
COpcNOCAL was r2 = 0.85, P <0.0001, bias ± SD was –0.43 ±
0.87 ml/minute; after 6 hours, r2 = 0.68, P = 0.0064, bias ± SD
was –0.83 ± 1.39 ml/minute; after 10 hours, r2 = 0.70, P = 0.0026,
bias ± SD was –0.81 ± 1.21 ml/minute. See Figures 1 and 2.
Conclusions The calibration interval has no effect on the reliability
of the COpc measurement.
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30:52-58.
P207
Is the pulse pressure variation a good predictor of fluid
responsiveness in mechanically ventilated patients with
low tidal volume?
C Costa, S Vieira, G Friedman, L Fialkow
Hospital de Clinicas de Porto Algre, Brazil
Critical Care 2009, 13(Suppl 1):P207 (doi: 10.1186/cc7371)
Introduction  Dynamic preload indicators are superior to static
indicators for predicting fluid responsiveness [1-3]. The aim of this
study is to evaluate the influence of a low tidal volume on the
capacity of pulse pressure variation (PPV) to predict fluid
responsiveness.
Methods A transversal and interventional study that included 30
critically ill patients with acute circulatory failure, sedated and
mechanically ventilated with a tidal volume of 6 to 7 ml/kg.
Mechanical ventilatory measurements including positive end-
expiratory pressure plateau and peak pressures, static compliance
and hemodynamic measurements including PPV, heart rate, mean
systemic and pulmonary arterial pressures, central venous
pressure, pulmonary capillary wedge pressure and cardiac index
were obtained before and after fluid challenge, performed with
1,000 ml crystalloids or 500 ml colloids. Fluid responsiveness was
defined as an increase in cardiac index of at least 15%.
Results  Thirty patients were enrolled: aged 56 ± 16.8 years,
APACHE score = 28 ± 8, male = 15; 19 patients with septic
shock, one patient with sepsis, five patients in postoperative liver
transplantation, three patients with acute pancreatitis, one patient
with cardiogenic shock and one patient in postoperative aortic
Available online http://ccforum.com/supplements/13/S1
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aneurysm. Before fluid challenge: total positive end-expiratory
pressure = 09 ± 3.7 cmH2O, static compliance = 34.3 ± 16.3
cmH2O, pulmonary capillary wedge pressure = 13.8 ± 5 mmHg,
central venous pressure = 11.6 ± 5 mmHg. Fourteen patients
were fluid responders (Figure 1). The best threshold value of PPV
was 10% (receiver operating characteristic curve area = 0.7,
95% CI = 0.51 to 0.9), sensibility of 50%, specificity of 94%, a
positive predictive value of 88%, a negative predictive value of
68%, a positive likelihood ratio of 8.0 and a negative likelihood
ratio of 0.53.
Conclusions  The baseline PPV is a good predictor of fluid
responsiveness in mechanically ventilated patients with low tidal
volume. The threshold value of 10% was associated with a
significant increase in cardiac index after volume expansion.
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Bland–Altman plot of COpcCAL and COpcNOCAL. Solid line, bias; dashed lines, ± 2SD.
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Introduction  Fluid responsiveness is still a cornerstone in
managing patients with severe sepsis and septic shock. Recently
new technologies have been generated for facilitating the accuracy
of predicting fluid responsiveness at the bedside, based on
cardiopulmonary interaction [1,2]. We evaluated the effectiveness
and accuracy of three dynamic indices, currently available in
intensive care monitoring devices, which are pulse pressure
variation (PPV) [3], stroke volume variation (SVV) and pulse
oximetry plethysmographic waveform variation (POPV) in septic
mechanically ventilated patients [4].
Methods A prospective clinical trial was conducted in 20 septic
patients 18 years of age and older who had invasive blood
pressure monitoring with an intraarterial cannula. PPV, SVV and
POPV (%) were calculated and compared with the percentage
cardiac index (CI) change. Patients with a CI increase induced by
volume expansion >15% were classified as responders, and
<15% as nonresponders. A parametric paired t test was used to
compare hemodynamic parameters at baseline and after volume
expansion. Student’s t test was used to compare hemodynamic
parameters in the responders and nonresponders groups. Receiver
operating characteristic curves were used to evaluate the
predictive value of various indices on fluid responsiveness.
P <0.05 was considered significant.
Results  We found a strong correlation existed for PPV for
detection of a volume expansion-induced change in CI (r2 =
0.794), followed by SVV (r2 = 0.667), and POPV (r2 = 0.633). The
areas under the receiver operating characteristic curves were 0.96
for PPV (P <0.001), 0.92 for SVV (P = 0.001), and 0.85 for POPV
(P = 0.008). Respiratory variation in POPV exceeding 14% (sensi-
tivity of 72%, specificity of 90%), SVV exceeding 11% (sensitivity
90%, specificity 92%), allowed detection of PPV exceeding 12%
(sensitivity 84%, specificity 96%).
Conclusions In the septic mechanically ventilated patients, PPV is
the most effective dynamic parameter for predicting fluid
responsiveness; all of PPV, SVV and POPV are well correlated
with the percentage change of CI.
References
1. Michard F, Teboul JL: Predicting fluid responsiveness in
ICU patients: a critical analysis of the evidence. Chest
2002, 121:2000-2008.
2. Bendjelid K, Romand JA: Fluid responsiveness in mechani-
cally ventilated patients: a review of indices used in inten-
sive care. Intensive Care Med 2003, 29:352-360.
3. Michard F, et al.: Relation between respiratory changes in
arterial pulse pressure and fluid responsiveness in septic
patients with acute circulatory failure. Am J Respir Crit
Care Med 2000, 162:134-138.
4. Feissel M, et al.: Plethysmographic dynamic indices predict
fluid responsiveness in septic ventilated patients. Intensive
Care Med 2007, 33:993-999.
P209
Cross-comparison of the trending accuracy of continuous
cardiac output measurement devices in postoperation
patients
HK Kim, M Hadian, D Severyn, MR Pinsky
University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Critical Care 2009, 13(Suppl 1):P209 (doi: 10.1186/cc7373)
Introduction  Arterial pulse analysis estimates of cardiac output
(CO) are less invasive than pulmonary artery catheter (PAC)-
derived ones. Although PAC bolus thermodilution CO (COtd)
values are the reference CO values for most clinical studies, there
is no defined gold standard. We therefore compared the co-
variance of three commercially available arterial pulse analysis
devices (FloTrac, LiDCO, PiCCO) and PAC with COtd and
continuous CO (CCO).
Methods Seventeen postoperative cardiac surgery patients were
studied for the first 4 hours post ICU admission. CO was
measured simultaneously by FloTrac, LiDCO and PiCCO using the
same arterial waveform. LiDCO and PiCCO were calibrated to the
first COtd measured on ICU admission. Values of CO were
compared before and after specific therapeutic interventions
(volume, vasoactive or inotropic infusions). Absolute values for CO
across all devices were compared by linear regression and
Bland–Altman analysis. Dynamic changes for CO across all
devices were compared by moment analysis.
Results In 17 patients, 72 paired simultaneous CO measurements
were collected. By linear regression analysis, all devices correlated
well with each other for absolute CO as r = 0.87 (PAC–LiDCO),
0.70 (PAC–PiCCO), 0.51 (PAC–FloTrac), 0.80 (LiDCO–PiCCO),
0.65 (LiDCO–FloTrac) and 0.50 (PiCCO–FloTrac) with P <0.001
in all pairs. By Bland–Altman analysis, the mean bias between CO
measurements by each paired device was –0.18 l/min (PAC–
LiDCO), 0.30 l/min (PAC–PiCCO), –0.43 l/min (PAC–FloTrac),
Available online http://ccforum.com/supplements/13/S1
Figure 1 (abstract P207)
Relationship between the PPV and the cardiac index variation.S86
0.12 l/min (LiDCO–PiCCO), –0.63 l/min (LiDCO–FloTrac) and
–0.73 l/min (PiCCO–FloTrac), with precision (1.96 SD, 95% CI) of
±1.56, ±2.26, ±3.37, ±1.98, ±2.97 and ±3.45 l/min, respectively.
By Pearson moment analysis, the dynamic change for CO was well
correlated between PAC–LiDCO, PAC–PiCCO, LiDCO–PiCCO
and LiDCO–FloTrac (r = 0.78, 0.56. 0.65 and 0.55, respectively).
However, FloTrac showed poor correlation with PAC and PiCCO
(r = 0.28 and 0.33, respectively).
Conclusions  In postoperative cardiac surgery patients, the
absolute CO of arterial pulse analysis devices showed good
correlation with each other and PAC COtd and CCO. However,
the dynamic change of CO was less correlated with each other
than the absolute CO. Because each arterial pulse analysis device
showed different correlations with PAC CO, the CO data from one
monitoring system can be used carefully in concert with another to
drive resuscitation protocols.
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Introduction  We planned to observe the performance of the
LiDCOplus (LiDCO Systems, UK), PiCCO (Pulsion Medical
Systems, Germany) and NICO (Novametrix-Respironics, USA)
continuous cardiac output monitors during therapeutic hypo-
thermia and rewarming post cardiac arrest. PiCCO calibration
failure during hypothermia has been reported [1,2]. Use of the
LiDCOplus and the NICO monitor during therapeutic hypothermia
has not been reported. The LiDCOplus pulse power analysis is
calibrated using a bolus of lithium chloride instead of
transpulmonary thermodilution. Function of the NICO is based on the
Fick principle and on partial rebreathing of carbon dioxide. LiDCOplus
and NICO performance should not be affected by hypothermia.
Methods Local research ethics committee approval was obtained.
Patients admitted to our ICU for therapeutic hypothermia after
cardiac arrest were recruited to the study following assent from the
next of kin. Hypothermia was induced with 2 l crystalloid at 4°C
and maintained using an Alsius Coolguard Icy Catheter (Alsius
Corp., USA) inserted via the femoral vein. A 5 F PiCCO catheter
was inserted in the femoral artery on the opposite side and
connected to the PiCCO and LiDCOplus monitors. A NICO
system was attached to the patient’s tracheal tube. Systems were
calibrated and recalibrated according to the manufacturer’s
instructions (PiCCO 8 hourly, LIDCOplus 24 hourly). The bladder
temperature was recorded and maintained at 33°C for 24 hours.
The temperature, heart rate, blood pressure, and cardiac output on
all three monitors were recorded hourly. After 24 hours, patients
were rewarmed at 0.25°C/hour to a target of 36.5°C.
Results  Six patients were recruited over 8 months. All patients
were at the target temperature of 33°C when cardiac output was
first recorded. No problems were encountered calibrating the
PiCCO, LiDCOplus or NICO monitors at temperatures as low as
33°C. All three monitors were observed to trend together
(Figure 1). Statistical analysis of these trends will be available at
the time of presentation.
Conclusions LiDCOplus, PiCCO and NICO perform comparably
in the temperature range of 33 to 36.5°C.
References
1. Ong T, Gillies MA, Bellomo R: Failure of continuous cardiac
output measurement using the PiCCO device during
induced hypothermia: a case report. Crit Care Resusc
2004, 6:99-101.
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Introduction In clinical practice, fluid responsiveness is tested by
inducing changes in the stroke volume (SV), as measured with
invasive monitoring techniques in often time-consuming proce-
dures. To be able to investigate the effects of changes in SV on
other hemodynamic parameters, there is the need for a preclinical
model that can be translated to clinical practice. For this purpose
we studied the effect of the head-up tilt (HUT) test and passive leg
raising (PLR) test on SV in five healthy volunteers.
Methods The tilt table test consisted of 3 minutes of supine rest
followed by a HUT of 70° on a manually operated tilt table and
ending with 3 minutes of supine rest. The PLR test consisted of
3 minutes of rest in a semirecumbent position of 30°, followed by
3 minutes PLR (lower limbs elevated at 30° and trunk in supine
position) and ending with 3 minutes of rest in a semirecumbent
position. Three HUTs and two PLR tests were performed. The SV
was measured continuously and noninvasively using a NICOM
(Cheetah Medical, Tel Aviv, Israel), based on chest bioreactance,
and a Finometer (TNO Biomedical Instrumentation, Amsterdam,
the Netherlands), based on the Modelflow method. The Finometer
also measured the mean arterial pressure.
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Results Both HUT and PLR induced significant changes in SV
(Figure 1). In addition the cardiac output changed significantly, but
not during HUT when measured with the Finometer. Although both
devices showed a similar response to the postural changes, the
baseline values and magnitude of these responses were not
identical. The mean arterial pressure remained constant during
these manoeuvres. The heart rate significantly increased during
HUT but not during PLR.
Conclusions  The combination of noninvasive monitoring tech-
niques with preload-induced SV modifications in healthy volunteers
provides an excellent preclinical model for the study of fluid
responsiveness. Although these hemodynamic monitors might
provide different results, this model should be very suitable to
assess the effect of SV variations on, for instance, parameters of
peripheral perfusion.
P212
Global end-diastolic volume as a predictor of the need for
massive transfusion in multiple-trauma patients with
hemorrhagic shock
N Saito, Y Sakamoto, K Mashiko
Chiba Hokusou Hospital, Nippon Medical School, Chiba, Japan
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Introduction The PiCCO system enables hemodynamic evaluation
and monitoring by two different approaches: the transpulmonary
thermal dilution technique and pulse counter analysis. Optimal
monitoring of cardiac preload is of paramount importance for the
hemodynamic management of multiple-trauma patients with
hemorrhagic shock. There have been only a few studies on the use
of the PiCCO system (Pulsion, Germany) in multiple-trauma
patients with hemorrhagic shock for hemodynamic monitoring. We
hypothesized that performing a cardiac adequate preload
evaluation with the PiCCO system would make it possible to
predict latent hemorrhagic progress.
Methods Data from 53 consecutive multiple-trauma patients (age
51 ± 17.8 years, injury severity score 30 ± 12.9) with hemorrhagic
shock at the scene of the injury or in the emergency room between
June 2007 and November 2008 were analyzed. All patients
underwent a hemodynamic evaluation with the PiCCO system. We
divided the patients into two groups according to whether they
received a massive transfusion (MT) (>2,000 ml packed red blood
cell transfusion after admission within 24 hours) and compared
their PiCCO data: cardiac output (CO), systemic vascular resis-
tance (SVR), indexed global end-diastolic volume (GEDVi), and
indexed extravascular lung water on admission to the ICU. The chi-
square test and paired t test were used to perform the statistical
analysis.
Results  Twenty-seven patients required massive transfusion.
Mortality was higher in the MT group (P  = 0.05), and the CO,
GEDVi and ITBVi values were significantly lower in the MT group
(Table 1).
Conclusions The parameters measured with the PiCCO system
enabled evaluation of the correct cardiac preload in the multiple-
trauma patients with hemorrhagic shock. GEDVi was useful as a
predictor of the need for MT.
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Introduction Pulse pressure variation (PPV) for prediction of fluid
responsiveness depends on the tidal volume (VT), and using VTs
of the recommended 6 ml/kg makes PPV unreliable [1]. So far,
nobody has suggested how to handle the VT when interpreting
PPV or other dynamic parameters, but we hypothesise that PPV is
proportional to VT and thus that PPV should be indexed to VT. The
aim was to investigate how three VT levels affected PPV at four
different intravascular volumes.
Methods The study was approved by the national animal ethical
committee. Eight anesthetised and ventilated pigs (23 to 27 kg)
were bled 25% of the blood volume (hypovolemia). PPV was
measured at ventilation with VTs of 6, 9 and 12 ml/kg (VT6, VT9
and VT12, respectively). Thereafter, depleted blood was replaced
with voluven (normovolemia) and PPV was again measured at the
three VT levels and subsequently at the +25% and +50%
hypervolemic levels also generated with voluven infusion.
PPV values were log-transformed and compared with a paired t
test. Comparisons were made at each intravascular volume level
between VT6 and VT9, VT9 and VT12, and VT6 and VT12.
Because three comparisons were performed, P <0.05/3 = 0.017
was considered significant.
Results All comparisons for PPV at different VTs were significantly
different (P <0.001); see Table 1 for factorial increases in PPV. At
–25% hypovolemia, PPV did not fully double with doubling of VT,
whereas PPV slightly more than doubled at normovolemia and
hypervolemia.
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MT group Non-MT group P value
CO (l/min) 4.88 ± 2.1 6.38 ± 2.8 0.034
SVR (dyn x s/cm5) 1,169 ± 364 1,452 ± 601 0.046
GEDVi (ml/m2) 554 ± 158 713 ± 238 0.007
Table 1 (abstract P213)
Comparisons of PPV at different VTs
Factorial increase in PPV
Volume VT6–VT9 VT9–VT12 VT6–VT12
–25% 1.28 to 1.34 1.17 to 1.28 1.51 to 1.70
0% 1.53 to 2.00 1.24 to 1.60 2.17 to 2.80
+25% 1.47 to 1.87 1.26 to 1.50 1.88 to 2.77
+50% 1.50 to 1.71 1.30 to 1.61 2.09 to 2.56
Data presented as the 95% CI.S88
Conclusions Our study in pigs showed that PPV strongly depends
on the VT and that PPV is nearly proportional to the VT, indicating
that the clinical value of PPV may be improved by TV indexation.
Reference
1. De Backer D, et al.: Pulse pressure variations to predict
fluid responsiveness: influence of tidal volume. Intensive
Care Med 2005, 31:517-523.
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Introduction The aim of the study was to see how many patients
were fluid responders on arrival in the ICU and to evaluate the
performance of dynamic preload indices in predicting fluid
responsiveness in fully sedated and mechanically ventilated
patients. The following indices were studied: pulse pressure
variation (PPV), stroke volume variation (SVV) and systolic
pressure variation (SPV).
Methods  Patients were monitored with the LiDCOTMplus and
received a fluid challenge (250 ml boluses of colloid in 5 min) to
ascertain fluid responsiveness. Patients in which a fluid challenge
produced a 10% increase in stroke volume were considered fluid
responders and thus the fluid challenge was repeated according to
the unit protocol [1]. In fully mechanically ventilated patients, the
PPV, SVV and SPV were recorded and receiver operating charac-
teristic (ROC) analysis was performed.
Results Thirty-three patients (mean age 64 years; SD ± 13.80;
mean BMI 27.34; 16 female and 17 male) were included; 23
patients were on spontaneous ventilation and 10 were totally fully
ventilated with a mean tidal volume of 8 ml/kg and positive end-
expiratory pressure of 5 cmH2O. Thirteen patients (40%) were
responders, of which five were mechanically ventilated. Areas
under the ROC curve (AUC) for dynamic predictors of fluid
responsiveness were examined for ventilated patients; for PPV,
AUC = 0.65 with SD ± 0.14, P = 0.28 showing a sensitivity of
67% and a specificity of 79% for a cutoff value of 14%; for SVV,
AUC = 0.73 with SD ± 0.14, P = 0.1 showing a sensitivity of 67%
and a specificity of 74% for a cutoff value of 9%; and for SPV,
AUC = 0.74 with SD ± 0.12, P = 0.09 showing a sensitivity of
67% and a specificity of 86% for a cutoff value of 8%.
Conclusions A high percentage of patients were fluid responsive
on arrival in the ICU following major surgery (40%). The PPV, SVV
and SPV have a potential to predict fluid responsiveness in
mechanically ventilated patients.
Reference
1. Pearse RM, et al.:  Early goal-directed therapy after major
surgery reduces complications and duration of hospital stay.
A randomised, controlled trial. Crit Care 2005, 9:R687-R693.
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Introduction  The echographic assessment of inferior vena cava
(IVC) diameter (IVCD) variation allows for fluid-responsiveness
prediction in ventilated septic patients [1,2]. Its applicability in
surgical patients is not established, partly due to the difficulty to
acquire a subxiphoidian (SX) view after abdominal surgery. The
transhepatic (TH) view of the IVC could provide an interesting
alternative.
Methods In this prospective, randomized, crossover, pilot study,
IVCD variation was assessed in consecutive mechanically
ventilated (volume control) ICU patients, with SX and TH views, in
random order by one operator. M-mode images were acquired at
100 mm/s, 2 cm below the junction of the IVC with the right atrium.
The minimal (Dmin) and maximal (Dmax) ICVD values were later
measured on pooled images. IVCD variation [2], defined as dIVC =
(Dmax – Dmin) / ((Dmax + Dmin) / 2), was compared between
both views (when available): dIVCsx and dIVCth for subxiphoidian
and transhepatic views, respectively.
Results Twenty-eight patients were included, 19 medical and nine
surgical. The TH view was obtained in all patients, the SX view in
only 22 of them with failures in four surgical and two morbidly
obese medical patients. Linear regression showed a strong corre-
lation between dIVCth and dIVCsx (n = 22, r2 = 0.98, P <0.001).
The agreement was satisfactory using Bland–Altman analysis
(Figure 1): bias was 0.26%, limits of agreement were –8.4 to
+7.9%. Results were similar for the IVC distensibility index [1].
Conclusions  Our results suggest that the SX view, when
unavailable, can be replaced by the TH view for the echographic
assessment of IVCD variation. Further study is ongoing to formally
establish its validity as a predictor of fluid responsiveness,
especially in surgical ICU patients.
References
1. Barbier C, et al.: Intensive Care Med 2004, 30:1740-1746.
2. Feissel M, et al.: Intensive Care Med 2004, 30:1834-1837.
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Global end-diastolic volume and global end-diastolic
volume index are age dependent in awake, spontaneous-
breathing patients after elective craniotomy
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Klinikum Bogenhausen, München, Germany
Critical Care 2009, 13(Suppl 1):P216 (doi: 10.1186/cc7380)
Introduction  Estimation of cardiac preload is an important pre-
requisite for adequate volume resuscitation. The global end-
diastolic volume (GEDV) and the global end-diastolic volume index
(GEDVI) are surrogate parameters for preload and have been
hypothesized to be age dependent [1]. The current study was
performed to assess the influence of age on the preload
parameters GEDV and GEDVI prospectively.
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Methods  One hundred and one patients (41 male, 60 female)
scheduled for brain tumour surgery were investigated using the
PiCCOplus device (Pulsion Medical Systems AG, Munich,
Germany). On postoperative day 1, the cardiac output, GEDV and
GEDVI were determined by transpulmonary thermodilution before
discharge from the ICU. The influence of predefined age groups
(21 to 40 years old, n = 12; 41 to 50 years old, n = 24; 51 to
60 years old, n = 20; 61 to 70 years old, n = 26; 71 to 83 years
old, n = 19) was tested using a Kruskal–Wallis test. The level of
significance was 5%.
Results  Age significantly influenced the GEDV (P = 0.0024) as
well as the GEDVI (P = 0.0007). Cardiac output (P = 0.3555),
mean arterial pressure (P = 0.0764) and systemic vascular resis-
tance (P = 0.1446) were not dependent on age.
Conclusions  The volumetric parameter GEDV is dependent on
age in haemodynamically healthy and spontaneously breathing
patients. Indexing to body surface area does not remove age
dependence. Targeting volume resuscitation using fixed ranges of
the GEDVI acquired by transpulmonary thermodilution without
reference to the patient’s age seems not to be appropriate.
Reference
1. Wolf S, et al.: ITBV and GEDV but not EVLW acquired by
transpulmonary thermodilution is age dependent in a
series of neurosurgical patients [poster]. Intensive Care
Med 2007, 33(S2):P0273.
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Introduction Haemodynamic monitoring is a cornerstone of inten-
sive care. In addition to parameters of preload and afterload, the
assessment of cardiac output (CO) is of paramount importance.
Thermodilution (TD) using the pulmonary artery catheter and
transpulmonary TD using the PiCCO device are the gold standards
for CO determination. After calibration by TD, the PiCCO device is
able to assess CO using pulse contour (PC) analysis. Despite an
overall good correlation of PC-CO and TD-CO in several studies,
the manufacturer suggests recalibration by TD after 8 hours. Little
is known about the long-term accuracy of PC-CO. Therefore it was
the aim of our prospective study to investigate the long-term
accuracy of PiCCO-2-derived PC-CO in the daily ICU routine.
Methods In 10 consecutive patients (five male, five female, age
65 ± 15 years) the PC-CO was recorded immediately before
recalibration by TD-CO. One hundred and ninety-four measure-
ments with a mean time-lag between two measurements of TD-CO
of 663.5 ± 371 min (100 to 2,700) were recorded. Mechanical
ventilation, catecholamine and arrhythmia occurred in 60 (31%),
132 (68%) and 154 (79%) of the measurements.
Results The 194 pairs of PC-CO and TD-CO showed a highly
significant correlation (P <0.001; r = 0.875). There was no signifi-
cant difference between PC-CO versus TD-CO (4.1 ± 1.6 vs.
4.07 ± 1.4 l/min m2). Analysis according to Bland–Altman
demonstrated a mean bias of –0.036 ± 0.778 l/min m2 (lower and
upper limits of agreement –1.56 and 1.49 l/min m2; percentage
error of 38%). The difference of PC-CO and TD-CO was not
correlated to the time-lag to the last calibration (P = 0.257;
r = –0.083 for uncorrected difference; P = 0.067;  r = 0.134 for
absolute values of the difference). Further analysis demonstrated
that the absolute value of the differences correlated to TD-CO
(P = 0.02,  r = 0.226). Subgroup analysis of 160 measurements
with CO-TD <5.5 l/min m2 demonstrated an improved bias of
0.085 ± 0.53 l/min m2 (lower/upper limits of agreement: –0.98
and 1.12 l/min m2) and a percentage error of 28%.
Conclusions  PiCCO-2-derived PC-CO and TD-CO are highly
significantly correlated. Accuracy is not influenced by the time-lag
to the last calibration. Similar to previous data, PC-CO might
overestimate very high CO, which usually does not influence
clinical practice. Recalibration should be considered in patients
with markedly increased PC-CO.
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recalibration and calibration drift
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Introduction We have previously demonstrated that an average of
at least two curves is necessary to improve the calibration of the
lithium dilution technique of the LiDCO™plus. The precision of the
new calibration process is able to detect a least significant change
(LSC) of 17% [1]. The primary aim of this study was to evaluate
the drift after an initial calibration with two lithium dilution curves.
The second aim of the study was to evaluate the relationship
between the magnitude of the time to recalibration and the
magnitude of the drift.
Methods  Patients requiring monitoring with the LiDCO™plus
received an initial calibration plus a second calibration when clinically
indicated. Data were downloaded from devices and analysed using
the LiDCO™viewPRO v.1 program. Absent, abandoned or rejected
calibration curves were excluded. Calibration factors from the first
and second calibrations were compared. All recalibrations in which
the drift was higher than the LSC (17%) were considered useful
calibrations. Regression analysis for the time to recalibration and drift
was performed. Receiver operating characteristic curve analysis was
performed for the time free of calibration and the usefulness of
calibrations (drift >17%).
Results A total of 45 files from 45 patients with two calibration
points were identified. Patient mean age was 62 (39 to 88) years,
mean height 1.69 (1.40 to 1.94) metres and mean weight 70.9 (40
to 155) kg. Time to recalibration varied from 5 to 39 hours. In 23
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GEDV in age groups
21 to 40 years old 41 to 50 years old 51 to 60 years old 61 to 70 years old 71 to 83 years old
GEDV (ml) 1,154 (1,442 to 980) 1,156 (1,295 to 975) 1,183 (1,352 to 1,074) 1,462 (1,630 to 1,182) 1,337 (1,567 to 1,157)
GEDVI (ml/m2) 612 (674 to 548) 598 (680 to 557) 652 (752 to 597) 756 (875 to 655) 734 (781 to 634)
Data presented as median (75th to 25th quartile).S90
(51%) patients the drift was lower than 17% (unnecessary
calibration). In 22 (49%) patients the drift was higher than 17%
(necessary calibration).
Regression analysis did not show any significant relationship
between the time to recalibration and drift. This was confirmed by
receiver operating characteristic curve analysis.
Conclusions The new implemented calibration process (using the
average of two curves) does not show any drift depending on time.
Despite this, 51% of the recalibrations are necessary (drift >17%).
Further data analysis is necessary to identify when to recalibrate.
Reference
1. Cecconi M, Dawson D, Grounds R, Rhodes A: Lithium dilu-
tion cardiac output measurement in the critically ill patient:
determination of precision of the technique. Online First
[Epub ahead of print].
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Introduction  Established methods to optimize cardiac function
and fluid balance based on flow-related variables are invasive or
require considerable attentiveness. The purpose of this study was
to guide intraoperative fluid and catecholamine therapy in patients
with pre-existing cardiac disease undergoing major abdominal
surgery using a recently introduced less-invasive device without
the need for manual calibration (FloTrac/Vigileo™) and to deter-
mine possible improvement in outcome by means of N-terminal
pro-brain natriuretic peptide (NT-proBNP) plasma levels and the
duration of hospital stay.
Methods  Forty American Society of Anesthesiologists III patients
scheduled for elective major abdominal surgery with pre-existing
cardiac disease (coronary artery disease, myocardial infarction,
cardiac surgery, heart failure, cardiomyopathy) were studied. Patients
were randomly allocated into a standard care group and an
intervention group, where a stroke volume variation (SVV) and
cardiac index (CI)-based protocol for volume and catecholamine
therapy was implemented until the end of surgery. In brief, CI
≥2.5 l/min/m2 was aimed for, with a SVV threshold value for fluid
challenge of 12%. After the baseline (skin incision), haemodynamic
data and plasma NT-proBNP levels were obtained after 180 minutes,
at the end of surgery, 5 hours post surgery, and on postoperative
days 1 and 2, and the ICU and hospital stays were recorded.
Results  Demographic data and Physiological and Operative
Severity Score for the Enumeration of Mortality and Morbidity
physiology and operation score values were comparable between
the groups. The intervention group received significantly more
colloid volume replacement and more dobutamine; crystalloid
volume replacement and norepinephrine consumption did not differ.
Plasma NT-proBNP levels were significantly higher in the standard
care group on postoperative days 1 and 2 (832 ± 675 vs. 1,633 ±
690 pg/ml and 1,097 ± 827 vs. 2,085 ± 871 pg/ml). The mean
hospital stay was reduced in the intervention group (14.8 ± 4.7
days) versus 20.6 ± 8.1 days in the standard care group
(P = 0.009), whereas the ICU stay did not differ significantly.
Conclusions  The use of uncalibrated arterial waveform analysis
(FloTrac/Vigileo™) for intraoperative patient optimization in patients
with pre-existing cardiac disease undergoing major abdominal
surgery is associated with a reduction of hospital stay and lower
plasma NT-proBNP levels.
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Evaluation of the effectiveness of different volume
replacement therapies in postoperative hypovolemic
patients using the PiCCO monitoring system
T Gondos1, Z Marjanek2, Z Ulakcsai3, Z Szabó4, L Bogár3, 
M Károlyi5, B Gartner6, J Futó7
1Semmelweis University, Budapest, Hungary; 2JÖK, Vác, Hungary;
3PTE, Pécs, Hungary; 4Uzsoki Hospital, Budapest, Hungary;
5Kenézy Hospital, Debrecen, Hungary; 6Petz Hospital, Györ,
Hungary; 7St Imre Hospital, Budapest, Hungary
Critical Care 2009, 13(Suppl 1):P220 (doi: 10.1186/cc7384)
Introduction  We have no exact information about the hemo-
dynamically relevant intravascular volume effect of different volume
replacements. The aim of the study was to describe the changes in
intravascular volume status 120 minutes after the start of the
infusions using a transpulmonary thermodilution technique (PiCCO
system; Pulsion).
Methods  The prospective, randomized, multicentre study of 11
ICUs involved 200 mixed postoperative hypovolemic patients in
Hungary between 2005 and 2008. Ten millilitres per kilogram of
lactated Ringer (LR) or 4% gelatin (GEL) or 6% hydroxyethyl-
starch 130/0.4 (HES), or 5% human albumin (HA) was infused to
50 patients in each group over 30 minutes. Hemodynamic
measurements were taken at baseline, 30, 45, 60, 90 and
120 minutes after the start of infusion.
Results  There were no significant differences in basic
demographic and laboratory data among the four groups.
Differences between baseline and 120-minute values of the same
solution were significant only for the colloids: mean arterial
pressure (MAP): HES 9%, HA 6%; central venous pressure (CVP):
GEL 14%, HES 28%, HA 19%; cardiac index (CI): GEL 15%,
HES 29%, HA 20%; global end-diastolic volume index (GEDVI):
GEL 6%, HES 17%, HA 11%; stroke volume variation (SVV): GEL
–12%, HES –15%, HA –25%; oxygen delivery index (DO2I): GEL
10%, HES 15%, HA 12%; central venous oxygen saturation
(ScvO2): GEL 5%, HES 6%, HA 3%. Significant intergroup
differences at 120 minutes: MAP: HES–LR; CVP: HES–LR,
HA–LR; CI: GEL–LR, HES–LR, HA–LR; GEDVI: GEL–LR,
HES–LR, HA–LR, HES–GEL; SVV: HES–LR, HA–LR; DO2I:
GEL–LR, HES–LR, HA–LR; ScvO2: GEL–LR, HES–LR, HA–LR.
The ratio of patients with normalized baseline hypovolemia
parameters at 120 minutes: CVP: LR 0%, GEL 27%, HES 47%,
HA 20%; CI: LR 0%, GEL 50%, HES 64%, HA 50%; GEDVI: LR
0%, GEL 25%, HES 68%, HA 44%; SVV: LR 3%, GEL 20%, HES
11%, HA 25%.
Conclusions  In postoperative hypovolemic patients, 10 ml/kg LR
solution has no demonstrable hemodynamic effect 120 minutes after
the start of infusion. The colloid solutions have slightly different
hemodynamic effects. Ten millilitres per kilogram of colloids can
improve the hemodynamic parameters but their level is only 30%
maximum comparing with the baseline at the end of the second hour.
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Introduction Our goal was to analyse the relationship between the
cardiac index (CI) and the global end-diastolic volume index
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(GEDVI), a volumetric preload parameter measured by the single
transpulmonary indicator dilution technique, in a mixed population
of intensive care patients. We hypothesized a close mathematical
connection underlying observed clinical changes.
Methods  An observational study (OTKA T 046538) in the
medical–surgical ICU of a teaching hospital. Hemodynamic data
from 32 patients (altogether 122 datasets) were included in the
analysis using the PiCCO system (Pulsion, Germany). The
CI–GEDVI relationship was investigated using a regression
analysis between the main components of the equation: GEDVI =
CI x (MTt – DSt) (MTt = mean transit time, DSt = downslope time).
To illustrate purely mathematical relationships, the theoretical
correlation lines were calculated and compared with the measured
data. To demonstrate the complex relationship among all three
parameters a three-dimensional (3D) presentation was applied.
Results The 3D presentation resulted in a good fit of the measured
values onto the theoretical surface (r = 0.98). In GEDVI–CI and
GEDVI–(MTt–DSt) there were aspects of the 3D surface where the
correlation was weak (r = 0.35 and 0.34). However, classifying the
data according to the ranges of the third parameter, a positive linear
regression was observable in each range with high correlation
coefficients. In the CI–(MTt–DSt) aspect of the 3D surface the
regression was better (r = 0.76), supporting the role of hydro-
dynamic rules, and the correlation curve crossed the theoretical iso-
GEDVI lines, suggesting the effect of the Frank–Starling mechanism.
Conclusions  Our study has demonstrated that there are three
mechanisms working at the same time in the relationship between
GEDVI and CI. The basic mathematical coupling is modified by
hydrodynamic rules and the final relationship is adjusted by
physiological factors. The complex analysis revealed that CI and
GEDVI are related parameters even in clinical situations. The
physiological influences can modify this relationship significantly,
however, especially in low ranges of CI. Evaluating the GEDVI we
have to consider the CI values because the intravascular volume
status depends on the relationship of these two parameters (high
GEDVI with low CI – volume overload, the same GEDVI with high
CI – normovolaemia).
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Introduction In critical illness, optimization of the fluid status is of
central importance. This study aims to investigate whether
radiographic estimation of the global end-diastolic volume index
(GEDI), the extravascular lung water index (ELWI) and the central
venous pressure (CVP) using computed tomography (CT) is able
to contribute to an early, noninvasive evaluation of fluid status.
Methods  Thirty-two CT scans, 26 ICU patients. Estimation of
GEDI, ELWI and CVP using CT. Transpulmonary thermodilution
using the PiCCO within at most 6 hours (mean 2.25 hours) before
or after CT.
Results The diagnostic accuracy of CT-based estimation of the
volume status (GEDI <680, 680 to 800, >800) was 25%.
Sensitivity and specificity at diagnosis of hypovolemia were 0%
and 100%, respectively. The positive predictive value (PPV) for
hypovolemia was 0%. The negative predictive value (NPV) was
74%. In prediction of a hypervolemia, radiographic estimation had
a sensitivity of 89% and a specificity of 62% (PPV 36%, NPV
96%). CT-estimated and PiCCO-assessed GEDI values were
significantly different (P < 0.005; overestimation of CT-estimated
GEDI in 91%). CT-based estimation of ELWI (<7 or >7 ml/kg) had
a diagnostic accuracy of 72%. The sensitivity for the prediction of
elevated ELWI was 92% (specificity only 13%, PPV 76%, NPV
33%). The ELWI estimated using CT and the PiCCO-assessed
ELWI were significantly different (P = 0.029; underestimation of
CT-estimated GEDI in only 6%). In prediction of CVP (1 to 9 or
>9 mmHg) the estimation using CT had an accuracy of only 53%.
Sensitivity for prediction of hypervolemia was only 48% (sensitivity
of 80%, PPV 93%, NPV 22%).
Conclusions Estimation of hemodynamic parameters using CT is
difficult. Estimation of the GEDI is not accurate, sensitive or
specific for prediction of hypovolemia. At prediction of hyper-
volemia, radiographic estimation of the GEDI is suitable. At
assessment of elevated ELWI, the radiologist overestimates ELWI
values (high sensitivity 92%, poor specificity, accuracy 72%). At
estimation of CVP, the radiographic estimation is not sufficiently
accurate, sensitive or specific. Values for the GEDI and ELWI
assessed using CT or PiCCO are significantly different. Diagnostic
sensitivity/specificity of radiographic estimation probably can be
improved by interdisciplinary training.
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Introduction Shock is a critical condition. The knowledge and skills of
the physician can improve the outcome of these patients. We
therefore studied the factors that affect physician knowledge and skill.
Methods  We enrolled 12 shocked patients admitted to the
medical ICU, their symptoms having been evaluated by the patient-
care team for defining the type of shock [1,2]. Venous cathe-
terization (central venous pressure) and arterial catheterization
(A-line) had been performed for invasive monitoring data [3]. After
that either clinical evaluation data or invasive monitoring data were
collected for analysis [4].
Results All 12 shock patients, seven men and five women, were
defined in four groups: hypovolemic, cardiogenic, obstructive and
distributive/septic shock in four cases, two cases, one case, and
five cases, respectively. Shock was defined by 38 volunteer
physicians, 27 men and 11 women. All physicians were studying in
the training program: 28 were in the residency program (first,
second and third years – 12, eight and eight physicians,
respectively), 10 in the fellowship training program (first and second
years equally). We found that training physicians can define the type
of shock by clinical evaluation in 65.7% (residents vs. fellows
64.29% vs. 80%, P <0.05), and fellowship physicians can define
the type of shock significantly better than residency physicians
(P <0.05). Male physicians can define the type of shock significantly
better than females (male vs. female 70.37% vs. 54.54%, P <0.05).
In meta-analysis, clinical evaluating factors such as jugular venous
pressure, capillary filling time and lung fine crepitation are correlated
significantly with invasive monitoring factors.
Conclusions  Physician experience is important for clinical
evaluation. It can be used for evaluating shocked patients nearly as
well as invasive monitoring. It can decrease procedure compli-
cations and cost. Gender is an interesting factor that affected
evaluating abilities, it should be studied in greater numbers and in a
different population for other significant statistics.
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Introduction The transpulmonary thermodilution technique enables
measurement of the extravascular lung water index (EVLWI), which
has been described in experimental and clinical studies to be
accurate when compared with the reference method (that is,
transpulmonary double indicator technique) [1,2]. In this study, the
influence of prone positioning on the reliability of the measurement
of the EVLWI and the pulmonary vascular permeability index (PVPI) –
as a measure of capillary function – by transpulmonary thermo-
dilution was assessed.
Methods  We prospectively studied 12 consecutive critically ill
patients (eight male, four female, age 20 to 64 years) receiving
mechanical ventilation, who for clinical indication due to severe chest
trauma or acute respiratory distress syndrome underwent modified
prone positioning and extended hemodynamic monitoring by the
transpulmonary thermodilution technique (PiCCO®; Pulsion Medical
Systems AG). In all patients, an arterial thermistor catheter (A.
femoralis) was placed and connected to a monitor (PiCCO®plus,
version 7.0 nonUS). Measurements of cardiac output, intrathoracic
blood volume (ITBV), EVLWI and PVPI (five central venous bolus
injections, 15 ml NaCl, <8°C) were performed 10 minutes before
and after turning the patients into a modified prone position (135°)
from a supine position. No changes in respirator settings and fluid
status were made. The statistical analysis was performed by linear
regression and according to Bland–Altman.
Results  The range for the EVLWI was 5.0 to 21.0 and 5.0 to
22.7 ml/kg at the two time points. Linear regression analysis
revealed r = 0.95 (mean bias 0.5 ml/kg, one standard deviation
1.4 ml/kg). Furthermore, the PVPI ranged from 1.9 to 5.3 before
and 1.7 to 5.8 after prone positioning. Correlation coefficient was
r = 0.96 (mean bias 0.04, one standard deviation 0.35). The linear
regression analysis with respect to the ITBV at the two time points
showed r = 0.96, respectively.
Conclusions  Our results suggest that measurement of
extravascular lung water and pulmonary vascular permeability
indexes by the transpulmonary thermodilution technique is not
influenced by prone positioning.
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Introduction The intra-aortic balloon pump (IABP) is a device used to
help the heart pump. During the IABP assistance, significant changes
in arterial pressure waveform occur. The so-called pulse contour
methods (PCMs) use proper algorithms to analyse the arterial
pressure waveform and obtain the cardiac output (CO) [1]. As a
consequence, changes in pressure waveform in patients on IABP
may affect the reliability of different PCMs. The aim of this study was
to investigated the reliability of a new PCM, the MostCare powered
by the pressure recording analytical method (PRAM) (Vytech Health,
Laboratoires Pharmaceutiques Vygon, Ecouen, France), by
comparing its CO values (PRAM-CO) with those determined by
bolus thermodilution (ThD-CO) during aortic counterpulsation.
Methods Eight patients requiring hemodynamic support with an
IABP after coronary surgery were studied. A thermodilution
pulmonary artery catheter was inserted. To compute the CO from
the analysis of the radial artery pressure waveform, the MostCare
was connected via a cable to the monitoring system (Hewlett
Packard, Andover, MA, USA). The comparisons of CO values by
the two techniques were carried out at four different IABP settings:
1:1, 1:2; 1:3, and 1:4. Pearson’s correlation and Bland–Altman
analysis were applied. Percentages of error were also calculated.
Results A total of 64 ThD-CO and PRAM-CO measurements were
evaluated. ThD-CO values ranged from 2.4 to 6.8 l/min; PRAM-CO
values ranged from 2.6 to 6.2 l/min. Mean ThD-CO values ranged
from 4.0 ± 0.8 to 4.3 ± 0.9 l/min. Mean PRAM-CO values ranged
from 3.9 ± 0.7 to 4.2 ± 0.8 l/min. At each IABP setting: (1)
correlations between the two methods were 0.90, 0.87, 0.88, and
0.86; (2) mean biases were 0.11, 0.05, 0.10, and 0.12; and (3)
percentages of errors were 19%, 20%, 19%, and 18%.
Conclusions  Bolus thermodilution and MostCare showed a good
agreement at each time of the study. Although the IABP altered the
arterial pressure wave profile this did not seem to affect the capability
of the MostCare to adequately estimate the CO. This new device
seemed to perform suitably in patients assisted with the IABP.
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Introduction  While it is known that extravascular lung water
(EVLW) estimated by transpulmonary single thermodilution
correlates closely with gravimetric measurements of lungs in
experimental animal models, the correlation in human beings,
especially in the clinical setting, is still unclear. The aim of our study
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was to validate EVLW measured by the PiCCO system in the
clinical setting.
Methods We retrospectively analyzed the data of all 23 cadavers
whose EVLW was measured using the single indicator trans-
pulmonary thermodilution system (PiCCO; Pulsion Medical
Systems, Germany) at four teaching hospitals from July 2004 to
November 2008. We evaluated the relationship between EVLW,
the postmortem lung weight and the amount of plural effusion.
Results Although the amount of the plural effusion was between
10 ml and 1,600 ml, we found very close correlation between pre-
mortem transpulmonary measurements of EVLW and postmortem
lung weight (Figure 1; n = 23, R = 0.954, R2 = 0.91).
Conclusions Measurement of the EVLW using the PiCCO system
is very closely correlated with gravimetric measurement of lung
weight, which is independent of the amount of pleural fluid.
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Introduction  There remains controversy concerning the use of
central venous oxygen saturation (ScvO2) or mixed venous oxygen
saturation (SvO2) as a marker for resuscitation, including their
interchangeability [1,2]. We tested the hypothesis that in sepsis
ScvO2 does not reliably predict SvO2, independent of the sepsis
origin.
Methods We determined ScvO2 and SvO2 in a group of patients
with sepsis in 6-hour intervals during the first 24 hours after acute
admission.
Results Data of 29 septic patients were collected: 10 patients
with abdominal sepsis and 19 patients with other sources of
sepsis (nonabdominal group) (Table 1). Univariate analysis from
the total population and both groups separately did not show any
parameter (cardiac output, cardiac index, dopamine, nor-
epinephrine, arterial saturation, hemoglobin, hematocrit and lactate)
affecting Δ(ScvO2 – SvO2). See Figure 1.
Conclusions We conclude that in sepsis ScvO2 does not reliably
predict SvO2, independent of the sepsis origin. The difference
between ScvO2 and SvO2 in sepsis appears not to be a fixed one.
Also, this difference seems independent of several hemodynamic
parameters.
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Introduction Low central venous saturation (ScvO2) in the post-
operative period is associated with poor outcome. We examined
Available online http://ccforum.com/supplements/13/S1
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EVLW and postmortem lung weight.
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Table 1 (abstract P227)
Baseline characteristics and delta values
Abdominal Nonabdominal P value
Age (years) 63 ± 8 66 ± 14 0.37
APACHE II score 23 ± 6 29 ± 8 0.02
ScvO2 (%) 74 ± 5 71 ± 10 0.51
SvO2 (%) 77 ± 8 69 ± 12 0.10
Lactate (mmol/l) 2.6 ± 1 2 ± 1.5 0.25
Δ 0.5 ± 3 2.3 ± 6 0.45S94
whether intraoperative ScvO2 is a predictor of outcome based on
the postoperative morbidity survey (POMS) and length of hospital
stay. The POMS is a method for describing complications
associated with major surgery [1]. It comprises a nine-point survey
and provides a generic measure of short-term postoperative
outcome.
Methods Prospective ScvO2 values were collected from patients
undergoing major abdominal surgery. This was done by intermittent
sampling of blood obtained from the distal lumen of a central
venous catheter placed in the jugular vein. The POMS was used to
assess outcome on postoperative days 1, 3, 5, 8, 15 and 21 if
applicable. To accommodate local practice, however, we excluded
urinary catheter, pain and mobility from the POMS as it was not a
true reflection of organ dysfunction in our study population. We
evaluated other individual postsurgical complications as outlined in
the POMS to establish whether intraoperative median, minimum
and ΔScvO2 (end of surgery value minus start of surgery value) are
related to outcome.
Results  Fifty-two patients (average age 67.8, SD 12.0) were
included. The Portsmouth Physiological and Operative Severity
Score for the Enumeration of Mortality and Morbidity revealed a
predicted morbidity of 54.2% and mortality of 3.3%. The
commonest complications were gastrointestinal and infection
(58.7% and 19.2%, respectively). We found no correlation
between median, minimum and ΔScvO2 with postoperative compli-
cation and length of hospital stay. However, ΔScvO2 for patients
who exhibited postoperative complication on day 3 was signifi-
cantly different from the patients who did not (P = 0.035) but the
actual difference was only 2%. Minimum ScvO2 correlated weakly
with high arterial lactate measured at the end of the procedure
(Spearman r = 0.32, P=0.025).
Conclusions  Intraoperative central venous saturation in patients
undergoing major abdominal surgery is not related to postoperative
outcome or length of hospital stay.
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Introduction  Bioelectrical impedance analysis (BIA) is a widely
used method for calculating body compartments in healthy
subjects and chronically ill patients. The resistance (R) – which is
correlated with total body water – and the reactance (Xc) –
depending on the capacitance of cell membranes – are measured
by BIA. The phase angle α, a mathematical relation between R and
Xc, has qualified as a prognostic marker in several severe diseases
[1]. We aimed at monitoring body composition during the clinical
course of ICU patients and to investigate the impact of illness
severity on BIA.
Methods In this observational study we performed BIA testing at
the frequencies of 50 kHz unilaterally between the wrist and ankle
with a body impedance analyzer. BIA of ICU patients took place on
three different measuring points: M1, M2 and M3 (days 2 to 3,
days 10 to 11 and days 14 to 15 after admission). Severity of
illness was monitored by Simplified Acute Physiology Score
(SAPS) II. BIA results of each patient were matched with a
standard collective according to sex, age, and body mass index.
Spearman’s rho (rs) has been calculated to analyze correlation
between  α and SAPS II. Nonparametric analysis of longitudinal
data was carried out to analyze two groups differentiated by SAPS
II (Group 1: ≤45 points, Group 2: >45 points).
Results Forty-eight patients received one measurement at M1, 28
patients were measured at all three measuring points. BIA of our
patients differed considerably from the normal collective. There
were significant differences between the patients grouped by
primary disease (abdominal cancer patients, nontumor patients,
neurosurgical patients, multiple trauma and acute respiratory
distress syndrome). α is correlated with the ICU score SAPS II on
admission at all three measuring points (M1: n = 48, rs = –0.296,
P <0.05; M4: n = 28, rs = –0.368, P <0.005; M5: n = 28, rs =
–0.525, P <0.005). While we did not find a significant change of R
in our subsequent measurement, there was a decrease of Xc
(P <0.05). Especially in the more serious ill patients (Group 2), this
has been observed (P <0.05).
Conclusions  BIA helps to estimate body composition at ICU
admission. It is associated with primary disease and severity of
illness. During the clinical course we observed a decrease of Xc,
indicating loss of body cell mass.
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Introduction Experimental and clinical research has successfully
evaluated the performance of the respiratory quotient as a useful
marker of anaerobic metabolism in shock from different causes.
The aim of the present study was to evaluate the estimated
respiratory quotient and venoarterial pCO2 difference as suitable
anaerobic metabolism signs and outcome markers in patients with
left ventricular dysfunction undergoing coronary artery bypass
surgery.
Methods  A prospective study including 87 patients with left
ventricular dysfunction undergoing coronary artery bypass surgery
with pump was performed from January 2006 to January 2008.
Hemodynamic and metabolic parameters were obtained during five
moments: after anesthesia induction and mechanical ventilation
initiation (T0), at end of surgery (T1), at admission to the
postsurgical ICU (T2), and 6 hours after (T3) and 12 hours after
ICU admission (T4). The venoarterial carbon dioxide tension
difference (ΔpCO2) and estimated respiratory quotient (eRQ) were
also calculated. Postoperative outcomes were compared regarding
clinical events and mortality.
Results In patients with unfavorable postoperative evolution, the
eRQ values as venoarterial ΔpCO2 presented significantly higher
values at T4 compared with other groups (1.94 ± 0.9 vs. 1.43 ±
0.65, P <0.05; 8.07 ± 3.24 vs. 5.66 ± 2.78, P <0.05). Patients
with unfavorable evolution had significant higher levels of arterial
lactate concentration at 6 hours after ICU admission (4.30 ± 2.47
vs. 2.72 ± 1.48, P <0.05). Stepwise logistic regression showed
that a higher age, higher estimated respiratory quotient at T4, and
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higher lactate at T3 were all independently associated with unfavor-
able postoperative evolution (OR = 1.12; OR = 3.45; OR = 1.46).
Conclusions  In a population of patients with left ventricular
dysfunction submitted to coronary artery bypass surgery, age,
postoperative arterial lactate, eRQ and venoarterial ΔPCO2 after
12 hours of ICU admission are independent predictors of
unfavorable outcome.
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Introduction Invasive and noninvasive measurements of pulmonary
artery pressures are used to diagnose and control patients with
pulmonary artery hypertension (PAH) [1-3]. In our hospital all
patients with PAH are diagnosed and first treated in the ICU.
Besides right heart catheterization (RHC), noninvasive estimate of
pulmonary artery systolic pressure (PASP) with transthoracic
echocardiography (TTE) is performed. As RHC is an invasive
procedure it is not suitable to repeat it. We compared values of
invasively and noninvasively measured PASP to examine
correlation so we could use TTE for ambulatory control and
estimation of treatment success in our patients.
Methods In a retrospective manner we examined the correlation
between pulmonary artery pressures estimated by TTE versus
RHC among our patients, diagnosed for PAH from 2003 to 2007.
The data were collected from 36 patients with PAH of different
cause (chronic pulmonary thromboembolism, 12 patients;
connective tissue disease, 10 patients; idiopathic pulmonary artery
hypertension, eight patients; other, six patients). Bivariate
correlations were used for statistical analysis.
Results The median time interval between methods was 2 (1 to
30) days. The median PASP by RHC was 74.8 (30 to 122) mmHg
and by TTE was 62.3 (41 to 110) mmHg (r = 0.65, P <0.0001). In
29 (80.6%) patients the difference between the two methods was
>20 mmHg, and in 10 (27.8%) patients it was <10 mmHg. We did
not find a difference between the two methods regarding the
cause of PAH.
Conclusions In our group of patients we found a week correlation
between invasively and noninvasively estimated PASP. However,
there has been a trend of good correlation for a small proportion of
our patients. We conclude that when the first measurements by TTE
and RHC correlate well we can use TTE for future evaluation of
disease progress and treatment response. When the measurements
of the two methods differ we have to exclude potential reversible
cause (different examiner, different conditions, to wide time interval)
and serial invasive measurements may be needed.
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Introduction Fluid infusion is an essential part of proper medical
and surgical management. The target hemodynamic parameters for
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goal-directed fluid therapy remain controversial, with concerns
regarding the risk of overhydration. We used a splanchnic
ischemia–reperfusion (I/R) model with a high mortality rate to test
whether fluid infusion aimed to target constant left ventricular end-
diastolic volume (LVEDV) would ameliorate physiologic and
biologic parameters in this situation.
Methods Two groups of adult rats were subjected to 90 minutes
of mesenteric ischemia followed by 150 minutes of reperfusion,
with one group (I/R+Vol) receiving fluids (one-half glucose 5% and
one-half Isohes®) to maintain the LVEDV at baseline levels during
reperfusion, and the other group (I/R) receiving no extra fluids. A
sham group (instrumented without I/R) served as controls.
Results In spite of a persisting acidosis, the LVEDV-directed fluid
therapy was able to prevent the rapid fatal outcome, without
evidence of overhydration (Figure 1), as demonstrated by the
absence of an increased lung wet/dry weight ratio.
Conclusions  Early LVEDV-directed fluid therapy markedly
improves the outcome from mesenteric I/R injury.
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Introduction  Patients undergoing elective aortic abdominal
aneurysm repair are at increased risk of perioperative mortality and
morbidity. The majority of deaths in this setting are related to
cardiac complications. Brain natriuretic peptide (BNP) has recently
emerged as a predictive value in this context [1]. The current study
tests this hypothesis.
Methods We studied 34 patients. After a preoperative interview by
a senior anesthetist who assessed cardiovascular status following
the recommendations proposed by the American College of
Cardiology-American Heart Association, BNP levels were obtained
just before surgery and were blinded to the anesthetist. Myocardial
injury was defined as a cardiac troponine concentration
≥1.5 ng/ml. Statistical analysis was performed using Student’s t
test.
Results We found cardiac troponine ≥1.5 ng/ml in five patients
with myocardial injury. The preoperative BNP value was 379
(SD ±282) pg/ml in patients with myocardial injury and 88.7
(SD ±61) pg/ml in those without events. The two-tailed P value
was 0.08.
Conclusions Preoperative BNP levels are higher in patients who
develop myocardial injury; however, the P  value was not quite
significant. This could be explained with intraoperative surgical
complications (technical difficulties, blood loss, acute hypotension,
longer cross-clamp) affecting the outcome of the patient with low
BNP.
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Introduction Central venous oxygen saturation (ScvO2) can reflect
the overall balance between the systemic oxygen delivery and
supply. Several recent studies reported the importance of ScvO2
monitoring in critically ill patients. Recently, ScvO2 monitoring with
fiberoptic catheters has been made available. The aim of this study
was to evaluate the correlation between the ScvO2 values
obtained by a fiberoptic catheter (CeVOX; Seda, Milan, Italy) and
those measured with a CO-oximeter (GEM 4000; Instrumentation
Laboratory Milan, Italy).
Methods After in vivo calibration of the fiberoptic catheter, blood
samples were collected at intervals of no more than 12 hours.
Twenty-nine critically ill patients from different aetiologies (septic
shock, acute lung injury/acute respiratory distress syndrome
pneumonia, pancreatitis, trauma), 21 male, with a mean age of
59.8 ± 17.7 years, mean weight 78.6 ± 10.0 kg and mean
Simplified Acute Physiology Score of 39 ± 14 were enrolled.
Results One hundred and nineteen samples were collected. The
ScvO2 measured with the fiberoptic catheter showed a weak
correlation (r2 = 0.46) with the CO-oximeter. The mean bias
(average difference between catheter readings and CO-oximeter
values), precision (standard deviation of the bias) and limits of
agreement (bias ± 2 SD of bias) were –0.17, 4.7 and –0.17 ± 9.4
respectively (Figure 1).
Conclusions  Considering the absolute value, the fiberoptic
catheter, after 12 hours of usage without any further calibration,
presented a weak accuracy. To improve the clinical management
we suggest performing in vivo calibration more frequently.
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Figure 1 (abstract P234)
Plot of the mean ScvO2 values versus their difference by the
Bland–Altman method.S97
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Introduction  Central venous oxygen saturation (ScvO2) is
considered comparable with mixed venous oxygen saturation
(SvO2) in the initial resuscitation phase of septic shock [1]. Our
aim was to assess their agreement in septic shock in the ICU
setting and the effect of a potential difference in a computed
parameter, namely oxygen consumption. In addition, we sought for
a central venous to pulmonary artery (PA) lactate gradient.
Methods We enrolled 37 patients with septic shock who were
receiving noradrenaline infusions and whose attending physicians
had placed a PA catheter for fluid management. Blood samples
were drawn in succession from the superior vena cava (CV), right
atrium (RA), right ventricle and PA. Hemodynamic and treatment
parameters were monitored and data were compared by
correlation and Bland–Altman analysis.
Results SvO2 was lower than ScvO2 (70.2 ± 11.4% vs. 78.6 ±
10.2%;  P  <0.001), with a bias of –8.45% and 95% limits of
agreement ranging from –20.23 to 3.33%. This difference
correlated significantly to the noradrenaline infusion rate and the
oxygen consumption and extraction ratio. These lower SvO2 values
resulted in a computed oxygen consumption calculated with
oxygen saturation of pulmonary artery blood higher than the oxygen
consumption calculated with oxygen saturation of central venous
blood (P <0.001), with a bias of 104.97 ml/min and 95% limits of
agreement from –4.12 to 214.07 ml/min. Finally, lactate concentra-
tion was higher in the CV and RA than in the PA (2.42 ± 3.15 and
2.35 ± 3.16 vs. 2.17 ± 3.19 mmol/l, P <0.01 for both compari-
sons).
Conclusions  Our data suggest that ScvO2 and SvO2 are not
equivalent in ICU patients with septic shock. Additionally, the
substitution of ScvO2 for SvO2 in the calculation of oxygen
consumption produces unacceptably large errors. Finally, the
decrease in lactate between RA and PA may support the hypo-
thesis that the mixing of RA and coronary sinus blood is at least
partially responsible for the difference between ScvO2 and SvO2.
Reference
1. Marx G, Reinhart K: Venous oximetry. Curr Opin Crit Care
2006, 12:263-268.
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Introduction  Studies have suggested that tissue oxygenation
saturation (StO2) values are insensitive in assessing peripheral
perfusion. StO2 measurements may be more correctly interpreted if
measured in association with the forearm-to-fingertip skin-tempera-
ture gradient (Tskin-diff). A Tskin-diff threshold of 0ºC has been
showed to reflect vasoconstriction. We aimed to propose a
different approach for the interpretation of StO2 by adding Tskin-
diff monitoring and to characterize the pattern of StO2 dynamics in
patients with peripheral vasoconstriction and vasodilation. We
hypothesize that monitoring StO2 with Tskin-diff can more
adequately predict ICU complications than StO2 itself.
Methods StO2 was continuously monitored on the thenar with an
InSpectra Model 325 probe (Hutchinson Technology Inc.,
Hutchinson, MN, USA). The Tskin-diff was obtained from two skin
probes (Hewlett Packard 21078A; Phips Medical Systems,
Eindhoven, the Netherlands) attached to the index finger and on
the radial side of the forearm. To describe the effect of variations in
skin temperature on StO2, we compared StO2 in survivors and
nonsurvivors stratified by the condition of peripheral circulation
(vasoconstriction, Tskin-diff >0; vasodilation, Tskin-diff <0). The
first measurement was registered within 24 hours and then every
24 hours until day 3. Differences between group means were
tested by the Mann–Whitney U test. P <0.05 was considered
statistically significant.
Results  We prospectively studied 41 consecutive critically ill
patients (survivors = 29; nonsurvivors = 12): age: 49 ± 16 years;
20 septic shock, 14 nonseptic shock, seven other. No differences
in StO2 were seen between survivors and nonsurvivors (day 1:
73 ± 9 vs. 78 ± 10; day 2: 74 ± 11 vs. 75 ± 11; day 3: 76 ± 10
vs. 77 ± 9). In survivors, StO2 values were significantly lower in
peripheral vasoconstriction than in vasodilation (day 1: 69 ± 8 vs.
76 ± 8; day 2: 68 ± 13 vs. 78 ± 7; day 3: 71 ± 10 vs. 80 ± 9;
P <0.05). In nonsurvivors, this association was seen only on day 1
(71 ± 8 vs. 86 ± 4; P <0.05). Compared with survivors on day 3,
nonsurvivors had lower StO2 values in peripheral vasodilation
(69 ± 6 vs. 80 ± 9, P = 0.02) and higher StO2 values in peripheral
vasoconstriction (83 ± 7 vs. 71 ± 10, P = 0.02).
Conclusions  Dissociation between StO2 and skin temperature
was seen more often in nonsurvivors. StO2 measured in
association with skin temperature can more adequately predict
ICU death than StO2 itself.
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Introduction  Near-infrared spectroscopy is a technique for
continuous, noninvasive, bedside monitoring of tissue oxygenation
(StO2). The nature of the relationship between the kinetics of StO2
and changes in peripheral circulation has not been investigated.
After successful regional anaesthesia blocks, local vasodilation and
increased local blood flow occur as a result of blockade of
sympathetic nerve fibers. We therefore studied the effects of
peripheral vasodilation induced by regional anaesthesia blocks on
resting StO2 values.
Methods We recruited healthy adult patients (n = 8) scheduled for
selective upper limb surgery under axillary sympathetic blocks.
StO2 was continuously monitored over the thenar of the blocked
arm using an InSpectra Model 325 probe (Hutchinson Technology
Inc., Hutchinson, MN, USA) from the beginning of the local
anesthetic (T0) injection until 30 minutes was elapsed (T30). The
contralateral arm was used as a control. Differences between
Available online http://ccforum.com/supplements/13/S1S98
group means were tested by Wilcoxon signed test. P <0.05 was
considered statistically significant.
Results StO2 values in the blocked arm were significantly higher in
all patients after the anaesthesia (Figure 1). T30 versus T0, 94 ± 2
versus 82 ± 3; P = 0.002. StO2 did not increase in the control
arm.
Conclusions  Peripheral vasodilation increases StO2 in normal
conditions.
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Effect of anemia on tissue oxygenation saturation and the
tissue deoxygenation rate during ischemia
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Introduction  The hypothesis was that anemia, independently of
hemodynamic stability, affects tissue oxygenation saturation (StO2)
and the deoxygenation rate during stagnant ischemia. The blood
hemoglobin concentration is determinant of oxygen delivery. In
anemic patients, oxygen delivery decreases and oxygen extraction
is increased. This leads to decreased venous hemoglobin
saturation and a lower tissue oxygen saturation. The rate of tissue
deoxygenation during ischemia is dependent on oxygen con-
sumption and on the amount of oxygen available in the tissue [1].
Methods In a prospective observational study we included 340
patients in the medical emergency room. On admission, StO2 and
the tissue deoxygenation rate during ischemia were measured by
near-infrared spectroscopy. Patients were divided into four groups
according to hemoglobin concentration and hemodynamic (HD)
stability: Group 1 (nonanemic, HD-stable patients), Group 2
(anemic, HD-stable patients), Group 3 (nonanemic, HD-unstable
patients), Group 4 (anemic, HD-unstable patients). Differences in
StO2 and the rate of tissue deoxygenation were analyzed.
Results  Anemic groups had a significantly lower hemoglobin
concentration compared with nonanemic groups (138 ± 16 vs.
76.5 ± 15 g/l, P <0.001). HD-unstable groups had significantly
higher lactate levels compared with HD-stable groups (1.6 ± 0.6
vs. 3.9 ± 1.6 mmol/l, P <0.001). The results are presented in Table
1. StO2 in Groups 2 and 3 was comparable, while the difference in
the deoxygenation rate in these groups was significant
(P = 0.007).
Conclusions  Anemia significantly affects StO2 and the deoxy-
genation rate. It probably contributes to lower StO2 equally as HD
instability. In contrast to HD instability, anemia causes more rapid
deoxygenation during ischemia.
Reference
1. Creteur J: Muscle StO2 in critically ill patients. Curr Opin
Crit Care 2008, 14:361-366.
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Introduction The aim of this study was to compare near-infrared
spectroscopy with global parameters of tissue oxygenation after
cardiac surgery, such as cardiac output (CI), mixed venous oxygen
saturation (SvO2) or lactate concentration. After cardiac surgery,
the circulating blood volume and cardiac function is regularly
reduced on the ICU [1]. This results in reduced microperfusion and
peripheral vasoconstriction. The noninvasive InSpectra StO2
monitor (Hutchinson Technology Inc., Hutchinson, MN, USA)
measures the oxygen saturation in the microcirculation of the
thenar muscle [2].
Methods Forty patients after cardiac surgery were monitored with
a StO2 monitor and a Swan–Ganz catheter measuring CI and
SvO2 on the ICU. Additionally intermittent lactate and blood gas
analysis was performed. ANOVA was used for statistics of results.
Results  The mean Euro-Score of the patients was 6.5 ± 3.7
including 24 aortocoronary bypass, five heart valve, three ascen-
ding aorta and eight combined cardiac operations. After admission
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Figure 1 (abstract P237)
Effect of peripheral blood flow variations in StO2 during regional block.
Table 1 (abstract P238) 
Group 1, n = 251 Group 2, n = 30 P value Group 3, n = 48 Group 4, n = 10 P value
StO2 (%) 80.5 ± 7.8 76 ± 7.7 0.003 76.5 ± 11.9 68.2 ± 9.6 0.04
Deoxygenation rate (%/min) 16.5 ± 6.7 19.6 ± 6.6 0.017 14.8 ± 7.4 16.7 ± 5.7 NS
Figure 1 (abstract P239)
Course of StO2, cardiac output, SvO2 and lactate concentration.S99
StO2, CI and SvO2 were significantly reduced (Figure 1). The
lactate concentration and noradrenaline dose were increased
(P <0.05). On day 1 the noradrenaline dose dropped after fluid
substitution, but only the StO2 value recovered.
Conclusions After heart surgery StO2 indicated the reduction as
well as the recovery of microcirculation early, whereas the lactate
concentration and SvO2 seemed to demonstrate a delayed
response especially of recovery. Management of postoperative
fluid and catecholamine therapy by StO2 to optimize micro-
circulation should be the subject of further studies.
References
1. Tschaikowsky K, et al.: Changes in circulating blood volume
after cardiac surgery measured by a novel method using
hydroxyethyl starch. Crit Care Med 2000, 28:336-334.
2. Myers DE, et al.: Noninvasive method for measuring local
hemoglobin oxygen saturation in tissue using wide gap
second derivative near-infrared spectroscopy. J Biomed
Opt 2005, 10:034017.
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Introduction Dynamic testing of muscle tissue oxygenation (StO2)
with near-infrared spectroscopy and vascular occlusion (VOT) has
been used to study pathophysiological states, but there is a
paucity of data for standardised techniques in normal subjects.
Three-minute VOT is frequently described. We have collected
StO2 data for this technique and compared them with a shorter
2-minute test.
Methods  Twenty-five subjects were studied using an InSpectra
650 monitor and a 15 mm probe. VOT was applied at systolic
blood pressure + 50 mmHg on opposite arms for 3-minute and
2-minute time periods. StO2 data are reported for baseline,
downslope (DS) and upslope (US)%/minute, overshoot%, area
over the ischaemic curve (AOC Isch) and area under the recovery
curve (AUC Rec)%/minute and recovery time (Rec Time) in
minutes. Differences were analysed using paired t tests. Individual
differences were then examined in relation to a predicted magni-
tude of response based on the ischaemic load and occlusion time.
Results Three-minute VOT versus 2 minutes: AOC Isch (–52.99
vs. –25.79%/min, P  <0.001), overshoot (14.96 vs. 13.2%,
P = 0.004), AUC Rec (18.89 vs. 15.33%/min, P  = 0.01), Rec
Time (2.37 vs. 2.05 min, P  = 0.004). DS (–11.18 vs.
–12.35%/min,  P  = 0.08) and US (212.99 vs. 201.24%/min,
P = 0.365) were not significantly different. The 2-minute ischaemic
load was 0.5 times that of 3 minutes (AOC Isch –25.79/–52.99).
The ratios of response parameters were compared with this value
using one-sample t tests and were significantly greater: overshoot
(0.89 ± 0.16, P <0.001), AUC Rec (0.86 ± 0.35, P <0.001), Rec
Time (0.88 ± 0.21, P <0.001).
Conclusions StO2 VOT is a promising tool that is likely to advance
our knowledge of microvascular function under ischaemic stress.
To standardise data interpretation it is imperative that similar
techniques are used. We have reported data for two reproducible
VOTs in a healthy control group. Understandably, there are
differences in hyperaemic response parameters that are dependent
on the ischaemic time; however, the relationship is no linear. Our
data suggest that although 2-minute VOT represents a halving of
the ischaemic load versus 3 minutes, subjects demonstrate almost
90% comparable hyperaemic responses. This suggests a
diminishing return in hyperaemia with longer occlusive time. Further
work is required to evaluate the efficacy and practicality of different
VOTs.
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Introduction Dynamic testing of muscle tissue oxygenation (StO2)
with near-infrared spectroscopy and vascular occlusion (VOT) is a
developing area of research in critical care. VOT is often performed
multiple times during analysis. We report the impact of repeated
VOT on StO2 parameters.
Methods  Twenty-five healthy subjects were studied with the
InSpectra 650 monitor and a 15 mm probe. VOT was set at
systolic blood pressure + 50 mmHg for 3 minutes in triplicate.
Each VOT was separated by a 5-minute rest period. StO2 data are
reported for baseline%, downslope (DS) and upslope (US)%/min,
overshoot%, area over the ischaemic curve (AOC Isch) and area
under the recovery curve (AUC Rec)%/min and recovery time (Rec
Time) in minutes. Data were compared by ANOVA.
Results See Table 1.
Conclusions  It is important to understand the impact of serial
VOT. We have observed sequential change in rates of StO2
decline during ischaemia (reduced DS gradients, total drop and
AOC Isch). Although the overshoot was unchanged, the AUC Rec
and Rec time demonstrated increases approaching significance.
These patterns imply a preconditioned adaptation to repeated VOT
and an exaggerated hyperaemic response. Further studies are
required to determine acceptable rest periods between VOTs to
ameliorate these changes.
Available online http://ccforum.com/supplements/13/S1
Table 1 (abstract P241)
Population StO2 means (±SD) for consecutive VOT and significance
StO2 curve  Baseline  Total drop  DS  US  AOC Isch  Overshoot  AUC Rec  Rec Time 
parameter (%) (%) (%/min) (%/min) (%/min) (%) (%/min) (min)
VOT 1 78.7 (±4.2) 33.4 (±7) –11.2 (±2.5) 213 (±55.8) –53 (±11.5) 15 (±3.8) 18.9 (±6.6) 2.4 (±0.4)
VOT 2 78.3 (±4.2) 29.8 (±6.2) –10 (±2.3) 240 (±58.8) –48.2 (±10.7) 14.9 (±3.7) 21.7 (±7.5) 2.6 (±0.4)
VOT 3 77.9 (±4) 28.2 (±5.5) –9.4 (±1.8) 220 (±45.3) –44.5 (±8.7) 15.3 (±3.5) 23.4 (±7.3) 2.6 (±0.5)
P value 0.79 0.01 0.02 0.19 0.02 0.92 0.09 0.09S100
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Introduction  Microcirculatory, leucocyte/endothelium interaction
and survival time effects of dobutamine in the dose of 5 μg/kg/
minute associated or not with volume resuscitation were studied in
the hamster window chamber model during resuscitation from
nonhypotensive endotoxemia [1,2].
Methods  Awake hamsters were submitted to endotoxemia with
intravenous injection of lipopolysaccharide (LPS) in the dose of
2 mg/kg. After 3 hours of LPS injection they were divided into four
groups: LPS (n = 6): received no treatment; VR (n = 6):
resuscitated with 40 ml/kg body weight of NaCl 0.9% in 1 hour
followed by 20 ml/kg body weight during the remaining 4 hours;
Dobuta (n = 6): received dobutamine infusion in the dose of
5 μg/kg/minute for 3 hours; Dobuta/VR (n = 6): resuscitated with
40 ml/kg body weight of NaCl 0.9% in the first hour followed by
20 ml/kg body weight during the remaining 2 hours, the last
combined with dobutamine in the dose of 5 μg/kg/minute. The
groups were compared with Control (n = 7): no treatment. Arteriolar
and venular diameters, functional capillary density (FCD), leukocyte
rolling and adhesion, and 72-hour survival time were evaluated.
Results Dobuta had lower arteriolar diameter than Control (51 ± 10
and 114 ± 10% from baseline). LPS and Dobuta had lower FCD
than Control and baseline values (18 ± 15; 16 ± 18; and 88 ± 6%
from baseline, in LPS, Dobuta and Control, respectively). VR and
VR/Dobuta restored FCD from baseline (382 ± 19 and 476 ± 30%
from baseline in VR and VR/Dobuta, respectively). FCD in VR and
VR/Dobuta were lower than Control. LPS and Dobuta had higher
leucocytes adhesion than Control (42.2 ± 10; 32.2 ± 31; and 4.0 ±
7.1 leucocytes/mm2 in LPS, Dobuta and Control groups, respec-
tively). There was no significant difference in survival time between
VR and Control, and VR/Dobuta and Control. Survival time was
significantly lower in LPS and Dobuta than Control.
Conclusions  Dobutamine associated or not with volume
resuscitation did not improve microcirculatory parameters,
leucocyte adhesion or survival time during resuscitation from
nonhypotensive endotoxemia while volume resuscitation restored
microcirculatory parameters and improved survival time.
References
1. Secchi A, et al.:  Dobutamine maintains intestinal villus
blood flow during normotensive endotoxemia: an intravital
microscopic study in the rat. J Crit Care 1997, 12:137-141.
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dopexamine on microcirculatory blood flow in the gas-
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Introduction  Microcirculatory, leukocyte/endothelium interaction
and 7-day survival time effects of human recombinant C-reactive
protein (rCRP) associated or not with volume resuscitation were
studied in the hamster window chamber model during resusci-
tation from nonhypotensive endotoxemia [1,2].
Methods  Awake hamsters subjected to endotoxemia with
intravenous injection of lipopolysaccharide (LPS) (2 mg/kg) were
divided, 1 hour after LPS injection, into four groups: LPS (n = 6):
no treatment; VR (n = 6): received 40 ml/kg body weight of NaCl
0.9% in 1 hour followed by 20 ml/kg body weight during the
remaining 4 hours; rCRP (n = 6): received rCRP infusion in the
dose of 24 μg/kg/hour during 5 hours; VR/rCRP (n = 6): received
40 ml/kg body weight of NaCl 0.9% in the first hour followed by 20
ml/kg body weight during the remaining 4 hours, and in the last
period it was combined with rCRP infusion in the dose of 24
μg/kg/hour. Groups were compared with Control (n = 6): no LPS.
Arteriolar and venular diameters, functional capillary density (FCD),
venular leukocyte rolling and adhesion, and 7-day survival time
were evaluated.
Results  LPS reduced FCD so it was maintained lower than
Control and baseline even after 24 hours (13 ± 11 and 100 ± 7%
from baseline in LPS and Control, respectively). Volume
resuscitation and rCRP restored FCD to baseline levels but it was
lower than Control after 24 hours (36 ± 25 and 32 ± 20% from
baseline in VR and rCRP, respectively). VR/rCRP restored FCD
and it was not different from Control (72 ± 26% from baseline in
rCRP). Arteriolar and venular diameters were not different among
groups. LPS increased the number of sticking leukocytes to the
venular wall (41.2 ± 13 and 1.1 ± 1 leucocytes/mm2 in LPS and
Control, respectively). rCRP and VR/rCRP significantly reduced
venular leukocyte adhesion (12.6 ± 7.1 and 11.8 ± 9.5
leucocytes/mm2 in rCRP and VR/rCRP, respectively). There was
no difference in rolling leukocytes among groups. The survival
curve was not significantly different in rCRP, VR and VR/rCRP
from Control.
Conclusions  rCRP associated or not with volume resuscitation
improved tissue perfusion, reduced the number of sticking
leukocytes and increased the survival time during endotoxemia in
the hamster model.
References
1. Joyce DE, et al.: Leukocyte and endothelial cell interactions
in sepsis: relevance of the protein C pathway. Crit Care
Med 2004, 32(5 Suppl):S280-S286.
2. Iba T, et al.:  Activated protein C improves the visceral
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Introduction To assess potential metabolic and microcirculatory
alterations in critically ill patients, near-infrared spectroscopy
(NIRS) has been used, in combination with a vascular occlusion
test (VOT), for the noninvasive measurement of tissue oxygen
saturation (StO2), oxygen consumption, and microvascular reper-
fusion and reactivity. However, the methodologies for assessing
StO2 are very inconsistent in the literature and results vary from
study to study. In this study we investigated the effects of the
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probe spacing and measurement site, using both a 15 mm and a
25 mm probe spacing on the thenar and the forearm, in healthy
volunteers.
Methods  StO2 was noninvasively measured in eight healthy
volunteers during 3-minute VOTs using two InSpectra Tissue
Spectrometers equipped with either a 15 mm or a 25 mm probe.
VOT-derived StO2 traces were analyzed for baseline, ischemic,
reperfusion, and hyperemic parameters.
Results Although not apparent at baseline, the probe spacing and
measurement site significantly influenced VOT-derived StO2
parameters (Figures 1 and 2). StO2 parameters in the hyperemic
phase of the VOT were shown to significantly correlate to the
minimum StO2 value after 3 minutes of ischemia.
Conclusions The present study showed that NIRS measurements
in combination with a VOT are measurement site and probe
dependent. Additionally, this study indicated that reactive
hyperemia depends on the extent of ischemic hit and supports the
use of a target StO2 over the use of a fixed time of occlusion.
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Introduction  It is known that formation of a gastric tube after
esophagectomy impairs microcirculatory perfusion in the anasto-
motic region. The impaired microcirculatory perfusion is caused by
poor arterial inflow and insufficient venous drainage, due to ligation
of three of the four gastric arteries. We therefore hypothesized that
improving venous drainage by giving nitroglycerin (NTG) and
titrating norepinephrine (NE) to increasing levels of mean arterial
pressure (MAP) would improve microcirculatory perfusion of the
distal part of the gastric tube.
Methods Five pigs, bodyweight 30.5 ± 0.5 kg (mean ± SD) were
anaesthesized and instrumented for continuous hemodynamic
monitoring. A median laparotomy was performed and a gastric
tube was reconstructed. Laser speckle imaging was used to
measure the microcirculatory blood flow (MBF) in the gastric tube.
Laser speckle imaging is a laser-based technique that measures
MBF in a macroscopic field at a video frame rate. NTG was titrated
to in order to achieve a central venous pressure below 10 mmHg.
MBF was measured at the base and at the distal site of the gastric
tube at MAP increasing stepwise from 50 to 110 mmHg. For this
purpose the MAP was decreased with infusion of propofol and
increased with infusion of NE. We determined the flow at the distal
site for each step compared with flow at the base of the gastric
tube (fraction of flow) in percentages.
Results  Hemodynamic values: MAP was increased in steps of
10 mmHg. The heart rate and cardiac output remained constant at
around 123 ± 28 bpm and 4.2 ± 1.0 l/min, respectively. Central
venous pressure and pulmonary artery occlusion pressure did not
change throughout the experiment. MBF results: at MAP below
70 mmHg the fraction of flow at the distal part was
23.49 ± 3.47%. This increased significantly to 31.12 ± 9.15% at
MAP between 70 and 90 mmHg. The fraction of flow for MAP
above 90 mmHg was 29.42 ± 6.84%. See Figure 1.
Conclusions Hypotension impairs flow in the distal part compared
with the base of the gastric tube. Normotension significantly
improves flow in this region. MBF in the distal part does not benefit
from increasing MAP to supranormal values.
Available online http://ccforum.com/supplements/13/S1
Figure 1 (abstract 244)
Mean ± SD StO2 values in the thenar during a 3-minute VOT. BSLN,
baseline.
Figure 2 (abstract 244)
Mean ± SD StO2 values in the forearm during a 3-minute VOT. BSLN,
baseline.
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Introduction  In burn-injured patients we have previously shown
that skin has a decreased autoregulatory blood flow adjustment.
Lack of such a function in skin would make uncontrolled use of
vasoconstrictors detrimental to this organ. If ischemia-like
conditions are produced in the skin, use could enhance the
inflammatory response and increase the risk of organ dysfunction.
We exposed local areas of the skin in healthy volunteers to
therapeutic levels of noradrenaline (NA) by infusion through micro-
dialysis (MD) intradermally, to investigate whether autoregulatory
escape is present in the skin during strong α1-adrenergic
stimulation.
Methods  Five subjects received three MD catheters (CMA 70)
intradermally in the lower arm. Catheters were perfused for a
90-minute stabilizing period, Ringer solution with 20 mmol/l urea,
for skin blood flow determinations (urea clearance). Thereafter NA
0.5 or 5 μg/ml was perfused (2 μl/min) for 60 minutes followed by
a buffer washout period. After this 0.5 mg/ml nitroglycerine was
perfused (2 μl/min) for 60 minutes. Samples were collected every
10 minutes and analysed for urea, lactate, pyruvate and glucose.
Results During perfusion with NA 5 and 0.5 μg/ml, skin blood flow
decreased significantly as indicated by changes in urea clearance;
increased lactate pyruvate quotients and corresponding rapid
decreases in tissue glucose levels. These changes further
increased during the perfusion of pure buffer. Normalization was
first noted during infusion of nitroglycerine.
Conclusions Both doses of NA, previously claimed to be physio-
logical, induce a reproducible and severe vasoconstriction as
indicated by effects on urea clearance, increases in lactate
pyruvate quotients and decreases in tissue glucose. These data
suggest that skin lacks an autoregulatory escape function and
ischemia was induced in the skin of healthy volunteers by the NA
infusion. The ischemia situation further deteriorated until an active
vasodilatation was started. In this skin vascular model, in healthy
volunteers, NA shows negative effects that may also be important
for the critical care setting. Further studies are needed to validate
these findings.
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Introduction The crucial role of the microcirculation in improved
neurological outcome in patients after successful resuscitation has
been discussed for many years. New noninvasive imaging
techniques enable the visualization and analysis of the micro-
circulation  in vivo. Our study utilised an orthogonal polarization
spectral (OPS) noninvasive imaging technique to test
microcirculation in patients after successful resuscitation.
Methods Between February and November 2008, 20 successfully
resuscitated patients were investigated in the medical intensive
care department of Albert Ludwigs University, Freiburg. OPS
measurements were performed at the time of mild therapeutic
hypothermia and after rewarming. These results were compared
with the results of a control group that consists of 15 healthy
people. OPS measurements were performed using the MicroScan
from MicroVisionMedical. The recorded sublingual microcirculation
images were analysed utilising the AVA software with a focus on
the microcirculation parameters of total vessel density (TVD,
mm/mm2) and perfused vessel density (PVD, mm/mm2).
Results  Patients after successful resuscitation showed a
significant decrease in the tissue-dependent microcirculation
compared with control (TVD: 5.33 ± 1.45 vs. 6.87 ± 1.07;
P = 0.002) and PVD (3.48 ± 1.59 vs. 6.69 ± 1.03; P = 0.0002).
Patients after successful resuscitation showed, during therapeutic
hypothermia, a significant increased microcirculation (TVD and
PVD) compared with the rewarmed phase (TVD: 6.41 ± 1.53 vs.
5.33 ± 1.45; P = 0.028; and PVD: 4.96 ± 2.3 vs. 3.48 ± 1.59;
P = 0.023). These effects were independent of the use of
catecholamines.
Conclusions We could demonstrate significant alterations of the
tissue-dependent microcirculation in patients after successful
resuscitation. Patients in the post-resuscitation phase showed
during therapeutic hypothermia an increased microcirculation,
reflecting TVD and PVD, compared with the microcirculation after
rewarming, independent of noradrenaline or dobutamine.
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Introduction Microcirculatory dysfunction is a key element in the
pathogenesis of severe sepsis and septic shock and is related to
endothelial dysfunction. Studies in vivo have shown that infusion of
magnesium sulphate increased endothelium-dependent vasodila-
tation in healthy people and patients with cardiac disorders, but the
effect on the septic patient’s vessels, especially small ones, is
unknown. We hypothesized that magnesium sulphate infusion can
improve microcirculation in patients with severe sepsis and septic
shock.
Methods Six septic patients (mean age 56 ± 16 years), who had
already been fluid resuscitated, underwent magnesium sulphate
infusion 2 g over 60 minutes with additional volume loading and
use of norepinephrine if required. Sublingual microcirculation was
evaluated using side dark-field videomicroscopy (MicroScan®;
MicroVisionMedical). Each patient’s microcirculation was evaluated
by examining three to six different sublingual areas (10 to
20 seconds/image). In all patients, measurements were obtained at
baseline and after 60 minutes. Images were analyzed by
semiquantitative scores of flow (mean flow index; proportion of
perfused vessels) and density (total vascular density; perfused
vascular density) of small vessels (<20 μm). Data are presented as
median values (percentiles 25 to 75).
Results  Data of this study have shown that perfused vascular
density increased from 9.7 (4.9 to 13.0) n/mm (at baseline) to 12.1
(10.1 to 13.6) n/mm (at 60 min), proportion of perfused vessels
increased from 70 (40 to 83)% to 77 (67 to 85)% but without
statistical significance, P = 0.068.
Conclusions  Magnesium sulphate has a tendency to improve
microcirculation in severe sepsis and septic shock patients, but
further studies are needed to obtain more detailed results.
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Introduction  The increase in endothelial capillary permeability
represents one of the early and significant hallmarks of sepsis. An
inflammatory-induced damage in endothelial glycocalyx has been
identified as the mechanism involved in this increase in perme-
ability in the condition of ischemia–reperfusion [1]. To date no data
are available for glycocalyx damage in sepsis. The aim of this study
was to evaluate whether sepsis-associated increase of
permeability is due to glycocalyx alteration.
Methods To induce sepsis, the cecal ligation and puncture (CLP),
a clinically relevant model of polymicrobial infection that mimics
human sepsis, was used [2]. Nine rats underwent CLP, two rats,
receiving laparotomy only, served as control. Rats were then
transcardially perfused with PBS and PBS + paraformaldehyde
4% at three different time points (3, 7 and 15 hours after CLP).
Kidneys were collected and processed for light and confocal
microscopy examination. Alterations in glycocalyx were studied
using digoxigenin-labelled lectin maackia amurensis agglutinin
(MMA) (to identify sialic acids, a large family of nine-carboxylated
sugars present on the cell surface) and mouse monoclonal
antibody against Syndecan-1 (an integral membrane proteo-
glycan).
Results  In control rats, the luminal surface of the glomerular
endothelium appeared intensely stained for MMA lectin and
Syndecan-1, indicating the presence of normal glycocalyx. Since
its early phase (3 hours), sepsis induced a significant alteration in
the glomerular endothelial glycocalyx, which worsened at later time
points (7 and 15 hours). At 15 hours, disruption of the glomerular
architecture was also present.
Conclusions Alterations in endothelial glycocalyx may represent
the first step of sepsis-related changes in permeability. It is likely
that treatments aimed at preserving glycocalyx may also prevent
not only the increase in permeability but possibly glomerular
disruption.
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Introduction  Sepsis-associated renal failure is a common
complication of septic shock. The current study investigates
whether an innovative score of electron microscopic tubular injury
(EMTI) is correlated with plasma creatinine concentration in ovine
endotoxemic shock.
Methods Twenty-nine awake healthy ewes received a continuous
endotoxin infusion until the mean arterial pressure (MAP) fell below
65 mmHg. Thereafter, sheep were optimally volume-resuscitated
and received norepinephrine to establish a MAP of 70 ± 5 mmHg.
After 12 hours animals were anesthetized and killed. Kidney tissue
samples (10 per animal) were analyzed with standard transmission
electron microscopy techniques. The EMTI score (0 to 12) was
determined as the sum of (1) vacuolar cell degeneration (0 to 3),
(2) basal membrane dissociation (0 to 3), (3) epithelial cell injury (0
to 3), and (4) luminal obstruction (0 to 3). The EMTI score was
averaged as the mean value of the 10 kidney samples of each
animal and was correlated with maximum plasma creatinine
concentrations by Pearson product moment correlation.
Results The EMTI score (median 5.9; 25% to 75% range 4.1 to
6.9) significantly correlated with the plasma creatinine concen-
tration (1.19; 1.06 to 1.34) with a correlation coefficient of R =
0.371 (P = 0.0476; Figure 1).
Conclusions The EMTI score is useful to quantify alterations of
renal tubular integrity and thereby reflects changes in renal function
in ovine endotoxemia. Scientific use of the EMTI score may provide
further insight into the pathophysiology of sepsis-associated renal
failure.
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Introduction A prominent role of inflammatory mediators such as
cytokines is increasingly recognized to play a prominent role in the
development of renal injury during sepsis. Because of its high
mortality rates, early detection of renal injury is of the utmost
importance and the discovering of renal biomarkers seems
promising in achieving this goal.
Methods  We induced endotoxin tolerance to accomplish an
attenuated proinflammatory state by intravenous injection of
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2 ng/kg/day lipopolysaccharide (LPS) on 5 consecutive days in
five healthy male volunteers. Renal function was monitored and
urinary proteome research was performed before and after LPS
administrations on days 1 and 5.
Results  Repeated LPS administrations induced an increase in
serum creatinine of 11 ± 3% (P  = 0.002) and a diminished
glomerular filtration rate of 33 ± 7% (P = 0.02) on day 3, which
was associated with the appearance of 15 peak intensities and an
increase in β2-microglobulin levels (P = 0.04) 6 hours after the first
LPS administration. Four of the 15 peak intensities correlated with
serum creatinine levels; namely, 3,950 (r = 0.91,  r2 = 0.84,
P = 0.03), 4,445 (r = 0.97, r2 = 0.94, P = 0.01), 6,723 (r = 0.94,
r2 = 0.88,  P = 0.02) and 7,735 mass per charge (r = 0.87,
r2 = 0.75,  P = 0.05). During day 5 of the repeated LPS
administrations, endotoxin tolerance developed and renal function
was restored, reflected by serum creatinine levels of 70 ± 6 μmol/l
(P = 0.2, day 1 compared with day 5) and by attenuated peak
intensities on the urinary proteome profiles (P <0.0001 for all
measured 15 peak intensities) and β2-microglobulin levels
comparable with baseline on the first day (P = 0.35).
Conclusions  Renal injury occurs on day 3 during repeated
endotoxemia, as adequately predicted by urinary proteome
research on day 1. A significant correlation was found between
four markers and the extent of renal injury, which may act as
potential new biomarkers for renal injury at an early stage of
inflammation. The inflammation-induced renal injury subsided when
LPS tolerance developed after 5 consecutive days of LPS
administrations.
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Introduction  Acute kidney injury (AKI) is common in patients
admitted to intensive care. Diagnosis of AKI relies on serum
creatinine and urine flow. These have disadvantages of low
specificity and sensitivity and a slow rate of change. Renal damage
results in release of tubular enzymes into the urine. Measurement
of urinary alpha glutathione S-transferase (αGST) and pi
glutathione S-transferase (πGST) may indicate AKI more acutely
and accurately than current methods of diagnosis.
Methods  Urine was collected from patients with a sepsis
diagnosis 4 hourly over 48 hours. Urine was frozen, and urinary
πGST and αGST measured. Fluid and vasopressor management
was recorded, but managed independently. Serum creatinine was
measured at 0, 24 and 48 hours. AKI was diagnosed using AKI
Network criteria [1].
Results We present the first 35 patients recruited, 20 were male,
15 female. Median patient age was 53 years. Median APACHE II
score was 13. Median ICU length of stay was 9 days. ICU mortality
was 14%, hospital mortality 23%. AKI was diagnosed in 26% of
patients. Statistical significance was tested by Wilcoxon signed-
rank test. Although the median πGST at 0 hours was elevated
(11.8 μg/l (non-AKI) versus 22 μg/l (AKI)) this was not statistically
significant between the two groups, P  = 0.985. πGST did not
demonstrate an increased urinary level in AKI versus non-AKI
(median values 0.89 μg/l vs. 3.4 μg/l at 0 hours). See Figure 1.
Conclusions  A trend towards early expression of πGST was
identifiable in this study. This may indicate early detection of AKI,
which may help guide therapeutic interventions. πGST does not
seem to be released as a biomarker using this sepsis model,
suggesting a more specific distal tubular injury. Further work is
required to determine levels of πGST in nonstressed kidneys.
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Introduction  Serum creatinine is a late marker of acute kidney
injury (AKI). Plasma neutrophil gelatinase (pNGAL) is an early
biomarker of AKI after cardiac surgery. The purpose of this study
was to assess the ability of pNGAL to predict AKI in ICU patients.
Methods All patients admitted to three ICUs of the same institution
were enrolled in this prospective observational study. pNGAL was
analyzed at ICU admission. RIFLE criteria were calculated at
admission and for each day during the first week. Patients were
classified according to RIFLE criteria (RIFLE 0 or 1). Four groups
were identified: RIFLE 0–0, 1–1, 1–0 and 0–1.
Results During this 1-month period, 88 patients were included in
the study. Thirty-six patients had RIFLE 0–0 with a mean pNGAL of
98 ± 60 nmol/l. Twenty-two patients had RIFLE 1–1 with a mean
pNGAL of 516 ± 221 nmol/l. Twenty patients had no AKI at
admission but developed AKI at 48 hours (24 to 96 hours) (RIFLE
0–1). In this case the mean pNGAL was 342 ± 183 nmol/l. Ten
patients had RIFLE 1–0 and the mean pNGAL was
169 ± 100 nmol/l. With a cutoff value of 155 nmol/l, the sensibility
and specificity to predict AKI were respectively 82% and 97%.
Seven patients needed extrarenal therapy, all of them had pNGAL
>155 nmo/l. The patients with pNGAL <155nmol/l had more
shock, more sepsis and a higher Simplified Acute Physiology
Score II score.
Conclusions pNGAL at ICU admission is an early biomarker of AKI
in a setting in which the timing of kidney injury is unknown. pNGAL
increases 48 hours before RIFLE criteria.
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Introduction Literature data suggest that the release of nitric oxide
(NO) by endothelial NO synthase contributes to functional
alterations of the peritoneal membrane induced by acute perito-
nitis. Experimental animal studies show that induced peritonitis was
characterized by structural changes in the peritoneal membrane
and increased permeability for urea and glucose, as well as
increased protein loss in dialysate [1]. Plasma cholinesterase
(PChE, 3.1.1.8) is an enzyme synthesized in the liver, molecular
mass from 345,000 to 371,000 Da. The aim of this study was to
evaluate the functional characteristics of the peritoneum,
determining PChE transfer from blood to dialysis fluid in peritonitis-
free patients and in patients with peritonitis.
Methods We measured PChE activity in plasma and peritoneal
dialysate in adult peritonitis-free patients (n = 20) and in patients
with peritonitis (n = 12). For determination of PChE activity, vein
blood samples were collected and stored at –20°C until analysed.
PChE activity was determined by the spectrophotometric method
of Ellman and colleagues [2], using butyryltiocholine as the
substrate (Sigma Chemical Co., St Louis, MO, USA). Statistical
analysis was made by Mann–Whitney U test and Wilcoxon
matched-pairs test.
Results  In both groups of examined patients we detected the
significant passage of PChE from blood to dialysis fluid
(P = 0.000089 for peritonitis-free patients and P = 0.002218 for
patients with peritonitis). The transperitoneal PChE passage
degree is statistically unchanged in patients with peritonitis in
relation to peritonitis-free patients (P = 0.119438).
Conclusions In all patients we detected significant transperitoneal
passage of PChE during peritoneal dialysis. During human
peritoneal dialysis there is no peritoneal permeability change for
macromolecules such as PChE protein complex in patients with
peritonitis.
References
1. Jie NI, et al.: J Am Soc Nephrol 2003, 14:3205-3216.
2. Ellman GL, et al.: Biochem Pharmacol 1961, 7:88-95.
P255
Early predictive value of neutrophil gelatinase-associated
lipocalin in adult ICU patients with acute kidney injury
H De Geus, J Le Noble, F Zijlstra, C Ince, J Bakker
Erasmus University Medical Center, Rotterdam, the Netherlands
Critical Care 2009, 13(Suppl 1):P255 (doi: 10.1186/cc7419)
Introduction We investigated the early predictive value of plasma
and urine neutrophil gelatinase-associated lipocalin (NGAL)
compared with serum creatinine in patients with acute kidney injury
(AKI) in a heterogeneous adult ICU population. Previous studies
display the excellent predictive value of urine NGAL for AKI in a
pediatric ICU setting [1,2].
Methods A prospective cohort study was conducted, including 63
patients. After ICU admission, plasma and urine samples were
collected at eight time points. NGAL measurements were performed
using an ELISA. The difference between the increase in NGAL and
the increase in serum creatinine was calculated in relation to the
time point at which maximum AKI was reached (T = 0). AKI was
defined according to Acute Kidney Injury Network definitions.
Results Mean age (±SD) in years and APACHE II (±SD) scores for
AKI I (n = 22), II (n = 21) and III patients (n = 20) were respectively
(56 ± 18, 21 ± 7), (58 ± 19, 25 ± 8) and (63 ± 13, 27 ± 7). In AKI
III patients, the difference between the increase in plasma NGAL
and the increase in serum creatinine expressed as a percentage
(95% CI) at 72, 48 and 24 hours prior to maximum AKI was 203%
(–169 to 574), –10% (–221 to 830) and –25% (–205 to 155). For
urine NGAL and serum creatinine the difference was respectively
584% (–603 to 1,770), 756% (12 to 1,499) and 726% (240 to
1,212). Figures 1 and 2 depict the increase in urine NGAL and
serum creatinine separately and their difference in relation to T = 0.
There was no positive difference in patients with AKI stages I and II
for urine or plasma at any time point prior to maximum AKI.
Conclusions NGAL is, compared with serum creatinine, an earlier
predictor of AKI III, in a heterogeneous adult ICU population. Urine
NGAL provides a larger and more sustained window of early
prediction than plasma NGAL in patients with developing AKI III.
The use of urine NGAL as an early predictive biomarker for AKI III is
therefore promising in an adult heterogeneous ICU setting.
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Introduction Echo-state networks are part of a group of reservoir
computing methods and are basically a form of recurrent artificial
neural networks. These methods can perform classification tasks
on time-series data. The recurrent artificial neural network of an
echo-state network has an echo-state characteristic. This echo
state functions as a fading memory: samples that have been
introduced into the network in a further past are faded away. The
echo-state approach for the training of recurrent neural networks
was first described by Jaeger [1]. In clinical medicine, until this
moment, no original research articles have been published to
examine the use of echo-state networks.
Methods The present study examines the possibility of using an
echo-state network for prediction of dialysis in the ICU. Therefore,
diuresis values and creatinine levels of the first 3 days after ICU
admission were collected from 830 patients admitted to the ICU
between 31 May 2003 and 17 November 2007. The outcome
parameter was the performance by the echo-state network in
predicting the need for dialysis between day 5 and day 10 of ICU
admission. Patients with an ICU length of stay <10 days or
patients that received dialysis in the first 5 days of ICU admission
were excluded. Performance by the echo-state network was then
compared by means of the area under the receiver operating
characteristic curve (AUC) with results obtained by two other time-
series analysis methods by means of a support vector machine and
a naive Bayes algorithm.
Results  The AUCs in the three developed echo-state networks
were 0.822, 0.818, and 0.817. There were no statistically
significant differences at the 0.05 level with the results obtained by
the support vector machine and the naive Bayes algorithms.
Conclusions This proof of concept study is the first to evaluate the
performance of echo-state networks in predicting the need for
dialysis in an ICU population. The AUCs of the echo-state
networks were good and comparable with the performance of
other classification algorithms.
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Introduction  Despite several prophylactic approaches such as
acetylcysteine, theophylline and sodium-bicarbonate, contrast-
induced nephropathy (CIN) remains a clinical problem. Regarding
the large number of studies on CIN, little is known about long-term
follow up of patients with CIN. The aim of our study was therefore
to analyse the outcome of patients with CIN included in eight
prospective studies on CIN conducted by our group, including
more than 1,200 patients.
Methods A systematic analysis of patients with CIN (defined as
increase in serum creatinine ≥0.5 mg/dl and/or ≥25% within
48 hours after contrast-medium (CM)) using chart review and a
telephone call to patients and to physicians involved in therapy
after CIN up to 1 year or up to death of the patient. Composite
primary endpoint: requirement of renal replacement therapy (RRT),
death, persistent increase in creatinine ≥0.3 mg/dl as compared
with baseline value. Further endpoints: time course of creatinine up
to 1 year after CM.
Results Among 85 cases with CIN, complete datasets sufficient
for analysis of the above-mentioned endpoints could be recorded
in 55 patients. Thirty-nine male and 16 female patients; age
85.5 ± 13.1 years; amount of CM 274 ± 181 ml; intravenous CM
application in 12 patients, intraarterial CM in 43 patients. The 28-
day mortality was 8/55 (15%). At least four patients (7.3%) were
treated with RRT. A total of 24/55 patients (44%) fulfilled the
criteria of the composite endpoint (RRT or death or persistent
increase in creatinine ≥0.3 mg/dl). Compared with baseline
creatinine (1.8 ± 1.2 mg/dl), creatinine levels after 24 hours
(2.3 ± 1.2 mg/dl; P <0.001), 48 hours (2.4 ± 1.4 mg/dl; P <0.001)
and 1 week (2.5 M 1.9 mg/dl; P = 0.033) were significantly
elevated. In 37 of the surviving patients, creatinine after 1 year was
not significantly higher than before CM (1.65 ± 1.05 vs.
1.46 ± 0.76 mg/dl; P = 0.1). However, patients who died or were
on RRT were not included in this comparison. In two of our eight
studies CIN was significantly associated with mortality.
Conclusions Our data indicate that CIN is associated with signifi-
cant mortality, requirement of RRT and/or persistent renal impair-
ment in nearly one-half of the patients. Since these data were
collected in patients included in studies aimed at prophylaxis of
CIN, the risk might be even more elevated in clinical routine. Prophy-
laxis of CIN should therefore be a major issue in patients at risk.
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Introduction Acute renal failure (ARF) is a common problem in
ICUs and is associated with a high mortality rate [1,2]. Early and
aggressive management of renal dysfunction through intermittent
or continuous renal replacement therapy (RRT) is now common
practice. The objective of this study was to review the outcome of
patients who received RRT in the multidisciplinary ICU of the
Johannesburg Hospital, South Africa.
Methods  A review of ICU records between January 2003 and
December 2004 of all patients requiring RRT in the ICU was
performed. Demographic data, reason for ICU admission, presence
of comorbidity, APACHE II score, the modality and duration of
dialysis, as well as the outcome in the ICU were documented. This
study was approved by the Human Research Ethics Committee of
the University of the Witwatersrand, and statistical analysis carried
out in conjunction with the Biostatistics Unit of the Medical
Research Council of South Africa using the Stata release 8.0
statistical package.
Results One hundred and fifty-six patients out of 2,200 admis-
sions (January 2003 to December 2004) were initiated on RRT.
One hundred and three patients were treated with intermittent
haemodialysis (IHD), 47 of whom died (45.6%). Twenty-three
Critical Care    March 2009 Vol 13 Suppl 1 29th International Symposium on Intensive Care and Emergency MedicineS107
patients underwent continuous venovenous haemodialysis, 20
(87%) of whom died. Twenty-two patients underwent both IHD
and continuous venovenous haemodialysis, 15 (68.2%) of whom
died. In eight patients there was no record of the mode of dialysis
administered. Multivariate logistic regression suggested that the
main factor associated with mortality was dialysis. Omitting the
mode of dialysis, the presence of sepsis and the use of inotropes
were independent risk factors associated with mortality.
Conclusions Continuous RRT allows renal support in patients who
would be unable to sustain IHD. The presence of sepsis and the
use of inotropic support, rather than the mode of dialysis, are
predictive of the outcome of ARF in the ICU. Of note, the overall
mortality rate for ARF in this study appears to be lower than
previously reported.
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Introduction Patients with severe sepsis or septic shock admitted
to the emergency room appear to benefit from early goal-directed
therapy, while this is unknown for patients admitted to the ICU from
the ward.
Methods We documented achievement of mean arterial pressure
>65 mmHg, central venous pressure >8 mmHg and central
venous oxygen saturation >70% within the first 12 hours after ICU
consultation. Creatinine in the week prior to ICU admission,
creatinine at ICU consultation and peak creatinine in the 2 weeks
after ICU admission were recorded.
Results Eighty-five patients were included, of which 40% achieved
all goals within 6 hours (early achievement), whereas 33% did not
but had all of them documented within the first 12 hours (no
achievement), 27% had incomplete documentation of goals. Forty-
four out of 85 patients (52%) developed acute kidney injury (AKI)
according to the RIFLE criteria. Patients with incomplete docu-
mentation, early or no achievement of goals were comparable at
baseline, APACHE II and interventions except for more use of
inotropes in the no achievement group. The course of creatinine in
patients was similar, regardless of achievement of goals: baseline –
ICU consultation – peak, presented as median (IQR): early
achievement group: 90 (61 to 119) – 118 (86 to 204) – 148 (86
to 249); no achievement group: 76 (56 to 98) – 121 (78 to 159) –
151 (88 to 205); incomplete documentation group: 81 (56 to 109) –
95 (65 to 175) – 114 (77 to 223). The patients that developed AKI
had a significant increase in creatinine from baseline to the time of
ICU consultation: baseline – ICU consultation – peak, presented
as median (IQR): no AKI: 75 (59 to 114) – 87 (64 to 123) – 92
(72 to 129); AKI: 84 (61 to 105), P = 0.638 – 145 (102 to 205),
P <0.001 – 196 (153 to 276), P <0.001. The development of AKI
was independent of achievement of physiologic goals of
resuscitation.
Conclusions In septic patients admitted from the ward there is no
association between the development of AKI and the timeliness of
achievement of physiologic resuscitation goals. In view of the
higher creatinine values measured at ICU admission in the patients
that eventually suffer from AKI, it appears that the insult has
occurred prior to the time of ICU consultation and that physiologic
resuscitation does not reverse it.
P260
Is goal-directed therapy useful in kidney transplantation?
M Ciapetti, S Di Valvasone, M Bonizzoli, A Di Filippo, A Peris
Careggi Teaching Hospital, Florence, Italy
Critical Care 2009, 13(Suppl 1):P260 (doi: 10.1186/cc7424)
Introduction  Patients with end-stage renal disease (ESRD) are
entitled to the kidney transplantation approach at surgery with
various modifications of the volemic status. According to some
studies [1,2], acute tubular necrosis risk can be reduced by
keeping a correct intravascular volume before graft reperfusion.
The aim of this study was to evaluate goal-directed therapy in the
early postoperative period in kidney transplantation.
Methods We observed 50 kidney transplant recipients divided into
two groups: 38 patients (Group A) underwent central oxygen
venous saturation (ScVO2) monitoring, and 12 patients (Group B)
were controls. Continuous central venous pressure (CVP) and
ScVO2 were monitored the in ICU [3]. In Group A the volemic
status by keeping CVP >5 mmHg and ScVO2 >70% was
optimized. We collected donors’ and transplant patients’ kidney
parameters (age, sex, death cause, ischaemia time), recipients’
parameters (age, sex, weight, height, BMI, duration of dialysis,
ESRD, Simplified Acute Physiology Score II), intraoperative
parameters (metabolic, respiratory and hemodynamic), hemo-
dynamic and kidney functioning parameters in the ICU (heart rate,
mean arterial pressure, CVP, ScVO2, lactate, diuresis, blood urea
nitrogen (BUN), creatinine, fluid balance), and outcome parameters
(ICU length of stay, acute rejection at 28 days, mortality at
6 months).
Results At each observation ScVO2 was >70% in all patients of
Group A. Diuresis was higher in Group A (at 6 hours, Group A:
1,082.6 ± 1,000.7; Group B: 757.2 ± 462.7; at 12 hours, Group
A: 1,020.5 ± 921.5; Group B: 835.4 ± 517.8). The heart rate at 0
hours was higher in Group B (Group A: 85.2 ± 13.2; Group B:
97.7 ± 27.7; P <0.05). Creatinine (at 0 hours, Group A: 6.9 ± 2;
Group B: 8.2 ± 3; at 12 hours, Group A: 7.2 ± 2.5; Group B: 9.3
± 0.07) and BUN (at 0 hours, Group A: 0.9 ± 0.4; Group B: 1.0 ±
0.3; at 12 hours, Group A: 1 ± 0.4; Group B: 1.1 ± 0.3) were
higher in Group B. The creatinine (Group A: –0.2 ± 1.2; Group B:
0.4 ± 0.7) and BUN (Group A: 0.06 ± 0.1; Group B: 0.1 ± 0.04)
reduction (12 to 0 hours) was higher in Group A. Diuretic
stimulation was reduced in 10 patients of Group A and zero of
Group B (P <0.05) and was interrupted in eight patients of Group
A and two of Group B.
Conclusions Postoperative intensive monitoring and optimization
of intravascular volume by CVP and ScVO2 grant fast recovery of
kidney functioning in transplant recipients, so reducing diuretic
stimulation, creatinine and BUN values.
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Introduction The aim of this study was to determine the clinical
characteristics and outcomes of critically ill adults with septic
acute kidney injury (AKI) stratified according to the AKI staging.
The Acute Kidney Injury Network (AKIN) definition for AKI had been
shown to predict important clinical outcomes such as hospital
mortality [1]. Sepsis is the most common cause of AKI resulting in
worse clinical outcomes when compared with other causes [2].
Methods An observational study conducted in a medical ICU of a
general hospital in Singapore over a 6-month period. Patients who
were admitted to the ICU with a diagnosis of sepsis and AKI (as
defined by the AKIN criteria) were prospectively enrolled. The
clinical characteristics and outcomes were determined and
stratified according to the AKIN criteria.
Results A total of 71 consecutive septic patients (60.6% Chinese,
32.4% Malays, 2.8% Indians) were enrolled. The mean age was
63.7 years with a male predominance of 67.6%. The median
Simplified Acute Physiology Score (SAPS) II score was 54. The
majority (60.6%) was AKI III, with 22.9% in stage II and 16.9% in
stage I. Overall hospital mortality was 39.4%. Patients who met
septic AKI III had significantly higher mortality compared with AKI I
and II (55.8% vs. 16.7% and 12.5%, respectively, P <0.001).
There was a significant difference in the mean SAPS II score
between the dead and alive patients (70 vs. 46, P  <0.001).
Multiple logistic regression analysis showed that AKI III (OR =
5.75, 95% CI = 1.2 to 25.5) and SAPS II score ≥65 (OR = 15.6,
95% CI = 3.5 to 68.2) were found to be independent predictors of
hospital mortality.
Conclusions In septic patients, AKI III appeared to be a strong
predictor of hospital mortality. This finding is similar to a previous
study [3], which also showed that in patents with AKI only AKI III
was an independent risk factor for hospital death.
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Introduction Acute renal failure (ARF) requiring renal replacement
therapy (RRT) is uncommon in trauma patients. The aim of this
study was to assess incidence and outcome in this patient group.
Methods  Adult trauma patients with ARF treated with RRT at
Ullevaal University Hospital between 1 January 1996 and 31
December 2007 were retrospectively reviewed. The hospital is the
regional trauma referral centre for approximately 1.93 million adult
(>18 years) persons. Individuals were identified and data were
collected using several institutional registries in addition to the
Norwegian renal registry. Patients were grouped according to
presence of rhabdomyolysis based on peak serum creatine kinase
levels exceeding 10,000 U/l or not. Categorical data were
compared employing the two-sided Pearson chi-square test,
whereas continuous data were compared utilizing the two-tailed
Mann–Whitney U test.
Results  There were 78,345 hospital admissions due to trauma
during the study period, 42 of these underwent RRT for ARF (after
excluding one person due to low age, three with nonrenal
indications for RRT and another three with chronic renal failure).
The incidence rate of post-traumatic ARF requiring RRT was
0.54‰, and was higher in males compared with females (33.72
vs. 6.05 per million persons, P  <0.01). The patients’ age was
median (range) 46.4 (18 to 84) years, and 85.7% were males.
Mortality rates were 23.8% (ICU/hospital), 35.7% (3 months) and
40.5% (1 year). Renal recovery, defined as independency from
RRT, occurred in all survivors after 3 months and 1 year.
Rhabdomyolysis was present in 18 persons (42.9%) and was only
registered in males. Trauma patients with rhabdomyolysis were
significantly younger (33.0 vs. 57.0 years, P = 0.01), needed RRT
earlier (3.0 vs. 6.5 days, P = 0.02) and had lower 3-month (16.7
vs. 50.0%, P  = 0.03) and 1-year (22.2 vs. 54.2%, P  = 0.04)
mortality rates compared with nonrhabdomyolytic persons.
Conclusions Post-traumatic ARF requiring RRT is rare and mainly
affects males of young age. There is still a considerable mortality
rate in these patients, and it seems that rhabdomyolytic persons
have a more favourable outcome compared with those without
rhabdomyolysis. Among survivors, recovery of renal function is
often seen, and few become dependent on chronic RRT.
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Introduction  There are limited data about the epidemiology of
acute kidney injury (AKI) in critically ill patients in Northern Ireland.
The aim of this study was to examine AKI within 24 hours of ICU
admission and its relation to outcomes (ICU mortality and hospital
mortality).
Methods A secondary analysis of prospectively collected data in
the Intensive Care National Audit and Research Centre Case Mix
Programme Database. The Case Mix Programme Database was
interrogated and data extracted from 22,313 admissions to eight
ICUs from 1999 to 2007. The presence of AKI was assessed
within the first 24 hours after admission (early AKI) and classified
according to the RIFLE criteria. Trends over time were described
for the RIFLE categories, and outcomes of admissions in each
category were summarised. Where available, information on the
use of renal replacement therapy during the ICU stay was
analysed.
Results  Trends in early AKI changed little over time: 35.5% of
patients sustained AKI (risk 13.5%, injury 11.1%, failure 9.8%,
end-stage 1.2%) and 9% of patients received renal replacement
therapy. Outcomes are presented in Table 1.
Conclusions For the first time we have established the incidence
of early AKI using the RIFLE criteria in Northern Ireland ICUs. This
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will inform renal service development in ICUs. The incidence of
severe AKI is high relative to the rest of the UK [1] although it is
low compared with the US [2]. Mortality increases with severity of
renal injury.
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Introduction  The Acute Dialysis Quality Initiative group has
proposed the RIFLE (Risk–Injury–Failure–Loss–End-stage renal
disease) classification to assess acute kidney injury (AKI). We
sought to evaluate the incidence of AKI in critically ill patients
according to the RIFLE classification and the correlation between
RIFLE class and hospital mortality.
Methods We performed a retrospective cohort study applying the
RIFLE classification on 1,138 patients admitted to the ICU during a
2-year period.
Results According to the RIFLE classification, 376 patients (33%)
had AKI during their ICU stay. When assessing the maximum
RIFLE class, 209 (18.3%) patients were classified Risk, 63 (5.5%)
as Injury and 104 (6.3%) as Failure. Female (OR = 1.53; 95% CI =
1.18 to 1.98; P = 0.001), nonsurgical admission (OR = 1.32; 95%
CI = 1.01 to 1.70; P = 0.039), APACHE II on admission above 25
(OR = 1.99; 95% CI = 1.06 to 3.76; P = 0.033), sepsis on
admission (OR = 2.20; 95% CI = 1.01 to 4.79; P = 0.046) and
chronic organ dysfunction (OR = 1.65; 95% CI = 1.09 to 2.50;
P = 0.017) were independent risk factors for AKI. Patients with
progressive RIFLE classification had increased hospital mortality,
with Risk 13.9%, Injury 22.2% and Failure 47%, as compared with
7.9% (P < 0.001) among patients without AKI. Furthermore, the
RIFLE class Failure was an independent predictor of 3-month
hospital mortality (OR = 2.37; 95% CI = 1.23 to 4.54; P = 0.009)
in addition to organ failure on admission (OR = 4.60; 95% CI =
2.31 to 9.18; P <0.001), use of vasopressor (OR = 2.34; 95%
CI = 1.09 to 5.00; P = 0.028), and APACHE II score on admission
(OR = 1.160; 95% CI = 1.11 to 1.21; P < 0.001).
Conclusions  Patients with increasing RIFLE classification had
significant elevated hospital mortality. Maximum RIFLE class Failure
was independently associated with 3-month hospital mortality.
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Introduction The objective of the present study was to evaluate
the incidence, risk factors and outcome associated with acute
kidney injury (AKI) as defined by the modified pediatric version of
RIFLE criteria (pRIFLE) in children with severe burn injury.
Methods The retrospective, descriptive cohort study included 123
patients admitted for more than 24 hours to a burn pediatric ICU
from 2006 to 2008. Burn injury severity was estimated using the
total body surface area burn (TBSA%), severity of illness was
estimated using the Pediatric Risk of Mortality (PRISM) score. The
pRIFLE criteria were applied and the patients were assigned to the
appropriate pRIFLE stratum (Risk, Injury, Failure) if they fulfilled
either estimated creatinine clearance, urine output criteria, or both.
Results The incidence of AKI was 40.7%, maximum RIFLE class
Risk, class Injury and class Failure occurred in 50%, 36% and
18%, respectively. Patients with maximum RIFLE class Risk, Injury
and Failure had ICU mortality rates of 0%, 5.6% and 57.1%,
respectively, compared with 1.4% for patients without AKI. We
observed statistically significant differences between the patients
with AKI and those without AKI in the following parameters: TBSA
(41.2 ± 17.7% vs. 24.2 ± 14.6%, P <0.001), admission PRISM
(8.6 ± 6.4 vs. 4.8 ± 3.4, P <0.01), number of surgical procedures
(3.7 ± 2.9 vs. 1.5 ± 1.5, P  <0.001), occurrence of abdominal
compartment syndrome (18% vs. 0%, P  <0.001), length of
mechanical ventilation (22.3 ± 27.6 days vs. 7.1 ± 11.4 days,
P <0.001) and length of ICU stay (37 ± 30.1 days vs. 14.6 ± 13.9
days, P <0.001). Logistic regression analysis indicated that PRISM
score (OR = 1.1, 95% CI = 1.0 to 1.2; P  = 0.05) and TBSA
(OR = 1.06, 95% CI = 1.0 to 1.1; P <0.001) were independent
risk factors for AKI in pediatric burn patients.
Conclusions  AKI estimated by pRIFLE criteria occurs in major
pediatric burns, and failure was associated with increased
mortality. Patients with AKI had higher admission burn and illness
severity, increased incidence of abdominal compartment syn-
drome, more operations, and had increased duration of mechanical
ventilation and length of ICU stay. AKI is a marker of increased
resource utilization and risk for adverse outcomes after burn injury
in children.
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Outcomes
No AKI (n = 14,385) Risk (n = 3,020) Injury (n = 2,446) Failure (n = 2,183) End-stage (n = 259)
ICU mortality 1,350 (9.4) 563 (18.6) 834 (33.8) 909 (41.6) 48 (18.5)
Hospital mortality 2,258 (16.8) 900 (31.9) 1,092 (47.2) 1,137 (55.9) 82 (32.7)
Data presented as n (%).S110
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Introduction  Evaluation of renal replacement therapy (RRT)
efficacy in heparin-induced thrombocytopenia (HIT) patients, using
the alternative anticoagulant bivalirudin. A decreased platelet count
(PC) is often seen after cardiopulmonary bypass with PC reduction
by about 30% to 50%, correlating with the duration of cardio-
pulmonary bypass. However, only a few of these patients will
develop HIT. Acute renal failure (ARF), followed by extracorporeal
RRT, was seen in 90% of the patients with critical PC reduction
found in the postoperative ICU. ARF has multiple etiology: baseline
disorders (congestive heart failure, acute heart failure), hypoxemia,
drugs used during surgery, and so on. The significance of post-
operative thrombocytopenia, including HIT, urges to differentiate its
causes and select appropriate patient care options, including use
of alternative anticoagulants, namely bivalirudin. Bivalirudin (Angio-
max™; The Medicines Company, Cambridge, MA, USA) is a
synthetic hirudin analog, which reversibly binds thrombin.
Bivalirudin is eliminated by enzymatic proteolysis (80%) and renal
clearance (20%). The serum half-life is 25 minutes in patients with
normal renal function, while it is longer in those with renal
dysfunction (3.5 hours).
Methods A retrospective study in HIT patients (clinical scoring and
laboratory assays) who underwent RRT.
Results Ten patients were studied, thereof four patients had low
PC, thrombotic complications, RRT and prolonged duration of stay
in the ICU – 17 days on average. Two of the patients had positive
tests (ranged from 0.45 to 1.62) on postoperative days 6 to 8 and
11 to 12. All of the patients had their anticoagulant switched from
heparin to bivalirudin, despite implanted circulation assisting
devices and RRT. Coagulation system status was evaluated by the
activated partial thromboplastin time, of which target value was
twice the upper normal range. The bivalirudin infusion dose ranged
from 50 μ/kg/hour to 100 μ/kg/hour, depending on the activated
partial thromboplastin time value. Bivalirudin was found to be at
least as safe and effective an anticoagulant as heparin.
Conclusions  HIT patients must be switched from heparin to
alternative anticoagulant. Bivalirudin is a safe and effective anti-
coagulant for extracorporeal RRT; however, the dose should be
adjusted individually. Bivalirudin has prolonged effect in ARF
patients and does not have antagonists.
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Introduction Clotting of haemofiltration circuits is a limiting factor
in achieving efficient continuous renal replacement therapy
(CRRT), yet systemic anticoagulation risks haemorrhage. Some
patients, such as those with liver failure, are traditionally managed
with no or minimal anticoagulation, because of abnormal clotting
tests and therefore increased perceived risk of bleeding [1].
Methods  We retrospectively reviewed the CRRT circuit life in
three groups of liver failure patients (acute liver failure (ALF), acute
on chronic liver failure (ACLF) and postelective liver transplantation
(LTx)), with two control groups (systemic sepsis (SS) and haema-
tological malignancy (Haem)), admitted to the Royal Free Hospital
ICU – a tertiary referral centre for liver disease and transplantation –
between 2003 and 2007. Ten consecutive patients in each of the
five groups were included in the study if they had renal failure and
required continuous haemofiltration (CRRT) for more than
48 hours.
Results The mean CRRT circuit life was significantly greater in the
Haem group, compared with the others; 28.5 ± 25.7 hours, versus
11 ± 10.5 ALF, 11.6 ± 6.6 ACLF, 7.4 ± 5.1 LTx and 9.9 ± 5.9 SS,
P <0.05, with the Haem group requiring fewest new CCRT circuits
within 48 hours; 2.7 ± 1.5 versus 4.3 ± 1.3 ALF, 4.2 ± 2.1 ACLF,
5.3 ± 1.5 LTx and 4.6 ± 1.5 SS, P  <0.05 and least blood
transfusions; 1.4 ± 1.3 versus 4.8 ± 4.2 ALF, 4.2 ± 4.1 ACLF,
2.2 ± 2.1 LTx and 3.2 ± 1.2 SS. Transmembrane pressures were
higher in those CRRT circuits that clotted due to the filter,
compared with other causes, such as access dysfunction (123 ±
74 vs. 71.8 ± 29.3 mmHg, P = 0.009). In those patients where
anticoagulation was started due to repeated filter clotting, the
CRRT circuit life improved from 5.6 ± 3.4 to 19 ± 12.7 hours,
P <0.01.
Conclusions  Despite abnormal standard laboratory coagulation
tests and thrombocytopenia, CRRT circuits clot frequently in liver
failure patients. Anticoagulation did improve CRRT circuit survival
without an obvious increase in bleeding or blood transfusion
requirement. Anticoagulation should therefore be considered in
these patients in cases of repeated circuit clotting.
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Introduction Acute kidney injury (AKI) requiring renal replacement
therapy (RRT) increases mortality in the critically ill patient. Our
objective was to systematically review randomized controlled trials
(RCTs) examining the effect of the RRT dose on mortality.
Methods  In duplicate, we searched Medline, EMBASE and the
Cochrane Central Register of Controlled Trials from inception to
December 2008, using terms for all RRT modalities, AKI, and
RCTs. Included RCTs compared different doses of RRT within a
given modality (effluent rate in continuous RRT (CRRT), number of
sessions per week in intermittent hemodialysis (IHD)) in patients
with AKI, and reported mortality or dialysis dependence. We
excluded RCTs that evaluated very high volume hemofiltration
(continuous effluent rates >60 ml/kg/hour). Risk ratios (RRs) with
95% confidence intervals for mortality and dialysis dependence
among survivors were calculated using random-effects models
(RevMan 5). We investigated subgroup effects by modality (CRRT
vs. IHD) and patient group (septic vs. nonseptic).
Results  Of 2,913 citations, seven RCTs (n = 2,255) met the
inclusion criteria. Four RCTs used CRRT (35 to 48 vs.
20 ml/kg/hour); two RCTs used IHD (daily vs. alternate day); and
the largest and only multicentre RCT (n = 1,124) integrated CRRT
and IHD in high-dose and standard-dose arms. RCTs were
generally of good quality. Meta-analysis did not demonstrate
reduced mortality with high-dose RRT (RR = 0.86, 0.70 to 1.06).
The effect was similar in patients (1) treated with CRRT (RR =
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0.87, 0.71 to 1.06, five trials, n = 1,552) and IHD (RR = 0.95, 0.59
to 1.51, three trials, n = 703), and (2) with sepsis (RR = 1.08, 0.96
to 1.22, n = 896) and without sepsis (RR = 0.88, 0.65 to 1.20,
n = 959) in the four trials with these data. High-dose RRT did not
decrease dialysis dependence among all survivors (RR = 1.09,
0.83 to 1.43, five trials, n = 774) or in the subgroup treated only
with CRRT (RR = 1.27, 0.62 to 2.59, three trials, n = 233). We
estimate that if the ongoing multicentre RENAL RCT (planned
n = 1,500, ClinicalTrials.gov NCT00221013) of high-dose versus
standard-dose CRRT demonstrates the expected absolute
mortality risk reduction (from 60% to 52%), the pooled mortality
benefit would just reach statistical significance.
Conclusions  Current evidence does not demonstrate reduced
mortality with high-dose RRT for AKI, even in the subgroup of
patients with sepsis-associated AKI. Forthcoming results of the
RENAL trial may contribute to more definitive results.
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Introduction The aim of this study was to evaluate the efficacy of
continuous renal replacement therapy (CRRT) in systemic inflam-
matory mediator removal in a group of patients with severe
sepsis/septic shock and related renal failure.
Methods  We conducted a prospective study, approved by the
ethics committee, enrolling 11 patients with severe sepsis/septic
shock under CRRT. We measured the cytokines using the
immunoassay method. The cytokine measurement was done every
morning until the end of renal support. We analyzed the following
data: age, severity scores (Simplified Acute Physiology Score
(SAPS) II, Sequential Organ Failure Assessment (SOFA)),
cytokines (TNF, IL-1β, IL-6 and IL-10) levels on pre-filter, post-filter
and ultrafiltrate samples. We correlated these data with filter
duration, considering 24 hours as the maximum theoretical limit for
effective cytokine removal.
Results  From the 11 patients enrolled, we collected 420 valid
samples to measure the cytokine levels. The mean age and SAPS
II were respectively 66 ± 10.7 years and 46 ± 27.1. The mean total
SOFA score at admission and at day 3 were 11.2 ± 4 and 12.7 ± 4
respectively, with ΔSOFA = +1.3 points (P >0.05). The mean ICU
hospitalization time was 25.9 ± 33.5 days. We have done
876 hours of dialytic therapy; 33 AN69 membranes were used,
during a mean time of 26.5 ± 25.6 hours. The mean total levels
found for cytokines are presented in Figure 1 and the levels
depending on the filter duration are in Figure 2. The ICU mortality
was 54.6%.
Conclusions  The present study does not allow us to define a
specific pattern for the removal of inflammatory mediators related
to CRRT. We observed a trend for cytokine reduction dependent
on filter duration with the higher efficacy removal until 24 hours.
The cytokine level found in the effluent does not reflect the
absolute reduction found in post-filter, and this effect could be
dependent on adsorption, according to other studies [1,2].
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Introduction  Adequate anticoagulation is a precondition to
improve blood epuration. In a prospective crossover trial, we
compared the removal of middle molecules in continuous renal
replacement therapy, by two methods that used either trisodium
citrate ACD (BRAUN Laboratories) or heparin as anticoagulation.
Methods Fourteen critically ill patients were treated by continuous
venovenous hemodiafiltration. The dialysate and hemofiltration
flows were 1,500 ml/hour each. All patients received two sessions
of 36 hours successively. Patients 1 to 7 received systemic
heparinization first, then regional anticoagulation by citrate.
Conversely, Patients 8 to 14 received heparin and then citrate.
Every 12 hours during each session of renal replacement (T0, T12,
T24 and T36), blood epuration of small molecules (urea,
creatinine) and middle molecules (β2-microglobulin, retinol binding
protein) were evaluated from blood and effluent samples.
Results At all time periods, there was no significant difference in
creatinine and urea clearances between citrate and heparin
treatment, except in T12 where creatinine clearance was signifi-
cantly higher when using citrate than when using heparin (38.5 ±
4.0 ml/min vs. 34 ± 4.1 ml/min, P = 0.02). We did not observe a
significant decline of urea and creatinine clearance during the
session. The retinol binding protein blood and effluent rates were
limited and stable during the session. Between T0 and T12, results
showed a significant improvement of β2-microglobulin clearance
with using citrate or heparin. After T12, β2-microglobulin clearance
decreased with citrate treatment and stayed stable with heparin.
Clearance seems to be higher with citrate than heparin, however,
with only a significant difference in T12 (20.1 ± 4.0 vs. 16.3 ±
3.1 ml/min, P = 0.02). Undergoing citrate treatment, we recorded
significant metabolic alkalosis (P = 0.0025) but without hypernatremia.
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Total cytokine levels.
Figure 2 (abstract P269)
Removal of inflammatory mediators according to filter duration.S112
Conclusions  Regional citrate anticoagulation in continuous
venovenous hemodiafiltration is an efficient and safe method of
anticoagulation. Its impact upon blood epuration of small or middle
molecules remains to be established.
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Introduction The aim was to study the practice pattern of using
the modern modalities of renal replacement therapy (RRT) (slow
low-efficiency dialysis (SLED) and continuous renal replacement
therapy (CRRT)) in hemodynamically unstable critically ill patients
in an Indian ICU.
Methods A retrospective observational study of hemodynamically
unstable patients with acute kidney injury (AKI) who needed RRT in
ICUs of a tertiary-care hospital. All patients who underwent SLED
and/or CRRT from September 2005 to April 2008 were taken up
for analysis. To maintain a mean arterial pressure (MAP)
>70 mmHg, patients who required noradrenaline >0.5 μg/kg/minute
were treated with CRRT whereas those requiring ≤0.5 μg/kg/minute
received SLED. Depending on haemodynamic stability patients
were switched from CRRT to SLED, or vice versa.
Results  From September 2005 to April 2008, 214 haemo-
dynamically unstable AKI patients, deemed unfit for intermittent
haemodialysis, underwent SLED/CRRT (continuous venovenous
hemofiltration (CVVH)/continuous venovenous hemodiafiltration
(CVVHDF)). Ten patients were switched to SLED after a median
48 hours of CRRT. See Figures 1 and 2.
Conclusions  In our ICU, the need for RRT in hemodynamically
unstable patients with AKI was significantly higher in the medical
patients, the commonest cause of AKI being sepsis. Patients who
were equally sick (comparable APACHE II scores) could be
effectively dialysed by SLED, as compared with CRRT.
Hemodynamic stability was maintained in the patients on SLED, as
none needed switchover to CRRT. The patients undergoing SLED
were dialysed during daytime by the haemodialysis nurse,
eliminating the need for a specialist nurse in the night. After a
median 48 hours of CRRT, it was possible to switch to SLED,
resulting in optimal utilization of resources. SLED was much
cheaper than CRRT. In a country like India where often there are
economical constraints, the judicious use of SLED will help us
optimize the need for CRRT.
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Observational cohort of renal replacement therapy patients
at a district general hospital ICU: case mix and outcomes
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Introduction  Previous studies have shown the mortality of ICU
patients requiring renal replacement therapy (RRT) to be high at
62.8% [1], and underpredicted by APACHE II scoring [2]. The
ICNARC Case Mix Programme gives mortality of 59.5% for 2003
to 2004. We aimed to review our patients to see how we compare.
Methods We prospectively collected data on all RRT episodes on
the ICU from 2005 to 2007: patient age, APACHE II score in the
first 24 hours, primary indication for RRT, RIFLE classification at
start of RRT, ICU and hospital length of stay (LOS), mortality at 30,
60, and 90 days, and recovery of renal function at 30 days.
Results We admitted 1,557 patients over the 3-year study period,
of which 18% were elective. A total of 210 patients received RRT
(data were available on 208). The median age was 66 years, 56%
were male, and mean APACHE II score was 25.4. Our hospital
mortality for all patients receiving RRT was 50.5%. One hundred
and seventy-six patients had RRT for acute kidney injury with a
hospital mortality of 51.1% (23 class Risk patients, 70 class Injury,
83 class Failure). No statistical difference in hospital mortality, ICU
LOS, or renal function recovery existed by RIFLE class. By
APACHE II score, the standardised mortality ratio was 0.98 (1.1 in
2005, 0.97 in 2006, and 0.86 in 2007). Main indications for
filtration were: acidaemia 51%, oliguria 9%, uraemia 13%, fluid
overload 7%, sepsis 6%, and hyperkalaemia <1%. The average
ICU LOS was 9 days for hospital survivors (IQR 5 to 21 days) and
4 days in nonsurvivors (IQR 2 to 8 days). Only three hospital
survivors were not alive at 90 days. Three out of 82 followed-up
patients still required dialysis at 30 days.
Conclusions  Our hospital mortality compares favourably with
other published work [1,3]. We found the APACHE II score to
predict mortality accurately, in contrast to published work showing
underprediction [2]. This may represent a better outcome in our
cohort. We were unable to demonstrate a correlation between the
RIFLE score at initiation of RRT and hospital mortality. This could
be due to small numbers, or to an equivalence of outcome for the
RIFLE classes once RRT is established.
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dysfunction and inflammation
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Introduction Continuous renal replacement therapies (CRRT) are
widely used for treatment of acute kidney injury in critically ill
patients. Little attention has been paid to the potential adverse
effects of CRRT related to extracorporeal circuit bioincompatibility.
Limited available evidence suggests that intermittent dialysis may
compromise hepatosplanchnic perfusion in acute renal failure
patients. By contrast, there are no data on the bio(in)compatibility
indices in patients treated by CRRT. To investigate this issue, we
utilized a long-term porcine model allowing a broad insight into
organ hemodynamic, microvascular, metabolic and other pathways
not accessible in human medicine.
Methods  Measurements were performed in 11 healthy instru-
mented animals. After baseline measurements, animals were
randomized to receive either no treatment (n = 6) or continuous
venovenous hemofiltration with a polysuphon membrane (CVVH,
n = 5). Further data were collected at 6 and 10 hours after the
randomization. During each time point the following data related to
(1) organ perfusion (hepatosplanchnic and renal blood flows), (2)
microcirculation (ileal mucosal and renal cortex laser Doppler
flowmetry and sidestream darkfield imaging), (3) energy balance
(arterial and regional pH, lactate/pyruvate and ketone body ratios),
(4) oxidative/nitrosative stress (thiobarbituric acid reactive species,
nitrates + nitrites), (5) inflammation (TNFα, IL-6) and (6) endothelial
dysfunction (von Willebrand factor, asymmetric dimethylarginine)
were collected.
Results Hemofiltration affected neither regional organ blood flows
nor ileal mucosal and renal cortex microvascular perfusion. No
changes in liver and kidney oxygen exchange and energy balance
were detected during the 10-hour treatment. Similarly, CVVH did
not interfere with surrogate markers of inflammation, oxidative/
nitrosative stress and endothelial dysfunction.
Conclusions In our model CVVH utilizing a modern biocompatible
polysulphon membrane did not induce any significant deleterious
effects in various biological systems. The importance of our
findings lies in the fact that any changes in the studied parameters,
if observed in future studies, cannot be attributed to the effects of
putative extracorporeal circuit bioincompatibility. Finally, our data
support the postulated concept of good biological tolerance of
CRRT.
Acknowledgement Supported by MSM 0021620819 – Replace-
ment of and support to some vital organs.
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Introduction  We studied the effects of continuous venovenous
hemofiltration (CVVH) on transpulmonary hemodynamic para-
meters in nine ventilated patients [1,2].
Methods  All together 32 calibrations were performed with and
without CVVH treatment. For each calibration three consecutive
injections of 20 ml cold saline were done via the central venous
line (CVL), giving a total of 186 thermodilutions.
Results Patient age was 72.3 ± 14, BMI 24.7 ± 3.8, SAPS II 56.2
± 15.7. Regardless of the catheter position, CVVH increased the
extravascular lung water index (EVLWi) from 11.3 ± 5 to 12.4 ±
6.3 (P = NS), while the cardiac index (CI) and global end-diastolic
volume index (GEDVi) decreased from 5.1 ± 1.8 to 4.2 ± 1.3
(P = 0.03) and from 1036 ± 298 to 885 ± 185 (P = 0.02),
respectively. The results of a subanalysis comparing correct
catheter position (CVL placed in jugular or subclavian vein and
dialysis catheter placed femorally) and faulty position (dialysis
catheter positioned between the thermodilution injection and
detection sites) are summarized in Table 1. In two patients
catheters were exchanged during the stay from the faulty to the
correct position, and this resulted in a significant decrease in all
parameters: CI dropped from 6.1 ± 0.9 to 5 ± 0.3 (P = 0.014),
GEDVi from 1253 ± 165 to 829 ± 161 (P = 0.001) and EVLWi
from 16.1 ± 7.1 to 8.7 ± 1.2 (P = 0.03).
Conclusions  In critically ill patients treated with CVVH, the
hemodynamic parameters obtained by PiCCO transpulmonary
thermodilution can be influenced: EVLWi increases while CI and
GEDVi drop. We hypothesize that this may be due to the position
of the CVL and dialysis catheters.
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Introduction The aim of this study was to establish the minimum
dataset that needs to be specified when presenting pharmaco-
kinetic data for critically ill patients with acute renal failure, and to
review the current literature to establish whether this minimum
Available online http://ccforum.com/supplements/13/S1
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Effect of CVVH on hemodynamic parameters in correct and faulty catheter positions 
CVVH correct  No CVVH correct  CVVH faulty  No CVVH faulty 
(n = 11) (n = 11) P value (n = 21) (n = 21) P value
CI (l/min/m2) 4.1 ± 0.9 4.5 ± 0.8 NS 4.3 ± 1.5 5.4 ± 2 0.04
GEDVi (ml/m2) 774.8 ± 83.8 810.6 ± 124.1 NS 942.1 ± 198.4 1,155.4 ± 294.6 0.009
EVLWi (ml/kg) 7.8 ± 2.2 7.8 ± 1.5 NS 14.8 ± 6.4 13.1 ± 5.3 NSS114
dataset is indeed reported. Antibiotic dosing for septic patients
with acute renal failure receiving continuous renal replacement
therapy is complicated, and failure to correctly dose may result in
either drug toxicity, or treatment failure and development of
resistance [1].
Methods  A dataset was established of the minimal number of
parameters that need be reported when calculating a drug-dosing
regimen. Patient demographics and markers of severity were
added to allow for patient population comparisons. A Medline
search was performed of the relevant literature, producing 76
studies from which completeness of the dataset was examined.
Results None of the studies analysed presented the full dataset
that we established as necessary (Figure 1). Of concern, basic
pharmacokinetic parameters such as the volume of distribution and
clearance were absent in a significant number of studies effectively
abrogating calculation of a meaningful dosing regimen.
Conclusions A large proportion of current studies do not report
key information necessary to devise a rational dosing regimen for
patients with acute renal failure receiving continuous renal
replacement therapy. We have presented a set of criteria we
believe are necessary to calculate an antibiotic-dosing regimen for
these patients and hope this will be a useful guide when reporting
future pharmacokinetic data.
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Introduction As a high proportion of patients who require con-
tinuous renal replacement therapy will also be receiving antibiotics,
the issue of whether significant amounts of antibiotic are adsorbed
by the haemofilter is relevant to critically ill patients. The aim of the
study is to determine the time course of adsorption of gentamicin
to a polyacrylonitrile filter (PAN) and a polyamide filter, respectively.
Methods A unit of expired whole blood was mixed with heparinized
lactated Ringer’s solution to made up a total volume of 1,000 ml.
Five hundred milliliters of this blood–crystalloid mixture was taken
to a glass chamber where it was agitated and heated. After the
equilibration period, 20% of a standard dose of the drug was
infused into the mixing chamber. The blood–crystalloid mixture was
then circulated through an in vitro continuous venovenous
hemofiltration model. The ultrafiltrate was returned to the mixing
chamber and no replacement fluid was infused. As a result, any
decrease in drug concentration could only occur due to adsorp-
tion. Samples were taken from the mixing chamber for measure-
ment of the drug concentration. At 90 minutes, the remaining
500 ml blood–crystalloid mixture will then be added to the mixing
chamber. Samples were taken again after another hour. If the fall in
drug concentration was less than those predicted from the dilution
effect following the increase in blood–crystalloid volume, it
indicates reversibility of adsorption. A second dose of drug was
then added and samples were taken afterwards. Adsorption of
antibiotic before and after the second dose was compared. Two
types of filter, namely a 0.6 m2 PAN hemofilter (Multiflow 100;
Hospal) and a 0.6 m2 polyamide hemofilter (Hemofilter 6S;
Gambro), were used in the study and four batches of tests were
repeated for each hemofilter.
Results  Drug adsorption by PAN hemofilters was significant,
whereas drug adsorption by polyamide hemofilters was much
lower compared with that of PAN hemofilters. Gentamicin
adsorption by PAN hemofilters was completed at 30 minutes and it
was irreversible.
Conclusions The adsorption properties of gentamicin by the two
hemofilters were markedly different.
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Reporting of required parameters for dose regimen calculation in the literature.S115
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Introduction  Ultrafiltration (UF) is effective and safe in treating
volume-overloaded patients with acute decompensated heart
failure (ADHF) and diuretic resistance [1]. Accurate determination
of the amount of fluid to be removed and maintenance of the
circulating blood volume are critically important [2]. The inferior
vena cava diameter (IVCD) and its collapsibility index (IVCCI) are
compromised in ADHF patients due to high right atrial pressure
[3]. We hypothesized that monitoring of IVCCI could be used to
optimize fluid removal rate during UF.
Methods Twenty patients (nine male, 11 female; age 76 ± 4, New
York Heart Association classes III to IV) admitted to our medical
ICU for ADHF were treated with UF (Aquadex System 100; CHF
Solutions, Minneapolis, MN, USA). The heart rate (HR), mean
arterial pressure (MAP) and IVCD with M-mode subcostal
echocardiography during spontaneous breathing were evaluated
before UF (T0), at 12 hours (T1) and at 24 hours (T2). The IVCCI
was calculated as follows: [(IVCDmax – IVCDmin) / IVCDmax] x 100.
Results The mean UF time was 25.5 ± 5 hours with a mean volume
of 259 ml/hour and a total ultrafiltrate production of 6.6 ± 2 l.
Differences between the T0 and T2 parameters are presented in
Table 1. Hypotension was observed only in those patients (2/20)
who reached IVCCI >35%. In all the other patients a significant
increase in IVCCI was obtained without any hemodynamic instability.
Table 1 (abstract P277) 
T0 T2 P value
MAP (mmHg) 85 ± 9 86 ± 12 NS
HR (bpm) 85 ± 6 85 ± 14 NS
IVCD (mm) 30.2 ± 6.3 27.3 ± 5.9 <0.5
IVCCI (%) 6.5 ± 1.7 33.3 ± 4.6 <0.001
Conclusions Inferior vena cava ultrasound is a rapid, simple and
noninvasive means for bedside monitoring of the intravascular
volume during UF.
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Introduction  Sepsis is mediated by many biologically active
inflammatory mediators, including interleukins. IL-6, IL-8, and IL-10
are correlated with increased mortality in septic shock acute renal
failure (ARF) [1]. ARF treatment requires renal replacement therapy
(RRT). The cytokine plasmatic level during and after hemodialysis
(HD) in septic ARF is partially described [2]. Polymethylmeth-
acrylate (PMMA) hemodialyser membranes own high adsorptive
capacity [3]. In this prospective observational trial, we study the
plasmatic level of IL-6, IL-8 and IL-10 during and after the first HD
seance with PMMA membrane in septic shock patients with ARF.
Methods Inclusion criteria: patients with septic shock <24 hours
as defined by the American College of Chest Physicians/Society of
Critical Care Medecine and requiring RRT (Injury in the RIFLE
criteria). The hemodialyser PMMA membrane was Filtrizer BK-1,6 F
(TORAY Industrie, Tokyo, Japan). Data and blood samples were
collected at: start of HD (D0), every hour during HD (D1; D2), at
the end of HD (endD); and 30, 60, 90, 120 and 180 minutes after
HD (postD0.5; postD1; postD1.5; postD2; postD3, respectively).
Solid-phase ELISA was used for cytokine measurements.
Statistical analysis was by Kruskall–Wallis nonparametric test.
Results  Ten patients were included. At D0: Sequential Organ
Failure Assessment (14.6 ± 0.8) and IGS 2 (Simplified Acute
Physiology Score II) (79.11 ± 4.73). At D0, IL-6, IL-8 and IL-10
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Relative IL-8 concentration versus baseline. *P <0.05.
Figure 2 (abstract P278)
Relative IL-10 concentration versus baseline. *P <0.05.S116
concentration values were 767 ± 191.2, 724.4 ± 191.7 and
168.5 ± 50.44 pg/ml, respectively. Relative serum IL-8 and IL-10
concentrations versus D0 are shown in Figures 1 and 2 (mean ±
SEM). The urea reduction between D0 and endD was 48.5%. The
norepinephrine rate and mean arterial pressure did not change
between D0 and endD (0.65 ± 0.12 vs. 0.57 ± 0.12 μg/kg/min,
and 76.40 ± 4.554 vs. 83.60 ± 4.349 mmHg, respectively; P = NS).
Conclusions  PMMA membranes showed transient efficiency in
IL-8 and IL-10 elimination by possible membrane saturation. The
IL-6 concentration was not modified. Three hours after HD, the IL-8
and IL-10 concentrations were back to baseline. This fast increase
could be explained by plasmatic rebound and must be kept in
mind. This rebound could be deleterious in this stage of sepsis.
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Introduction  Removal of cardiodepressant autoantibodies by
immunoadsorption (IA) has been reported to induce early haemo-
dynamic improvement in patients with dilated cardiomyopathy
(DCM). The Immusorba TR-350 (Asahikasei-Kuraray Medical Co.
Ltd, Japan) (TR) is an IA column currently used for Myasthenia
gravis or Guillain-Barré syndrome. This column, in which
tryptophan is immobilized as a ligand, has a property to have high
affinity to IgG subclass 3. With this property, imunoglobulin
substitution is not usually required after the IA treatment. Since
cardiodepressant antibodies belong to IgG subclass 3, we
investigated the effect of IA using this column on cardiac function
in patients with DCM.
Methods  Seventeen DCM patients (left ventricular ejection
fraction (LVEF) <30%) participated in the study. IA was conducted
every other day three to five times. Blood was drawn at the rate of
80 to 100 ml/minute by direct venipuncture or from the blood
access catheter and it was first passed through the plasma-
separating column. The separated plasma was then passed
through the TR at the rate of 20 ml/minute. A total of 1,500 to
2,000 ml plasma was processed per one session. Either heparin or
nafamostat mesylate was used as an anticoagulant. The LVEF was
measured by quantitative gated single photon emission computed
tomography. The cardiodepressant antibodies were assayed ex
vivo [1]. The β1-adrenergic and muscarinic M2-acetylcholine
receptor antibodies were measured by ELISA.
Results  After the three to five sessions of IA treatment,
cardiodepressant antibodies were almost completely cleared from
the circulation. Three months after the IA sessions, the LVEF
increased significantly from 18.7 ± 2.3 to 23.2 ± 2.6%, P <0.05.
The average increase rate was 33.1 ± 12.6% from the baseline.
Limited to the 10 patients who initially revealed the high titer of
cardiodepressant antibodies, the increase in LVEF was greater
(54.5 ± 16.8% from the baseline). The cardiodepressant anti-
bodies were not detected at this period except in one patient. All
patients tolerated IA without any complication. Any cardiac event
or mortality did not take place over the period of 3 months.
Conclusions The IA treatment with TR may bring benefit in left
ventricular function in patients with DCM, particularly in those with
a high titer of cardiodepressant antibodies. Further long-term
follow-up is, however, required before confirming its efficacy.
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Introduction Polymyxin-B hemoperfusion has been shown to lower
mortality in sepsis [1]. The effects of a new endotoxin adsorber
(Alteco LPS Adsorber; Alteco Medical AB, Lund, Sweden) on the
length of noradrenaline (NA) treatment and lipopolysaccharide
blood levels in abdominal septic shock were evaluated.
Methods  Following consent a 2-hour hemoperfusion with LPS
adsorber was began in five patients [2]. Sepsis guidelines were
followed [3]. Two historical controls per case were selected.
Results  The mean total duration of NA infusion was 46 hours
shorter in the adsorber group compared with the control group
(95% CI = –104 hours to 12 hours, P = 0.165) (Table 1). The
average length of NA infusion was 17.4 ± 6.8 hours (5.8 to
23.8 hours) following the start of adsorption treatment. The level of
LPS decreased in all but one study patient and all were without NA
at 24 hours. The mean Sequential Organ Failure Assessment
decrease was 3.4 ± 1.7 from baseline to 24 hours post treatment
The average length of hospital stay was 3.4 days shorter in the
adsorber group (95% CI of the difference, –21.7 to 14.8 days,
P = 0.881). All study patients were alive on day 28 and one control
died in the hospital.
Conclusions  Single 2-hour LPS hemoperfusion was associated
with a rapid decrease in NA dose, reversal of septic shock, and
decrease in organ dysfunctions and LPS concentrations. The total
duration of NA infusion and hospital stay were shorter compared
with historical controls, but the difference was not statistically
significant in this small study.
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Clinical characteristics of the study patients and the controls
Patients Controls 
(n = 5) (n = 10) P value
Age 64 ± 16 65 ± 13 NS
Male/female 2/3 4/6 NS
Simplified Acute Physiology Score II 38 ± 11 46 ± 11 NS
Sequential Organ Failure Assessment 9.6 ± 2 7.7 ± 2 NS
ICU length of stay 6.2 ± 3 6.4 ± 3 NS
Hospital length of stay 23 ± 13  27 ± 17 NS
NA infusion (hours) 34 ± 12 81 ± 77 NS
Data presented as mean ± SD.S117
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Introduction  The aim of the study was to evaluate the first
experience with endotoxin adsorption in complex intensive care of
critically ill patients with sepsis after heart surgery.
Methods Eleven adult patients were studied. Patients were divided
into two groups: undergoing Alteco LPS adsorption procedures
(n = 6), and undergoing hemoperfusion using Toraymyxin columns
(n = 5). Intensive therapy of sepsis in both groups included anti-
bacterial therapy, hemodynamic and respiratory support, preven-
tion of thromboembolism, stress ulcer prophylaxis, nutritive
support, and studied extracorporeal techniques to endotoxin
removal (two procedures for every patient).
Results Endotoxin adsorption procedures were started on average
at day 8 after surgery in patients with systemic inflammatory
response syndrome and confirmed Gram-negative infection. As the
result of procedures, hemodynamic indices improved in both
groups while the dose of inotropic support decreased. Also we
noted the improvement of oxygenating lung function. Positive
dynamics of procalcitonin, endotoxin and inflammation mediator
concentrations were noted. A favorable influence of studied
procedures on the course of the infective process was confirmed
by the dynamics of leukocyte count and the tendency to normali-
zation of body temperature. Blood cultures taken several days after
the procedures were negative. There was no deterioration of
hemodynamic indices during and after procedures. No cases of
thrombosis of the extracorporeal contour were noted. Data are
presented in Figure 1 as mean ± SEM.
Conclusions Both studied procedures are safe. Clinical studies
should be continued to define the place of endotoxin adsorption in
complex treatment of critically ill patients with sepsis.
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Introduction Septic shock is a condition associated with diffuse
coagulopathy and multiple organ failure, and frequently leads to
death. Direct hemoperfusion using a polymyxin B-immobilized fiber
column (DHP-PMX) has been used for the treatment of septic
shock [1]. On the other hand, there is another kind of acute blood
purification therapy, but the optimal column of continuous veno-
venous hemodiafiltration (CVVHDF) is still controversial.
Methods We treated 88 septic shock patients by DHP-PMX. The
patients were divided into two groups based on the survival outcome
and on the improvement in the circulatory dynamics immediately after
DHP-PMX (Group A: increase of systolic blood pressure (SBP) by
more than 30 mmHg (44 cases); Group B: increase of SBP by
30 mmHg or less (44 cases)). In another study conducted to review
the best choice of acute blood purification therapy after DHP-PMX,
the patients were divided into three groups: groups undergoing
CVVHDF using a polymethylmethacrylate membrane hemofilter
(PMMA) (28 cases), CVVHDF using a polyacrylonitrile membrane
hemofilter (26 cases), and no CVVHDF after DHP-PMX (34 cases).
Results There were 48 survival cases and 40 expired cases. The
overall survival rate was 54.5% (good outcome judging from the
APACHE II score), and outcome significantly related to APACHE II
score, Sepsis-Related Organ Failure Assessment score and blood
lactic acid value before treatment (P <0.0001). The improvement
rates of the blood pressure (increased by more than 30 mmHg)
were 50.0% and significantly low blood lactic acid level in Group
A. For another examination, only the PMMA CVVHDF group
showed a better outcome (survival rate of 78.6%) compared with
the other groups (P = 0.0190). In addition, only the PMMA
CVVHDF group showed significant improvements of the blood
lactic acid on day 3 (P = 0.0011).
Conclusions Our study suggests that DHP-PMX treatment was
effective in the early phase of septic shock before critical increase
of the blood lactic acid levels. The optimal column for CVVHDF, as
determined by improvement of the blood lactic acid levels,
following DHP-PMX treatment is the PMMA column.
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Introduction  The endotoxin adsorption method polymyxin B
immobilised fiber with direct hemoperfusion (PMX-DHP) has been
used for treatment of patients with severe sepsis and septic shock
primarily caused by Gram-negative infections in Japan [1]. One
Available online http://ccforum.com/supplements/13/S1
Figure 1 (abstract P281)
DHP-PMX, hemoperfusion with the use of Toraymyxin columns; MAP,
mean arterial pressure; WBC, white blood cells; PLT, platelets; PCT,
procalcitonin.S118
hundred and twenty-six septic patients who had severe sepsis or
septic shock due to intra-abdominal infections were treated with
PMX-DHP.
Methods These patients were separated into two groups: whose
who survived for at least 28 days after the start of PMX-DHP
therapy (survival: 85 cases) and those who did not (nonsurvival: 41
cases). Background factors and inflammatory mediators were
examined in each group. PMX-DHP was assessed with the
changes of clinical parameters (heart rate, systolic arterial pressure,
mean arterial pressure, PaO2/FiO2) and various cytokines (TNFα,
IL-6, IL-8, IL-1ra, PAI-1). Sepsis was diagnosed according to the
criteria of the American College of Chest Physicians/Critical Care
Medicine Consensus Conference Committee.
Results A total of 91.7% of survival cases were principally treated
with surgical procedure. On demographic data, Goris’s multiple
organ failure score only showed significant differences between
the groups (survival cases: 5.8 ± 2.8, nonsurvival cases: 8.0 ± 2.6,
P <0.05). Procalcitonin (PCT) before PMX-DHP in all patients was
59.1 ± 97.2 ng/ml and tended to decrease, 54.7 ± 81.7 ng/ml
after PMX-DHP. PCT was 67.3 ± 109.6 ng/ml before PMX-DHP
and significantly decreased to 54.7 ± 82.1 ng/ml immediately after
PMX-DHP in the survival group, but, it did not change significantly
in the nonsurvival group. There was a significant correlation
between endotoxin and PCT (r = 0.527, P <0.001).
Conclusions  Our results may suggest that PMX-DHP for the
patients with severe sepsis or septic shock caused by intra-
abdominal infections can improve hemodynamic changes and
pulmonary oxygenation, and also reduce systemic inflammatory
cytokines and serum PCT in the survival group.
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Introduction Sepsis is the leading cause of mortality in intensive
care, but data on new therapies are inconclusive. Coupled plasma
filtration adsorption (CPFA) is a new extracorporeal technology for
septic shock and may improve haemodynamic respiratory function
and mortality. The aim of this study is to evaluate during CPFA the
haemodynamic response and respiratory function and the
reduction of inflammatory markers.
Methods Eighteen septic patients have been enrolled in this study
within 8 hours from sepsis diagnosis. Every patient had three
CPFA treatments for 8 hours with Q blood = 200 ml/hour, Q ultra-
filtration = 30 ml/kg/hour and Q plasma = 20% of Q blood. At T0
(basal), T1 (after first cycle), T2 (after second cycle), T3 (after third
cycle) and T4 (after 72 hours) we evaluated haemodynamic
parameters, norepinephrine dosage, PaO2/FiO2 ratio and plasma
IL-6, and procalcitonin. All data are expressed as the mean ± SD.
ANOVA was used to compare changes during the times of study.
P <0.05 was statistically significant.
Results Table 1 presents the main results of the study.
Conclusions In contrast with a recent experimental study in septic
pigs [1], data from this study confirm that CPFA improves
haemodynamics during septic shock. This improvement may be
related to the reduction of IL-6 and first of all of procalcitonin.
Procalcitonin clearance during CPFA may have a role in the
improvement of shock-related vasoparalysis, as calcitonin receptor
family complexes have been implicated recently in the
pathogenesis of sepsis.
Reference
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of print]
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Introduction  We reported the clinical efficacy of a newly
developed cytokine adsorption column (CTR-001; Kaneka Co.,
Osaka, Japan) for the septic patients at the previous meeting.
Especially, increasing blood pressure was remarkable during use
of CTR-001 in septic shock patients. In this study, we investigate
that clinical efficacy concerning the improvement of APACHE II
and SOFA scores.
Methods A prospective randomized, controlled clinical trial was
performed in this study. The newly developed column contains
microporous cellulose beads with a hexadecyl alkyl chain as the
ligand. Eighteen patients with early septic shock or septic organ
dysfunction were enrolled. Nine of the 18 were randomized to
direct hemoperfusion (DHP). All patients received supportive
intensive care, and those randomized to DHP received direct
hemoperfusion for 4 hours more than two times up to 14 times
during 14 days. We measured the plasma concentration of IL-6,
IL-8, IL-1β, and TNFα. The APACHE II score and SOFA score
were evaluated for each patient on the 1st, 7th, 14th and 28th day
after starting treatment before the treatment in the morning.
Results The decrease of APACHE II score from the pretreatment
level at the 7th day was significantly larger in the CTR-001
treatment group than in the control group (P = 0.0189; Mann–
Whitney test). On the other hand, there were no significant
changes of the SOFA score at the 7th day. Adsorption column-
related serious adverse events were not observed in the DHP
group. The concentration of IL-6 and IL-8 in the plasma decreased
from the pretreatment level in the DHP group significantly
(P = 0.0464, P = 0.0464 respectively; Wilcoxon test).
Conclusions The newly developed direct hemoperfusion column
improved the septic shock better than the ordinary supportive
intensive care. This new cytotoxic removal column may play an
important role in treatment of patients with septic shock.
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T0 T4 P value
Mean arterial pressure (mmHg) 67 ± 5 83 ± 7 <0.01
Norepinephrine (μg/kg/min) 0.23 ± 0.1 0.04 ± 0.08 <0.001
PaO2/FiO2 195 ± 15 268 ± 25 <0.05
IL-6 (pg/ml) 409 ± 25 114 ± 110 0.10
Procalcitonin (pg/ml) 40 ± 15 5 ± 2 <0.001S119
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Introduction  The aim was to verify the hypothesis that
extracorporeal therapy with a polymyxin B (PMX) fibre column may
prevent septic shock-induced organ dysfunction and that early
treatment of septic shock with PMX hemoperfusion may improve
patient outcome.
Methods One hundred and sixteen patients with septic shock who
were admitted to the ICU of 35 hospitals were enrolled in this
study from April 2006 through March 2008. PMX treatment was
performed immediately after septic shock was diagnosed. All
patients were followed up for 28 days after enrollment in the study,
and 28-day mortality was assessed. Arachidonylethanolamide, 2-
arachidonoylglycerol, IL-6, lipopolysaccharide, lactic acid, and the
Sepsis-related Organ Failure Assessment score were determined
before PMX treatment and at 24, 72, and 168 hours after the
treatment.
Results At the end of PMX treatment, the mean arterial pressure
and plasma HCO3
– were significantly increased (P <0.01), and the
plasma level of lactate was significantly decreased (P  <0.05).
Seven days after treatment, the PaO2/FiO2 ratio was significantly
increased (P  <0.05), and the plasma level of creatinine and
arachidonylethanolamide were significantly decreased (P <0.05).
Of the 57 surviving patients, 24 patients were treated with PMX
within 6 hours after the diagnosis of the septic shock (early group)
and 33 did not treat within 6 hours (late group). There was no
significant difference between the early and late groups about 28-
day mortality (41.5% and 37.7%, respectively; P = NS), whereas
serum creatinine and the PaO2/FiO2 ratio were significantly
improved (P <0.05). The ICU stay was shorter in the early group
than the late group (10.6 vs. 16.4 days; P = 0.088).
Conclusions Hemoperfusion with PMX was a safe and effective
treatment for improvement of hypotension and hypoperfusion in
septic shock patients. PMX treatment within 6 hours after
diagnosis of septic shock would be beneficial with respect to
oxygenation and renal function.
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Introduction  Direct hemoperfusion therapy with polymyxin-B
immobilized fibers (PMX-DHP)  has been widely applied as the
therapeutic method for the patients with septic shock in Japan
since 1994. Optimal usage of PMX-DHP for the patients with
septic shock remains a matter of debate, mainly because of a lack
of adequately designed clinical trials.
Methods The observational study, carried out in 21 hospitals in
Japan, was designed to investigate the effects of PMX-DHP for
patients with septic shock. A total of 36 patients with septic shock
were enrolled between April 2004 and January 2005.
Results  Forty-four percent (16/36) was acute peritonitis, which
required laparotomy and lavage of the peritoneum before PMX-
DHP. The other 56% (20/36) was unable to remove the site of
infection, such as urinary tract infection, respiratory infection and
unknown cause of infections. Inhospital death rates were 6%
(1/16) in patients with acute peritonitis and 55% (11/20) in those
without acute peritonitis (P = 0.0446). The early indication rates of
PMX-DHP, within 24 hours since the onset of septic shock, were
61% (22/36). Among those 22 patients, the rate of achieving
mean arterial pressure more than 65 mmHg within 6 hours of the
onset of septic shock was 63% (14/22), and 18% (4/22) achieved
65 mmHg within 24 hours.
Conclusions In this group of septic patients, the better survival
rates of patients with acute peritonitis were associated with PMX-
DHP. Early induction of PMX-DHP also contributed to recovering
adequate arterial blood pressure.
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Introduction  Type II phospholipase A2 (type II PLA2) is a rate-
limiting enzyme in the eicosanoid cascade. We investigated type II
PLA2 and eicosanoids during polymyxin-B-immobilized fiber direct
hemoperfusion (PMX-DHP) of septic shock patients.
Methods  A highly sensitive nephelometry method was used to
measure endotoxin. The 11 patients all had positive endotoxin
levels (>1.1 ng/ml). Their mean age was 69 years (range: 43 to
85 years). The mean APACHE II score was 32 points, and the
mean SOFA score was 14 points. PMX-DHP was performed twice
in every patient.
Results The endotoxin level of every patient converted to negative
after two PMX-DHP sessions, and they rapidly recovered from
shock. The patient’s TNFα values decreased significantly (from
296 to 133 pg/ml) in response to the two PMX-DHP sessions, and
their LBT4 values (from 114 to 77 pg/ml), PGF1α values (from 32
to 19 pg/ml), and TXB2 values (from 79 to 57 pg/ml) also all
decreased significantly. The 28-day mortality rate was 9%, and the
180-day mortality rate was 18%.
Conclusions The results suggested that type II PLA2 produced in
response to stimulation (for example, endotoxins or proinflam-
matory cytokines) may further activate the arachidonic acid
cascade, induce the production of various lipid mediators, and be
involved in the formation of various pathological conditions. It
seemed that production of these humoral factors decreased as a
result of suppression of the inflammatory response by performing
PMX-DHP and that their suppression was linked to the
improvement in pathology.
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Introduction Several studies have shown the effectiveness of non-
renal indication of continuous renal replacement therapy (CRRT) or
endotoxin-adosorbing fibers (direct hemoperfusion therapy with
polymyxin-B immobilized fibers (PMX-DHP)) for patients with
septic shock in improving unstable cardiovascular status. This
nonrenal indication of CRRT might be the additional benefits that
resulted in adsorbing various bioactive lipid mediators with dialyser
membranes. PMX-DHP is also known to adosorb various bioactive
mediators except endotoxin. In this investigation, the additional
benefits of CRRT and PMX-DHP were assessed in patients with
septic shock.
Methods Polymethylmethacrylate (PMMA), polysulfone, polyacrylo-
nitrile and polymyxin-B immobilized fiber (PMXBIF) were investi-
gated after use in patients with septic shock. Various adosorbed
bioactive lipid mediators, mainly arachidonylethanolamide and 2-
arachidonylglycerol, in these fibers were measured with gas
chromatography/mass spectrometry/selected-ion monitoring using
the isotope dilution method.
Results  Bioactive lipid mediators, such as 2-arachidonylglycerol
and arachidonylethanolamide, were adosorbed most in PMXBIF
and then in PMMA, while polysulfone and polyacrylonitrile
adosorbed a relatively low amount of lipid mediators.
Conclusions The amount of adosorbed bioactive lipid mediators
with PMXBIF and PMMA cannot be disregarded. It is necessary to
take this result into consideration for selection of the dialyser
membrane at the time of nonrenal indication of CRRT for patients
with septic shock.
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Introduction Ultrasound is increasingly used to facilitate central
venous catheter and regional anesthetic block placement [1,2].
Bacterial colonization of ultrasound probes has been demonstrated
and the potential for cross-contamination between patients exists
[3]. There are few, if any, studies investigating this for procedures
performed by anesthesiologists, in the operating room and ICU.
Methods  Following Institutional Review Board approval, 18
ultrasound probes utilized by anesthesiologists were sampled after
1 week of average usage during 2 months in 2008. Standard
microbiologic techniques were used [4]. Data were recorded,
stored securely, and analyzed using appropriate statistics.
Results Sixty-nine samples were obtained. Forty-nine percent of
samples showed bacterial colonization. Coagulase-negative staphylo-
coccus was identified in 42.6%. The incidence of Staphylococcus
aureus (1.4%) and Gram-negative bacteria (4.4%) was low.
Conclusions Ultrasound probes utilized in busy operating rooms
and ICUs at a tertiary-care facility are a potential source for
contamination and cross-contamination. Further studies of
ultrasound use, probe contamination with the potential to serve as
a vector for pathogens, and cleaning protocols are indicated.
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Introduction  Although several precautions are taken or studies
using national guidelines are conducted for preventing device-
associated infections (DAI), it is still a big problem with high
morbidity and mortality rates, related to frequent and long-term
usage of invasive devices [1]. The aim of the study is to assess the
incidence of DAI and to determine the microorganisms and
resistance patterns of the pathogens.
Methods  All microbiological tests of DAI patients in the ICU
between January 2007 and November 2008 were analyzed. All
microorganisms isolated from patients were recorded and their
resistance patterns were also ascertained.
Results  Sixty-nine patients were diagnosed as DAI using the
criteria of the Centers for Disease Control. Ventilator-associated
pneumonia (VIP) was the most frequent, with an incidence of
49.3% (n = 35), followed by catheter-associated urinary tract
infection (CR-UTI) (n = 20) and central venous catheter-associated
bloodstream infection (CVC-BSI) (n = 15) with an incidence of
28.9% and 21.8%, respectively. The most frequent pathogens in
VIP cases were Pseudomonas aeruginosa in 57% of cases (80%
of which were resistant to fluoroquinolones), enterobacteriaceae
species in 22% of the cases (50% of which were resistant to
ceftriaxone) and Staphylococcus aureus in 8% of the cases
(100% of which were methicillin resistant). The most frequent
pathogens in CR-UTI cases were enterobactericeae in 60% of
cases (70% of which were resistant to ceftriaxone), enterococci
species in 25% of the cases (none of the enterococci was
resistant to vancomycine) and P. aeruginosa in 15% of cases
(100% of which were resistant to flouroquinolones). The most
frequent pathogens in CVC-BSI cases were coagulase-negative
staphylococci in 66% of cases (75% of which were methicillin
resistant), S. aureus in 20% of the cases (85% of which were
resistant to methicilline) and enterobacteriaceae species in 14% of
cases (30% of which were ceftriaxone).
Conclusions DAI increase the mortality and morbidity rates in the
ICU. Therefore it is important to know the possible pathogen
microorganisms and their resistance patterns for the success of
the selection of the ampiric antibiotic treatment.
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Introduction Up to 20% of patients receiving mechanical venti-
lation for >48 hours will develop ventilator-associated pneumonia
(VAP) [1]. Dental plaque and oropharyngeal (OP) secretions of
intubated patients often contain organisms capable of causing
VAP [2].
Methods  An intervention to improve oral hygiene (8-hourly OP
cleaning/suctioning, toothbrushing and instillation of chlorhexidine
gel) was commenced in one zone of an adult general ICU. Nursing
staff in the rest of the ICU delivered standard oral hygiene
(concurrent control). No other specific VAP prevention strategies
were used in any patient. All patients on mechanical ventilation
were reviewed daily for VAP using National Nosocomial Infections
Surveillance criteria [3].
Results  In a 4-month period, 71 patients were admitted to the
intervention zone (Group A) and 189 patients were admitted to
control beds (Group B). Table 1 summarises the results with
values for age, APACHE II score and length of ICU stay shown as
medians and interquartile ranges.
Conclusions Use of an intervention to improve oral hygiene was
associated with a reduction in the incidence of VAP.
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Introduction Ventilator-associated pneumonia (VAP) is a frequent
nosocomial infection with an average incidence of 20% of ICU
patients undergoing mechanical ventilation. Elevation of the head
of the bed to >30° (semirecumbent position) is a recommended
strategy to reduce gastric reflux, and subsequent aspiration of
colonized gastric contents. However, the efficacy of this strategy to
prevent VAP remains controversial. We studied the relationship
between gravity and VAP in a swine model, an omnivore with
gastrointestinal physiology similar to humans.
Methods  Twenty-six female Yucatan minipigs were randomized
into four groups: (A) eight pigs were mechanically ventilated with
an orientation of the trachea approximately 45° above horizontal for
72 hours. In the remaining three groups (B to D) the head of the
bed was oriented 10° below horizontal (Trendelenburg position):
(B) six pigs were mechanically ventilated for 72 hours; (C) six pigs
were mechanically ventilated for 72 hours with enteral feeding; and
(D) six pigs were mechanically ventilated for 168 hours with enteral
feeding. At the end of the study period, pigs were electively
sacrificed and quantitative lung microbiological cultures performed.
Results All eight pigs kept in a semirecumbent position developed
pneumonia and respiratory failure (PaO2/FiO2 = 132 ± 139 mmHg
vs. 479 ± 42 mmHg, P <0.0001) with a median of 5.5 lobes out of
six colonized. Sixteen pigs kept in the semirecumbent position had
sterile lungs and two pigs ventilated in the Trendelenburg position
for 7 days developed a low level of colonization. Body orientation
was the only significant predictor of lung colonization and pneu-
monia (P <0.001).
Conclusions The semirecumbent position is uniformly associated
with lung colonization and respiratory failure by 72 hours. In
contrast. the positioning of the trachea and the endotracheal tube
below the horizontal prevented the development of VAP.
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Introduction  The objective was to determine the frequency of
gastroesophageal reflux (GER) in mechanically ventilated pediatric
patients and its role as a risk factor for ventilator-acquired
pneumonia (VAP) that may be enhanced among these patients.
Methods  The study was conducted in a pediatric ICU of Ain
Shams University Hospital on 24 mechanically ventilated patients
(16 VAP patients and eight without VAP as controls, with mean
age 16.6 ± 20.5 and 18.6 ± 22.4 months, respectively). Esopha-
geal 24 hour pH-metry beside clinical and laboratory evaluation of
the underlying problem and severity of the patient’s condition were
carried out.
Results All VAP patients had GER (50% alkaline reflux, 12.5%
acidic reflux and 37.5% combined reflux) compared with 75% of
non-VAP patients (100% alkaline reflux). The total reflux time was
found to be significantly longer among VAP (50 minutes) versus
non-VAP (3 minutes) patients. There was a significant increase in
acidic reflux parameters among nonsurvivors versus survivors
(P <0.001).
Conclusions  GER is a constant incident in our mechanically
ventilated pediatric patients, with alkaline reflux being more
common than acidic reflux. Both acidic reflux and alkaline reflux
Available online http://ccforum.com/supplements/13/S1
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Length of stay  Admission APACHE II  Total  Number of  VAPs/1,000 
Group Age (years) (days) score ventilator-days VAPs ventilator-days
A 51 (30 to 64) 7 (4 to 11) 16 (13 to 18) 457 2 4.37
B 56 (29 to 69) 8 (4 to 13) 18 (14 to 20) 1,584 12 7.57S122
were found to be associated with development of VAP and the
total reflux time is found to be a reliable parameter to pick up VAP
patients. However, acidic reflux was found to be related to high
mortality.
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Introduction The objective was to study a cohort of general ICU
patients electively reintubated with the LoTrach tracheal tube (tube
exchange) to determine safety and to audit postprocedural
ventilator-associated pneumonia (VAP). Emergency reintubation
following elective or unplanned extubation is a known risk factor for
subsequent VAP [1]; however, there are no published data on the
effects of protocol-based elective tube exchange. The LoTrach
tube prevents the pulmonary aspiration that occurs with
conventional cuffs [2] and allows subglottic secretion manage-
ment, thereby directly influencing two key steps in the patho-
genesis of VAP.
Methods Sequential patients (53 patients in 14 months) receiving
the LoTrach tracheal tube and cuff pressure controller were
studied. Patients either underwent an elective tube exchange
(using a bougie, preprocedural preoxygenation, gastric tube
aspiration, muscle relaxation and direct laryngoscopy to clear
upper airway secretions) or were primary LoTrach intubations on
the ICU. Three clinicians independently examined the critical care
electronic patient record. VAP was identified by a fall in the
PaO2/FaO2 ratio >25% or a clinical pulmonary infection score >5
and the presence of a positive qualitative tracheal aspirate. The
international consensus criteria for VAP diagnosis were also used,
as was the institution of antimicrobial therapy (if this was triggered
by a clinical suspicion of VAP, then for the purposes of this study
VAP was diagnosed).
Results  Forty-four (83%) patients underwent elective tube
exchange. No complications were noted associated with the
procedure. There were no episodes of VAP while the LoTrach was
in situ. On an intention-to-treat basis there was a 1.8% VAP rate
because one patient who required emergency reintubation
following elective extubation received a conventional tube and
developed VAP 2 days later. No other patients had antimicrobials
begun for chest infections.
Conclusions  There were no complications associated with
elective tube exchange and no subsequent cases of VAP in this
cohort of patients who were reintubated with the LoTrach tube.
Elective tracheal tube exchange can be safely performed in general
ICU patients.
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Introduction Aspiration of subglottic secretions is recommended
by the American Thoracic Society, for the prevention of ventilator-
associated pneumonia (VAP) [1], but has a poor implementation
rate in some countries [2]. VAP is the most frequent infection in
ventilated patients, occurring in up to 27% of cases [1].
Methods We studied 993 patients from September 2005, over a
39-month period, following the introduction of our ventilation care
bundle, which includes 30° head-up position, deep vein
thrombosis and peptic ulcer prophylaxis, sedation holds and using
chlorhexidine for mouth care. VAP is difficult to diagnose and
definitions vary. Our diagnoses were made prospectively by a
single consultant microbiologist using the validated Clinical
Pulmonary Infection Score. After 18 months we introduced the Hi-
Lo Evac/Lanz Mallinckrodt endotracheal tubes with suction applied
using a 10 ml syringe 2-hourly, as our study intervention.
Results The benchmark for European ICUs is a rate of 5% to 15%
(HELICS; Hospital In Europe Link for Infection Control through
Surveillance) and in America is 3 to 20 cases per 1,000 ventilator-
days (NNIS; National Nosocomial Infections Surveillance System).
For the 18 months following the implementation of care bundles,
our VAP rate was 5.39% (25/463 patients) with an incidence of
14 cases per 1,000 ventilator-days. Following the study inter-
vention the VAP rate fell to 1.5% (8/530 patients) and the
incidence to 4.17 cases per 1,000 ventilator-days. Our cohort of
patients over the period had no difference in APACHE II scores.
The difference between the groups following the employment of
subglottic secretion reached statistical significance with relative
risk 3.57 (95% CI = 1.63 to 7.85, P <0.001).
Conclusions  Our study confirms the benefit of subglottic
secretion clearance to reduce the occurrence of VAP.
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Introduction Nosocomial pneumonia is the leading cause of death
from hospital-acquired infections. Ventilator-associated pneumonia
(VAP) is the most frequent ICU-acquired infection in mechanically
ventilated patients. The purpose of our study is to assess the
prevalence and the etiologic pathogens of VAP in our ICU, as well
as its impact on morbidity and mortality.
Methods A prospective observational study in a multidisciplinary
eight-bed ICU. During an 18-month period, 160 consecutive
patients with a length of stay (LOS) ≥48 hours were enrolled in the
study. Data were collected using a specially designed software
and included age, gender, APACHE II score on admission, days on
mechanical ventilation, LOS and ICU outcome. Patients were
stratified into two groups: Group A included patients who did not
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develop VAP (n = 144), and Group B patients in whom VAP
diagnosis was confirmed (n = 16). In Group B, isolated pathogens
and their in vitro susceptibilities were also recorded. VAP
diagnosis was established on the basis of clinical criteria and
positive quantitative cultures of bronchial aspirates (≥105 colony-
forming units/ml). Data were analyzed using Student’s t test and
the Mann–Whitney rank-sum test.
Results Age (64 ± 18 vs. 70 ± 13 years, P = 0.257) and APACHE
II score on admission (18.9 ± 7.6 vs. 18.8 ± 9.7, P = 0.965) were
similar in both groups. Calculated VAP incidence was 5.87/1,000
ventilator-days (four early and 12 late-onset VAP). Duration of
mechanical ventilation (17 ± 22 vs. 30 ± 12 days, P < 0.001) and
LOS (19 ± 22 vs. 34 ± 15 days, P  <0.001) were statistically
longer in Group B. Isolated pathogens included: Acinetobacter
baumannii (10 patients), Klebsiella pneumoniae (four patients),
Pseudomonas aeruginosa (two patients), other Gram-negative
(one patient). Overall antibiotic resistance to carbapenemes was
88%, to aminoglycosides 82%, to aztreonam 94%, to piperacillin/
tazobactam 82% and to colimycin 6%. ICU mortality was
considerably higher in Group B (24.3% vs. 43.8%).
Conclusions  All VAP cases in our ICU were caused by Gram-
negative multidrug-resistant bacteria. Colimycin seems to be our
major therapeutic weapon against these strains. VAP prolongs the
duration of mechanical ventilation and LOS, and contributes to
higher mortality rates in ICU patients requiring mechanical ventilation.
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Introduction Surveillance of hospital-acquired infections in inten-
sive care wards is a very important but time-consuming process
requiring involvement of all medical personnel [1]. This means
published data on infections after cardiac surgery are rather limited
[2]. The aim of this study was to analyze the epidemiology and
etiology of ventilator-associated pneumonia (VAP) following
coronary surgery in ICU patients.
Methods The surveillance was based on the active method. Cases
of infections were detected by the hospital Infection Control Team
in cooperation with the unit personnel in accordance with Centers
for Disease Control definitions during 2007. Data on surgical site
infections (SSI; 33 cases) served as the background for validation
of VAP surveillance.
Results Altogether 53 VAP cases after 2,170 surgical events were
detected. The ventilator utilization ratio was 0.52. The total
cumulative VAP incidence rate was 2.2% and the ventilator-
associated hospital-acquired pneumonia rate was 18.3/1,000
ventilator-days; mortality was 1.9%. The total cumulative incidence
SSI rate was 1.4%. Etiological factors of VAP were Gram-negative
bacilli (Pseudomonas aeruginosa – 10.4%, Escherichia coli –
12.5%, Klebsiella pneumoniae – 16.7%) and Candida albicans.
Conclusions In the analyzed setting, in which surveillance of SSI
has been run since 2002, detected SSI incidence rates are similar
to those reported in the National Nosocomial Infections
Surveillance and Krankenhaus Infectionen Surveillance System
programs [3,4]. However, obtained data on the epidemiology of
VAP are different. Also, there are differences in both the
epidemiology and microbiology of VAP in this hospital and results
reported from other cardiac surgery wards. This indicates a
necessity for introducing effective surveillance of hospital-acquired
pneumonia after cardiac surgery procedures in the ICU.
Acknowledgement Partially financed by K/ZDS/000649.
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Introduction Ventilator-associated pneumonia (VAP) is the most
frequent ICU-acquired infection among patients receiving mecha-
nical ventilation. The aim of our study was to test the incidence, the
rate of mortality and the impact of VAP to prolong the duration of
ICU stay, in our both medical and surgical ICU.
Methods  During a 32-month period, from November 2005 to
August 2008, 127 patients were admitted to our ICU; 114 of them
had received mechanical ventilation and were included retro-
spectively in our study. The sum of the mechanical ventilation days
was 1,330. The patients compared were divided into two groups.
Group A included 28 patients (24.5% of the total) with VAP (five
early and 23 late), and Group B included 86 patients with no VAP.
Results The incidence of VAP was 24.5% in patients receiving
mechanical ventilation, or 21 of episodes per 1,000 days of
mechanical ventilation. We detected no statistically significant
difference among the two groups according to age (mean ± SD):
64.62 ± 15.9 and 64.53 ± 16.9, P = 0.97, nor the APACHE II
score (mean ± SD): 19.96 ± 6.8 and 19.33 ± 7.79, P = 0.7. We
detected a statistically significant difference among the two groups
according to the duration of ICU stay (days, mean ± SD): 33.75 ±
20 and 10.27 ± 11.29, P <0.0001. We detected a difference
according to the rate of mortality, 32.14% and 22.09%, respec-
tively, although not statistically significant, P = 0.31, OR = 1.67.
Conclusions The incidence of VAP in our study is similar to other
studies, which varies from 8% to 28%. VAP prolongs the duration
of ICU stay, while the attributable mortality rate for VAP is still
debated. Nevertheless, we have to improve our clinical approach in
order to recognize better the risk factors and to develop a more
effective prevention program.
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Introduction  Clara cell protein 10 (CC-10) is a low-molecular-
weight protein secreted in large quantities by nonciliated Clara
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cells. Differences in CC-10 concentrations have been demon-
strated in several inflammatory lung diseases (for example,
bronchial asthma and chronic eosinophilic pneumonia). Moreover,
there is evidence that in infectious pulmonary diseases the type of
microorganism (for example, Pseudomonas aeruginosa) influences
CC-10 activity. In this study we evaluated the presence of CC-10
in bronchoalveolar lavage (BAL) fluid as a potential marker for
ventilator-associated pneumonia (VAP) in critically ill patients with a
suspicion of VAP.
Methods  Between January 2003 and December 2007 all
consecutive BAL fluid samples from critically ill patients in the ICU
of the Maastricht University Medical Center clinically suspected of
VAP were included. Patients were divided into two groups: micro-
biologically confirmed VAP (VAP group), and microbiologically not
confirmed VAP (non-VAP group). VAP was microbiologically
confirmed if BAL fluid cultures yielded ≥104 colony-forming
units/ml and/or microscopic analysis revealed ≥2% intracellular
organisms. The CC-10 concentration was measured with a
commercially available ELISA, and retrospective analysis was
performed. Areas under the curve of receiver operating
characteristic curves were calculated for CC-10 concentrations.
Results A total of 196 BAL fluid samples were included from 196
patients (123 men, 73 women). Seventy-nine out of 196 episodes
of suspected VAP (40.3%) were microbiologically confirmed. The
median CC-10 concentration in the VAP group was 3,019 ng/ml
(range: 282 to 65,546) versus 2,504 ng/ml (range: 62 to 30,240)
in the non-VAP group (P = 0.06), with an area under the curve of
0.586. In addition, CC-10 concentrations were not significantly
different between the non-VAP group and the VAP group caused
by a specific organism (for example, P. aeruginosa) (P = 0.386).
Conclusions  CC-10 concentration in BAL fluid is not a useful
marker to differentiate between VAP and non-VAP.
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Introduction Human metapneumovirus (hMPV) is a paramyxovirus
that has been shown to cause respiratory infections in children, the
elderly and immunocompromised patients. In this study we
retrospectively evaluated the presence of hMPV in bronchoalveolar
lavage fluid (BALF) of critically ill patients.
Methods  Between January 2005 and December 2007 all
consecutive BALF samples from critically ill patients in the ICU of
the Maastricht University Medical Center clinically suspected of
hospital-acquired pneumonia were included. BALF work-up
included: differential cell count, quantitative bacterial culture, PCR
for relevant respiratory pathogens and additional stains and
cultures guided by clinical suspicion. All samples were analysed
retrospectively by quantitative real-time PCR targeting the
nucleoprotein gene of hMPV.
Results A total of 144 BALF samples were included from 121
patients in the ICU (75 men and 46 women). RNA of hMPV was
detected in two out of 144 BALF samples (1.4%) of two patients.
The first hMPV-positive patient had an underlying hematological
malignancy (multiple myeloma). Already being treated with broad-
spectrum antibiotics, the patient developed signs of respiratory
distress. Five days after hospital admission, the patient was
admitted to the ICU because of respiratory insufficiency. A BAL
performed the same day yielded no causative microorganism at
that time. The second hMPV-positive patient had been admitted to
the hospital with a community-acquired pneumonia for which no
causative organism was identified. Five days after hospital
admission, progressive respiratory insufficiency necessitated ICU
admission. Twelve days after ICU admittance a bronchoalveolar
lavage was performed, which yielded Candida albicans in
102 colony-forming units/ml. In both patients no causative micro-
organism for pneumonia could be identified during hospitalisation,
and therefore we speculate that hMPV may at least have
contributed to or perhaps even caused the respiratory deterioration
under antibiotic therapy.
Conclusions  In critically ill patients 1.4% of collected BALF
samples revealed the presence of hMPV RNA. Therefore, hMPV
may play a part in respiratory complications in ICU patients. An
additional study is necessary to investigate the extent to which
hMPV contributes to respiratory failure in patients admitted to the
ICU.
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Introduction  The aim of this study was to analyse trends in
antibiotic susceptibility and minimum inhibitory concentration (MIC)
distribution in European ICUs based on data from the Mystic
surveillance study initiated in 1997 [1].
Methods  Twenty-eight ICUs in Belgium, Croatia, Finland,
Germany, Spain, Sweden and the UK contributed with nonrepeat
isolates of Pseudomonas aeruginosa (n = 3,241), Escherichia coli
(n = 3,306), and Klebsiella pneumoniae (n = 1,660). Only non-
repeat isolates taken on clinical indication were included. Two
models were used for trend analysis: Model A: changes in
susceptibility (S), intermediate (I) and resistance (R) using the
EUCAST breakpoints [2] described by the logistic regression
model pR = 1 / (1 + exp(–aR – bR x year)) and Model B: changes in
MIC distribution 2logMIC = aM + bM x year. The parameters bR and
bM describe the time dependence, and the hypotheses bR = 0 and
bM = 0 can be tested. Year was used as the independent variable
in both models.
Results Resistance (I+R%) rates in 2007 and trend analysis ((+
increase, – decrease), (P values for changes in susceptibility/MIC
distribution from 1997 to 2007)): P. aeruginosa: imipenem 43%
((+/+), <0.001/<0.001)) (Figures 1 and 2), meropenem 27%
((+/+), (0.01/0.04)), ceftazidime 32% ((+/+), (0.035/<0.001)), cipro-
floxacin 32% ((–/–) (0.39/0.79)), gentamicin 22% ((–/–),(0.002/
0,019));  E. coli: imipenem 0.6% ((–/–) (<0.013/<0.001)),
meropenem 0% ((+/–) (0.66/<0.001)), cefotaxime 9% ((–/+),
(0.61/0.17)), ciprofloxacin 25% ((+/+), (<0.001/0.07)), gentamicin
14% ((+/+), (0.14/0.44)); and K. pneumoniae: imipenem 0%
((–/–) (<0.001/<0.001)), meropenem 0.5% ((–/–) (0.89/<0.001)),
cefotaxime 13% ((–/–), (<0.001/0.3)), ciprofloxacin 17% ((+/–),
(0.017/0.78)), gentamicin 21% ((+/–), (0.16/0.61)).
Conclusions  Significantly (P  <0.05) increasing resistance rates
(I+R%) and increasing MICs (2log MIC) were found among P.
aeruginosa to carbapenems and ceftazidime. For other species–
antibiotic combinations there were either low (<1%) resistance
rates or not the same significant changes demonstrated with the
two trend models. This study showed that trend analysis based on
MIC distributions was not more sensitive than trend analysis based
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on changes in susceptibility (I+R). High (>27%) resistance rates
were seen for all tested drugs against P. aeruginosa while low
(<1%) resistance rates were only shown for carbapenems against
E. coli and K. pneumoniae.
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Introduction Pseudomonas aeruginosa remains one of the most
important pathogens in the nosocomial setting, where it is a
common causative agent of bacteremia [1,2]. The aim of this study
was to evaluate the antimicrobial resistance of Pseudomonas spp.
strains isolated from inpatients hospitalized in the ICU of our
hospital throughout a 3-year period.
Methods  A total of 175 clinical isolates of Pseudomonas spp.
collected from January 2006 to December 2008 were investigated
in this study. Each isolate was obtained from a different patient.
Identification and routine antibiograms of the isolates were carried
out using the Vitek 2 automated System (BioMerieux®, Marcy
I’Etolie, France). The minimum inhibitory concentrations of
imipenem, meropenem and colistin were also determined by the
agar dilution method according to Clinical Laboratory Standards
Institute guidelines.
Results The isolates included in our study originated from blood
cultures 70 (40%), urine 53 (30.3%), bronchial aspirates 23
(13.1%), central venous catheters 18 (10.3%) and others 11
(6.3%). The resistance rates changed from 2006 to 2008 as
follows: amikacin: 72 to 83%, aztreonam: 90 to 95%, ceftazidime:
81 to 89%, ciprofloxacin: 79 to 85%, colistin: 0 to 0%, mero-
penem: 72 to 83%, imipenem: 72 to 83%, netilmicin: 72 to 83%,
piperacillin/tazobactam: 71 to 80%, tobramycin: 72 to 83%,
ticarcillinlin/clavulanic acid: 71 to 80%.
Conclusions Pseudomonas spp. infections are particularly serious
for incubated ICU patients with 40 to 50% mortality rates. In our
hospital, the percentage of Pseudomonas spp. multiresistant
isolates has increased dramatically over the past 3 years. The
majority of isolates were resistant to 15 or more antibiotics. What is
most worrying is the fact that there is a prevalence of a multiresistant
phenotype that was only sensitive to colistin. The emergance and
rapid spread of multidrug-resistant isolates of Pseudomonas spp.
are of great concern worldwide. It is necessary to limit the overuse of
antibiotics and to implement a new antibiotic policy.
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Introduction  Nosocomial infections remain the main cause of
morbidity and mortality in burn patients. Ongoing surveillance of
infections in burned patients is essential to detect changes in
epidemiology and to guide better empirical antibiotherapy and
infection control policies. The aim of this study was to analyze the
bacterial flora and the antibiotic resistance of isolates in a burn
department during a 2-year period.
Methods  From 1 January 2005 to 31 December 2006, 1,268
strains were isolated from different specimens. Antimicrobial sus-
ceptibility testing has been carried out by the disk diffusion method
as referred by the French Society of Microbiology. All data were
stored in a laboratory database using whonet 5.3 software. Dupli-
cate isolates defined as the same bacterial species for the same
patient with the same antimicrobial susceptibility profile were excluded.
Results  The most frequently identified species were Staphylo-
coccus aureus (19.8%),  Pseudomonas aeruginosa  (15.8%),
Acinetobacter baumannii (11.8%), and Providencia stuarttii
(9.5%). The rate of methicillin-resistant S. aureus (MRSA) was
68.1%. All isolates were fully susceptible to glycopeptides. P.
aeruginosa resistance was 35.6% and 35.4% respectively for
ceftazidime and imipenem. Concerning A. baumannii, 98.7% of
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strains were resistant to ceftazidime, 59.5% to imipenem and
87.5% to ciprofloxacin. In total, 77.3% of P. stuarttii isolates were
resistant to ceftazidime. The frequencies of resistance to
ceftazidime, ofloxacin and amikacin of Klebsiella pneumoniae were
respectively 60.9%, 25.4% and 47.1%. The survey of resistance
showed a global decrease in 2006 versus 2005. The rate of
MRSA was 61% in 2005 versus 51.6% in 2006. The resistance of
ceftazidime was 80.6% in 2005 versus 26.9% in 2006 in P.
aeruginosa. The imipenem resistance showed also a decrease in
2006 in A. baumannii and  P. aeruginosa. The amelioration of
hygiene, particularly washing hands after introduction of hydro-
alcoholic solutions, and the collaboration between microbiologists
and clinicians could explain the decrease of resistance showed in
the burn department.
Conclusions Comparative to the previous years, S. aureus is still
the commonest pathogen in the burn department. The incidence of
antimicrobial resistance has decreased during 2006 after a peak of
multiresistance during 2005. The measures of prevention taken
were efficient and should be re-enforced.
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Introduction  Staphylococcus aureus is a potential pathogenic
microorganism and a causative agent of ~25% of infections in
intensive care patients. Optimal empiric therapy may reduce
morbidity and mortality. Therefore, it is essential to provide the
clinician with resistance data of the local circulating strains and
patients pathogens. A national surveillance program of the Dutch
Antibiotic Resistance Surveillance Group was started in the
Netherlands in 1996 to gain insight into the emergence of
microbial resistance at local, regional and national levels. This
study describes the findings of resistance development of S.
aureus from ICUs of 14 large referral hospitals all over the
Netherlands over a 10-year period from 1996 to 2006.
Methods  In the first 6 months of each year, the participating
hospitals collected clinical isolates from, among others, blood and
respiratory samples. In total 943 isolates were collected: 250 from
three hospitals in the north, 187 from two in the east, 229 from five in
the west and 280 from four in the south. The susceptibility to
relevant antibiotics was determined by micro broth dilution according
to the Clinical and Laboratory Standards Institute guidelines.
Results  Resistance to penicillin fluctuated over time at ~75%;
seven methicillin-resistant S. aureus were isolated (0.7%).
Resistance to clarithromycin increased to 10% in 2003, but
decreased in 2006 to 6%, the level before 2003. Resistance to
clindamycin fluctuated over time from 4 to 8%. Doxycyclin resis-
tance varied between 2 and 10%. No resistance to vancomycin,
teicoplanin and linezolid was demonstrated. Resistance to
gentamicin and rifampicin was sporadically found. The prevalence
of fluoroquinolone resistance was between 0 and 4% until 2002.
In 2003, a peak in the prevalence of fluoroquinolone resistance
(ciprofloxacin 14% and moxifloxacin 8%) was observed.
Resistance to ciprofloxacin remained at this high level until 2005
and decreased in 2006. Resistance to moxifloxacin decreased
immediately. Regional differences were observed for ciprofloxacin,
with the highest resistance in the western and southern parts and
with doxycyclin with the lowest resistance rate in the northern part.
Conclusions During the 10-year study period only an increase in
resistance to ciprofloxacin was observed. The data presented still
justify the empiric choice of flucloxacillin (with rifampicin or
gentamicin depending on the indication) in case of an infection
probably caused by S. aureus in ICU patients.
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Introduction Vancomycin is known to induce postantibiotic effect
but some data suggest that bactericidal activity is time dependent.
Presently, the optimal dosing regimen for administration of
vancomycin remains unknown. The aim of this open prospective
randomized study was to compare clinical and microbiological
efficacy of continuous infusion versus intermittent administration of
vancomycin in critically ill patients.
Methods Patients admitted to the interdisciplinary ICU suffering
from infection indicated to vancomycin administration with
predicted duration of treatment of at least 4 days were randomized
to receive either a 15 mg/kg intravenous loading dose of
vancomycin followed by a daily 15 mg/kg continuous infusion
(continuous group) or intermittent administration of 15 mg/kg
vancomycin intravenously every 12 hours (intermittent group).
Antibiotic therapy was stopped at improvement of clinical state and
laboratory signs of subsidence of infection. Failure of antimicrobial
therapy was defined as persistence or progression of signs and
symptoms of infection, development of new clinical findings
consistent with active infection or death from infection. The age,
APACHE II score, type of infection, length of ICU stay, length of
mechanical ventilation, mortality, clinical and microbiological failure
and length of vancomycin therapy and total dose of vancomycin
were assessed. The Sequential Organ Failure Assessment score,
white blood count, C-reactive protein and renal function at the
beginning and at the end of therapy were evaluated. The
Mann–Whitney test, unpaired t  test and chi-squared test were
used accordingly; P <0.05 was considered statistically significant.
Results A total of 65 patients were enrolled and randomized in the
continuous (n = 33) and intermittent (n = 32) groups. No
significant differences between both groups in all assessed
parameters were found. Clinically evaluated failure of therapy in the
continuous versus intermittent groups was in 12 (36%) patients
versus eight (25%) patients, and microbiological failure in seven
(21%) patients versus eight (25%) patients.
Conclusions Continuous infusion and intermittent administration
of vancomycin in critically ill patients provided equivalent clinical
and microbiological outcome.
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Introduction The hyperdynamic stage occurring in sepsis may be
responsible for an increase in renal blood flow that may lead to
Critical Care    March 2009 Vol 13 Suppl 1 29th International Symposium on Intensive Care and Emergency MedicineS127
increased elimination of some drugs, namely vancomycin. The aim
of this study was to evaluate the effects of 24-hour creatinine
clearance (CrCL) higher than 130 ml/min/1.73 m2 on vancomycin
serum levels, and to identify an accurate marker of this condition.
Methods This study was carried out in a multipurpose ICU, on 120
critical septic patients, 36% with septic shock (42 patients), 67
men (72.5%), average age 56 ± 21 years, average APACHE II
score and Simplified Acute Physiology Score (SAPS) II of 17.2
and 42.2, respectively. We studied 120 consecutive vancomycin
treatments (continuous perfusion) and we assessed therapeutic
levels (20 to 30 μg/ml) on days 1, 2 and 3 (V1, V2 and V3).
Patients were divided into two groups according to CrCL: G1
≤130 ml/min/1.73 m2 (n = 77); G2 >130 ml/min/1.73 m2 (n = 43).
Both groups had similar vancomycin dosage on day 0 (47.7/46.6
mg/kg; P = 0.26).
Results Average age, APACHE II score and SAPS II were 62.6/44
years, 18.8/14.2 and 45/36.9, respectively, for G1 and G2
(P <0.05). Average CrCL in G1: 76.7 ml/min/1.73 m2; average
CrCL in G2: 176 ml/min/1.73 m2 (P <0.05). Serum proteins and
albumin were, respectively, 5.26/5.64 g/dl and 2.84/3.17 g/dl
(P <0.05), and urinary creatinine (UCr), urinary urea and 24-hour
urine output were 34.6/71 mg/dl, 437/625 mg/dl and 2,450/
2,846 ml, respectively (P <0.05). V1, V2 and V3 were 20/14.3,
24.3/17.6 and 26.5/20.3 μg/ml, respectively, for G1 and G2
(P <0.05 on each day). The correlations between V1 and CrCL
were –0.47 (G1) and –0.33 (G2), both with P <0.05. The area
under the curve (AUC) of the receiving operating curves of UCr,
urinary urea and blood urea nitrogen (BUN) as markers of high
clearance status (>130) were 0.85 (95% CI = 0.77 to 0.91), 0.72
(95% CI = 0.63 to 0.80) and 0.66 (95% CI = 0.55 to 0.73),
respectively, and this area was maximal for a subgroup of patients
(76 patients) without shock (AUC: 0.9; 95% CI = 0.81 to 0.96 for
UCr). Best cutoff point for UCr: > 58mg/dl; for BUN: <17 mg/dl.
Conclusions  Over-increased CrCL identifies a subgroup of
younger patients, with lower severity scores and high incidence of
subtherapeutic vancomycin concentrations on the first 3 days –
especially on day 1 (39/43 patients; 90.7%). A UCr concentration
above 58 mg/dl can be a sensitive (70%) and specific (87%)
marker of this condition. The addition of BUN <17 mg/dl as a
second marker increases specificity to 97.4%.
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Introduction Vancomycin-resistant enterococci (VRE) have been
recognised as microorganisms capable of causing epidemics in
critically ill patients [1]. The present report describes an outbreak
involving VRE colonisation in our ICU.
Methods After several weeks of severe nursing shortage, when
often there were only three nurses for 10 critically ill patients, the
first VRE was isolated from one of the two blood cultures of a
trauma patient. Rectal swabs of all of the patients’ and ICU staff
were collected. Because there was no patient who had been
discharged to the ward during this period no further analysis was
required.
Results Enterococcus casseliflavus was isolated from six out of
the 10 patients’ rectal swabs. Once the outbreak was identified, all
patients were placed under strict contact isolation and cohorted,
and barrier precautions were instituted. Four patients who had
negative rectal swabs were isolated in another ICU. Five of the
patients did not demonstrate signs of infection and were accepted
as colonisation. ICU staff had negative rectal swabs. Two of the
patients who had positive rectal swabs had died because of
underlying primary disease (acute myocardial infarction, acute
respiratory distress syndrome due to aspiration pneumonia). The
first patient who had a positive blood culture was treated with
intravenous Linezolid and discharged to home after 14 days.
Another patient who had sepsis due to necrotising fasciitis was
discharged to the ward after obtaining three negative rectal swabs.
The other patient who had non-Hodgkin lymphoma and pneumonia
was discharged to the ward after obtaining three negative rectal
swabs. The last patient was isolated in another room and followed
up for 4 weeks and discharged to the ward after obtaining three
negative rectal swabs.
Conclusions The outbreak was controlled by continuous imple-
mentation of the infection control programme. A long ICU stay,
hemodialysis, and nursing shortage are risk factors for VRE
development. Transmission of VRE can be facilitated by the hands
of the staff. We conclude that this outbreak may be due to the
shortage of nursing during summer.
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Introduction  This study aims to describe the vancomycin,
teicoplanin and linezolid susceptibility patterns of methicillin-
resistant  Staphylococcus aureus (MRSA) blood culture isolates
from patients in the private sector in Gauteng, South Africa.
Screening tests for heterogeneous glycopeptide intermediate S.
aureus (hGISA) strains were also performed. MRSA isolates with
vancomycin minimum inhibitory concentrations (MICs) of 1 to
2 mg/l are associated with worse clinical outcomes [1]. Further-
more, hGISA infections are associated with clinical failure of
glycopeptide therapy [2].
Methods  MICs for vancomycin, teicoplanin and linezolid were
performed on 50 randomly collected MRSA strains from blood
cultures according to Clinical Laboratory Standards Institute guide-
lines. Screening for hGISA was performed using the Etest (AB
BIODISK) Macromethod as well as the new Etest Glycopeptide
Resistance Detection.
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Susceptibility patterns of MRSA isolates (n = 50)
Vancomycin Teicoplanin Linezolid
(mg/l) (mg/l) (mg/l)
MIC50 1.5 2 1.5
MIC90 2 3 2
Breakpoint S ≤2S   ≤8S   ≤4S128
Results  The results of susceptibility patterns are depicted in
Table 1. Fifty percent (25/50) and 20% (10/50) of the strains
screened positive for hGISA using the Etest Macromethod and
Etest Glycopeptide Resistance Detection, respectively.
Conclusions  We recommend that clinically relevant MRSA
isolates be reported with MICs for vancomycin, teicoplanin and
linezolid, and that glycopeptide treatment failure warrants further
testing of the MRSA isolate to detect possible hGISA. Ideally
hGISA should be confirmed by population analysis profile testing,
which was not available to us for this study.
References
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Introduction  Telavancin (TLV) is an investigational lipoglyco-
peptide with activity against Gram-positive pathogens. The Assess-
ment of Telavancin for Treatment of Hospital-acquired Pneumonia
(ATTAIN) programme studied TLV for the treatment of hospital-
acquired pneumonia (HAP). This analysis compared the clinical
cure rates achieved with TLV or vancomycin (VAN) for severely ill
and older patients.
Methods  ATTAIN 1 and ATTAIN 2 were methodologically
identical, randomised, double-blind, phase 3 studies. Adult patients
with pneumonia acquired after 48 hours in an inpatient acute-care
or chronic-care facility, or acquired within 7 days after being
discharged following ≥3 days of hospital stay were randomised to
TLV 10 mg/kg intravenously every 24 hours or VAN 1 g intra-
venously every 12 hours for 7 to 21 days. A test-of-cure (TOC) visit
was conducted 7 to 14 days after end-of-study treatment. Com-
pliant patients who had a clinical response of either cure or failure
at TOC were considered clinically evaluable (CE).
Results  Pooled clinical cure rates at TOC for several clinically
relevant subgroups including the elderly as well as patients with
severe HAP at baseline are presented in Figure 1. The percentage
of patients reporting at least one treatment-emergent adverse
event was comparable between the TLV and VAN groups (80% vs.
79%, respectively).
Conclusions  Although not statistically significant, TLV achieved
numerically higher cure rates than VAN for treatment of HAP in
severely ill and older patients with comparable treatment-emergent
adverse events.
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Introduction Betalactam efficacy is determined by the duration of
time that concentrations remain above the minimum inhibitory
concentration (MIC). Some studies have found that the adminis-
tration of betalactams by continuous infusion maintains constant
concentrations above the MIC of susceptible organisms over the
course of therapy; but limited data exist on the clinical efficacy of
betalactams administered by continuous infusion. The purpose of
this study was to evaluate the clinical efficacy of piperacillin/
tazobactam by continuous infusion (CI) administration or by
intermittent infusion (II) for the treatment of ventilator-associated
pneumonia (VAP) caused by Gram-negative bacilli.
Methods  A retrospective cohort study (1 June 2002 to 31
December 2007) of patients with VAP caused by Gram-negative
bacilli who received initial empiric antibiotic therapy with
piperacillin/tazobactam. We analyzed two contemporary cohorts:
one received piperacillin/tazobactam by CI (first received a loading
dose of piperacillin/tazobactam 4/0.5 g over 30 minutes, and after
4/0.5 g infused over 360 minutes every 6 hours) and the other by II
(4/0.5 g over 30 minutes every 6 hours). The administration of
piperacillin/tazobactam by CI or II was prescribed according to the
physician’s discretion.
Results  Significant differences were not found between both
groups of patients (37 with CI and 46 with II) in baseline data.
Logistic regression analysis showed a higher probability of clinical
cure of VAP by CI than by II (33/37 (89.2%) vs. 26/46 (56.5%);
OR = 7.4; 95% CI = 1.96 to 37.42; P = 0.001). Logistic
regression analysis showed a higher probability of clinical cure of
VAP by CI than by II when the microorganism causative of VAP
had a MIC of 8 μg/ml (8/9 (88.9%) vs. 6/15 (40.0%); OR = 10.8;
95% CI = 1.01 to 588.24; P = 0.049) and a MIC of 16 μg/ml (7/8
(87.5%) vs. 1/6 (16.7%); OR = 22.9; 95% CI = 1.19 to 1,880.78;
P = 0.03); but not when it had a MIC of 4 μg/ml (18/20 (90.0%)
vs. 19/25 (76.0%); OR = 2.8; 95% CI = 0.42 to 31.67; P = 0.41).
Conclusions  Administration of piperacillin/tazobactam by con-
tinuous infusion may have more clinical efficacy than administration
by intermittent infusion for the treatment of nosocomial pneumonia.
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Introduction The guidelines of the Centers for Disease Control
and Prevention do not recommend the use of an antimicrobial or
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antiseptic-impregnated catheter for short-term catheterization and
recommend avoiding femoral access to reduce the risk of central
venous catheter-related bacteremia (CVC-RB). The objective of
this study was to determine the incidence of CVC-RB with
rifampicin–miconazole-impregnated catheters (RM-C) and stan-
dard catheters (S-C) in femoral venous access; and the cost of
CVC-RB with both types of catheter.
Methods  A cohort study, conducted in a 24-bed polyvalent
medical–surgical ICU of a university hospital. We included patients
admitted to the ICU from 1 June 2006 to 30 September 2007,
who underwent femoral venous catheterization. The cost of CVC-
RB included the cost of antimicrobial agents and the diagnosis
methods; but other costs were not included (such as prolongation
of ICU stay, mechanical ventilation, extrarenal depuration, etc.).
Results We inserted 73 RM-C during 634 catheter-days and 111
S-C during 927 catheter-days. We diagnosed eight CVC-RB in
the S-C group and none in the RM-C group. The incidence of
CVC-RB with RM-C was significantly lower than with S-C (0 vs.
8.62 per 1,000 catheter-days, OR = 0.13, 95% CI = 0.00 to 0.86;
P  = 0.03). The total cost in the RM-C group was €7,300 (73
central venous catheters (CVC) per €100 each CVC, and none
CVC-RB), the mean cost per catheter was €100 (€7,300/73
CVC), and the mean cost per catheter-day was €11.51
(€7,300/634 CVC-days). The total cost in the S-C group was
€15,330 (111 CVC per €30 each CVC = €3,330, more than
€12,000 per the eight CVC-RB), the mean cost per catheter was
€138 (€15,330/111 CVC), and the mean cost per catheter-day
was €16.54 (€15,330/927 CVC-days).
Conclusions  RM-C could decrease the incidence of femoral
venous catheter-related bacteremia and are more efficient than
standard catheters.
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Introduction Pediatric patients in the ICU are highly vulnerable to
invasive fungal infections [1]; Candida has been reported to be the
third most common pathogen in pediatric ICU wards [2]. However,
information on new antifungal therapies in children remains limited.
Micafungin (MICA) is a once-daily antifungal agent of the
echinocandin class.
Methods A retrospective review of MICA pediatric data from six
trials.
Results  MICA was received by 296 children for invasive candi-
diasis, refractory invasive candidiasis, refractory invasive asper-
gillosis, prophylaxis in hematopoietic stem cell transplantation
(HSCT) patients, or to assess pharmacokinetics (PK). Most patients
aged <1 year were premature (38/66), whereas most children aged
>1 year were HSCT recipients or undergoing another therapy for a
hematological malignancy (181/230). Maximum daily dose was
similar for patients aged <1, 1 to 4, 5 to 8, 9 to 12 and 13 to
15 years with medians of 2.0, 1.5, 1.5, 1.9 and 1.5 mg/kg,
respectively. Treatment success rates are shown in Figure 1. MICA
showed linear PK, with a higher clearance in neonates than in older
children and adults. Common adverse events (incidence ≥2%) were
transient increases in transaminases, hypokalemia, hyperbili-
rubinemia and increased alkaline phosphatase.
Conclusions  MICA is a safe and efficacious agent for the
treatment and prophylaxis of pediatric invasive fungal infections in
the ICU setting.
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Introduction  Rickettsia conorii infection, the agent of
Boutonneuse fever, presents usually in a form considered benign,
with serious complications in less than 10% of patients. Its
mechanism of infection consists of vascular endothelial invasion by
the microorganism and subsequent vasculitis and tissue necrosis.
The process is usually localized or limited to the skin but can
progress with malignant severe systemic involvement [1,2].
Methods A series of three cases of patients with multiple organ
failure admitted to an ICU with confirmed diagnosis of Bouton-
neuse fever is presented (positive serology or tissue PCR).
Results Common to all the patients was the rapid development of
the disease (average: 3 days) from the initial complaints of fever
after a bite by an unidentified agent and development of
generalized rash, and the diagnosis of multiple organ failure
(average Simplified Acute Physiology Score II: 59; average
Sequential Organ Failure Assessment score on admission: 12.6).
All developed respiratory failure requiring invasive mechanical
ventilation, haematological failure with haemolytic anaemia and
acute renal failure suggestive of serious widespread vasculitis.
One of the cases developed lethal refractory septic shock within
6 hours of admission. Tetracycline antibiotic therapy was started
early in all patients, based on clinical and epidemiological data,
since initial microbiological results were negative.
Conclusions This series of cases illustrates the most severe form
of Boutonneuse fever, usually associated with comorbidities such
as diabetes, malignant disease, immunodeficiency or delay in the
diagnosis and appropriate antibiotic therapy, which was not the
case in these patients.
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Introduction Infectious characteristics, the infection source, and
appropriate antibiotics are analyzed in relation to mortality in a
cohort of patients with severe sepsis and septic shock.
Methods  An observational and prospective cohort study over
1 year of all patients admitted to one of the adult ICUs of the three
major university hospitals in Beirut. Demographics, appropriate ICU
therapies within 48 hours of admission, appropriate antibiotic
prescription within 48 hours of admission, antibiotic duration and
number were registered. Infections were defined as definite or
suspected. The infectious source, microbial agents and anti-
biograms were identified. Data were collected only during the ICU
stay, and outcome was recorded at hospital discharge (alive or
dead).
Results One hundred and twenty-seven patients with an average
age of 65 years were enrolled, 52% of admissions were from the
emergency room and 83% were medical patients. Fifty-eight
percent of the patients had severe sepsis within 48 hours of
admission. The average APACHE II and Sequential Organ Failure
Assessment scores were 21 and 7, respectively. Immuno-
deficiency was present in 30%. Overall mortality was 45%.
Definite infection was diagnosed in 61% of the patients and
bacteremia in 31.5%. Appropriate antibiotic prescription was
significantly higher in patients with less severe sepsis compared
with severe sepsis (>1 organ failure). Mortality was significantly
higher in patients prescribed a higher number of antibiotics while
the length of antibiotic prescription was not different between
survivors and nonsurvivors. Escherichia coli (n = 14) was the most
common isolate in blood cultures, followed by Candida (n = 5).
Fungal pathogens were significantly more associated with
nosocomial infections and with mortality. Multiresistant
pseudomonas was significantly more associated to mortality
compared with extended spectrum beta lactamase or methicillin-
resistant  Staphylococcus aureus. Positive urine culture was
protective of a higher organ failure score. In multivariate analysis,
Gram-negative bacteria, a nosocomial source and immuno-
deficiency were all associated with an increased risk of death.
Conclusions  Inappropriate antibiotic prescription is associated
with more severe sepsis. Mortality is higher in nosocomial sepsis.
Candida is a serious nosocomial agent in severe sepsis and is
associated with increased mortality as well as multiresistant
pseudomonas aeruguinosa.
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Introduction The usefulness of microbiological surveillance in ICU
patients is under debate [1,2]. It can signal infection/colonization
sites, most frequent germs and their antibiotic susceptibility. Our
study aimed to investigate changes in the microorganism rate and
their antibiotic susceptibility in ICU patients along with efforts to
change antibiotic practice and infection control policies in the ICU.
Methods A prospective study was performed in a 19-bed mixed
ICU in an emergency university hospital. Blood, catheters,
respiratory secretions, surgical wound secretions and urine were
cultured any time in the case of infection suspicion or every 4 to
5 days in the case of patients with ICU length of stay >5 days.
Cultures were counted no matter the infection or colonization
status. Antibiotic use was recorded as daily drug doses/100 beds
(DDDs). The study included two time periods: January to June
2007 (P1 – 839 admitted patients) and January to June 2008 (P2 –
779 admitted patients). Comparison between the two periods
included overall and site-specific rates of positive cultures, patterns
of germs, antibiotic susceptibility and antibiotic usage.
Results  The overall number of positive cultures decreased by
31.8% (P <0.01) and per patient by 15% (P <0.01) in P2 versus
P1. Germ patterns changed little over time, most frequently found
being  Staphylococcus aureus,  Acinetobacter spp, coagulase-
negative staphylococci and Pseudomonas spp. According to the
site, coagulase-negative staphylococci isolated from the blood-
stream decreased from 42% to 26% (P = 0.01), but Acinetobacter
spp. in the respiratory tract increased from 34.5% to 43%,
concurrently with a reduction in Klebsiella spp from 12.7% to 3%.
Antibiotic use decreased by one-half in P2 versus P1 (68.7 DDDs
vs. 113.8 DDDs, P = 0.01). Ciprofloxacin dropped from first (P1)
to seventh (P2) position (75% decrease) and resulted in a
decrease in ciprofloxacin resistance of S. aureus from 94% to
46% (P <0.01).
Conclusions Changes in infection control policies and antibiotic
use resulted in a decreased number of positive cultures in ICU
patients and a decline in antibiotic resistance in some strains.
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Introduction  Appropriate intravenous, broad-spectrum empiric
antimicrobial therapy should be initiated as rapidly as possible for
suspected severe infections in the presence of hypotension.
Timing and delay of initial administration of effective antimicrobial
therapy is an important predictor of survival [1]. It is hypothesized
that appropriate prehospital-initiated intravenous, broad-spectrum
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empiric antimicrobial therapy will reduce the delay of administration
and will reduce mortality [2].
Methods  One hundred and ninety-eight patients meeting the
criteria for septic shock on initial clinical presentation prehospital
were randomized to receiving broad-spectrum intravenous anti-
microbial therapy and fluid per guided protocol or to receiving
intravenous fluid only.
Results Out of 198 septic shock patients, 99 received prehospital
antimicrobial therapy. Blood cultures were taken prior to adminis-
tration. Both groups were comparable in all aspects. There were
83 male and 26 female patients in the test group, and 79 male and
20 female patients in the control group (P=0.021). Mean age was
67.9 ± 10.5 years in the test group and 63.8 ± 11.0 years in the
control group (P=0.186). The APACHE II score in the test group
and in the control group was statistically not significant
(P=0.661). In the test group 28%, compared with the control
group 53%, of patients had community-acquired pneumonia
(P=0.083). The mean intensive care stay in the test group was
6.8 ± 2.1 days and in the control group it was 11.2 ± 5.2 days
(P=0.001). The first antimicrobial administration after emergency
department admission time in the control group was 3.4 ± 2.6
hours (P=0.02). The 28-day mortality rate was significantly
reduced to 42.4% (test group) compared with 56.7% in the
control group (P = 0.049, OR = 0.56; 95% CI = 0.32 to 1.00).
Conclusions  The adjuvant treatment of patients with a guided
prehospital-initiated broad-spectrum antimicrobial therapy with
intravenous fluid reduces the delay in antimicrobial administration
and significantly reduces the 28-day mortality rate in patients with
septic shock.
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Introduction Intravenous and aerosolized colistin are being used
increasingly, in the critical care setting, for treating patients with
nosocomial infections due to multidrug-resistant Gram-negative
bacteria. The objective of this study was to report our experience
of colistin use in multiresistant Acinetobacter baumanii.
Methods A retrospective review of patients’ charts for those
admitted to the surgical intensive unit, between September 2007
and September 2008. Infected patients with multiresistant acineto-
bacter treated with intravenous and aerosolized colistin were
reviewed.
Results Fifteen patients were identified, 13 men and two women.
The patients ranged in age from 21 to 65 years. The patients were
admitted to intensive care for polytrauma (10 cases), chest trauma
(three cases) and cerebrovascular accident (two cases). The main
infections were ventilator nosocomial pneumonia (100%), surgical
site infection (6.6%), primary bacteremia (13%), catheter infection
(20%), and meningitis (13%). The bacteria responsible were A.
baumanii (100%),  Pseudomonas aeruginosa (46%),  Staphylo-
coccus aureus (26%), Klebsiella pneumoniae (6%), Enterobacter
cloacae (6%), and Morganella morganii (6%). All patients had
normal renal function at the onset of antibiotic therapy. Five
patients received colistin monotherapy, six patients received
combination therapy colistin with imipenem or third-generation
cephalosporin, and four patients received colistin with teicoplanine.
The colistin was used at 4 mg/kg/day administered intravenously
and aerolized colistin at 2 mg/kg for 8 to 16 days. A favourable
response was observed in 12 cases. Overall mortality was three
cases. Colistin induced reversible nephrotoxicity in one case and a
reversible neuropsychiatric event was observed in one case.
Bacterial eradication was confirmed in 14 patients (93%).
Conclusions  Garnacho-Montero and colleagues reported that
intravenous colistin was as effective as imipenem [1]. Our findings
with colistin can be considered encouraging in comparison with
previous experience.
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Introduction  Aminoglycosides, especially gentamicin, are exten-
sively used for treatment of severe infections. A dose of 7 mg/kg is
recommended to achieve a high peak serum concentration.
However, its accumulation is associated with adverse reactions,
notably renal injury. Knowledge of gentamicin pharmacokinetics in
critically ill patients is therefore crucial to therapeutic success and
prevention of toxicity.
Methods Patients’ demographic and clinical data were collected.
We studied gentamicin pharmacokinetic data from patients treated
between January 2006 and June 2008 in two ICUs. Patients were
eligible if the gentamicin dose was selected to achieve high serum
levels (target concentration of 16 to 24 μg/ml) and if pharmaco-
kinetic data from such patients, specifically peak and trough levels,
were measured after the first dose. The Sawchuk and Zaske one-
compartment pharmacokinetic model [1] was used to calculate the
gentamicin volume of distribution (Vd), maximum concentration
(Cmax) and clearance.
Results We studied 32 patients with a mean age of 63 years (24
men). Mean Sequential Organ Failure Assessment score was 7.65
and the mean Charlson comorbidities score was 3.54. The median
Vd was 0.41 l/kg (IQR 0.36 to 0.46 l/kg). Only four patients had a
Vd equal to or less than 0.26 l/kg, usually found in the healthy
population. We found no correlation between Vd and age,
Charlson comorbidities score, Sequential Organ Failure Assess-
ment score, and creatinine serum level (r2 = 0.016, 0.18, 0.037,
and 0.067, respectively). The presence of mechanical ventilation
and septic shock had no influence on Vd (P = 0.59 and P = 0.14,
respectively). Women had a significantly higher mean Vd/kg (0.51
vs. 0.39 l/kg, P  = 0.002) and, therefore, lower Cmax (15.2 vs.
18.5 μg/ml, P = 0.016). In a logistic regression model, only sex
(female: OR = 0.032; 95% CI = 0.03 to 0.387) and the dose/kg
(per mg/kg: OR = 3.21; 95% CI = 1.17 to 8.79) were significantly
associated with the achievement of Cmax above 16 μg/ml.
Available online http://ccforum.com/supplements/13/S1S132
Conclusions The gentamicin Vd cannot be predicted by age, the
presence of renal failure or any studied comorbidities. Therefore, in
order to obtain adequate therapeutic levels as soon as possible, a
high first gentamicin dose (that is, at least 7 mg/kg) should be
given to all patients. In women, even higher doses may be needed.
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Introduction The Surviving Sepsis Campaign Guideline 2008 [1]
recommends starting appropriate antibiotic therapy within 1 hour
after making the diagnosis of septic shock. In the ICU of our
emergency center, we perform empiric antibiotic therapy for septic
shock patients within 6 hours after admission.
Methods Cases of severe sepsis or septic shock diagnosed and
treated in the ICU of our emergency center for more than 48 hours
between January 2005 and September 2008 were retrospectively
analyzed. The cases were divided into a survival group and a
nonsurvival group, and were compared in relation to primary
diagnosis, clinical findings, and type of pathogen. The chi-square
test and paired t test were used to perform the statistical analysis.
Results There were 107 cases, 24 cases of severe sepsis and 83
cases of septic shock, and 73 of them were in males. The mean and
standard deviation of the patients’ age was 66.4 ± 15 years. The
severity of their illness according to the APACHE II score was 22.3 ±
8, and their Sequential Organ Failure Assessment score was 9.1 ± 4.
The causes of the sepsis were pneumonia (51.4%), peritonitis
(13.1%), and soft tissue infection (13.1%). Mortality was 26.2%.
There were 79 cases in the survival group and 28 in the nonsurvival
group. The two groups are presented in Table 1. We performed a
multivariate regression analysis to identify prognostic factors, and the
only independent prognostic factors were age (OR = 0.955
(P= 0.022; 95% CI = 0.91 to 0.99)), acute respiratory disease
syndrome (ARDS) (OR = 5.789 (P= 0.002; 95% CI = 1.91 to 17.4))
and base deficit (OR = 1.113 (P= 0.008; 95% CI = 1.02 to 1.2)).
Early appropriate antibiotic therapy (EAAT) was not correlated with
survival.
Table 1 (abstract P320)
Survival Nonsurvival P value
Early appropriate antibiotic therapy (%) 67 60.7 0.645
Gram-positive coccus (%) 39.2 53.5 0.297
Gram-negative rod (%) 29.1 39.2 0.351
Conclusions  EAAT did not affect the outcome. The prognostic
factors for severe sepsis and septic shock identified in this study
were age, base deficit and ARDS.
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Introduction Airway aspiration (AWA) of gastric content is a very
frequent complication in patients presenting to emergency rooms
after incidents linked to a depressed level of consciousness. The
routine use of antibiotics in this situation determines a high-
pressure selection for multiresistant microorganisms. However,
how often AWA is the causative situation for early ventilator-
associated pneumonia is not known. Also a gold standard for a
diagnostic workup is needed. Our aim was to know how frequent
AWA determines infectious aspiration pneumonia confirmed by
evolution and microbiological samples, and to propose a
methodological approach to rule out antibiotic usage.
Methods Over a 2-year period, in 82 patients admitted to our ICU,
AWA was confirmed by the direct observation of gastric content
when orotracheal intubation was performed by a trained physician
due to a Glasgow coma scale below 12. Usual diagnosis: acute
brain injury, 52 patients (73%); Simplified Acute Physiology Score
II 37 ± 11; age, 44 ± 15 years; all were mechanically ventilated,
average 6 ± 2 days; ICU stay ± 10 days; mortality 21%. Rectal
fever, leukocytosis, thoracic radiology and PaO2/FiO2 were recorded
on a daily basis. The Clinical Pulmonary Infection Score (CPIS) and
semiquantitative tracheal aspirates (SQTA) were performed twice: in
the first 48 hours and between the third and fifth days.
Results  Out of 82 patients, 23 (28%) developed clinically and
microbiologically confirmed pneumonia. Fever and leukocytosis
showed no significant differences in patients with or without
pneumonia during the first 5 days. Also the PaO2/FiO2 index was
not different. As for radiology, when unilateral focal condensation
was present, pneumonia was confirmed later (relative risk = 3.3,
95% CI = 1.7 to 6.4). CPIS in the first 48 hours showed a negative
predictive value for pneumonia of 89%, and SQTA with no
microorganism growth a negative predictive value of 96%. In our
patient group, 42 (51%) had CPIS <6 and SQTA growth; in them
no antibiotic usage is recommended. On the contrary, out of 20
patients who had CPIS ≥6 and positive SQTA, 16 (75%) developed
pneumonia within the first 5 days of the ICU stay; this group
deserves antibiotics. CPIS ≥6 without pneumonia, probably due to
lung inflammation, was observed in 10 out of 28 patients (36%).
Conclusions  (1) In our ICU population, pneumonia develops in
only 28% of those presenting with AWA. (2) Through CPIS <6
and negative SQTA performed in the first 48 hours we could
identify that in more than one-half of AWA patients antibiotics are
not needed. (3) CPIS is not a reliable early indicator of pneumonia
in patients with AWA.
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Introduction The proinflammatory cytokine TNF plays a critical role
in the formation of severe sepsis when it is excessively released.
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Recently, it was revealed through our animal models that intra-
venous administration of freeze-dried sulfonated human normal
immunoglobulin (IVIG) makes anti-inflammatory effects by
enhancing insulin-like growth factor 1 (IGF-1) production through
stimulation of sensory nerves, which inhibits the production of TNF.
In this study, we examined whether IVIG for septic patients
enhances IGF-1 production.
Methods Fourteen septic patients indicating a high level of soluble
E-selectin were surveyed, who were transported to our hospital
from April to November 2007. They were divided into two groups,
IVIG group (G-group, 5 g/day x 3 days, nine cases, 67.2 ± 8.64
years old) and nonadministered group (control group, C-group, five
cases, 69 ± 12.9 years old).
Results  In the G-group, the values of IGF-1 on the fifth day
(162.22 ± 52.91 ng/ml) and seventh day (150.44 ± 29.06 ng/ml)
were significantly higher than that on day 0 (88.59 ± 29.79 ng/ml,
P <0.05). Furthermore, The value of IGF-1 of the G-group
(162.22 ± 52.91 ng/ml) was significantly higher than that of the C-
group (68.80 ± 24.04 ng/ml) on the fifth day (P <0.05).
Conclusions We revealed that IVIG for septic patients enhances
IGF-1 production. Furthermore we will enhance the effect of
sulfanated immunoglobulin compared with that of intact immuno-
globulin in the difference of the anti-inflammatory effect and the
mechanism.
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Introduction It is known that severe sepsis causes multiple organ
failure and high mortality. Intravenous immunoglobulin (IVIG) is
used for severe sepsis patients. The mechanism of IVIG is clearly
unknown. Suggested, however, is the possibility that IVIG prevents
organic injury by suppressing the inflammation. Soluble fibrin (SF)
is intermediate between fibrinogen and fibrionoligomer. It is better
than fibrinogen as the material for thrombin. IVIG is used as one of
the effective factors for repair of the damaged vascular endo-
thelium. In this study we used SF as a marker of severity of illness
in patients with or without IVIG and compared the levels of SF in
two groups.
Methods Nineteen severe septic patients were divided into two
groups. The control group (n = 9) was not given and the other
group (n = 10) was given IVIG (5 g/day for 3 days). SF of serum
from patients was measured on 0 days, 1 day, 3 days, 5 days and
7 days, and the results were analyzed.
Results  The levels of SF were: control group: 4.77 ± 9.44
(0 days), 3.13 ± 2.53 (1 day), 3.33 ± 2.75 (3 days), 2.53 ± 2.58
(5 days), 2.58 ± 3.75 (7 days); other group: 7.71 ± 8.28 (0 days),
12.26 ± 16.75 (1 day), 14.34 ± 25.56 (3 days), 8.06 ± 9.08
(5 days), 11.95 ± 12.71 (7 days). There was a significant
difference in the levels of SF between groups with and without
IVIG at 1 day, 5 days and 7 days.
Conclusions  Monocyte has the Fcγ receptor. It is thought that
stimulating Fcγ of monocyte with IgG plays a role in increasing SF.
Without severe DIC, increasing fibrin is used in the repair of the
damaged vascular endothelium as a matrix and it prevents the
invasion of germs. It is thought that increasing fibrin is the
appropriate stimulation for coagulation and one of the reactions of
biomechanical defense. We think SF is one of the important
factors for the damaged cell and a useful marker of severity for
severe sepsis. We also think IVIG is effective for severe sepsis.
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Introduction Previous studies have recommended the use of low-
dose corticosteroids in patients with septic shock. Specifically,
response to corticotropin tests has been recognized as a
prognostic factor in critically ill patients, especially in patients with
no response to the corticotropin test. A recent large randomized
controlled trial evaluating the efficacy of low-dose corticosteroids
revealed no benefit on overall survival or in patients with no
response to corticotropin in patients with severe sepsis and septic
shock. Recently, recommendations for the diagnosis and manage-
ment of corticosteroid insufficiency in critically ill adult patients
were published as consensus statements from an international task
force by the American College of Critical Care Medicine [1].
However, some studies were not included in these statements.
Methods  We conducted a systematic search of EMBASE and
MEDLINE (through August 2008) for double-blind randomized
clinical trials that evaluated the effect of corticosteroids on
mortality in patients with severe sepsis and septic shock. Study
selection criteria were all trials before August 2008 in which
participants were randomized to corticosteroids or placebo and in
which mortality was reported.
Results Data from 17 randomized, controlled trials with a total of
3,638 participants were analyzed. Corticosteroid use was not
associated with a risk reduction in overall mortality (pooled risk
ratio = 0.99 (95% CI = 0.90 to 1.09), P  = 0.823). Low-dose
corticosteroids (150 to 300 mg/day) did not show benefit on all-
cause mortality in patients with severe sepsis and septic shock
(risk ratio = 0.92 (95% CI = 0.79 to 1.06)). Furthermore, low-dose
corticosteroids in patients with severe sepsis and septic shock
who did not respond to the corticotropin test showed no benefit on
28-day mortality (risk ratio = 0.91 (95% CI = 0.76 to 1.09)).
Corticosteroids use was not associated with increased compli-
cations, such as gastrointestinal bleeding or increased infections.
Conclusions  This meta-analysis indicated that administration of
low-dose corticosteroids was not beneficial on overall mortality in
patients with severe sepsis or septic shock.
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Introduction In the CORTICUS study, despite the fact that the
median time to shock reversal was shorter in the hydrocortisone
(HC) group, improvement of outcome was not demonstrated. This
is explained as an increased incidence of superinfection, including
new episodes of sepsis or septic shock, but the explanation seems
to be unclear so there are still debates about the study. We
examined the outcome of HC therapy and the effect on later
infectious complications, especially fungal infection.
Methods  A retrospective cohort study. Ninety-six adult patients
>18 years old with septic shock treated at single university general
ICU. Initially, fluid therapy, inotropic support, transfusion and
management of infection were carried out according to the
guideline of survival sepsis campaign, and we assessed the
adrenal function by adrenocorticotropic hormone stimulation test
(250 μg). In the earlier period (April 2004 to March 2007), 200 mg
HC was administered to the nonresponders. Later (April 2007
onwards), HC was given only to patients that were poorly
responsive to fluid resuscitation and vasopressor therapy. We
assessed the 28-day and 90-day survival rate, hospital discharge
rate, the incidence of new septic shock, the positive rate of
endotoxin and β-D-glucan.
Results  Out of 96 patients, 38 patients were determined as
responders and 58 as nonresponders. The Sequential Organ
Failure Assessment score was higher in nonresponders (11 ± 3.3
vs. 13.6 ± 3.7, P = 0.0014). For the 58 nonresponders, HC was
used for 40 patients (HC group). The 28-day survival rate was
higher in HC (61% vs. non-HC 44%, P = 0.49), but the 90-day
survival rate decreased to 33% in HC and 28% in non-HC
(P = 0.47), and the discharge rate reversed as 25% in HC versus
28% in non-HC (P = 0.84). The incidence of new septic shock
was 20% in HC, 11% in non-HC. The positive rate of endotoxin
did not increase before and after treatment in both groups. The
mean concentration of β-D-glucan did not increase in non-HC
(59 ± 99 to 48 ± 44 pg/ml), but it significantly increased in HC
(50 ± 70 to 69 ± 186 pg/ml) (P = 0.049).
Conclusions The 28-day survival rate was higher in the HC group
than the non-HC group as reported in the French study, but no
beneficial effect was seen in longer outcome, consistent with the
CORTICUS study. Moreover, HC therapy may have a risk to
increase fungal infection.
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Introduction The purpose of this study was to assess neurological
function and examine blood–brain barrier (BBB) permeability
changes in septic encephalopathy after cecal ligation and perfora-
tion (CLP). The protective effect of high-dose methylprednisolone
administration on BBB derangement and neurological dysfunction
was also investigated.
Methods  An experimental prospective randomized study was
performed on 42 adult male Sprague–Dawley rats. Sepsis was
induced through CLP. A bolus 30 mg/kg methylprednisolone
administration followed by intravenous injection of 5.4 mg/kg/hour
for 8 hours was given immediately after CLP in septic and sham-
operated rats. Control groups for both septic and sham-operated
rats were injected with equal volumes of saline.
Results Neurological function was assessed at 8, 12, and 24 hours
after sepsis induction. Those rats surviving for 24 hours post
procedure were anesthetized and decapitated for investigation of
BBB integrity using a spectrophotometric assay of Evans blue dye
extravasations. A significant decrease in neurological function and
a significant increase in BBB permeability were observed with the
induction of sepsis compared with the sham-operated controls.
Administration of methylprednisolone caused a significantly
improved reflex responsiveness and decreased brain tissue Evans
blue dye content in septic rats.
Conclusions  The present investigation shows that methylpred-
nisolone administered immediately after sepsis induction via CLP is
associated with better neurologic scores, which might be related
to its positive effects on sepsis-induced BBB permeability changes.
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Introduction  Mechanical ventilation (MV) may evoke damage to
healthy lungs leading to ventilator-induced lung injury (VILI). We
hypothesized that downregulation of pulmonary inflammation may
attenuate VILI. The present study investigated whether lung inflam-
mation and injury can be restored by dexamethasone (Dex). To
prevent the systemic negative side effects of free Dex, we targeted
Dex by delivering anti-E-selectin Dex liposomes into activated
endothelium of inflamed lungs.
Methods Mice were tracheotomized and ventilated in the pressure
control mode for 5 hours with 50% oxygen levels, 2 cmH2O
positive end-expiratory pressure and 12 cmH2O peak inspiratory
pressure (lung protective, LP-MV) or 20 cmH2O peak inspiratory
pressure (lung injurious, LI-MV). Nonventilated mice were used as
controls. Free Dex, anti-E-selectin or isotype IgG Dex liposomes
were given systemically at initiation of MV. After 5 hours, lung injury
was determined by arterial oxygen levels, tissue edema and
bronchoalveolar lavage protein levels. Pulmonary inflammation was
assessed by myeloperoxidase activity and IL-1β, keratinocyte-
derived chemokine and E-selectin mRNA.
Results  LI-MV decreased oxygenation levels, increased tissue
edema and increased bronchoalveolar lavage protein levels as
compared with LP-MV, suggesting that lung function was
deteriorated by LI-MV. Both MV strategies enhanced pulmonary
inflammation. Anti-E-selectin Dex liposomes and free Dex, but also
IgG Dex liposomes, reduced ventilator-induced lung inflammation.
However, Dex treatment did not diminish lung injury.
Conclusions  Systemic administration of targeted and free Dex
attenuates VILI-associated pulmonary inflammation, but not lung injury.
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Introduction  The objective of this study was to determine the
incidence and risk factors for relative adrenal insufficiency (RAI) in
cardiopulmonary bypass (CPB) patients and the impact on
postoperative hemodynamic status.
Methods A prospective cohort study was performed on elective
CPB patients on a 24-bed ICU of a tertiary university hospital. RAI
was defined as a rise in serum cortisol ≤9 μg/dl after the adminis-
tration of 250 μg cosyntropin. Plasma cortisol levels were measured
preoperatively, immediately before and 30 minutes, 60 minutes and
90 minutes after the administration of cosyntropin (250 μg).
Results We included 120 from 137 consecutive patients, of whom
17 met criteria for exclusion (eight off-pump, two surgical
emergencies, two with endocarditis, five corticoid dependency).
We studied 84 (70%) males and 36 (30%) females. Mean age
67 ± 12 years. Plasma cortisol levels were measured pre-
operatively, immediately before, 30, 60, and 90 minutes after the
administration of cosyntropin and at 24 postoperative hours. The
RAI (Δcortisol ≤9 μg/dl) incidence was 77.5%. Etomidate was the
only independent risk factor associated with RAI (OR = 8.51, 95%
CI = 3.09 to 23.42). RAI patients needed more vasopressor
requirements just after surgery (P = 0.04), and at 4 postoperative
hours (P = 0.01). Pretest and post-test plasma cortisol levels were
inversely associated with maximum norepinephrine dose in the
same time periods (ρ = –0.22, P = 0.02; ρ = –0.18, P = 0.05;
ρ = –0.21, P = 0.02; and ρ = –0.22, P = 0.02, respectively).
Conclusions RAI and lower cortisol levels in CPB patients induce
postoperative vasopressor dependency. Use of etomidate in these
patients is a modifiable risk factor for the development of RAI that
should be avoided.
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Introduction  Although critical-illness-related corticosteroid
insufficiency (CIRCI) is common in septic shock patients, its
diagnosis and management remain controversial [1,2]. The recent
consensus conference on CIRCI reported that baseline total serum
cortisol and that after 250 μg synthetic ACTH is insufficient to
evaluate the adrenal response to sepsis [1]. To our knowledge,
there is no CT-scan study that has evaluated adrenal gland imaging
during septic shock. The aim of our study was to describe the
adrenal gland volume evaluated by CT scan during septic shock.
Methods  A single-center study during 1 year. Two groups of
patients who benefited from an abdominal CT scan were studied.
Patients who presented septic shock, an ACTH test and an
abdominal CT scan in the 72 hours before or after the onset of
shock were included in the group septic shock (shock +). Patients
who benefited from an abdominal CT scan but did not present any
shock were included in the group nonshock (shock –). CIRCI was
defined as a delta serum total cortisol less than 9 μg/dl after an
ACTH test of 250 μg. The main endpoint was the total adrenal
gland volume evaluated by CT scan with semiautomatic software
(Myriane Intrasense, Montpellier, France).
Results  In the preliminary results we compared 66 patients in
septic shock with 20 patients without any shock. In the septic
shock group, the Simplified Acute Physiology Score II score was
46 (40 to 56) and mortality in the ICU was 36%. The total adrenal
gland volume is presented in Table 1. The ACTH test was not
evaluable in four patients in the group septic shock leading us to
analyse 62 patients.
Conclusions Our preliminary results showed for the first time that
in septic shock the total adrenal gland volume is three to four times
higher than in nonseptic patients. The diagnosis and outcome
impact of this increase volume should be better evaluated.
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Introduction  The effects of systemic steroids in patients with
severe community-acquired pneumonia (CAP) requiring mecha-
nical ventilation in a medical ICU (MICU) remain vague about
mortality [1-4]. The aim was to evaluate systemic steroids
improving survival in patients with severe CAP requiring
mechanical ventilation in the MICU in this study.
Methods A retrospective, observational study in 88 patients with
severe CAP requiring mechanical ventilation in the MICU of the
Asan Medical Center, Ulsan University, Seoul, South Korea. We
collected information about clinical and laboratory data, and
28-day and 3-month survival from electronic medical records.
Results From January 2005 to November 2006 we included 88
patients with severe CAP requiring mechanical ventilation in the
MICU. Clinical baseline characteristics, APACHE II score and
Sequential Organ Failure Assessment score were similar between
the steroid group and the nonsteroid group. Steroids were highly
used in acute respiratory distress syndrome (21/23), and shock
(57/75) of severe CAP complication, respectively. Using multi-
variate analysis, longer hospital stay (OR = 1.162; 95% CI =
1.055 to 1.279), shorter ICU stay (0.824; 0.719 to 0.944), and
improving Sequential Organ Failure Assessment score difference
Available online http://ccforum.com/supplements/13/S1
Table 1 (abstract P329)
Septic group  Septic group 
with CIRCI  without CIRCI  Nonseptic group 
(n = 37) (n = 29) (n = 20)
Total adrenal  16.4 ± 4.4 16.1 ± 4.8 5.5 ± 2.6*
gland volume (cm3)
Response to the ACTH test did not influence the adrenal volume. *P <0.05.S136
from day 1 to day 7 (1.447; 1.103 to 1.898) were associated with
an increased 3-month survival. But systemic steroids did not
improve 28-day and 3-month survival.
Conclusions  The effects of systemic steroids in patients with
severe CAP requiring mechanical ventilation in the MICU did not
improve survival.
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Introduction Several studies, largely retrospective, have suggested
improved outcomes and a reduction in inflammatory response in
patients who develop infection whilst on statin therapy. This study
reports outcomes for patients on established statin therapy
admitted to hospital with presumed infection compared with those
patients not on a statin.
Methods  The study was approved by the Princess Alexandra
Hospital Research Ethics Committee and conducted from May
2006 to October 2008 as part of a randomised controlled study
investigating continuing established statin therapy. A daily
computer-generated report identified all patients admitted to
hospital with a potential diagnosis of infection.
Results  From a total of 2,291 patients screened, 2,239 were
considered to have presumed infection. Of these, 2,161 were
aged >30 years and were included in the final analysis (statin users =
633, no statin use = 1,528). The statin group was significantly
older with a mean age (± SD) of 69 ± 12 versus 61 ± 16 years
(P = 0.0001) and included more men (62.1% vs. 55.2%,
P = 0.004). The source of presumed infection was not statistically
different between the groups (overall chi-square P = 0.16). A
presumed respiratory source was the most common in both
groups (statin 35.5% vs. no statin 37.1%, respectively) followed by
skin (19.0 vs. 20.3%), gastrointestinal (17.8 vs. 14.1%), urosepsis
(13.0 vs. 11.7%) and other sources (14.7 vs. 16.8%). Two or more
SIRS criteria was seen in 65.4% of the statin group patients and
67.8% of the no statin group (P = 0.30). Hospital mortality was
similar in both groups (7.4% statin group and 6.5% no statin
group, P = 0.64), as was the rate of ICU admission (17% statin
group and 16% no statin group; P = 0.63). Hospital length of stay
was not significantly different between the groups
(11.4 ± 15.4 days in the statin group and 12.5 ± 26.2 days in the
no statin group, P = 0.10).
Conclusions In a heterogeneous cohort of patients admitted to
hospital with presumed infection, prior statin therapy was not
associated with an improved outcome or reduced systemic inflam-
matory response. The age and gender differences observed are in
keeping with previous literature and support the assertion that
statin users represent a different patient group to those not using
statin therapy.
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Introduction  Statins may prevent organ dysfunction in patients
with infections, but the optimal time for this therapy is unknown.
Our objective was to determine the evolution of inflammation in
patients treated for infection on general wards and the impact of
previous statin use.
Methods We performed a single-centre prospective cohort study
(April to September 2008) in unselected patients admitted to
medical wards with infection, collecting data on demographics,
comorbidities, and statin use before admission; and 10-day follow-
up data on intensive care or high-dependency unit (ICU/HDU)
admission and death, systemic inflammatory response syndrome
(SIRS) criteria and organ dysfunction (using a modified Sequential
Organ Failure Assessment (SOFA) score), and infection markers
(C-reactive protein (CRP), white blood cells (WBC)). Evolution of
organ dysfunction, SIRS, WBC and CRP were analysed descrip-
tively; continuous data are expressed as the mean (SD) or median
(Q1 to Q3). The effect of statins was explored in regression
models accounting for within-patient correlation, with P  <0.05
taken as statistically significant.
Results  Two hundred and nine patients were admitted with
infections (lung 51.0%, urinary 34.2%, skin/soft tissue 18.5%,
other 5.2%; ≥1 infection/patient possible): age 63.8 years (20.7),
49.8% male, Charlson score 2 (1 to 3), previous statin users
27.8%, WBC 15.6 (12.0) x 109/l, CRP 105 (113) mg/l. On
admission, 88.9% had ≥1 SIRS criterion (median 2 (1 to 3)) and
72.3% had modified SOFA score ≥1 (median 1 (0 to 2)), with no
statin versus non-statin group differences. CRP, WBC, and the
proportion of patients with ≥1 SIRS criterion and modified SOFA
score ≥1 decreased over time (P <0.0001), but generalized linear
mixed models showed no effect of statins (P = 0.98, 0.51, 0.55,
and 0.25) when adjusted for time, age, sex, and Charlson score.
By day 10, seven patients were admitted to the ICU/HDU, four
patients had died, and 64 patients had ≥1 day with a higher
modified SOFA score versus admission. Overall, 35.9% of patients
developed this combined outcome (statin (44.8%) vs. non-statin
(32.5%); OR = 1.66, 95% CI = 2.85 to 3.25 after adjustment for
age, sex, Charlson score).
Conclusions Ward patients with infection often develop some organ
dysfunction, but the risk of death/higher care is low. Trials of statins to
prevent such clinically important outcomes would need to be large.
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Introduction Autonomic dysfunction in relation to cardiovascular
system morbidity and mortality has been reported. The objective of
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this study was to study cardiac autonomic balance and heart rate
variability (HRV) indices in acute rheumatic fever.
Methods  A prospective study was conducted on three groups.
Group I included 20 patients with acute rheumatic carditis. Group
II included 20 patients with no cardiac involvement (10 with chorea
(Group IIa) and 10 with arthritis (Group IIb)). Group I included 10
in failure (Group Ia) and 10 compensated (Group Ib). Group III
included 20 healthy controls. Plasma norepinephrine (NE) assay,
echocardiography, cardiovascular autonomic function tests
(5AFTs) and 24-hour ambulatory ECG (Holter) monitoring for
arrhythmias and HRV. Studied HRV variables included the
standard deviation of all normal RR intervals (SDNN) and the
percentage of differences between adjacent normal RR intervals
that are greater than 50 ms (PNN50).
Results Group I had significantly higher values for 5AFTs score,
NE, supraventricular premature beats (SVPBS) and ventricular
premature beats (VPBS) (P <0.001). Measured variables were
more affected in Group Ia compared with Group Ib (Table 1) and in
patients with heart failure New York Heart Association class IV
compared with class Group III.
Conclusions  Acute rheumatic carditis is associated with
significant autonomic dysfunction. HRV indices can be used for
risk stratification in those patients.
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Introduction  We have recently shown that recombinant human
activated protein C (rhAPC) improved pulmonary function [1] and
cardiac performance [2] in ovine acute respiratory distress
syndrome and sepsis. Peroxynitrite (ONOO–) is known to
inactivate adrenoreceptors in sepsis. It can be detected with equal
amounts of 3-nitrotyrosine (3-NT). rhAPC has been effective to
reduce lung 3-NT levels in sepsis [1]. We therefore hypothesized
that rhAPC might reduce cardiac 3-NT levels as well, and studied
cellular enzymes involved with the ONOO– pathway in cardiac
tissue.
Methods Fifteen sheep (33 to 38 kg) were operatively prepared
for chronic study and randomly allocated to either the sham (un-
injured, untreated), control (injured) or treatment (rhAPC) groups
(n = 5 each). After a tracheotomy, acute lung injury was produced
in the control and rhAPC groups by insufflation of cotton smoke,
followed by instillation of Pseudomonas aeruginosa bacteria into
the lungs according to an established protocol [1]. The sheep
were studied for 24 hours in the awake state and ventilated with
FiO2 1.0. In the treatment group, rhAPC (24 μg/kg/hour) was intra-
venously administered, beginning 1 hour post injury. Heart tissue
3-NT, myeloperoxidase (MPO), and malondialdehyde (MDA)
contents were measured (ELISA) after 24 hours. Data presented
as the mean ± SEM; *significance, P <0.05.
Results After 24 hours, 3-NT levels (nM/ml/mg) were 19 ± 3 in
sham and were significantly increased in the control group (101 ±
11*). The rhAPC group (22 ± 18*) showed significantly lower 3-NT
tissue levels then controls. MDA levels (μM/ml/mg) were 48 ± 5 in
sham and were significantly increased in the control group (85 ±
3*). The rhAPC group (41 ± 3*) showed significantly lower MDA
tissue levels then controls. The MPO activity (mU/mg) showed no
differences between groups: sham (180 ± 11), control (200 ± 15),
and rhAPC (210 ± 20), respectively.
Conclusions rhAPC has no influence on cardiac MPO levels, but
significantly reduced heart tissue 3-NT and MDA levels in ovine
acute respiratory distress syndrome and septic shock, thereby
improving cardiac performance. These findings may lead to further
investigations of rhAPC and cardiovascular function.
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Introduction  The pathophysiology and molecular mechanisms
involved in sepsis are complex and poorly understood. We
performed a proteomics study to characterize early host responses
to sepsis as determined by altered plasma proteome in a porcine
model of peritonitis-induced sepsis.
Methods In seven instrumented and mechanically ventilated pigs,
sepsis was induced by inoculating autologous faeces. Haemo-
dynamics, oxygen exchange, inflammatory responses, oxidative and
nitrosative stress, and other laboratory parameters were monitored.
Plasma samples were obtained before and 12 hours after the
induction of hyperdynamic sepsis. Plasma proteins were resolved
by two-dimensional electrophoresis. Proteins that changed in
abundance were identified by mass spectrometry (MS, quadrupole
TOF/TOF MS and MS/MS).
Available online http://ccforum.com/supplements/13/S1
Table 1 (abstract P333)
Group Ia (n = 10) Group Ib (n = 10) Group IIa (n = 10) Group IIb (n = 10) Group III (n = 20)
5AFTs score 6.7 (0.95) 3.2 (0.92) 0.6 (0.5) 0.6 (0.5) 0.6 (0.5)
Plasma NE (pg/ml) 3,061 (1,008) 1,638 (1,129) 455 (111) 438 (113) 423.5 (115)
SVPBs 13 (8.9) 8.6 (5.9) 0.9 (0.7) 1 (0.67) 0.8 (0.77)
VPBs 50.7 (26.4) 13.6 (5.48) 0.7 (0.82) 0.7 (0.8) 0.8 (0.83)
Data presented as mean (SD).S138
Results From approximately 1,500 protein spots in each gel, levels
of 47 proteins spots were significantly altered in the septic plasma
samples compared with corresponding baseline ones. MS
identified 35 protein forms representing 22 unique proteins whose
plasma levels were increased, whereas 12 forms of eight unique
proteins were significantly decreased during sepsis.
Conclusions  We identified a set of plasma proteins with
significantly altered levels during an early phase of sepsis in a
porcine model of peritonitis-induced sepsis using a proteomics
approach. Most of these altered proteins have important roles in
the inflammatory response. Some findings are novel, and exploring
their roles may lead to the identification of new therapeutic targets.
Acknowledgement  Supported by MSM 0021620819 –
Replacement of and support to some vital organs.
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Introduction Studies have demonstrated that silymarin (milk thistle)
has cytoprotective effects and induces apoptosis. We hypothe-
sized that silymarin decreases sepsis-induced acute lung injury
(ALI) in a cecal ligation and puncture (CLP) rat model through its
anti-inflammatory and antioxidant effects.
Methods  Forty-eight rats were randomized to sham (n = 16),
control (n = 16), and silymarin (n = 16) groups. ALI was induced
with CLP in the control and silymarin groups. Animals in the
silymarin group received silymarin 50 mg/kg/day for 3 days before
the experiment and 2 days afterward. Serum and bronchoalveolar
lavage fluid TNFα, IL-1β, and IL-6; lung tissue malondialdehyde
and glutathione levels; lung histopathologic examination; and lung
wet-to-dry (w/d) weight ratio measurements were used to compare
and evaluate the severity of lung injury between the groups.
Apoptosis was quantitated using paraffin sections of lung by
fluorescent terminal deoxynucleotidyltransferase-mediated dUTP
nick end-labeling. Survival analyses were also performed.
Results Mortality rates for the silymarin and control groups were
37.5% and 87.5%, respectively (log-rank P = 0.0503). Compared
with the silymarin group, the control group exhibited significantly
more severe lung injury, as indicated by higher mean values for
serum and bronchoalveolar lavage fluid TNFα (P = 0.01 for both),
IL-1β (P ≤ 0.028 for both), and IL-6 (P ≤ 0.01 for both); neutrophil
infiltration of the lungs (P = 0.003); pulmonary edema (P = 0.001);
total lung histopathologic injury score (P <0.001); w/d (P = 0.019);
and lung-tissue malondialdehyde (P = 0.011) levels. Lung tissue
glutathione levels were significantly higher in the silymarin group
than the control group (P = 0.001). Compared with the control
group, induction of apoptosis was increased in the silymarin group
(P = 0.003).
Conclusions Silymarin reduces the severity of sepsis-induced ALI
and may also improve survival in a CLP rat model. These beneficial
effects of this agent are probably due to its inhibitory effects on the
inflammatory process and oxidative injury and its proapoptotic effect.
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Introduction Nattokinase is a serin protease derived from fermen-
tation of boiled soy bean that has a potent fibrinolytic effect [1].
The aim of this experimental study was to investigate the effects of
nattokinase on plasma fibrinogen levels, whole blood viscosity and
mortality in rats with sepsis.
Methods  Fifty adult female Wistar rats were used in the study.
Nattokinase (6 mg/day) was given via the intragastric route for 7 days.
Sepsis was induced by cecal ligation–puncture. Analysis of plasma
fibrinogen levels, whole blood viscosity and survival was performed.
Results  Mean plasma fibrinogen levels of rats that received
nattokinase prior to cecal ligation–puncture were lower than the
others that did not receive nattokinase prior to cecal ligation–
puncture and the sham-operated group, but the differences were
not statistically significant. Mean blood viscosity of rats analyzed
with the Rheolog™ scanning capillary viscometer was lower in the
nattokinase-supplemented animals with cecal ligation–puncture
group at a 1/second shear rate (P <0.05) (Figure 1). Nattokinase
supplementation did not significantly influence survival rates and
survival times of the rats after cecal ligation–puncture.
Conclusions The results of our in vivo study were not sufficient to
prove the fibrinogenolytic effect of nattokinase but confirmed the
results of a previous in vitro study investigating the effect of
nattokinase on blood viscosity. More in vivo and in vitro studies
with large study populations are required to investigate the use of
nattokinase to prevent and treat sepsis-related disseminated
intravascular coagulation.
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Comparison of mean blood viscosity data of the groups Lap (sham-
operated group), CLP (cecal ligation–puncture group) and Nat + CLP
(nattokinase-supplemented cecal ligation–puncture group).S139
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Introduction  Hospital-acquired pneumonia and its most serious
manifestation, ventilator-associated pneumonia, are associated
with high rates of mortality and account for 25% of all infections in
the ICU [1]. Pneumonia in mechanically ventilated (MV) patients is
often complicated by the involvement of multidrug-resistant (MDR)
Gram-negative bacteria [2]. This multinational study explored
physicians’ prescribing behaviour when treating Gram-negative
pneumonia in MV patients.
Methods  Online interviews were conducted with 510 critical/
intensive care, infectious disease and pulmonary/respiratory specia-
lists in the USA (n = 130), Germany (n = 100), Mexico (n = 100),
Spain (n = 80) and Japan (n = 100). Participants were practicing
physicians (3 to 31 years), were involved in the management of MV
patients and were familiar with treatment strategies for pneumonia.
Results  The involvement of Gram-negative (vs. Gram-positive)
bacteria in pneumonia in MV patients was perceived to carry greater
mortality risks. Most physicians (63 to 77% in all countries except
Japan; 41% in Japan) were extremely concerned about the impact
on treatment outcomes of increasing antibiotic resistance in Gram-
negative species. Excessive antibiotic use and failure to effectively
de-escalate antibiotic therapy were perceived as key contributors to
resistance development. Achieving rapid cure (78%) and minimizing
the duration of MV (76%) were cited as the most important aims of
treatment. Key considerations for antibiotic selection were activity
against Gram-negative bacteria, including MDR strains, and relative
extent of lung tissue penetration. Over 80% of respondents saw
aerosolized antibiotics as a valuable potential addition to the current
treatment armamentarium (no antibiotic aerosols are currently
licensed for pneumonia), particularly for elderly patients and those
with respiratory distress, who are at risk of the worst outcomes.
Conclusions Gram-negative pneumonia in MV patients is a serious
complication in ICUs. Antibiotic prescribing for Gram-negative
pneumonia among respondents is influenced by the risk of MDR
bacterial involvement. Aerosolized antibiotics are seen as a
potentially valuable adjunct to systemic therapies for treating
Gram-negative pneumonia in MV patients.
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Introduction The aim was to produce and pilot a data collection
proforma aiding the diagnosis of sepsis in the burns population. It
should be relevant, reliable and lead to reproducible results. We
also looked at the data collected to assess the relevance of any
findings. In June 2007, the American Burn Association Consensus
Conference [1] produced standardized definitions in an attempt to
aid clarification of sepsis in those already fulfilling the diagnosis of
a systemic inflammatory response syndrome (SIRS). This would
allow more consistent diagnosis and accuracy to further trials
occurring in this field. The intention is that the proforma will be
used by the INTERBURNS research group for a large prospective
study.
Methods This was a retrospective case series. Patients included
were those admitted to a regional burns unit with more than 20%
burns during December 2007, numbering four. These patients
were matched for age, sex, and mechanism of injury. The initial
proforma was produced on the basis of the American Burn
Association recommendations [1]. Data were collected and
reviewed. This revealed potential confounding factors, so the
proforma was modified and data recollected. A daily diagnosis of
SIRS and sepsis was made from the information collected.
Results Data were collected at 12 p.m. daily initially. It was noted
that haemofiltration and noradrenaline were routinely used.
Dressing changes occurred in the morning, leading to increased
analgesia, sedation and the release of inflammatory mediators
confounding physiological parameters measured. Therefore the
proforma was modified and the data recollected at 6 a.m. daily,
thus achieving reliable and reproducible data. Despite the small
numbers, the data indicated a potential association between an
increase in noradrenaline dose of 25% and either instigation of a
treatment modality or a diagnosis of SIRS not previously identified,
or both.
Conclusions  The proforma is reproducible and gives relevant
reliable data for further analysis. The results have highlighted the
need for further research to clarify any association between
noradrenaline and its place in the diagnosis of sepsis. This
proforma and its subsequent utilisation by the INTERBURNS
research group should improve our ability to diagnose sepsis and
instigate early treatment in this patient population.
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Introduction The purpose of the study was to describe the effective-
ness of the Surviving Sepsis Campaign bundles with regard to both
implementation and outcome in patients with septic shock.
Methods  A single-center prospective observational study of
patients admitted to the medical–surgical ICU fulfilling criteria for
the international sepsis definitions. After a widespread 2-month
educational program, implementation of Surviving Sepsis
Campaign Resuscitation Bundles (RB) and Management Bundles
(MB) were accomplished. A reinforcement educational program
was performed in October 2007. Patients were recruited from
September 2005 to August 2008.
Available online http://ccforum.com/supplements/13/S1S140
Results We analyzed 384 episodes of septic shock. The mean
age was 64.5 ± 15 years, APACHE II score 23.2 ± 7.2, Sequential
Organ Failure Assessment score 9.5 ± 3, and global hospital
mortality 37.5%. The rate of compliance with the RB was 35.4%.
There were significant differences in mortality between compliant
(C) and noncompliant (NC) groups despite the similar charac-
teristics and the severity of septic shock. The mortality rate was
42.5% in the NC group and 23.6% in the C group. The
compliance rate with MB was only 10%, there were no differences
in mortality between C and NC groups (41% vs. 37%). When the
influence of age, severity, emergency department origin, and ICU
admission delay was controlled by multivariate analysis,
compliance with RB was independently associated with survival
(OR = 0.39, 95% CI = 0.22 to 0.70, P <0.01). Compliance rates
with RB during three consecutive 12-month time periods were
34%, 23% and 45.4%, respectively (P <0.01); inhospital mortality
rates in those periods were 37%, 47% and 31%, respectively
(P = 0.03). Compliance with MB decreased from 20% (first
period) to 3% (third period).
Conclusions  Implementation of RB was associated with
decreased mortality in patients with septic shock. The compliance
rate with MB was poor and had no impact on survival.
Acknowledgements Supported by IFIMAV Expte. PRF/07/04 and
the Instituto de Salud Carlos III. Expte. PI070723.
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Introduction The aim of the study is to verify the impact of the
implementation of the diagnostic and therapeutic bundles
suggested by Sepsis Surviving Campaign (SSC) [1] on the out-
come of patients with severe sepsis and septic shock.
Methods A retrospective analysis of the outcome of severe sepsis
and septic shock patients before, during and after the
implementation of the bundles according to the SSC in an eight-
bed polyvalent ICU. We evaluated ICU and hospital mortality, the
length of stay, the level of compliance to the bundles and its impact
on the mortality. Statistical analysis was performed using the chi-
square test.
Results A total of 127 patients were enrolled from 2005 onwards
(38 patients in 2005, 43 patients in 2006 and 46 patients in
2007). We observed a reduction of the overall ICU and hospital
mortality from 73% to 43%, not statistically significant, even if the
difference between the observed and predicted mortality showed a
statistically significant improvement (P = 0.027) (Figure 1). On the
contrary, the length of stay [2] was 18 days in 2005, 23 days in
2006, 25 days in 2007. Our compliance was respectively 59% in
2006 and 55% in 2007 for resuscitation bundles and 58% in
2006 and 78% in 2007 for management bundles. The mortality
was higher (70%) in the group with an overall compliance score ≤6
compared with 40% for those with a score ≥7.
Conclusions Even though the main difficulty was to timely reach
the targets of the bundles, the existence of a protocolized
approach to severe sepsis and septic shock seems to contribute
to the reduction of mortality in our population of patients.
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Introduction  The purpose of this study was to describe the
effectiveness of the Surviving Sepsis Campaign bundles with
regard to both implementation and outcome in surgical patients
with septic shock.
Methods  A single centre prospective observational study of
surgical patients admitted to the ICU from September 2005 to
August 2008 fulfilling criteria for the international sepsis
definitions.
Results  We analyzed prospectively 149 surgical patients with
septic shock. The mean age was 69 ± 13 years, APACHE II score:
23 ± 7, Sequential Organ Failure Assessment: 8 ± 2. The mortality
rate was 34.2% in the ICU and 42.3% in the hospital. There were
no significant differences in the characteristics and the severity of
septic shock between the compliant (C) and noncompliant (NC)
groups. We found differences in the ICU and hospital mortality
between the C and NC groups in two Resuscitation Bundles (RB):
central venous oxygen saturation (ScvO2) ≥70% (25% vs. 43%,
P = 0.01 and 32% vs. 52%, P = 0.02) and source control (14%
vs. 56%, P <0.001 and 24% vs. 63%, P <0.001, respectively).
The compliance rate of all RB was 27% and there were significant
differences in mortality between the C and NC groups (17% vs.
40%,  P = 0.01 and 35% vs. 49%, P = 0.009 in the ICU and
hospital, respectively). There were no significant differences in the
ICU and hospital mortality with the Management Bundles
compliance. In the multivariate analysis, source control, ScvO2
≥70%, compliance of all RB, mechanical ventilation, APACHE II
and Sequential Organ Failure Assessment were independently
associated with mortality. When the influence of age and severity
was controlled by logistic regression, source control was
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Severe sepsis and septic shock hospital mortality.S141
independently associated with survival (OR = 0.17, 95% CI = 0.05
to 0.55, P = 0.003).
Conclusions  Implementation of the RB was associated with
decrease mortality of surgical patients with septic shock. Among
all sepsis bundle elements, the source control was the only
independent predictor of survival. The compliance of Management
Bundles had no impact on survival.
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Introduction Patients with severe sepsis and septic shock still have
a high mortality rate, despite improvements in intensive care therapy.
In the present study we assessed the impact of a standard operating
algorithm adjusted on international treatment recommendations in
patients with severe sepsis and/or septic shock (for example, volume
resuscitation, hemodynamic control, glycemic control, substitution of
selenium and/or hydrocortisone and the use of recombinant human
activated protein C (rhAPC)) on the outcome.
Methods A retrospective analysis of 144 patients admitted to our
medical ICU in 2004 and 2006. In 2004, before implementation of
the standard operating procedure (SOP), 74 patients fulfilling
criteria for diagnosis of severe sepsis and/or septic shock were
analysed and compared with 70 patients after implementation of
evidence-based SOP in 2006.
Results  Both groups did not show any difference in initial
APACHE II score and clinical baseline characteristics. With imple-
mentation of the SOP, use of volume in the first 6 hours (1,506 vs.
2,154 ml,  P <0.05) and in the first day (4,005 vs. 6,122 ml,
P <0.001) significantly increased. Furthermore, treatment with hydro-
cortisone, selenium and insulin increased after implementation of the
SOP significantly. Catecholamines and rhAPC were unaffected.
Mortality in the patient group without SOP was 57%, and in the
intervention group with SOP the mortality was 38.5% (P <0.05).
Conclusions Owing to the implementation of a standard algorithm,
a significant increase in volume therapy and adjunctive sepsis
therapy were realised more frequently compared with patients
treated without the SOP and could be associated with a lower
mortality rate in patients. The realisation of an evidence-based
SOP in daily practice in patients with severe sepsis and/or septic
shock might be effective, shown in the alteration of treatment
practice and the reduction of mortality.
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Introduction  The objective of this study was to describe the
epidemiology, consumption of resources and outcome of patients
with severe sepsis.
Methods  A prospective, observational and multicenter study
performed in six Spanish ICUs. Only patients with severe sepsis
were included.
Results A total of 122 patients with severe sepsis were included
(female 33.1%; mean age 58.01 ± 15.40 years; mean APACHE II
score at admission to the ICU 21.10 ± 8.89). The source of the
infection was respiratory in 56.2%, abdominal in 19.2% and other
foci in 24.6%. Sepsis-related Organ Failure Assessment (SOFA)
scores at the time of diagnosis of severe sepsis were the following:
global 10.21 ± 3.75, respiratory 2.66 ± 1.08, haematological
0.75 ± 1.10, hepatic 0.70 ± 1.01, cardiovascular 3.54 ± 1.22,
neurological 0.96 ± 1.50, and renal 1.46 ± 1.61. Rates of organ
failure were the following: respiratory 93.8%, haematological
38.5%, hepatic 37.7%, cardiovascular 90.8%, neurological 35.4%
and renal 55.4%. The rate of use of medical resources was as
follows: adrenergic agents 90.8%, mechanical ventilation 86.2%,
extrarenal depuration 20% and recombinant activated protein C
15.4%. Mean length of stay in the ICU was 16.88 ± 18.98 days.
The mortality rate in the ICU was 43.44%. We found that lactic
acid serum levels (OR = 1.26, 95% CI = 1.11 to 1.43, P <0.001),
SOFA score (OR = 1.24, 95% CI = 1.12 to 1.37, P <0.001) and
plasminogen activator inhibitor-1 (PAI-1) plasma levels (OR = 1.02,
95% CI = 1.01 to1.03, P=0.001) at the time of diagnosis were
predictors of mortality.
Conclusions Severe sepsis is an important cause of mortality and
it incurs a considerable use of resources. Lactic acid serum levels,
SOFA score and PAI-1 plasma levels at diagnosis were found to
be predictors of mortality.
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Introduction  A multicentre, prospective, observational study
conducted in four intensive therapy units (ITUs) in India from June
2006 to September 2008 to determine the incidence and outcome
of severe sepsis among adult patients.
Methods All patients admitted to the ITU were screened daily for
SIRS, organ dysfunction and severe sepsis as defined by the ACCP
and SCCM. Patients with severe sepsis were further studied.
Results A total of 4,183 ITU admissions were studied. SIRS with
organ dysfunction was found in 1,286 (30.74%) patients, of which
688 (53.50%) were due to severe sepsis. The incidence of severe
sepsis was 16.45% of all admissions. The mean age of the study
population was 56.72 years (SD = 18.20), of which 62.63% were
male. The median APACHE II score was 19 (IQR 18 to 20) with
predominant (90.93%) medical admission. The ITU mortality of all
admissions was 17.70% and that of severe sepsis was 46.30%.
The hospital mortality and 28-day mortality of severe sepsis were
53.39% and 55.05%, respectively. The standardized mortality ratio
of severe sepsis patients was 2.20. The median duration of stay in
the ITU for the severe sepsis cohort who survived was 4 days (IQR
4 to 5). The number of episodes where infection was the primary
reason for admission to the ITU was 98.11%. Culture positivity
was found in 44.48%. Lung was the predominant source of sepsis
(35.90%). Gram-negative organisms were responsible for 57.86%
of cases and Gram-positive for 16.63%. The rest were parasitic,
viral and fungal infections.
Conclusions Severe sepsis was common in Indian ITUs. The ITU
mortality was higher compared with the western literature. Gram-
positive infections were less common although the incidence of
parasitic and viral infection was higher than in the West.
Available online http://ccforum.com/supplements/13/S1S142
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Introduction Sepsis is a significant cause of morbidity and mor-
tality worldwide. Early recognition and treatment are of paramount
importance in reducing mortality; this has been highlighted by the
Surviving Sepsis Campaign (SSC) [1]. A consensus of opinion
exists as to Time Zero being the first instance where severe sepsis
is present. We undertook a study of newly qualified doctors in a
university teaching hospital, to evaluate how effective they were at
recognising severe sepsis; and whether a simple intervention could
improve their ability to perform this task.
Methods  The case file of a patient with septic inflammatory
response syndrome leading to severe sepsis was identified and
anonymised. Time Zero was identified by the investigators based
on the SSC criteria. The case file was distributed to a sample of
junior doctors over a 2-month period. They were asked to study the
retrospective case record and fill in a questionnaire identifying
when they felt Time Zero occurred. These data were collected and
then the doctors were given an educational tool about the SSC
guidelines and the definition of Time Zero. They were then asked to
reappraise the case and reassess the Time Zero point based on
their new knowledge.
Results  Thirty junior doctors participated; all had less than
4 months postgraduate experience. Time Zero was correctly
identified on the first attempt by 17% (n = 5) of the juniors. Time
Zero estimates ranged from –70 to +920 minutes of the actual
value. After implementation of the teaching tool, 100% of the
doctors correctly identified Time Zero according to the SSC criteria.
Conclusions  These results show that there can be significant
discrepancies in the accuracy of prediction of Time Zero, which in
turn could have significant implications for the diagnosis and timely
inception of treatment in severe sepsis. A simple intervention such
as an educational tool based on current SSC guidelines can
improve the accuracy and speed of diagnosis, and this may have
an effect on morbidity and mortality.
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Introduction ICU infection is an important cause of morbidity and
mortality. Equally, it is important to establish to what extent
physicians are capable of making effective diagnoses and
implement correct treatment for sepsis. A national prevalence of
ICU infection study was conducted in South African ICUs to
evaluate these two issues.
Methods  Approval to conduct the study was obtained from all
appropriate authorities. A 1-day prevalence of sepsis study was
undertaken on 16 August 2005. A proportional probability sample
was determined from all ICUs in the country. Attending physicians
were asked to indicate their diagnosis and treatment on the day of
the study. Relevant clinical data were collected for each patient
and reviewed by two independent intensivists.
Results All units chosen agreed to participate. The 28-day hospital
mortality was 58 of 248 patients (23%). The prevalence of each
category of the SIRS [1] criteria and associated percentage
mortality respectively was nil 59 (8%), SIRS 120 (9%), sepsis 40
(28%), severe sepsis 13 (35%) and septic shock 16 (41%). One
hundred and ninety-six patients were deemed to have one of the
sepsis diagnoses by the primary physician, an overdiagnosis of
51%. Antibiotic prescription and associated mortality percentage
respectively were: appropriate 82 (12%) and inappropriate 100
(28%). Antibiotic therapy was changed correctly after microbiology
data in 21 of 88 patients (24%). Duration of therapy was correct in
51 of 183 patients (28%).
Conclusions  The prevalence of sepsis and the associated
mortality is similar to that described in other studies [1]. Physicians
tend to overdiagnose sepsis. Antibiotic prescribing practices were
incorrect with respect to selection, modification after microbiology
data and duration of treatment. A major deficiency in diagnostic
and therapeutic ability among physicians was identified in this
study. Appropriate steps must be taken to remedy this deficiency.
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Introduction Severe community-acquired pneumonia (sCAP) is an
exaggerated inflammatory and coagulation response to infection.
sCAP has high rates of mortality and necessitates modified
treatment to that for mild/moderate community-acquired pneu-
monia (CAP). Despite the grave nature of this condition it is poorly
characterised. A systematic review was performed to gauge
current data and identify unmet needs associated with sCAP.
Methods  MEDLINE was searched for English-language papers
concerning sCAP published after 1998.
Results There are a number of published indices for diagnosing
sCAP but these are difficult to use in the clinical setting. In the
literature, sCAP is defined as CAP requiring admittance to an ICU
or as CAP that results in death. Current International Statistical
Classification of Disease and diagnosis-related group codes do
not specify whether pneumonia is community acquired or hospital
acquired or indicate the severity of the infection. Estimates of the
prevalence of sCAP in patients with CAP range from 6.6 to 16.0%
[1,2]. Mortality rates for patients with sCAP range from 10 to 55%
[3,4]. The discrepancy in these rates emphasises the variation in
hospital practices due to the lack of an objective definition of
sCAP. The absence of a clear definition for sCAP could result in
inappropriate treatment of this life-threatening condition, increasing
mortality rates. There are scant data concerning the costs of
treating sCAP; increased expenditure for patients with sCAP
versus those with CAP results from ICU treatment, increased
length of hospital stay, mechanical ventilation, vasopressor use and
rehabilitation costs. It is expected that the clinical and cost benefits
of new therapies will be more easily recognised if sCAP is
consistently defined. Defining sCAP appropriately requires a
focused international initiative and collaboration between clinicians
and payers.
Conclusions  There is a major unmet need for a meaningful
definition of sCAP. Poor characterisation of sCAP has resulted in
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variable reports of its prevalence and may result in inappropriate
treatment leading to increased mortality in this patient population.
The results of this systematic review form the basis for developing
a new treatment pathway to improve outcomes for patients with
sCAP.
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Introduction In this observational cohort study we attempted to
elucidate a haemoglobin (Hb) target that favours the mortality
outcome in severe sepsis patients. The optimum level of Hb to
influence outcome in severe sepsis is yet to be determined.
Although the analysis of severe sepsis patients in the Canadian
transfusion requirement in critical care study [1] did not find any
mortality benefit with a Hb level of 10 g/dl or above, the early goal-
directed therapy trial [2] showed significant mortality benefit by
achieving haematocrit ≥30%, equivalent to a Hb value of 10 g/dl,
during the early treatment period. This pilot study was therefore
undertaken to look for any relationship between Hb levels and
mortality in severe sepsis patients admitted to the ICU.
Methods All patients 16 years or older with severe sepsis or septic
shock who stayed longer than 24 hours between July 2006 and
June 2007 were retrospectively included in the study. Patient
demographics, Hb levels measured by the blood gas analyser
during their period of severe sepsis and outcome data were
collected. Binary logistic regression analysis was performed with
ICU survival and 28-day survival as the dependent variables.
Results Of the 62 patients enrolled in the study, the average age
was 66.8 years (16 to 87 years), with mean admission APACHE II
score and Simplified Acute Physiology Score II being 18 (8 to 30)
and 58 (17 to 78), respectively. Their ICU and 28-day mortality
rates were 35.5% and 41.9%, respectively. On analysis no
significant relationship was found between average Hb, Hb
variation, minimum Hb, maximum Hb, and number of units
transfused with ICU or 28-day survival. In addition, no significant
relationship was found between Hb falling below thresholds of 7,
8, 9, or 10 g/dl, or variation from an Hb of 7, 8, 9, 10 g/dl during
severe sepsis and the ICU survival or 28-day survival.
Conclusions  While a haematocrit of 30% represents a
physiological optimum between viscosity and oxygen carriage, the
equivalent Hb from this pilot study shows no advantage in the
outcome of severe sepsis. This study suggests that any effect Hb
levels may have on the outcome from severe sepsis is likely to be
small.
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Introduction  We have investigated genetic and clinical factors
associated with the hyperdynamic state (HS) after heart surgery
with extracorporeal circulation (ECC).
Methods We performed a prospective cohort study of consecutive
patients who underwent elective heart surgery with ECC. The HS
was defined as hyperthermia (>38ºC), cardiac index (CI)
>3.5 l/min/m2 and systemic vascular resistance index (SVRI)
<1,600 dynes x s/cm5 x m2. The study included demographic
variables, gene polymorphisms (A/G) of TNFβ+250, G/A-1082 of
IL-10, polymorphism of IL-1 receptor antagonist, comorbidity, type
of surgery, serum levels of IL-6, and postoperative course. We
used the Pearson chi-square test or Fischer exact test, and the
Student t test for univariate analysis, with forward stepwise logistic
regression for multivariate adjustment.
Results  Eighty patients were studied, of whom 22 (27.5%)
developed HS. The presence of allele G of TNFβ+250 poly-
morphism was associated with an increased incidence of HS
(68% vs. 37%; P = 0.011). In the multivariate analysis, a longer
duration of ECC, and the presence of the G allele, were
associated with the development of HS.
Conclusions The G allele of TNFβ+250 polymorphism, and pro-
longed extracorporeal circuit times, may favour the development of
a hyperdynamic state after heart surgery with ECC.
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Introduction The objective of this study was to evaluate the effect
of the 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene
polymorphism on the plasma PAI-1 levels and outcome in critically
ill patients with severe sepsis.
Available online http://ccforum.com/supplements/13/S1S144
Methods A prospective, observational and multicenter study carried
out in six Spanish ICUs. Only patients with severe sepsis were
included. Epidemiological data, severity scores, site of infection and
outcome of sepsis were recorded. Measurement of PAI-1 plasma
levels (at diagnosis, 72 hours and 7 days of diagnosis of severe
sepsis) and the DNA genotyping of the PAI-1 were carried out.
Results A total of 122 patients with severe sepsis were included.
Nonsurvivor patients (n = 53) exhibited higher PAI-1 plasma
concentrations than the survivor patients (n = 69) at the time of
diagnosis of severe sepsis (60.17 ± 30.34 vs. 42.51 ± 28.85;
P = 0.001), at 72 hours (34.74 ± 20.79 vs. 17.91 ± 12.85;
P ≤0.001), and at 7 days (35.93 ± 21.16 vs. 24.77 ± 15.85;
P = 0.07). PAI-1 plasma levels at diagnosis were found a predictor
of mortality (OR = 1.02, 95% CI = 1.01 to 1.03, P = 0.001). We
did not find significant differences between 4G/5G PAI-1 gene
polymorphisms in the PAI-1 plasma levels (49.20 ± 26.15 with
4G/4G genotype, 49.39 ± 30.63 with 4G/5G genotype, and
48.06 ± 32.26 with 5G/5G genotype), and in the mortality (10/23
(41%) with 4G/4G genotype, 25/60 (40%) with 4G/5G and
18/39 (47%) with 5G/5G).
Conclusions  PAI-1 plasma levels at the time of diagnosis are
markers of an unfavourable prognosis in patients with severe
sepsis. We have not, however, found any correlation between the
4G/5G PAI-1 gene polymorphism, plasma levels of PAI-1 or
mortality of patients with severe sepsis.
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Introduction Former studies have shown that monocyte apoptosis
is crucial for the final outcome of sepsis in the field of acute
pyelonephritis [1]. The significance of apoptosis in acute intra-
abdominal infection was studied.
Methods  Acute peritonitis was induced after cecal ligation and
puncture in 17 male New Zealand rabbits. Four sham-operated
rabbits were also studied. Peripheral blood mononuclear cells
were isolated after Ficol gradient centrifugation; monocytes were
further isolated after plastic adherence. Apoptosis of monocytes
was estimated after staining positive for annexin V and negative for
propidium iodine by flow cytometric analysis.
Results Monocyte apoptosis is presented in Table 1. A rate of
apoptosis greater than 40% was found in six animals after
24 hours; it was lower than 40% for 11 animals. The median
survival of the former was 15.2 days and of the latter 4.2 days (log-
rank: 5.49, P = 0.019).
Conclusions  Sepsis arising in the field of peritonitis is
accompanied by inhibition of apoptosis of monocytes. The rate of
apoptosis 24 hours after sepsis induction is detrimental for the
survival of the septic host.
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Introduction Sepsis is a multiple-gene disease resulting from the
interaction of environmental and genetic components. Matrix metallo-
proteinase-9 (MMP-9) has been demonstrated to play an important
role in organ dysfunction and outcome of sepsis [1-3]. However,
genetic predisposition of MMP-9 to sepsis remained unknown.
Methods Seven common SNPs within the functional regions of
MMP-9 gene (rs17576, rs2274756, rs2250889, rs9509,
rs3918240, rs3918241 and rs3918242) were investigated in 192
patients with severe sepsis and 262 healthy controls. Meanwhile,
the plasma levels of MMP-9 were measured via ELISA.
Results The genotype distributions and allelic frequencies of the
above seven SNPs were not significantly different between patients
with severe sepsis and controls, as well as between surviving and
nonsurviving patients with severe sepsis (all P >0.05). Haplotype
GGCTTTC, AGGTCTC, GGCCTTC, GACTTAT and AGCCCTC
are the five most common haplotypes. The distribution of the
haplotypes was also comparable among the defined groups. The
median plasma levels of MMP-9 was 37.66 ng/ml in 32 patients
within the first 24 hours following the diagnosis of severe sepsis,
and 30.15 ng/ml in 19 healthy controls. Compared with those in
surviving patients with severe sepsis (median 37.66 ng/ml, n = 16)
and healthy controls, the concentrations of MMP-9 appeared an
increasing trend in nonsurviving patients with severe sepsis (median
36.06 ng/ml, n = 16).
Conclusions  The present findings suggest that common poly-
morphisms within the function regions of MMP-9 gene may not
play a major role in the predisposition to severe sepsis in the
Chinese Han cohort. The plasma levels of MMP-9 may associate
with the outcome of severe sepsis. Further studies in large
samples need to be guaranteed.
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Introduction IL-10 is an anti-inflammatory cytokine with pleiotropic
effect in immunoregulation and inflammation. Several recent
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Table 1 (abstract P353)
Apoptosis of monocytes over follow-up
Median (%) 1.5 hours 4 hours 24 hours 48 hours
Sham 21.4 45.1 16.3 27.9
Peritonitis 18.5 10.9* 21.9* 13.3
*P < 0.05 between groups.S145
papers reported association of the IL-10 –1082G allele with
adverse outcome in sepsis [1,2]. The study objective was to
investigate whether IL-10 promoter polymorphism –1082 G/A is
associated with adverse outcome in severe sepsis and septic
shock patients.
Methods The study was conducted in the mixed medical–surgical
adult ICU of P. Stradinš Clinical University Hospital in Riga in 2007
and 2008. A total of 103 critically ill patients who met the
proposed severe sepsis and septic shock criteria were included.
The IL-10 –1082 polymorphism was genotyped by sequencing. All
patients were followed up throughout their stay in the ICU to
clinical outcome. The frequency distributions of the genotypes in
the subgroups were compared using the Pearson chi-square test.
P <0.05 was considered to indicate statistical significance.
Results Of the 103 patients observed, 44 (43%) had an adverse
outcome in the ICU. In the survival group 11 (19%) had G/G at
position –1082 of the IL-10 gene, 25 (42%) were heterozygous
G/A, and 23 (39%) were homozygous A/A. In the nonsurvival
group five (11%) had G/G, 30 (68%) had A/G, and nine (21%)
had the A/A genotype. The polymorphism frequencies between
survival and nonsurvival differed significantly (P = 0.034, χ2 = 6.8).
The relative risk for adverse outcome in IL-10 –1082 alternative G
allele carriers (G/G and G/A genotypes) was 1.6 (95% CI = 0.91
to 2.83).
Conclusions  We found association of the IL-10 promoter
polymorphism –1082 G/A with clinical outcome in severe sepsis
and septic shock patients; alternative –1082 G allele carriage
seems to be associated with greater risk for adverse outcome in
the studied patient population.
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Introduction Activated protein C (APC) has been shown to have
beneficial effects on the inflammatory process and coagulation
during sepsis. Inflammation and coagulopathy impair the micro-
vasculature and therefore disturb oxygen transport to the tissue.
The hypothesis of our study was that APC treatment improves
renal microvascular oxygenation and kidney function in endotoxin-
induced acute renal failure in the rat.
Methods In 18 anesthetized and ventilated (FiO2 0.4) male Wistar
rats, the arterial blood pressure and renal blood flow were
recorded. The renal microvascular PO2 was continuously measured
by phosphorescence lifetime technique. All animals received a
lipopolysaccharide (LPS) bolus (10 mg/kg) to induce endotoxemic
shock. All rats received fluid resuscitation (hydroxyethyl starch
130 kDa) 1 hour after LPS application. In one group of animals,
APC (drotrecogin alpha, Xigris®; Lilly) was continuously infused in
a concentration of 10 μg/kg/hour. Another group received a
continuous infusion of 100 μg/kg/hour APC.
Results Data are presented in Figure 1.
Conclusions APC at a concentration of 100 μg/kg/hour signifi-
cantly restored kidney function compared with standard fluid
resuscitation during endotoxemia. This application best improved
the mean arterial pressure. APC had no beneficial effects,
however, on the average renal microvascular PO2.
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Introduction  Angiopoietin-2 (Ang-2) is a mediator produced by
endothelial cells [1]. It is in doubt whether its production in the
intubated septic host is due to an effect of anesthetic medication
or to the sepsis process. The present study attempted to provide
an answer.
Methods  In 10 mechanically ventilated pigs, anesthesia was
maintained by sevoflurane inhalation. Then shock was induced by
the intravenous administration of 25 mg/kg lipopolysaccharide
(LPS) of Escherichia coli 111: B4 in eight pigs; two were controls.
Blood was collected by a Swan–Ganz catheter and by a peripheral
vein. Ang-2 was estimated by an enzyme immunoassay.
Results  The median Ang-2 of the peripheral circulation among
controls and pigs at shock was at baseline 1,403.2 and
2,390.6 pg/ml (P = NS), respectively; at 1 hour 914.2 and
2,192.5 pg/ml (P = 0.048), respectively; and at 2 hours 2,013 and
1,738.7 pg/ml (P = NS). Respective values of the lung circulation
were 995.8 and 1,738.7 pg/ml at baseline (P = NS); 831.3 and
1,663.3 pg/ml at 1 hour (P = NS); and at 2 hours 943.8 and
1,757.8 pg/ml (P = NS).
Conclusions Ang-2 is a mediator involved in the advent of shock
not influenced by the administration of sevoflurane.
Reference
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FR = fluid resuscitation; T0 = baseline; t1 = 1 hour after LPS bolus; 
t2 = resuscitation (3 hours); MAP = mean arterial pressure; RBF =
renal blood flow; RVR = renal vascular resistance; CLcrea = creatinine
clearance; cμPO2 = cortical microvascular PO2; mμPO2 = medullary
microvascular PO2.S146
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Introduction Lectin-like oxidized low-density lipoprotein receptor-1
(LOX-1) is a major endothelial receptor for oxidized low-density
lipoprotein [1]. Its expression is induced by pro-atherogenic stimuli
as well as by inflammatory cytokines. LOX-1 acts also as an
adhesion molecule involved in leukocyte recruitment. The systemic
leukocyte activation in sepsis represents a crucial factor in the
impairment of the microcirculation of different tissues, causing
multiple organ failure and death. The aim of our experimental study
was therefore to evaluate the effects of LOX-1 inhibition on the
endotoxin-induced leukocyte adherence within the intestinal
microcirculation using intravital microscopy.
Methods Group 1 (n = 10 Lewis rats) remained untreated and
served as the control group. In Group 2 (n = 10) endotoxemia was
induced by intravenous administration of 2 mg/kg lipopolysaccha-
ride (LPS). In Group 3 (n = 10) endotoxemic animals were treated
with 10 mg/kg anti-Lox-1-IgG. Endotoxemic animals of Group 4
(n = 10) were treated with an unspecific IgG. Following 2 hours of
endotoxin challenge or placebo administration, intestinal micro-
circulation was evaluated using intravital microscopy. LOX-1
expression was quantified by western blot and reverse-trans-
cription PCR.
Results  LOX-1 inhibition reduced significantly the leukocyte
adherence in the submucosal venules of the intestinal wall
(P <0.05). Functional capillary density of the intestinal muscular
layers as well as in the mucosa increased following administration
of the LOX-1-antibody in comparison with untreated LPS animals
(P <0.05). At the mRNA level, LOX-1 expression was significantly
increased in the untreated LPS group (P <0.05) whereas animals
with LOX-1-antibody administration showed a significant reduction
of the expression (P <0.05).
Conclusions  LOX-1-antibody administration in experimental
endotoxaemia significantly reduced leukocyte adherence and
increased microvascular perfusion within the intestinal micro-
circulation. The inhibition of the lectin-like oxidized low-density
lipoprotein receptor-1 may represent an attractive target for the
modulation of endotoxin-induced impairment of the micro-
circulation in sepsis.
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Introduction Activation of the cholinergic anti-inflammatory path-
way via vagus nerve stimulation or a7nAChR agonists improves
outcome in animal models of endotoxemia, sepsis and experi-
mental arthritis. This vagal anti-inflammatory pathway is mediated
by the nicotinergic a7nACh receptor that can be selectively
stimulated by GTS-21. Up to now, the anti-inflammatory effects of
oral administration of GTS-21 in humans in vivo have not been
investigated. The aim of this study was to investigate the anti-
inflammatory effects of oral administration of GTS-21 on the
inflammatory response in the human endotoxemia model.
Methods  We performed a double-blind placebo-controlled
randomized study in 12 healthy, nonsmoking male volunteers (18
to 28 years) during experimental endotoxemia. Subjects received
150 mg GTS-21 or placebo orally three times daily 3 days before
lipopolysaccharide (LPS) injection and on the day of the experi-
ment, the last dose 1 hour before LPS administration (t = –1). One
hour after the last dose of GTS-21 or placebo, LPS derived from
Escherichia coli O:113 was injected (2 ng/kg intravenously).
Results  The main study endpoint was the concentration of
circulating cytokines after LPS in the absence and presence of
GTS-21. The effects of GTS-21 on TNFα and IL-10 release are
shown in Figures 1 and 2. There was a trend towards a decrease
in TNFα levels and an increase in IL-10 levels after GTS-21
administration. A similar trend was observed in levels of other
proinflammatory and anti-inflammatory cytokines.
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Conclusions  GTS-21 suppresses TNFα and stimulates IL-10
release during human endotoxemia in healthy human volunteers,
resulting in a shift towards a more anti-inflammatory pattern. This
effect may have potential for in vivo modulation of the innate
immune response.
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Introduction The purpose of our study was to determine the acute
inflammatory response of critically ill (ICU) and haemodialysis (HD)
patients and to compare the cytokine profiles induced by different
classes of pathogens in these two patient populations vulnerable
to infections.
Methods We studied production of IL-6 and TNFα in response to
stimulation of whole blood with 1 μg lipoteichoic acid (LTA) and
1 μg mannan for 6 hours in ICU patients with various medical
causes of admission and in HD patients just before dialysis.
Results Blood samples were taken from 11 ICU patients (eight
males; age 63.83 ± 10.73 years; APACHE II score 21.12 ± 3.45)
and from nine HD patients (six males; age 65.11 ± 10.37 years).
Results are presented in Table 1. Between the two patient groups,
no differences were found concerning the intensity of the inflam-
matory response.
Conclusions The basic concentration of IL-6 was higher in ICU
patients. After ex vivo challenge with LTA and mannan, no
differences in the intensity of the inflammatory response were
detected between the two groups. LTA is a much more potent
immunostimulator than mannan in both ICU and HD patients.
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Introduction  Asymmetric dimethylarginines (ADMA) and sym-
metric dimethylarginines (SDMA) are markers of protein break-
down; both compete with arginine for cellular transport and are
excreted in urine. In addition, ADMA is a nonselective inhibitor of
NO synthase, and is also metabolized by dimethylarginine-
dimethylaminohydrolase (DDAH), a specific hydrolase whose
activity in stress is controversial [1]. While the ADMA increase is
associated with adverse events in many critical conditions, little
attention has been focused on the role of SDMA [2].
Methods  In three Italian university ICUs we measured plasma
ADMA, SDMA, their ratio (a marker of ADMA catabolism, a rough
indicator of DDAH activity), arginine, IL-6, TNFα, and C-reactive
protein (CRP) level at days 1, 3, 6, 9, 12 and at discharge in 72
consecutive patients with severe sepsis/septic shock.
Results Basal glycaemia, creatinine, IL-6, TNFα, CRP, ADMA and
SDMA were higher than normal; arginine was normal. ADMA was
related to total Sequential Organ Failure Assessment and arginine,
inversely related to IL-6 and CRP; SDMA was related to Simplified
Acute Physiology Score II score, daily, worst-day, total Sequential
Organ Failure Assessment score, blood urea, creatinine, and
arginine. The ADMA/SDMA ratio was inversely related to IL-6. In
58 patients discharged alive, creatinine, IL-6 and CRP decreased
over time, ADMA increased, SDMA remained stable, and the
ADMA/SDMA ratio increased. In 14 patients who died in the ICU,
creatinine, IL-6, TNFα, CRP, and ADMA did not vary, SDMA
significantly increased, and ADMA/SDMA ratio variation was not
significant. In both groups the last ICU day confirms data trends.
SDMA but not ADMA was associated with ICU mortality.
Conclusions In severe sepsis SDMA is a more robust predictor of
organ failure/mortality than ADMA. Stress reaction seems to
activate ADMA catabolism, while in survivors, when inflammation
subsides, the catabolism seems to be reduced.
References
1. Zoccali C, et al.:  Asymmetric dimethyl-arginine (ADMA)
response to inflammation in acute infections. Nephrol Dial
Transplant 2007, 22:801-806.
2. O’Dwyer MJ, et al.: Septic shock is correlated with asym-
metrical dimethyl arginine levels, which may be influenced
by a polymorphism in the dimethylarginine dimethy-
laminohydrolase II gene: a prospective observational
study. Crit Care 2006, 10:R139.
P362
IL-2 modulates IFNγ γ mRNA gene expression in cultured
peripheral blood mononuclear cells from septic patients
M White1, R Grealy1, D Doherty2, D Kelleher2, R McManus2, 
T Ryan1
1St James Hospital, Dublin, Ireland; 2Institute of Molecular
Medicine, Trinity College, Dublin, Ireland
Critical Care 2009, 13(Suppl 1):P362 (doi: 10.1186/cc7526)
Introduction  IL-2 activates numerous key cells in the immune
system [1]. We have previously demonstrated that IFNγ mRNA
gene expression in peripheral blood mononuclear cells (PBMC) is
downregulated in patients with sepsis compared with healthy
controls [2]. Here we investigated IFNγ gene expression in
cultured PBMC from healthy controls and patients with severe
sepsis and examined whether exogenous IL-2 can influence IFNγ
mRNA expression.
Methods PBMC were isolated from five healthy controls and five
patients with severe sepsis and were cultured in 24-well plates.
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Cytokine concentrations before and after LTA and mannan challenge
ICU IL-6 ICU TNFα HD IL-6 HD TNFα
Baseline (pg/ml) 363.2 ± 363.1 85.75 ± 56.05 88.78 ± 152.6 34.75 ± 27.17
LTA challenge (pg/ml) 2,128 ± 94.86, P <0.0001 4,836 ± 2,607, P <0.0001 2,057 ± 120.7, P <0.0001 4,175 ± 2,180, P = 0.0035
Mannan challenge (pg/ml) 812.1 ± 562.0, P = 0.0377 168.9 ± 119.9, P = 0.0904 170.9 ± 158, P = 0.2787 56.75 ± 42.01, P = 0.3687S148
Cells were incubated in medium alone or stimulated with either
1 μg/ml lipopolysaccharide (LPS) for 24 hours (activate monocytes
and B cells), 3 μg/ml anti-CD3 (mAb) for 4 hours (activate T cells),
or 10 ng/ml phorbol myristate acetate (PMA) + 1 μM ionomycin for
4 hours (activate all cells). Each experiment was performed in the
absence and presence of 50 U recombinant IL-2 (rIL-2). Total RNA
was isolated and reverse transcribed. IFNγ mRNA gene expression
was quantified with quantitative RT-PCR. Results were analysed
with ANOVA and the t test where appropriate.
Results IFNγ mRNA production is lower in PBMC of patients with
sepsis compared with healthy controls (P = 0.03) but similar when
measured in the presence of rIL-2. With T-cell stimulation, IFNγ
mRNA was greater in PBMC from septic patients compared with
controls (P = 0.02) but similar in the presence of rIL-2. With LPS
stimulation of monocytes and B cells, IFNγ mRNA was lower in
PBMC from septic patients compared with controls (P = 0.02), but
similar in the presence of rIL-2. With PMA stimulation, IFNγ mRNA
was similar in PBMC from septic patients and controls in the
presence and absence of rIL-2.
Conclusions  IFNγ mRNA production is reduced in PBMC in
sepsis but can be stimulated ex vivo to produce normal IFNγ levels.
In the absence of rIL-2, IFNγ mRNA production is inducible in
T cells but not in monocytes and B cells. IL-2 modulation of IFNγ
mRNA production appears to be stimulus dependent, and may
contribute to the host defence mechanism.
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Introduction  Our purpose was to assess the effects of super-
physiologic dosages of human purified C1-esterase inhibitor
infusion (C1INH) on complement-dependent pathways of systemic
inflammatory response in patients with sepsis.
Methods In the terms of an open-label prospective control study,
human purified C1INH (Bicizar; BioGenius LLC, Russia) was
administered at total dosage of 12,000 U to 20 sepsis patients.
Patients (n = 22) who did not receive C1INH infusion were
enrolled as controls. C3 and C4 complement subunits, IL-6, C-
reactive protein and procalcitonin results were analyzed in quartiles
according to C1INH baseline activity.
Results C1INH activity was different in quartiles at entry in both
groups (P <0.03). C1INH infusion resulted in elevation of C1INH
activity in the treatment arm (Figure 1). The most significant
difference was observed between the upper quartiles of the
groups (P <0.01). The degree of C1INH activity shift had a nega-
tive association with the baseline results (r = –0.635, P <0.01). C3
(P <0.01) and C4 (P <0.05) levels displayed a more rapid and
pronounced rise after C1INH infusion in patients with higher
baseline C1INH activity. The C-reactive protein concentration
dropped significantly in patients who received C1INH (130 mg/l
(28 to 293)) already on the third day of the study in comparison
with the control (185 mg/l (72 to 343); P = 0.022). The same
trend characterized the IL-6 level. Patients with elevated
procalcitonin values at the onset of sepsis had a more significant
C1INH increase (r = 0.635, P <0.05).
Conclusions Downregulation of complement activity with C1INH
might help to contain severe systemic inflammation. Presumably,
the response to C1INH infusion was related to its baseline activity.
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Introduction  Microparticles (MPs) are membrane vesicles with
procoagulant and proinflammatory properties released during cell
activation and might be potentially involved in the pathophysiology
of septic shock [1,2]. The present study was designed to assess
the effects of MPs from septic origin on systemic hemodynamics
as well as on the inflammatory, oxidative and nitrosative stresses.
Methods  We designed a prospective, randomized, controlled
experimental study with repeated measurements. Forty healthy rats
were randomly allocated to three groups: 10 animals inoculated
with MPs isolated from control rats (cMPs), 15 animals inoculated
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C1INH activity in the Bicizar (q) and control groups (c): analysis in quartiles.S149
with MPs isolated from sham rats (shMPs) and 15 animals
inoculated with MPs isolated from rats with peritonitis (sMPs). Rats
were anesthetized, mechanically ventilated and were infused with
the same amount of cMPs or shMPs or sMPs. We measured the
heart rate, mean arterial pressure, carotid artery blood flow and
portal vein blood flow. Hemodynamic parameters were recorded
during 7 hours, and then animals were sacrificed. The aorta and
heart were harvested for further in vitro tissue analyses.
Results (1) The cellular origin (phenotype) but not the circulating
concentration of MPs was different in septic rats, characterized by
a significant increase in leukocyte-derived MPs. (2) sMPs but not
cMPs or shMPs decreased the mean arterial pressure without any
effect on carotid artery and portal vein blood flows. (3) Rats
inoculated with sMPs exhibited an increase in superoxide ion
production and NF-κB activity, overexpression of inducible NO
synthase with subsequent NO overproduction and decrease in
endothelial NO synthase activation.
Conclusions Rats with sepsis induced by peritonitis exhibited a
specific phenotype of MPs. Inoculation of sMPs in healthy rats
reproduced hemodynamic, septic inflammatory patterns, asso-
ciated with oxidative and nitrosative stresses.
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Introduction  Pharmacological actions of gaseous biological
mediator hydrogen sulfide (H2S) include vasodilatation, inhibition
of mitochondrial respiration as well as induction of suspended
animation-like state [1,2]. Its beneficial cellular actions include
cytoprotection and anti-inflammatory effects [2].
Methods Rodent models of ischemia and reperfusion of the heart,
murine and ovine models of acute respiratory distress syndrome, a
canine model of cardiopulmonary bypass, porcine models of
myocardial infarction and thoracoabdominal aortic aneurysm
surgery were used. H2S was administered in an iso-osmolar, pH-
neutral intravenous formulation (IK-1001).
Results In a mouse model of myocardial infarction, a significant
protection by IK-1001 was seen in terms of reduction of
myocardial infarct size. These effects were accompanied by
reduction in myocardial IL-1 levels and reduction in neutrophil
infiltration [3]. The cardiac protection of H2S was confirmed in a
porcine model of myocardial ischemia [4] and in a canine model of
cardiopulmonary bypass surgery. IK-1001 was also protective in
murine and ovine models of acute respiratory distress syndrome,
where improvement in survival and pulmonary function was
accompanied by a reduction in oxidant stress and suppression of
the production of IL-6 and inhibition of the expression of inducible
nitric oxide synthase [5]. In models of thoracoabdominal aneurysm
surgery, reperfusion was accompanied with significant increases in
the production of IL-1 and IL-6, which were reduced by IK-1001.
IK-1001 also improved renal function, provided hemodynamic
stabilization and attenuated oxidative DNA damage [6].
Conclusions  H2S thus exerts organ-protective and anti-inflam-
matory effects in various animal models of critical illness. The
mechanisms may involve metabolic effects leading to the induction
of hypothermia, antioxidant mechanisms, modulation of gene
expression, activation of KATP channels, and inhibition of inflam-
matory cell activation.
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Introduction Kidney ischemia is one of the mechanisms of acute
renal failure and it is known that the free oxygen radicals play an
important role in this type of injury. We tested the hypothesis that
dimethyl sulphoxide (DMSO), a free radical scavenger, has a
protective role in a renal ischemia–reperfusion animal model [1].
Methods Renal ischemia was induced to 45 male, New Zealand
rabbits. The subjects were divided into three groups based on
ischemia duration: 30, 60 or 90 minutes. Each group was divided
into three subgroups: (a) DMSO previous to ischemia, (b) DMSO
after ischemia, (c) control group. All subjects were given 6 hours of
reperfusion. Three blood samples were taken at baseline, ischemic
and reperfusion phases. Each sample was tested for serum
creatinine, blood ureic nitrogen and urea. After reperfusion,
bilateral nephrectomy was performed on each subject before
euthanasia. A pathological analysis evaluated tubular and base-
ment membrane changes. The level of injury was scaled in three
stages: mild, moderate and severe.
Results The histological analysis showed severe damage in 33%
of the control group, compared with 0% in both treatment groups
(chi-square P = 0.00) (Table 1). Blood chemistry analysis in the
control group at 60 and 90 minutes of ischemia showed higher
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Proportion estimate of histopathological findings
n = 45 Control (%) DMSO pre (%) DMSO post (%)
Mild 46 40 60
Moderate 20 60 40
Severe 33 0 0S150
values than both treatment groups. Creatinine values were
analyzed over a proportion estimate, showing that 26% of subjects
in the control group had an improvement comparing the ischemic
phase versus the reperfusion phase. Treatment groups showed
that 46% and 60% of the subjects improved their creatinine values
when DMSO was administered pre ischemia and post ischemia,
respectively.
Conclusions The animal model showed an increasing trend of all
blood chemistry parameters evaluated in the control group. DMSO
applied as prophylaxis or treatment post ischemia demonstrates
diminished renal function deterioration. Histological analysis revealed
the absence of severe lesions when DMSO is administered.
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Introduction  It has been reported that the blood level of
carboxyhemoglobin (CO-Hb) is increased in critically ill patients
such as those with sepsis or multiple trauma [1,2]. Because
carbon monoxide (CO) is one of the metabolites of heme
catabolism, it has been suggested that there may be increased
breakdown of heme in these patients. Heme oxygenase (HO) is the
enzyme involved in the rate-limiting step for catabolism of heme-
containing proteins. It was recently reported that HO-1 acts as a
potent anti-inflammatory agent and antioxidant through its products
[3]. HO-1 may therefore be an inducible defense against cellular
stress that occurs during the inflammatory process [1,4]. Against
this background, we decided to evaluate the relation among the
blood level of CO, HO-1 expression by monocytes, oxidative
stress, and the outcome of sepsis.
Methods Thirty patients who fulfilled the criteria for severe sepsis
or septic shock and 17 other patients without sepsis during their
stay in the ICU were studied. HO-1 expression by monocytes,
arterial CO, oxidative stress, and cytokines were measured.
Results Arterial blood levels of CO, cytokines, as well as monocyte
HO-1 expression were higher in septic shock patients than in
nonseptic patients. Increased HO-1 expression was significantly
correlated with the arterial CO concentration and oxidative stress.
There was a positive correlation between survival and higher HO-1
expression or CO level.
Conclusions  We found that the increase of endogenous CO
production in sepsis mainly reflects increased heme turnover
secondary to upregulation of HO-1, which is partially in response
to systemic oxidative stress. A strong correlation between the
blood CO level and survival supports the beneficial effect of HO-1
upregulation and increased CO production in patients with sepsis.
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Introduction  IL-18 is said to be involved in organ injury. We
investigated the IL-18 values of septic acute lung injury (ALI) and
acute respiratory distress syndrome (ARDS) patients.
Methods The subjects were 38 patients during the 3-year period
from 2004 to 2007 from whom it was possible to collect a blood
specimen within approximately 6 hours of the onset of septic ALI or
ARDS. Their mean age was 67 years, and their mean APACHE II
score was 29. Their Sequential Organ Failure Assessment score
was 13, and their mean PaO2/FiO2 ratio was 170. The PaO2/FiO2
ratio was 246 in the ALI group and 135 in the ARDS group. There
were four cases (10.5%) in the 28-day mortality group, and six
cases (15.8%) in the 90-day mortality group.
Results  The value of IL-18 in the dead group was significantly
higher than in the surviving group (1,649 ± 1,056 pg/ml vs. 4,523 ±
2,798 pg/ml; P  <0.05), and in the ARDS group was also
significantly higher than in the ALI group (2,467 ± 1,880 pg/ml vs.
1,314 ± 800 pg/ml; P <0.05).
Conclusions These results suggested that IL-18 may play a major
role in progression of ARDS in respiratory disorder as multiple
organ failure.
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Introduction Sepsis is often accompanied by myocardial depres-
sion; one of the possible mechanisms includes mitochondrial injury.
We hypothesized that opening of the mitochondrial permeability
transition pore (mPTP) may occur during sepsis-induced
myocardial depression. We investigated the opening of the mPTP
in septic hearts by measuring cytochrome C release into the
cytosol.
Methods  Sepsis was induced in rats by 7.5 mg/kg lipopoly-
saccharide injection intraperitoneally. After 4 hours, hearts were
excised and mounted in a Langendorff setup to study myocardial
contractility  ex vivo. Subsequently, hearts were frozen and 5 μm
cryostat sections were made. Sections were stained for cytochrome
C using immunohistochemistry. Healthy rats served as controls.
Results  Septic animals showed a decreased contractility
(P <0.005) and lower developed pressure (P <0.001) when
compared with healthy controls. Immunohistochemistry revealed no
release of cytochrome C in healthy or septic hearts.
Conclusions Cytochrome C is not released during sepsis-induced
myocardial depression. These results indicate that the mito-
chondrial permeability pore may not be involved in the
development of myocardial dysfunction during sepsis.
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Introduction Comparing genomic changes in mice strains demon-
strating physiologic differences with pathologic insults is a novel
approach to elucidate potential mechanisms. Our hypothesis was
that murine strains exhibit different cardiac/genomic responses to
specific pathogens.
Methods The end-systolic pressure–volume relationship (ESPVR)
and end-diastolic pressure–volume relationship (EDPVR) cardiac
performance was compared in B6, C57 and FVB mice (pressure–
volume loops, Millar catheter; isoflurane anesthesia) 4 hours after
zymosan (ZYM) or endotoxin (LPS) intraperitoneally. Gene expres-
sion profiles unique to mouse strain/baseline/treatment were
created using two-way ANOVA/two-fold filtering.
Results ESPVR improved in B6/C57 mice after ZYM (Figure 1).
Diastolic compromise (Figure 2) occurred in FVB mice following
ZYM but in B6 mice after LPS. Genomic analyses within strains
revealed pathogen-specific differences: for example, ZYM-treated
FVB mice (diastolic impairment) demonstrated downregulation of
key cell cycle, vascular endothelial growth factor, L-type calcium
channel genes, with upregulation of T-cell receptor and the src-
family kinase (exaggerated inflammatory response).
Conclusions Comparative genomic analyses provide new insights
into septic cardiac pathophysiology.
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Introduction  Cardiac dysfunction is one of the key features in
sepsis and septic shock, yet its mechanism is poorly understood.
We aimed to investigate the pathophysiology of cardiac dys-
function in sepsis by integrating echocardiographic with
biochemical and inflammatory markers.
Methods  Over 14 months, 127 consecutive, septic/systemic
inflammatory response syndrome (SIRS) patients in our ICU were
collected. All patients underwent transthoracic echocardiography
with measurements of systolic and diastolic function, and blood
samples were collected and serum separated for measurements of
biomarkers. All clinical parameters were collected from the ICU
charts during the days of echocardiography studies and blood
sampling. Outcome measures were ICU, inhospital survival and
survival up to 2 years. Patients with segmental wall motion
abnormality – indicating myocardial infarction or regional ischemia
and/or significant mitral or aortic disease – were excluded from the
analyses.
Results Out of 86 patients without regional myocardial dysfunction
and/or significant valvular disease, 36 (42%) died during follow-up,
almost all of them within the first 6 months. Thirty-one (36%)
patients had positive blood cultures and they were more
tachycardic and hypotensive and had shorter E-wave deceleration
time than SIRS (negative culture) patients (P = 0.024). The
echocardiographic measurements most predictive of mortality by
Cox survival analysis were E-wave/Em ratio (Exp(β) = 1.12,
P = 0.006) and pressure gradient over the tricuspid valve (Exp(β)=
1.04,  P <0.0001). Among the biomarkers, N-terminal pro-brain
natriuretic peptide (NT-proBNP), and IL-18 were the strongest
predictors of mortality (P = 0.004 and P <0.001). Troponin and
NT-proBNP best correlated with higher E-wave/Em ratio, and
lower Em and Sm waves and with the cytokines TNFα and IL-8.
The left ventricular end-diastolic volume, left ventricular end-
systolic volume or left ventricular ejection fraction  did not predict
survival and did not correlate with troponin or NT-proBNP
elevation.
Conclusions  After exclusion of all patients with coronary artery
disease and/or significant valvular dysfunction, there is still a
significant incidence of troponin and NT-proBNP elevation in
septic/SIRS patients. Echocardiographic features most signifi-
cantly associated with troponin and NT-proBNP elevation were
measures of diastolic dysfunction (high E-wave/Em ratio, low Sm
and Em). Measures of systolic dysfunction did not correlate with
troponin or NT-proBNP elevation.
Available online http://ccforum.com/supplements/13/S1
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RVUs, relative volume units.
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Introduction Osmotically acting amino acids, such as glutamine,
can be cytoprotective following injury in vitro and  in vivo. As
threonine (THR) can also induce cell-swelling, the aim of this study
was to investigate the potential for THR to induce cellular
protection in intestinal epithelial-18 cells and to elucidate the
mechanism by which it may work.
Methods Cells were treated for 15 minutes with increasing doses
of THR up to 20 mM, with/without subsequent heat stress (HS)
injury. Cell survival was evaluated via MTS assay 24 hours
following lethal HS (44°C x 50 min). All HS groups were
normalized to their non-HS controls. Western blot analysis was
used to determine active caspase-3 activity (an indicator of
apoptosis), and heat shock protein 25 (HSP25) expression/cellular
localization in cells subjected to non-lethal HS (43°C x 45 min).
Enhanced nuclear translocation of HSP25 has been linked to
decreased apoptosis. Microscopy was used to visualize cell size
and morphology since cytoplasmic HSP25 has been shown to
enhance actin stabilization during cellular stress.
Results THR increased cell survival in a dose-dependent manner
(P = 0.008 vs. HS controls (CT)), n = 3. A control amino acid
cocktail (20 mM valine, alanine and phenylalanine) failed to provide
protection from lethal heat stress. Active caspase-3 activity was
highest in HS cells and decreased with THR (P = 0.0006 vs. HS
CT). HSP25 was predominantly cytoplasmic in non-HS cells and
increased in a dose-dependent manner with THR (P = 0.0006 vs.
CT). HS caused nuclear translocation of HSP25, and this effect
was increased even further with THR treatment (P <0.05 vs. HS
CT). Microscopy showed preserved cell size and structural
integrity of the actin cytoskeleton in HS cells treated with THR.
Cell size decreased during HS by 40 ± 5% (P = 0.003 vs. non-HS
controls). These effects were completely attenuated with THR
treatment (P = 0.00001 vs. HS CT).
Conclusions THR protected cells from lethal HS by decreasing
apoptosis. THR can induce HSP25 in CT cells, and enhance
nuclear translocation in HS cells. THR treatment preserved the
structural integrity of the actin cytoskeleton and prevented cellular
crenation during HS. It is possible that THR’s mechanism of
cellular protection involves cytoskeletal stabilization and decreased
apoptosis-mediated by HSP25.
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Introduction Risk stratification is a major problem in the care of
critically ill patients. To date, there is no widespread acceptance of
any prognostic marker for ongoing risk stratification. In the present
study we aim to determine whether N-terminal pro-brain natriuretic
peptide (NT-pro-BNP) serves as a marker of dynamic risk
stratification.
Methods This prospective observational study was performed in
the ICU of the Department of Cardiology/Medical University of
Vienna between August 2004 and June 2007. Adult patients with
a length of ICU stay ≥48 hours were included. In addition to routine
clinical and laboratory assessment, blood samples for deter-
mination of NT-pro-BNP were obtained in all patients on admission
(NT-pro-BNP-0h) and after 48 hours (NT-pro-BNP-48h). NT-pro-
BNP plasma levels were assessed by use of commercially available
kits.
Results  Out of 286 patients included (196 male (68.5%), age
64 ± 14 years), there were 226 ICU survivors (79%). ICU survivors
had significantly lower NT-pro-BNP-0h as well as NT-pro-BNP-48h
levels compared with ICU nonsurvivors (7,063 ± 9,183 vs.
15,254 ± 12,850 pg/ml, P <0.0001, NT-pro-BNP-0h; and 8,304 ±
9,147 vs. 17,302 ± 12,687 pg/ml, P <0.0001, NT-pro-BNP-48h,
respectively). There was no statistically significant change in NT-
pro-BNP levels in ICU survivors compared with ICU nonsurvivors
(Δ-NT-pro-BNP 1,240 ± 7,814 vs. 2,047 ± 11,081 pg/ml, P =
0.624), but significantly more ICU survivors had a decrease in NT-
pro-BNP within 48 hours (37% vs. 33%, P  <0.0001). In Cox
regression models, NT-pro-BNP-0h, NT-pro-BNP-48h and
increase/decrease of NT-pro-BNP were independent predictors of
ICU mortality within 28 days, with NT-pro-BNP-48h being the most
potent parameter (NT-pro-BNP-0h Wald 11.289, P = 0.001; NT-
pro-BNP-48h Wald 17.630, P <0.001; increase/decrease Wald
4.992, P = 0.025, respectively). The area under the receiver opera-
ting characteristic curve with respect to prediction of ICU survival
was 0.714 (P <0.0001) for NT-pro-BNP-0h, 0.713 (P <0.0001)
for NT-pro-BNP-48h and 0.489 (P = 0.800) for Δ-NT-pro-BNP.
Conclusions  NT-pro-BNP reflects not only the severity of the
disease on ICU admission, but – more importantly – the plasticity
of NT-pro-BNP monitors the severity of the disease during the ICU
stay.
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Introduction Endothelin-1 is known to be elevated in patients with
various pulmonary and nonpulmonary diagnoses. CT-pro-endo-
thelin-1 (CT-pro-ET-1) is a stable precursor molecule of endothelin-
1. In the present study we tested whether CT-pro-ET-1 is elevated
in critically ill patients admitted to the ICU with respiratory failure.
Moreover, we tested whether an elevation of CT-pro-ET-1 is a
predictor of an adverse outcome.
Methods In this prospective observational study we included 78
patients with documented respiratory failure on ICU admission and
266 patients with various other diagnoses and without respiratory
failure. Blood samples for determination of CT-pro-ET-1 were
obtained in all patients on ICU admission. CT-pro-ET-1 was
determined by use of a new sandwich immunoassay.
Results Respiratory failure was attributed to a primary pulmonary
cause in 66 patients: chronic obstructive pulmonary disease
(n = 15), pulmonary hypertension (n = 7), pneumonia (n = 17),
acute respiratory distress (n = 3), pulmonary embolism (n = 6),
postoperative respiratory failure (n = 12) and various/mixed causes
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(n = 6). A total of 12 patients had respiratory failure because of
primary cardiogenic edema. Patients presenting with primary
pulmonary failure on ICU admission had significantly higher
CT-pro-ET-1 levels compared with patients with diagnosis of
cardiogenic pulmonary edema and patients without respiratory
failure (193 ± 117 vs. 160 ± 67 vs. 148 ± 94 pmol/l, P = 0.007).
In patients with primary pulmonary failure and in patients with
cardiogenic edema, there was no statistically significant difference
in CT-pro-ET-1 levels between ICU survivors and ICU nonsurvivors
(195 ± 155 vs. 191 ± 127 pmol/l, P = 0.908 and 160 ± 75 vs.
164 ± 5 pmol/l, P = 0.940). In contrast, in the mixed cohort of
critically ill patients without respiratory failure, CT-pro-ET-1 levels
were statistically significantly lower in ICU survivors compared with
ICU nonsurvivors (140 ± 93 vs. 179 ± 95 pmol/l, P = 0.007).
Conclusions CT-pro-ET-1 plasma levels are increased in patients
admitted to the ICU because of respiratory failure. Elevated plasma
levels of CT-pro-ET-1 are a potent marker of adverse outcome in
our mixed cohort of critically ill patients. In the subgroup of patients
admitted to the ICU because of respiratory failure due to a primary
pulmonary cause or due to cardiogenic edema, however, elevation
of CT-pro-ET-1 did not provide statistically significant prognostic
information.
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Introduction Trauma cases who have altered consciousness are
candidates for missed injury of the abdomen. A specific marker of
severe abdominal trauma would therefore be considered useful for
rapid evaluation and treatment of abdominal injuries in trauma
cases. On the other hand, high-mobility group box-1 protein
(HMGB1) has been widely studied in relation to its role in sepsis
and inflammation [1,2].
Methods We measured the serum HMGB1 concentrations in 50
consecutive trauma patients as early as possible after they arrived
in the emergency room. All cases with an abbreviated injury scale
over 3 were enrolled in the study. The correlations between the
serum HMGB1 levels and the body region of injury were examined.
Then, a comparative evaluation of the injury severity score, revised
trauma score and probability of survival was conducted in the
patients with and without elevated serum HMGB1 concentrations.
In addition, we measured the serum HMGB1 levels in 45 septic
shock patients and the relationship between the HMGB1 level and
underlying disease.
Results There were no significant correlations between the serum
HMGB-1 levels and the presence of severe head, chest or
extremity injury. On the other hand, the serum HMGB1 levels were
significantly higher in the subject group with severe abdominal
injury (mean HMGB-1 level, 16.9 ng/ml; 10 cases) as compared
with that in the subject group without severe abdominal injury
(mean HMGB-1 level, 2.2 ng/ml; 40 cases) (P = 0.0069). In septic
shock patients, the serum HMGB1 levels were significantly higher
in the subject group with peritonitis (mean HMGB-1 level,
19.1 ng/ml; 22 cases) as compared with that in the subject group
without peritonitis (mean HMGB-1 level, 8.8 ng/ml; 23 cases)
(P = 0.0447).
Conclusions According to our data, high serum levels of HMGB1
were not correlated with an increased likelihood of head injury,
chest injury or extremity injury, but were significantly correlated with
the presence of severe abdominal injury. This result suggests the
possibility of the serum HMGB-1 level representing a specific
marker of severe abdominal injury.
References
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Introduction  The conventional sepsis diagnosis, using the
cultivation technique, needs 24 hours for bacterial identification
and 36 hours for fungal. The use of empiric therapy makes the
growth of bacteria and fungi slower or may yield negative findings
in many cases of septic shock. The molecular technique can
contribute to a more rapid and specific diagnosis in septic patients.
SeptiFast detects 26 bacterial and fungal species DNAs, using the
PCR in real time and giving results after 6 hours. This is important
for de-escalation therapy and beginning of appropriate antibiotic
treatment. The aim of this study is to evaluate the sensibility and
the specificity of the SeptiFast test versus traditional diagnosis.
Methods We enrolled 16 patients admitted to the ICU in the past
6 months with surgical severe sepsis and septic shock. All patients
were treated with empiric antibiotics at the time of testing. Fungal
and bacterial DNA was detected by the LightCycler SeptiFast. We
compared the results of molecular diagnosis with the cultivation
technique (BACTEC 9050) and microbiological blood culture
Results The preliminary results are presented in Table 1.
Table 1 (abstract P376)
Comparison of results
BACTEC SeptiFast
Coagulase-negative staphylococci 7 6
Acinetobacter baumanii 34
Klebsiella 34
Pseudomonas aeruginosa 23
Enterococcus faecalis 88
Stenotrophomonas maltophilia 11
Conclusions  The results of BACTEC and SeptiFast were the
same in 12/16 (75%) patients. In 3/16 (18%) patients the
SeptiFast test showed a positive result, not detected by BACTEC.
In only 1/16 (6%) we found a positivity in BACTEC, and negativity
in SeptiFast. This result was probably due to contamination of
samples for BACTEC. SeptiFast is a valuable add-on to the
traditional gold standard with cultivation methods, also during
antimicrobial treatment. This study represents a limited assessment
of the PCR’s performance. To properly assess the clinical value of
this technique, a prospective study with a larger population could
be useful.
Available online http://ccforum.com/supplements/13/S1S154
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Introduction Differential diagnosis of systemic inflammation versus
sepsis is based primarily on clinical criteria and laboratory tests
that lack the required sensitivity and specificity. This dilemma holds
true for medical as well as surgical patients, for example after
bypass surgery or autoimmune disease. Both populations are
characterized by the presence of signs of systemic inflammation or
by increased risk for nosocomial infection and, thus, reflect patient
populations at risk for sepsis with significant diagnostic
uncertainty. Novel and robust biomarkers are urgently needed to
correctly and timely identify infection as the underlying cause of a
systemic host response because each hour of delay of anti-
infectious therapy leads to increased mortality.
Methods We analyzed the clinical utility of a new class of trans-
criptomic biomarkers derived from circulating leukocytes. Prospec-
tively collected whole blood samples from 460 patients admitted to
the operative ICU were included in a microarray/quantitative PCR
study to identify sensitive and specific biomarkers. The
identification of a signature specific for the discrimination between
systemic inflammatory response syndrome and sepsis in patients
suffering from shock and organ dysfunction was performed in
independent training and test phases. The training set of 96
patients was selected by an independent ICU committee.
Results An algorithm was established combining and transforming
the gene-expression signals into a continuous, nondimensional
score indicating either infectious or noninfectious causes for organ
dysfunction. The resulting classificator was validated in a test set
comprising 1,784 ICU-days of 364 patients. For each marker, a
robust quantitative PCR assay was established. The final
microarray signature could be transferred into a multiplex quanti-
tative PCR format retaining full sensitivity and specificity with time
to result of approximately 5 hours. Moreover, it could be
demonstrated that the combination of seven biomarkers possesses
the same accuracy compared with the complete biomarker set.
The AUC in the test group was determined as 0.79 (procalcitonin
0.65, C-reactive protein 0.67).
Conclusions With its high predictive value for the differentiation
between infectious and none infectious causes of shock and organ
dysfunction, this new class of biomarkers may help to identify
patients with life-threatening infections among patients at risk and
to guide therapy, for example with anti-infective agents.
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Introduction Sepsis in the early stage is a common disease in
emergency medicine, and rapid diagnosis is essential. The aim of
our monocentric observational study (characterization of patients
with sepsis in the emergency department) was to compare
pathogen diagnosis by blood cultures (BC) and PCR.
Methods  Two (aerobic and anaerobic) BC and blood for PCR
testing were taken from the patients immediately after admission,
before initiating antibiotic therapy. For PCR testing we used the
LightCycler SeptiFast (Roche Diagnostics, Basel, Switzerland),
which enables rapid diagnosis of the 20 most important sepsis-
pathogens. SeptiFast test kits were provided free of charge.
Results We analyzed 95 patients with suspected severe infection.
Thirty-four patients (35.8%) had a PCT value ≥2 ng/ml and were
classified as septic. In septic and nonseptic patients, age (63.8 ±
17.7 vs. 62.9 ± 7.4 years, P  = NS) and male sex (60.3% vs.
64.1%, P = NS) were comparable. Thirty-five patients (36.8% of
total and 44.1% of septic) had positive BC, and 32 patients
(33.7% of total and 52.9% of septic) had positive PCR tests.
Septic patients showed significantly more positive PCR results
than nonseptic patients (P <0.01). No difference was found for
BC. PCR showed an accordance of 84.4% to BC. In 11.4% of
patients BC was positive and PCR was negative (agent not in PCR
recognition spectrum, n = 2 (Micrococcus luteus); agent in the
PCR spectrum, but not found, n = 6 (Streptococcus spp. and
coagulase-negative  Staphylococcus spp.); different pathogens
identified by PCR and BC, n = 3). In seven patients (7.3%) with
negative BC, additional, mostly Gram-negative bacteria were found
by PCR. The PCR-positive in comparison with PCR-negative
patients had significantly higher values for procalcitonin (17.3 ±
26.4 vs. 13.8 ± 57.2 ng/ml, P <0.01), IL-6 (4,220 ± 14,385 vs.
626 ± 1,666 pg/ml, P <0.01) and APACHE II score (19.1 ± 9.1
vs. 14.6 ± 8.8, P <0.05) and Sequential Organ Failure Assess-
ment score (4.5 ± 3.4 vs. 2.9 ± 2.6, P <0.05). For BC-positive
patients a difference was found only for Sequential Organ Failure
Assessment score (4.0 ± 3.0 vs. 2.9 ± 2.6, P <0.05).
Conclusions In septic patients in the emergency department, PCR
identifies pathogens in about 50%. A positive PCR correlates with
sepsis severity as well as the inflammatory response of the host.
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Introduction  Infectious complications in immunocompromised
patients and critically ill patients represent a serious clinical
problem. In these individuals, not only common nosocomial agents
but also very unusual pathogens, pathogens with specific cultiva-
tion demands or fastidious pathogens can be identified. Timely
information on the causative agents is highly important for rapid
and accurate clinical decision-making and targeted pharmaco-
therapy.
Methods Patients fulfilling the criteria for sepsis, severe sepsis and
septic shock, as well as patients with hematological malignancies,
patients undergoing chemotherapy, and transplant and post-
transplant patients were included in our cohort. We developed a
system employing pathogen-specific probes and real-time PCR
technology to detect the 25 most frequent human pathogens
causing severe nosocomial infections and five fastidious
pathogens causing pulmonary infections. Each sample has also
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been tested using a pan-bacterial and pan-fungal broad-range
PCR system coupled with direct sequencing of PCR products for
precise identification of the causative agents.
Results  We have investigated 548 clinical samples (peripheral
blood 236 samples, bronchoalveolar lavage (BAL) 186 samples,
cerebrospinal fluid 32 samples, sputum 29 samples, aspirate from
thorax cavity 19 samples, drainage fluids 12 samples, abscesses
11 samples, urine 10 samples, tissue 13 samples). In addition to
common pathogens we have identified a set of unusual and
fastidious pathogens: Chlamydiophilla pneumoniae (BAL), Myco-
plasma pneumoniae (BAL),  Peptostreptococcus micros (thorax
cavity),  Fusobacterium nucleatum,  Listeria monocytogenes and
Porphyromonas endodontalis (cerebrospinal fluid), Candidatus
Neoehrlichia mikurensis (peripheral blood), Mycobacterium
tuberculosis (tissue, cerebrospinal fluid), Aspergillus flavus (tissue,
sputum),  Malassezia pachydermatis (tissue), and Cryptococcus
carnescens (BAL).
Conclusions  A pathogen-specific real-time PCR technique
coupled with direct pan-bacterial and pan-fungal sequencing
represents a very fast and useful tool to accelerate and refine the
diagnostics of infections in critically ill patients.
P380
Microalbuminuria: a biomarker of sepsis
S Basu1, M Bhattacharya1, A Majumdar1, T Chatterjee2, S Todi1
1AMRI Hospitals, Kolkata, India; 2Jadavpur University, Kolkata, India
Critical Care 2009, 13(Suppl 1):P380 (doi: 10.1186/cc7544)
Introduction Assessment of microalbuminuria as a diagnostic tool
in predicting sepsis in the critically ill patient.
Methods A prospective observational study in a 20-bed ICU in a
tertiary-care hospital. Microalbuminuria estimated as the spot urine
albumin–creatinine ratio (ACR, mg/g) was measured on ICU
admission (ACR1) and after 24 hours (ACR2). A total of 242
patients were recruited for the study between January 2007 and
May 2008. Patients with an ICU stay of less than 24 hours,
pregnancy, menstruation, anuria, hematuria, urinary tract infection,
and proteinuria due to renal and postrenal structural diseases were
excluded.
Results Patients with sepsis (n = 95) had a significantly higher
median ACR1 (145.8 (IQR 46 to 305)) and ACR2 (104.3 (IQR 33
to 179)) in comparison with those without sepsis (n = 147)
(ACR1 = 56.6 (IQR 27 to 111) and ACR2 = 37.8 (IQR 18 to 93))
(P < 0.0001) (Figure 1). In a receiver operating characteristic
curve analysis, ACR1 emerged as the most reliable indicator of
sepsis (area under curve (AUC) of ACR1 = 0.710 >AUC of
ACR2 = 0.694). ACR1 concentration of 145.7 mg/g had sensi-
tivity of 50.5% and specificity of 87.1% with positive predictive
value of 71.6% and negative predictive value of 73.1% in
diagnosis of sepsis.
Conclusions Absence of significant microalbuminuria at the time
of ICU admission is unlikely to be associated with sepsis.
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Introduction Endotoxin (ET) is a structural molecule of the Gram-
negative bacilli extracellular membrane, which activates target cells
including macrophages and neutrophils, and causes septic shock.
But it is known that the conventional ET measurement method has
many problems; for example, a discrepancy between plasma ET
concentration and clinical manifestation in the septic patient. We
therefore evaluate the usefulness of a new developed method to
measure the plasma ET activity (endotoxin activity assay (EAA)) [1]
in patients under sepsis compared with the ordinary method of the
limulus amebocyte lysate (LAL) assay.
Methods  With institutional approval and informed consent, we
measured the EAA in 40 patients (aged 63.5 ± 17.7 years)
admitted to the ICU. The EAA was measured using a chemi-
luminometer (Autolumat LB953; EG & G. Berthold). Patients were
divided to five categories: (1) control group, (2) systemic inflam-
matory response syndrome (SIRS) group, (3) sepsis (SIRS and
infection) group, (4) severe sepsis group, and (5) septic shock
group. We then compared the EAA level between each group and
control group. We made the statistical evaluation by unpaired t test
and a significant difference was P <0.05.
Results  The EAA levels were significantly increased as sepsis
severity rises. The measured EAA levels were (0.18 ± 0.09),
(0.33 ± 0.19), (0.39 ± 0.16), (0.65 ± 0.25) and (0.78 ± 0.34) in
control, SIRS, sepsis, severe sepsis and septic shock groups,
respectively. In the LAL method, four of the severe sepsis group
and two of the septic shock group exceeded the cutoff value. In
the EAA level, severe patients had a tendency to exceed the cutoff
value. There was no significant correlation between the EAA level
and ET density.
Conclusions This newly developed method named EAA measures
ET using anti-lipopolysaccharide monoclonal antibody. Our trial
suggests this method can evaluate the severity of sepsis correctly
compared with the usual method of measuring ET.
Reference
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Introduction  The PROWESS study and later trials of activated
protein C (APC) treatment in sepsis have shown only modest
reductions in mortality. A recent Cochrane systematic review
(CD004388) records doubtful efficacy and serious adverse
effects. To optimize the benefit/risk ratio of APC treatment of each
patient, a biomarker of protein C (PC) activation is urgently
needed, and the use of such a marker, APC–protein C inhibitor
(PCI), has been investigated in the present study.
Methods  APC–PCI was measured in acid citrate plasma by
means of a newly developed sandwich ELISA (median normal
value 0.13 ng/ml, range 0.07 to 0.26, n = 16). Levels of APC–PCI
and PC were monitored (daily to alternate days) in 135
consecutive critically ill patients, 53 of whom had sepsis during the
observation period. The state of PC activation to APC was
categorized as nonactivated (APC–PCI <0.25 ng/ml), moderately
activated (APC–PCI = 0.25 to 0.72 ng/ml) or highly activated
(APC–PCI >0.72 ng/ml), based on maximum APC–PCI values in
relation to the normal range.
Results  The maximum APC–PCI values ranged from 0.03 to
29 ng/ml, median 0.44 ng/ml. The overall mortality of the 53 sepsis
patients was 32% (17/53). The mortality in the PC activation
groups was significantly different (P = 0.032, chi-square test):
nonactivated 44% (7/16), moderately activated 13% (3/23) and
highly activated 50% (7/14). A bell-shaped mortality relationship
was noted, with high mortalities in both the nonactivated and highly
activated groups, and a much lower mortality in the moderately
activated group. Subdividing the PC activation groups according
to APACHE II score yielded the highest mortality, 71% (5/7), in the
nonactivated subgroup with APACHE II ≥25, whereas the
APACHE II score showed no relationship with mortality in the other
PC activation groups. Minimum PC levels did not correlate with
APC–PCI and showed no significant differences between the
activation groups.
Conclusions  Nonactivation of PC in sepsis may represent the
failure of an appropriate protective response and is therefore
associated with increased mortality, especially when the APACHE
II score is elevated. Septic patients without PC activation and a
high APACHE II score may be those who are most likely to benefit
from APC treatment. PC measurements were not predictive of PC
activation as indicated by APC–PCI levels.
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Introduction As a stress hormone, arginine vasopressin (AVP) is
significantly increased in acute hemodynamic instability. AVP is
released in response to osmotic and haemodynamic changes
aiming to maintain fluid volume and vascular tone. Copeptin is a
stable fragment of pre-pro-vasopressin that is synthesised and
released in equimolar quantities as AVP. Unlike AVP, copeptin is
highly stable ex vivo. We aimed to test the prognostic potency of
an elevation of copeptin in patients with cardiogenic shock.
Methods  In this prospective observational study we included
consecutive patients with cardiogenic shock admitted to the ICU
of the Department of Cardiology/Medical University of Vienna
between November 2004 and March 2006. In all patients, blood
samples for determination of routine laboratory tests and N-
terminal pro-brain natriuretic peptide (NT-pro-BNP) and copeptin
plasma levels were obtained on admission. Copeptin was
assessed using an immunoassay in the chemiluminescence/coated
tube format. Copeptin, NT-pro-BNP, age, gender, presence of
acute renal failure and mechanical ventilation were analysed for
prediction of ICU survival.
Results  We included 91 consecutive patients (66 male (72%),
age 66.5 ± 11.4 years) with diagnosis of cardiogenic shock on
ICU admission. All patients required intravenous inotropic support,
19 patients (21%) were treated with an intraaortic balloon counter-
pulsation and nine patients (9%) were on extracorporeal circulatory
support (eight patients (8%) had an extracorporeal membrane
oxygenation, one patient (1%) was on novacor support). Fifty-six
patients (62%) survived and 35 patients (38%) died. Copeptin
plasma levels were significantly higher in ICU nonsurvivors than in
ICU survivors (164.4 ± 117.8 vs. 248.2 ± 256.6 pg/ml, P = 0.034).
In a logistic regression model, copeptin was the best predictor of
ICU survival, with only NT-pro-BNP providing independent
additional information (copeptin OR = 1.002; P = 0.001 and
NT-pro-BNP OR = 1.001; P = 0.05).
Conclusions Elevated plasma levels of copeptin are a strong and
independent predictor of adverse outcome in patients with
cardiogenic shock.
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Introduction Early diagnosis of sepsis is crucial for management
and outcome of critically ill patients. The use of clinical parameters,
white cell count or body temperature proved far from ideal in
identifying patients who need antimicrobial therapy. The lack of a
sensible and specific marker of infection may be responsible for
delaying or prolonging antibiotic use [1]. The aims of this work
were to test the predictive ability of the serial monitoring of IL-6,
procalcitonin (PCT), and C-reactive protein (CRP) to stratify the
different levels of sepsis and to assess whether their measurement
could add to the therapeutic decision-making process during long-
term ICU stay.
Methods In a prospective observational study we studied the time
course of inflammatory markers in consecutive cases of long-term
critical illness in the general ICU of a university hospital. Daily sera
were subsequently analyzed for CRP, PCT and IL-6 (only in the last
16 patients) in all patients with length of stay >6 days.
Results We enrolled 26 patients, for a total of 592 days. In seven
patients that never experienced severe sepsis/septic shock CRP,
PCT and IL-6 levels decreased over time, the 14 who recovered
had a reduction of markers, while no variation was found in five
patients expired in sepsis. One hundred and ninety-eight days
classified as severe sepsis/septic shock had CRP (72.1 (43.4 to
127.8 IQR) vs. 90.8 (46.8 to 213.9)), PCT (0.19 (0.09 to 0.49) vs.
1.9 (0.49 to 4.92)) and IL-6 (83.90 (57.25 to 133.85) vs. 199.18
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(105.51 to 289.27)) higher than 394 SIRS/sepsis days, P <0.001.
Prediction of severe sepsis/septic shock (receiver operating
characteristic area) was 0.59 ± 0.03 for CRP, 0.82 ± 0.02 for PCT
and 0.76 ± 0.03 for IL-6 (P <0.001). Forty-four antibiotic courses
were recorded; the initial value of markers was higher than the last
day, and mean course values were higher than those without
antibiotics. Adopting 0.25 ng/ml as the PCT cutoff value between
infection expected to be treated with antibiotics and inflammation
without the need for antibiotic therapy, inappropriate antibiotic
treatment was given on 202/592 days.
Conclusions Daily measure of PCT, at variance of CRP or IL-6, is
accurate in discriminating a day spent in severe sepsis/septic
shock. An antimicrobial therapy policy based only on clinical
diagnosis proved ineffective, with 34% of inappropriate days that
could have been saved using a PCT-guided antibiotic strategy.
Reference
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Introduction A procalcitonin (PCT) algorithm was demonstrated to
reduce antibiotic exposure in patients with lower respiratory tract
infections (LRTI) in several randomised controlled trials. Data on
the efficacy of PCT-guided antibiotic stewardship in real life and
outside study conditions are lacking.
Methods  We prospectively monitored antibiotic therapy and
adherence to the published PCT algorithm in consecutive
hospitalized patients with LRTI admitted to the Kantonsspital Aarau
(Switzerland), a former ProHOSP study hospital [1], between April
and November 2008.
Results Median age of the 130 included patients (36% females)
was 70 (IQR 57 to 82) years. Community-acquired pneumonia
was diagnosed in 78%, while 17% had acute and 5% had
exacerbation of chronic bronchitis. Mortality rate was 11.5% and
6.9% of patients needed ICU admission. In 70% of patients
(n = 91), antibiotics were administered or withheld according to
the PCT algorithm. In the 39 patients (30%) where the PCT
algorithm was overruled, the main reasons were severe
immunosuppression (30%), high-risk LRTI (13%), other infections
(8%) and clinical judgement of the treating physician (33%).
Overall, the median duration of antibiotic therapy was 6 days (IQR
1 to 10), 4 days (IQR 0 to 7) when the PCT algorithm was
followed and 10 days (IQR 8 to 14) when it was overruled,
respectively. In patients with community-acquired pneumonia,
median days on antibiotic therapy was 7 days (IQR 4 to 10), which
was similar to the PCT group in a trial in the same institution
(P = 0.44) [1].
Conclusions  The present study mirrors the use of PCT-guided
antibiotic therapy in clinical practice and outside trial conditions.
Antibiotic exposure, however, strongly depends on the adherence
to a clinical PCT algorithm.
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Introduction  In previous smaller trials, a procalcitonin algorithm
reduced antibiotic use in patients with lower respiratory tract
infections. However, the feasibility and safety of this approach in a
multicenter setting has not been demonstrated.
Methods  We enrolled 1,359 consecutive patients with lower
respiratory tract infections admitted to emergency departments of
six tertiary-care hospitals in Switzerland. Patients were randomized
to administration of antibiotics based on a procalcitonin algorithm
with predefined cutoff ranges for initiating or stopping antibiotics
(procalcitonin group) or according to standard guidelines (control
group). Procalcitonin was measured locally in each hospital and
instructions were web-based. The primary endpoint of this
noninferiority trial was the composite adverse outcome of death,
ICU admission, disease-specific complications or recurrent infec-
tion requiring antibiotic treatment within 30 days.
Results The rate of overall adverse outcomes was similar in the
procalcitonin and the control group (15.5% vs. 18.9%; difference
–3.4%, 95% CI = –7.5% to 0.5%). In the procalcitonin group,
antibiotic exposure (that is, number of days on antibiotics per
patient) was significantly lower as compared with the control group
overall (34.8% reduction, P <0.001), and in subgroups of patients
with community-acquired pneumonia (n = 925, 32.4% reduction),
exacerbation of chronic obstructive pulmonary disease (n = 228,
50.4% reduction) and acute bronchitis (n = 151, 65.0%
reduction). Antibiotic-associated side effects were less frequent in
the procalcitonin group as compared with the control group
(19.8% vs. 28.1%; P <0.001).
Conclusions In this multicenter setting, without increasing the rate
of adverse outcomes, procalcitonin guidance markedly reduced
antibiotic exposure and antibiotic-associated side effects in
patients with lower respiratory tract infections.
ClinicalTrials.gov identifier NCT00350987.
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Introduction Procalcitonin (PCT) is routinely used as a specific
marker of severe bacterial infections and sepsis. The highly
sensitive method of PCT measurement allows using PCT as a
Available online http://ccforum.com/supplements/13/S1S158
marker of local bacterial infections. By this method, the normal
value of PCT is defined as <0.25 ng/ml – but according to some
publications PCT <0.1 ng/ml is a more reliable cutoff point to
reject diagnosis of local bacterial infection. Some patients after
major surgery have nonspecific signs of infection (for example,
fever, leukocytosis) that is usually discussed as true infection and
antibiotic therapy (ABT) is provided. We tried to optimize ABT in
patients undergoing cardiac surgery with cardiopulmonary bypass
using PCT.
Methods  Sixty-six patients aged from 2 days to 72 years (39
adults, 27 children) with nonspecific signs of infection without its
focus were studied. Seventy-six PCT tests from blood plasma were
made (PCT sensitive LIA; BRAHMS, Germany) to decide whether
ABT is sufficient or antibiotics should be prescribed/changed/
discontinued.
Results Based on PCT testing results we have made following
decisions (see Figure 1). As Figure 1 shows, when PCT was
<0.1 ng/ml antibiotics were discontinued or not prescribed in 61%
of cases. In 30% of cases we prolonged ABT for several days.
Only in 9% cases were antibiotics changed. In patients who had
PCT of 0.1 to 0.25 ng/ml we tended to continue or change ABT
(77%). If elevated PCT levels (>0.25 ng/ml) were detected, we
prescribed (20%) or reinforced (73%) ABT in the majority of
cases. In total we discontinued or did not prescribe antibiotics in
31/76 cases (41%) taking into consideration the results of PCT
testing. We did not register progression of bacterial infection in
those cases with the exception of one 10-month patient with mild
exacerbation of bronchitis.
Conclusions There is a big need to optimize ABT in postoperative
period in cardiac surgery patients due to significant overuse of
antibiotics. PCT-guided tactics are safe and allowed reduction of
unnecessary antibiotic usage in patients with nonspecific signs of
infection. At the same time, supernormal PCT levels are a strong
indicator to prescribe or change ABT.
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Introduction  Procalcitonin (PCT) is a marker of sepsis and the
levels correlate with the severity of illness.
Methods  A prospective, observational study conducted in the
medical surgical intensive therapy unit of a tertiary-care centre in
India. Three hundred critically ill adult patients with suspected
sepsis during any time of the intensive therapy unit stay in whom
PCT was estimated were included in the study. PCT was assessed
by quantitative immunoluminometric assay. The demographics of
the study population, and APACHE II and APACHE IV scores were
recorded.
Results Demographic character of the study population was as
follows: median age 61 years, male:female ratio 174:126, median
APACHE II and APACHE IV scores 17 and 59, respectively, and
medical:surgical patients 265:35. See Table 1 and Figure 1 for
receiver operating characteristic analysis.
Conclusions PCT is a reliable marker for prognostication with a
high negative predictive value and comparable with APACHE
prediction models.
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Figure 1 (abstract P387)
Figure 1 (abstract P388)
Receiver operating characteristic analysis of APACHE II, APACHE IV
and PCT.
Table 1 (abstract P388)
Comparison between APACHE II, APACHE IV and PCT
APACHE II APACHE IV PCT
Area under the curve 0.66 0.693 0.63
Cutoff value 17 57.5 0.93
Sensitivity 64 71.6 73.6
Specificity 62.4 57.4 57.6
Positive predictive value 41.95 41.41 41.84
Negative predictive value 80.33 82.78 84.04S159
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Introduction It has been suggested that plasma C-reactive protein
(CRP) levels measured on discharge from the ICU may be a useful
predictor of either unplanned readmission or unexpected death on
the ward. Previous work has found that raised plasma CRP
independently predicted, in separate studies, each of these two
poor outcomes [1,2]. We investigated whether these results could
be repeated in our mixed medical/surgical ICU for a composite
poor outcome measure combining death and readmission.
Methods We prospectively enrolled a cohort comprised of all ICU
admissions over 1 year. We collected admission clinical and
demographic data and APACHE II scores. At discharge we
recorded the white cell count and serum levels of CRP and
albumin, and we observed death and readmission outcomes up to
2 weeks after ICU discharge. This time period was chosen on the
grounds that an association between discharge CRP and
postdischarge outcome should relate to persisting inflammatory
activity and would be of most relevance in the short term.
Results Of 1,487 admissions to our ICU, 181 (12.2%) resulted in
the patient’s death on the ICU and 110 (7.4%) ended with either
the patient’s discharge to another hospital or ICU and thus their
loss to follow up. Eleven patients discharged for palliation were
excluded from analysis. A total of 1,185 (79.7%) were discharged
to a ward in the hospital and so could potentially have suffered an
unexpected deterioration resulting in ICU readmission or death. Of
these, 117 (9.9%) of the discharge episodes were followed by an
unexpected poor outcome of either readmission (n = 83, 7.0%) or
death (n=34, 2.9%) within 2 weeks. A composite outcome
measure combining these two poor outcomes was associated with
age, higher APACHE II score, and a low plasma albumin on ICU
discharge. Means and median values were compared using
P <0.05 as the test of significance. Plasma CRP on discharge from
the ICU was not associated with this composite measure.
Conclusions In a mixed medical/surgical ICU, CRP on the day of
discharge is not associated with a poor outcome measure of
unexpected readmission or ward death.
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Introduction  Neonates are recommended smaller doses of
morphine than adults and, accordingly, we hypothesised that the
distribution of morphine and its metabolites over the blood–brain
barrier differs between these age groups. In addition, neonatal
asphyxia, with potentially harmful effects on the brain, in theory,
might further affect the pharmacokinetics of substances over the
blood–brain barrier.
Methods During anaesthesia, microdialysis probes were inserted
into the brain cortex and in a central vein of 11 exteriorized near-
term lambs (127 gestation days) and six nonpregnant adult sheep.
Five of these lambs were subjected to 10 minutes of asphyxia
through umbilical cord occlusion during delivery. Morphine,
1 mg/kg, was thereafter intravenously administered as a 10 minute
constant infusion. Microdialysis and blood samples were collected
for up to 360 minutes after morphine administration, and analyzed
using liquid chromatography followed by tandem mass
spectrometry. Data presented as the mean ± SD.
Results The morphine unbound drug brain:blood distribution ratio
(Kp,uu) was 1.19 ± 0.20 and 1.89 ± 0.51 for the sheep and
premature lambs without asphyxia, respectively (P = 0.018). The
half-lives in the blood and brain cortex, clearance, volume of
distribution, and distribution in the brain of unbound drug were all
numerically significantly higher in the adult sheep as compared
with the premature lambs. The morphine-3-glucuronide Kp,uu values
were 0.27 ± 0.16 and 0.17 ± 0.15 in sheep and premature lambs
(P = NS), indicating a net efflux from the brain in both groups.
Induced asphyxia did not affect the results.
Conclusions The morphine Kp,uu was above unity, indicating a net
influx of morphine into the brain. In addition, influx was significantly
higher in premature lambs than in adult sheep. We interpret this as
an active transport of morphine into the brain, which may be
counteracted with increased efflux with age. Further, neonatal
asphyxia did not change these pharmacokinetic findings. The Kp,uu
in the sheep was different from the values obtained in humans
(0.64), rats (0.49), mice (0.5) and pigs (0.47), where a net efflux of
morphine from the brain was observed.
Available online http://ccforum.com/supplements/13/S1S160
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Introduction  Decreased intestinal microcirculatory blood flow
(MBF) is an important contributor to perioperative morbidity.
Epidural anesthesia (EA) may improve intestinal MBF [1] but other
researchers found that EA decreases cardiac output (CO) and
thus compromises intestinal MBF [2]. We tested whether EA plus
intravenous colloids result in increased intestinal MBF compared
with colloid administration alone.
Methods Twenty pigs (30 ± 2.5 kg) were anesthetized and venti-
lated. A laparotomy was performed for instrumentation and a colon
anastomosis. After baseline measurements the animals were randomly
assigned to one of the following treatments: Group HES, hydroxyethyl
starch (130/0.4) was given to maintain SvO2 ≥60%; Group EA, in
addition to the same colloid treatment an epidural catheter was
inserted at the lumbar level and after a bolus of 4 ml ropivacain 0.2%,
7 ml/hour were continuously administered. The CO and MBF in the
mucosa of the jejunum, colon and anastomosis were measured.
Results  In both groups the CO and MBF increased similarly
(Table 1). No difference in the circulatory parameters between the
two groups was found. However, in Group EA significantly more
fluids (56%) were administered to achieve SvO2 ≥60%.
Table 1 (abstract P393)
Comparison of the treatment groups
Group HES Group EA
HES (ml) 831 ± 94 1296 ± 81*
Mean arterial pressure (%) 130 ± 3 124 ± 6 
CO (%) 143 ± 7 143 ± 6
MBF jejunum 145 ± 8 107 ± 8
MBF colon 133 ± 6 130 ± 3
MBF anastomosis 166 ± 27 150 ± 17
Data presented as percentage ± SEM of baseline unless otherwise stated.
*P <0.01 compared with group CO.
Conclusions The present study did not show any positive effects
of epidural anesthesia on intestinal microcirculatory blood flow. On
the contrary, over 50% more fluids were needed to maintain similar
perfusion parameters than with fluids alone. Such a fluid load as
needed in the epidural group may potentially be harmful.
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Introduction The aim of this study was to undertake a randomized
trial between lumbar continuous epidural analgesia and continuous
femoral blockade in adults undergoing major knee surgery,
including comparison of analgesic efficacy [1], side effects, patient
satisfaction and rehabilitation indices [2].
Methods We studied 91 patients in 2 years that were randomized
into two groups: epidural group (EG) 40 and femoral group (FG)
51. All patients received spinal anesthesia with 1 ml of 1% bupiva-
caine without a narcotic. The EG received a 5 ml/hour continuous
infusion in elastomeric pump with 0.125% bupivacaine and
morphine 20 μg/ml. The FG received a 5 ml/hour continuous infu-
sion in an elastomeric pump with 0.125% bupivacaine and
tramadol 1 mg/kg/day + ketorolac 30 mg intravenously x 3.
Results No statistically significant difference was noted between
the two groups about pain scores (VAS at rest and on movement),
nausea, vomiting, arterial hypotension, morphine consumption,
headache, pruritus, patient satisfaction and rehabilitation indices
(active knee flexion). A statistically significant difference was noted
between the two groups about contralateral analgesia, urinary
retention that required bladder catheterization and motor block
with major incidence in the EG.
Conclusions  Continuous femoral blockade represents the best
balance between analgesia and side effects as a choice of
postoperative analgesic technique for major knee surgery,
especially as the risk of injury to the neuraxis is negligible. Overall,
however, we believe that there is no sufficient evidence that lumbar
epidural analgesia should not be used routinely.
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Introduction Volatile anaesthetics using the anesthetic conserving
device (ACD) have become an alternative ICU sedation regimen
[1,2]. The purpose of this study was to evaluate postconditioning
effects following sevoflurane or propofol administration in patients
after elective cardiac surgery.
Methods  Fifty patients either received sevoflurane via ACD or
propofol for ICU sedation. The primary endpoint was a change in
troponine T (TNT), besides measures of myocardial creatine kinase
(CK-MB), N-terminal pro brain natriuretic peptide (NT-proBNP) and
haemodynamics. Measure points were set at baseline, end of
surgery, 24 hours and 48 hours after surgery.
Results  TNT and CK-MB levels were significantly higher
(P <0.0001) at all measure points compared with baseline in each
group, without any significant differences between both groups.
NT-proBNP values were significantly lower following sevoflurane at
24 and 48 hours (P <0.05) compared with propofol (Figure 1).
Conclusions Postoperative sevoflurane sedation via ACD led to
lower NT-proBNP levels at 24 and 48 hours, while TNT and CK-
MB values were comparable in both study groups.
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Introduction Daily interruption of continuous infusions of sedatives
(wake-up calls (WC)) has been found previously to promote more
rapid withdrawal of ventilatory support in ICU patients. Bispectral
index (BIS) monitoring has been reported to adequately describe
the depth of sedation in critically ill patients. We compared the
effectiveness and safety of both sedation strategies in a mixed
medical–surgical ICU population.
Methods Patients expected to need sedation for at least 1 day
were randomly assigned to a WC strategy, sedation guided by
BIS, or a control group. Clinical assessment of the sedation depth,
the Ramsay score, was performed in all three groups. Primary
outcome: ICU length of stay (LOS); secondary outcomes: duration
of mechanical ventilation, accidental removal of indwelling devices,
ICU readmission rate, hospital LOS, 90-day mortality, and stressful
events (interview at ICU exit and after 3 months).
Results In four ICUs, three academic and one teaching hospital, a
total number of 617 patients was randomized; 205 to the WC
strategy, 202 to sedation guided by BIS, and 210 to the control
group. The study groups were well balanced according to baseline
characteristics. Neither ICU LOS (median (IQR) 11 (6 to 21)
(WC), 12 (7 to 23) (BIS), and 11 (6 to 24) days (control),
P = 0.67) nor duration of mechanical ventilation (median 165 (0 to
581) (WC), 158 (3 to 590) (BIS), and 163 (5 to 385) hours
control,  P = 0.97) were different between groups. Accidental
removal of indwelling devices was encountered 37 times (10 times
in nine patients (WC), six times in five patients (BIS), and 21 times
in 11 patients (control), P = 0.01). The ICU readmission rate,
hospital LOS, and 90-day mortality were not different between
groups. Interviews showed similar stress experiences.
Conclusions  Although a significant higher number of incidents
with indwelling devices occurred in the control group, no additional
differences between the three sedation regimens were revealed.
Although current guidelines on ICU sedation have incorporated
WC next to clinical sedation scales, the results from this larger
study do not promote either WC or BIS in guiding sedation of ICU
patients.
P397
Safety and length of different sedations for endoscopic
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Introduction Endoscopic procedures have improved thanks to the
fact that they are performed currently under sedation. We describe
a series of endoscopic studies, sedated by the Intensive Care
Department. Different sedation protocols are described, empha-
sizing some patients sedated with ketamine plus midazolam, drugs
rarely reported for adults.
Methods  Patients older than 18 years, whose performed
endoscopic, colonoscopic or both procedures under sedation
were performed by the Intensive Care Department of the Hospital
del Tajo. Data were collected for 6 months. Demographic
characteristics, medical history, American Society of Anesthes-
iology classification, drugs bolus and total dosages, respiratory and
hemodynamic data, the length of procedure and recovery, and
complications were collected. Tolerance was assessed by an
endoscopist, with a 1 (very bad) to 5 (very good) scale. Different
indices of two groups of treatment were compared, propofol-
fentanyl (Group A) versus ketamine-midazolam (Group B) using
the chi-square test and the Student t test.
Results In total, 245 procedures were included. The procedures
were 168 (66.6%) colonoscopies, 34 (13.9%) endoscopies and
43 (17.6%) both procedures together. Tolerance: 33.5% were 5;
58.8% were 4; 4.5% were 3; 0.8% were 2. There were 72
(29.39%) complications, the most common hypotension being 22
(8.98%) and respiratory depression 12 (4.9%). Length of
procedure was 31.20 minutes (SD = 15.53) and recovery time
was 64.86 minutes (SD = 37.56). Comparing Group A versus
Group B, hypotension (12.67% vs. 2.9%, P = 0.023) and respira-
tory depression (6.67% vs. 0%, P = 0.03) were more frequent with
Group A. Group B presented a higher percentage of vomiting (0%
vs. 5.8%, P = 0.009) and hallucinations (0% vs. 11.59%,
P < 0.001). The length of recovery was longer for Group B
(61.12 min vs. 78.98 min, P = 0.008).
Conclusions Sedation for endoscopic procedures performed by
intensivists is safe and well tolerated for most patients, with a
similar percentage of complications compared with previous
reports. Ketamine plus midazolam are safe and could be useful for
short-length sedation in patients with a high risk of respiratory
depression.
Available online http://ccforum.com/supplements/13/S1
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sedation in cardiac ICU patients
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Introduction Sedation is an integral part of the management of
patients requiring mechanical ventilation in the ICU. At present,
sedation is usually managed by clinical assessments, often in
conjunction with a protocol for adjusting drug doses. This
approach has been shown to decrease ventilation times and is
considered the best practice in recent guidelines [1]. Such scales,
however, provide only intermittent and, to some extent, subjective
information about the patient’s state. Also, not every scale used in
clinical practice is validated for ICU use and interobserver variation
may occur.
Methods We have developed a novel method that analyzes the
patterns in the electromyographic (EMG) component of the frontal
biopotential signal that are associated with activation and arousal
processes. By quantifying the amount and magnitude of the
response patterns in the past 60 minutes, a responsiveness index
(RI) ranging between 0 and 100 (0 corresponds to a
nonresponsive patient and 100 to a high amount of responses) is
derived. Previously, we have compared the RI with EEG spectral
entropy [2] in general ICU patients. Now we have studied the
performance of the RI with 17 cardiac ICU patients and compared
these with the development dataset analyzed by Viertiö-Oja and
colleagues [2]. A subgroup of 17 patients (of total 30 patients)
with a clinically assessed low probability of encephalopathy was
used as the primary development data. The patients in both
datasets were consenting adult ICU patients with non-neurologic
primary ICU diagnosis. A modified Ramsay score was used as a
reference of the sedation level.
Results The performance of the RI in reference to the Ramsay
scores was analyzed by computing the prediction probability (PK).
The development and test data contained 213 and 96 eligible
Ramsay assessments, respectively. The PK for separating deep
sedation levels 4 to 6 from levels 1 to 3 was 0.91 (0.03) in the
development data and 0.96 (0.02) in the test data. For separating
all Ramsay levels, the PK values in the development data and test
data were 0.82 (0.02) and 0.89 (0.02), respectively.
Conclusions These results showed good RI performance in the
cardiac ICU data. The RI continues to show promise as an
indicator of the level of sedation in ICU patients.
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Introduction Noninvasive ventilation (NIV) and sedation protocols
during invasive mechanical ventilation (IMV) can both separately
reduce the duration of mechanical ventilation in ICU patients.
However, no study has shown the impact of these two concepts
when associated.
Methods  All consecutive patients admitted to a 14-bed
medical–surgical ICU were retrospectively studied from 2000 to
2006 after implementation of NIV (2000 to 2001) and sedation
protocols (2003 to 2004). The duration of mechanical ventilation
shown by categories was analyzed using a chi-square test.
Results During the 7 years of the study, 2,839 admissions were
performed in 2,511 patients (59 ± 17 years, women 36%, medical
admission 43%, Simplified Acute Physiology Score II 38 ± 17,
mortality in the ICU 17%). The incidence and duration of IMV
significantly decreased during the study (P <0.001) (Figure 1). The
NIV use progressively increased during the study period, both in
medical and surgical patients.
Conclusions  These results showed that the implementation of
sedation protocols for intubated patients added to the imple-
mentation of NIV decreased moreover the duration of IMV.
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Does choice of sedative agent affect duration of ICU stay,
mortality or neurological outcome in patients undergoing
therapeutic hypothermia?
M Gillies, R Pratt, J Borg, J Brooks, C Mckenzie, S Tibby
Guy’s & St Thomas’ NHS Foundation Trust, London, UK
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Introduction  The effect of therapeutic hypothermia on sedative
drug clearance and neurological prognostication is unknown.
Hypothermia has been shown to affect clearance of drugs
metabolised by the cytochrome p450 system (fentanyl, midazolam
and muscle relaxants) [1]. We undertook a retrospective study to
ascertain whether the use of remifentanil sedation was associated
with reduced duration of ICU stay, ventilation, mortality or neuro-
logical outcome compared with fentanyl in patients undergoing
therapeutic hypothermia.
Methods  Data were collected on all patients undergoing thera-
peutic hypothermia in a 2.5-year period using the Carevue ICU
Database (Phillips) and case-note review. All patients received
propofol and either remifentanil or fentanyl as sedation. Patient
demographic data included age, weight, sex, APACHE II, time to
return of spontaneous circulation and arrest type. Measured
outcomes were ICU-free days, ventilator-free days, ICU mortality,
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hospital mortality and neurological outcome at hospital discharge.
Good neurological outcome was classified as Pittsburgh Cerebral
Performance Criteria grade 1 to 2 at hospital discharge [2].
Predictive models used multivariable logistic regression.
Results  Eighty-three patients received therapeutic hypothermia
(crude ICU mortality 43%, median APACHE II score 18); of which
54 received fentanyl sedation and 29 remifentanil. In the
multivariable models, remifentanyl was not associated with ICU
(P = 0.35) or hospital (P = 0.22) mortality or good neurological
outcome (P = 0.75). However, remifentanyl was associated with a
positive trend towards an increase in both ventilator-free and ICU-
free days (both P = 0.08).
Conclusions  Use of remifentanil was not associated with a
reduction in ICU or hospital mortality, nor with good neurological
outcome. However, there was a trend to increased ventilator-free
and ICU-free days. This effect needs to be confirmed prospectively
with a larger dataset. Caution must be exercised regarding the
effect of delayed sedative drug metabolism on neurological
assessment in patients who have undergone therapeutic
hypothermia, especially drugs metabolised by the cytochrome
p450 system.
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Introduction  Pinhole gated single photon emission computed
tomography (SPECT) and transthoracic echocardiography (TTE)
are easier, more time sparing and much more animal friendly in the
assessment of the left ventricular (LV) function in rats compared
with the techniques used in the past. Where the aim of previous
studies was to determine the cardiac function under different
anaesthetics in an extracorporeal model, the aim of our study is to
find the ideal anaesthetic for the assessment of the cardiac
function in the rat.
Methods  Two different studies were performed using pinhole
gated SPECT and TTE in male Wistar rats. For the TTE study 32
rats were randomised to four groups and were anaesthetized with
two different products with a washout period of 3 days. A linear
probe was used for assessing M-mode images and LV volumes
(ml) were calculated using an ellipsoid model 10 minutes after
administration of anaesthesia. Pentobarbital (50 mg/kg) intra-
peritoneally, propofol (200 mg/kg) intraperitoneally, midazolam
(70 mg/kg) intraperitoneally, isoflurane (2%), sevoflurane (2%) or
desflurane (7%) were the anaesthetics studied. For the pinhole
gated SPECT study, 48 rats were scanned two times with a
1-week interval: once under pentobarbital (60 mg/kg intraperito-
neally) anesthesia for the control study, and a second time using
the same anesthetics as the TTE study. Pinhole gated SPECT was
performed 1 hour after intravenous injection of 330 MBq 99mTc-
MIBI. Parameters of cardiac function were derived using
quantitative gated SPECT.
Results Augmented ejection fractions were observed for midazolam
compared with all other anaesthetics (85% in the SPECT study and
91% in the TTE study). Anterior wall thickening was remarkably
augmented: 84 ± 9% compared with propofol 51 ± 12% (P <0.001)
and pentobarbital 64 ± 23 (P  = 0.03) in the TTE study, but no
difference was observed in the inferior thickening. In the SPECT
study, augmented wall thickening was observed in the lateral, inferior,
septal and anterior region (all P<0.001) compared with pentobarbital.
Conclusions Anaesthetic agents seem to play a role in regional
contractile function, affecting global LV function. Previous studies
demonstrate conflicting results concerning the effect of midazolam
on cardiac function. Both of our studies suggest that, at the given
dose, midazolam has a positive inotropic effect.
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versus dexmedetomidine–midazolam
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Introduction Dexmedetomidine has been described as having a
positive cerebral hemodynamic effect by reducing the cerebral
blood flow/cerebral metabolic index ratio (CBF/CMI ratio) and
improving CFB self-regulation; however, no data are available on
how this actually modifies brain metabolism.
Methods We performed a multicenter, prospective, randomized,
active comparator (dexmedetomidine–propofol or dexmedeto-
midine–midazolam) study. We included consecutive adult patients
(>18 years old) admitted to ICUs with hemorrhagic stroke and
moderate or severe brain edema (measured directly at surgery or
by CT scan) who needed sedation for at least 72 hours after
randomization. We excluded patients with mild brain edema,
contraindications to the use of sedatives and those who could not
have a jugular venous line placed. Randomized groups received
sedation using dexmedetomidine + midazolam (Group 1) or dex-
medetomidine + propofol (Group 2). We obtained basal measure-
ment of several variables indirectly related to cerebral metabolism
(jugular venous O2 saturation – SvjO2, jugular arteriovenous O2
difference – Da-vjO2, cerebral oxygen extraction – CEO2,
estimated cerebral metabolic rate – ECMRO2) and repeated these
measurements after 72 hours. Statistical analysis was performed
using chi-square and proportions for categorical variables, and the
median, standard deviation and Student t  test for continuous
variables. We considered P ≤0.05 significant.
Results  Twenty-eight consecutive patients were included (15
male), average age 61.2 ± 8.6 years, presenting with moderate
brain edema (5/28, 17.9%) or severe brain edema (23/28,
82.1%). Both randomized groups had 14 patients. We found no
difference between groups in SvjO2 (P = 0.49 basal, P = 0.19 at
72 hours), Da-vjO2 (P = 0.68 basal, P = 0.67 at 72 hours), CEO2
(P = 0.49 basal, P = 0.19 at 72 hours), or ECMRO2 (P = 0.34
basal, P = 0.50 at 72 hours).
Conclusions  No significant differences in the measured brain
metabolism variables were found among the two groups. We
suggest comparing these two groups versus a placebo group in
another study.
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Introduction We evaluated the potential benefits of adding mag-
nesium sulphate (MgSO4) to ketamine (K) in a patient controlled
analgesia (PCA) model with tramadol (T) on postoperative pain
and cognitive function in major abdominal surgery.
Methods  Twenty-four abdominal open surgery patients were
included in a double-blind, randomized study. After extubation a
PCA pump with T was placed to promote optimal analgesia. In the
first group K was added (0.5 mg/ml) to the pump (Gk, n = 6), in
the second group it was MgSO4 (0.03 mg/ml) (Gm, n = 6), in the
third group MgSO4 was adjunct to K (Gm-k, n = 6) and in the last
group NaCl 0.9% was added and served as the control group (Gc,
n = 6). Consumption of T and the cognition (using the Mini-Mental
State of Examination (MMSE) [1]) were evaluated at the end of
hospitalisation in the ICU. For statistical analysis, a Shapiro–Wilk
test, Wilcox text and Student t test were used.
Results K and MgSO4, separately added to T, did not improve
significantly its global consumption, demonstrating comparable
postoperative pain scales between groups (P  = 0.08). MgSO4
coupled with K (Gm-k) improved postoperative pain compared with
Gc (P  <0.05). This combination reduced the mean global T
consumption by 15% (±5% SD) during the first 24 hours and by
25% (±8% SD) during the second day of pump infusion compared
with the other groups (P <0.02). K and MgSO4 did not modify
cognitive functioning compared with the control group (mean
MMSE scoring: >28 ± 2, SD) (P = 0.1).
Conclusions  Adding a low dose of K or MgSO4 to T in post-
operative major abdominal surgery did not improve analgesia but
the combination of both had a statistical sparing effect on T
consumption. Magnesium plays a determinant role, by interacting
in the glutaminergic pathways, on the K effect. Cognitive deter-
minants in ICU patients are not modified by a low dose of K.
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Introduction  Little is known about the potential hemodynamic
benefits of continuous ketamine sedation and analgesia in adult
ICU patients.
Methods  In a pilot multicenter, prospective, double-blind,
randomized control trial, we screened 66 adult ICU patients who
required sedation and analgesia. Patients meeting entry criteria
were randomized to continuous infusion of ketamine (study) or
fentanyl (control) for >24 hours to achieve a Ramsay Sedation
Scale of 4. We recorded lung compliance and airway resistance.
Sixty percent of patients (3/5) received ketamine with low-dose
midazolam for 24 hours followed by midazolam only and 40% (2/5)
received fentanyl. We measured dynamic compliance and airway
resistance for both groups before sedative infusion and every
4 hours thereafter.
Results  There was a statistically significant increase in the
dynamic compliance in the study group compared with the control
group (P <0.05). There was a statistically significant decrease in
the airway resistance in the study group compared with the control
group (Figure 1).
Conclusions This preliminary report illustrates the possible value
of ketamine for continuous ICU sedation and analgesia.
P405
Etomidate versus ketamine for rapid sequence intubation
in acutely ill patients: a multicenter randomized controlled
trial
P Jabre1, X Combes1, A Ricard-Hibon2, P Mirat3, JF Cibien4, 
C Bourzeix5, M Dahouadi6, F Adnet7
1Mondor Hospital, Créteil, France; 2Beaujon Hospital, Clichy,
France; 3Necker Hospital, Paris, France; 4Montauban Hospital,
Montauban, France; 5Nancy Hospital, Nancy, France; 6Nimes
Hospital, Nimes, France; 7Avicenne Hospital, Bobigny, France
Critical Care 2009, 13(Suppl 1):P405 (doi: 10.1186/cc7569)
Introduction  Critically ill patients often require emergency
intubation with administration of etomidate as the sedative agent.
The use of etomidate has been challenged as it causes a reversible
adrenal insufficiency probably leading to an increase in hospital
morbidity.
Methods In this prospective, randomized, controlled, single-blind
trial, we assigned 234 patients to receive 0.3 mg/kg etomidate and
235 patients to receive 2 mg/kg ketamine for intubation. The
primary endpoint was the maximum value of the Sequential Organ
Failure Assessment score (SOFAmax) during the first inhospital
3 days. (ClinicalTrials.gov number, NCT00440102.)
Results The mean SOFAmax score between the two groups was
not significantly different (10.3 ± 3.7 for etomidate vs. 9.6 ± 3.9 for
ketamine; P = 0.056). There was no significant difference in 28-
day mortality (81 (35%) deaths vs. 72 (31%) deaths, P = 0.36),
the number of patients needing catecholamine (137 (59%) patients
vs. 120 (51%) patients, P  = 0.10), median (IQR) ventilator-free
days (12 (0 to 25) days vs. 15 (0 to 26) days, P = 0.36) and
median (IQR) hospital-free days (4 (0 to 22) days vs. 6 (0 to 23)
days, P = 0.57). Adrenal insufficiency incidence was significantly
higher in etomidate than ketamine group (86% vs. 48%, P <0.001).
There was no significant difference between the two groups in
intubation conditions. There was no significant difference in
outcome between the etomidate and ketamine groups on
prespecified subgroup analysis (trauma or sepsis patients).
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Conclusions  Our results do not provide evidence for contra-
indicating etomidate during emergency intubation in critically ill
patients. However, ketamine can constitute a good alternative.
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Introduction  Ultra-rapid opioid detoxification (UROD) as a new
technique for abstinence is in progress. While diarrhea and
vomiting are two frequent withdrawal symptoms, clonidine can
effectively suppress such complications. This study aimed to
investigate the effects of clonidine (oral) on diarrhea and vomiting
during and after UROD.
Methods A double-blind randomized clinical trial was conducted in
Farabi Hospital in Kermanshah, in the west of Iran. We assigned
88 patients to three groups: C1 (0.2 mg) = 29, C2 (0.4 mg) = 29
and C3 (1 mg) = 30 patients. Clonidine was gavaged to patients
after general anesthesia. After that, patients were monitored for
diarrhea and vomiting during (4 to 5 hours) and after (12 hours)
UROD. They were matched with respect to the type of drug
abused and its route of administration.
Results Three groups were comparable in terms of demographic
characteristics and use of treatments except for use of different
doses of propofol and midazolam. The most commonly misused
drug was crack (19.3%). While there was no statistically differ-
ences between three groups in terms of development of diarrhea
during UROD, the greater proportion of patients in group C1
(31.0%) developed diarrhea after UROD (P = 0.001). Three
groups were comparable in terms of developing vomiting either
during or after UROD. Compared with group C2 (1,248 ± 226.4)
and C3 (1,100 ± 232.3), the mean dosage of propofol was larger
among group C1 (1,336.2 ± 248.9) (P = 0.001). Such results
were similarly seen with midazolam (P = 0.04).
Conclusions Consistent with some other reports [1], this study
showed that the use of larger dose of clonidine can effectively
decrease the incidence of diarrhea after UROD. It can also
decrease the need for larger doses of hypnotic and sedative drugs.
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Introduction  Paracetamol (PCM) is a drug with analgesic and
antipyretic properties. Despite its frequent use, little is known
about its efficacy and pharmacokinetics (PK) when intravenously
administered in the critically ill patient. A previous study suggests
that therapeutic concentrations are not always reached [1]. The
primary aim of this open-label, multiple-dose study was to evaluate
intravenous PCM therapy in critically ill, secondary aim was to
study the PK of intravenous PCM.
Methods Ventilated patients needing PCM treatment according to
our ICU protocol (1 g PCM intravenously four times daily) were
eligible for inclusion. Excluded were those with severe liver failure
and those treated with PCM on the time of admission to the ICU.
Blood samples were collected at 0, 30, 60, 180 and 300 minutes
after the first and, if possible, the fifth and 21st doses. A
computerized model was used to estimate population PK.
Results Nineteen patients were included of which 13 were male,
with a mean APACHE IV score of 94.8. No antipyretic effect could
be measured in any of the patients. PK parameters have been
calculated for all patients after the first PCM dose. The half-life was
2.2 hours, the volume of distribution was 1.03 l/kg, and the
clearance was 0.33 l/kg/hour. Data from 15 patients could be
analysed after the fifth dose and from five patients after the 21st
dose. The PK of intravenous PCM in our population show a
biphasic profile (Figure 1). One hour after the dose, the mean
serum concentration level was below the therapeutic level. In 18
out of 19 patients serum concentration dropped below 5 mg/ml
before the next dose, resulting in a lack of build-up of a suitable
therapeutic level of PCM after multiple dosages.
Conclusions The recommended dose of 1 g intravenous PCM four
times daily is not sufficient to achieve a therapeutic effect in critically
ill patients. This can be explained by the low serum levels reached.
These results warrant the development of an adequate dosing
scheme for intravenous PCM followed by a large clinical trial
studying the effects and safety of this regimen in critically ill patients.
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Introduction  The development of delirium within the ICU and
postoperatively is an important problem in the ICU, and it has
previously been associated with an increased hospital mortality.
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Methods  The preoperative risk of cardiac or respiratory events
was scored using the revised cardiac risk index (RCRI) and the
preoperative respiratory failure index (PRFI) in 403 patients. The
outcome measure of delirium was included with those of cardiac
and respiratory events
Results Of the 403 noncardiac surgical patients, 50 were cared
for in the ICU and 353 were cared for in a high-intensity bed or a
surgical ward bed postoperatively. Delirium occurred in 10 (20%)
patients admitted into the ICU versus 15 (4.2%) of those admitted
to the surgical wards (P  <0.001). Independent predictors of
developing delirium included the patient’s age, the PRFI, and
assignment to the ICU a priori. The RCRI was not an independent
predictor of delirium. (See Table 1.)
Conclusions  In a cohort of patients undergoing high-risk
noncardiac surgery, age, PRFI, and assignment to the ICU a priori
predicted the development of delirium.
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Introduction Delirium is a common complication in the ICU. The
attention of researchers has shifted from the treatment to the
prevention of the syndrome, necessitating the study of associated
risk factors.
Methods  In a multicenter study of one university hospital, two
community hospitals and one private hospital, newly admitted adult
patients were included when reaching a Glasgow coma scale
greater than 10. Nurse researchers assessed the patients for
delirium using the NEECHAM confusion scale. Risk factors were
split into four groups: patient characteristics, chronic pathology,
acute illness and environmental factors. Odds ratios were
calculated using univariate binary logistic regression.
Results  A total population of 508 patients was screened for
delirium. The 36 studied factors showed some variability according
to the participating hospitals. The overall delirium incidence was
29%. For patient characteristics, age was not a significant factor.
Intensive smoking (OR = 2.04) and living singly at home (OR =
1.94), however, contributed to the development of delirium. In the
group of chronic pathology, a pre-existing cognitive impairment
seemed important as a risk factor (OR = 2.41). In the group of
factors related to acute illness, the use of drains, tubes and
catheters, acute illness scores, the use of psychoactive
medication, a complete sedation or coma and a preceding period
of mechanical ventilation showed significant ORs ranging from
1.04 to 13.66. Environmental risk factors were noise, induced by a
high number of alarms (OR = 5.37), isolation (OR = 3.81), the
absence of visit (OR = 2.83), the absence of visible daylight (OR =
1.80), a bed in a shared ICU room (OR = 1.70), a transfer from
another ward or hospital (OR = 3.01) and admittance through the
emergency room (OR = 2.19).
Conclusions The present multicenter study indicated four groups
of risk factors for delirium in the ICU. Particularly among those
related to the acute illness and the environment, several factors are
suitable for preventive action.
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Introduction  Delirium is a frequent problem in the ICU and is
associated with a poor prognosis. Delirium in the ICU seems to be
underdiagnosed by nursing and medical staff. Several detection
methods have been developed for use in ICU patients. The aim of
this study was to compare the value of three detection methods
(the Confusion Assessment Method for the ICU (CAM-ICU), the
Intensive Care Delirium Screening Checklist (ICDSC) and the
impression of the ICU physician) with the diagnosis of a
psychiatrist, neurologist or geriatrician.
Methods  All patients were eligible for inclusion. We excluded
deeply sedated patients (Ramsay score greater than 4), comatose
patients (Glasgow coma score less than 8), patients in whom no
informed consent was obtained, patients who did not speak or
understand Dutch or English, or patients who were deaf. Delirium
evaluations were performed by different investigators indepen-
dently and blinded to each other assessments. The CAM-ICU was
used by a trained ICU nurse, the ICDSC was administered by
another ICU nurse, the ICU physician was asked whether a patient
was delirious or not. Further, a psychiatrist, geriatrician, or neuro-
logist serving as reference rater diagnosed delirium using DSM-IV
criteria, based on all available information.
Results During an 8-month period, 126 patients (mean age 62.4,
SD 15.0; mean APACHE II score 20.9, SD 7.5) admitted to a 32-
bed mixed medical and surgical ICU were studied. The CAM-ICU
showed higher sensitivity and negative predictive value (64% and
83%) than the ICDSC (43% and 75%). The ICDSC showed better
specificity and positive predictive value (95% and 82% vs. 88%
and 72%). The sensitivity of the physicians view was only 29%,
with 96% specificity, 75% positive predictive value and 74%
negative predictive value.
Conclusions  The present study shows that the impression of
intensive care physicians is not sensitive enough to identify
delirium. In this investigation in a mixed ICU population, the CAM-
ICU had a higher sensitivity than the ICDSC [1].
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Introduction Sedation agents and opioids present an important
subgroup of medications known to promote delirium. This study
was designed to test the hypothesis that intravenous magnesium
administration reduces the incidence of delirium occurrence by
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Characteristic Odds ratio 95% CI error P value
Intercept 0.00047
PRFI 1.04 1.00 to 1.09 0.02 0.036
Age, per year 1.06 1.01 to 1.12 0.024 0.011
ICU bed allocated 1.80 1.07 to 3.01 0.26 0.027S167
causing less sedative consumption in a mixed population of ICU
patients.
Methods  Sixty-three adult medical and surgical ICU patients
requiring mechanical ventilation were randomized to receive
magnesium (2 g bolus intravenously, continued by 16 g/day infusion,
target range 1.0 to 2.0 mmol/l) or saline. Patients were sedated
with remifentanil and midazolam titrated to achieve the desired
level of sedation measured by the Richmond Agitation and
Sedation Scale (RASS). Those patients achieving a RASS score
of ±1 or 0 were monitored daily for delirium using the Confusion
Assessment Method for the ICU (CAM-ICU). The incidence of
delirium, delirium duration, daily remifentanil and midazolam con-
sumption were compared between groups. Statistical performance
was compared using Mann–Whitney U and chi-square tests.
Results The groups were comparable in terms of age, gender, and
admission APACHE II (17.2 ± 5 vs. 18.5 ± 8) and Sequential
Organ Failure Assessment (4.9 ± 2 vs. 5.6 ± 3) scores. The
incidence of at least one episode of delirium occurrence was 25%
in the magnesium group and 27.3% in the control group. The
magnesium group achieved the desired level of sedation of RASS
score ±1.0 much earlier than the control group and spent more
time within that level of RASS score (68% vs. 36%) Addition of
magnesium resulted in more days without delirium (89% vs. 55%).
There was a reduction in the daily remifentanil and midazolam
consumption in the magnesium group.
Conclusions This is a preliminary report of an ongoing study. Our
results demonstrated that addition of magnesium to the sedation
protocol lowers both the remifentanil and midazolam consumption
and resulted in more days without delirium in a mixed population of
ICU patients.
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Introduction The aim of the study was to identify the causes of
memory dysfunction after brain traumatic injury. Recently, a light
anaesthesia, more than a deep anaesthesia, has been accused of
causing postoperative cognitive dysfunction [1]. Conversely, the
daily sedative interruption in ICU patients does not result in
adverse mental outcome [2]. Patients affected by brain injury can
have severe memory dysfunction after discharge [3].
Methods One hundred and twenty-one patients were admitted to
an emergency department ICU in 2007 with major trauma (injury
severity score >15) and severe to moderate brain injury (Glasgow
coma scale <13). Of these patients, 25 died in the days following
trauma. Thirty-four of them – submitted, during the ICU stay, to
several lengths of sedation (17.2 ± 9.2 days; range 1 to 40) –
were evaluated at the follow-up visit 6 months after discharge from
the ICU. As a part of neurological evaluation, verbal and visuo-
spatial memory tests were administered to the patients to obtain a
diagnosis of memory dysfunction. During the ICU stay, from the
ICU database (FileMaker Pro 5.5v2; FileMaker, Inc.,  Santa Clara,
CA, USA) with authorization of the Careggi Teaching Hospital
Committee of the Emergency Department, the following para-
meters were collected for every patient: age, sex, abbreviated injury
scale, injury severity score, Simplified Acute Physiology Score II, in
the field Glasgow coma scale, Marshall score, worst values of
lactates and ScvO2 within 24 hours from trauma, length of
sedation and ICU stay. The median of each collected parameter in
the group of patients was used as the cutoff value to divide them
into two categories: risk factor for memory dysfunction present or
absent. A two-by-two analysis was carried out and Fisher’s exact
test was used for comparisons. P <0.05 was considered significant.
Results  Memory dysfunction was observed in 15 out of 34
patients. Only Marshall score >2 (8/15 vs. 3/19; P <0.05)
represented a significant risk factor for memory dysfunction.
Conclusions In brain traumatic injury patients the extent of brain
damage, qualified by the Marshall score, is related to late memory
dysfunction regardless of the length of sedation and the severity of
the initial clinical picture.
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Introduction In recent years there has been increasing evidence
that resuscitation strategy with different fluids can have widely
divergent impacts on the immune response. This study was
undertaken to determine the COX-2 and E-selectin expression in
the lung tissue in the swine model during an acute normovolemic
hemodilution (ANH) procedure with hydroxyethyl starch (HES
130/0,4), normal saline solution (NS) or gelatin (GEL).
Methods Twenty-eight pigs were anesthetized, instrumented and
randomized into four groups: control, ANH + HES, ANH + NS and
ANH + GEL. Animals in the ANH group were submitted to ANH to
a target hematocrit of 15% with volume replacement performed
with HES and GEL at a 1:1 ratio and NS at a 3:1 ratio. The
withdrawn blood was returned to the animals 120 minutes after the
end of hemodilution. After euthanasia, the chest cavity was opened
and the lobes of the lung were removed and fixed in 10%
formaldehyde solution. After the histopathological assessment, the
lungs were prepared with antibody anti-COX-2 and E-selectin. The
pathologist, who was blinded to the experimental protocol, scored
the expression of COX-2 and E-selectin by semiquantitatively
evaluating the intensity (absent – 0, weak – 1, moderate – 2 and
strong – 3) and incidence (absent – 0, 10% – 1, 10 to 50% – 2,
50 to 75% – 3 and 75 to 100% – 4) of positively stained endo-
thelium of the interstitial pulmonary microvasculature. The total
index was obtained from the sum of the frequency and the intensity
scores. For the immunohistochemistry score, a nonparametric
Fisher’s test was used.
Results The intravascular leukocytes expression of COX-2 in the
NS group was weak and differed significantly only from the GEL
group (P  <0.05). In contrast, groups HES and GEL showed a
moderate and strong COX-2 expression, respectively, which was
different from the control group (P <0.05, P <0.001, respectively).
Available online http://ccforum.com/supplements/13/S1S168
E-selectin expression in the HES and GEL groups differed
significantly from the control. In the HES and GEL groups, a weak
to moderate expression of E-selectin (P  <0.05, P  <0.001) was
detected in endothelial cells from pulmonary arteries and veins.
Conclusions Fluid replacement during ANH increased inflamma-
tion determined by an increase in COX-2 and E-selectin expression.
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Introduction Transfusions of allogeneic red blood cells (RBC) are
associated with viral and bacterial infections, activation of
inflammatory pathways, transfusion-related acute lung injury and
transfusion-associated circulatory overload. To reduce and prevent
such harmful consequences, a clear indication for transfusion of
RBC is required. However, our clinical experience shows that the
method of assessing hematocrit is of crucial importance when
implementing a strict trigger-dependent transfusion practice with
the aim of preventing unnecessary transfusions, especially in non-
bleeding critically ill patients. The aims of the present study were
therefore to compare two different hematocrit-assessing methods
used in clinical routine and to determine whether the results
obtained by these two methods would influence our RBC
transfusion management.
Methods A total of 50 patients treated on our ICU for at least
5 days in which daily blood counts including hematocrit analysis
were performed were investigated (250 paired samples).
Hematocrit was analyzed using our blood gas analyzer (ABLflex
800) located on our ICU and the routine method used by the
central laboratory (ADVIA® 2120).  Post hoc, patients were
grouped according to the predefined transfusion triggers (24%
and 28%) used on our surgical ICUs for different illnesses.
Results  Bland–Altman analysis for repeated measurements
showed a good correlation with a bias of +1.39% and two
standard deviations were ± 3.12%. The 24% hematocrit group
(n = 30) showed a correlation of r2 = 0.87 and the kappa was
0.56; that is, 22.7% of the cases would have been differently
transfused. In the 28% hematocrit group (n = 20) there was a
correlation of r2 = 0.8 and the kappa was 0.58; that is, 21% of the
cases would have been differently transfused.
Conclusions  Despite a good agreement between the two
methods with which hematocrit is determined in clinical routine, the
calculated difference of 1.4% will substantially influence trans-
fusion practice, resulting in erroneous RBC transfusion in approxi-
mately 21% of our patients. This, in turn, could endanger these
patients. Consequently, the transfusion trigger used in clinical
routine is strongly dependent on the used method of analysis and
must be taken into account.
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Introduction Anemia is common in patients with heart failure, and
the combination of erythopoietin and intravenous iron has been
shown to improve their clinical status. We investigated the effect of
correction of anemia on cardiac function in patients with
congestive heart failure (CHF) with just intravenous iron.
Methods Sixty-four patients with severe CHF (NYHA III or IV), a
left ventricular ejection fraction (EF) ≤35% despite maximally
tolerated doses of CHF medication and whose hemoglobin levels
(Hb) were <12 gr% were randomized into two equal groups:
treatment group (n = 32) receiving iron sucrox complex (200 mg
weekly for 6 weeks), and control group (n = 32) receiving saline.
Patients did not receive erythopoietin throughout the study.
Results See Figure 1.
Conclusions Correction of anemia may be an important addition to
the treatment of CHF. Intravenous iron is a simple therapy that
increases Hb, reduces symptoms and improves EF in anemic
patients with CHF.
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Introduction Transfusion is a common treatment in the pediatric
ICU (PICU). No study has evaluated the clinical effect of length of
storage of red blood cell (RBC) units in children. We undertook an
analysis of a large PICU transfusion database to assess any effect
of RBC length of storage on clinical outcome in children admitted
to a PICU.
Methods  A prospective, observational study conducted in 30
North American PICUs between September 2004 and March
2005 [1]. Data collected on consecutive patients aged <18 years
with a PICU stay >48 hours included length of storage (days) for
transfused RBC units, daily severity of illness score (multiple organ
dysfunction syndrome (MODS)), PICU length of stay, and 28-day
mortality. Data were analyzed in transfused patients with recorded
length of storage according to the oldest RBC unit length of
storage per patient. The primary outcome measure was develop-
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ment of new or progressive MODS after transfusion. The
secondary outcomes analyzed were 28-day mortality and PICU
length of stay. Odds ratios were adjusted for age, number of
MODS at admission and total number of transfusions using a
multiple logistic regression model.
Results From a total of 977 enrolled children, 49% (475) were
transfused with 2,146 transfusion events: 115 (24%) were
transfused once and 360 (76%) had multiple transfusions. The
length of storage was recorded for 1,288 transfusions (60%) with
a median length of storage of 14 days. The recorded length of
storage for at least one RBC unit was known in 329 transfused
patients (69%). For patients receiving blood older than the median
length of storage (>14 days), the adjusted odds ratio for
development of new or progressive MODS was 1.81 (95% CI =
1.03 to 3.18, P <0.01). There were no significant differences in the
total length of PICU stay (adjusted mean difference +0.04 days,
95% CI –0.04 to +0.13) or mortality odds ratios (0.94, 95% CI =
0.33 to 2.54).
Conclusions In children admitted to the PICU, transfusion of RBC
units stored for more than 14 days seems to be associated with a
significantly increased risk of MODS. Further studies are warranted
to ascertain the effect of RBC unit length of storage on outcome in
critically ill children.
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Introduction The World Health Organisation states that it is not a
case of if, but when, the next influenza pandemic strikes. In the
event of a pandemic, intensive care resources are predicted to be
overwhelmed [1]. One means of allocating and maintaining ICU
support is the triage protocol developed by Christian and
colleagues [2] based on the Sequential Organ Failure Assessment
score, comorbidity, and age. This study assesses the efficacy of
the triage criteria on all patients admitted to our 28-bed ICU.
Methods Data required to apply the triage protocol were collected
for consecutive critical care admissions over a 60-day period.
Triage categories were assigned as per the protocol and the out-
come data were collected from the hospital patient data system.
Results Of the 255 admissions, 190 were nonelective. Of these,
the triage category was blue (that is, would have been refused
admission to ICU) on admission for 32, and a further 29 who were
not (that is, were deemed appropriate ICU admissions by the triage
protocol) became blue by 48 hours. Of these 61 patients, 29 were
discharged from hospital alive. For our sample of emergency
admissions, the sensitivity of the triage protocol for correctly
identifying patients at admission who survive to hospital discharge
was 0.87. The corresponding specificity was 0.27.
Conclusions Thirty-two per cent of emergency admissions would
have been denied critical care using the triage protocol, of which
48% survived to hospital discharge. We conclude that the triage
criteria are not fit for purpose: they are neither sensitive nor
specific enough to differentiate survivors from nonsurvivors, and
would still leave clinicians with too many patients for too few beds.
References
1. Menon D, Taylor B, Ridley S: Modelling the impact of an
influenza pandemic on critical care services in England.
Anaesthesia 2005, 60:952-954.
2. Christian MD, Hawryluck L, Wax RS, Cook T, Lazar NM, Her-
ridge MS, et al.: Development of a triage protocol for criti-
cal care during an influenza pandemic. Can Med Assoc J
2006, 175:1377-1381.
P419
Do trauma patients on ventilators in the emergency
department need multiple blood gas analysis to optimize
treatment?
MS Moeng
Johannesburg Hospital, Houton, Johannesburg, South Africa
Critical Care 2009, 13(Suppl 1):P419 (doi: 10.1186/cc7583)
Introduction The importance of adequate ventilatory support after
severe trauma is highly stressed. However, this may lead to a
tendency to hyperventilate trauma patients [1] put on a ventilator in
the emergency department. The aim of this study was to
investigate whether trauma patients on ventilator in the emergency
department are hyperventilated.
Methods A prospective collection of data for trauma patients put
on a ventilator in the emergency department. The questionnaire
included demographic information, indication for ventilation,
analysis on initial and repeat arterial blood gases, and management
changes. Patients were recruited over a period of 6 months from 1
November 2006 to 30 April 2007.
Results Fifty-nine patients were identified, 54 (91.5%) were male
and five (8.5%) were female. Age ranged from 4 to 60 years. The
indication for ventilator treatment was isolated head injury in 28
(47.5%) patients, polytrauma in 13 (22%) patients, polytrauma
with severe head injury in nine (15.3%) patients and isolated
airway and ventilation indication in the remaining nine (15.3%)
patients. Thirty-seven patients had a Glasgow coma scale (GCS)
of 3 to 8, 13 had GCS of 9 to 12, and nine patients had GCS of
13 to 15. The first arterial blood gas was done within 10 minutes of
ventilator treatment in 48 (81%) of the cases, whereas the second
was done within 90 minutes in 41 (69.5%) of the cases. In 23
(39%) patients, pCO2 was less than 30 mmHg on the first gas,
and in 19 (32%) patients on the second gas. Oxygenation was
adequate with levels above 200 mmHg in 40 (68%) of initial and in
47 (80%) of second gases. The most common ventilatory manipula-
tion was a reduction in minute volume after the first gas in 14
(24%). Reduction of inspiratory oxygen was the most common
change after the second gas in 28 (47%). The number of cases that
should have had ventilatory adjustment was reduced from 12 (20%)
after the first arterial blood gas to one (1.7%) after the second.
Conclusions  Although there was a tendency to hyperventilate
patients on ventilators in the emergency department in our
institution, satisfactory ventilation was achieved almost uniformly
after the second blood gas analysis.
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Introduction  We investigated the incidence, determinants, and
consequences of CT scans performed at outlying hospitals on
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patients who met the criteria for immediate transfer to a level I or II
trauma center. Guidelines disseminated through advanced trauma
life support (ATLS) facilitate the movement of patients to the
appropriate level of care, contributing to a 25% reduction in
mortality [1]. Acquisition of CT scans of severely injured patients at
outlying nontrauma hospitals violates those guidelines.
Methods We conducted a retrospective review of trauma patients
transferred from outlying hospitals to UPMC Presbyterian Hospital
between 1 January 2000 and 31 December 2007 who met criteria
for immediate transfer to a level I trauma center (n = 5,707). We
used multivariable random-effect logistic regression to explore the
association between pretransfer CT scanning and mortality.
Secondary outcomes included medical costs attributable to
duplicate CT scanning and the clinical outcomes of duration of
ventilator dependence, ICU length of stay (LOS), and total LOS.
Covariables included patient (age, race, gender, insurance, mecha-
nism of injury, injury severity score (ISS)), provider (ATLS certifi-
cation) and hospital (trauma level designation) characteristics.
Results Of 3,219 patients who received scans prior to leaving the
outlying hospital, 2,411 patients had their scans repeated. In our
analysis, patients with age >80 years or with an ISS >16 had a
higher odds of receiving a scan (OR = 2.23, 95% CI = 1.72 to
2.88; OR = 1.55, 95% CI = 1.31 to 1.83). Patients after a
motorcycle collision, after a penetrating injury, or without insurance
had a lower odds of receiving a CT scan (OR = 0.78, 95% CI =
0.63 to 0.96; OR = 0.15, 95% CI = 0.11 to 0.21; OR = 0.62,
95% CI = 0.53 to 0.73). Acquisition of CT scans prior to transfer
did not improve mortality, ICU LOS, total LOS or duration of
mechanical ventilation. Using the 2008 Medicare physician fee
schedule allowance, we estimated that the duplication of scans
resulted in a cost of $2,091,817.
Conclusions Despite robust evidence supporting the immediate
transfer of severely injured patients, over one-half of the cohort
transferred to UPMC Presbyterian received a CT scan prior to their
transfer. Performance of scans at outlying facilities increased costs
but did not improve outcomes.
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Introduction  Blunt abdominal traumas (BAT) are frequent and
potentially life-threatening events in children. The aim of this study
was to evaluate the initial workup, and to design a score that would
allow ruling out significant intra-abdominal organ injuries.
Methods Data were collected prospectively from 147 consecutive
patients admitted for BAT in a tertiary-care hospital, over a 30-
month period. The statistical significance of various parameters
(trauma mechanism, clinical examination, laboratory tests and
ultrasound findings) was analyzed in relation to intra-abdominal
injuries. To fix the cutoff limits for the various laboratory tests, we
used receiver operating characteristic (ROC) curves. The items
with the highest negative predictive value (NPV) were then
selected, and their respective relative risk was computed. This was
then integrated in a score (named Blunt Abdominal Trauma in
Children (BATiC)), which was tested on our population.
Results  Among the 31 parameters evaluated, 10 differed
significantly between the two groups: abdominal pain, signs of
peritoneal irritation, hemodynamic instability, white blood cell
(WBC) count, lactate dehydrogenase (LDH), alanine aminotrans-
ferase (AST), aspartate aminotransferase (ALT), lipase, creatinine,
and abdominal ultrasound. For the six laboratory examinations,
cutoff limits were determined using the ROC curves: AST >60 IU/l,
ALT >25 IU/l, LDH >330 IU/l, WBC count >9.5 g/l, lipase
>30 IU/l, and creatinine >50 IU/l. Based on their respective relative
risks for abdominal organ injury, the following points were
attributed for these items: abnormal abdominal Doppler ultrasound
(4), abdominal pain (2), peritoneal irritation (2), hemodynamic
instability (2), AST >60 IU/l (2), ALT >25 IU/l (2), WBC count
>9.5 g/l (1), LDH >330 IU/l (1), lipase >30 IU/l (1), creatinine
>50 μg/l (1). A score ≤7 had a NPV of 97%, and included 67% of
the studied population.
Conclusions These results suggest that in hemodynamically stable
patients with a normal abdominal Doppler ultrasound, and a BATiC
score ≤7, intra-abdominal lesions are very unlikely, and systematic
CT scan or hospital admission may be avoided.
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Introduction Damage control is one of the useful strategies for
trauma patients with hemorrhagic shock and critically ill patients
with septic shock. We often perform gauze packing for the first
step of damage control (damage control surgery). We are anxious
about infection of packed gauze, and some experts said that we
should remove the packed gauze within 48 to 72 hours. However,
there is no evidence concerning the relation between duration of
packing and risk of infection of the packed gauze. The aim of this
study is to clarify this relation.
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Duration of packing and bacterial culture of packed gauze.S171
Methods  A prospective observational case-series study. We
performed bacterial culture of the removed gauze in patients who
underwent gauze packing in damage control surgery and removal
of the packed gauze. We examined the relation between the
duration of packing and risk of infection of the packed gauze.
Results  Twenty-one patients were enrolled. The duration of
packing ranged from 19 to 146 hours. Bacterial culture was
negative in 52% of cases and positive in 48% of cases. Bacterial
culture was positive in all cases in whom the duration of packing
was over 100 hours. The duration of packing was longer in positive
bacterial culture cases than in negative (no statistical difference).
More cases were positive in bacterial culture in cases with
gastrointestinal perforation (GIP) than without GIP (no statistical
difference). However, many cases with GIP were obligated to
continued packing for a long duration. There was no relation
between bacterial culture and preoperative and operative bleeding
(Figure 1).
Conclusions Gauze packing in damage control surgery is thought
to be safe within 96 hours from the viewpoint of infection. We
cannot determine the relation between bacterial infection and GIP.
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Introduction Abdominal compartment syndrome (ACS) represents
a potentially life-threatening condition in critically ill patients. The
control of intra-abdominal pressure (IAP) plays a pivotal role in
prevention/treatment of ACS. We compared the efficacy of two
different therapies – open and open-vacuum-assisted closure
(open-VAC) treatment [1] – on resolution of intra-abdominal
hypertension/prevention of ACS.
Methods  We prospectively analyzed data of 26 consecutive
patients admitted to the ICU of our emergency department
(Careggi Teaching Hospital, Florence) with sepsis from an
abdominal source, hemorrhagic shock, and major trauma. All
patients underwent laparotomic surgery before ICU admission with
open-VAC treatment. As a control group we retrospective analyzed
17 patients admitted with the same diagnosis and treated with
open treatment. IAP was evaluated by measuring the urinary
bladder pressure [2]. Patients’ demographic and clinical charac-
teristics, and laboratory parameters were collected from the ICU
database (FileMaker Pro 5.5v2; FileMaker, Inc., USA) with
authorization of the Careggi Teaching Hospital Committee of the
Emergency Department. For each patient, data were collected
before the surgical treatment with a closed abdomen (T1), 6 hours
after ICU admission (T6), after 24 hours (T24), 24 hours after
abdomen closing (T24C), and at monitoring suspension (TMS).
Statistical analysis: Student’s t test (*P <0.05). Data reported as
the mean ± SD.
Results The two groups were similar in demographic and clinical
characteristics. The open-VAC group patients showed a signifi-
cantly shorter length of stay in the ICU (open: 20.58 ± 15.97;
VAC: 11.46 ± 11.99) and had a shorter time before laparotomy
closure (open: 6.82 ± 3.85; VAC: 4.57 ± 2.88) if compared with
the control group. Finally, both IAP values from T1 (open: 17.9 ±
6.41; open-VAC: 15.1 ± 5.68) to T24C (open: 15.7 ± 3.4; open-
VAC: 12.6 ± 2.63) and lactate levels from T1 (open: 6.34 ± 4.65;
open-VAC: 4.1 ± 3.1) to T6 (open: 5.72 ± 5.71; open-VAC:2.62 ±
2.08) and T24 (open: 5.66 ± 5.81; open-VAC: 2.15 ± 2.12) were
significantly lower in a time-dependent manner in the open-VAC
group.
Conclusions  The present study suggests that the open-VAC
could have more beneficial effects than the traditional open
technique in the treatment of patients with intra-abdominal
hypertension/ACS.
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Introduction The aim of this study was to analyze the incidence,
features and consequences of upper gastrointestinal tract bleeding
(UGITB) in patients admitted to an ICU in a 6-year period.
Methods A retrospective observational study in an ICU of a university
hospital. We recorded the UGITB episodes of all admissions (6,245
patients) from January 2001 to December 2007 excluding those in
whom the UGITB motivated the admission, or it occurred within the
first 48 hours. UGITB was defined as: melena and or nasogastric
tube bleed with or without anemia, or anemia with a concomitant
lesion on G-scope. All patients were on UGITB prophylaxis.
Demographic data, APACHE II score, previous medical history and
risk factors for the development of UGITB were recorded. Also the
information regarding G-scope findings, type of treatment received
and consequences of the episode were recorded.
Results  We included a total of 73 patients (1.17%), 46 male
(63%). The average APACHE II score was 22 – global mortality of
49%. The relative incidence distributed for age groups shows
more incidence in the 41 to 50 years group. Six patients were on
oral anticoagulation (8.2%), 14 on platelet anti-aggregation
(19.1%), and one patient on low molecular weight heparin (1.4%).
There were 11 patients with chronic liver disease (15% and 3.3%
of total admissions (TA), three with previous history of UGITB
(4.1% and 1.93% TA), four with peptic ulcer disease (5.5% and
1.16% TA) and two patients with inflammatory bowel disease
(2.8%). We analyzed: organ failure, sepsis, coagulopathy and
nutrition, and we found an important association of UGITB with
sepsis, shock, organ failure and mechanical ventilation nutrition [1].
Presentation of UGITB: hematemesis/bleeding nasogastric tube
52 (71.2%), melenas 10 (13.7%) and acute anemia 11 (15%).
Endoscopic findings: ulcers 43%, erosions 37%, esophagitis and
gastritis 10%. G-scope was performed in 54 patients (74%): 12 of
them (16.4%) required sclerosis, one patient (1.4%) a Sengs-
taken-Blakemore tube, and two patients (2.8%) arteriography with
embolization. Most of the episodes resolved spontaneously. The
overall mortality was 49.3% (36 patients); 1.1% of deaths were
directly related to the UGITB.
Conclusions In our series UGITB is not a common entity, and the
most frequent findings were ulcers and erosions. UGITB must be
considered a new severity criterion because although it is neither
related with the typical predisposing factors nor age, in these
patients we observed higher mortality than the expected for their
APACHE II score.
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Introduction  The advent of multiple trauma is accompanied by
lymphopenia often due to apoptosis. This may be due to the
existence of a circulating factor modulating apoptosis. The
presence of such a factor in the serum of patients was assessed.
Methods Serum was sampled at standard time intervals from 21
patients bearing multiple injuries and admitted to the ICU.
Peripheral blood mononuclear cells (PBMCs) were isolated from
five healthy volunteers after gradient centrifugation over Ficoll.
PBMCs were stimulated overnight in a 96-well plate with 0.1 ml
sampled serum. The percentage of annexin-V+/PI–/CD4+ cells and
annexin-V+/PI–/CD14+ cells were estimated by flow cytometry.
Results were compared with those obtained after cell incubation
with serum of healthy volunteers.
Results Median induction of apoptosis of CD4 lymphocytes and of
CD14 monocytes after incubation with serum of healthy volunteers
was 1.89% and 30.56%, respectively. Median percentages of
apoptotic CD4 lymphocytes and CD14 monocytes of PBMCs after
incubation with patient’s serum sampled on consecutive days after
admission are shown in Table 1. Similar results for patients compli-
cated with sepsis on the first day of its advent are also presented.
Table 1 (abstract P425)
Induction of apoptosis of PBMCs after incubation with patients’
serum
Advent of 
Median Day 1 Day 4 Day 7 sepsis
CD4 cells (%) 3.57* 4.04 3.57* 3.48*
CD14 cells (%) 3.00* 41.43 3.00 33.3
*P <0.05 compared with incubation with patients’ serum.
Conclusions  Incubation with serum of patients with multiple
trauma-induced apoptosis of CD4 lymphocytes and of CD14
monocytes. These data strengthen the hypothesis for the existence
of a circulating factor inducing apoptosis after multiple trauma.
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Introduction  We tested the hypothesis that treatment with an
enone-containing compound, p-hydroxyphenylpyruvate (pHPP), the
first intermediate in the tyrosine catabolism pathway, could
ameliorate the survival time in rats subjected to profound hemor-
rhagic shock (HS) in the absence of resuscitation. We based this
hypothesis on the knowledge that ethyl pyruvate (EP) and related
enone-containing compounds are protective in numerous in vitro
and  in vivo models of oxidant-mediated and cytokine-mediated
cellular and organ injury.
Methods We compared the anti-inflammatory effects of EP and
pHPP using U373 cells exposed to IL-1β and RAW 264.7 cells
exposed to lipopolysaccharide. Volume-controlled HS was initiated
by withdrawing 21.7 ml blood per kg body weight over 20 minutes,
followed by an additional 14 ml/kg over 40 minutes. A continuous
infusion was delivered during the final 20 minutes of hemorrhage.
Groups of six rats randomly received: (1) 2.8 ml saline per kg or
4% of total estimated blood volume (EBV); (2) 2.8 ml/kg of 0.25
nM pHPP; (3) 1.4 ml/kg of 0.50 nM pHPP; (4) 1.4 ml/kg (2% EBV)
of 0.25 nM homogentisic acid (HGA); (5) 1 g dichloroacetic acid
(DCA) in 2.8 ml/kg; or (6) DCA plus 0.25 nM pHPP in 2.8 ml/kg.
Results  Cell culture studies revealed that pHPP blocked
expression of CD54 in U373 cells and blocked release of NO￿ and
decreased induction of inducible nitric oxide synthase mRNA in
RAW cells at lower concentrations compared with EP. We
therefore tested its efficacy in a profound hemorrhagic shock
model. Rats in both groups receiving pHPP survived significantly
longer (P <0.001) than rats receiving vehicle alone. All rats in the
vehicle group were dead by 140 minutes. Five out of 12 animals
treated with pHPP survived longer than 4 hours and one rat
survived for 455 minutes. Prompted by the recognition that pHPP
is an endogenous metabolite converted to HGA in the tyrosine
catabolism pathway, we sought to determine whether treatment
with HGA could extend survival in the same HS model. The
percentage of treated rats that survived until 5 hours in groups 2 or
4 was 33.3%. No statistical significance was observed among rats
in groups 2, 3, 4. In order to obtain additional information regarding
the mechanism responsible for the protective effects, we
administered an inhibitor of the tyrosine catabolism, dichloroacetic
acid alone or in addition to pHPP. Accordingly, the data showed
that all rats in groups 5 or 6 died within 4 hours.
Conclusions  These findings show that administration of a
nanomolar dose of pHPP markedly improves survival following
lethal HS. This improvement is very probably related to a direct
pharmacologic effect of pHPP on inflammation that is shared with
EP and together with pHPP acting as an anaerobic carbon source.
Infusion of drug in only 2% of the EBV strongly suggests that these
effects are not related to resuscitation.
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Introduction Recombinant activated factor VII (rFVIIa; Novoseven)
is indicated for treatment of bleeding in hemophilic patients with
antibodies against factor VIII or factor IX. Although not licensed or
agreed for other indications, its use for refractory hemorrhage is
increasingly reported. We reviewed our experience with off-label
use of rFVIIa in this indication.
Methods  We retrospectively reviewed all patients treated with
rFVIIa from March 2004 to November 2008 in our hospital. Those
included in a multicentric study (n = 10) or treated within approved
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(n = 3) or nonhemorrhage (n = 4) indications were excluded. Initial
use imposed constringent guidelines implementation. According to
these, use of rFVIIa requires cross-checking for active correction of
hypothermia, acidosis, and coagulation factors and consideration
for any feasible haemostatic surgery or embolisation.
Results  Forty-two patients were included. Median age was 39
years and 60% were male. The underlying condition was trauma in
14% of cases and surgery-associated hemorrhage in 76%.
Bleeding stopped in 79% of cases. Potentially associated
thromboembolic complications were observed in five (11.9%)
cases, only one being very probably linked to rFVIIa. The overall 30-
day mortality was 40.5%. The initial experience was followed by a
decline in the use of rFVIIa, and the release of guidelines followed
by a continuous increase. We observed a progressive decline in
the 30-day mortality rate, from 70% in the first 10 patients to 17%
in the last 10 (Figure 1). The average number of blood transfusions
before rFVIIa remained stable but the median rFVIIa doses
decreased from 206 μg/kg in the first 10 patients to 80 μg/kg in
the last 10.
Conclusions  Local guidelines release did not decrease the
number of cases but seem to impact on when and to whom rFVIIa
is administered. Their release, associated with increasing experi-
ence, was associated with a striking lowering of mortality rate.
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Introduction  At pharmacological doses, recombinant activated
factor VII (rFVIIa) bypasses conventional steps in coagulation
cascade and directly generates a thrombin burst on the activated
platelets at the injury, leading to the generation of fully stabilized
tight fibrin clot.
Methods  Using the experience of our institute and an Internet
search. In one of the largest prospective, randomized, multicentric
studies of rFVIIa, 301 patients with blunt/penetrating trauma were
enrolled – of whom 277 patients at the end of study were
analyzable. The trial included 399 patients, all diagnosed by CT
scan within 3 hours of intracerebral hemorrhage onset. Patients
were randomly assigned to receive placebo (n = 96), 40 μg/kg
(n = 108), 80 μg/kg (n = 92), or 160 μg/kg (n = 103) doses of
rFVIIa within 1 hour of the baseline scan. The results of the Survival
of Myocardial Infarction Long-Term Evaluation study (that is, the
largest controlled study showing the relationship between genetic
polymorphisms and disease) demonstrated that propensity to high
factor VII levels is not associated with a risk for myocardial
infarction.
Results  One study has demonstrated that one single dose of
rFVIIa (80 μg/kg) could reduce transfusion requirements in
cirrhotic patients undergoing orthotopic liver transplant. Compared
with 29% growth in the placebo arm, intracerebral hemorrhage
volume growth in the 40, 80, and 160 μg/kg arms was 16%, 14%,
and 11%, respectively (corresponding to a relative reduction of
45%, 52% and 62%).
Conclusions  Use of rFVIIa should be reserved for salvageable
patients with coagulopathic bleeding that is unresponsive to
existing medical therapies. Definitive surgical control of accessible
sites of hemorrhage is nevertheless a necessary intervention.
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Introduction Recombinant activated factor VII (rFVIIa) plays a key
role in hemostasis. The aim of this study was the clinical evaluation
of the efficacy of rFVIIa in the treatment of bleeding during and
after abdominal and cardiac surgery.
Methods A meta-analyses of case-series studies (n = 67) on the
treatment of bleeding with rFVIIa regarding reduction or cessation
of bleeding and mortality. We used the questioners of Novo
Nordisk to assess the indications and effectiveness of treatment.
We compared the amount of blood loss within 12 hours before
and within 12 hours after giving rFVIIa, and the dynamics of
bleeding. In 10 patients the bleeding started after surgery
intraoperatively, in 57 patients severe hemorrhage developed in the
postoperative period. We also compared the full blood count and
laboratory coagulation profile parameters before treatment, and 2
and 12 hours after treatment. In cardiac surgery rFVIIa was
administered 5 to 49 minutes after neutralization of heparin with
protamine sulfate. The dosage of rFVIIa was 39.23 ± 20.70 μ/kg
We used Student’s t test for statistical analysis.
Results  After administration of the first median dose (14.45 to
81.35 μg/kg) of rFVIIa, bleeding stopped in 47 patients. Bleeding
was markedly decreased in 15 patients. Five patients who did not
benefit from initial rFVIIa administration received additional drug in
a dose of 38.25 μg/kg with good results. The average blood loss
within 12 hours before treatment was 2,510.00 ± 1,642.07 ml,
and the average blood loss within 12 hours after treatment was
1,057.75 ± 810.67 ml. The average dynamics of bleeding before
treatment were 216.35 ± 138.82 ml/hour, and 87.90 ± 67.82 ml/hour
after treatment. Transfusion requirements were reduced for packed
red blood cells, fresh frozen plasma, platelets, and crystalloid
and/or colloids. Reduction in transfusion requirements was
statistically significant (P ≤0.05).
Conclusions The meta-analysis of case series showed that in a
mean of 85% patients rFVIIa achieved at least a reduction of
bleeding, reducing the need for hemotransfusions.
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Introduction Recombinant activated factor VII (rFVIIa; Novoseven)
is indicated for treatment of bleeding in hemophilic patients with
antibodies against factor VIII or factor IX. Although not licensed or
agreed for other use, it is increasingly reported for refractory
hemorrhage. Implantation of a circulatory assist device requires
tight anticoagulation therapy and may be complicated by massive
bleeding. We report our experience with off-label use of rFVIIa in
nine patients with circulatory assistance.
Methods  We retrospectively reviewed all patients treated with
rFVIIa for massive bleeding secondary to anticoagulation during
circulatory assistance between March 2004 and November 2008.
rFVIIa use and dosage was decided according to local guidelines
when available (released in May 2006). According to these
guidelines, systematic crosscheck for active correction of hypo-
thermia, acidosis, and coagulation factors with parallel considera-
tion for any feasible interventional embolisation or haemostatic
surgery are required for authorization of rFVIIa use.
Results Nine patients with circulatory assistance received rFVIIa.
Median patient age was 43 years (<1 to 55). Eight patients
underwent cardiac surgery (including two heart transplants). One
had a bipulmonary transplant. The device was an extracorporeal
membrane oxygenator in seven patients and a ventricular assist
device in two patients. Median rFVIIa dose was 100 μg/kg (45 to
180), split into two or three injections in six cases. Bleeding control
was obtained in five patients (60%). The mortality rate at 30 days
was 40%, including two within 48 hours from failure to control
hemorrhage. We observed one thromboembolic complication
(stroke) which may potentially be related to rFVIIa administration.
Conclusions Our series suggests that the cautious use of rFVIIa
may be an option in patients with a circulatory assist device
suffering from massive hemorrhage refractory to conventional
treatment.
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Introduction  Recombinant activated factor VII (rFVIIa) is
increasingly used for the treatment of acquired coagulopathies
associated with uncontrolled haemorrhage. Consensus guidelines
[1] have been published for the administration of rFVIIa in this
setting. We examined the off-licence use of rFVIIa in our 1,071-bed
tertiary referral hospital.
Methods Hospital blood-bank data were examined from the first off-
licence use of rFVIIa in November 2002 until August 2008. Case
notes were reviewed on these patients to gain demographics,
indications and dosage of rFVIIa. Pathology data were cross-
referenced to gain results before and after administration of rFVIIa.
Results Twenty-two patients were identified over the 6-year period
who received off-licence rFVIIa. The majority of uses were in
cardiac surgery (nine patients), followed by general/vascular
surgery (five patients), and trauma (four patients). Of these
patients, 41% (nine patients) did not survive >24 hours. Mean
dosage was 7.8 mg (89.4 μg/kg) and was given after mean
transfusions of 24.8 units of packed red cells, 13 units of fresh
frozen plasma, 3.5 units of pooled platelets and 2 units of
cryoprecipitate, in the preceding 24 hours. At this time, blood tests
reveal a mean of 91 platelets (SD = 54.9), but nearly one-quarter
of patients received the drug with a platelet count <50;
prothrombin time 17.9 seconds, activated partial thromboplastin
time 58.7 seconds, and pH 7.18. Mean temperature prior to rFVIIa
administration was 34.7°C. Full APACHE II data were available for
64% of the patients with a mean of 18.3 (SD = 6.5), and for the
trauma patients a mean revised trauma score of 5.9. Following the
administration of rFVIIa, the mean prothrombin time reduced to
13.4 seconds at 1 hour. Sixty-eight per cent of patients (15)
received blood product transfusions in the immediate 24 hours
after having rFVIIa with a mean of 2 units packed red cells, 3.2
units fresh frozen plasma, 1.5 units pooled platelets and 1.1 units
cryoprecipitate.
Conclusions  In our establishment, off-licence use of rFVIIa has
often been unsuccessful and may have been used as salvage
therapy. There is heterogeneity in prescribing rFVIIa and its use
does not conform to European guidelines [1]. Controversy
continues about the merits of using off-licence rFVIIa at all [2].
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Introduction Massive postpartum bleeding remains a major cause
of maternal morbidity and death. An estimated 90% of such deaths
might be preventable.
Methods rFVIIa was used in our ICU in the treatment of 12 women
with severe or life-threatening postpartum bleeding (PPB) in 2005
to 2008 due to placenta previa accrete, rupture of the uterus and
pre-eclampsia with haemolysis, elevated liver enzymes and low
platelets. The average patient age was 30 years. We used the
questioners of Novo Nordisk to assess the indications and
effectiveness of treatment. All patients had normal coagulation
parameters before surgery. We compared the amount of blood
loss within 12 hours before and 12 hours after giving rFVIIa, the
dynamics of bleeding (assessed in ml/hour) before and after
treatment and coagulation profile parameters. We used small
doses of rFVIIa (15.25 to 50 μg/kg). We used Student’s t test for
statistical analysis of the laboratory data prior to and after rFVIIa.
Results Indications for administration of rFVIIa were considered
when sudden blood loss exceeded 1,800 ml or when continuing
blood loss of 500 ml/hour (in the drain). Patients after rFVIIa
treatment received a lower number of packed red cell transfusions
(4.0 ± 4.46 vs. 9.61 ± 6.7, P = 0.007), compared with before
treatment. In addition, the median amount of crystalloid/colloids
administered decreased markedly. After administration, rFVIIa
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bleeding stopped in eight patients. Bleeding markedly decreased
in two patients during 3 hours. Two patients who did not benefit
from initial rFVIIa administration received additional drug in a dose
of 35.65 μg/kg with good results. No adverse effects were directly
related to treatment with rFVIIa.
Conclusions  Clinical reports and hematologic data suggest
improvement for more than 80% of women after rVIIa administration.
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Introduction The study compared the efficacy of viscoelastography
(VG) versus thromboelastography (TEG) for monitoring of peri-
operative coagulation balance after abdominal surgery for cancer.
Methods  A complete coagulation screen, the activated clotting
time (ACT), TEG and VG were performed before surgery and at
the end of the operation, and monitoring of LMWH anticoagulation
therapy on postoperative days 1, 2, 3, and 7. We tested the
hypothesis that the parallel use of standard TEG and VG can fully
access the postoperative state of blood coagulation.
Results  The elastic shear modulus of standard MA (Gt) and
VGMVA (Gh), which reflect the total clot strength and pro-
coagulatory protein component, was calculated. The difference
was an estimate of the platelet component (Gp). There was a 14%
increase of standard MA, corresponding to a 48% increase of Gt
(P <0.05) and an 80 to 86% contribution of the calculated Gp to
Gt. Using multiple linear regression, all coagulation, TEG and VG
variables were used to model perioperative thrombophylia. The
results showed that some components of TEG failed to identify
hypercoagulation (r <0.2, P <0.75). However, three components
of the routine coagulation assay, including the bleeding time,
prothrombin time and platelet count, could be modeled to show
prolonged postoperative hypercoagulability (P <0.01). We
conclude that all components of the VG test reflect postoperative
coagulopathies. Serial standard TEG and viscoelastic analysis may
reveal the independent contribution of platelets and of
procoagulatory proteins to clot strength.
Conclusions These results suggest that viscoelastic techniques
might be useful in the determining the coagulation status in cancer
patients perioperatively. Hypercoagulability is not reflected
completely by standard coagulation monitoring and TEG, and
seems to be predominantly caused by increased platelet reactivity.
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Introduction Elevated coagulation factor VIII activity (FVIII:C) has
been associated with increased risk for both venous and arterial
thrombosis. The current study evaluated the influence of factor VIII
levels and interactions with gender on all-cause mortality in a large
Austrian cohort.
Methods A total of 11,203 individuals were included in this study.
The median observation period was 5 years, covering a total of
46,000 person-years. The death rate was 17.1%.
Results Compared with individuals within the reference category
(FVIII:C <94%) hazard ratios gradually increased from 1.4 (95% CI =
1.1 to 1.8) in the 152 to 170% category (fifth decile) to finally 4.4
(95% CI = 3.5 to 5.5) in the >313% category (highest decile, all
P <0.05). The association between FVIII:C levels and mortality
remained essentially unchanged when considering noncancer
mortality, all-cause vascular mortality or mortality due to ischemic
heart disease. Compared with males, females with elevated FVIII:C
had a worse outcome resulting in higher hazard ratios reaching 6.8
(95% CI = 4.6 to 9.9) within the highest decile compared with
males (hazard ratio = 3.4, 95% CI = 2.6 to 4.5).
Conclusions  In our large patient cohort we are firstly able to
demonstrate that FVIII:C plasma activity is strongly associated with
all-cause mortality. Additionally, FVIII:C appears to interact with
gender. Especially in women, FVIII:C might help identifying high-
risk cohorts that might benefit from individualized prevention
strategies.
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Introduction We have investigated the hypothesis that in whole
blood the incipient clot formed at the gel point (GP) is
characterised by a fractal microstructure [1,2] and that this could
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be detected in healthy and anticoagulated blood. We compared
the gel time (GT) required to form the incipient clot and the
corresponding fractal dimension (df) against laboratory markers of
haemostasis and thromboelastography (TEG).
Methods Blood samples were taken from 52 healthy adults and
similarly 34 individuals whose blood had been anticoagulated with
heparin over the therapeutic range.
Results  The incipient clot in normal blood is established as a
sample-spanning network cluster at the GP [2]. The value of df in
whole healthy human blood is 1.74 (±0.07), which indicates a high
degree of branching in the fibrin network at criticality and is
commensurate with that reported to arise in other biological
systems. There was a significant reduction in the value of df and a
corresponding prolongation in the GT in the heparin group as
compared with the healthy group (Figure 1).
Conclusions We describe for the first time that the incipient clot
formed at the GP of whole blood is characterised by a fractal
microstructure. The values of df and GT discriminate between clot
structure in healthy and anticoagulated blood. The relationship
between these new markers may provide a basis for exploring the
relationship between coagulation pathways and clot quality.
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Introduction  Severe traumatic or intraoperative blood loss
necessitates massive transfusion. This blood loss and the dilution
of coagulation factors result in insufficient haemostasis. Treatments
to enhance the haemostatic capacity need to be evaluated. An
acquired bleeding model due to a dilutional coagulopathy was
developed in the rabbit to estimate the contribution of PCC
(Beriplex P/N; CSL Behring) on haemorrhage.
Methods  Rabbits were anesthetised using isofluran and were
mandatorily ventilated. The animals were instrumented to monitor
the cardiovascular and respiratory system. Dilutional coagulopathy
was induced by phased blood withdraw, salvaged erythrocyte
retransfusion and volume substitution with hydroxyethyl starch.
After the dilutional procedure the bleeding was inflicted by cutting
the lateral kidney pole. To characterise the model, animals were
allocated to groups: I, sham operation (no dilution, placebo
treatment; n = 5); II, negative control (dilution, placebo treatment;
n = 7); III, PCC 25 U/kg intravenously (dilution, verum treatment;
n = 6). Coagulation factor activity, thrombin generation (TGA),
prothrombin time (PT) and the bleeding from the kidney wound
were assessed.
Results Rabbits without a dilutional coagulopathy demonstrated
rapid onset of haemostasis. Post-injury blood loss (BL) and time to
haemostasis (TH) were 4.7 ± 2.4 ml and 4.4 ± 1.1 minutes,
respectively. After the dilution procedure coagulation factors were
reduced to less than 50% of baseline. Haemostasis deteriorated
after colloid transfusion (BL 60.0 ± 25.9 ml, TH 19.1 ± 2.2 min).
The TGA showed normal lag phase but only 50% of the normal
peak thrombin level. The PT was prolonged after the dilution about
1.8-fold. Using PCC treatment it was demonstrated that the peak
thrombin level was corrected (P  <0.0001) and the BL (21.5 ±
11.1 ml; P <0.01) as well as TH (12.4 ± 1.4 min; P <0.01) were
decreased significantly.
Conclusions In this rabbit model of a dilutional coagulopathy it
was demonstrated that a dilution of coagulation factors of more
than 50% affects TGA, PT and bleeding. Restoration of
coagulation factors II, VII, IX and X using PCC corrects the TGA
and reduces BL and TH. This model could be used to investigate
new drugs in dilutional coagulopathy.
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Introduction Approximately 70% of all fire victims in the USA who
die within the first 12 hours post burn die from smoke inhalation
injury (SIJ). Airway edema combined with obstructive casts
produced from cellular debris, fibrin clots, polymorphonuclear
leukocytes, mucus and mucin B5 are believed to cause the airway
obstruction contributing to pulmonary failure.
Methods A single-center retrospective study with historical control
over a 5-year period of 30 mechanically ventilated adult subjects
admitted within 48 hours of their bronchoscopy with confirmed SIJ.
Both the experimental (n = 16) group and control (n = 14) groups
were treated with ventilator support but the former received in
addition 10,000 units of nebulized heparin sulfate mixed in 3 ml
normal saline every 4 hours and 3 ml 20% nebulized N-
acetylcysteine plus 0.5 ml albuterol sulfate every 4 hours for 7
consecutive days starting on the day of admission. We calculated
APACHE III scores on admission in addition to the daily lung injury
score for 7 days.
Results There was no significant difference in admission APACHE
III scores (38.7 vs. 34.6; α = 0.05) or lung injury scores (0.7 vs.
1.1; α = 0.05) between the experimental and control groups. The
experimental group showed significant improvement in lung injury
scores (P <0.05) over the duration of the study, with the greatest
benefit seen over the first 7 days (0.91 ± 0.14 vs. 1.79 ± 0.41;
P <0.01). Respiratory resistance and compliance measurements
revealed significant improvement in the experimental group
reaching a significance level of P <0.01 by day 4. There was a
statistically significant survival benefit in the experimental group
that was most pronounced in patients with APACHE III scores
>35. Survival for the control group versus experimental group was
0.5714 ± 0.1497 versus 0.9375 ± 0.0605, respectively (RR =
–0.0055; 95% CI = –0.0314 to 0.0204; HR = 1.003).
Conclusions The use of aerosolized unfractionated heparin and N-
acetylcysteine attenuates lung injury and the progression of acute
lung injury in ventilated adult patients with SIJ.
References
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Introduction  Low molecular weight heparin (LMWH) dosing
protocols for deep vein thrombosis prophylaxis in critically ill
patients (CIPs) are not based on pharmacologic studies in these
patients. Antithrombotic LMWH activity correlates with peak anti-
activated factor X (aFXa) levels (4 hours post injection) of 0.1 to
0.2 IU/ml. The hypothesis of this study is that most CIPs do not
achieve therapeutic levels for prevention of DVT.
Methods  A prospective study of CIPs randomized to receive
enoxaparin once daily intravenously 0.5 mg/kg, subcutaneously
0.5 mg/kg or subcutaneously 40 mg. Blood was sampled for peak
and trough aFXa levels (5 days). Inclusion criteria: CIPs aged
≥18 years, expected to require mechanical ventilation >3 days.
Exclusion criteria: full anticoagulation, platelets <75,000, creatinine
clearance <30 ml/min/m2, BMI >30, International Normalized Ratio
>1.7, contraindication to anticoagulation. Outcome measures:
primary, achievement of target peak/trough levels of aFXa;
secondary, monitoring the effect of concomitant administration of
noradrenalin on aFXa levels.
Results Included were 35 patients (5, 15 and 15 accordingly).
Mostly male (n = 23, 66%), nonsmokers (n = 23,66%) aged 68 ±
15 years (range 25 to 92) with a BMI of 25 ± 3 (range 17 to 30).
Most were admitted for diseases of the digestive/respiratory
systems (ICD-9). APACHE scores were 19 ± 4 (range 12 to 29).
Forty percent underwent surgery before ICU admission (n = 14).
Upon inclusion, 34% (n = 12) were receiving noradrenalin, blood
pressures averaged 83 ± 6 mmHg, blood creatinine 1.08 ± 0.27,
platelets 206,942 ± 95,128 and International Normalized Ratio
1.3 ± 0.16. No protocol resulted in aFXa levels within the
therapeutic range; peak levels were too high and trough levels too
low. The only significant difference between patients receiving/not-
receiving noradrenalin was found in the trough levels of the SQ
0.5 mg/kg protocol. Hemorrhagic/thorombotic complications
included: one gastrointestinal bleeding (SQ 40 mg) and two distal
inferior limb DVTs (SQ 0.5 mg/kg and intravenous 0.5 mg/kg
protocols). ICU length of stays averaged 9 ± 6 days (median 8,
range 4 to 33). Three patients died for causes seemingly unrelated
to the study (overwhelming fungal sepsis, severe pneumonia and
malignant reperfusion syndrome post carotid endarterectomy).
Conclusions Current DVT prophylaxis protocols do not result in
peak aFXa levels within the recommended antithrombotic range in
CIPs. This suggests subtherapeutic levels of LMWH activity and
should lead to further studies on optimal dosing in these patients.
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Introduction  Amniotic fluid embolism (AFE) is a catastrophic
complication of pregnancy. The incidence of AFE is very rare, and
the clinical presentation; central hemodynamic data in humans are
typically obtained more than 1 hour after the event and from only
the subset of women who have survived the initial insult. This
makes the exact pathophysiology remain elusive, despite numerous
attempts at understanding AFE syndrome. We tried to evaluate the
effect of amniotic fluid on blood coagulation by making a simple in-
vitro model, using an activated clotting time (ACT) monitor.
Methods  Sixteen healthy women undergoing elective cesarean
section under spinal anesthesia. A venous sampling line was
inserted before induction of anesthesia. After artificial rupture of
the membrane, amniotic fluid was carefully obtained by the
surgeon. At the same time, 10 ml venous blood was obtained from
the sampling line, and two series of samples were made; (1) 5 ml
venous blood with 0.1 ml amniotic fluid (group 1), and (2) 5 ml
venous blood alone (group 2 = control). ACT was measured using
2 ml sample in each group.
Results The ACT was 66.5 ± 20.9 seconds in Group 1 versus
102.4 ± 15.8 seconds in Group 2 (P <0.0001). Especially, there
was one case that coagulated immediately after mixing the
amniotic fluid and the ACT could not be obtained in Group 1
(excluded from analysis). The strong coagulation ability by amniotic
fluid was induced immediately, even in very small doses.
Conclusions  A dose of 0.1 ml was enough to form the 5 ml
venous blood thrombosis, which is thought to be a sufficient
amount to cause AFE, and we consider that its pathophysiology
resembles pulmonary embolism. We suggest that AFE may be
induced by a smaller dose such as 0.1 ml amniotic fluid than it had
been thought. A part of the mechanism of amniotic fluid embolism
in humans can be explained by pulmonary embolism theory by
making a simple in vitro AFE model.
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Introduction Right heart mobile thrombi (RHMT) are not frequent in
patients with acute pulmonary embolism (APE); however, bear a
significant risk of APE recurrence and hemodynamic compromise.
Immediate therapy is recommended, but the optimal approach is
considered to be controversial in the absence of controlled trials [1].
Methods  We report an analysis of 21 out of 209 (10%)
consecutive patients with echocardiographically diagnosed RHMT
managed at our institution during the past 5 years. For demo-
graphics, vital signs and laboratory values on entry see Table 1.
Results Eight (38%) out of 21 patients with RHMT presented with
massive, 12 (57%) submassive and one with small APE. Right
ventricle overload was detected in 20 out of 21 patients (95%).
Fifteen (71%) patients were thrombolysed, three (14%) patients
have undergone surgical embolectomy. Thrombolysis was
successful in 13 out of 15 (87%) patients, RHMT was dislodged in
two patients; in one of them with fatal outcome, the other one was
Available online http://ccforum.com/supplements/13/S1
Table 1 (abstract P441)
With RHMT Without RHMT P value
n 21 188
Age 57.6 57.1 NS
Women 11 101 NS
Systolic blood pressure 105.6 124.3 <0.001
Heart rate 106.1 92.5 0.02
Tropinin I 0.396 0.186 0.03
Tropinin I maximal 2.094 0.436 0.005
Brain natriuretic peptide 873 287 0.025S178
urgently managed by venoarterial extracorporeal membrane
oxygenation and subsequently by surgical embolectomy. The 30-
day mortality was 10% (n = 2) in RHMT and 6% (n = 11 out of
188) in patients without RHMT.
Conclusions  Systemic thrombolysis is a safe and effective
treatment for APE with RHMT. Urgent venoarterial extracorporeal
membrane oxygenation as a rescue option for hemodynamic
collapse in thrombus dislodgment opens a new therapeutic bridge
to further decision and treatment.
Reference
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Introduction Heparin-induced thrombocytopenia (HIT) is a serious,
prothrombotic, immune-mediated adverse reaction triggered by
heparin therapy. When HIT is diagnosed or suspected, heparins
should be discontinued and an alternative, fast-acting, parenteral,
nonheparin anticoagulation such as argatroban should be initiated.
The recommended initial dose of argatroban in HIT is 2 μg/kg/
minute with following adjustment to the activated partial thrombo-
plastin times (aPTTs). There are limited and inconsistent data
about dosing of argatroban therapy in ICU patients with multiple
organ dysfunction syndrome [1,2].
Methods Evaluation of 11 patients with sepsis or multiorgan dys-
function syndrome treated with argatroban to demonstrate dosing
adjustment difficulties of argatroban in critically ill ICU patients.
Results  Eleven ICU patients with sepsis or multiple organ
dysfunction syndrome were treated with argatroban for suspected
HIT (n = 11; mean thrombocyte count 44,727) using a mean
argatroban starting dose of 0.46 μg/kg/minute (min 0.04; max
0.56) to achieve aPTTs >60 seconds or aPTTs of 1.5 to three
times the baseline aPTT. In 10 patients (91%), desired levels of
anticoagulation were achieved. Adjustment to aPTT required dose
reduction in five patients (45%). Patients were treated for a mean
of 4 days. The final mean dose in these critically ill ICU patients
was 0.33, about one-sixth of the usually recommended dose,
probably reflecting the degree of illness and that there was a
tendency to target the lower end of the therapeutic aPTT range.
Conclusions  Patients with multiple organ dysfunction syndrome
and HIT can be effectively treated using argatroban. In critically ill
patients, the dosing of argatroban has to be adjusted. In all patients
with multiorgan failure syndrome a decrease in the initial dosage is
mandatory. Further studies are needed to fully elucidate argatroban
elimination and dosage adjustments for intensive care patients.
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Introduction ICU patients are a very high-risk population for deep
vein thrombosis (DVT) and prophylaxis is often underused. This
study was aimed to develop an educational program for ICU
physicians to increase DVT prevention.
Methods  This study has been developed in two steps. By the
retrospective one we assessed DVT incidence in patients admitted
from December 2004 to December 2005 who were ≥18 years old
and had been in the ICU longer than 72 hours. Exclusion criteria
were DVT within the previous 6 months, thrombophilic profile, and
high haemorrhagic risk. After this period all ICU physicians were
trained to perform compression ultrasonography (CUS) for DVT
screening; moreover, a DVT risk scoring form was introduced into
the clinical practice. In the prospective phase we enrolled patients
referred to the ICU from January 2007 to March 2008: inclusion
and exclusion criteria were the same as the retrospective step. ICU
physicians assessed the DVT risk, scoring daily for each patient, so
as to prescribe the best DVT prophylaxis, and CUS screening was
performed twice a week. Then we compared the two steps of the
study.
Results During the prospective step we observed an increase in
prophylaxis prescription: elastic stockings administration increased
from 42.80% to 64.00% (P <0.000) and the use of pneumatic
compression devices increased from 3.17% to 4.90% (P = NS);
low molecular weight heparin (U/kg) prescription did not change
over the study periods. In the prospective phase the DVT incidence
in the ICU was 4.5%, significantly lower than the 10.31% observed
in the retrospective step (P <0.05). This reduction was obtained in
spite of the increase in the number of CUS screening for DVT:
from 1.94 ± 1.38 CUS/patient (retrospective phase) to 2.42 ±
2.02 CUS/patient (P <0.014).
Conclusions ICU physician involvement in DVT risk management
can be achieved through a training program to practice CUS
screening and introduction of a DVT risk scoring form into the
clinical practice. In our ICU these interventions were associated
with a significant reduction in DVT incidence.
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mortality in pneumonia and sepsis survivors
FB Mayr1, S Yende1, JA Kellum1, G D’Angelo2, DC Angus1
1University of Pittsburgh, PA, USA; 2Washington University School
of Medicine, St Louis, MO, USA
Critical Care 2009, 13(Suppl 1):P444 (doi: 10.1186/cc7608)
Introduction Prothrombotic conditions, like myocardial infarction
and pulmonary embolism, are more common after respiratory
infections, but underlying mechanisms are unclear. We hypo-
thesized that the imbalance between procoagulant and fibrinolytic
response during community-acquired pneumonia (CAP) persists at
hospital discharge and increases the risk of 1-year mortality.
Methods  We conducted a 1-year follow-up of 893 hospital
survivors of the GenIMS study, an observational cohort of subjects
with CAP. We measured coagulation and fibrinolysis markers
(antithrombin (AT), thrombin–antithrombin (TAT) complexes, factor
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IX, D-dimer, and plasminogen activator inhibitor 1 (PAI-1)) at
hospital discharge. We used a Gray’s model to estimate time-
varying hazard ratios of death over 1 year, and the National Death
Index to determine all-cause and case-specific mortality.
Results  Geometric means of factor IX and AT activities, TAT,
PAI-1, and D-dimer levels were 117.8%, 91.6%, 3.6 ng/ml,
3.7 IU/ml and 605.5 ng/ml, respectively. Although the majority of
patients (88.4%) had clinically recovered at hospital discharge,
coagulation markers were frequently abnormal. D-dimer, TAT and
PAI-1 levels were abnormal in 80%, 40% and 11% of patients.
Subjects with higher TAT, D-dimer, and PAI-1 levels were more
likely to die over 1 year, even after adjusting for patient
demographics, comorbidities, and severity of illness. Risk of death
was highest initially and decreased over time (for each log-unit
increase the range of adjusted hazard ratios were 1.39 to 1.01
(P = 0.01), 1.48 to 1.03 (P = 0.004), and 1.50 to 0.76 (P = 0.005)
for TAT, D-dimer, and PAI-1, respectively). The adjusted hazard
ratios remained unchanged when analyses were limited to subjects
discharged home, or stratified by severe sepsis occurrence. Most
subjects died due to cardiovascular disease (27.8%) and cancer
(29.9%). Chronic lower respiratory tract infection (14.6%),
infection (10.4%), renal failure (7.6%), and other causes (9.7%)
accounted for the remaining deaths.
Conclusions A prothrombotic state at hospital discharge is asso-
ciated with increased 1-year mortality in CAP survivors. Pharma-
cologic interventions targeted to reduce coagulation abnormalities
after acute infection should be investigated to improve long-term
outcomes.
Acknowledgement FBM was supported by T32 HL007820-10.
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Introduction  Venous thromboembolic disease (VTD) is an
important cause of morbimortality of critically ill patients, whom
frequently have several VTD risk factors but lack the appropriate
preventive measures. We conducted a study to identify the VTD
risk factors, prevalence and use of prophylaxis in our ICU.
Methods We conducted a prospective, observational study of all
patients admitted to the adult ICU of our hospital in a 4-month
period. We documented epidemiological data, VTD risk factors,
and use of thromboprophylaxis. We used a risk scale that stratified
patients in one of four levels of thromboembolic risk (low,
intermediate, high, and very high) according to the number of VTD
risk factors present. Daily clinical screenings for pulmonary or
peripheral venous thromboembolism (VTE) were performed.
Patients were contacted 30 days after discharge from the ICU to
assess for any post-ICU VTE events.
Results  Two hundred and eighteen consecutive patients were
included (134 males) with an average age of 61 ± 18.6 years. The
average length of stay at the ICU was 5.7 ± 12.9 days. The most
frequent risk factors were age >60 years (83%), obesity (41%),
smoking (33%), recent major surgical procedure (30%), and
diabetes (22%). A total of 51.4% (112/218) of the patients had
five or more VTD risk factors (very-high-risk category), while 34%
(74/218) had three to four VTD risk factors (high-risk category).
Less than 50% of the patients received any thromboprophylaxis.
Most of those that had VTD prophylaxis used mechanical devices
(96/218; 44%), followed by low molecular weight heparins such
as enoxaparin (82/218; 38%). Twelve patients developed an
identifiable thrombotic event: six male patients developed VTE
while in the ICU; two of them developed massive pulmonary
embolism and died. On follow-up assessment we contacted 183
patients and identified six that developed clinical data of a new,
nonsevere VTE event after ICU discharge. All 12 patients who
developed VTE had five or more VTD risk factors, locating them in
the very-high-risk category.
Conclusions Most of the patients admitted to our ICU had several
risk factors that predisposed them to VTE events. In spite of that, less
than one-half of our patients received VTD prophylaxis. VTE deve-
loped only in patients who had five or more risk factors. We suggest
performing regular VTE assessments in this group of patients.
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Introduction All colloid solutions have negative effects on blood
coagulation, but these effects are dependent on the dose and type
of fluid administered [1,2]. Since cardiopulmonary bypass
increases the risk of postoperative bleeding, we examined to what
extent various doses of rapidly degradable hydroxyethyl starch
(HES) or gelatin, in comparison with Ringer’s acetate, impaired
whole blood coagulation after cardiac surgery.
Methods Forty-five patients received three relatively rapid boluses
(each 7 ml/kg) of either 6% HES (130/0.4) (n = 15), 4% gelatin
(n = 15), or Ringer’s acetate (n = 15) in a randomized, blinded
fashion after elective on-pump cardiac surgery to maintain optimal
intravascular volume. The study solution was continued as an
infusion (7 ml/kg) for the following 12 hours. The total cumulative
dose of the study solution was 28 ml/kg. If signs of hypovolemia
were observed, Ringer’s acetate was given. Blood coagulation was
assessed by thromboelastometry (ROTEM).
Results Clot formation time was prolonged, and the alpha-angle as
well as maximum clot firmness (MCF) decreased similarly after
infusion of 7 ml/kg both colloid solutions (P <0.05). These ROTEM
parameters, indicative of delayed clot formation and impaired clot
strength, still deteriorated after the cumulative doses of 14 ml/kg
and 21 ml/kg colloids (P  <0.05). In contrast, after infusion of
14 ml/kg and 21 ml/kg Ringer’s acetate MCF increased slightly but
significantly. Some signs of disturbed coagulation were seen in the
gelatin group on the first postoperative morning: MCF and the α
angle were still decreased in comparison with the Ringer group
(P <0.05). Signs of excessive fibrinolysis were not observed.
Chest tube output was comparable between all groups. No clinical
thromboses were observed.
Conclusions  HES (130/0.4) 7 ml/kg or gelatin impaired clot
formation and firmness shortly after cardiac surgery. This effect
became more pronounced as the dose increased. Ringer’s acetate
increased blood coagulation capacity slightly.
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Introduction Administration of resuscitation fluids has been asso-
ciated with the development of metabolic and electrolytic
disturbances. The duration and severity of such metabolic acidosis
appear to depend on many factors, and the acidosis may continue
for hours after the initial intervention. It is unknown whether
different types of fluids may affect such changes differently.
Ringerfundin is a recently developed crystalloid with similar proper-
ties to human plasma, perhaps resulting in less electrolytic and
acid–basic disorders. Accordingly, we conducted a randomized
controlled study of fluid resuscitation in a clinical oncologic ICU.
The aim of this study was to determine the effects of resuscitation
on patients’ electrolyte concentrations and acid–base status.
Methods Forty patients in the first hours after diagnosis of septic
shock (early hours) were randomized to receive solutions of either
Ringer’s lactate (n = 20) or Ringerfundin (n = 20) for fluid resus-
citation. The amount of fluid needed to reach the goals of therapy
was compared between groups. Also, bicarbonate, base excess,
pH, chloride, sodium, potassium, calcium, magnesium, albumin,
anion gap, SIDe, SIG and lactate were compared at baseline, 2
hours after initial therapy, 6 hours after and 24 hours after.
Results  There were no differences in demographic, baseline
characteristics, electrolytic and acid–basic status of the groups
before therapy. After randomization, bicarbonate and base excess
increased significantly at 2 hours and 6 hours in the Ringerfundin
group compared with Ringer’s lactate group (P <0.0001). Patients
who received Ringer’s lactate presented a significantly greater
increase in serum chloride (P <0.002) and a lower clearance of
lactate after 2 hours, 6 hours and 24 hours (P <0.002). There were
no differences in amount of fluid needed, SIG, SIDe and anion gap
between groups.
Conclusions When comparing Ringer’s lactate and Ringerfundin,
the choice of resuscitation fluid is an independent predictor of
acid–base status and serum electrolytes. Ringerfundin adminis-
tration was associated with a better preservation of electrolytic and
acid–basic pattern.
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Introduction Disorders of acid–base equilibrium are common in
critically ill patients. The Stewart approach has been found useful
in explaining these disorders, where conventional analysis was
deficient. However, much uncertainty remains about the usefulness
and clinical meaning of this new approach. The aim of our study
was to compare the traditional method based on the analysis of
standard base excess (SBE) and anion gap with the Stewart
approach based on the analysis of the independent variables in
septic shock.
Methods  A prospective observational study with all patients
admitted to the ICU of our hospital for septic shock between
September 2007 and July 2008. Na+, K+, Ca2+, Mg2+, Cl–, pH,
PaCO2, lactate, phosphorus, albumin were measured at admission.
Bicarbonate, SBE, anion gap corrected for albumin (AGc), Cl
corrected for water excess/deficit (Clc), apparent and effective
strong ion differences and strong ion gap (SIG) were calculated.
Unmeasured anions were identified if SIG >6 mEq/l.
Results  Thirty-one patients were included. Metabolic acidosis
(SBE <–3 mEq/l) was found in 20 (64.5%) patients, while the
Stewart approach identified metabolic acidosis in 27 (87%)
patients. The traditional approach failed to identify seven cases of
metabolic acidosis (five patients considered normal and two having
an alkalosis).The inclusion of AGc in the traditional analysis based
on SBE resulted in a different clinical interpretation of acid–base
status than the Stewart method in only two (6.4%) patients. The
Stewart approach did not identify one patient with metabolic
acidosis observed with the use of SBE and AGc. Hyperlactatemia
(lactate >2 mmol/l) was present in 18 (58%) patients. SIG and
AGc were elevated in 25 (81%) and 24 (77.4%) patients.
Hypoalbuminemia was found in all patients. Patients with normal
SBE and high SIG had lower Clc than patients with low SBE
(103.1 ± 2.3 vs. 108 ± 3.6; P = 0.03). Albumin was not different
between these two groups. The normal SBE found with high SIG
was almost completely explained by the alkalinizing effect of
hypochloremia. AGc and SIG showed a very good self-correlation
(r2 = 0.708; P = 0.001). Thirteen patients died before day 28. All
metabolic acid–base variables failed to predict outcome.
Conclusions  The Stewart approach and traditional method
associating the AGc are clinically interchangeable in identifying the
acid–base disorders in septic shock patients. Because of its
simplicity and very good correlation with the complex calculation of
SIG, AGc must be used in clinic practice. Critically ill patients may
present high SIG with a normal value of SBE as a result of
associated hypochloremic alkalosis.
P449
Acidbase.org: online decision support in complex
acid–base disorders using the Stewart approach
P Elbers1, R Gatz2
1St Antonius Hospital, Nieuwegein, the Netherlands; 2Skaraborg
Central Hospital, Skovde, Sweden
Critical Care 2009, 13(Suppl 1):P449 (doi: 10.1186/cc7613)
Introduction  The Stewart approach to acid–base management
has evolved to be the method of choice [1]. While the quantitative
approach and the traditional Henderson–Hasselbalch method do
not mathematically exclude one another, the Stewart approach may
provide better mechanistic insight in complex acid–base distur-
bances. However, the approach is perceived as complex, requiring
many calculations. This is why we developed an online tool that
may facilitate its use.
Methods  We programmed several scripts interacting with a
MySQL database. Users may reach the application online [2] and
must enter acid–base and chemistry data. Cases can be saved
anonymously for later review. A tool is provided to run hypothetical
scenarios by changing different physiological parameters. The
application was tested using historical data from the author’s
hospital and limited public use.
Results  The application has been online since January 2008
(Figure 1). Initial testing led to various improvements. Without
advertising, over 500 doctors worldwide have used the software
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generating a total of 15,000 page-views as of December 2008.
Feedback by users is voluntary and indicates multiple changes in
diagnostic and/or therapeutic strategies.
Conclusions  We have shown it is feasible to build an online
software application that aids in the interpretation of complex
acid–base disorders using the Stewart approach. In addition this
tool enables the clinician to judge the impact of possible
intervention using simulation. We will next set out to investigate the
impact of exposure to this decision support tool on clinical patient
management.
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Introduction This is a comparative study of factors involved in the
development of acid–base disorders in surgical patients. The aim
of this study was to isolate factors that may affect the severity of
alkalosis, the prolongation of hospitalization and the final outcome
in patients admitted to an ICU.
Methods Data were collected retrospectively from the electronic
database of the surgical ICU of Hippocration Hospital, Athens,
Greece. Inclusion criteria were defined as patients that developed
metabolic alkalosis (pH >7.45 and [HCO3
–] >24) at a certain time
during their hospitalization. Patients were divided into two groups;
group I included those with 7.45 <pH ≤7.55 and group II those
with pH >7.55. Statistical analysis was performed between groups
with regard to gender, age, type of surgery, blood urea
concentration, white blood cell count, hematocrit, APACHE II
score, serum potassium concentration, creatinine levels, total
bilirubin levels, the presence of sepsis criteria, the recurrence of
the disorder, the need for mechanical ventilation, the total days of
the disorder, the length of hospital stay, the post-admittance day
when the maximum pH was recorded, the post-surgery day of
maximum pH, the use and the quantity of furosemide adminis-
tration, the use and quantity of dobutamine administration, the use
of human albumin and the survival. Statistical analysis was
performed with the use of chi-square for comparison of data.
Results Data charts from 1999 to 2005 were reviewed. In total,
987 patients were admitted to the ICU in this time period. Of
these, 239 (24.2%) patients developed metabolic alkalosis at a
certain time in their course. Group I included 210 patients (87.9%)
and group II included 29 patients (12.1%). From the parameters
that were analyzed, statistical significance was observed between
the two groups in the value of the blood urea concentration, in the
amount of sepsis criteria that were present and in the development
of recurrence. We did not observe a statistical difference between
the groups in creatinine levels, in the furosemide quantity or in
serum potassium concentration.
Conclusions  The severity of metabolic alkalosis is affected by
renal function as expressed by blood urea concentration and the
severity of sepsis–septic shock. Moreover, unlike what we
expected, furosemide administration did not prove of importance in
the development of the alkalosis in this study.
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Introduction  Acid–base disorders are common in critically ill
patients, and they are generally associated with greater morbidity
and mortality. The objectives of this study are to find out whether
the diagnostic evaluation of acid–base disorders in a population of
critically ill patients can be improved using Stewart’s method
compared with the traditional model, and whether acid–base
variables are associated with hospital mortality.
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ROC curves for the models including SOFA, age, albumin and
chloride.S182
Methods  This prospective observational study took place in a
university-affiliated hospital in Porto Alegre, Brazil, during the
period of February to May 2007. We recorded clinical data and
acid–base variables from 175 patients at ICU admission.
Results  The evaluation according to Stewart’s method would
allow an additional diagnosis of metabolic disorder in 59 (33.7%)
patients. Individually, none of the variables appear to be good
predictors of hospital mortality. However, using the multivariate
stepwise logistic regression, we had a model with good discrimi-
nation containing the SOFA score, age, chloride and albumin (area
under receiver operating characteristic curve = 0.80; 95% CI =
0.73 to 0.87). See Figure 1.
Conclusions The Stewart approach, compared with the traditional
evaluation, allows identifying more patients with major acid–base
disturbances. Hypoalbuminemia and hyperchloremia were
associated with mortality.
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Introduction  The current literature does not support buffers in
acidosis except when facing proven losses of bicarbonates [1].
However, human studies are lacking and data are supported by in
vitro or animal studies that showed the side effects of bicar-
bonates. The aim of this study was firstly to describe the frequency
of buffering therapy in ICU and secondly to compare the outcome
between patients treated by buffers (buffer group) or not
(nonbuffer group).
Methods  A prospective, multiple-center, observational study. All
patients presenting a severe metabolic or mixed acidosis (pH
<7.20) were screened. Acidoketosis was secondarily excluded.
The mechanism of acidosis was defined by classical analyses [2].
At admission, Simplified Acute Physiology Score (SAPS) II and
Sequential Organ Failure Assessment (SOFA) scores, pH,
bicarbonatemia, lactatemia, dialysis, mechanical ventilation and
vasopressor use were recorded. At ICU discharge, lengths of stay,
mechanical ventilation and mortality were recorded. Data are
presented as the medians and quartile ranges and compared with
the Mann–Whitney and Fisher’s exact tests.
Results One hundred and forty-six were included for analysis. The
main diagnosis at admission was septic shock (36%) and cardiac
arrest (12%). Ninety were not treated with buffers and 56 were
treated at day 0. Severity scores at admission (SOFA 10 (7 to 13)
vs. 11 (9 to 13) and SAPS II 62 (50 to 81) vs. 71 (54 to 81)),
frequency of vasopressors (86% vs. 93%), dialysis (17% vs. 26%)
and mechanical ventilation (86% vs. 93%) in the nonbuffer and
buffer groups, respectively, were not different. Bicarbonatemia was
significantly lower in the buffer group than in the nonbuffer group
(15 (10.3 to 18.0) vs. 13.4 (8.0 to 17.0); P <0.05). No significant
difference was observed between groups for length of stay in the
ICU (5 (3 to 7) vs. 4 (2 to 8) days), length of mechanical ventilation
(4 (2 to 5) vs. 3 (2 to 4) days) and mortality (58 vs. 59%) in the
nonbuffer and buffer groups respectively.
Conclusions In this multiple-center observational study, buffering
practices was heterogeneous. Buffering therapy in severe acidosis
(pH <7.20) does not seem to influence the ICU outcome. Further
clinical studies should be performed to better define the impact of
buffering therapy in selected patients in severe acidosis.
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Introduction Hypophosphataemia is a common treatable problem
in ICU, and is indicative of many pathophysiological processes that
occur in critical illness. This audit’s objective was to quantify the
incidence, severity and timing of hypophosphataemia in the ICU.
Namely, the incidence of hypophosphataemia on ICU admission
and the incidence that develops following admission.
Methods  A retrospective audit of data entered into the
computerised medical record database (CareVue) from all
admissions between 27 April 2006 and 7 July 2008. The time,
date and value of all serum phosphate concentrations were
analysed. Abnormal phosphate concentrations were categorised
as following: critically low (<0.3 mmol/l), low (<0.7 mmol/l), high
(>1.5 mmol/l).
Results A total 689 out of 795 patients admitted during this period
had a serum phosphate recorded. Table 1 presents the
classification of phosphate concentrations on admission to the ICU
and the minimum reached during their ICU admission. The
incidence of hypophosphataemia on admission to GRI ICU is 10%,
of which <1% is at a critical concentration. The incidence of
hypophosphataemia during the whole of the ICU stay rises to 42%.
Five per cent of ICU admissions get critical hypophosphataemia at
some point during their ICU stay; 69% of these patients have a
normal or high phosphate concentration on admission, 19% have a
low admission phosphate and 13% are admitted with a critically
low phosphate concentration.
Conclusions Hypophosphataemia is common in ICU admissions.
Most commonly it develops subsequent to admission to the ICU
and reaches critical concentrations in 5% of ICU admissions. The
timing of this fall in phosphate may indicate specific
pathophysiological processes and merits further investigation.
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Phosphate concentrations in ICU admissions (n = 689)
Severity On admission ICU minimum
Critical 4 32
Low 69 289
Normal 364 311
High 256 89S183
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Introduction Hypernatraemia is a prognostically serious complica-
tion in the neurointensive care unit. A typical, well-known syndrome
associated with acute brain disease is central diabetes insipidus
(cDI). However, cDI is not a frequent reason of hypernatraemia in
neurointensive care. There are other causes of hypernatraemia,
most frequently osmotherapy by mannitol or renal failure [1]. The
purpose of our study was to evaluate retrospectively all hyper-
natraemias in patients with acute brain diseases admitted to our
neurologic–neurosurgical care unit (NNICU) over a period of
5 years.
Methods We analysed all patients with acute brain disease and
serum sodium above 150 mmol/l. Firstly we diagnosed cDI
according to serum and urine osmolality, hourly diuresis, renal
function parameters and response to desmopressin. The remaining
hypernatraemias were categorised as non-cDI. Patients without
measured serum osmolality were excluded.
Results  There were 75 hypernatraemic patients (mean age
56.8 years; 41 male) with the following diagnoses: stroke 43,
tumour 20, trauma 7, hydrocephalus 4 and epilepsy 1. The mean
Glasgow coma scale (GCS) on onset of hypernatraemia was 12 ±
3.4, the mean Glasgow outcome scale (GOS) upon discharge
from the NNICU was 3.3 ± 1.4. We found cDI only in eight
patients (altogether 15 days). We classified 59 patients as non-cDI
hypernatraemia (163 days). The remaining patients were not
evaluated because they had no serum osmolality measurements.
Between the two groups there were no differences in GCS
(P = 0.631), GOS (P = 0.857), serum sodium (P = 0.736), and
serum osmolality (P = 0.476), but patients with cDI had low urine
osmolality (P  = 0.001). On the other hand, the non-cDI group
received more antioedematic therapy (P  = 0.013) and diuretics
(P = 0.019). In this group, mannitol was received in 48 (81.4%)
patients and six (10.2%) had creatinine clearance below the
reference range (range <1.15 ml/s).
Conclusions In neurointensive care cDI is not the most common
type of hypernatraemia. Most hypernatraemias are non-cDI due to
anti-oedematic therapy and kidney dysfunction.
Reference
1. Aiyagari V, Deibert E, Diringer M: Hypernatremia in the neu-
rologic intensive care unit: how high is too high? J Crit
Care 2006, 21:163-172.
P455
Impact of hypernatremia, hyponatremia and their
comparison on ICU mortality
M Mokhtari, M Kouchek, M Miri, R Goharani
SBU Medical Sciences, Tehran, Iran
Critical Care 2009, 13(Suppl 1):P455 (doi: 10.1186/cc7619)
Introduction  Serum sodium homeostasis is important in the
critically ill patient [1-3]. We studied the effect of hypernatremia,
hyponatremia and their comparison on ICU mortality in our patient
population.
Methods We studied 274 patients hospitalized in a general ICU of
a major teaching hospital in Tehran, Iran, cross-sectionally,
between 2004 and 2006. Patients’ biographical data, reasons for
admission, hyponatremia (sodium less than 135 mEq/l) and
hypernatremia (sodium more than 145 mEq/l) during the ICU stay
were recorded and their effects on mortality were assessed.
Results  The mortalities of patients with hyponatremia (34.33%
versus 15.37% with OR = 5.69 and 95% CI from 2.87 to 11.30)
and with hypernatremia (55.17% versus 17.78% with OR = 2.80
and 95% CI from 1.43 to 5.49) were significantly higher than
patients without it. The mean age of patients with sodium
imbalance was higher compared with those without it (hypo-
natremia and hypernatremia 52.25 ± 21.12 vs. 44.40 ± 20.28
years and 55.59 ± 19.69 vs. 48.52 ± 21.83 years, respectively).
Mortality was significantly higher in hypernatremic compared with
hyponatremic patients (55.2% vs. 34.3%, respectively, 95% CI
from 7.7% to 33.9%; P = 0.0034).
Conclusions Serum sodium imbalances carry unacceptably high
mortality [4]. Patients with hypernatremia showed higher ICU
mortality as compared with those with hyponatremia.
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Introduction Hyponatremia has been identified as a risk factor for
increased morbidity and mortality in patients with chronic heart
failure (HF) but there are few data for its prevalence and clinical
implication in patients with acute decompensated HF.
Methods  One hundred and eighty-two patients (142 male, age
72.1 ± 11.6 years) presented as worsening HF, NYHA III to IV,
48% with ejection fraction ≤30%, 43% of ischemic etiology, were
enrolled during the period from August 2007 to July 2008. In a
retrospective analysis we investigated the relationship between
hyponatremia and inhospital mortality, 60-day mortality and 60-day
rehospitalization. We divided the patients into three groups
according to their admission serum sodium. Group A, Na
≥136 mEq/l. Group B, Na = 135 to 131 mEq/l. Group C, Na
≤130 mEq/l.
Results Patients in Group C had a more severe heart failure, lower
blood pressure, lower ejection fraction and increased mortality
(6.4% in Group C vs. 3.4% in B vs. 1.8% in A, P  <0.05 for
inhospital mortality), (13.7% in Group C vs. 7.2% in B vs. 4.7% in
A, P <0.05 for 60-day mortality), (39.3% in Group C vs. 29.1% in
B vs. 27.2% in A, P <0.05 for rehospitalization). In multivariable
analysis, either moderate hyponatremia (Group B) or severe
hyponatremia (Group C) still remained predictors of death. Group
Available online http://ccforum.com/supplements/13/S1S184
B: hazard ratio = 1.72 95% CI = 1.40 to 2.17. Group C: hazard
ratio = 2.88 95% CI = 1.97 to 3.1.
Conclusions Our data confirm the independent prognostic value
of hyponatremia, even moderate, in patients with acute decom-
pensated HF. Serum sodium on admission is an important
predictor of increased mortality and rehospitalization.
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Introduction The objective of this study was to identify differences
in liver function tests (LFT) between patients admitted to a general
ICU (GICU) and a cardiothoracic ICU (CTICU), and the effect on
mortality. Liver dysfunction (LD) in critically ill patients is common
and is associated with increased mortality and prolonged ICU stay
[1]. Patients undergoing cardiothoracic surgery are anecdotally at
increased risk of LD as a consequence of haemodynamic
instability.
Methods A retrospective study of all first admissions to the CTICU
and the GICU between 1 October 2006 and 31 March 2007 was
performed. LFT were obtained from the Chemical Pathology
Department. Patient demographics and mortality were established
from the hospital electronic patient record.
Results A total of 481 patients were admitted to the CTICU and
661 to the GICU. Compared with the GICU, patients admitted to
the CTICU were older (66.9 vs. 59.7 years, P <0.05), more likely
to be male (71% vs. 58%, P <0.05) and more likely to survive (30-
day mortality 8.5% vs. 22%; P <0.05). At the time of admission,
albumin was <35 g/dl in 94% of patients and declined thereafter.
Excluding albumin, LFT were entirely normal in 50% and 54% on
admission to the GICU and the CTICU. Abnormal LFT on
admission were associated with increased mortality (Table 1).
Conclusions Abnormal LFT are common in critically ill patients on
admission to the ICU. Patients with subtle LD on admission are at
increased risk of mortality in both groups. An abnormal bilirubin has
a greater impact in patients admitted to the CTICU than the GICU.
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Introduction The sexual hormone pattern of the chronic critically ill
patient has been recently considered as one of determinants of the
catabolic state that delays recovery and conditions the outcome of
the disease. It is characterized by a reduction of the pituitary
production of luteinizing hormone-follicle-stimulating hormone
(LH-FSH) and consequently of the peripheral androgens; on the
contrary, the levels of estrogens are increased due to the
enhanced activity of aromatase [1]. The objective of our study was
to evaluate the pattern of sexual hormone production to identify a
correct replacement therapy.
Methods Thirteen men with chronic critical illness with a mean age
of 70 years and a mean APACHE score of 18 have been enrolled.
Patients with endocrinological pathologies or in therapy with
hormones, cortisones or dopamine have been excluded. The
analysis of the sexual endocrine function was determined on the
seventh day of stay in the ICU, considering the mean of four
nocturnal measurements of LH-FSH, androstenedione, dehydro-
epiandrosterone sulfate, testosterone and estradiol.
Results Only three patients showed a reduction of LH-FSH under
normal levels, 10 patients had normal levels of LH-FSH. All 13
patients had normal or elevated levels of androstendione, a pre-
cursor of testosterone. Levels of testosterone and dehydro-
epiandrosterone sulfate were decreased under normal levels in all
patients. Levels of estrogens were elevated above normal levels in
all patients.
Conclusions The present study shows that in the early phase of
chronic critical illness the reduction of testosterone could only
partially be determined by the decreased pituitary stimulation. The
normal levels of androstenedione, a precursor of testosterone,
suggest an impairment of the intracellular pathway of androgen
production through an inhibition of the 17β-hydroxysteroido-
dehydrogenase. Considering these results, an exogenous
stimulation of testosterone production with LH-FSH secreta-
gogues could be unisexual or not sufficient to rebalance the
testosterone levels [2]. Furthermore, the increased conversion of
peripheral androgens in estrogens mediated by aromatase is
confirmed in this study. The use of aromatase inhibitors could be
considered as a therapeutic way to rebalance the hormone axes in
critical illness.
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Abnormal LFT on admission to the ICU and associated 30-day mortality
GICU BIL CTICU BIL GICU ALT CTICU ALT GICU ALP CTICU ALP GICU GGT CTICU GGT
Abnormal on admission (%) 37.9 29.5* 20.3 19.7 12.6 5.2* 33.0 20.2*
Mortality odds ratio (95% CI) 1.35  1.99  2.23 5.07 2.24 2.92 1.87 4.01
(0.93 to  (1.05 to  (1.46 to  (2.62 to  (1.34 to  (1.08 to  (1.28 to  (2.08 to 
1.97) 3.79)* 3.39)* 9.83)* 3.74)* 7.59)* 2.73)* 7.70)*
BIL, bilirubin; ALT, alanine transferase; ALP, alkaline phosphatase; GGT, γ-glutamyltransferase. *P <0.05.S185
P459
Economic comparison of the traditional bathing method
with the basinless bathing method in coma patients
MJ Sucre, A De Nicola
San Leonardo Hospital, Castellammare di Stabia, Italy
Critical Care 2009, 13(Suppl 1):P459 (doi: 10.1186/cc7623)
Introduction The coma patient is a particular and unique patient:
he depends completely on the caregivers, more than a neonate.
The bed bath of a coma patient is important to maintain his
personal hygiene, to clean and refresh, to monitor skin condition
and to promote comfort. Modern ICU management must offer a
high quality of coma patient care and should be constantly fighting
for cost-effective ways of providing that care.
Methods The aim of this study was to compare the traditional bed-
bathing method with the basinless bed-bathing method. The study
focused on nurse satisfaction or acceptance, and the costs of two
methods. The study comprised 100 baths of coma patients: 50
completed using the Comfort Bath® (a prepackaged disposable
bed bath) and 50 completed using the traditional method. In
addition, 30 nurses were recruited and interviewed about their
preferences and opinions. The economic study type was cost-
minimization and, in part, cost-effectiveness analysis.
Results  For skin softness, administration ease, and nurse
satisfaction, there were statistical variations between the two sets
of scores, in favour of the Comfort Bath® method. Nurses
expressed a clear and significant preference for the disposable
bath, corroborating findings by other investigators [1]. The direct
costs were: for the soap, water, laundry, equipment and labour, for
the time taken to perform the bed-bathing, for logistics and
depreciation. The overall cost was less for the disposable bath due
to savings in nurses’ time and salary (Table 1).
Table 1 (abstract P459)
Costs of bath technology required
Traditional bath Comfort Bath®
Total bath costs  18.46  16.74
Savings 1.73
Conclusions The present study confirmed that Comfort Bath®, a
one-step bed bath, is an economic and preferred alternative to the
basin of water. Considering the cost-minimization, the cost-
effective use and the significant preference, this prepackaged
disposable bed bath symbolizes a new concept in coma patient
hygiene.
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Introduction Weight is frequently required to determine the dose
of many medications and is important in quantifying treatments
such as haemofiltration and calorific requirement. We present the
findings of an audit to determine how frequently a patient’s weight
is estimated in one ICU and the results of a pilot study to deter-
mine the accuracy of an estimated weight in the critically ill patient.
Methods A prospective audit of 100 admissions to an ICU was
undertaken over a 6-week period. Data were collected from
observation charts and hospital notes. Following data analysis a
pilot study was undertaken to assess the accuracy of the estimated
weight of patients in the ICU. Urine bags and drains were emptied
before weighing and the same number of pillows and blankets was
ensured on each bed. Due to a short loan period of scales, only 18
patients could be weighed.
Results Audit The median (IQR) patient weight was 75 kg (64 to
85). Ninety-four ICU observation charts had a weight recorded,
and of these 38 (40.4%) were estimated. Sixteen out of 20 (80%)
medical patients and 22/74 (29.7%) surgical patients had an
estimated weight. Sixty-three per cent of patients had a recent
accurate weight recorded in the notes and only 43 (68.3%) had
the same weight recorded on the ICU observation chart. Seventy
per cent of patients required a weight for cardiac output monitoring
and 54% for drug dose calculation. Pilot study The median (range)
measured weight was 92 (66.8 to 137.4) kg. Twelve out of 18 had
an estimated weight on the ICU chart. The mean (precision) of
estimation was 10.1 (±21.4) kg. Seven out of 12 (58%) had a
greater than 10% difference between the estimated and true
weights. Of the six patients who had a recent accurate weight
documented in the notes, the mean difference (precision) between
that and the true weight was 5.8 (±4.0) kg. Two out of six (33%) had
a greater than 10% difference between estimated and true weights.
Conclusions A patient’s weight is an important parameter in guiding
therapy. A large proportion of ICU patients have their weight
estimated. In some cases this is unnecessary as a recent weight can
be found in the notes. A more comprehensive study is required to
assess the clinical impact of weight estimation on the ICU.
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Introduction Alcohol misuse is associated with many conditions
requiring ICU management [1]. In 2006/2007, 1.53% of all
hospital admissions were related to alcohol misuse (regional audit).
We conducted a prospective audit in a tertiary referral adult ICU to
ascertain the proportion of ICU capacity used for the treatment of
conditions related to alcohol misuse.
Methods Patients admitted to a tertiary referral ICU between 1
November 2006 and 31 March 2007 were prospectively audited
with the aim of identifying all cases in which the reason for
admission could be attributed to acute or chronic alcohol misuse.
Blood alcohol levels, past history from the patient/relatives or
previous relevant clinical investigations and/or diagnoses were
reviewed for evidence of acute or chronic alcohol misuse.
Results  Of 318 ICU admissions during the audit, 9.43% (30
admissions – 20 male/10 female) were judged to be due to either
acute (19 of 30) or chronic (11 of 30) alcohol consumption. The
mean patient age was 48.7 years (SD 14.1, range 25 to 74).
Blood alcohol level on admission to hospital was available in 13
patients (43%), the median value being 170 mg% (IQR = 66 to
274). Seventeen patients (56.6%) were admitted following trauma,
of whom 10 (33.3%), had brain injuries. The median length of stay
(LOS) in the ICU was 10 days (IQR = 4 to 15) and the median
LOS in hospital was 22 days (IQR = 10 to 38). The ICU mortality
Available online http://ccforum.com/supplements/13/S1S186
rate was 23.3% (seven out of 30) and hospital mortality was 30%
(nine out of 30). During the audit period, a total of 2,567 ICU bed-
days were available, of which 357 bed-days (13.9%) were used to
treat this group of patients. The mean ICU occupancy during this
period was 95.6%.
Conclusions Alcohol misuse was implicated in almost 10% of ICU
admissions – over six times the equivalent rate for total hospital
admissions. These admissions required approximately 14% of total
ICU capacity at a time when occupancy was almost 100%.
Intensive care is a finite and expensive hospital resource. Public
health bodies should be informed of the proportion of that resource
required to treat alcohol-related illness and injury.
Reference
1. O’Brien J, et al.: Alcohol dependence is independently
associated with sepsis, septic shock, and hospital mortal-
ity among adult intensive care unit patients. Crit Care Med
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Introduction Patients with systemic rheumatic diseases may be
admitted to the ICU because of pulmonary, renal or multiple organ
dysfunction, caused by worsening of the rheumatic disease,
infection or adverse effects of immunosuppressive drugs.
Methods In a 3-year period, 14 patients (six males/eight females),
18 to 80 years old (average 56.78), with systemic rheumatic
diseases were admitted in the ICU. Four of them had rheumatoid
arthritis, one systemic lupus erythematosus, three dermatopoly-
myositis, one Sjogren’s syndrome, two vasculitis, two systemic
sclerosis and one psoriatic arthritis. Three of them were admitted
to the ICU after major surgical operation, nine of them because of
respiratory failure and the others because of coma and/or shock.
The admission APACHE II score, chest X-ray, bronchial secretion
cultures, and PaO2/FiO2 were recorded, as well as the broncho-
alveolar lavage findings, when it was necessary, and the final
outcome.
Results Nine patients were admitted because of acute respiratory
failure: APACHE II score ranged from 17 to 28, X-ray showed
diffuse alveolar infiltrates, PaO2/FiO2 ranged from 75 to 184, only
two patients had positive cultures of bronchial secretions. Two
patients were admitted after major surgical operation, one after
necrotizing pancreatitis: APACHE II score ranged from 9 to 21,
X-ray showed diffuse alveolar infiltrates with a cavity in one,
PaO2/FiO2 >300, the bronchial secretions cultures were negative.
One patient was admitted because of coma and one other
because of shock: APACHE II score was 25 and 32, respectively,
X-ray without any acute process, PaO2/FiO2 was >200 and none
of them had positive cultures of bronchial secretions. Broncho-
alveolar lavage was performed on six patients: on the second day
from ICU admission in four patients, on the eighth day in one
patient and on the 21st day in one patient. The total mortality rate
was 50% (7/14).
Conclusions  Early bronchoalveolar lavage (during the first 48
hours from admission) could help in differential diagnosis between:
exacerbation of rheumatic disease, infection, drug-induced
respiratory failure, and alveolar hemorrhage.
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Introduction  We monitored the distances covered by nurses
during their work in the ICU. An automatic step counter was used
to estimate the distances.
Methods Seventeen nurses were monitored during 102 hours in
total. Eight of them were responsible for one ICU patient during the
monitoring period and nine took care of two patients at the same
time.
Results The mean distance covered was 0.9 (range 0.4 to 1.3)
km/hour, resulting in a mean 10.7 km per 12-hour shift. The
distance was significantly different according to the number of
patients the nurse was responsible for. The nurses taking care of
two patients walked significantly more compared with the nurses
with one patient (1.0 with range 0.9 to 1.3 compared with 0.7 with
range 0.4 to 1.1 km/hour, P = 0.027). During their shift the nurses
walked a mean 12.3 km when taking care of two patients and
8.9 km when working with only one ICU patient.
Conclusions  Nurses need to cover long distances during their
everyday work. In some cases the walking distance may be
expected to reach 15 km during the 12-hour shift. Optimization of
the working load and logistics to reduce the walking distances
should be the goal.
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Introduction  Admitting patients to the ICU is one of the triage
processes needed during mass casualty events (MCE). The high
occupancy of the ICU and the fact that it cannot be readily
evacuated make this process even more challenging [1,2]. We
compared the triage to the ICU in terror-related MCE versus other
trauma in Israel.
Methods A retrospective cohort study of all patients recorded in
the Israeli National Trauma registry (ITR) that were injured in MCE
secondary to terrorist acts by explosions from 1 October 2000 to
31 December 2005. Medical records of all patients hospitalized in
the ICU were retrieved and reviewed. Over-triage was defined as a
patient that is discharged from the ICU within 24 hours of
admission without any specific intervention besides monitoring.
Under-triage was defined as an admission to the ICU more than
24 hours after an admission to a different department.
Results  The ITR included 122,208 patients during the study
period. A total of 1,272 patients (1.0%) were injured in terror-
related MCE. Three hundred and sixty-five patients (28.7%) of the
MCE group and 9,093 patients (7.5%) of the non-MCE group
were admitted to the ICU. Eighty-one (6.4%) of the patients in the
MCE group and 2,445 (2.0%) of the patients in the non-MCE
group were admitted to the ICU and discharged within 24 hours
(P <0.0001). A total of 3.3% of the patients in the MCE and 9.2%
of the patients in the non-MCE group were admitted to the ICU
more than 24 hours after admission to another department.
Patients that were over-triaged to the ICU during MCE had
significantly more injuries, and to more body regions, than the
patients that were over-triaged to the ICU due to non-MCE trauma.
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Conclusions  Over-triage to the ICU is probably unavoidable in
MCE. This fact and the increased injury severity, anticipated in
terror-related MCE, should lead the hospital to adopt a plan for
expansion of the ICU capabilities. A post-event ICU re-evaluation
round and judicious patient discharge may reduce prolonged
overuse of ICU resources.
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Introduction The objective of this study was to determine whether
onsite intensivist coverage would improve the outcome of weekend
and afterhour admissions in our ICU.
Methods In a cohort study at a tertiary-care medical–surgical ICU
staffed 24 hours/7 days by onsite consultant intensivists with
predominantly North American Critical Care Board certifications, we
included all ICU admissions (January 2007 to February 2008) from
a prospectively collected ICU database. Results were stratified
based on the time of the admission (daytime (8:00 to 17:00) or
afterhour time (17:01 to 07:59)) and the day of the week (weekday
or weekend). Predicted mortality rates were calculated using an
APACHE IV prediction model. The primary outcome was hospital
mortality, and standardized mortality ratios (SMRs) were calculated.
Results A total of 1,315 admissions were included in the study.
Forty-eight percent of patients were admitted in daytime and 52%
in afterhour time with average APACHE IV scores of 59.8 and 55,
respectively (P <0.01), the SMR for the daytime group was 0.86
(95% CI = 0.69 to 1.05, P = 0.15) compared with an SMR of the
afterhour group of 0.98 (95% CI = 0.84 to 1.15, P = 0.83).
Seventy-two percent of patients were admitted on a weekday and
28% on weekends with average APACHE IV scores of 57.7 and
58.7, respectively (P = 0.52); there was no significant difference in
mortality rates between the weekday and weekend groups (17.3%
vs. 21.4, P = 0.09, with SMRs of 1.05 vs. 0.89). After adjustment
for severity of illness it appears that there is a trend towards a
lower mortality rate for daytime and weekday admissions compared
with afterhour and weekend admissions; however, there is no
statistical difference.
Conclusions Our results indicate no difference in mortality rates
for weekend and afterhour admissions to an ICU that is staffed by
onsite certified intensivists.
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Introduction The audit was commissioned by the Scottish Govern-
ment Health Department to identify the number of acutely ill adults
transported between hospitals by the Scottish Ambulance Service
(SAS). Currently interhospital transfer (IHT) of acutely ill adults
requiring medical escorts is undertaken by the SAS Accident and
Emergency (A&E) ambulances or by dedicated transport teams (for
example, Glasgow Shock Team and Emergency Medical Retrieval
Service).
Methods The audit ran for 20 weeks. Patients over 16 years old
who required intervention/vital signs monitoring during transfer or
who required a nursing or medical escort were defined as acutely
ill. Audit forms were placed in every A&E ambulance.
Results A total of 3,068 forms were received, with 2,396 audited.
Twenty per cent were emergencies, 73% urgent and 7% planned.
The median SAS journey times, patient and dedicated team
journey times are presented in Table 1. The majority of IHTs
occurred for specialist management (65.9%) or specialist
investigation (23%). A total of 820 IHTs were clinically escorted,
including the Glasgow Shock Team (n = 192) and the Emergency
Medical Retrieval Service (n = 13). Two hundred and forty-eight
patients were ventilated (10.3%). Eighty-four (3.5%) IHTs required
clinical intervention to correct clinical deterioration. An adverse
event occurred in 1.5% (22). One hundred and thirteen (18%)
escorted IHTs by nondedicated transport teams had unsecured
medical equipment versus 2/205 (0.97%) in dedicated transport
teams (P  = 0.004). Equipment failures occurred in 9/97(9.2%)
ventilated transfers by nondedicated teams versus 1/156 (0.6%)
by dedicated teams (P = 0.001). The SAS executive information
service data showed a total number of IHTs during the audit period
conveyed by A&E ambulances as 19,747 (18,343 adults). This
approximates to a total of 51,342 per annum (47,692 adults) or
917 adults per week.
Conclusions  The most frequent reason for IHT is specialist
management or investigation. Adverse events are reassuringly
uncommon. Unsecured medical equipment and equipment failure
during an IHT is significantly more frequent when undertaken by
nondedicated transport teams.
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Introduction  Patients who undergo transfer to the ICU of an
academic referral centre represent a group of sicker patients with
increased risk for grim prognosis than those admitted directly.
These patients’ weight in terms of increased resource utilization is,
however, less studied. This study aimed to compare the outcome
and resource consumption between directly admitted patients and
those transferred from a peripheral hospital to the ICU of a large
tertiary-care referral centre.
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Journey times (hh:mm)
SAS n = 2,396 Median 01:08
Patients n = 2,396 Median 00:44
Ventilated patients n = 248 Median 00:28
Dedicated team n = 205 Median 03:05S188
Methods  A prospective observational cohort study was
conducted. All consecutive patients admitted to the medical and
surgical ICU from 15 September 2007 to 15 December 2007
were retained for analysis. Severity of illness by means of the
Sequential Organ Failure Assessment (SOFA) score, length of stay
(LOS), and outcomes were gathered per admission. Data are
presented as numbers (%) or as mean ± standard deviation. All
statistical tests were performed as appropriate. The level of
significance was set at P <0.05.
Results Crude comparison of directly admitted (n = 500) versus
transfer patients (n = 85) revealed that transfer patients had signi-
ficantly higher severity of illness as expressed by the admission,
mean, and maximum SOFA score (P = 0.042,  P = 0.034, and
P = 0.005), but not by the APACHE II score (P = 0.422), respec-
tively. Transfer patients necessitated higher resource consumption
as defined by the need for mechanical ventilation (P <0.001),
vasopressor therapy (P = 0.01), medical imaging (respectively, CT
or MRI) (P <0.001), urgent surgical intervention during their stay in
the ICU (P <0.001), sedative drugs (P <0.001), and tracheostomy
placement (P <0.001) compared with directly admitted patients,
whereas no significant differences were found regarding need for
renal replacement therapy (P = 0.47) and blood transfusion
(P = 0.41), respectively. A significant increased ICU LOS (8.6 ±
11.1 days vs. 4.9 ± 7.4 days, P <0.01) was observed for trans-
ferred patients, whereas no difference was found for hospital LOS
(23.6 ± 27.4 days vs. 24.5 ± 25.7 days, P = 0.81). When
comparing both groups, those transferred from other hospitals
were found to have worse outcome as demonstrated by higher ICU
and inhospital mortality rates (16.5% vs. 8.6%, P = 0.03, and
29.6% vs. 14.5%, P = 0.002). Even after adjustment for severity of
illness, being transferred was found to be independently asso-
ciated with higher inhospital mortality (OR = 2.84, 95% CI = 1.41
to 5.72) (receiver operating characteristic = 0.87, 95% CI = 0.83
to 0.91, P <0.001) (Hosmer and Lemeshow, chi-square, 6.27;
degrees of freedom, 8; P = 0.617).
Conclusions  Patients transferred to the ICU of a tertiary-care
referral centre generally consume more resources and have worse
outcome as compared with directly admitted patients.
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Introduction  For improvement of patient safety, monitors and
ventilator workstations are equipped with alarms. However, alarms
are only suggestive if they indicate critical variations in the patient’s
condition. Great numbers of false alarms can lead to a crying wolf
phenomenon with consecutive ignored critical situations. The
objective of this study was to characterize the patterns of alarming
of a currently available patient vital sign monitor (Kappa XLT;
Draeger) and an anesthetic workstation (Zeus; Draeger) during
cardiac surgery.
Methods  A prospective, observational study including 25
consecutive elective cardiac surgery patients. In all patients a
predefined alarm setting was used. During 25 surgical procedures,
all incoming patient data and alarms from the monitor and the
anesthetic workstation were digitally recorded. Additionally, the
anesthesiological workplace was filmed from two different views to
assess reaction to the alarms. All events of alarming were retro-
spectively annotated. Alarms were categorized: valid/not valid,
relevant/not relevant and medical reaction yes/no. Alarms were
annotated as relevant if measurement was technically correct and
showed a threshold violation. Alarms were relevant if there was a
need for medical reaction.
Results  During 124 hours of recording, 9,460 alarms in 48
categories were registered. A total of 3,054 (32%) alarms were of
technical origin or static alarms and were not considered. The
remaining 6,406 alarms were further analyzed. In total, 1,954
alarms were not valid and not relevant. A total of 4,452 alarms
were valid (69%), 1,742 of these were clinically relevant and
induced a reaction of the physician, 1,773 were relevant without a
reaction of the physician. About 65% of the considered alarms
were threshold violations (48% blood pressure). Nine hundred and
thirty-seven alarms were valid but not relevant.
Conclusions Approximately 80% of the total 9,460 alarms had no
therapeutic consequences. Thirty-one per cent of the considered
alarms were annotated as not valid. Sixty-nine per cent of the
considered alarms were valid alarms, separated into 39% relevant
alarms, 21% nonrelevant alarms and 40% relevant alarms without
reaction of the physician. The majority of the static alarms occurred
during the use of the extracorporeal circulation. Implementation of
procedure-specific settings and optimization in artefact or
technical alarm detection could improve patient surveillance and
safety.
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Introduction To develop models that are discriminative for second-
day discharge (SDD) after non-emergency cardiac surgery [1].
Methods  We evaluated electronic medical records of 453
consecutive adult non-emergency cardiac surgery patients, from
June 2006 to May 2007. The following variables were considered
as inputs: (a) one-time characteristics: sex, age, weekday, BMI,
duration of surgery, length of first day; (b) binary variables (yes/no):
cardiopulmonary bypass, external pacing, midazolam, hemo-
dynamic drugs; (c) continuous variables: pulmonary artery
pressure, arterial blood pressure, heart rate, cardiac output, PaO2,
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PaCO2, FiO2, creatinine; (d) categorical values: Glasgow coma
scale eye–motor–verbal, Bloomsbury score, pain score, positive
end-expiratory pressure; (e) averages over time: urine output, blood
loss, piritramide and propofol dosage; (f) percentage of time on
mechanical ventilation. Variables associated with SDD in univariate
analysis were entered into six multivariate logistic regression
models. We calculated the area under the receiver operating
characteristic curve (aROC) for discrimination; calibration was
evaluated by Hosmer–Lemeshow goodness-of-fit.
Results  Ninety-nine patients (21.9%) were discharged on the
second day. All models showed good discrimination (aROC =
0.881 to 0.905) and calibration (P >0.05) (Figure 1). Nine
determinants were associated with SDD in all models: sex, age,
weekday, hemodynamic drugs, systolic arterial blood pressure,
heart rate, verbal Glasgow coma scale, urine output and
percentage of time on mechanical ventilation. Entering these nine
terms into a combination model could improve discrimination
(aROC = 0.933) but led to overfitting (P = 0.0143).
Conclusions An electronic medical record can be used to create
risk prediction models after cardiac surgery. We derived nine
parameters associated with SDD.
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Introduction The clinical deterioration of patients is often heralded
by a decline in physiological parameters by up to 24 hours [1].
NICE clinical guideline 50 (NCG 50) was published in July 2007 –
‘Recognition of and response to acute illness in adults in hospital’ –
with the aim of improving the care of acutely ill patients. We under-
took an audit to determine how our institution currently performed.
Methods Case records were randomly collated documenting the
management of 89 adult patients admitted to and discharged from
critical care over a 2-month period. An audit tool was developed to
compare these cases against all 25 NCG 50 standards using 50
complete and 39 incomplete datasets.
Results  One hundred per cent compliance with NCG 50 was
achieved in 2/25 (8%) parameters – measurement of admission
heart rate and physiological observations ≤12 hourly. Furthermore,
8/25 (36%) achieved 94% compliance including blood pressure
measurement, oxygenation, response to deterioration and a written
discharge plan. However, 4/25 (16%) parameters had ≤50%
compliance including documentation of routine observations and
their recording frequency.
Conclusions This audit has shown that compliance with NCG 50
standards is excellent in several key areas. In order to improve
where standard adherence was suboptimal we have introduced a
novel strategy to ensure that ward-based documentation of the
observation frequency is now mandatory, with specific guidelines
for escalation dependent on the clinical scenario. We believe the
results of this audit are likely to be applicable to other
organisations and suggest that a similar action plan be considered
to ensure NCG 50 goals are achieved.
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Introduction  The system of an inhospital rapid response team
(RRT) is desired to be set up. Our hospital adopted a unique rapid
response system (RRS) constructed with two different systems
(organized and systematic system to activate RRT members, and
nonorganized and nonsystematic system to gather doctors and
nurses near the scene) with an inhospital whole paging system
(doctor call (DC)). The object of this study is to clarify the
usefulness and problems of our RRS.
Methods We examined the records of 55 patients enrolled in our
RRS for the past 2.5 years and evaluated the change of the death
rate in whole discharged patients before and after the establish-
ment of the RRS. Our unique RRS is as follows. A hospital staff
member who finds a collapsed patient/visitor or a patient/visitor
requiring urgent medical support or another staff near the scene
calls the inhospital whole paging system (DC), which is announced
in all areas of the hospital. Staff of the Critical Care and Emergency
Center (CCE Center) bring an automated extracorporeal defibril-
lator and one bag prepared for the emergency crisis for one
person. Other staff near the scene bring a monitor, oxygen,
emergency cart and stretcher. We established an inhospital
educational course for basic life support and basic resuscitation
skill and a self-educating system using an e-learning system.
Results  The events mainly occurred in the diagnostic and
treatment room, waiting area, examination room for blood sampling
or X-ray examination in the outpatient department (55%) and in the
lavatory (5%). They seldom occurred in the critical care area (2%).
The reasons why bystanders decided to start up the RRS are
suspected cardiac arrest (13%), loss of consciousness (18%),
witnessed falling down (31%), and lying down (16%). The mean
time interval between the event and DC is 0.96 and that between
the event and responding staff arrival at the scene is 1.81 minutes,
respectively. The definitive diagnoses were cardiopulmonary arrest
in 15%, cardiac event in 5% and psychiatric in 27%. In nine
cardiopulmonary arrest cases, 33% were identified as an indication
of resuscitation because of ‘do not attempt resuscitation’ during
activity. The RRT managed 59% of the patients within 1.1 minutes.
Both the hospital death rate per total discharged patients and that
excepting patients treated in our CCE Center showed a
decreasing tendency after official organization in the hospital as a
regular system.
Conclusions Our unique RRS is thought to work well. However, it
needs to be helped by other doctors working nearer the scene
than the RRT.
Available online http://ccforum.com/supplements/13/S1S190
P472
Influence of medical emergency team call system
introduction on critically ill patients
M Pavlik, V Zvonicek, L Dadak, T Bartosik, V Sramek
Saint Ann’s University Hospital, Brno, Czech Republic
Critical Care 2009, 13(Suppl 1):P472 (doi: 10.1186/cc7636)
Introduction  Many patients admitted to hospital develop early
signs of instability (such as tachycardia, hypotension, hypoxemia,
and so on) before a critical event occurs [1]. Often those patients
are admitted to the ICU with significant delay after multiple organ
failure has developed. Different systems of early detection of
unstable patients have been designed, one of them called the
medical emergency team (MET) call system. The efficacy of
systems is still debated [2,3]. Introducing this system in our
university hospital was supposed to improve the mortality and
length of ICU stay for patients admitted to the ICU through this
system.
Methods The MET was established in our hospital in June 2006.
Two groups of patients admitted to the ICU during a 2-year period
were compared (before the MET call system and after its
introduction).
Results The standard group of patients admitted to the ICU within
a 6-month period before introducing the MET call system included
115 patients; male/female 76/39; APACHE II score 25 (18 to 31);
age 63 (53 to 74) years; length of stay 4 (2 to 9) days; mortality
22.6%, and was compared with the group admitted through the
MET system: 100 patients; male/female 58/42; APACHE II score
23 (21 to 29); age 69 (59 to 75) years; length of stay 5 (3 to 9)
days; mortality 32%. Variables are expressed as the median (IQR).
There were no statistically significant differences between groups
calculated by the chi-square and Mann–Whitney U tests.
Conclusions  The mortality and length of ICU stay of patients
admitted to the ICU by the standard system compared with those
admitted through the MET call system were not different. Early
detection of the critically ill patients in the university hospital is
supposed to improve their management and outcome. According
to our results, we cannot so far confirm this statement.
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Introduction  Hematopoietic stem cell transplantation (HSCT) is
the standard treatment for various hematological disorders. While
offering the potential for cure, it continues to be associated with
significant morbidity and mortality, with 10 to 40% of recipients
requiring admission to the ICU. Critical Care Outreach (CCO) is a
service designed to provide timely access to ICU-level care and
earlier stabilization of critically ill patients. The objective of our
study was to compare outcomes of adult HSCT recipients before
and after the initiation of a CCO team.
Methods Adults undergoing HSCT at The Ottawa Hospital were
divided into the pre-CCO cohort (January 2000 to December
2004,  n = 520) and the post-CCO cohort (January 2005 to
December 2007, n = 309). The primary outcome was nonrelapse
mortality at day 100 post-transplant (NRM-100). Secondary
outcomes were incidence of ICU admission, duration of ICU
admission, incidence of mechanical ventilation (MV), duration of
MV, APACHE II score and number of failing organs at time of ICU
admission, and NRM-100 for patients admitted to the ICU.
Results  Following the introduction of CCO, there was a trend
towards reduced NRM-100 (10.2% vs. 8.4%, P = 0.46) and
reduced incidence of ICU admission (13.6% vs. 12.3%, P = 0.65)
for all HSCT patients. For those admitted to the ICU, there were no
significant differences pre-CCO and post-CCO in the proportion
of patients requiring MV (70.3% vs. 78.6%, P = 0.47), duration of
MV (8.9 vs. 8.5 days, P = 0.87), length of ICU admission (12.6 vs.
17.4 days, P = 0.25), APACHE II score (23.8 vs. 23.5, P = 0.78),
and NRM-100 (48% vs. 50%, P  = NS). The number of failed
organs upon admission to the ICU, however, was significantly
reduced (2.31 vs. 1.85, P  = 0.039). Patients undergoing allo-
geneic transplants post-CCO had a nonsignificant reduction in
NRM-100 (22.5% vs. 18.0%, P = 0.25), and for those admitted to
the ICU we detected a trend towards reduced duration of MV
(10.4 vs. 6.0 days, P = 0.11) and improved NRM-100 (71.4% vs.
53.8%, P = 0.19).
Conclusions CCO in a tertiary care HSCT program is associated
with a trend towards reduced nonrelapse mortality and ICU
admission. Patients transferred to the ICU in the post-CCO era
had fewer failed organ systems at the time of ICU admission.
Those patients at highest risk of treatment-related complications
appeared to experience greater overall benefit from the CCO
intervention. Our experience suggests that CCO be considered an
important service for HSCT transplant centres.
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Introduction Our hypothesis was that critically ill patients admitted
to our district general ICU were frequently receiving suboptimal
resuscitative care and monitoring prior to ICU admission. A confi-
dential enquiry over 10 years ago in two hospitals in England found
such a situation [1].
Methods  All patients admitted to our ICU from 1 January to 8
March 2008 had their case notes, monitoring charts and drug
prescriptions reviewed by an ICU consultant. The adequacy of
resuscitative care and monitoring was assessed using a 10 cm
visual analogue scale (VAS). Where care was felt to be
inadequate, reasoning was documented. If a central venous
catheter (CVC) had been inserted, the specialty of the doctor who
performed the procedure was documented.
Results There were 64 admissions during the study period, eight
were excluded (ICU transfers from other hospitals) and all 56
remaining were analysed. Median VAS scores for adequacy of
resuscitative care and monitoring are presented in Table 1. In nine
(17%) patients care was felt to be inadequate. The two most
common reasons (five patients each) were inadequate circulatory
management, particularly failure to commence inotropic/vaso-
pressor therapy, and inadequate monitoring, particularly fluid
balance and invasive cardiovascular monitoring. CVCs were
Critical Care    March 2009 Vol 13 Suppl 1 29th International Symposium on Intensive Care and Emergency MedicineS191
inserted by ICU/anaesthetic staff on 56% of occasions, by
emergency department staff on 25% of occasions, surgical staff on
13% and medical staff on 6%.
Conclusions Suboptimal resuscitative care and monitoring prior to
ICU admission is present in a significant minority of our patients
and appears particularly related to the management of hypotension
and shock. Further training focusing on these areas (including
CVC insertion) for noncritical care trained staff may help improve
patient care and outcome.
Reference
1. McQuillan P, et al.: Confidential inquiry into quality of care
before admission to intensive care. BMJ 1998, 316:1853-
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Introduction  During 2009 the European working time directive
(EWTD) requires trainee doctors to work an average 48-hour week
[1]. Hospitals will be seeking novel methods to cover existing
medical rotas. We aimed to establish whether it would be
reasonable to reduce current levels of out-of-hours (OOH) medical
cover in cardiac ICUs (CICUs) based upon current UK practice.
Methods  All UK units caring for cardiac surgical patients were
contacted in January 2008. OOH medical cover was ascertained
by speaking to either a consultant or a senior nurse. The 30-day
survival rate and annual caseload for all cardiac surgery over a
3-year period up to March 2006 were analysed [2].
Results Thirty-nine CICUs were contacted. Three were excluded
because of incomplete data. OOH anaesthetic specialist registrar
(ASpR) cover for CICUs is presented in Table 1. The 30-day
survival rate for cardiac surgery over a 3-year period ending March
2006 was either the same as or higher than expected based on
predictive EuroSCORE data for all units. One centre performing
<1,000 cases per year employed a nurse practitioner trained in
intubation and central venous cannulation rather than having a
dedicated ASpR.
Conclusions  Units undertaking >1,000 cases per year have
dedicated OOH ASpR cover. EuroSCOREs are increasing
amongst UK cardiac surgical patients because of increasing age,
and this leads to lower predicted survival [3]. A reduction in
medical cover on CICUs to facilitate implementation of the EWTD
would be counterintuitive and outside current UK practice for units
performing >1,000 cases per year. Novel models exist but more
work is required to establish their safety in larger units.
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Introduction Patient outcome has been linked to the timing of the
first senior medical review in emergency medical admissions to
hospital, and after ICU admission [1,2]. The National Confidential
Enquiry into Patient Outcome and Death (NCEPOD) 2005 report
revealed that in participating UK ICUs 75% of new ICU patients
had a consultant intensivist review within 12 hours of admission
[3]. This is now a recommended standard, although data were only
available for 40% of patients, and neither supportive patient
outcome data nor pre-ICU review timings were cited.
Methods By retrospective review of patients’ ICU medical notes,
we studied the length of time in hours to first consultant intensivist
review before and after ICU admission in 122 consecutive
patients. We also examined mortality and length of stay (LOS)
outcomes in patients reviewed early (<12 hours) and late
(>12 hours) after ICU admission. Continuous data are expressed
as the median (IQR).
Results Overall, data were available for 96 patients reviewed after
ICU admission (median = 6.0, IQR = 1.1 to 14.7 hours), 79 (82%)
of these reviews being early (median = 3, IQR = 0.5 to 7.5). ICU
mortality for the early group was 31.6% during a median ICU LOS
of 1.8 days (IQR = 0.9 to 7.9). Median review time for the late
group (n = 17) was 21 hours (IQR = 18.5 to 28.4), with an ICU
mortality of 23.5%, during a median ICU LOS of 8.1 days (IQR =
2.1 to 14). The early group had a significantly shorter ICU LOS
(P = 0.007, two-sided Mann–Whitney test) than the late group,
and there was no significant proportional difference in ICU
mortality between the two groups. Furthermore, before ICU
admission, 56/122 patients (46%) had been reviewed by a
consultant intensivist (median = 2.2, IQR = 1.2 to 4.0 hours), and
in many patients this constituted the only such review prior to
12 hours into ICU admission.
Conclusions Review by a consultant intensivist is common before
ICU admission. Early review after ICU admission may be
Available online http://ccforum.com/supplements/13/S1
Table 1 (abstract P474)
Adequacy of resuscitative care and monitoring VAS scores
Oxygen Airway Breathing Circulation Monitoring
9.2 (0 to 9.7 (8.8 to 9.3)) 9.1 (4.6 to 9.8 (9.0 to 9.3)) 9.2 (1.5 to 9.6 (8.9 to 9.3)) 8.8 (1.5 to 9.6 (5.6 to 9.3)) 8.8 (0.8 to 9.7 (5.5 to 9.2))
Data presented as median (range (IQR)).
Table 1 (abstract P475)
Anaesthetic cover for UK CICUs outside normal working hours
Resident Resident 
Number of operations/year ASpR – yes ASpR – no
Less than 1,000 6 19
More than 1,000 11 0S192
associated with a shorter length of ICU stay. Timing of the first
review is likely to be influenced by many factors, other than
NCEPOD recommendations.
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Introduction  Intermediate care or step-down units are widely
introduced to improve utilization of critical care resources, to
smooth transition for patients transferred from the ICU and to
reduce the ICU length of stay. However, the effect that
intermediate care units can have on the case-mix of specific ICUs
and how this relates to measures of morbidity, mortality and
severity of illness is not clear.
Methods  We analyzed data from two cohorts of ICU patients
staying >24 hours, which were prospectively collected from March
2000 to April 2001 and from March 2006 to April 2007 in a 12-
bed cardiologic–pulmonary ICU in a tertiary-care center university
hospital. Two intermediate care step-down units were introduced
in between, with the units fully operational in 2005. We compared
demographics, measures of resource use, severity of illness and
mortality.
Results Totals of 705 and 389 patients (–45%) were admitted in
2000/01 and in 2006/07. There were no significant differences in
gender distribution or age (68% vs. 64% male, mean age 64 ± 13.5
vs. 66 ± 14.2 years). While acute coronary syndrome remained the
most common diagnosis (33% vs. 32%), a larger proportion of
patients were admitted due to cardiogenic shock (8% vs. 26%)
and sepsis (2% vs. 8%). More patients were admitted after out-of-
hospital cardiac arrest (8% vs. 25%) and on MV (14% vs. 35%).
ICU mortality increased from 9% to 22% with subsequent mortality
outside the ICU equal at 4% for both cohorts. The mean
Sequential Organ Failure Assessment score on the admission day
increased from 2.1 ± 2.9 to 7.6 ± 2.8 for survivors and 7.7 ± 4.8
to 10.8 ± 3.0 for the dead. ICU length of stay (LOS) increased
from 5 ± 10.2 to 8 ± 12.2 days for survivors and 7 ± 10.8 to 12 ±
14.8 days for the dead, while hospital LOS was nearly unchanged
regardless of survival status. Physician staffing and nurse-to-patient
ratios did not change (two physicians and 1:3 during days and one
physician and 1:4 during nights).
Conclusions The implementation of an intermediate care unit led
to a significant change in the ICU case-mix with increased ICU
LOS, mortality and severity of illness of patients admitted. Effects
on nurse workloads, team job satisfaction, and critical care triage
should be further analyzed to optimize the treatment of these
critically ill patients.
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Introduction  A recent Scottish Medical and Scientific Advisory
Committee report has recommended greater intensivist input into
high-dependency units (HDUs). At Stirling Royal Infirmary, patients
in the HDU remained under speciality team care, in an open unit
model, leading to significant inconsistencies in quality of care. In
December 2007 a closed unit policy was implemented with
intensivists providing clinical leadership of the unit. We hypo-
thesized that having a single team responsible for all HDU patients
would improve continuity of care, with this being reflected in
clinical outcome.
Methods  The Scottish Intensive Care Society’s database,
Wardwatcher™, was used to retrospectively gather data from the
12 months preceding, and 12 months following critical care
involvement in the HDU. We investigated three outcome measures
of patients who required transfer to the ICU from the HDU during
these periods: requirement for renal replacement therapy (RRT),
length of stay (level 3 days), and ICU mortality.
Results Following critical care involvement in the HDU, the total
number of HDU admissions per annum fell from 1,372 to 1,197,
allowing for the closure of two HDU beds. Ninety-three patients
were transferred to the ICU from the HDU in the pre-change
12 months, compared with 67 subsequently. There were no
significant differences in age, APACHE II scores, or requirement
for mechanical ventilation. The requirement for RRT decreased
significantly from 32% to 16% (P = 0.02). This alone is associated
with a cost saving of between £15,000 and £25,000. The mean
length of stay (level 3) reduced from 7.0 days to 6.0 days, which in
combination with the reduction in ICU admissions saved 250 level
3 bed-days over 12 months. Finally there was a trend towards
reduced ICU mortality (31% vs. 19%, P = 0.09).
Conclusions Implementing a critical-care-led closed unit policy in
the HDU was associated with an immediate reduction in both HDU
and ICU bed-days, allowing planned bed closures. There was a
significant reduction in need for RRT and a trend towards reduced
ICU mortality. Finally this organisational change has been carried
out with significant cost savings that are likely to be sustained.
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Introduction  A closed model of ICU care is associated with
improved outcomes and less resource utilization in mixed medical
and surgical ICUs as well as traumatic ICUs. However, most of our
country ICUs use an open model, especially in surgical ICUs due
to lack of specialized physicians. The aims of this study are to
compare the effects of closed and open models on ICU mortality
and length of ICU stay.
Methods  We conducted a retrospective study to compare two
periods of time that used an open model (July 2002 to June 2004;
1,038 patients) and a closed model (July 2004 to June 2006;
1,231 patients) on a single general surgical ICU in a university
hospital. The closed model was defined as an ICU service led and
managed by an intensivist. The open model was an ICU service in
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which critically ill surgical patients were managed by host surgeons
individually.
Results A total of 2,269 patients were included in this study (open
vs. closed; 1,038 vs. 1,231). The overall ICU mortality rate was
decreased statistically significantly in the closed model (27.4% vs.
23.4%; P = 0.03). This effect was obvious in patients who were
admitted to the ICU for more than 48 hours (22.7% vs. 13.9%;
P <0.01). After adjusting for differences in baseline characteristics,
the relative risk of death in a closed model ICU was 0.85 (0.74 to
0.98; P = 0.02) compared with the open model. The effect was
explicit in patients admitted to the ICU for more than 48 hours
(0.60 (0.47 to 0.76); P  <0.01), in nontraumatic patients (0.81
(0.64 to 1.01)) and a trend toward to statistical significance in
patients older than 65 years (0.81 (0.64 to 1.01); P = 0.07). In
addition, the closed model ICU also decreased, the length of ICU
stay (5.4 ± 7.1 vs. 4.6 ± 6.1 days; P <0.01) and the adjusted risk
ratio was 0.45 (0.26 to 0.78; P ≤ 0.01) when compared with the
open model.
Conclusions The closed model that can be led and managed by
an intensivist is associated with a reduction in overall ICU mortality
and a greatest effect in patients admitted for more than 48 hours.
Furthermore, this model also decreases the ICU length of stay.
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Early transfer to a high-volume ICU (upgrading) reduces
mortality
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Introduction The outcome of ICU treatment is improved in high-
volume compared with low-volume ICUs [1]. It is unclear whether
transfer of patients from a low-volume to a high-volume ICU
(upgrading) improves outcome and whether early transfer is
beneficial.
Methods In a retrospective cohort study the timing of upgrading
was determined and related to mortality. Included were all
upgraded patients transported to our level 3 ICU between 2002
and 2008. The APACHE II score was determined in the first
24 hours after admission to the high-volume ICU. Odds ratios, the
Mann–Whitney test and multiple regression were performed.
Results Three hundred and eighty-five patients were included with
a mean age of 62 years (SD = 14.8) and mean APACHE II score
of 22.5 (SD = 8.4). The median time to transfer was 1 day (IQR =
4). Patients transported immediately after stabilisation to the high-
volume ICU (ICU length of stay (LOS) before transfer = 0) had a
mortality rate of 9% (Figure 1). Mortality in patients with ICU LOS
before transport >0 was 25% (P <0.001). In a multiple regression
analysis a higher APACHE II score was associated with increased
mortality (OR = 1.1, 95% CI = 1.0 to 1.2), as was APACHE II
predicted mortality. Immediate transfer was associated with a
decrease in ICU mortality (OR = 0.38; 95% CI = 0.18 to 0.80) and
hospital mortality (OR = 0.51; 95% CI = 0.27 to 0.95). In patients
with upgrading as the explicit reason for transport the findings
were the same (OR = 0.15; 95% CI = 0.03 to 0.71).
Conclusions In this retrospective cohort study patients who were
immediately transferred from a low-volume to a high-volume level 3
ICU had a lower mortality compared with patients with delayed
transfer, which was independent of the APACHE score.
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Introduction The present study aims to compare the diagnostic
categories and outcomes for teenagers admitted to the paediatric
ICU (PICU) and the adult ICU over a 3-year period. The UK
Paediatric Intensive Care society has agreed consensus standards
for the care of critically ill patients up to the age of 16 years [1].
The UK National Service Framework for Children defines a child as
‘all those under 19 years’ [2]. To date, there are no specific
national standards addressing the care of teenagers on intensive
care.
Methods  All patients aged between 16 and 19 years of age
admitted to both the adult ICU and the PICU were retrospectively
enrolled between January 2005 and June 2008. A revised version
of the Paediatric Index of Mortality (PIM2) was used to calculate
predicted mortality in the two groups.
Results  A total of 50 and 46 patients aged between 16 and
19 years were admitted to the adult ICU and the PICU, respec-
tively. The average predicted risk of mortality for those aged 16 to
19 years on the adult ICU was 3.98% and the actual mortality was
comparable at 4%. On the PICU, the average predicted risk of
mortality for those aged 16 to 19 years was 5.23% and the actual
mortality for this age group was higher than predicted at 6.52%.
On the PICU, 50% of the total admissions had a primary diagnosis
of congenital disorder followed by 13% with neuromuscular
disorders. On the adult ICU, trauma accounted for 31% of total
admissions, followed by diabetic ketoacidosis at 17%. Interest-
ingly, self-harm/overdose accounted for 11.5% of teenage
admissions to the adult ICU compared with none on the PICU.
Conclusions The outcomes for patients aged 16 to 19 years are
similar in both the PICU and the adult ICU; however, there is
significant variation in the diagnostic profile. Further larger-scale
studies are needed to develop a standardised and pragmatic
approach to this age group of patients.
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Introduction  Verbal orders (VOs) drug therapy refers to drug
administration without prescription, usually in the context of
telephone instructions from a physician at a remote location or
other circumstances involving delayed prescription. In some
medical care settings VOs may constitute 2 to 13% of medication
orders [1]. Prescription errors associated with VOs are reputedly
common [2], although some studies suggest otherwise [3].
Although prescription errors are not uncommon in critical care [4],
little is known about VOs in this setting.
Methods We prospectively audited VOs in a hardcopy-prescribing
five-bed ICU setting over a period of 3 weeks, with voluntary data
entry by any member of staff issuing or receiving a drug therapy VO.
We collected information regarding VO timing, medication involved,
clinical indication, and subsequent drug event prescription.
Results  Nine VOs were recorded during multiple drug
interventions for 19 ICU patients in this period, with a VO event
rate of 1 for every 10 ITU bed-days. All VOs were for intravenous
prescription only medication, five of which were for fluid therapy to
treat acute physiological deterioration. Other drugs included
metoclopramide, furosemide, atracurium, and adrenaline. No VOs
for opiates were recorded. Reasons for initial nonprescription
included remote location, aseptic procedure, and emergency
treatment. Eight prescriptions were completed within 2 hours. No
VOs were recorded during overnight shifts. All grades of medical
staff issued VOs. One transcription error was noted. No adverse
events were noted.
Conclusions Critical care VOs are not uncommon. Minimisation
can be achieved by good communication, hardcopy or electronic
bundle prescribing, locally agreed independent nonphysician
prescribing arrangements, or drug administration in specific
settings, particularly pre-prescription of fluid bolus therapy.
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Introduction  In 2000 the ICU in a teaching hospital in the
Netherlands changed from open to closed format. In this
retrospective study, outcomes of high-risk surgical patients before
and after the organizational change were compared.
Methods  From 1990 to 2004, all surgical patients were
prospectively collected in a database containing information about
the type of surgery, use of the ICU, length of hospital stay,
complications, and mortality. Multivariate logistic regression was
used on these data to develop a risk prediction model for mortality.
The model consisted of the variables acute hospital admission,
acute surgery, severity of surgery and age. Severity of surgery was
based on a classification of surgical operations used in teaching
hospitals in the Netherlands, scoring operations as one to seven
points. More than three points was defined as severe. Age was
divided into quartiles. Points were scored per variable. In total, six
points could be scored: acute admission, acute surgery and severe
surgery received one point. Age scored zero to three points. A total
score of four points or more was defined as high risk. The model
was validated through cross-validation. The area under the receiver
operating characteristics curve was 0.9. ICU use, morbidity and
mortality before and after the change from open to closed format
were retrospectively evaluated.
Results  Two groups were defined: Group A: high-risk surgical
patients in the ICU in 1996 and 1997 (open format, n = 230) and
Group B: high-risk surgical patients in the ICU in 2003 and 2004
(closed format, n = 228). The primary outcome was inhospital
mortality. Secondary outcomes were inhospital morbidity and
length of ICU stay. The groups were comparable in age, gender
and type of surgery.
Mortality of the ICU patients was 25.4% in Group A and 15.9% in
Group B (P <0.01, 95% CI = 2.5 to 17.3). This was a relative
change of 37.6%. Morbidity was 48.3% in Group A and 46.3% in
Group B. The average length of ICU stay was 2.5 days in Group A,
and 4.8 days in Group B (P = 0.001).
Conclusions  Changing an ICU organization to a closed format
reduces mortality in high-risk surgical patients, without affecting
morbidity.
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Introduction The aim of this study was to assess the accuracy of
setting the angle of the head of a bed to the semi-recumbent
position. Ventilator-acquired pneumonias (VAPs) account for 31%
of all ICU infections. Aetiology appears to be aspiration of
contaminated oropharyngeal and gastric secretions around the
endotracheal tube. The semi-recumbent position compared with
the supine position is known to significantly reduce the incidence
of VAP (8% vs. 34%) [1]. Hence the National Institute for Clinical
Excellence in the UK publishing a recommendation that ventilated
patients be nursed at an angle of 30° to 45°.
Methods Fifty-five members of ICU staff were asked to set the
angle of the head of a standard ICU bed to 30° and 45°. The
estimated bed angle was then measured accurately using a
Mathey Dearman protractor.
Results When estimating the head of the bed, nursing staff were
the most accurate (Table 1) while other staff significantly
underestimated the angle of the bed. We also found that greater
experience of working in the ICU is likely to improve ability to
estimate the angle of the head of bed accurately.
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Conclusions Evidence suggests patients should be nursed in the
semi-recumbent position to prevent VAP. However, we have found
estimating the angle of a bed by eye is difficult and often
inaccurate. Simple aids that highlight the angle of the bed have
been shown to improve compliance to the semi-recumbent
position by up to 71.5% compared with 21% in one study [2].
Such aids to set the angle of the bed should be introduced in
common practice to improve compliance with VAP guidelines.
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Introduction  The objective of this study was to compare the
results from a microcosting analysis of a cohort of ICU patients
with the reimbursement based on existing diagnosis-related group
(DRG) systems. Hence, we open the discussion on resource
allocation using ICD-10 coding and its impact on intensive care.
Methods A prospective study costing 58 consecutive admissions
over a 2-month period in a mixed medical/surgical ICU. Subse-
quently, aligning these patient costs with the attributed costs using
ICD-10 coding. Medical records in Ireland are coded using ICD-10
for diagnoses and for procedures. Experienced clinical coders
assign codes, which are entered into the code mapping program
(AR-DRG V5.0).
Results  Our microcosting study demonstrated that the median
daily ICU cost (IQR) was €2,205 (€1,932 to €3,073) and the
median total ICU cost was €10,916 (€4,294 to €24,091). The
microcosting study demonstrated that the total ICU cost for 58
admissions was €1,200,524. Reimbursement for the total hospital
stay including the ICU stay based on DRGs was €782,077.
During our study, use of antifungals, hemodialysis and blood
products were found to be independent predictors of increased
ICU cost. These frequently used intensive care treatments are not
adequately costed.
Conclusions  Advances in intensive care diagnostics and
treatment contribute to the high cost of this specialty. Current
DRG-based funding fails to adequately capture and cost ICU
activity, and thus underfunds intensive care. We recommend that
an ICU-specific DRG coding be developed for intensive care.
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Introduction Families of critically ill patients spend a considerable
amount of time in hospital, both beside their loved ones in the ICU
and outside the unit waiting to visit them or to receive news. No
published data are available to date on the provision of waiting
rooms in Italy’s pediatric ICUs (PICUs) and on the facilities
available to patients’ families and visitors. We investigated these
aspects in the course of a national survey concerning visiting
policies in Italian PICUs.
Methods An email questionnaire was sent to the heads of all 34
Italian PICUs asking about their visiting policies. Questions about
waiting rooms and facilities for patients’ families and visitors were
also included.
Results The response rate was 100%. The median daily visiting
time was 300 minutes (range 30 minutes to 24 hours). No waiting
room was provided in 32% of PICUs. In other PICUs, families and
visitors were provided with seats (50% of PICUs), armchairs
(32%), lockers for personal effects (32%), magazines and books
(18%), drinks machines (15%) and snack machines (6%). A
bathroom was available to families and visitors in 41% of units, use
of the PICU’s kitchen in 3% and access to the hospital canteen in
47%.
Conclusions  Overall these data indicate that in Italian PICUs,
alongside a clear tendency to apply restricted visiting policies,
there is limited attention to the comfort of families of patients in the
PICU. Comfort is one of five domains (in addition to reassurance,
proximity, information and support) associated with the needs of
families who have critically ill loved ones [1,2]. Our survey could
contribute to promoting more attentive and supportive care for the
patient’s family [3].
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Introduction  To optimize patient care, knowledge of patient
satisfaction and its determinants is essential. So far few researchers
have focused on this subject in intensive care medicine. The
purpose of this study was to measure the level of patient
satisfaction and determine its influencing factors in ICU patients.
Available online http://ccforum.com/supplements/13/S1
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Mean estimates
Group 30° estimate  45° estimate 
Nurses 30.4 43.1
Doctors 27.1 42.1
Other staff 26.1 39.6S196
Methods  In a pilot study, we developed a questionnaire that
consisted of 60 questions in eight domains (General satisfaction,
Reception, Physical care, Mental care, Empathy and attention,
Communication and information, Surroundings and Physical
discomfort). Answering possibilities ranged from 1 (not satisfied) to
5 (completely satisfied). In the final study, 23 March to 29 May
2008, all consecutive adult patients from a 29-bed, tertiary-care,
medical, surgical, neurosurgical and thoracic–surgical ICU were
interviewed within 4 days after discharge. Demographics and
clinical characteristics were obtained from electronic records.
General linear modeling (GLM) with Bonferroni–Holmes correction
was used to study the relationship between overall patient
satisfaction scores and the eight domains, corrected for patient
and ICU-related factors. The model was tested for clinically
relevant interaction between determinants.
Results Ninety-eight patients were interviewed. The mean overall
patient satisfaction score was 4.60 (SD = 0.93). Of the eight
domains, only Communication and information (P = 0.039)
appeared to be significant in predicting general satisfaction. Also
sex (P = 0.046), length of ICU stay (P = 0.042), the interaction
between Communication and information and age (P = 0.016), and
the interaction between Communication and information and
Minimal Mental State Examination score (P = 0.013) were signifi-
cant. An indepth analysis of Communication and information
showed that the interaction of communication with birth country
(P <0.0001) and with duration of mechanical ventilation
(P = 0.041) was significant. This implies that, for Dutch versus
non-Dutch patients and patients longer on mechanical ventilation,
clear communication with doctors and nurses was particularly
important.
Conclusions Patient satisfaction was high in this mixed population
of ICU patients. From an especially developed questionnaire,
Communication and information was the most important predictor.
In addition, older age, female sex, Dutch nationality, longer ICU stay,
long duration of mechanical ventilation and a high Minimal Mental
State Examination score were related to less satisfied patients.
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Introduction Almost all patients with life-threatening conditions are
incapacitated to give informed consent for participation in
emergency critical care research. Deferred proxy consent (DPC) is
an ethically valid surrogate for informed patient consent. Here we
present our experience in two emergency trials [1].
Methods  We analysed the use of DPC in the Early Lactate-
directed Therapy in Intensive Care Trial (NCT 00270673) and the
NGAL study (TC 1405).
Results  In the lactate-directed therapy trial, 362 patients were
randomized. In 75.4% DPC could be obtained, 3.9% of the
relatives refused DPC and in 20.7% DPC could not be obtained
before the end of the study (= 72 hours). In the NGAL study, 550
patients were randomized. DPC or patient consent was obtained in
89.8%, 0.7% refused DPC and in 9.4% DPC could not be
obtained due to early patient death. In both studies combined, only
in 2% was DPC refused and in 10% consent could not be
obtained due to early patient death.
Conclusions DPC is an ethically valid and practically feasible way
to include patients in emergency critical care trials.
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Introduction  As overall survival times increase for patients with
cancer due to novel antitumour treatments, there will be an
inevitable escalation in the number of such patients who present to
intensive care with intercurrent acute illness, and sepsis is the
most frequent diagnosis in this context. Epidemiologic estimates of
sepsis among cancer patients are limited. The aim of this study
was to assess survival in cancer patients admitted to an ICU with a
diagnosis of sepsis, trying to identify predictive factors of mortality.
Methods  A prospective cohort study in an ICU at a university
cancer referral center. From a total of 95 patients admitted to the
ICU during a period of 3 months, 78 patients had the diagnosis of
sepsis into 24 hours of admission. Patient charts were analyzed
with respect to underlying disease, cause of admission, APACHE II
score, need and duration for mechanical ventilation, neutropenia
and development of septic shock, type of infection, time to anti-
biotic therapy, as well as ICU survival and survival after discharge.
Results  ICU survival of septic patients was 76%, and 1-month
survival was 66%. In a multivariate analysis, prognosis was
negatively influenced by respiratory insufficiency, the need for
mechanical ventilation, and development of septic shock and renal
failure after 72 hours of ICU stay. Admission after cardiopulmonary
resuscitation yielded high ICU mortality. Age, neutropenia, type of
infection, and underlying disease did not influence outcome
significantly. Admission APACHE II scores were significantly
higher in nonsurvivors but failed to predict individual outcome
satisfactorily.
Conclusions A combination of factors must be taken into account
to estimate a critically ill cancer patient’s prognosis in the ICU
admitted because of sepsis. The APACHE II scoring system alone
should not be used to make decisions about therapy prolongation.
As ICU mortality is 24%, comparable with severely ill noncancer
patients, general reluctance to admit cancer patients to an ICU
does not seem to be justified.
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Introduction Toxic epidermal necrolysis (TEN) or Lyell’s syndrome
is a severe bullous skin disease induced by drugs. It is charac-
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terized by an extensive skin rash with blisters and exfoliation similar
to that of major burns. This study presents our experience of
treating and management of TEN in a burn center.
Methods  We retrospectively analysed the charts of all patients
with severe skin disease admitted to the burn center of Tunis
between 2001 and 2008. The patients were evaluated according
to their history of pre-existing diseases and medication, suspected
cause, extent of skin involvement (TBSA), mucosal involvement,
definitive diagnosis, therapy, complications and outcome. Results
were collected and examined with SPSS 16.0 software.
Results During the study period, 21 patients with severe bullous
skin disease were admitted. Fifteen of them had TEN (three
patients per year). All patients were referred from outside
institutions, especially from dermatology departments, mean
hospital duration of 4 ± 2 days. The group of 15 patients consisted
of 10 women and five men. The average age was 50 ± 17 years.
The average affected skin area was 49 ± 15% of TBSA. The
suspected causal agent was aspirin in three cases, phenobarbital
in three cases, allopurinol in three cases, antibiotics in two cases
and paracetamol in one case. It was unknown in three cases. It
was medical prescription in 10 cases, automedication in three
cases and unknown in two cases. The mean time delay between
drug intake and the onset of symptoms was 4.5 ± 1.5 days.
Mucosal involvement was observed in all patients, such as ocular,
gastrointestinal, respiratory and genital localizations. The most
common complications ware: sepsis, ARDS and hematological
disorders (two pancytopenia and one CIVD). The mean duration of
hospitalization was 9 ± 6 days. The overall mortality rate was 30%.
There was a significant statistical difference between survival and
nonsurviving patients, in involved skin area (P = 0.04) and septic
complications (P <0.001).
Conclusions TEN is a severe mucocutaneous reaction, associated
with high morbidity and mortality. Management of theses patients
must be provided cautiously by an experienced interdisciplinary
team in an ICU.
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Introduction Pesticide poisoning constitutes a problem that often
occurs in the daily medical practice and mainly concerns the rural
areas of Greece. The purpose of this project is to mention the
epidemic characteristics and our observations on unintentional
pesticide and herbicide poisonings in the prefecture of Rodopi,
Greece.
Methods  In our retrospective study that refers to a period of
2 years (January 2006 to December 2007), 152 patients suffering
from pesticide poisoning were offered medical treatment in the
pathologic ward of the General Hospital of Komotini. One hundred
and nineteen (78.30%) of them were patients who unintentionally
suffered pesticide poisoning. The remaining 20 (13.15%) were
poisoned with pharmaceutical substances of domestic use. There
were also 13 (8.55%) cases of attempted suicide with intentional
intake of an overdose of antidepressants that were exempt from
our study.
Results Fourteen out of the 119 patients (11.76%) were trans-
ferred to hospital in a state of a coma (Glasgow coma scale <8)
and were treated in the ICU and underwent blood refinery. There
were two deaths (2/119 or 1.68%). The average age of our
patients was 37 years (14 to 89). The proportion of men/women
was 2.4/1 (84/35) and the poisonings took place at the beginning
of the summer.
Conclusions  Unintentional pesticide poisonings are frequent in
our area. They concern people of low educational level, mainly men
of a reproductive age [1,2]. The time spent from the intake of the
pesticide to their transfer to hospital plays an important role in the
successful treatment of such cases [3]. Moreover, for a positive
outcome in these severe cases it is essential that these patients
are treated in ICUs [3,4].
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Introduction We reviewed clinical characterization of patients with
organophosphate poisoning admitted to the ICU as well as the
mortality rate [1].
Methods  A retrospective study, without need for local ethical
committee approval, of patients with organophosphate poisoning
who were admitted to the ICU between 2004 and 2008.
Sociodemographic data, psychiatric history, the organophosphate
compound, time elapsed since ingestion, clinical presentation and
complications, laboratory data, Simplified Acute Physiology score
(SAPS) II and treatment approach were analyzed. Biomarkers used
on admission: serum cholinesterase level, arterial pH and lactic
acid. The influence of obidoxime and atropine therapy on the
patient outcome was also analyzed.
Results  Twenty patients were admitted to the ICU. Dimethoate
was the compound most often involved, in which 55% of the
patients were females. The mean age recorded was 54.3 ± 14.7
years. The time between exposure and treatment initiation was not
quantified in 65% of patients, but when discriminated it was in the
majority of cases less than 1 hour. Clinical muscarinic signs in
85% of the cases, nicotinic signs in 55% and central nervous
signs in 95%. An intermediate syndrome was identified in one
case. Most frequent complications identified were pneumonitis
85%, miocarditis 35% and renal failure 50% of the patients. The
mean SAPS II value was 36.6 ± 16.9. Selective decontamination
and treatment with obidoxime (continuous intravenous infusion
after the loading dose) and atropine was verified in every patient
(Figure 1). The total ICU mortality was 40%.
Conclusions Clinical severity and serum cholinesterase levels and
acidosis were the independent variables that mostly seemed to
have contributed for the final result. High doses of atropine
seemed to be more favorable to a good outcome. Even though the
number of patients included in this review was small, the results
may alert us to the importance of an organized approach helped by
protocols between the emergency department/emergency room
Available online http://ccforum.com/supplements/13/S1S198
and the ICU, in order to successfully manage patients with
organophosphate poisoning.
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Introduction Metformin-associated lactic acidosis (MALA) is a life-
threatening condition (up to 50% mortality is described [1]) and its
developing rate increases with the number of contraindications to
the treatment.
Methods  We retrospectively observed cases of lactic acidosis,
searching for MALA cases, admitted to the ICU from January 2008
to November 2008.
Results We present three patients. Patient 1 is a 63-year-ols man
with type 2 diabetes who came to the emergency department (ED)
with leg pain for 2 days; he was on metformin 3 g daily. Laboratory
results showed acute renal failure (ARF) and lactic acidosis (pH
6.88; lactate 23 mmol/l). Angiography imaging showed acute
bilateral lower arm ischemia. Continuous venovenous haemo-
filtration (CVVH) was started due to ARF and acidosis (Table 1).
Patient 2, a 77-year-old man with type 2 diabetes, came to the ED
with vomiting and diarrhea for 3 days. He was on metformin 3 g
daily. Laboratory results showed ARF, lactic acidosis (pH 6.80;
lactate 18 mmol/l) and sepsis indexes (white blood cells
19.000/μl, serum procalcitonin 10.85 μg/l); due to ARF and
acidosis, CVVH was started. Patient 3 is a 72-year-old woman with
type 2 diabetes who came to the ED with diarrhea and vomiting for
4 days; she was on metformin 3 g daily. Laboratory results showed
leucocytosis, ARF and lactic acidosis (pH 6.83; lactate 16 mmol/l).
No signs of lactic acidosis differential diagnosis were found, so
CVVH was started due to ARF and acidosis.
Conclusions All three patients survived after support therapy and
CVVH were started. In these cases, metformin could be the
principal causal agent of acidosis or has a worsening clinical
condition and accelerates acidosis development effect.
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Introduction Critically ill patients require high-intensity care may
be at especially high risk of iatrogenic injury because they are
severely ill [1]. We sought to study the incidence and nature of
adverse events in the critical care setting.
Methods  We conducted a prospective 6-month observational
study in a medicosurgical ICU. We included patients whose length
of stay was >24 hours. Reporters were asked to provide the
identification of the adverse events, date and time, and details with
regard to the risk factors. The morbi-mortality was also recorded.
Results A total of 250 patients were admitted to the ICU during an
observation period, 102 were included. The incidence of adverse
events was 59.8%. We found 222 adverse events (2.2 adverse
events per patient). The most common adverse events as
categorized by organ systems were metabolic (52%), cardio-
vascular, respiratory and finally infectious. Among all adverse
events, only hyperglycaemia and hypoglycaemia were considered
to be iatrogenic adverse events. No association was observed
between adverse events and mortality.
Conclusions We found that the incidence of adverse events was
59.8%. Some prior critical care safety studies have identified fewer
adverse events than this one (3 to 37%) [2]. This difference may
have occurred because methods are not standardized; important
differences refer to the definitions of the concept of iatrogenic,
modes of assessment (prospective, retrospective or transversal),
population size, and the observation period. The high incidence of
adverse events in our study is due to the exhaustive assessment of
adverse events.
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Introduction The present study intended to identify and analyze
the significance of drug–drug interaction (DDI) in critically ill
patients.
Methods  All consecutive adult patients admitted to a
medical/surgical ICU of a tertiary-care hospital, from September
2006 to April 2007, were included in this prospective obser-
vational study. Patients who stayed less than 48 hours were
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Figure 1 (abstract P492)
LOS, length of stay; CRP, C-reactive protein; ER, emergency room.
Table 1 (abstract P493) 
Start CVVH  4 hours  24 hours 
(mmol/l) (mmol/l) (mmol/l)
Patient 1 – lactate 23.0 20.0 6.3
Patient 2 – lactate 10.3 3.1 2.4
Patient 3 – lactate 28.0 20.0 4.8S199
excluded. All the drugs that were given during the ICU stay were
checked for the presence of potential interactions as per the
reference manual. DDIs that were detected clinically or through
investigations were recorded and also any therapeutic actions
taken for DDIs were noted.
Results  The study included 400 patients (Table 1). Sixty-four
percent (n = 256) of patients from the study cohort had potential
DDI. The total number of potential DDI found in all prescriptions
was 602; however, only in 34% (n = 208) was DDI actually
observed; of which a clinically relevant interaction (requiring drug
modification or other therapeutic intervention) was observed in
49.5% (103 of 208). The average number of drugs used per
patients was nine (SD ±4) and potential DDIs found per patient
were two (SD ±2). The drug interactions were classified into three
groups, minor (55.29%), moderate (23.08%) and major (21.63%)
according to the severity of and requirement for drug modification.
Conclusions  DDIs are common in the ICU population in the
presence of polypharmacy, and a substantial proportion of them
are clinically relevant.
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Introduction We studied our ICU database to estimate the effect
of metastatic cancer and haematological malignancy on hospital
mortality after intensive treatment.
Methods  The Reinier de Graaf Hospital is a 500-bed
nonacademic teaching hospital with a 30-bed dedicated medical
oncology ward supervised by a team of medical oncologists and a
10-bed mixed intensivist-led ICU. Data on all patients admitted to
the ICU including illness severity scores, the presence of meta-
static cancer or haematological malignancy and hospital mortality
are prospectively collected in the ICU database. We studied the
hospital mortality of all consecutive patients in the database
admitted from 2004 until 2007 with respect to the presence or
absence of metastatic cancer or haematological malignancy.
Results  A total of 2,951 patients were admitted in the study
period. Patients with metastatic cancer or haematological malig-
nancy were older and had higher illness severity scores on
admission to the ICU (Table 1). Not surprisingly, hospital mortality
was significantly higher in patients with metastatic cancer or
haematological malignancy. We performed logistic regression
analysis to see whether the higher mortality could be explained by
the usual other confounders. After correction for APACHE II
expected mortality, age, admission type, sepsis and mechanical
ventilation, we found however that the presence of metastatic
cancer or haematological malignancy independently increases the
risk of dying (OR = 1.7 (95% CI = 1.1 to 2.8, P = 0.024)).
Conclusions Hospital mortality is higher in patients with metastatic
cancer or haematological malignancy than in other patients, even
after correction for age, APACHE II expected mortality, admission
type, sepsis and mechanical ventilation.
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Introduction  Recently introduced interventions including early
goal-directed therapy (EGDT) improve the mortality of severe
sepsis/septic shock. We undertook this study to describe the
trend in the mortality rate of vasopressor-dependent septic shock
over a 10 year-period.
Methods We used the APACHE III database of our institution to
identify patients with septic shock. Patients with an ICU admission
diagnosis of infection and who were on a vasopressor on the first
ICU day were considered to have vasopressor-dependent septic
shock. We divided the study period into pre-EGDT (1997 to
2000), transit (2001, 2002), and post-EGDT (2003 to 2006). We
calculated the standardized mortality ratio (SMR) with the 95%
confidence interval.
Results Of 53,096 admissions, 4,981 (9.4%) had a diagnosis of
infection. The hospital mortality rates of the patients with and
without infection were 21.2% and 9.3%, respectively (P <0.001).
Vasopressor was infused in 1,340 (26.9%) of the patients with
infection. The hospital mortality rate of the vasopressor-receiving
patients with infection was 32.4% compared with 17.1% of those
who did not receive vasopressor (P <0.001). The SMR of the
vasopressor-dependent septic patients was lowest during the
post-EGDT period (Table 1).
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Demographics of study population
Age (mean ± SD) (years) 61 ± 16.9
Male:female 239:161
APACHE II (mean ± SD) 16 ± 8
Table 1 (abstract P496) 
MC/HM no MC/HM yes P value
Number 2,805 146
Mean age 66.1 (16.5) 68.5 (11.5) <0.001
Mean APACHE II score 13.6 (7.6) 17.2 (6.8) <0.001
APACHE II expected mortality 19.5% 28.2% <0.001
Mortality 439 (15.7%) 39 (26.7%) 0.001
MC/HM, metastatic cancer or haematological malignancy.
Table 1 (abstract P497)
Mortality of vasopressor-dependent septic shock during the study period
Study period Number Predicted mortality (%) Mortality (n (%)) SMR (95% CI)
Pre-EGDT 417 31.5 133 (31.9) 1.015 (0.850 to 1.203)
Transit 285 37.7 117 (41.1) 1.093 (0.904 to 1.310)
Post-EGDT 638 40.0 184 (28.8) 0.722 (0.621 to 0.834)S200
Conclusions The hospital mortality rate of patients admitted to the
ICU for infection is higher than that of patients admitted for other
reasons. The hospital survival rate of patients with vasopressor-
dependent septic shock has improved in the post-EGDT era.
P498
Patients with severe sepsis and solid tumours: outcome
and prognostic factors
S Pereira, C Dias, A Martins, S Quintela, F Faria
Instituto Português de Oncologia de Francisco Gentil, EPE, Porto,
Portugal
Critical Care 2009, 13(Suppl 1):P498 (doi: 10.1186/cc7662)
Introduction Admission to the ICU and the appropriate selection
of patients improved the treatment and survival rates of critical
oncological patients [1]. Infection is an important complication in
these patients, which frequently leads to acute organ dysfunction
and even death [2,3]. The objective is to evaluate the outcome and
prognostic factors in a group of patients with severe sepsis and
solid tumours.
Methods A retrospective observational study of collected data in
140 consecutive admissions to the ICU over a 24-month period at
our oncological hospital; 108 patients were evaluated, corres-
ponding to 140 admissions to the ICU (19.5% of total admissions).
Results Age, sex, the underlying disease and tumour stage (TNM
classification), type of previous anticancer treatment, performance
status, severity scores (APACHE II, Simplified Acute Physiology
Score II, Sequential Organ Failure Assessment), ICU and hospital
mortalities and hospital outcome at 3, 6 and 12 months were
analysed. The majority were male with median age 64.5 years;
26% had head and neck tumours, 21% oesophagus and gastric
cancers, 16% colon and rectum cancer, 9% breast cancer, 1%
genitourinary tumours and 14% other solid tumours; 91.4% of
patients required mechanical ventilation, 42% vasopressors, and
4% kidney replacement therapy. Decisions to forgo (withhold or
withdraw) life-sustaining therapies were taken in 19% of patients.
In the patients with the intention to treat, the ICU and hospital
survival rates were 76.5% and 56.3%. Survival rates at 3, 6 and 12
months were 97%, 81% and 45%, respectively.
Conclusions  Severity scores (APACHE II, Simplified Acute
Physiology Score II, Sequential Organ Failure Assessment) in the
first 24 hours did not discriminate clearly between survivors and
nonsurvivors [1]. Mortality for cancer patients with severe sepsis
turned out to be unrelated to age [4]. Clinical judgment between
oncologists and intensive care physicians is necessary to improve
the selection of patients who might benefit from intensive care [5].
Long-term survival is predicted by cancer disease-prognostic factors.
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Introduction  Acute lung injury (ALI), including acute respiratory
distress syndrome (ARDS), mortality rates are high despite
advances in the management of patients with this condition. Our
objectives were to compare the ALI/ARDS mortality rates and the
ALI mortality risk factors between two cohort studies of the same
ICU in different periods of time: 1999/2000 (2000 cohort [1]) and
2004/2007 (2007 cohort).
Methods  A prospective cohort that included 1,115 patients
admitted to the ICU between April 2004 and April 2007 who
needed mechanical ventilation for at least 24 hours. These results
were compared with a previous cohort of 1,301 patients admitted
to the same ICU between April 1999 and April 2000 [1]. In both
studies all patients were evaluated regarding the presence/
development of ALI/ARDS according to the 1994 American–
European Consensus Conference. Data were compared between
the two cohorts using Student’s t or chi square tests. Multivariate
analysis by conditional logistic regression was used to identify ALI
mortality risk factors.
Results  In ALI patients (n = 50, 2000 cohort; n = 347, 2007
cohort) we observed: (i) an increase in both hospital mortality (from
50 to 67%, P  = 0.02) and ICU mortality (from 44 to 63%,
P = 0.01); (ii) a higher mean (±SD) APACHE II score (from 17.7 ±
6.5 to 23.7 ± 8.2, P <0.001), and (iii) an increased percentage of
patients with three or more organ failures (from 30 to 42%,
P <0.001). Regarding ARDS patients (n = 30, 2000 cohort;
n = 307, 2007 cohort), there were an increase in hospital mortality
(from 47% to 68%, P  = 0.03), in the mean (±SD) APACHE II
score (from 17.6 ± 6.9 to 23.6 ± 8.3, P <0.001) and in medical
patients (from 46 to 73%, P = 0.01). The factors independently
associated with increased hospital mortality in ALI patients were
renal (P = 0.002) and hematological (P = 0.02) failures in the 2000
cohort. In the 2007 cohort, renal (P = 0.01) and hematological
(P = 0.02) failures, use of vasoactive drugs (P <0.001) and ICU
length of stay (P <0.001) were independently associated with
mortality.
Conclusions We observed an increase in the mortality rates of
patients with ALI/ARDS, which are more severely ill. Renal and
hematological failures remained independently associated with
mortality in these patients. The results suggest that ALI/ARDS
patients in our ICU have more severe illness, what could explain
the increase in the mortality rates, highlighting the relevance of a
better understanding of such findings.
Reference
1. Fialkow L, et al.: Acute lung injury and acute respiratory
distress syndrome at the intensive care unit of a general
university hospital in Brazil: an epidemiological study
using the American-European Consensus Criteria. Inten-
sive Care Med 2002, 28:1644-1648.
P500
Demographic changes over a 12-year period in intensive
care
V Hariharan, JJ Paddle
Royal Cornwall Hospital, Truro, UK
Critical Care 2009, 13(Suppl 1):P500 (doi: 10.1186/cc7664)
Introduction  We describe the demographic characteristics of
patients admitted to the ICU of a large general hospital over the
past 12 years and the severity of their condition on admission,
examining the relationships between these changes and trends in
mortality and length of stay (LOS).
Methods All patients admitted to the ICU from 1 January 1996 to
31 December 2007 were included in this retrospective study. We
captured data on age, sex, admission category, APACHE II
predicted mortality, duration of ICU stay, and hospital mortality.
Statistical analysis was conducted with SPSS version 15.0 using
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logistical regression models. To investigate trends in mortality
independent of demographic changes in the ICU population,
expected deaths based on the age–sex mortality experience
across the whole 12-year period were calculated for each year.
Expected mortality rates based on APACHE II probability of death
scores were also calculated for each year.
Results In total 7,158 patients were included in this study. There
was no significant trend in median age across the 12 years
studied; however, there has been a steady increase in the
proportion of ICU patients over the age of 80. In 1996, 6% were
over 80 years old and by 2008 it was 12.5%. There was no
significant trend in the sex distribution of ICU patients (60:40 male
to female). The LOS for medical and emergency surgical patients
is similar, with an average of 6 days. However, the LOS of elective
surgical patients has increased from around 3 to 4 days. The
median APACHE II probability of death for ICU patients increased
over the period, the significant linear trend (P  = 0.001, logistic
regression) showing an increase of almost 1% per year. The
hospital mortality over the study period was 20%. During this
period mortality rates rose in correlation with predicted mortality,
before starting a downward trend in 2003 to eventually fall below
APACHE II predicted levels in 2007.
Conclusions The average age of ICU admissions is not signifi-
cantly increasing over time. However, the proportion of patients
aged over 80 has almost doubled to 12.5%. The severity of illness
has increased and this is seen across all categories of admission,
but seems to be due particularly to an increase in the subgroup of
over 80 year olds. There has been no consistent change in
mortality rates over the 12-year period.
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Introduction The aim of this study was to investigate the clinical
characteristics and prognostic factors of a consecutive series of
patients with severe acute pancreatitis (SAP). SAP is charac-
terized by high morbidity and mortality.
Methods Clinical data of SAP patients admitted to our hospital
from January 2006 to January 2008 were retrospectively reviewed.
Collected data included the age, gender, etiology, length of
hospitalization, APACHE II score at admission, local and organ/
systemic complications of the patients.
Results Of the 125 acute pancreatitis patients, 42 developed SAP
[1]. The mean age of SAP patients was 57 years, male/female
22/20 patients, the commonest etiology was cholelitiasis (43.5%),
the mean length of hospitalization was 60 days, the mean score of
APACHE II was 8.1. Fifty-seven percent of the patients developed
necrosis, 23% abscessus, 11% pseudocyst. Fifty-eight percent
developed organ/systemic failure. A total of 25.2% (11/42) of the
SAP patients died. Respiratory failure was the most common organ
dysfunction (90.0%) in deceased SAP patients, follow by
cardiovascular failure (86.4%), and renal failure (50.0%). In the
SAP patients, 90.9% (9/11) developed multiple organ/systemic
failures. There were significant differences in age, length of
hospitalization, APACHE II score and incidences of respiratory
failure, cardiovascular failure, renal failure between deceased SAP
patients and surviving SAP patients [2]. By multivariate logistic
regression analysis, the independent prognostic factors for
mortality were respiratory failure, cardiovascular failure and renal
failure.
Conclusions  SAP patients are characterized by advanced age,
high APACHE II score and organ failure, and their death is mainly
due to multiple organ/systemic failures. In patients with SAP,
respiratory, cardiovascular and renal failure can predict the fatal
outcome and more attention must be paid to their clinical
evaluation.
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Introduction Organ dysfunction is usually evaluated by gravity
scores (Logistic Organ Dysfunction Score, Multi-Organ Dys-
function Score and Sequential Organ Failure Assessment), aimed
to predict the patient’s hospital outcome [1,2]. Despite their
diffusion, these scores do not provide indications about the
treatment’s efficacy for each patient. Our aim was to utilize the
previous organ dysfunction scores to perform early strategies to
preserve organ function. This study tested the following hypo-
thesis: first, that the previous organ dysfunction scores can detect
clustering of organ dysfunctions; second, that each clustering
could have an own sequence; and, finally, that we can develop a
model to predict from the scores at ICU admittance the organ
dysfunctions after the seventh day.
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Table 1 (abstract P502)
Percentage error of model prediction for each organ
Organ %
Liver 18
Heart 14
Kidney 17
Lung 12
Haematic 12
Nervous 5
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Methods We retrospectively collected scores, at admission and
daily for 6 days, of 85 ICU patients admitted in a 6-month period at
Sant’Andrea University Hospital of Rome, Italy. The inclusion
criteria were: at least two organ dysfunctions measured by one of
the three scores and ICU stay ≥24 hours. Data were processed by
cluster analysis (VARCLUS di SAS System). We used a
discriminant linear model for the prediction of organ dysfunction.
Results The results are reported in Table 1 and Figure 1. The scores
we used detect three clusters of organ dysfunction characterized
by a different outcome. The model we elaborate allows one to
predict with great accuracy the organ dysfunction over time.
Conclusions The present study can provide the clinician with a
useful tool to enact therapeutic strategies to prevent additional
organ damage.
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Introduction The purpose of this study was to determine the utility
of an initial serum lactate measurement for identifying high risk of
death in patients admitted to the ICU.
Methods In a cohort study at a tertiary-care nontrauma medical–
surgical ICU, we included all ICU admissions (May 2007 to
February 2008) from a prospectively collected ICU database.
Patients’ gender, age, admission physiologic measurements, lactic
acid, and APACHE IV score were noted. Outcome was acute
phase death (death within 3 days of admission) and inhospital
death. Outcome was stratified by the initial serum lactic acid level
in three groups: low, 0.0 to 2.0; intermediate, 2.1 to 3.9; high,
4.0 mmol/l or above.
Results Total of 882 patients were included in the study, acute
phase death rates were 2.5%, in the low group, 5.1% in inter-
mediate group and 8.1% in the high group, whereas inhospital
mortality rates were 13.9%, 28.6%, and 38.7%, respectively.
Acute-phase deaths and inhospital deaths increased linearly with
lactate. An initial lactate ≥4.0 mmol/l was associated with at least a
threefold higher odds ratio for both acute-phase deaths 2.8 (95%
CI = 1.1 to 7.3) and inhospital mortality 3.4 (95% CI = 2.0 to 5.8).
Conclusions An initial lactate ≥4.0 mmol/l substantially increases
the probability of acute-phase death and inhospital mortality in
critically ill patients.
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Introduction  The APACHE II scoring system has not been
validated in burn injuries. The validation studies were performed in
the general and cardiac ICUs of teaching hospitals in the USA;
units that did not admit burn injuries [1]. We correlated known
predictors of mortality in burns (age, percentage total burn surface
area (%TBSA), inhalation injury) [2,3] with mortality data in our
burns cohort. This was repeated for the APACHE II score to
investigate its predictive value.
Methods We identified all patients with burns admitted to our ICU,
linked to the South East Scotland Regional Burns Unit, from 1995
to 2005. Demographic data and APACHE II score at 24 hours
were found on the ICU database. The case notes for each patient
were reviewed to verify the %TBSA and survival.
Results The cohort comprised 100 patients: 75% male. The age
range was 14 to 87 years (mean 45.2; median 45). Injury severity
was assessed by %TBSA: range 0 to 99% (mean 23.8%, median
16%, IQR = 8.6 to 30%). Zero %TBSA is inhalation injury only.
APACHE II scores ranged from 7 to 42 (mean 15.9, median 15,
IQR = 10 to 19.5). The apparent fall in mortality at scores 27 to 31
is due to low numbers (n = 3) in this group. Both the %TBSA and
APACHE II score correlate with increasing mortality (Figure 1).
Stepwise logistic regression analysis was performed: %TBSA and
APACHE II score both behaved as independent predictors of
mortality (P <0.0001), as did age (P = 0.002). This cohort behaves
as other published data [2,3].
Conclusions Scoring systems with applicability to all critically ill
patients provide a standardised objective assessment tool allowing
comparison between groups, and can inform clinical decision-
making. The strong correlation shown between APACHE II score
and mortality provides evidence for the utility of APACHE II scoring
in critically ill patients with burn injuries.
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Introduction The scoring systems (SS) can be used globally to
estimate the severity of critically ill patients. In status asthmaticus
(SA), these SS were not evaluated to predict mortality. Our aim is
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to evaluate the ability of nonspecific scores (APACHE II and
Simplified Acute Physiology Score (SAPS) II) to predict outcome
in SA in a medical ICU.
Methods  A prospective and monocentric study during 8 years
(2000 to 2007) included all patients who were admitted to our unit
for SA. Demographic and clinical data were collected at admission.
We collected also therapeutic aspects in all patients. Daily, a follow-
up of the SS value was calculated with their average. We defined a
subgroup that has been mechanically ventilated to evaluate the value
of SS in SA, because mechanical ventilation is a main prognostic
factor among others. Modulus evaluation required a discriminative
application using receiver operating characteristic curves. The
statistic analysis has been based on SPSS 11.0 for windows.
Results A total of 246 cases of SA (9.7% of all patients admitted
in our unit) have been counted during the duration of study. The
mean value of APACHE II and of SAPS II was 8 ± 5 and 20 ± 10,
respectively. The mortality rate was 12%. In the subgroup, 90% of
patients had APACHE II score ≤8 and 77% of them had SAPS II
<20. Both scoring systems had a weak discrimination, with an area
under the curve (receiver operating characteristic) 0.655 and
0.557 for SAPS II and APACHE II, respectively.
Conclusions APACHE II and SAPS II are not good prognostic
tools for status asthmaticus. A new and more adapted evaluation
tool is required.
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Introduction  The performance of general prognostic models in
patients with transplantation in need for ICU admission is poor,
showing a tendency towards significant underestimation of the risk
of dying. The objective of our study is to evaluate the APACHE II
score and Simplified Acute Physiology Score (SAPS) 3 and their
90-day mortality prediction after liver, renal and pulmonary
transplantation.
Methods A prospective cohort study in a transplantation ICU in
Porto Alegre, Brazil, during the period May 2006 to July 2007.
Clinical data of 277 post-transplantation patients admitted to the
ICU were collected at admission and the SAPS 3 and APACHE II
score calculated with respective estimated mortality rates. The
area under the receiver operating characteristic curve (AUROC)
was obtained for both scores.
Results Patients enrolled included 172 men and 105 women, with
mean age 45 ± 2 years. There were 86 (31%) liver transplanta-
tions, 170 (61.3%) renal transplantations and 21 (7.6%) pulmo-
nary transplantations. The 90-day mortality for liver, renal and
pulmonary transplantation was: 12 (15.4%), four (3%) and four
(26.3%). The mean SAPS 3 score was 40 ± 10.2, 21 ± 5.8 and
63 ± 19, and the APACHE II score was 25 ± 8.2, 16 ± 5.9 and
17 ± 21.4, respectively. Comparing the AUROC from both scores
we observed: in liver transplantation the AUROC for SAPS 3 was
0.677 (95% CI = 0.447 to 0.887) versus 0.749 (95% CI = 0.623
to 0.875) for APACHE II; in renal transplantation the AUROC for
SAPS 3 was –0.619 (95% CI = 0.355 to 0.882) versus 0.604
(95% CI = 0.355 to 0.882) for APACHE II; in pulmonary trans-
plantation the AUROC for SAPS 3 was –0.936 (95% CI = 0.805
to 1.06) versus 0.750 (95% CI = 0.489 to 1.01) for APACHE II.
Conclusions  In these preliminary results, no differences were
observed comparing SAPS 3 and APACHE II in the mortality
prediction from liver, renal and pulmonary transplanted patients.
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Introduction  The aim of this study was to determine inter-rater
reliability of APACHE II scores between an ICU specialist and a
well-trained ICU fellow.
Methods In a prospective observational study, two raters collect
APACHE II scores on 50 consecutive patients in a medical ICU
respectively. Intraclass correlation coefficients were calculated for
the APACHE II total score, the APACHE II component scores, and
the Glasgow coma scale components. Concordance correlation
coefficients for each chosen value of the APACHE II component
were assessed.
Results Mean (standard deviation) APACHE II scores were 21.6
(8.2) for the specialist, and 21.7 (7.1) for the fellow. The intraclass
correlation coefficient was 0.848 for the APACHE II total score.
Within the score components, the inter-rater reliabilities of acute
physiology score, age, and chronic health evaluation were 0.860,
0.987, and 0.645, respectively. See Table 1. Further analysis of
each chosen value of the APACHE II component found the lowest
reliability for the mean artery pressure, which was 0.482. Further
investigation discovered that the most common reason for inter-
rater difference is data dropout.
Table 1 (abstract P507)
Overall agreement
Items Interclass correlation coefficient
APACHE II score 0.848
Acute physiology score 0.860
Age 0.987
Chronic health evaluation 0.645
Conclusions The agreements of the APACHE II score among the
two collectors was good, but there were more differences in
collecting the value of mean artery pressure, for which the original
data could not be read directly from medical chart.
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F Franchi, L Cubattoli, P Mongelli, C Porciani, M Nocci, 
E Casadei, S Scolletta, P Giomarelli
University of Siena, Italy
Critical Care 2009, 13(Suppl 1):P508 (doi: 10.1186/cc7672)
Introduction  Simplified Acute Physiology Score (SAPS) II and
SAPS III are valuable scoring systems used to predict the risk of
mortality in the ICU. The main purposes of this study were to
assess the strength of both the scores in predicting the mortality
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risk, to check which one gained the best performance, and to
ascertain whether they also achieved a good level of morbidity risk
prediction in our patient population.
Methods  Two hundred and forty-one patients (82 female, 159
male, mean age 53 ± 23), out of 393 admitted to our ICU over
12 months, were included in the study. Exclusion criteria were age
<18, and ICU stay <24 hours. SAPS II and SAPS III were
prospectively collected. The derived probability of death was
calculated according to the original descriptions. To evaluate the
capability of morbidity risk prediction of these scoring models, the
GIVITI definitions (Italian Group for the Evaluation of Interventions
in the ICU) of organ dysfunction and failure were used. Univariate
and multivariate analyses were applied. The area under the receiver
operating characteristic curve (AUC) was calculated.
Results Median values for SAPS II and SAPS III were 35 and 58,
respectively. Mortality and morbidity rates resulted 16% and
40.5%, respectively. The mean ICU stay was 9 ± 10 days.
Although the univariate analysis found similar statistical signifi-
cances (P <0.001) for both the scores, at the multivariate analysis
only SAPS II maintained a statistical significance (P <0.001) in
predicting the probability of death. Moreover, SAPS II showed a
significantly higher AUC (0.91 vs. 0.73, SAPS II vs. SAPS III,
respectively, P <0.05). With respect to morbidity, the AUC of both
the scores gained a poor level of predictive power (AUCs = 0.618
and 0.605, SAPS II and SAPS III, respectively). However, in the
subgroup of patients admitted to our ICU for major trauma (41% of
patients), SAPS III reached a high degree of discriminative
strength in predicting the morbidity rate (AUC = 0.81, P <0.01).
Conclusions SAPS II seemed a suitable tool in predicting the risk
of death, but not morbidity. Conversely, SAPS III, even though it
did not gain a sufficient degree of predictive power toward
mortality, could be a useful morbidity risk model when applied to
major trauma patients. In our ICU, SAPS II and SAPS III are not
interchangeable, but they should be carefully used in the right
circumstances. This might avoid the pitfalls leading to errors in
forecasting mortality and morbidity risk.
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Introduction Scoring systems represent classification systems or
point systems that have been designed for making quantitative
statements regarding the severity of a disease, its course and its
prognosis [1]. These systems are based on physiologic abnor-
malities and have been successful in measuring severity of illness
among critically ill patients [2]. The APACHE IV system has already
been validated in our population at King Faisal Specialist Hospital
and Research Center [3], and the purpose of this study is to
evaluate the performance of this system in a subset of patients with
acute renal failure.
Methods  Fifty-four consecutive patients with acute renal failure
defined as a creatinine value ≥1.5 mg/dl and urine output
<410 ml/24 hours were admitted to a medical/surgical ICU
between January 2007 and March 2008 and were enrolled in the
study. The length of stay and mortality percentages were predicted
using APACHE IV, and both variables were compared with the
observed data. The Wilcoxon rank sum test is used to calculate
statistical significance for continuous data and the chi-square test
for categorical data.
Results A total of 54 patients with mean age of 53.8 years were
included. Fifty-six percent were males; 62% of patients were
medical, 38% were surgical. The predicted ICU length of stay of
6.3 days (SD = 2, range of 2.1 to 10.2) was insignificantly lower
than the observed ICU length of stay of 8.0 days (SD = 8.5, range
of 1 to 45) (P <0.12: Wilcoxon test for nonparametric) (Figure 1).
The observed mortality of 44.4% was not statistically different from
predicted mortality of 42.1 (χ2 = 0.07, P = 0.8) (Figure 2). The
standardized mortality ratio is 1.06 (P = 0.79, 95% CI = 0.7 to 1.5).
Conclusions The APACHE IV predicted mortality and length of
stay equations perform well in a subset of patients with acute renal
failure in our population.
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Introduction APACHE II has been used worldwide for measuring
ICU performance. The patient cohort from which APACHE II was
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Observed and predicted length of stay (LOS).
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Observed and predicted mortality among patients.S205
derived was calibrated and validated two decades ago. Due to
substantial advancement in critical care, a new cohort was studied
recently and APACHE IV was derived for benchmarking ICU
performance. The objective of the study is to compare APACHE II
with APACHE IV outcome prediction in the same cohort of
critically ill population.
Methods The study was carried out in a 40-bed mixed medical–
surgical, adult, semiclosed ICU at a tertiary-care centre. All
consecutive patients from January 2007 to October 2008 were
studied. Patient demography was recorded. APACHE II and
APACHE IV scores were calculated on each patient and statistical
comparison was performed.
Results  During the study period the total ICU admission was
3,647 patients. Patients with limitation of life support and
discharge against medical advice were excluded. Cases where
data were incomplete were also excluded, and 2,919 patients
were finally analyzed. The median APACHE II and APACHE IV
scores of the study cohort were 12 (8 to 18) and 44 (30 to 62).
The median predicted mortality over the study period was
significantly higher with APACHE II scoring in comparison with
APACHE IV (15 (8 to 25) vs. 4.6 (1.66 to 12.67)) (P = 0.00001).
The standardized mortality ratio was likewise significantly lower
with APACHE II in comparison with APACHE IV (median = –0.87
vs. 2.85, mean = –1.13 vs. 8.18) (Figure 1) (P = 0.00001).
Conclusions Currently, APACHE II benchmarking overestimates
ICU performance and APACHE IV might be more relevant tool to
estimate ICU performance.
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Introduction  APACHE IV is a successful scoring system
assessing severity of illness and prognosis of ICU patients [1]. It
has been evaluated and validated in our patients for mortality
outcome [2]. The objective of this study was to validate the
APACHE IV benchmark for patients admitted with severe sepsis
and septic shock to the ICU and to compare the performance of
the APACHE IV system with APACHE II.
Methods In a cohort study at a tertiary-care medical–surgical ICU
with a total of 35 acute-care beds, we included all ICU patients
with the diagnosis of severe sepsis and septic shock between 1
January 2007 and 29 February 2008 from a prospectively
collected ICU database. Observed mortality rates were compared
with predicted mortality rates for both the APACHE II and
APACHE IV scoring systems, and standardized mortality ratios
(SMR) were determined. The mortality percentages were predicted
using the APACHE IV system and were compared with the
observed data. The chi-square test is used to calculate statistical
significance for categorical data.
Results One hundred and seventy-two patients were included in
the study with an average age of 48.9 years, 53% of patients were
males and 47% were females with observed mortality of 33.1%.
The average APACHE II score was 20.7 with predicted mortality of
39.9% and SMR 0.83 (95% CI = 0.63 to 1.06, P = 0.15)
compared with an average APACHE IV score of 73.1 with
predicted mortality of 32.2% and SMR of 0.99 (95% CI = 0.78 to
1.32, P = 0.82) (Figure 1). The hospital mortality calibration curve
for APACHE IV shows good calibration, with the line of perfect fit
agreement lying within the 95% CI for all the risk ranges. P values
of more than 0.05 in all risk ranges confirm adequate calibration.
Although the curve shows that observed mortality differs from
expected in the ranges of 20 to 40%, there is no statistical
significance for its deviations from perfect fit (Figure 2).
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A2 SMR, APACHE II standardized mortality rate; A4 SMR, APACHE IV
standardized mortality rate.
Figure 1 (abstract P511)
Observed versus predicted mortality rates in the APACHE II and
APACHE IV systems.
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Conclusions The present study demonstrates that the APACHE IV
system performs acceptably in our patients with severe sepsis and
septic shock and can be utilized as a performance assessment tool
in our population.
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Introduction  The study aim was to determine whether patients
who stay in the ICU for >24 hours after cardiac surgery develop
persisting psychological symptoms.
Methods  After Institutional Review Board and Local Research
Ethics Committee approval, we approached consecutive patients
who underwent first-time coronary artery bypass graft surgery with
ICU stay >24 hours (long stay group (LS)). For each LS patient,
we recruited a short stay (SS) patient with <24 hours ICU stay,
matched by age and sex. Patients with known psychological
disorder or previous ICU admission were excluded. At 3, 6 and
12 months following hospital discharge, patients completed four
psychological questionnaires: Experience after Treatment in
Intensive Care 7 Item Scale (ECTI-7), Hospital Anxiety and
Depression (HAD), Short-Form 36 (SF-36), adapted Trauma
Symptom Checklist-33 (TSC-33). Results were analysed using
repeated measures analysis of variance, using SPSS. Preoperative
EuroScore and left ventricular function were included to adjust for
baseline disease severity.
Results  We studied 302 paired patients. Table 1 presents the
mean differences and significance level between LS and SS
groups for each questionnaire (HAD components anxiety 1 and
depression 2, SF-36 components physical 3 and mental 4,
TSC-33). Patients who stayed >24 hours in ICU had significantly
poorer scores on all scales up to 12 months post surgery, even
when adjusted for baseline disease severity.
Conclusions Patients who stayed in the ICU for >24 hours post
cardiac surgery scored higher on several psychological evaluation
questionnaires when compared with patients who stayed
<24 hours. This indicates the possibility of greater psychological
distress for at least 12 months after cardiac surgery.
Table 1 (abstract P512)
Mean differences and significance levels between LS and SS
groups
Question Mean difference 95% CI P value
ETIC-7 0.84 0.4 to 1.3 <0.001
HAD anxiety 1 0.84 0.2 to 1.5 0.016
HAD depression 2 1.04 0.5 to 1.6 <0.001
SF-36 physical 3 –5.8 –8.2 to –3.4 <0.001
SF-36 mental 4 –5.4 –7.7 to –3.1 <0.001
TSC-33  1.8 0.2 to 3.5 0.024
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Introduction Classification trees have not been amply used in an
ICU setting. Logistic regression modeling for prognosis in the ICU
is still the current standard. This study examines the possibility of
the clinical use of classification trees for mortality prediction in
patients with haematological malignancies admitted to the ICU.
Recently, new modeling tools based on classification tree
algorithms have become available [1,2]. These new modeling tools
have proven to be accurate and robust in domain applications
outside the clinical setting. Moreover, classification tree models
can be constructed easily by the ICU clinician and have the advan-
tages over logistic regression to give a clear insight into the data.
Methods Three hundred and fifty-two patients with haematological
malignancies that were admitted to the ICU between 1997 and
2006 for a life-threatening complication were included. Two
hundred and fifty-two patient records were used for training of the
models and 100 were used for validation. In a first model 12 input
variables were included, and in a second more complex model 17
input variables were used for model development. These two
models were consecutively constructed using Classification and
Regression Tree (CART®), Multivariate Adaptive Regression Splines
(MARS®), Random Forests (RF™) and TREENET™ software (Salford
Systems, San Diego, CA, USA). Discrimination was evaluated
using the area under the receiver operating characteristic curves
(±SE). All results were then compared with the results obtained by
a logistic regression model.
Results  The area under the receiver operating characteristic
curves in the validation datasets for the decision tree and
smoothing splines analyses were 0.744, 0.713, 0.743, and 0.750
for model 1 and were 0.802, 0.714, 0.731 and 0.756 for model 2,
for CART®, MARS®, RF™ and TREENET™, respectively.
Conclusions The present study stands as a proof of concept for
the use of classification tree algorithms for mortality prediction in
an ICU setting.
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Introduction The aim of the study was to relate the health-related
quality of life (HRQL) evaluated 6 months after major trauma and
traumatic brain injury with the initial parameters of clinical picture
and with the length of ICU stay and sedation. HQRL is reduced in
ICU patients, admitted for any reason, after 6 months from
discharge [1,2]. The summarized Short-Form 36 (SF-36), compre-
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hending physical functioning, general health, and social function-
ing, is useful to evaluate HQRL after major trauma [3].
Methods One hundred and twenty-one patients were admitted to
an emergency department ICU in 2007 with major trauma (injury
severity score >15) and severe to moderate brain injury (Glasgow
coma scale <13). Of these, 25 died in the days following trauma.
Thirty-four of these were evaluated, during the follow-up visit,
6 months after discharge from the ICU. HRQL was assessed by
the SF-36 questionnaire. At admission to the ICU, from the ICU
database (FileMaker Pro 5.5v2; FileMaker, Inc., USA) with
authorization of the Careggi Teaching Hospital Committee of the
Emergency Department, the following parameters were collected
for every patient: age, sex, abbreviated injury scale, injury severity
score, Simplified Acute Physiology Score II, in the field Glasgow
coma scale, Marshall score at the first head CT, worst values of
lactates and ScvO2 within 24 hours from trauma. Also, the length
of sedation and ICU stay were collected. The mean summarized
SF-36 was related with the Pearson test to the other parameters.
Results Only lactate levels showed a significant correlation with
the mean summarized SF-36 (y = –0.0035x + 4.83; R = 0.59;
P = 0.007).
Conclusions In the patients affected by major trauma and brain
traumatic injury, the HRQL appears to be related to the severity of
the clinical picture on the first day of trauma assessed by lactate
levels regardless of the length of ICU stay and sedation.
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Introduction ICU treatment of surgical patients comes along with
major disadvantages that have to be justified by an acceptable
short-term and long-term outcome. Short-term effects of ICU
treatment have been well documented, but this is the first study to
describe the long-term effect in a large cohort after surgical ICU
admission on survival.
Methods Of all surgical patients admitted to the ICU of a single
hospital between 1995 and 2000, patient characteristics, disease
category, APACHE II score and survival were prospectively
registered. A continuous follow up until 6 to 11 years after
discharge was achieved.
Results Of the 1,822 patients included, 936 (51%) had died. Fifty-
two patients were lost to follow up. Overall ICU and inhospital
mortalities were 11% and 16%. Age, gender, APACHE II score and
surgical diagnosis were independently associated with long-term
survival. Mortality increased with age of admittance to the ICU,
whereas female patients had a lower chance of dying (Figure 1).
Long-term mortality rates in various surgical diagnostic groups varied
between 29% for trauma and 70% for oncological patients. In gas-
trointestinal, oncological, general surgical and/or high-aged patients
this negative effect even exceeds 5 years. In general, 10 years after
ICU discharge the survival was only 50%. The mortality ratio was
increased twofold in comparison with the general population.
Conclusions Survival after ICU treatment follows distinct patterns
in which age, gender, surgical diagnosis and APACHE II score are
independent determinants. A negative effect of an ICU stay
appears to be long lasting.
Available online http://ccforum.com/supplements/13/S1
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Introduction The aim of our study was the comparison of quality of
life before admission to the ICU and 1 year after the discharge
from ICU.
Methods Quality of life was examined in patients admitted to the
interdisciplinary ICU of a university hospital from January 2000 to
December 2004 for more than 3 days. The EuroQoL-5D and State
Trait Anxiety Inventory questionnaires were used for the evaluation
of quality of life, anxiety and psychological outcome. The Wilcoxon
signed-rank test and the chi-square test were used accordingly;
P <0.05 was considered statistically significant. Stepwise multiple
logistic regression analysis was performed to evaluate the
dependence of quality of life after the discharge on the following
assessed parameters: age, severity of the state at the time of ICU
admission, length of ICU and hospital stay, length of mechanical
ventilation, extent of organ dysfunction during ICU stay, and
previous quality of life. The study was approved by the hospital
ethical committee.
Results Questionnaires were sent by mail to 483 patients, and
194 patients answered (41.16%). One year after discharge from
the ICU, 39 (20.1%) patients were less mobile, 56 (28.9%) had
worse quality of self-care, 76 (39.2%) of patients complained of a
lower level of normal daily activities, 87 (44.8%) of patients
suffered from a higher level of pain and 58 (29.9%) of patients
perceived a higher degree of anxiety. Significant elevation of
anxiety for both women and men (22.3% and 19.3% respectively)
was found by the State Trait Anxiety Inventory questionnaire. All of
the above mentioned changes were significant (P  <0.0001). A
stepwise multiple logistic regression identified age (OR = 1.03,
95% CI = 1.004 to 1.059; P = 0.025), length of stay (OR = 1.06
95% CI = 1.02 to 1.10; P  = 0.008), length of mechanical
ventilation (OR = 1.05, 95% CI = 1.01 to 1.09; P = 0.017), and
level of pain (OR = 8.92, 95% CI = 1.14 to 69.64; P = 0.037) and
anxiety (OR = 1.04, 95% CI = 1.00 to 1.08; P = 0.048) before
admission to the ICU as independent predictors of worsening of
quality of life 1 year after the discharge.
Conclusions One year after the discharge from the ICU, patients
suffered from deterioration in all aspects of quality of life evaluated
by the questionnaires used. Quality of life 1 year after the
discharge from intensive care was influenced by its previous level,
by the age, by the length of stay and by the length of mechanical
ventilation.
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Introduction Mortality after critical illness is higher and recovery is
slower in the elderly compared with younger patients. Elderly
patients recovering from critical illness may show reduced health-
related quality of life (HRQOL) [1]. We studied the impact of ICU
stay on HRQOL of octogenarians, and compared their HRQOL
with the same age-matched general population.
Methods  We performed a long-term prospective study in a
medical–surgical ICU. Patients ≥80 years (n = 129) admitted for
>48 hours were included. We used the Short-Form 36 (SF-36) to
evaluate HRQOL before ICU admission (using proxies), at ICU
discharge and at hospital discharge and at 3, 6 and 12 months
following ICU discharge. Furthermore we compared HRQOL
before ICU admission and 12 months after ICU discharge with
those of an age-matched general Dutch population. The Wilcoxon
signed rank test was used for evaluating changes between two
time points. To analyze individual changes over time, a MANOVA
test was used, with Wilks’ lambda as the multivariate test.
Results  Mortality was considerable in the 129 included
octogenarians. Patients could be evaluated 6 months (n = 48) and
12 months (n = 27) after ICU discharge (11 patients were lost to
follow-up, 70 patients died). All SF-36 dimensions changed
significantly over time (all P <0.001), with the exception of the role-
emotional dimension. However, after an initial drop, HRQOL
recovered to pre-ICU levels in all dimensions. The physical
component scores changed significantly over time (all P <0.001),
whereas the mental component scores showed only a modest
decline at ICU discharge but recovered rapidly and had improved
to higher than baseline values with longer follow-up to 12 months
after ICU discharge. The pre-admission HRQOL in surviving
octogenarians was already lower when compared with the age-
matched general population and remained so at 12 months after
ICU discharge.
Conclusions  Critically ill octogenarians demonstrate a sharp
decline of HRQOL during the ICU stay and a gradual improvement
during the 6 months and 12 months following ICU discharge to
baseline values. Recovery begins following ICU discharge to the
general ward. This implies that intensive care treatment in patients
≥80 years is worthwhile.
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Introduction  Outcome from intensive care has focused on
reducing morbidity–mortality during hospitalization, but nowadays
it incorporates the assessment of long-term survival and quality of
life in survivors [1]. Our aim was to assess morbidity (physical and
psychological) and health-related quality of life (HRQL) in patients
discharged from the ICU.
Methods  A longitudinal prospective and descriptive study of
patients discharged from the ICU. They were interviewed at 3, 6
and 12 months at an outpatient clinic. Assessment of physical
morbidity was performed each time, as well as Folstein’s Mini
Mental State Examination (MMSE) for cognitive evaluation, Barthel
index and Short-Form 36 version 2 (SF-36) to evaluate functional
activity and HRQL.
Results We included 132 patients (13 with less than 1 year of
follow-up); mean ± SD age 37 ± 17 years. Clinical data: Simplified
Acute Physiology Score II 30 ± 14; stay in the ICU 21 ± 16 days,
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in hospital 39 ± 28 days. Causes of admission: neurologic 59,
septic 27, trauma 18. Required mechanical ventilation, 107 (81%)
patients. In the first interview 130 patients were at home. A year
after discharge, 90 patients survived, three died and 26 were lost
to follow up. At first control 22 patients had dysphonia, six tracheal
stenosis and eight swallowing-related problems; pressure ulcers,
16 patients. Four were aphasics, 50 with muscle weakness,
paralysis or numbness. In 46 patients, psychological disorders
were diagnosed; 32 anxiety/depression, 14 sleep disorders. Sixty-
five patients had a previous job, only 14 (21%) returned to work at
3 months, rising to 22 (34%) at 1 year. Only 13 patients had a
MMSE with a cutoff point <27. The SF-36 showed better results in
all areas in patients with ≤10 days stay, being significant for
physical function. Higher physical dependence was associated
with worse perception of health and quality of life. Comparing
SF-36 dimensions at 3, 6 and 12 months, better results were
obtained in most of them. Longitudinal analysis of the Barthel index
showed at 1 year that most patients were low dependent or
independent.
Conclusions  Follow-up of critically ill patients after discharge
allows us to identify common physical and psychological problems.
The results showed worse HRQL perception in patients with
longer stays. A year after discharge, most patients showed a great
improvement in HRQL perception and lower physical dependency
levels.
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